data_2mv0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mv0 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.817 0.342 . . . . 0.070000000000000007 111.189 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -53.52 136.23 38.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.10000000000000001 111.235 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.25 144.97 32.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.13 111.173 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.32 16.77 63.82 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.211 -0.756 . . . . 0.17000000000000001 111.211 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.06 149.67 52.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.20000000000000001 111.22 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -122.86 101.22 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.23000000000000001 111.171 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.1 t -98.18 125.06 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.27000000000000002 111.212 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.6 mt -121.07 112.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.29999999999999999 111.202 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -92.09 92.75 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.33000000000000002 111.221 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -71.02 150.12 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.37 111.176 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -132.13 111.98 11.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.162 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.04 174.11 26.32 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.171 -0.771 . . . . 0.42999999999999999 111.171 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 -50.18 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.46999999999999997 111.195 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -125.01 -135.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.5 111.192 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.49 -7.65 78.17 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.53000000000000003 111.224 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -64.77 -54.67 27.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.56999999999999995 111.201 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.32 -40.69 97.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.59999999999999998 111.228 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.84 -53.35 44.79 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.225 -0.75 . . . . 0.63 111.225 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.0 tp -70.68 -32.4 69.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.67000000000000004 111.239 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.76 97.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.202 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.33 -38.27 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.219 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.91 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.77000000000000002 111.193 173.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.46 -38.42 96.32 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 0.80000000000000004 111.22 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.7 -44.42 96.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.82999999999999996 111.176 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.98 -41.49 92.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.87 111.209 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -59.28 -48.35 81.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.90000000000000002 111.241 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -64.35 -34.11 77.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.93000000000000005 111.185 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -69.18 -31.64 70.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.96999999999999997 111.22 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.05 -31.36 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.221 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.5 p -101.85 -29.87 11.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 1.03 111.201 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.04 5.68 83.0 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.223 -0.751 . . . . 1.0700000000000001 111.223 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.58 121.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 1.1000000000000001 111.219 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -61.67 119.51 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 1.1299999999999999 111.176 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.02 131.08 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 1.1699999999999999 111.247 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -123.43 110.26 14.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.2 111.164 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.7 t -101.84 131.77 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 1.23 111.186 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -152.92 169.98 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 1.27 111.215 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -140.3 76.87 25.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.3 111.194 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.83 80.0 2.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.724 1.616 . . . . 1.3300000000000001 111.213 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 29.7 t0 -52.29 162.97 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 1.3700000000000001 111.215 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 93.0 mttt 68.12 43.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.3999999999999999 111.173 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.29 -21.56 64.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 1.4299999999999999 111.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.89 -27.27 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 1.47 111.204 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -114.18 -25.48 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 1.5 111.209 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -94.37 -36.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 1.53 111.13 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 85.7 t80 -63.51 -43.06 77.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 1.5700000000000001 111.199 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 88.6 Cg_exo -53.05 -31.35 53.45 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.716 1.611 . . . . 1.6000000000000001 111.213 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -64.19 -32.94 74.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 1.6299999999999999 111.206 -173.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.7 m -100.06 -26.22 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 1.6699999999999999 111.167 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.7 111.206 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.33 -4.91 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.73 111.243 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -115.0 5.0 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 1.77 111.203 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.57 58.65 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.176 -0.77 . . . . 1.8 111.176 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 56' ' ' GLY . 94.2 m-20 -120.02 -165.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 1.8300000000000001 111.193 -176.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 55' ' ' ASP . . . 117.23 -162.96 12.67 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.159 -0.776 . . . . 1.8700000000000001 111.159 170.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.88 178.17 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.711 1.607 . . . . 1.8999999999999999 111.206 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.46 -40.85 10.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.9299999999999999 111.189 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.38 138.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 1.97 111.18 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.8 tt -143.92 138.78 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 2.0 111.199 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' A' ' 264' ' ' ALA . 29.8 m-85 -105.12 142.78 34.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 2.0299999999999998 111.233 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -134.49 155.6 50.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 2.0699999999999998 111.194 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.411 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . . . -68.13 159.22 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 2.1000000000000001 111.153 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -53.98 -33.58 57.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 2.1299999999999999 111.2 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -82.11 -49.94 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 2.1699999999999999 111.205 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -65.32 -31.13 72.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 2.2000000000000002 111.19 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -56.8 -36.11 69.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.23 111.18 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.08 -39.18 49.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.15 -0.78 . . . . 2.27 111.15 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.23 64.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.772 . . . . 2.2999999999999998 111.171 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.24 -49.3 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 2.3300000000000001 111.222 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.88 78.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 2.3700000000000001 111.212 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -58.2 -41.8 84.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.214 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.0 p -66.83 -17.9 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 2.4300000000000002 111.213 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.6 25.79 37.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.228 -0.749 . . . . 2.4700000000000002 111.228 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.61 2.54 44.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 2.5 111.205 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.17 117.27 28.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 2.5299999999999998 111.225 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.82 153.36 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.235 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.62 129.19 39.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 2.6000000000000001 111.206 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.36 129.59 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 2.6299999999999999 111.227 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 p -129.36 87.08 54.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 2.6699999999999999 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -58.48 150.17 70.22 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 2.7000000000000002 111.209 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -43.78 139.68 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 2.73 111.201 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.84 -39.59 39.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 2.77 111.174 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.79 85.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 2.7999999999999998 111.197 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -66.93 -40.07 87.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 2.8300000000000001 111.215 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.39 -30.87 71.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 2.8700000000000001 111.172 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.64 -35.02 67.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 2.8999999999999999 111.212 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.99 -16.22 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 2.9300000000000002 111.224 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -75.52 121.76 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 2.9700000000000002 111.191 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -69.14 144.79 95.69 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 3.0 111.217 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.36 -34.89 72.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.666 1.577 . . . . 3.0299999999999998 111.235 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 7.6 m-30 -64.62 -32.65 74.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 3.0699999999999998 111.184 -175.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -108.1 -21.61 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 3.1000000000000001 111.175 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -70.25 -41.32 73.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 3.1299999999999999 111.188 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.86 -27.82 63.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 3.1699999999999999 111.216 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.12 -21.03 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.2000000000000002 111.213 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.0 m -111.68 25.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 3.23 111.165 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -102.71 167.88 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 3.27 111.201 171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -163.29 130.02 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 3.2999999999999998 111.152 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 65.0 21.48 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 3.3300000000000001 111.224 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.96 11.16 77.21 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.193 -0.763 . . . . 3.3700000000000001 111.193 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -122.84 143.03 50.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 3.3999999999999999 111.195 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.5 tp -75.09 118.74 18.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 3.4300000000000002 111.189 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 pt -117.53 -20.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 3.4700000000000002 111.203 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.13 177.09 9.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 3.5 111.227 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -140.84 142.62 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 3.5299999999999998 111.209 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.3 155.98 41.6 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.728 1.618 . . . . 3.5699999999999998 111.217 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 tp -134.74 -30.0 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 3.6000000000000001 111.186 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.49 149.64 29.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 3.6299999999999999 111.22 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -124.99 120.58 58.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 3.6699999999999999 111.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -124.68 157.22 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.7000000000000002 111.191 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.05 155.01 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 3.73 111.236 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.34 175.8 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 3.77 111.173 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.3 p -171.78 170.19 5.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 3.7999999999999998 111.175 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.49 ' C ' HD21 ' A' ' 115' ' ' LEU . 5.9 tt -97.1 99.94 11.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 3.8300000000000001 111.212 175.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.16 127.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 3.8700000000000001 111.194 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -140.26 160.81 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 3.8999999999999999 111.177 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -75.77 109.02 9.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 3.9300000000000002 111.183 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -81.33 -37.8 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 3.9700000000000002 111.173 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -54.97 -45.14 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 4.0 111.205 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.81 -61.25 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 4.0300000000000002 111.17 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.9 mt -127.58 92.64 42.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 4.0700000000000003 111.21 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.01 -19.0 46.21 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.665 1.577 . . . . 4.0999999999999996 111.205 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -98.47 105.83 32.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 4.1299999999999999 111.2 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.51 164.91 23.4 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.697 1.598 . . . . 4.1699999999999999 111.227 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.05 125.43 17.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.68 1.587 . . . . 4.2000000000000002 111.196 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.48 -23.64 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 4.2300000000000004 111.185 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.423 HG21 ' H ' ' A' ' 130' ' ' GLU . 14.3 t -157.48 -177.25 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 4.2699999999999996 111.186 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -71.49 -25.3 62.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 4.2999999999999998 111.163 -170.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.423 ' H ' HG21 ' A' ' 128' ' ' THR . 98.7 mt-10 -71.25 -17.26 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 4.3300000000000001 111.215 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -100.41 4.38 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 4.3700000000000001 111.226 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.51 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 24.8 mm -75.23 -51.03 3.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.4000000000000004 111.176 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.51 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 94.6 Cg_endo -74.58 -13.39 22.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.692 1.595 . . . . 4.4299999999999997 111.181 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.7 78.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 4.4699999999999998 111.178 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.03 -30.05 22.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 4.5 111.194 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.82 -33.43 75.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 4.5300000000000002 111.181 168.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.77 -45.08 72.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 4.5700000000000003 111.161 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.35 -30.48 71.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 4.5999999999999996 111.254 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.74 -14.66 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.178 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.65 -44.56 73.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 4.6699999999999999 111.226 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.93 -16.86 60.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 4.7000000000000002 111.213 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -95.11 3.01 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 4.7300000000000004 111.225 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.96 25.19 69.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.243 -0.743 . . . . 4.7699999999999996 111.243 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -136.97 -179.93 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 4.7999999999999998 111.227 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.2 t -149.9 140.29 22.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 4.8300000000000001 111.196 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.33 -45.6 19.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 4.8700000000000001 111.227 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.444 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 31.8 tp -77.79 124.84 28.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 4.9000000000000004 111.176 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 99.3 mmm -124.99 50.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 4.9299999999999997 111.214 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -76.36 147.4 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 4.9699999999999998 111.214 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -71.66 102.05 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 5.0 111.219 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.31 -19.14 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.201 -172.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -39.96 96.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 5.0700000000000003 111.157 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 154' ' ' PRO . 55.8 mt-10 -98.56 160.03 29.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.21 168.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 153' ' ' GLU . 66.7 Cg_endo -77.36 3.51 6.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.668 1.578 . . . . 5.1299999999999999 111.225 -174.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -49.41 -55.01 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 5.1699999999999999 111.248 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.67 36.54 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 5.2000000000000002 111.192 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.2 p -126.34 -22.95 3.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 5.2300000000000004 111.152 168.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 88.8 t90 -67.56 -48.26 44.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 5.2699999999999996 111.2 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 91.5 Cg_endo -76.99 -14.97 16.73 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.713 1.608 . . . . 5.2999999999999998 111.192 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.85 -44.28 93.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 5.3300000000000001 111.229 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 87.2 mt -65.45 -45.03 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 5.3700000000000001 111.189 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.19 65.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 5.4000000000000004 111.162 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.13 72.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.175 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -64.97 -27.01 68.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.231 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.41 -3.64 50.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.226 -0.75 . . . . 5.5 111.226 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.8 -12.97 70.65 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.171 -0.771 . . . . 5.5300000000000002 111.171 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.93 130.33 31.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 5.5700000000000003 111.176 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.18 21.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 5.5999999999999996 111.195 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -140.0 90.11 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 5.6299999999999999 111.194 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.199 -178.214 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 57.1 t0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.814 0.34 . . . . 5.9000000000000004 111.193 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.3 pt -112.27 16.37 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 5.9299999999999997 111.197 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.29 -28.97 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 5.9699999999999998 111.194 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -74.99 169.72 17.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 6.0 111.216 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.43 124.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 6.0300000000000002 111.206 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.99 -18.94 25.56 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.0 m -68.66 -14.58 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.75 0.309 . . . . 6.0999999999999996 111.161 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -88.26 5.0 43.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 6.1299999999999999 111.208 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -95.28 150.02 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 6.1699999999999999 111.207 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.18 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 6.2000000000000002 111.22 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.92 99.91 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.206 -0.758 . . . . 6.2300000000000004 111.206 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.24 90.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 6.2699999999999996 111.223 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.4 -35.07 79.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.2999999999999998 111.213 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.07 92.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 6.3300000000000001 111.22 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.7 -45.25 96.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.166 -0.774 . . . . 6.3700000000000001 111.166 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.7 tp -71.9 -32.57 67.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 6.4000000000000004 111.213 178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.5 m -62.29 -40.1 95.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 6.4299999999999997 111.181 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -59.75 -45.92 90.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 6.4699999999999998 111.187 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.8 tp -53.16 -59.47 4.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 6.5 111.197 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 6.5300000000000002 111.194 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.27 -41.41 94.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 6.5700000000000003 111.233 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.4 -23.01 54.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 6.5999999999999996 111.17 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.66 -43.2 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.217 168.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.91 -24.23 62.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 6.6699999999999999 111.207 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -89.73 5.46 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 6.7000000000000002 111.214 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 63.61 37.5 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 6.7300000000000004 111.193 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -110.76 -34.98 6.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 6.7699999999999996 111.253 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 76.4 mtp -108.79 154.41 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 6.7999999999999998 111.161 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -127.02 111.56 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 6.8300000000000001 111.215 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.71 -17.9 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 6.8700000000000001 111.182 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -84.51 -26.09 28.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 6.9000000000000004 111.25 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -61.23 132.25 53.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 6.9299999999999997 111.181 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -139.39 -165.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 6.9699999999999998 111.189 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -58.77 -50.06 75.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 7.0 111.144 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.0 p -69.56 -32.61 71.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.192 -171.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.75 -46.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 7.0700000000000003 111.188 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.17 93.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 7.0999999999999996 111.219 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.49 -46.04 87.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 7.1299999999999999 111.199 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.26 96.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 7.1699999999999999 111.191 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.0 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 7.2000000000000002 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -70.59 -45.03 66.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 7.2300000000000004 111.212 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.76 -32.72 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 7.2699999999999996 111.226 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -83.49 -26.11 30.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 7.2999999999999998 111.159 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.28 19.92 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.168 -0.773 . . . . 7.3300000000000001 111.168 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -70.99 -30.07 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 7.3700000000000001 111.227 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.2 p -117.08 164.18 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 7.4000000000000004 111.217 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.78 -22.28 31.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 7.4299999999999997 111.205 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.64 170.28 21.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 7.4699999999999998 111.177 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.7 t -148.0 140.0 24.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 7.5 111.195 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 147' ' ' LEU . 88.2 mt -112.82 117.01 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 7.5300000000000002 111.183 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -158.83 177.68 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 7.5700000000000003 111.169 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -79.6 170.46 54.19 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.227 -0.749 . . . . 7.5999999999999996 111.227 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.35 -17.08 21.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 7.6299999999999999 111.207 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -70.3 -30.08 66.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 7.6699999999999999 111.168 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.63 -4.84 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 7.7000000000000002 111.154 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.442 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 4.2 t90 -62.26 -29.52 70.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 7.7300000000000004 111.215 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 92.0 p -64.85 -21.43 66.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 7.7699999999999996 111.224 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.2 -30.1 12.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 7.7999999999999998 111.218 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 83.3 mt -65.28 -34.68 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.227 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -80.16 7.83 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 7.8700000000000001 111.219 -169.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.5 m -58.31 -32.5 68.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 7.9000000000000004 111.207 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 66.5 m -69.98 -19.0 63.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 7.9299999999999997 111.21 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 60.43 38.91 19.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 7.9699999999999998 111.217 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.45 169.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 8.0 111.204 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -73.36 107.78 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 8.0299999999999994 111.206 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -102.44 133.42 47.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 8.0700000000000003 111.176 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -104.01 179.34 25.03 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.206 -0.758 . . . . 8.0999999999999996 111.206 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.9 137.89 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.757 0.313 . . . . 8.1300000000000008 111.193 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -145.88 -175.21 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 8.1699999999999999 111.214 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.2 t -78.87 125.24 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 8.1999999999999993 111.253 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.531 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 56.7 tp -79.7 -51.37 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 8.2300000000000004 111.202 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 89.2 Cg_endo -80.38 154.94 21.65 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.696 1.597 . . . . 8.2699999999999996 111.209 -173.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 85.1 m -124.98 109.88 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 8.3000000000000007 111.164 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.78 104.78 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 8.3300000000000001 111.22 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 55.25 35.05 24.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 8.3699999999999992 111.23 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.86 76.15 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.192 -0.763 . . . . 8.4000000000000004 111.192 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -129.99 109.97 16.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 8.4299999999999997 111.209 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.77 150.3 61.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.693 1.595 . . . . 8.4700000000000006 111.168 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 83.7 p -139.34 -72.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 8.5 111.232 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 47.3 tptt -159.42 129.89 3.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 8.5299999999999994 111.193 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.431 ' HA ' ' HG3' ' A' ' 248' ' ' PRO . 51.3 Cg_exo -55.03 157.04 14.19 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.739 1.626 . . . . 8.5700000000000003 111.22 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -67.28 146.0 54.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 8.5999999999999996 111.208 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 85.7 t -109.72 113.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 8.6300000000000008 111.175 -171.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.07 115.04 5.01 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.163 -0.775 . . . . 8.6699999999999999 111.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.4 t -101.89 116.42 45.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 8.6999999999999993 111.2 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 63' ' ' ALA . 10.4 mp -73.16 144.82 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 8.7300000000000004 111.225 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 99.4 p -142.43 159.63 41.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 8.7699999999999996 111.203 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.428 ' HB3' ' CD2' ' A' ' 61' ' ' PHE . . . -130.52 156.23 45.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 8.8000000000000007 111.198 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.15 175.55 20.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.264 -0.735 . . . . 8.8300000000000001 111.264 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.8 129.97 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 8.8699999999999992 111.183 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.54 120.96 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.181 -173.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.76 -23.46 66.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 8.9299999999999997 111.186 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.0 58.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 8.9700000000000006 111.236 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.1 t -83.28 121.46 76.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 9.0 111.183 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.12 3.32 7.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.705 1.603 . . . . 9.0299999999999994 111.201 169.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.26 36.92 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 9.0700000000000003 111.241 -172.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -62.34 -24.11 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 9.0999999999999996 111.232 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.69 -30.48 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 9.1300000000000008 111.252 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -72.09 -43.37 64.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 9.1699999999999999 111.206 174.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.68 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 9.1999999999999993 111.218 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.79 -56.35 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.2300000000000004 111.2 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -65.46 -43.03 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 9.2699999999999996 111.183 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.39 -50.21 73.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 9.3000000000000007 111.19 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 284' ' ' LEU . 59.6 tp -58.76 -53.13 61.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 9.3300000000000001 111.203 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.79 -30.67 56.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 9.3699999999999992 111.181 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -97.62 -27.4 14.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 9.4000000000000004 111.238 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.71 -64.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 9.4299999999999997 111.223 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 45.5 tp -60.85 -41.84 96.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 9.4700000000000006 111.242 -166.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 37.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.205 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 97.4 m -114.78 141.38 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 9.5299999999999994 111.249 170.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -49.05 -40.49 31.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 9.5700000000000003 111.221 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.06 -46.37 85.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 9.5999999999999996 111.14 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.66 -40.55 90.27 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.241 -0.744 . . . . 9.6300000000000008 111.241 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.29 -35.5 81.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 9.6699999999999999 111.185 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.75 -40.85 84.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 9.6999999999999993 111.224 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 9.7300000000000004 111.22 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.79 -37.66 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 9.7699999999999996 111.182 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -81.88 5.06 20.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.428 . . . . 9.8000000000000007 111.207 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.15 -33.22 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 9.8300000000000001 111.209 165.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -107.42 -38.73 5.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8699999999999992 111.179 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -87.78 161.44 44.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.9000000000000004 111.191 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -55.03 144.65 67.65 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.671 1.581 . . . . 9.9299999999999997 111.186 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.37 -20.6 64.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 9.9700000000000006 111.232 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.94 -26.81 67.71 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.185 -0.766 . . . . 10.0 111.185 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.18 133.99 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 10.029999999999999 111.191 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.6 138.66 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 10.07 111.191 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.49 -48.02 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 10.1 111.186 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 85.0 mt -116.82 152.54 34.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 10.130000000000001 111.242 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -54.44 -37.24 64.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 10.17 111.182 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.0 p -56.18 -29.46 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 10.199999999999999 111.195 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -88.59 -35.83 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 10.23 111.2 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -60.06 -27.44 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 10.27 111.205 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.33 -30.4 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.151 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.77 -31.65 35.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 10.33 111.193 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.45 -21.72 62.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 10.369999999999999 111.219 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.95 66.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 10.4 111.203 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.82 -30.08 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 10.43 111.145 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 119.03 75.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.178 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.49 -35.47 96.69 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.73 1.62 . . . . 10.5 111.217 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -85.08 -51.11 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 10.529999999999999 111.218 -172.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.19 -39.81 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 10.57 111.172 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.04 85.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 10.6 111.187 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.21 86.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 10.630000000000001 111.181 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -64.51 -44.87 89.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 10.67 111.187 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.8 mmm -67.07 -34.65 78.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 10.699999999999999 111.183 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.5 -45.85 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 10.73 111.194 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -73.18 -22.42 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 10.77 111.159 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.05 -31.82 65.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 10.800000000000001 111.248 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.97 -18.29 64.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 10.83 111.177 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.25 -8.89 59.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 10.869999999999999 111.202 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -104.83 -141.89 11.13 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 10.9 111.226 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -145.0 136.34 25.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 10.93 111.174 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.2 mm -77.58 128.94 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 10.970000000000001 111.194 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 37.5 mmt -79.55 116.01 57.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 11.0 111.231 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.94 155.12 57.98 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.724 1.616 . . . . 11.029999999999999 111.195 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -97.61 20.09 12.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 11.07 111.202 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.91 128.27 91.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 11.1 111.153 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.24 -43.59 52.38 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.714 1.61 . . . . 11.130000000000001 111.223 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -64.99 -40.77 95.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 11.17 111.186 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.4 mmm -64.73 -39.37 93.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 11.199999999999999 111.214 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.1 t -60.52 -45.82 92.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.179 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.3 88.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 11.27 111.211 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -64.87 -33.45 76.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 11.300000000000001 111.18 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -69.97 -39.78 75.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 11.33 111.222 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 344' ' ' ARG . 34.6 m-85 -64.97 -30.08 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 11.369999999999999 111.211 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.61 71.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.18 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 93.5 t -85.5 -29.46 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 11.43 111.202 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 341' ' ' TYR . 99.6 mtt180 -65.2 -25.3 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 11.470000000000001 111.219 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 76.0 p -85.99 -29.72 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 11.5 111.213 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.72 92.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.529999999999999 111.189 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.47 -23.43 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 11.57 111.21 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.9 mm -88.33 -38.04 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 11.6 111.206 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -65.0 -32.42 74.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 11.630000000000001 111.214 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.3 -39.8 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 11.67 111.19 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.23 86.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 11.699999999999999 111.199 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.7 p -80.73 -19.43 45.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 11.73 111.209 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 90.58 18.03 50.07 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.222 -0.751 . . . . 11.77 111.222 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -70.2 -37.98 75.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 11.800000000000001 111.228 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -147.0 168.74 20.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 11.83 111.176 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 45.0 p -81.18 175.14 10.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 11.869999999999999 111.141 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.88 -44.74 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 11.9 111.161 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.17 -48.15 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 11.93 111.18 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.59 -36.23 80.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 11.970000000000001 111.193 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.02 70.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 12.0 111.216 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.55 -15.92 55.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 12.029999999999999 111.219 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.18 -49.12 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 12.07 111.202 168.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.76 -39.04 92.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 12.1 111.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.45 -46.65 89.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 12.130000000000001 111.221 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.71 -47.63 76.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 12.17 111.178 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 12.199999999999999 111.197 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.6 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.779 0.323 . . . . 0.070000000000000007 111.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.15 129.93 42.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.10000000000000001 111.215 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -57.68 128.97 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.13 111.206 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.91 48.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -126.33 98.02 5.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.771 0.319 . . . . 0.20000000000000001 111.195 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.05 119.72 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.23000000000000001 111.204 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.29 118.83 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.27000000000000002 111.238 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.411 HG12 ' HB ' ' A' ' 59' ' ' ILE . 76.9 mt -121.21 112.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.29999999999999999 111.189 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -103.38 117.12 33.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.33000000000000002 111.222 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 7.1 tt -115.61 137.05 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.37 111.208 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.64 114.94 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.40000000000000002 111.228 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.01 -172.46 39.86 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.209 -0.756 . . . . 0.42999999999999999 111.209 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -108.47 -39.18 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.329 . . . . 0.46999999999999997 111.219 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.14 149.83 43.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.5 111.191 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.26 0.83 4.52 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.215 -0.754 . . . . 0.53000000000000003 111.215 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 37' ' ' VAL . 43.8 p90 -62.71 -20.09 64.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.56999999999999995 111.204 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.67 -30.5 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 0.59999999999999998 111.205 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.69 -47.24 91.61 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.24 -0.744 . . . . 0.63 111.24 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.58 -30.79 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.67000000000000004 111.173 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.29 83.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.69999999999999996 111.21 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.4 -39.69 91.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.173 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 82.5 t -71.23 -34.85 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.77000000000000002 111.144 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.16 -27.12 73.83 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.182 -0.767 . . . . 0.80000000000000004 111.182 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 -48.4 81.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.82999999999999996 111.197 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.0 -41.79 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.87 111.205 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.37 -51.34 69.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.90000000000000002 111.274 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.93 -38.16 90.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.93000000000000005 111.262 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.36 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.96999999999999997 111.159 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.32 -35.01 12.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.186 -173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -103.4 -29.96 10.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.03 111.234 -174.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.55 4.56 79.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.166 -0.774 . . . . 1.0700000000000001 111.166 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.2 124.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 1.1000000000000001 111.24 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.94 150.06 47.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 1.1299999999999999 111.153 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -125.02 125.12 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 1.1699999999999999 111.234 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -121.33 109.84 15.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 1.2 111.221 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 17' ' ' TYR . 35.1 t -105.07 130.12 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.187 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -151.07 166.49 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 1.27 111.198 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -100.03 123.26 47.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 1.3 111.216 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -79.6 165.03 23.11 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.617 1.545 . . . . 1.3300000000000001 111.201 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -121.0 141.03 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 1.3700000000000001 111.187 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 55.04 46.71 23.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 1.3999999999999999 111.238 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.02 -50.72 68.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 1.4299999999999999 111.211 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -52.57 -43.64 65.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 1.47 111.169 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.5 111.185 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -97.08 -7.0 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.192 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.483 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 5.2 m-30 -55.19 -54.8 46.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 1.5700000000000001 111.155 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -70.66 -12.21 30.84 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.68 1.587 . . . . 1.6000000000000001 111.21 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.98 -8.61 51.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.154 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.97 -57.68 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 1.6699999999999999 111.209 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.29 -23.11 43.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 1.7 111.199 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.58 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.73 111.172 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -104.2 -19.88 13.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.77 111.182 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.09 58.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.161 -0.775 . . . . 1.8 111.161 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -129.59 -165.43 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.8300000000000001 111.182 -170.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.42 -165.76 14.37 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.195 -0.762 . . . . 1.8700000000000001 111.195 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.49 167.16 27.78 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.665 1.577 . . . . 1.8999999999999999 111.201 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -80.04 -62.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 1.9299999999999999 111.186 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.411 ' HB ' HG12 ' A' ' 9' ' ' ILE . 92.5 mt -99.78 139.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 1.97 111.208 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 tt -141.53 134.91 30.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 2.0 111.225 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.42 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 64.5 m-85 -106.43 144.93 32.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 2.0299999999999998 111.315 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -156.39 148.45 23.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 2.0699999999999998 111.248 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.41 158.0 24.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 2.1000000000000001 111.175 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -60.6 -17.02 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 2.1299999999999999 111.244 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -42.91 -48.34 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 2.1699999999999999 111.159 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -134.98 27.45 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 2.2000000000000002 111.162 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.53 -42.61 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 2.23 111.176 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.77 -46.42 93.49 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.92 89.28 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.181 -0.767 . . . . 2.2999999999999998 111.181 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.05 -43.59 73.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 2.3300000000000001 111.157 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.84 -37.58 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 2.3700000000000001 111.143 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -67.07 -30.81 70.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.151 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -73.79 -13.89 61.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 2.4300000000000002 111.16 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.81 19.14 52.72 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.169 -0.772 . . . . 2.4700000000000002 111.169 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.89 -38.61 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.806 0.336 . . . . 2.5 111.234 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 tp -102.63 132.32 48.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 2.5299999999999998 111.239 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.54 137.09 32.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 2.5699999999999998 111.207 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -77.52 156.12 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 2.6000000000000001 111.203 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.2 mt -113.79 122.67 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 2.6299999999999999 111.204 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.2 m -120.58 96.74 48.88 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 2.6699999999999999 111.15 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.03 148.2 49.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.732 1.621 . . . . 2.7000000000000002 111.226 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -81.76 -179.37 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 2.73 111.188 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.73 -45.81 74.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 2.77 111.19 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.88 86.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 2.7999999999999998 111.232 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.41 -36.46 84.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 2.8300000000000001 111.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.71 -34.59 78.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 2.8700000000000001 111.235 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -71.35 -34.97 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 2.8999999999999999 111.155 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.1 -20.55 59.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 2.9300000000000002 111.186 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.6 mt -75.02 135.26 41.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 2.9700000000000002 111.193 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -63.29 138.89 97.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 3.0 111.162 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -50.15 -47.74 22.69 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.647 1.565 . . . . 3.0299999999999998 111.186 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.14 -47.66 81.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.0699999999999998 111.169 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -70.77 -21.69 62.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 3.1000000000000001 111.212 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -69.97 -41.53 74.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 3.1299999999999999 111.233 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -78.05 -24.01 47.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 3.1699999999999999 111.252 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.62 90.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 3.2000000000000002 111.197 -174.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.71 79.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.23 111.207 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HB3' HD21 ' A' ' 103' ' ' LEU . 54.4 ptt85 -156.68 161.05 39.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 3.27 111.163 175.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -159.98 136.37 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 3.2999999999999998 111.246 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 64.98 29.89 12.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 3.3300000000000001 111.216 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.77 53.89 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.187 -0.765 . . . . 3.3700000000000001 111.187 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -165.07 147.44 8.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 3.3999999999999999 111.159 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 98' ' ' ARG . 94.2 mt -64.9 136.39 56.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 3.4300000000000002 111.232 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 pt -115.2 -14.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 3.4700000000000002 111.224 -176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.0 172.92 5.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 3.5 111.226 -174.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -119.73 123.43 28.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 3.5299999999999998 111.18 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.8 139.54 33.72 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.667 1.578 . . . . 3.5699999999999998 111.2 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.32 -4.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 3.6000000000000001 111.223 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.75 144.75 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 3.6299999999999999 111.193 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.67 128.22 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 3.6699999999999999 111.242 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.68 151.21 46.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 3.7000000000000002 111.218 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.64 164.98 11.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 3.73 111.215 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 tp -143.85 124.1 13.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 3.77 111.214 172.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.9 p -163.05 -174.29 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 3.7999999999999998 111.17 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.9 tp -103.48 120.08 40.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 3.8300000000000001 111.177 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.574 HD13 ' N ' ' A' ' 116' ' ' ILE . 3.8 mp -102.93 141.36 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 3.8700000000000001 111.24 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -136.8 150.61 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 3.8999999999999999 111.159 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -91.28 117.33 29.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.9300000000000002 111.251 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.09 -34.88 79.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 3.9700000000000002 111.196 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.94 -47.6 84.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 4.0 111.205 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.2 tp -80.35 -52.36 7.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 4.0300000000000002 111.186 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.53 99.53 52.56 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 4.0700000000000003 111.174 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 -17.84 19.12 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.739 1.626 . . . . 4.0999999999999996 111.159 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 55.5 t-20 -85.01 116.81 67.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 4.1299999999999999 111.144 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 55.9 Cg_endo -67.42 117.9 5.19 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.716 1.61 . . . . 4.1699999999999999 111.232 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.97 129.62 31.17 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.718 1.612 . . . . 4.2000000000000002 111.181 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.01 -45.09 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 4.2300000000000004 111.186 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.6 t -136.3 -177.59 4.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 4.2699999999999996 111.173 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.65 -34.16 21.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 4.2999999999999998 111.207 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.77 -15.61 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 4.3300000000000001 111.215 -163.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -91.45 -9.44 44.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 4.3700000000000001 111.186 -176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.589 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 93.1 mt -74.02 -45.0 6.59 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 4.4000000000000004 111.195 -171.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.7 Cg_exo -57.0 -40.38 84.52 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.67 1.58 . . . . 4.4299999999999997 111.191 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.37 99.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 4.4699999999999998 111.183 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.411 HD21 ' HE3' ' A' ' 224' ' ' MET . 65.7 tp -63.95 -42.98 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.427 . . . . 4.5 111.268 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.95 -35.05 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.239 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.04 -37.02 75.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 4.5700000000000003 111.218 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.04 -31.91 69.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 4.5999999999999996 111.176 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.0 mt -82.18 -15.9 51.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 4.6299999999999999 111.155 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.93 -44.53 63.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 4.6699999999999999 111.156 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.37 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 4.7000000000000002 111.24 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.03 -7.29 33.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 4.7300000000000004 111.196 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.16 62.43 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.163 -0.775 . . . . 4.7699999999999996 111.163 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 74.4 mmtt -114.96 179.28 3.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.8 0.333 . . . . 4.7999999999999998 111.212 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -137.82 143.94 41.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 4.8300000000000001 111.196 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -59.78 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 4.8700000000000001 111.249 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.411 HD23 HD11 ' A' ' 132' ' ' ILE . 64.6 tp -128.13 115.64 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 4.9000000000000004 111.166 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.8 mmm -111.68 136.03 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 4.9299999999999997 111.198 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 156' ' ' PHE . 54.5 p90 -171.68 164.99 6.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 4.9699999999999998 111.27 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -79.69 112.71 17.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 5.0 111.211 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.2 tp -63.18 -32.36 73.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 5.0300000000000002 111.182 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -96.66 7.54 46.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 5.0700000000000003 111.229 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -110.04 114.23 56.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 5.0999999999999996 111.172 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.32 -39.22 81.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.697 1.598 . . . . 5.1299999999999999 111.214 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -50.49 -40.02 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 5.1699999999999999 111.154 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 31.8 m-85 -79.96 -37.52 34.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 5.2000000000000002 111.273 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.3 p -105.17 17.73 23.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 5.2300000000000004 111.156 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.558 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 88.3 t90 -66.73 -49.67 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 5.2699999999999996 111.286 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 83.6 Cg_endo -80.01 -14.92 12.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 5.2999999999999998 111.193 -174.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.9 tp -60.95 -33.99 74.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 5.3300000000000001 111.175 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.35 -30.02 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 5.3700000000000001 111.244 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.09 -43.75 10.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 5.4000000000000004 111.208 -172.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.4 -11.48 59.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 5.4299999999999997 111.213 -169.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -78.59 -4.42 48.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 5.4699999999999998 111.241 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.84 12.25 2.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.199 -0.76 . . . . 5.5 111.199 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.04 -19.66 25.74 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.241 -0.743 . . . . 5.5300000000000002 111.241 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.61 109.98 11.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 5.5700000000000003 111.172 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 68.39 35.3 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 5.5999999999999996 111.138 173.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.78 54.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 5.6299999999999999 111.235 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 5.6699999999999999 111.157 174.343 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 53.7 t0 . . . . . 0 CA--C 1.523 -0.074 0 CA-C-O 120.804 0.335 . . . . 5.9000000000000004 111.201 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.3 pt -98.36 -2.25 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 5.9299999999999997 111.166 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.01 -33.91 38.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 5.9699999999999998 111.165 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -64.76 139.99 58.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 6.0 111.173 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.0 t -72.93 123.88 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 6.0300000000000002 111.18 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.14 93.24 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -76.0 -24.94 16.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.769 0.319 . . . . 6.0999999999999996 111.171 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -89.6 64.51 6.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 6.1299999999999999 111.13 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -138.76 160.0 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 6.1699999999999999 111.222 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.41 80.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 6.2000000000000002 111.164 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.04 -47.36 83.05 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.4 90.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 6.2699999999999996 111.183 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.55 -44.14 91.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 6.2999999999999998 111.18 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.03 79.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.18 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.53 -45.03 97.18 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.225 -0.75 . . . . 6.3700000000000001 111.225 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.94 -38.55 86.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 6.4000000000000004 111.223 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -59.96 -50.91 71.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.233 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.28 -38.18 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 6.4699999999999998 111.213 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.8 tp -49.99 -53.22 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 6.5 111.203 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.6 -33.26 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 6.5300000000000002 111.162 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -54.72 -42.86 72.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 6.5700000000000003 111.249 176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.42 -33.34 74.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 6.5999999999999996 111.132 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.91 -48.7 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 6.6299999999999999 111.125 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.92 -25.95 31.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 6.6699999999999999 111.163 -171.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.95 15.5 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 6.7000000000000002 111.202 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.01 52.3 5.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 6.7300000000000004 111.214 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -115.12 -34.47 5.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 6.7699999999999996 111.209 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 98.9 mmm -139.81 169.34 17.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.147 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -153.06 175.03 13.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 6.8300000000000001 111.215 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -86.9 2.65 48.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 6.8700000000000001 111.141 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.39 1.8 55.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 6.9000000000000004 111.186 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.6 p -80.9 164.99 22.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 6.9299999999999997 111.259 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -158.12 170.0 23.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.149 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -59.66 -48.58 81.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 7.0 111.252 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 88.7 p -70.86 -30.01 66.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 7.0300000000000002 111.201 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.25 -46.97 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 7.0700000000000003 111.227 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.8 88.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 7.0999999999999996 111.2 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.81 -42.12 88.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 7.1299999999999999 111.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.05 94.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.177 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.42 -34.27 77.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 7.2000000000000002 111.164 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -64.59 -43.17 94.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 7.2300000000000004 111.231 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.77 -35.87 81.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2699999999999996 111.223 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -77.62 -26.61 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2999999999999998 111.205 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.01 31.64 22.78 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.228 -0.749 . . . . 7.3300000000000001 111.228 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -90.08 -6.01 55.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 7.3700000000000001 111.186 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 95.8 m -106.58 132.11 52.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 7.4000000000000004 111.253 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -86.81 -44.22 11.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 7.4299999999999997 111.253 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.411 ' HE3' HD21 ' A' ' 135' ' ' LEU . 61.9 mtm -135.39 152.65 51.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 7.4699999999999998 111.157 -174.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -161.69 147.06 13.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 7.5 111.22 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.42 115.7 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 7.5300000000000002 111.244 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -154.9 166.82 32.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 7.5700000000000003 111.264 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.65 -176.46 18.38 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.219 -0.752 . . . . 7.5999999999999996 111.219 166.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -56.15 -26.73 61.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.671 1.581 . . . . 7.6299999999999999 111.218 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -60.18 -22.05 62.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 7.6699999999999999 111.21 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.03 24.98 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 7.7000000000000002 111.178 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -101.81 10.03 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 7.7300000000000004 111.241 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.8 p -70.49 -32.68 70.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 7.7699999999999996 111.213 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -89.04 -34.02 16.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 7.7999999999999998 111.212 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.46 -38.85 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 7.8300000000000001 111.207 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -72.74 -32.26 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 7.8700000000000001 111.188 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -99.31 8.72 44.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 7.9000000000000004 111.175 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 239' ' ' LYS . 85.1 p -70.71 -18.43 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 7.9299999999999997 111.171 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 238' ' ' SER . 94.9 mttt 63.92 24.02 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 7.9699999999999998 111.211 -170.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.76 131.25 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 8.0 111.18 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.13 133.78 51.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 8.0299999999999994 111.144 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -145.34 158.68 43.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 8.0700000000000003 111.197 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.01 179.69 18.01 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.178 -0.769 . . . . 8.0999999999999996 111.178 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 73.5 t -133.52 131.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 8.1300000000000008 111.188 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 46.4 p -119.74 167.82 11.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 8.1699999999999999 111.163 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.77 119.94 51.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 8.1999999999999993 111.216 -166.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.54 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . 85.9 mt -82.97 -42.97 0.87 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 8.2300000000000004 111.221 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 247' ' ' LEU . 76.5 Cg_exo -45.48 113.28 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.71 1.606 . . . . 8.2699999999999996 111.183 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 92.3 m -124.57 134.36 52.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 8.3000000000000007 111.216 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -127.17 117.74 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 8.3300000000000001 111.233 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 57.24 34.97 25.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 8.3699999999999992 111.17 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.51 13.21 82.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.168 -0.773 . . . . 8.4000000000000004 111.168 176.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.439 ' HA ' ' HD2' ' A' ' 254' ' ' PRO . 63.7 tp60 -130.0 110.01 16.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.337 . . . . 8.4299999999999997 111.192 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 253' ' ' GLN . 64.9 Cg_endo -69.48 142.04 48.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.671 1.581 . . . . 8.4700000000000006 111.222 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.6 p -125.01 -84.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 8.5 111.245 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.26 155.2 76.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 8.5299999999999994 111.266 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 155.0 72.37 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.725 1.617 . . . . 8.5700000000000003 111.247 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -76.9 132.04 38.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 8.5999999999999996 111.127 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -106.72 126.77 62.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 8.6300000000000008 111.247 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.01 149.42 16.79 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.165 -0.774 . . . . 8.6699999999999999 111.165 170.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 77.2 t -125.54 130.4 72.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 8.6999999999999993 111.216 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 56.1 tp -97.66 121.05 39.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 8.7300000000000004 111.222 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 72.4 m -123.64 146.94 47.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 8.7699999999999996 111.194 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -78.14 162.93 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 8.8000000000000007 111.192 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.29 171.51 36.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.215 -0.754 . . . . 8.8300000000000001 111.215 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.71 132.31 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 8.8699999999999992 111.196 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -59.99 120.89 10.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 8.9000000000000004 111.211 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.84 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 8.9299999999999997 111.194 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -98.9 -0.3 42.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 8.9700000000000006 111.216 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -64.95 131.09 95.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 9.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.95 -15.09 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.715 1.61 . . . . 9.0299999999999994 111.214 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -123.52 61.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 9.0700000000000003 111.175 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -72.27 -22.53 61.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 9.0999999999999996 111.25 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -33.15 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 9.1300000000000008 111.159 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.2 -41.56 90.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 9.1699999999999999 111.198 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.16 94.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 9.1999999999999993 111.215 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -55.36 -49.94 70.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 9.2300000000000004 111.2 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -62.16 -56.92 13.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 9.2699999999999996 111.258 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.55 -55.05 33.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 9.3000000000000007 111.183 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.46 -50.01 74.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 9.3300000000000001 111.24 -172.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.03 -49.73 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 9.3699999999999992 111.223 -172.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -98.39 -13.45 20.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 9.4000000000000004 111.164 -158.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.53 -49.89 1.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 9.4299999999999997 111.203 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.03 -53.45 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 9.4700000000000006 111.191 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.5 mp -76.75 59.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.23 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.3 p -139.76 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 9.5299999999999994 111.209 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -56.78 -47.5 80.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 9.5700000000000003 111.231 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.36 -33.24 69.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 9.5999999999999996 111.261 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.84 -47.89 88.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.26 -0.736 . . . . 9.6300000000000008 111.26 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.18 -50.09 62.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.767 0.318 . . . . 9.6699999999999999 111.156 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.73 -35.05 73.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 9.6999999999999993 111.187 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.16 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.7300000000000004 111.191 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.71 -44.06 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 9.7699999999999996 111.173 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.51 -0.11 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 9.8000000000000007 111.21 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -77.58 -16.36 58.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 9.8300000000000001 111.164 168.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -110.47 -33.18 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 9.8699999999999992 111.244 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -96.2 160.23 30.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 9.9000000000000004 111.189 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.97 154.06 23.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.736 1.624 . . . . 9.9299999999999997 111.216 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.16 -6.9 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 9.9700000000000006 111.142 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.54 -44.01 85.69 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.17 -0.772 . . . . 10.0 111.17 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.43 125.46 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.731 0.3 . . . . 10.029999999999999 111.205 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.3 p -152.06 141.14 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 10.07 111.189 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -139.02 35.86 2.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 10.1 111.218 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.14 148.0 46.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 10.130000000000001 111.152 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.06 -49.98 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 10.17 111.204 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.4 p -68.79 -25.36 64.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 10.199999999999999 111.209 -173.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -79.99 -50.49 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 10.23 111.23 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.98 -38.34 72.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.171 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.11 -39.85 93.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 10.300000000000001 111.167 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -75.48 -32.82 60.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 10.33 111.173 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.16 -24.3 57.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 10.369999999999999 111.168 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.78 -14.56 62.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 10.4 111.201 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.24 -30.06 70.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 10.43 111.209 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -78.52 117.65 67.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 10.470000000000001 111.148 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.71 -34.99 86.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.685 1.59 . . . . 10.5 111.146 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.74 -29.71 67.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.529999999999999 111.219 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.78 -29.96 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 10.57 111.224 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.38 94.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 10.6 111.205 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.2 99.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.206 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.3 m -68.03 -44.63 76.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.196 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 56.7 mtt -73.74 -37.11 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.22 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.77 -44.01 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 10.73 111.23 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -64.8 -36.8 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 10.77 111.179 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.49 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 10.800000000000001 111.156 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -72.03 -37.45 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 10.83 111.117 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.03 -0.02 54.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.149 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.34 -136.77 9.49 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.245 -0.742 . . . . 10.9 111.245 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -149.07 147.29 28.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 10.93 111.188 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.3 pt -117.11 162.61 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 10.970000000000001 111.205 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -59.37 117.43 22.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 11.0 111.188 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 149.36 88.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.672 1.581 . . . . 11.029999999999999 111.183 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -105.05 39.91 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 11.07 111.202 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 74.9 mt -88.74 118.76 69.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 11.1 111.255 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.83 -17.97 13.58 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.674 1.582 . . . . 11.130000000000001 111.225 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.14 -5.01 58.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 11.17 111.226 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.6 mmm -110.77 19.1 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 11.199999999999999 111.255 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.1 m -65.65 -50.94 63.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 11.23 111.181 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.15 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 11.27 111.217 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -71.13 -47.27 58.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 11.300000000000001 111.216 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -70.13 -35.77 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 11.33 111.261 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -58.15 -51.96 67.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 11.369999999999999 111.196 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -31.49 72.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 11.4 111.143 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.21 -43.07 88.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 11.43 111.181 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.31 -40.05 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 11.470000000000001 111.167 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.3 m -57.3 -41.11 79.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 11.5 111.212 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.01 71.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 11.529999999999999 111.194 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.04 -25.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.186 -172.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.79 -46.03 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 11.6 111.195 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.53 -27.39 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 11.630000000000001 111.221 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.77 -39.13 36.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 11.67 111.184 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.48 86.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 11.699999999999999 111.216 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -74.4 -14.97 60.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 11.73 111.203 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.39 31.89 40.18 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.14 -0.784 . . . . 11.77 111.14 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -100.01 -38.28 8.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.78 0.324 . . . . 11.800000000000001 111.177 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -124.96 159.18 31.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 11.83 111.207 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.3 p -81.66 176.92 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 11.869999999999999 111.204 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 10.7 m -70.59 -21.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 11.9 111.199 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -89.84 -36.71 14.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 11.93 111.187 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -69.09 -36.72 77.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.151 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.92 87.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 12.0 111.171 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.84 -32.48 73.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 12.029999999999999 111.191 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.94 -59.96 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 12.07 111.248 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.38 -41.1 89.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 12.1 111.235 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.26 85.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 12.130000000000001 111.19 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.7 -46.45 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 12.17 111.202 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.2 m . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 12.199999999999999 111.208 -177.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.862 0.363 . . . . 0.070000000000000007 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.18 150.1 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.10000000000000001 111.214 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.03 125.13 22.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.13 111.217 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.74 14.29 58.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.143 -0.783 . . . . 0.17000000000000001 111.143 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -132.06 155.01 48.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 0.20000000000000001 111.23 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -116.27 109.98 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.23000000000000001 111.186 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.94 123.76 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.27000000000000002 111.179 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.29999999999999999 111.264 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.401 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.3 m0 -109.98 128.74 55.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.33000000000000002 111.175 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.5 mt -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.37 111.165 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -62.34 122.17 15.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.40000000000000002 111.224 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.9 -174.31 15.14 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.14 -0.784 . . . . 0.42999999999999999 111.14 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -99.95 -19.93 16.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.46999999999999997 111.264 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.45 144.16 28.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.5 111.175 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.73 -18.81 8.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.174 -0.771 . . . . 0.53000000000000003 111.174 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -47.59 -55.12 9.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.767 0.318 . . . . 0.56999999999999995 111.197 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -94.23 -27.04 16.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.59999999999999998 111.268 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.13 -57.23 19.33 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.255 -0.738 . . . . 0.63 111.255 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.7 tp -74.57 -29.14 61.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.67000000000000004 111.229 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -32.6 63.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.69999999999999996 111.164 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -59.21 -33.54 71.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.72999999999999998 111.172 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.26 -40.16 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.77000000000000002 111.228 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.25 -28.94 71.68 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.285 -0.726 . . . . 0.80000000000000004 111.285 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.66 -42.52 99.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.82999999999999996 111.135 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.3 -48.45 70.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.87 111.165 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -56.17 -44.16 79.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.90000000000000002 111.197 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.29 -42.07 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.93000000000000005 111.178 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.89 -35.0 69.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.96999999999999997 111.257 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -78.71 -35.9 44.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.256 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -106.26 -28.31 10.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 1.03 111.212 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.75 5.06 74.94 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.24 -0.744 . . . . 1.0700000000000001 111.24 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mm -86.5 114.78 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 1.1000000000000001 111.219 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.92 124.06 19.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 111.181 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.36 126.14 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 1.1699999999999999 111.177 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -126.46 116.77 21.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 1.2 111.234 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.5 125.01 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 1.23 111.186 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.401 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.6 mt-10 -132.71 161.35 34.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 1.27 111.194 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -117.15 102.78 52.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 1.3 111.188 172.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.56 167.95 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.709 1.606 . . . . 1.3300000000000001 111.186 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.6 t0 -100.19 102.86 14.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 1.3700000000000001 111.142 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.18 70.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 1.3999999999999999 111.2 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 68.5 mt -59.98 -20.69 59.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 1.4299999999999999 111.214 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -49.23 -35.03 16.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 1.47 111.185 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -109.86 -25.58 10.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 1.5 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 43' ' ' LEU . 87.1 tttt -79.98 -24.4 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 1.53 111.141 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.473 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -50.67 -57.39 13.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 1.5700000000000001 111.2 -177.098 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -68.61 -24.65 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.663 1.575 . . . . 1.6000000000000001 111.209 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.11 -37.31 72.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.173 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -88.59 -24.16 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 1.6699999999999999 111.197 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.26 -30.82 71.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 1.7 111.158 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.0 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 1.73 111.273 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -101.53 -15.39 17.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 1.77 111.131 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.5 32.55 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.208 -0.757 . . . . 1.8 111.208 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -110.02 169.97 8.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 1.8300000000000001 111.179 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.44 179.99 31.86 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.21 -0.756 . . . . 1.8700000000000001 111.21 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.37 -178.08 3.55 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.669 1.579 . . . . 1.8999999999999999 111.154 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -84.55 -56.53 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.9299999999999999 111.241 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -114.16 138.93 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 1.97 111.283 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.68 121.07 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 2.0 111.193 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -98.2 107.89 20.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 2.0299999999999998 111.162 167.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -148.33 157.26 43.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 2.0699999999999998 111.172 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.7 140.95 53.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.1000000000000001 111.226 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -58.62 -26.19 63.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 2.1299999999999999 111.149 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -76.7 -6.7 53.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 2.1699999999999999 111.232 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -129.13 -24.94 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 111.19 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.04 -29.98 67.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 2.23 111.187 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -28.82 73.57 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.21 -0.756 . . . . 2.27 111.21 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.78 -31.89 59.77 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.159 -0.776 . . . . 2.2999999999999998 111.159 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -64.54 -36.15 83.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.203 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.77 69.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 2.3700000000000001 111.153 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -55.33 -42.59 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 2.3999999999999999 111.2 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 99.9 p -70.64 -15.05 62.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 2.4300000000000002 111.222 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.22 22.04 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.195 -0.762 . . . . 2.4700000000000002 111.195 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -107.24 -8.67 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 2.5 111.25 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -105.08 135.08 47.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 2.5299999999999998 111.214 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.96 134.97 53.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 2.5699999999999998 111.166 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -74.5 91.03 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 2.6000000000000001 111.243 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.95 98.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 2.6299999999999999 111.154 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.6 m -91.46 115.39 64.38 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 2.6699999999999999 111.224 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -56.39 144.99 81.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.702 1.601 . . . . 2.7000000000000002 111.169 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.96 163.05 28.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 2.73 111.134 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.31 -36.39 53.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 2.77 111.187 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.64 74.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 2.7999999999999998 111.263 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -70.25 -31.23 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 2.8300000000000001 111.226 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -57.56 -33.86 68.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 2.8700000000000001 111.216 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -81.72 -16.1 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 2.8999999999999999 111.245 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 305' ' ' LYS . 70.1 mmtt -85.02 -35.03 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 2.9300000000000002 111.199 -170.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.63 161.14 20.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 2.9700000000000002 111.141 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -60.02 144.67 86.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 3.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.96 -25.12 66.96 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.684 1.589 . . . . 3.0299999999999998 111.224 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -65.68 -49.05 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 3.0699999999999998 111.18 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.5 p -89.12 -24.13 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.262 -0.426 . . . . 3.1000000000000001 111.204 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -69.96 -46.79 64.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 3.1299999999999999 111.192 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.89 -15.43 61.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 3.1699999999999999 111.188 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.24 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 3.2000000000000002 111.179 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.15 78.92 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 3.23 111.227 -169.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.415 ' HB3' HD21 ' A' ' 103' ' ' LEU . 33.7 ptt-85 -149.82 165.1 33.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 3.27 111.193 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -131.97 114.43 14.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 3.2999999999999998 111.221 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 61.94 37.2 15.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 3.3300000000000001 111.163 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.8 7.68 83.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.213 -0.755 . . . . 3.3700000000000001 111.213 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.96 107.25 15.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 3.3999999999999999 111.171 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.415 HD21 ' HB3' ' A' ' 98' ' ' ARG . 58.0 mt -59.33 128.99 39.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 3.4300000000000002 111.12 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -112.36 -20.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 3.4700000000000002 111.228 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.35 176.0 6.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 3.5 111.268 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -113.25 127.32 26.96 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 3.5299999999999998 111.231 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 263' ' ' SER . 42.1 Cg_endo -67.45 138.95 47.72 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.718 1.612 . . . . 3.5699999999999998 111.273 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.4 mm -116.14 -47.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 3.6000000000000001 111.243 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.73 154.98 50.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 3.6299999999999999 111.179 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 134.96 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 3.6699999999999999 111.252 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -124.9 123.41 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 3.7000000000000002 111.186 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.26 151.18 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 3.73 111.218 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.2 tp -138.18 125.81 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 3.77 111.166 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 t -159.98 -168.54 2.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 3.7999999999999998 111.179 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.95 125.54 36.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 3.8300000000000001 111.173 -168.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.86 139.99 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 3.8700000000000001 111.267 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -136.55 144.92 44.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 3.8999999999999999 111.205 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -75.52 123.5 25.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 3.9300000000000002 111.216 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -70.97 -30.1 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 3.9700000000000002 111.185 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -77.85 -43.26 30.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 4.0 111.209 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.14 -44.64 59.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 4.0300000000000002 111.163 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -128.54 77.3 77.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 4.0700000000000003 111.238 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.69 -25.01 74.97 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.659 1.573 . . . . 4.0999999999999996 111.198 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -105.19 100.07 23.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 4.1299999999999999 111.26 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.0 155.4 52.8 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.706 1.604 . . . . 4.1699999999999999 111.196 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 154.55 59.31 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.691 1.594 . . . . 4.2000000000000002 111.253 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -85.32 -15.64 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 4.2300000000000004 111.192 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.2 t -160.0 162.66 34.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 4.2699999999999996 111.192 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -59.4 -23.25 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 4.2999999999999998 111.215 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.43 -22.83 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.3300000000000001 111.185 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -96.76 2.97 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 4.3700000000000001 111.226 -176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.519 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 70.4 mt -66.93 -54.33 21.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 4.4000000000000004 111.191 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 67.5 Cg_endo -71.78 -18.52 28.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.735 1.623 . . . . 4.4299999999999997 111.233 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.98 -24.69 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 4.4699999999999998 111.197 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.2 -6.88 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 4.5 111.162 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.37 -35.01 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 4.5300000000000002 111.174 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.03 -39.88 83.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 4.5700000000000003 111.213 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.61 -27.85 68.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 4.5999999999999996 111.158 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.01 -0.36 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 4.6299999999999999 111.207 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.15 -26.27 68.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 4.6699999999999999 111.228 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.97 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 4.7000000000000002 111.232 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -99.92 -20.01 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 4.7300000000000004 111.183 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.61 24.8 44.88 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.145 -0.782 . . . . 4.7699999999999996 111.145 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -119.04 164.94 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 4.7999999999999998 111.19 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t -111.34 158.46 19.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 4.8300000000000001 111.213 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.1 -72.86 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.178 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.3 tp -156.94 129.0 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 4.9000000000000004 111.166 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mmm -84.73 140.55 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 4.9299999999999997 111.242 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.02 138.42 53.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 4.9699999999999998 111.165 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -82.91 119.78 24.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 5.0 111.209 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.406 HD22 HD11 ' A' ' 195' ' ' LEU . 99.0 mt -114.81 -25.52 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 5.0300000000000002 111.181 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.07 -39.82 90.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 5.0700000000000003 111.184 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.97 118.4 56.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 5.0999999999999996 111.208 -172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.96 -34.91 88.34 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.654 1.569 . . . . 5.1299999999999999 111.16 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -53.5 -37.69 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 5.1699999999999999 111.215 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.28 25.63 8.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 5.2000000000000002 111.245 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.3 p -103.34 -15.23 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 5.2300000000000004 111.154 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.558 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 75.0 t90 -68.67 -48.2 32.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 5.2699999999999996 111.217 175.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 67.6 Cg_endo -74.79 -4.36 15.29 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.674 1.582 . . . . 5.2999999999999998 111.193 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.8 mt -65.3 -21.04 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 5.3300000000000001 111.176 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.7 mt -109.68 -41.46 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 5.3700000000000001 111.173 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 159' ' ' PRO . . . -65.02 -44.47 89.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 5.4000000000000004 111.232 -175.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.01 -34.33 78.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 5.4299999999999997 111.233 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -64.2 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 5.4699999999999998 111.219 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.57 23.74 6.74 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.248 -0.741 . . . . 5.5 111.248 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.53 -22.05 17.61 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.169 -0.772 . . . . 5.5300000000000002 111.169 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.44 ' O ' ' HB1' ' A' ' 168' ' ' ALA . 68.1 t80 -111.59 145.15 39.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 5.5700000000000003 111.122 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 167' ' ' TYR . . . 67.55 22.79 9.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 5.5999999999999996 111.175 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.36 173.22 11.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 5.6299999999999999 111.171 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 5.6699999999999999 111.166 175.42 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.5 t0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.781 0.324 . . . . 5.9000000000000004 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.86 -34.11 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 5.9299999999999997 111.198 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -30.04 71.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 5.9699999999999998 111.156 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -65.59 143.03 57.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 6.0 111.169 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 183' ' ' VAL . 70.9 t -47.83 124.08 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 6.0300000000000002 111.142 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -98.48 14.31 62.18 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.229 -0.749 . . . . 6.0700000000000003 111.229 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.462 ' H ' HG12 ' A' ' 181' ' ' VAL . 25.0 m -123.63 31.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 6.0999999999999996 111.189 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -127.67 9.95 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 6.1299999999999999 111.25 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.38 161.38 14.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 6.1699999999999999 111.148 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.17 72.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 6.2000000000000002 111.148 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.32 -37.09 90.43 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.177 -0.769 . . . . 6.2300000000000004 111.177 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.2 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 6.2699999999999996 111.185 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.74 -40.76 75.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 6.2999999999999998 111.254 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.55 -28.91 68.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.146 -0.479 . . . . 6.3300000000000001 111.207 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -20.13 66.74 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.154 -0.778 . . . . 6.3700000000000001 111.154 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.407 HD22 HG23 ' A' ' 347' ' ' VAL . 86.7 mt -104.99 -34.9 7.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 6.4000000000000004 111.203 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.9 m -64.56 -52.53 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 6.4299999999999997 111.233 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.62 -38.62 87.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 6.4699999999999998 111.193 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.406 HD11 HD22 ' A' ' 151' ' ' LEU . 54.1 tp -58.17 -53.33 59.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 6.5 111.203 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.77 -42.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 6.5300000000000002 111.212 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.92 -39.67 86.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 6.5700000000000003 111.204 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 84.7 mt -70.4 -35.4 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 6.5999999999999996 111.23 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.24 -40.79 89.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.188 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.79 -24.62 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 6.6699999999999999 111.205 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.71 5.18 52.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 6.7000000000000002 111.22 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 60.65 35.26 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 6.7300000000000004 111.224 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -74.88 -34.06 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.215 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -145.21 149.93 35.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 6.7999999999999998 111.17 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -94.65 151.52 19.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 6.8300000000000001 111.243 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.94 -24.53 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 6.8700000000000001 111.229 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.77 -16.75 56.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 6.9000000000000004 111.146 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -56.4 118.03 4.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 6.9299999999999997 111.232 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -119.97 -164.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 6.9699999999999998 111.22 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.09 -47.83 81.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 7.0 111.167 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 82.5 p -75.09 -25.51 58.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 7.0300000000000002 111.183 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.5 mm -67.65 -52.26 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 7.0700000000000003 111.182 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.99 90.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 7.0999999999999996 111.201 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.39 -42.46 91.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 7.1299999999999999 111.218 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.08 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.173 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -26.67 68.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 7.2000000000000002 111.224 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -81.65 -45.28 15.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 7.2300000000000004 111.197 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.66 -30.12 64.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 7.2699999999999996 111.188 -174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -9.75 56.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 7.2999999999999998 111.222 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.16 32.87 51.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.194 -0.762 . . . . 7.3300000000000001 111.194 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -81.43 -29.33 33.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.764 0.316 . . . . 7.3700000000000001 111.191 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.1 p -100.24 160.04 14.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 7.4000000000000004 111.204 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.06 -24.76 16.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 7.4299999999999997 111.189 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 90.2 mmm -109.88 149.94 29.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 7.4699999999999998 111.168 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -159.64 179.61 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 7.5 111.174 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.2 mt -121.1 124.17 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 7.5300000000000002 111.178 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -165.01 179.94 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 7.5700000000000003 111.279 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 229' ' ' PRO . . . -74.84 139.33 25.1 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.245 -0.742 . . . . 7.5999999999999996 111.245 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' A' ' 228' ' ' GLY . 53.6 Cg_exo -53.32 129.84 35.51 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.67 1.58 . . . . 7.6299999999999999 111.188 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 57.39 49.93 12.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 7.6699999999999999 111.217 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.86 75.37 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 7.7000000000000002 111.226 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.413 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 48.4 m0 -68.28 -17.13 64.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 7.7300000000000004 111.146 -170.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 97.0 p -66.18 -19.97 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 7.7699999999999996 111.208 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -118.98 -19.41 8.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 7.7999999999999998 111.105 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.8 mt -90.77 -61.33 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.195 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.97 -39.55 75.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 7.8700000000000001 111.205 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 83.9 m -52.45 -44.93 65.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 7.9000000000000004 111.159 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 84.9 p -81.27 -10.47 59.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 7.9299999999999997 111.195 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 59.99 40.23 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 7.9699999999999998 111.247 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.63 135.06 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 8.0 111.161 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -73.85 111.24 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 8.0299999999999994 111.227 -175.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.31 145.02 44.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 8.0700000000000003 111.159 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.08 178.65 17.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.189 -0.764 . . . . 8.0999999999999996 111.189 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.89 139.96 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 8.1300000000000008 111.166 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.1 t -142.5 176.55 8.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 8.1699999999999999 111.209 171.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.57 112.85 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 8.1999999999999993 111.139 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.506 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 40.6 tp -63.46 -53.76 49.47 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 8.2300000000000004 111.212 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 70.8 Cg_endo -74.81 147.34 34.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.688 1.592 . . . . 8.2699999999999996 111.191 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.4 m -116.27 125.34 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 8.3000000000000007 111.177 174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -99.98 90.08 4.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 8.3300000000000001 111.188 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 52.14 55.47 9.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 8.3699999999999992 111.19 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 99.27 -23.59 35.68 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.221 -0.752 . . . . 8.4000000000000004 111.221 171.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -129.95 109.97 16.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 8.4299999999999997 111.232 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -54.98 130.71 42.2 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.719 1.613 . . . . 8.4700000000000006 111.194 173.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.7 t -114.97 -94.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 8.5 111.188 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.94 145.53 30.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 8.5299999999999994 111.185 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.73 -176.42 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.731 1.62 . . . . 8.5700000000000003 111.175 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -86.58 156.4 20.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 8.5999999999999996 111.201 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.14 117.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 8.6300000000000008 111.179 -173.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.57 150.05 19.03 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.222 -0.751 . . . . 8.6699999999999999 111.222 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.98 121.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.894 0.378 . . . . 8.6999999999999993 111.183 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.4 tp -95.44 110.93 22.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 8.7300000000000004 111.214 172.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 89.5 p -112.51 151.7 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 8.7699999999999996 111.156 -171.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -111.48 126.93 55.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 8.8000000000000007 111.176 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.98 177.68 19.12 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.236 -0.746 . . . . 8.8300000000000001 111.236 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 80.2 mt -111.67 122.87 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 8.8699999999999992 111.184 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -60.75 128.9 38.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 8.9000000000000004 111.137 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.85 63.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 8.9299999999999997 111.232 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -87.17 -5.01 59.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 8.9700000000000006 111.108 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.9 t -80.43 132.39 58.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 9.0 111.179 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.68 -5.4 14.73 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.749 1.633 . . . . 9.0299999999999994 111.191 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -118.0 59.92 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 9.0700000000000003 111.218 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -77.76 -28.89 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 9.0999999999999996 111.243 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.45 -38.6 65.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 9.1300000000000008 111.265 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.41 -37.73 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 9.1699999999999999 111.199 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.83 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 9.1999999999999993 111.216 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.1 -48.85 70.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 9.2300000000000004 111.192 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.69 -47.6 77.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 9.2699999999999996 111.127 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.05 -41.06 74.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 9.3000000000000007 111.21 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.14 -3.76 58.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.3300000000000001 111.223 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.41 -50.01 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 9.3699999999999992 111.244 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -121.21 4.96 10.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 9.4000000000000004 111.163 -164.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -125.0 -62.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 9.4299999999999997 111.143 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.56 -53.29 58.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 9.4700000000000006 111.155 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 64.1 mt -85.03 60.8 6.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 9.5 111.199 -174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.6 p -134.94 167.53 20.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 9.5299999999999994 111.248 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.47 -34.62 78.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 9.5700000000000003 111.177 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.07 -35.18 22.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 9.5999999999999996 111.166 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.81 -48.76 63.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.69 -28.25 65.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 9.6699999999999999 111.232 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -69.41 -36.12 76.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 9.6999999999999993 111.148 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.01 78.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 9.7300000000000004 111.187 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -70.41 -39.95 77.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 9.7699999999999996 111.217 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.14 5.02 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8000000000000007 111.139 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -54.65 -50.21 68.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 9.8300000000000001 111.182 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -106.8 -18.16 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 9.8699999999999992 111.147 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -103.08 162.76 19.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 9.9000000000000004 111.277 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.45 144.93 48.67 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 121.729 1.619 . . . . 9.9299999999999997 111.198 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.23 -6.89 59.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 9.9700000000000006 111.18 -170.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -56.96 -35.9 70.95 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.139 -0.784 . . . . 10.0 111.139 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.19 127.98 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 10.029999999999999 111.12 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.77 129.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 10.07 111.236 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -125.13 26.48 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 10.1 111.168 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 36.2 tp -157.65 130.99 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 10.130000000000001 111.221 -172.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 86.7 tttt -61.78 -46.52 89.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 10.17 111.188 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 68.0 m -55.07 -38.25 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 10.199999999999999 111.16 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -71.39 -41.81 69.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 10.23 111.226 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.58 -34.27 66.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 10.27 111.237 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.48 -29.98 68.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 10.300000000000001 111.244 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -96.52 -30.02 13.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 10.33 111.142 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.45 -30.95 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 10.369999999999999 111.182 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.14 -9.12 54.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 10.4 111.196 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.93 -28.42 67.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 10.43 111.156 173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -80.62 115.59 56.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.470000000000001 111.177 173.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.52 -38.81 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.726 1.618 . . . . 10.5 111.205 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.64 -39.87 70.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.166 -172.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.67 -40.04 76.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 10.57 111.194 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.59 -43.37 89.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 10.6 111.234 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.93 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 10.630000000000001 111.158 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 90.0 m -63.37 -43.06 98.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.199 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.98 -38.32 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 10.699999999999999 111.19 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -63.27 -46.16 88.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.197 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.96 -33.79 76.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 10.77 111.212 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.05 -45.68 84.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 10.800000000000001 111.167 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.23 -39.84 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 10.83 111.174 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -95.95 6.15 49.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 10.869999999999999 111.224 -174.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.65 -156.03 26.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.234 -0.746 . . . . 10.9 111.234 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -130.6 116.18 17.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 10.93 111.249 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 97.7 mt -105.08 137.0 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 10.970000000000001 111.209 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 83.0 mtp -63.35 130.57 94.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 11.0 111.235 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 50.7 Cg_exo -55.01 144.39 68.67 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 11.029999999999999 111.204 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -120.17 55.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 11.07 111.151 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 335' ' ' GLN . 82.0 mt -126.63 130.42 23.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 11.1 111.215 -178.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.13 -29.22 74.23 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.697 1.598 . . . . 11.130000000000001 111.229 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.42 ' H ' HG22 ' A' ' 333' ' ' ILE . 90.6 mt-30 -64.02 -41.71 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 11.17 111.19 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 95.3 mmm -65.34 -37.25 86.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 11.199999999999999 111.249 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 39.4 t -59.92 -41.41 91.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 11.23 111.242 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.41 -36.65 83.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 11.27 111.252 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -64.98 -36.69 85.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 11.300000000000001 111.183 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -68.22 -29.76 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 11.33 111.177 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -62.76 -41.4 99.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 11.369999999999999 111.187 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.37 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 11.4 111.267 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.7 -42.59 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 11.43 111.153 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.5 -45.12 95.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 11.470000000000001 111.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.4 m -64.99 -39.94 94.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 11.5 111.241 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.29 -45.42 91.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 11.529999999999999 111.162 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.407 HG23 HD22 ' A' ' 192' ' ' LEU . 70.1 t -64.72 -40.52 89.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 11.57 111.243 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.1 mt -65.13 -43.82 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 11.6 111.222 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.78 -37.37 87.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 11.630000000000001 111.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.0 -44.37 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 11.67 111.203 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.03 79.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 11.699999999999999 111.218 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.4 p -82.93 -14.95 53.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 11.73 111.22 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.25 12.26 65.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.22 -0.752 . . . . 11.77 111.22 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -70.04 -40.81 74.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 11.800000000000001 111.145 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -129.89 166.92 19.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 11.83 111.248 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -83.46 174.47 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 11.869999999999999 111.181 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -44.1 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 11.9 111.187 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.92 -42.75 80.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 11.93 111.201 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -64.74 -40.35 95.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 11.970000000000001 111.211 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.91 -48.49 73.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 12.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.26 -23.18 60.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 12.029999999999999 111.198 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.12 -48.48 73.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 12.07 111.186 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.63 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 12.1 111.241 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.54 93.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 12.130000000000001 111.173 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.35 -40.62 97.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 12.17 111.16 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 95.9 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 12.199999999999999 111.248 178.782 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.763 0.316 . . . . 0.070000000000000007 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -95.58 139.96 31.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.243 -0.435 . . . . 0.10000000000000001 111.231 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.68 125.04 21.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.13 111.199 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.64 5.21 60.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.2 -0.76 . . . . 0.17000000000000001 111.2 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HG2' ' HB2' ' A' ' 34' ' ' LYS . 96.0 mttt -133.47 148.56 51.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.20000000000000001 111.116 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.2 mt -113.74 140.76 48.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.23000000000000001 111.152 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.93 110.89 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.27000000000000002 111.178 172.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.464 HG12 ' HB ' ' A' ' 59' ' ' ILE . 69.8 mt -113.79 116.21 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.29999999999999999 111.235 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.447 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 38.7 m0 -105.46 119.76 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.33000000000000002 111.164 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.43 139.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.37 111.208 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -67.63 119.31 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.142 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.81 -177.99 26.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.144 -0.782 . . . . 0.42999999999999999 111.144 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -102.71 -35.03 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.46999999999999997 111.138 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.83 163.26 28.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.5 111.201 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.41 -7.9 9.01 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.149 -0.781 . . . . 0.53000000000000003 111.149 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -60.75 -23.23 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.317 . . . . 0.56999999999999995 111.188 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -67.23 -36.43 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.59999999999999998 111.167 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.59 -44.86 94.46 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.28 -0.728 . . . . 0.63 111.28 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.15 -32.74 70.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.753 0.311 . . . . 0.67000000000000004 111.162 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.03 92.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.69999999999999996 111.181 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -61.41 -34.76 75.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.72999999999999998 111.207 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.95 -39.78 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.77000000000000002 111.256 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.09 79.78 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.27 -0.732 . . . . 0.80000000000000004 111.27 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.07 -37.39 84.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.337 . . . . 0.82999999999999996 111.227 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.89 -37.43 87.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.87 111.169 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -30.0 67.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.90000000000000002 111.183 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.39 -36.48 66.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.93000000000000005 111.145 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -82.79 -39.15 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.96999999999999997 111.238 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.71 -50.22 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.199 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -102.46 -49.34 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.03 111.202 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.44 21.57 3.01 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.213 -0.755 . . . . 1.0700000000000001 111.213 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.56 122.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 1.1000000000000001 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 6' ' ' LYS . 99.1 mttt -87.97 127.75 35.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 1.1299999999999999 111.182 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.22 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 1.1699999999999999 111.218 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -115.42 125.05 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 1.2 111.158 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -114.95 126.38 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.195 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -129.96 162.6 28.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.27 111.201 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -112.32 106.84 55.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.228 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.447 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 78.7 Cg_endo -75.51 175.82 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.66 1.573 . . . . 1.3300000000000001 111.194 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -131.49 109.84 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 1.3700000000000001 111.219 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 58.07 69.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 1.3999999999999999 111.183 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.02 -18.59 61.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 1.4299999999999999 111.199 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -64.54 -15.08 60.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.202 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -99.24 -34.84 10.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 1.5 111.195 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -89.89 -48.66 7.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.53 111.208 -166.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 2.6 m-30 -56.47 -47.49 98.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.19 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 80.3 Cg_exo -50.46 -35.07 44.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.731 1.62 . . . . 1.6000000000000001 111.229 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -79.86 -47.47 15.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 1.6299999999999999 111.247 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 47' ' ' PHE . 22.0 m -78.42 -16.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 1.6699999999999999 111.256 -174.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 1.7 111.204 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.66 -15.49 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 1.73 111.208 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -108.5 -14.97 14.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 1.77 111.194 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.55 30.25 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.249 -0.74 . . . . 1.8 111.249 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -110.16 169.99 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.327 . . . . 1.8300000000000001 111.221 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.48 -173.83 25.72 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.201 -0.76 . . . . 1.8700000000000001 111.201 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.63 173.22 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.68 1.587 . . . . 1.8999999999999999 111.258 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -88.77 -50.93 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 1.9299999999999999 111.221 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.464 ' HB ' HG12 ' A' ' 9' ' ' ILE . 84.9 mt -116.27 132.97 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.97 111.162 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.1 mt -114.2 117.56 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 2.0 111.139 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -114.07 106.5 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 111.234 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -150.46 159.97 44.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 2.0699999999999998 111.155 -166.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.12 158.52 27.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.213 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -71.58 -2.8 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 2.1299999999999999 111.197 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.41 -30.94 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 2.1699999999999999 111.188 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mmt-85 -129.95 -27.92 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 2.2000000000000002 111.159 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -55.04 -43.34 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 2.23 111.211 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.31 -28.32 72.1 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.244 -0.742 . . . . 2.27 111.244 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.71 -11.32 81.88 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.145 -0.782 . . . . 2.2999999999999998 111.145 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -69.6 -29.94 67.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.717 0.294 . . . . 2.3300000000000001 111.188 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.71 -35.18 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 2.3700000000000001 111.242 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -70.02 -38.71 75.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 2.3999999999999999 111.202 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.3 p -69.82 -19.99 63.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 2.4300000000000002 111.221 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.31 23.98 25.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.168 -0.773 . . . . 2.4700000000000002 111.168 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.6 30.91 6.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 2.5 111.234 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.9 tp -151.1 115.32 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 2.5299999999999998 111.224 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.77 162.44 24.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 2.5699999999999998 111.184 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -85.65 86.86 7.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 2.6000000000000001 111.211 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 mm -98.47 101.93 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 2.6299999999999999 111.15 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -92.94 120.76 66.89 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 2.6699999999999999 111.203 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.14 141.27 80.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.713 1.609 . . . . 2.7000000000000002 111.194 176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -89.65 -174.28 4.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.24 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.67 -38.63 67.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 2.77 111.209 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.22 79.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 2.7999999999999998 111.187 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.82 -22.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 2.8300000000000001 111.155 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -62.52 -29.62 70.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 2.8700000000000001 111.168 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -97.61 -30.17 13.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 2.8999999999999999 111.205 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -79.98 -35.17 37.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 2.9300000000000002 111.255 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -94.57 149.49 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.9700000000000002 111.192 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -73.35 135.02 79.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 3.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.07 -46.94 29.25 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.643 1.562 . . . . 3.0299999999999998 111.208 -170.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.52 -46.82 85.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 3.0699999999999998 111.241 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.3 p -82.41 -15.92 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 3.1000000000000001 111.228 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 85.8 t90 -65.98 -52.34 50.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 3.1299999999999999 111.259 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -85.78 9.98 14.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 3.1699999999999999 111.271 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.89 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 3.2000000000000002 111.239 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -104.07 24.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 3.23 111.175 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.2 ttt180 -76.57 129.98 37.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 3.27 111.206 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -157.95 132.81 8.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 3.2999999999999998 111.241 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 68.49 35.05 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 3.3300000000000001 111.149 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.59 -35.13 4.93 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.226 -0.75 . . . . 3.3700000000000001 111.226 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -130.62 171.95 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 3.3999999999999999 111.182 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.8 mp -77.94 145.17 36.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 3.4300000000000002 111.231 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.8 14.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 3.4700000000000002 111.136 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -168.92 178.89 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 3.5 111.15 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -110.07 117.54 51.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 3.5299999999999998 111.177 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.04 136.73 76.42 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.71 1.607 . . . . 3.5699999999999998 111.204 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.1 mm -112.96 -60.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 3.6000000000000001 111.3 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -154.93 162.61 41.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 3.6299999999999999 111.145 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.01 159.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 3.6699999999999999 111.193 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.25 126.76 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 3.7000000000000002 111.137 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.02 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 3.73 111.219 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.4 tp -124.26 111.58 16.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 3.77 111.19 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 t -166.91 -171.65 1.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 3.7999999999999998 111.18 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.2 tp -53.06 108.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 3.8300000000000001 111.198 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 244' ' ' VAL . 81.0 mt -92.55 114.13 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 3.8700000000000001 111.153 165.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -124.28 153.63 41.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 3.8999999999999999 111.165 -169.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -85.05 113.46 21.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 3.9300000000000002 111.147 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.34 -30.85 69.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 3.9700000000000002 111.182 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -72.1 -30.21 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 4.0 111.135 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.2 -13.8 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 4.0300000000000002 111.24 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 38.1 tp -142.97 79.79 14.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 4.0700000000000003 111.214 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.17 -19.48 29.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.757 1.638 . . . . 4.0999999999999996 111.205 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -120.16 89.97 43.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 4.1299999999999999 111.183 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.55 157.48 48.77 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.27 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.38 154.74 45.9 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.77 1.646 . . . . 4.2000000000000002 111.172 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.56 -5.24 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 4.2300000000000004 111.217 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -164.3 156.14 16.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 4.2699999999999996 111.19 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -59.79 -18.84 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 4.2999999999999998 111.221 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.67 -14.46 60.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 4.3300000000000001 111.164 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.67 6.03 47.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 4.3700000000000001 111.202 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.5 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 30.3 mm -74.19 -44.17 6.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.2 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 89.7 Cg_exo -49.24 -41.91 41.14 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.662 1.575 . . . . 4.4299999999999997 111.217 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.26 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 4.4699999999999998 111.167 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.16 -52.75 11.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 4.5 111.261 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.96 -37.79 61.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 4.5300000000000002 111.206 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.42 -57.72 10.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 4.5700000000000003 111.191 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.94 -30.61 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 4.5999999999999996 111.233 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.0 mt -77.08 -30.44 55.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 4.6299999999999999 111.248 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.98 -37.5 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 4.6699999999999999 111.216 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.62 -28.45 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 4.7000000000000002 111.213 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.45 -1.66 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 4.7300000000000004 111.149 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.25 25.26 40.63 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -129.95 160.09 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 4.7999999999999998 111.19 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.9 t -138.82 144.86 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 4.8300000000000001 111.219 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.03 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 4.8700000000000001 111.17 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 mt -110.38 121.58 45.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 4.9000000000000004 111.118 169.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.8 tpp -150.16 115.26 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 4.9299999999999997 111.211 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.7 176.0 7.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 4.9699999999999998 111.226 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -79.91 120.26 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 5.0 111.153 160.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 151' ' ' LEU . 4.0 mm? -90.23 -37.96 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 5.0300000000000002 111.223 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -65.16 -42.34 93.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 5.0700000000000003 111.146 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.9 126.45 75.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 5.0999999999999996 111.205 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.29 -21.26 31.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.681 1.587 . . . . 5.1299999999999999 111.202 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.39 -38.2 73.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 5.1699999999999999 111.192 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -99.33 14.93 27.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 5.2000000000000002 111.2 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.2 p -103.1 -10.92 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 5.2300000000000004 111.169 173.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.545 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 51.5 t-105 -72.43 -42.74 8.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 5.2699999999999996 111.19 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 70.8 Cg_exo -55.04 -33.27 82.76 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.73 1.62 . . . . 5.2999999999999998 111.171 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.407 HD13 ' HG ' ' A' ' 195' ' ' LEU . 63.1 mt -69.26 -24.63 64.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 5.3300000000000001 111.188 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 49.0 mm -81.3 -40.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 5.3700000000000001 111.218 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.15 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 5.4000000000000004 111.162 174.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.52 76.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 5.4299999999999997 111.153 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.04 -62.03 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 5.4699999999999998 111.206 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.99 -8.34 70.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.236 -0.746 . . . . 5.5 111.236 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.44 55.1 3.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.167 -0.773 . . . . 5.5300000000000002 111.167 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.78 151.67 33.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 5.5700000000000003 111.256 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 48.19 42.26 17.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 5.5999999999999996 111.24 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -139.93 78.82 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 5.6299999999999999 111.163 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 5.6699999999999999 111.216 -174.507 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.79 0.329 . . . . 5.9000000000000004 111.178 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 pt -95.28 5.45 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 5.9299999999999997 111.25 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.56 28.18 8.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 5.9699999999999998 111.191 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -82.25 169.97 15.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 6.0 111.157 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 95.6 t -112.87 124.84 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 6.0300000000000002 111.169 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -66.2 -39.36 94.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.212 -0.755 . . . . 6.0700000000000003 111.212 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.51 0.08 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 6.0999999999999996 111.156 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -106.16 -4.84 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 6.1299999999999999 111.226 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -83.31 160.04 21.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 6.1699999999999999 111.22 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.69 70.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 6.2000000000000002 111.193 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.82 -33.67 63.77 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.237 -0.745 . . . . 6.2300000000000004 111.237 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.76 -28.63 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 6.2699999999999996 111.154 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.04 -64.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 6.2999999999999998 111.157 -174.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.39 -34.78 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 6.3300000000000001 111.151 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -33.44 87.23 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.273 -0.731 . . . . 6.3700000000000001 111.273 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.0 tp -75.0 -39.58 61.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 6.4000000000000004 111.236 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.9 m -54.57 -46.47 73.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.179 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -63.19 -47.6 81.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 6.4699999999999998 111.177 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.491 ' C ' HD21 ' A' ' 195' ' ' LEU . 8.5 tt -50.0 -54.03 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 6.5 111.209 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.43 -36.47 76.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.144 -0.48 . . . . 6.5300000000000002 111.19 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.07 -35.02 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.5700000000000003 111.203 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.44 -27.14 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 6.5999999999999996 111.194 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.91 -36.91 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 6.6299999999999999 111.241 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.79 -21.66 59.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 6.6699999999999999 111.265 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -90.04 3.68 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 6.7000000000000002 111.216 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 62.26 35.09 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 6.7300000000000004 111.235 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -106.9 -30.01 9.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 6.7699999999999996 111.19 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 95.7 mtp -125.92 160.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 6.7999999999999998 111.169 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -125.2 118.92 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 6.8300000000000001 111.265 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.84 -24.07 67.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 6.8700000000000001 111.223 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -81.83 -10.09 59.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 6.9000000000000004 111.173 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.8 m -54.59 108.54 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.174 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -89.98 179.82 5.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 6.9699999999999998 111.202 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -63.28 -49.09 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 7.0 111.248 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.1 p -65.06 -24.03 67.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 7.0300000000000002 111.167 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.31 -47.95 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 7.0700000000000003 111.272 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.27 90.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.208 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.43 -51.97 63.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 7.1299999999999999 111.247 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.76 94.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 7.1699999999999999 111.201 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.45 94.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 7.2000000000000002 111.213 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.93 -45.48 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 7.2300000000000004 111.181 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -69.94 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 7.2699999999999996 111.201 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.85 -11.78 56.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.2999999999999998 111.206 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.33 26.12 48.81 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.163 -0.775 . . . . 7.3300000000000001 111.163 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -78.53 -34.44 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 7.3700000000000001 111.199 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 84.9 m -123.87 112.42 17.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 7.4000000000000004 111.172 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.29 93.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 7.4299999999999997 111.18 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 62.3 ttp -127.31 119.99 27.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 7.4699999999999998 111.226 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 41.1 p -127.58 179.97 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 7.5 111.19 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.16 118.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 7.5300000000000002 111.24 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -108.23 120.83 43.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.438 . . . . 7.5700000000000003 111.199 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 232' ' ' TRP . . . -77.87 -172.9 39.87 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.254 -0.739 . . . . 7.5999999999999996 111.254 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.13 -34.45 87.66 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.618 1.545 . . . . 7.6299999999999999 111.163 -175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -71.59 -31.54 67.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 7.6699999999999999 111.234 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.77 6.67 13.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 7.7000000000000002 111.239 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.461 ' N ' ' O ' ' A' ' 228' ' ' GLY . 92.3 t90 -54.15 -36.39 63.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 7.7300000000000004 111.227 -170.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.1 p -62.39 -17.37 58.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 7.7699999999999996 111.228 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -57.63 -49.93 74.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 7.7999999999999998 111.234 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.0 tp -74.45 -28.47 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 7.8300000000000001 111.158 -173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.75 -35.29 57.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 7.8700000000000001 111.233 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 76.1 m -67.15 -31.66 72.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 7.9000000000000004 111.163 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 60.6 p -69.62 -15.03 63.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 7.9299999999999997 111.171 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 58.44 50.24 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 7.9699999999999998 111.187 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.07 175.83 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 8.0 111.183 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -85.32 119.48 25.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 8.0299999999999994 111.15 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.44 160.07 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 8.0700000000000003 111.24 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -164.21 -168.17 25.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.245 -0.742 . . . . 8.0999999999999996 111.245 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 116' ' ' ILE . 77.6 t -131.25 140.08 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 8.1300000000000008 111.205 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -122.69 -173.76 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 8.1699999999999999 111.248 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.12 113.44 43.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 8.1999999999999993 111.188 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.544 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 74.2 mt -83.88 -45.41 0.78 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 8.2300000000000004 111.145 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 79.3 Cg_endo -80.64 156.01 21.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.694 1.596 . . . . 8.2699999999999996 111.168 -167.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 62.9 p -119.8 161.31 20.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 8.3000000000000007 111.279 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -123.36 100.94 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 8.3300000000000001 111.187 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 59.4 32.82 22.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 8.3699999999999992 111.221 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.82 62.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -122.11 110.03 33.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 8.4299999999999997 111.165 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 61.2 Cg_endo -70.37 143.74 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.669 1.579 . . . . 8.4700000000000006 111.248 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -139.54 -74.93 0.36 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 8.5 111.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.439 ' HB3' ' HD2' ' A' ' 257' ' ' PRO . 71.4 mmtt -131.26 158.55 74.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 8.5299999999999994 111.231 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 256' ' ' LYS . 60.0 Cg_endo -75.56 161.76 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.662 1.575 . . . . 8.5700000000000003 111.257 -174.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -73.97 125.76 28.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 8.5999999999999996 111.198 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.2 t -111.08 124.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 8.6300000000000008 111.196 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -81.77 143.74 23.59 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.175 -0.77 . . . . 8.6699999999999999 111.175 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 65.7 t -121.11 130.03 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 8.6999999999999993 111.167 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.38 131.95 52.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 8.7300000000000004 111.176 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.5 p -145.07 154.74 42.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 8.7699999999999996 111.2 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -119.14 132.59 56.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 8.8000000000000007 111.117 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.22 -179.32 16.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.184 -0.766 . . . . 8.8300000000000001 111.184 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -108.78 130.65 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.788 0.328 . . . . 8.8699999999999992 111.237 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -60.7 134.06 56.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 8.9000000000000004 111.144 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.98 -18.43 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 8.9299999999999997 111.201 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.98 58.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 8.9700000000000006 111.248 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.0 t -65.0 127.93 93.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 9.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.01 -14.97 20.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.743 1.629 . . . . 9.0299999999999994 111.234 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -130.02 74.95 1.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 9.0700000000000003 111.202 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -80.08 -22.91 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 9.0999999999999996 111.22 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -74.12 -35.56 64.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 9.1300000000000008 111.215 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.7 -42.48 77.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 9.1699999999999999 111.259 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -38.98 92.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 9.1999999999999993 111.189 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -56.19 -51.45 67.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 9.2300000000000004 111.204 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.33 -42.12 99.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 9.2699999999999996 111.115 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.92 -42.45 80.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 9.3000000000000007 111.225 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.1 -3.55 58.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 9.3300000000000001 111.167 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -103.21 -50.83 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 9.3699999999999992 111.169 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -124.73 4.88 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 9.4000000000000004 111.266 -164.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -125.07 -70.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 9.4299999999999997 111.143 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 66.3 tp -65.43 -57.58 7.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 9.4700000000000006 111.246 -172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.96 61.78 7.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 9.5 111.218 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 31.4 p -129.94 -171.13 2.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 9.5299999999999994 111.223 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -75.5 -9.91 58.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 9.5700000000000003 111.196 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -116.13 -33.81 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 9.5999999999999996 111.214 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.78 -51.04 31.94 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.158 -0.777 . . . . 9.6300000000000008 111.158 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.02 -20.69 59.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.74 0.305 . . . . 9.6699999999999999 111.135 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.1 -47.17 84.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 9.6999999999999993 111.186 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.13 80.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 9.7300000000000004 111.218 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.54 -39.72 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 9.7699999999999996 111.177 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.92 7.27 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 9.8000000000000007 111.252 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.89 -43.04 80.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 9.8300000000000001 111.237 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -98.45 -20.41 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.8699999999999992 111.248 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.96 155.24 47.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 9.9000000000000004 111.202 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.21 144.98 79.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.714 1.609 . . . . 9.9299999999999997 111.251 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 24.51 12.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.168 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -66.95 -27.2 73.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.205 -0.758 . . . . 10.0 111.205 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.98 27.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 10.029999999999999 111.203 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.6 p -159.0 141.02 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 10.07 111.19 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.68 60.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 10.1 111.168 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 38.5 tp -60.25 125.06 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 10.130000000000001 111.157 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.64 -34.85 72.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 10.17 111.261 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 47.0 t -53.78 -52.2 60.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 10.199999999999999 111.184 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -66.46 -44.14 83.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 10.23 111.199 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -52.78 -42.45 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 10.27 111.261 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.81 -40.59 79.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.228 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -29.96 63.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 10.33 111.26 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.32 -17.86 33.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 10.369999999999999 111.226 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.81 -17.45 63.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 10.4 111.216 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.7 -30.67 71.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 10.43 111.177 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -77.93 118.25 70.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 10.470000000000001 111.221 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -57.6 -39.89 84.64 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.704 1.603 . . . . 10.5 111.181 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.66 -40.04 69.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 10.529999999999999 111.255 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.3 mt -69.97 -40.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 10.57 111.163 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.96 78.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 10.6 111.223 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.78 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 10.630000000000001 111.162 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -68.57 -42.84 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 10.67 111.216 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.0 mtt -66.51 -34.39 77.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 10.699999999999999 111.244 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.65 -47.08 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.152 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -76.05 -31.66 58.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 10.77 111.218 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.5 93.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 10.800000000000001 111.277 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 10.83 111.221 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.43 13.69 17.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.216 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.6 -175.02 40.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.162 -0.775 . . . . 10.9 111.162 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . 0.469 ' HA ' ' OE1' ' A' ' 328' ' ' GLU . 5.2 tp10 -99.96 139.65 35.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 10.93 111.226 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 94.3 mt -94.75 130.43 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 10.970000000000001 111.165 -171.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 47.2 ttm -60.0 116.64 18.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 11.0 111.17 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.61 160.16 18.17 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.764 1.643 . . . . 11.029999999999999 111.246 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -109.85 20.21 18.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 11.07 111.113 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 333' ' ' ILE . 3.8 mp -86.12 122.93 72.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 11.1 111.171 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.99 -47.02 29.82 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.669 1.579 . . . . 11.130000000000001 111.269 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.81 -46.31 90.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 11.17 111.293 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.424 ' H ' HG22 ' A' ' 333' ' ' ILE . 67.1 mtt -60.06 -43.05 95.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 11.199999999999999 111.129 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.3 m -57.23 -41.14 78.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 11.23 111.117 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.63 94.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 11.27 111.213 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -71.7 -29.63 64.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.300000000000001 111.226 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -59.94 -51.98 67.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 11.33 111.163 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.73 -38.44 86.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 11.369999999999999 111.132 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -54.8 -37.72 66.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 11.4 111.211 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.4 t -71.7 -40.69 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 11.43 111.182 174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -51.06 -37.68 47.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 11.470000000000001 111.148 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.5 p -94.24 -26.98 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 11.5 111.184 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.08 -38.03 89.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 11.529999999999999 111.152 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.61 -21.6 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 11.57 111.203 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.95 -45.54 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 11.6 111.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 11.630000000000001 111.268 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.06 -39.59 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 11.67 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.28 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 11.699999999999999 111.161 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.9 p -78.31 -13.66 59.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 11.73 111.163 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.94 25.87 33.29 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.213 -0.755 . . . . 11.77 111.213 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -90.07 -48.55 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 11.800000000000001 111.178 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -124.99 165.22 18.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 11.83 111.242 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -84.77 175.06 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 11.869999999999999 111.131 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.7 t -59.31 -44.86 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 11.9 111.185 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 11.93 111.254 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.13 -44.67 87.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 11.970000000000001 111.221 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.67 94.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 12.0 111.226 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.75 -24.99 48.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 12.029999999999999 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.43 -48.31 78.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 12.07 111.178 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -69.46 -33.91 73.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 12.1 111.118 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.5 75.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 12.130000000000001 111.184 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -70.02 -56.66 6.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 12.17 111.151 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 12.199999999999999 111.171 -173.003 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.837 0.351 . . . . 0.070000000000000007 111.229 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -98.15 155.09 17.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.10000000000000001 111.139 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -93.67 155.05 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.13 111.212 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.24 16.82 54.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.235 -0.746 . . . . 0.17000000000000001 111.235 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.81 160.0 21.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.746 0.308 . . . . 0.20000000000000001 111.237 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.448 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.6 pp -145.89 153.95 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.254 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.35 135.26 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.27000000000000002 111.187 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.418 HD13 HG23 ' A' ' 37' ' ' VAL . 83.5 mt -115.6 124.97 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.29999999999999999 111.222 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -103.61 105.15 15.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.33000000000000002 111.233 172.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.454 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.8 tt -115.48 137.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.37 111.187 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -81.03 108.94 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 111.195 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.0 -173.15 46.07 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.217 -0.753 . . . . 0.42999999999999999 111.217 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -104.98 -53.04 2.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.819 0.343 . . . . 0.46999999999999997 111.186 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.12 18.71 5.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.5 111.156 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.96 -23.65 69.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.183 -0.767 . . . . 0.53000000000000003 111.183 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -53.81 -32.71 53.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.56999999999999995 111.184 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.45 -41.56 96.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.59999999999999998 111.214 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -34.88 83.39 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.218 -0.753 . . . . 0.63 111.218 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 284' ' ' LEU . 83.1 mt -81.95 -25.87 34.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 0.67000000000000004 111.197 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.63 47.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.69999999999999996 111.207 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.72999999999999998 111.246 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.56 -17.85 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.77000000000000002 111.182 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.77 -31.94 81.37 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.207 -0.757 . . . . 0.80000000000000004 111.207 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.67 -46.15 80.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.82999999999999996 111.178 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.68 -50.03 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.87 111.235 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.90000000000000002 111.199 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.79 -39.09 80.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.93000000000000005 111.223 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.23 -32.22 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.96999999999999997 111.24 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -71.31 -40.53 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.248 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.4 p -113.91 -29.97 6.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 1.03 111.181 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.62 -0.3 63.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 1.0700000000000001 111.22 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.3 mm -76.57 110.99 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.1000000000000001 111.211 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.0 124.99 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 1.1299999999999999 111.225 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.54 121.49 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 1.1699999999999999 111.171 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.16 121.31 37.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 1.2 111.241 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.418 HG23 HD13 ' A' ' 9' ' ' ILE . 40.7 t -118.18 125.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 1.23 111.136 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.27 165.73 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 1.27 111.172 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -121.45 70.07 23.45 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.215 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.42 161.99 33.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.687 1.591 . . . . 1.3300000000000001 111.231 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -124.82 -178.32 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.3700000000000001 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 54.99 39.73 31.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 1.3999999999999999 111.217 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.95 -9.17 59.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 1.4299999999999999 111.186 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.24 -27.98 69.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 1.47 111.209 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.07 -34.59 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.5 111.212 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.25 -46.43 80.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 1.53 111.183 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.537 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 81.1 t80 -62.56 -53.41 57.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 1.5700000000000001 111.132 -173.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 46.8 Cg_endo -67.76 -25.73 39.45 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.686 1.591 . . . . 1.6000000000000001 111.172 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -65.21 -35.27 80.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 1.6299999999999999 111.271 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -97.29 -26.17 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.6699999999999999 111.213 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.96 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 1.7 111.242 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.72 67.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.73 111.152 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 p -96.69 3.54 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.77 111.162 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.72 20.24 56.48 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.21 -0.756 . . . . 1.8 111.21 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' ' 56' ' ' GLY . 87.7 m-20 -119.99 -166.02 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 1.8300000000000001 111.222 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' H ' ' HB3' ' A' ' 55' ' ' ASP . . . 113.53 -164.87 12.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.205 -0.758 . . . . 1.8700000000000001 111.205 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.17 -176.32 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.714 1.609 . . . . 1.8999999999999999 111.221 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 276' ' ' ALA . 43.4 m-20 -103.33 -40.26 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.9299999999999999 111.252 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.37 138.36 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 1.97 111.226 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 42.0 mm -113.96 122.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.0 111.267 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.454 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 27.1 m-85 -100.02 110.96 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 2.0299999999999998 111.242 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.485 ' C ' ' CD1' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -145.03 -175.0 4.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 2.0699999999999998 111.228 -173.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.12 176.75 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 2.1000000000000001 111.16 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -87.43 14.58 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 2.1299999999999999 111.18 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -96.75 -29.97 13.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 111.193 172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -118.28 12.35 13.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 2.2000000000000002 111.164 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -70.01 -21.15 63.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 2.23 111.242 -172.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.97 -12.74 83.14 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.51 -54.34 37.94 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.26 -0.736 . . . . 2.2999999999999998 111.26 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 5.2 m-30 -88.89 -20.43 24.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.3300000000000001 111.196 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.48 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 2.3700000000000001 111.236 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -68.67 -31.03 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 2.3999999999999999 111.166 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -75.18 -28.96 60.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 2.4300000000000002 111.192 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.28 31.56 33.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.253 -0.739 . . . . 2.4700000000000002 111.253 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -99.58 1.16 43.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.75 0.31 . . . . 2.5 111.199 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.76 131.53 34.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 2.5299999999999998 111.26 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 149.23 34.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 2.5699999999999998 111.194 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.07 124.37 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 2.6000000000000001 111.224 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.6 mt -115.05 129.4 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 2.6299999999999999 111.212 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -125.03 104.63 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 2.6699999999999999 111.152 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.98 148.52 45.36 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.714 1.609 . . . . 2.7000000000000002 111.207 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -84.91 179.99 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.215 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.4 -49.89 74.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 2.77 111.212 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.2 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 2.7999999999999998 111.194 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.02 -45.06 83.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 2.8300000000000001 111.216 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.31 -27.93 69.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.199 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -94.64 -19.71 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 2.8999999999999999 111.204 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -79.92 -29.99 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 2.9300000000000002 111.247 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.412 ' HA ' ' H ' ' A' ' 305' ' ' LYS . 6.7 mp -96.12 150.52 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 2.9700000000000002 111.169 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.19 135.66 96.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 3.0 111.154 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.1 -47.64 24.81 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.73 1.62 . . . . 3.0299999999999998 111.161 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.8 -54.96 23.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 3.0699999999999998 111.239 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.7 m -60.06 -36.87 78.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 3.1000000000000001 111.161 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -65.65 -42.73 91.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 3.1299999999999999 111.182 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.19 -19.92 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 3.1699999999999999 111.242 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -30.0 67.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 3.2000000000000002 111.219 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.406 HG22 ' HD3' ' A' ' 107' ' ' PRO . 27.4 m -106.07 18.78 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 3.23 111.182 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -100.01 130.06 46.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 3.27 111.206 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -141.6 119.8 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 3.2999999999999998 111.148 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 65.55 43.85 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 3.3300000000000001 111.233 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.51 -42.27 2.35 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.178 -0.769 . . . . 3.3700000000000001 111.178 171.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -109.97 -178.78 3.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.807 0.336 . . . . 3.3999999999999999 111.216 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.47 154.47 18.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 3.4300000000000002 111.213 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.7 pt -113.99 -4.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 3.4700000000000002 111.157 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 167.22 21.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 3.5 111.181 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.3 m-30 -110.61 137.88 20.86 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 3.5299999999999998 111.17 170.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 46.9 Cg_exo -61.59 143.7 97.08 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.652 1.568 . . . . 3.5699999999999998 111.213 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.1 mt -109.2 -58.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 3.6000000000000001 111.195 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.62 160.9 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 3.6299999999999999 111.217 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -107.77 145.87 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 3.6699999999999999 111.191 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -120.04 -179.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 3.7000000000000002 111.196 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.55 167.89 16.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 3.73 111.198 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.512 HD22 ' HD3' ' A' ' 159' ' ' PRO . 65.1 tp -161.55 118.47 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 3.77 111.175 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -162.15 -178.02 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 3.7999999999999998 111.206 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.2 tp -95.09 126.72 40.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 3.8300000000000001 111.15 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.2 mt -109.27 132.66 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 3.8700000000000001 111.173 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -148.7 159.16 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 3.8999999999999999 111.17 -172.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.33 117.55 30.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 3.9300000000000002 111.177 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -68.72 -47.49 66.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 3.9700000000000002 111.23 -175.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.69 -39.13 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 4.0 111.269 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.7 tp -65.48 -42.54 92.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.154 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.1 mt -125.02 73.46 65.59 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 4.0700000000000003 111.111 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.58 142.3 16.19 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.195 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -70.64 149.76 95.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 4.1299999999999999 111.222 -12.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 89.4 Cg_exo -52.21 132.48 43.96 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.676 1.584 . . . . 4.1699999999999999 111.222 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 76.2 Cg_exo -53.08 133.55 52.56 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.723 1.615 . . . . 4.2000000000000002 111.223 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -112.68 -17.11 12.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 4.2300000000000004 111.198 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -157.33 176.92 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 4.2699999999999996 111.186 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -75.13 -19.96 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 4.2999999999999998 111.221 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.1 -13.19 61.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 4.3300000000000001 111.205 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -107.29 13.69 26.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 4.3700000000000001 111.2 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.572 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 94.3 mt -76.63 -41.26 2.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.197 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 85.8 Cg_exo -53.37 -28.39 43.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.739 1.626 . . . . 4.4299999999999997 111.167 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.96 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 4.4699999999999998 111.166 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.8 tp -79.15 -43.92 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 4.5 111.241 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -31.81 71.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 4.5300000000000002 111.21 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.67 -28.73 58.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 4.5700000000000003 111.206 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -80.12 -32.07 39.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 4.5999999999999996 111.261 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 91.7 mt -86.13 -7.67 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 4.6299999999999999 111.182 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.95 -44.94 78.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 4.6699999999999999 111.133 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.74 68.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 4.7000000000000002 111.144 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.61 -8.8 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 4.7300000000000004 111.211 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 27.53 60.25 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.206 -0.758 . . . . 4.7699999999999996 111.206 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 75.1 mmtt -115.55 159.13 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.873 0.368 . . . . 4.7999999999999998 111.177 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.9 t -98.86 153.92 18.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 4.8300000000000001 111.229 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.74 -26.75 64.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 4.8700000000000001 111.167 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.16 154.92 34.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 4.9000000000000004 111.16 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.8 mtm -108.11 115.7 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 4.9299999999999997 111.256 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.479 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 93.8 m-85 -95.5 130.81 42.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 4.9699999999999998 111.244 -154.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -117.69 77.29 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 5.0 111.152 164.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 149' ' ' PHE . 96.6 mt -97.86 -0.83 44.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 5.0300000000000002 111.139 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -71.54 -22.04 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 5.0700000000000003 111.224 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.44 150.96 53.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.269 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.17 -15.03 18.47 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.679 1.586 . . . . 5.1299999999999999 111.205 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.18 -29.21 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 5.1699999999999999 111.146 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -74.11 -41.03 62.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 5.2000000000000002 111.199 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -96.34 -8.56 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 5.2300000000000004 111.187 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.495 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 77.2 t90 -58.04 -46.0 99.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 5.2699999999999996 111.186 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.512 ' HD3' HD22 ' A' ' 113' ' ' LEU . 98.4 Cg_endo -84.05 -20.08 4.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.65 1.567 . . . . 5.2999999999999998 111.197 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.35 -45.86 75.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.164 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.96 -33.61 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 5.3700000000000001 111.198 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.46 -4.16 59.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 5.4000000000000004 111.217 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.02 72.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.4299999999999997 111.245 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -91.08 -10.06 43.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.179 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.25 25.12 49.37 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.153 -0.779 . . . . 5.5 111.153 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.82 -1.99 36.74 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.214 -0.755 . . . . 5.5300000000000002 111.214 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.13 106.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 5.5700000000000003 111.237 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 64.55 22.25 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 5.5999999999999996 111.211 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.37 147.29 28.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 5.6299999999999999 111.166 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 5.6699999999999999 111.194 -177.251 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.6 t0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.797 0.332 . . . . 5.9000000000000004 111.22 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.9 tt -69.97 -17.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 5.9299999999999997 111.203 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -80.04 -17.45 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 5.9699999999999998 111.17 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.82 169.92 16.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 6.0 111.2 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.57 91.23 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 6.0300000000000002 111.167 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.07 32.1 7.86 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.162 -0.775 . . . . 6.0700000000000003 111.162 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.45 -22.58 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.759 0.314 . . . . 6.0999999999999996 111.143 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -99.6 12.51 36.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.197 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.44 141.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 6.1699999999999999 111.177 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.43 -37.01 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 6.2000000000000002 111.179 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.63 -32.73 45.21 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.15 -0.78 . . . . 6.2300000000000004 111.15 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.82 -48.51 58.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.339 . . . . 6.2699999999999996 111.196 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -69.8 -24.17 63.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 6.2999999999999998 111.172 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 6.3300000000000001 111.187 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.07 -39.73 96.52 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.232 -0.747 . . . . 6.3700000000000001 111.232 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.5 tp -72.33 -30.62 64.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 6.4000000000000004 111.227 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.1 m -64.41 -42.69 95.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 6.4299999999999997 111.22 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -58.72 -47.18 85.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 6.4699999999999998 111.207 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.3 tp -46.56 -45.04 18.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 6.5 111.18 174.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -74.02 -36.85 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 6.5300000000000002 111.175 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.97 -36.84 68.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 6.5700000000000003 111.171 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.13 -32.86 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 6.5999999999999996 111.195 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.43 -40.03 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 6.6299999999999999 111.104 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.85 -29.63 70.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 6.6699999999999999 111.151 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -76.19 -8.96 58.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 6.7000000000000002 111.225 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 64.85 35.09 8.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 6.7300000000000004 111.174 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -129.15 53.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 6.7699999999999996 111.173 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 47.5 ttm -159.15 147.63 18.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 6.7999999999999998 111.224 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -146.5 114.63 6.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.429 . . . . 6.8300000000000001 111.159 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.42 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 6.8700000000000001 111.183 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.38 -25.89 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 6.9000000000000004 111.211 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.8 p -75.24 149.89 38.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 6.9299999999999997 111.213 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.78 -165.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 6.9699999999999998 111.211 -170.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.86 -51.87 67.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.0 111.165 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.1 p -70.83 -29.71 65.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 7.0300000000000002 111.244 -171.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.99 -45.03 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 7.0700000000000003 111.223 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 7.0999999999999996 111.171 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.24 -41.45 94.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 7.1299999999999999 111.22 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.0 -36.29 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 7.1699999999999999 111.158 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.06 93.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 7.2000000000000002 111.167 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.38 -33.44 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 7.2300000000000004 111.212 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -60.06 -39.35 85.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 7.2699999999999996 111.236 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 -30.22 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 7.2999999999999998 111.2 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.1 34.99 13.08 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.259 -0.737 . . . . 7.3300000000000001 111.259 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.14 -35.0 68.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 7.3700000000000001 111.204 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.9 m -129.99 139.18 51.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 7.4000000000000004 111.189 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.35 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 7.4299999999999997 111.143 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -85.09 153.68 22.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 7.4699999999999998 111.241 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.1 t -169.3 179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 7.5 111.287 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.34 118.63 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 7.5300000000000002 111.17 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -160.69 177.89 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 7.5700000000000003 111.189 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.79 -134.38 7.83 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.168 -0.773 . . . . 7.5999999999999996 111.168 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.77 -177.11 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.169 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 69.87 17.95 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 7.6699999999999999 111.161 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.66 -24.09 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 7.7000000000000002 111.188 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 97.9 m95 -69.52 -14.95 63.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 7.7300000000000004 111.123 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.6 p -64.96 -20.95 66.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 7.7699999999999996 111.216 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.05 -28.56 8.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 7.7999999999999998 111.225 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.2 mt -64.85 -45.11 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 7.8300000000000001 111.254 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -74.55 -33.8 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 7.8700000000000001 111.198 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.7 m -64.14 -44.6 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 7.9000000000000004 111.234 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.9 p -78.18 -15.04 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 7.9299999999999997 111.235 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.63 45.97 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 7.9699999999999998 111.217 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.84 141.21 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 8.0 111.157 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -74.87 78.69 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 8.0299999999999994 111.209 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -89.96 127.65 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 8.0700000000000003 111.183 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -100.4 166.39 19.72 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.223 -0.751 . . . . 8.0999999999999996 111.223 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 88.5 t -139.6 134.98 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.773 0.32 . . . . 8.1300000000000008 111.253 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.2 t -135.06 150.17 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 8.1699999999999999 111.21 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.4 t -70.29 110.81 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 8.1999999999999993 111.16 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.507 ' N ' ' HD2' ' A' ' 248' ' ' PRO . 53.0 tp -75.38 -47.82 4.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 8.2300000000000004 111.282 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 247' ' ' LEU . 85.7 Cg_endo -78.41 143.2 19.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.764 1.642 . . . . 8.2699999999999996 111.228 -173.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 78.8 m -107.74 133.59 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 8.3000000000000007 111.182 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -108.46 99.71 9.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 8.3300000000000001 111.221 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 57.69 35.14 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 8.3699999999999992 111.12 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 98.6 -15.57 60.84 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.175 -0.77 . . . . 8.4000000000000004 111.175 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -130.06 110.0 16.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 8.4299999999999997 111.161 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.8 151.69 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.7 1.6 . . . . 8.4700000000000006 111.268 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 98.9 p -137.6 -75.01 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 8.5 111.201 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -134.07 163.35 51.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 8.5299999999999994 111.163 -174.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.97 144.47 56.5 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.721 1.614 . . . . 8.5700000000000003 111.173 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -73.81 140.59 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 8.5999999999999996 111.185 -175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.441 HG12 HG21 ' A' ' 261' ' ' VAL . 61.6 t -107.1 106.76 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 8.6300000000000008 111.221 -170.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -84.93 85.08 1.58 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.169 -0.773 . . . . 8.6699999999999999 111.169 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 259' ' ' VAL . 36.9 t -68.18 142.35 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 8.6999999999999993 111.188 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.87 154.9 18.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 8.7300000000000004 111.257 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 91.2 p -143.71 155.13 44.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 8.7699999999999996 111.199 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' ILE . . . -121.76 124.3 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 8.8000000000000007 111.245 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -103.97 177.29 24.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.177 -0.769 . . . . 8.8300000000000001 111.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 87.5 mt -124.14 132.0 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 8.8699999999999992 111.2 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -69.32 114.28 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.148 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.54 -24.72 66.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 8.9299999999999997 111.163 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 8.9700000000000006 111.217 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -66.06 136.74 95.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 9.0 111.235 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.79 -12.1 26.24 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.727 1.618 . . . . 9.0299999999999994 111.206 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.59 21.51 8.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 9.0700000000000003 111.201 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -62.78 -21.88 66.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 9.0999999999999996 111.174 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.36 -34.5 77.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 9.1300000000000008 111.194 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 9.1699999999999999 111.155 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . . . -65.03 -41.86 94.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 9.1999999999999993 111.168 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.75 -44.55 81.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 9.2300000000000004 111.234 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -80.11 -52.75 7.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 9.2699999999999996 111.227 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -63.8 -37.05 85.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 9.3000000000000007 111.224 -171.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 284' ' ' LEU . 40.1 tp -68.12 -48.16 66.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 9.3300000000000001 111.187 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -72.08 -28.98 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 9.3699999999999992 111.182 -173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -99.56 -40.2 7.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 9.4000000000000004 111.181 -166.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.17 -54.84 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 9.4299999999999997 111.15 -169.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 20' ' ' LEU . 95.1 mt -64.1 -49.59 71.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 9.4700000000000006 111.148 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.85 51.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 9.5 111.165 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 76.7 p -124.97 -175.94 3.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 9.5299999999999994 111.153 170.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -53.29 -40.56 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 9.5700000000000003 111.197 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.35 -37.95 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 9.5999999999999996 111.134 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.37 -43.24 93.09 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.99 -36.23 83.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 9.6699999999999999 111.231 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -69.04 -41.86 77.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 9.6999999999999993 111.204 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.26 87.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 9.7300000000000004 111.154 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 68.0 t -74.91 -40.83 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 9.7699999999999996 111.17 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -75.93 -2.93 32.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 9.8000000000000007 111.203 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.05 -38.14 67.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 9.8300000000000001 111.195 165.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -108.5 -34.03 6.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 9.8699999999999992 111.158 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.03 160.63 40.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 9.9000000000000004 111.205 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.65 139.38 67.29 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.667 1.578 . . . . 9.9299999999999997 111.167 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.38 -24.19 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 9.9700000000000006 111.153 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.77 -28.84 70.71 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.153 -0.779 . . . . 10.0 111.153 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.91 122.83 13.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.779 0.323 . . . . 10.029999999999999 111.228 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.85 136.6 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.16 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -103.36 -34.79 8.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 10.1 111.188 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.16 138.72 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 10.130000000000001 111.176 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.412 ' H ' ' HA ' ' A' ' 89' ' ' LEU . 59.8 tttm -61.36 -39.04 89.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 10.17 111.222 168.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 44.6 t -56.05 -48.62 75.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 10.199999999999999 111.175 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.55 -37.71 83.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 10.23 111.224 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.67 -36.74 77.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 10.27 111.173 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.73 -30.03 70.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 10.300000000000001 111.248 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.4 -32.16 62.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 10.33 111.198 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.22 -26.18 62.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 10.369999999999999 111.226 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.88 -19.22 65.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 10.4 111.324 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.48 -24.93 67.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 10.43 111.221 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -101.92 109.99 61.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 10.470000000000001 111.205 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.97 -32.92 80.78 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.659 1.573 . . . . 10.5 111.188 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.55 -28.09 67.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 10.529999999999999 111.264 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -91.01 -38.5 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 10.57 111.218 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.02 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 10.6 111.254 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.48 -35.5 74.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 10.630000000000001 111.231 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.1 p -91.33 -19.95 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 10.67 111.211 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.0 mmt -74.21 -35.92 63.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 10.699999999999999 111.205 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.5 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 10.73 111.285 171.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.32 -42.75 99.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 10.77 111.2 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.42 93.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 10.800000000000001 111.21 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.05 -42.5 99.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 10.83 111.179 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -94.95 7.53 45.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 10.869999999999999 111.198 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.88 -162.66 35.9 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.268 -0.733 . . . . 10.9 111.268 172.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -119.8 132.38 55.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 10.93 111.213 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.17 136.22 25.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 10.970000000000001 111.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 50.0 tpp -59.93 114.41 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 11.0 111.247 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 38.7 Cg_exo -60.31 133.74 51.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.678 1.585 . . . . 11.029999999999999 111.221 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -94.18 72.81 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 11.07 111.207 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 80.4 mt -123.15 116.11 28.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 11.1 111.185 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.06 -33.45 73.6 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.632 1.555 . . . . 11.130000000000001 111.26 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -71.46 -27.86 63.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 11.17 111.23 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -86.88 -20.62 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 11.199999999999999 111.157 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 98.2 p -64.15 -29.98 71.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.178 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.97 -49.51 70.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 11.27 111.247 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -56.76 -48.74 77.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 11.300000000000001 111.173 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -68.75 -43.58 75.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 11.33 111.176 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 -73.89 -30.55 62.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 11.369999999999999 111.259 -176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.65 75.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 11.4 111.188 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.28 -21.82 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 11.43 111.279 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -56.56 -48.93 76.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 11.470000000000001 111.186 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 71.0 p -65.2 -29.7 70.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 11.5 111.175 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.03 -44.22 89.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 11.529999999999999 111.173 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.77 -38.52 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.173 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.92 -42.69 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 11.6 111.208 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -65.0 -39.17 93.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 11.630000000000001 111.21 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.45 -21.96 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 11.67 111.206 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.52 -30.39 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 11.699999999999999 111.22 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.5 p -86.16 -22.16 27.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 11.73 111.181 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.85 30.35 26.56 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.233 -0.747 . . . . 11.77 111.233 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -109.94 2.61 19.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 11.800000000000001 111.238 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -159.58 137.01 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 11.83 111.212 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 62.1 p -70.0 164.97 22.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 11.869999999999999 111.255 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.5 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 11.9 111.233 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.19 -46.99 88.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 11.93 111.207 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.87 -37.53 79.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 11.970000000000001 111.191 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.69 92.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 12.0 111.214 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 94.5 mt -74.98 -24.89 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 12.029999999999999 111.18 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.71 -49.3 73.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 12.07 111.167 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.84 -34.21 77.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.208 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.01 -59.56 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 12.130000000000001 111.2 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -54.94 -43.25 73.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 12.17 111.209 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 83.7 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 12.199999999999999 111.26 178.871 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.1 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.777 0.323 . . . . 0.070000000000000007 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -55.01 130.04 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.10000000000000001 111.226 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.27 129.44 40.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.13 111.194 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.62 27.94 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.258 -0.737 . . . . 0.17000000000000001 111.258 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.98 132.53 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.20000000000000001 111.252 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.71 120.02 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.23000000000000001 111.211 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.34 115.04 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.27000000000000002 111.212 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.419 HG12 ' HB ' ' A' ' 59' ' ' ILE . 73.6 mt -115.05 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.29999999999999999 111.197 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -110.09 129.06 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.33000000000000002 111.194 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.0 mt -101.42 115.08 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.37 111.158 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -97.7 89.24 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.40000000000000002 111.225 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.5 -145.65 7.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.264 -0.735 . . . . 0.42999999999999999 111.264 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.47 22.77 8.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.46999999999999997 111.195 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -102.29 156.87 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.5 111.248 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.95 -164.98 38.01 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.185 -0.766 . . . . 0.53000000000000003 111.185 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -158.98 25.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.56999999999999995 111.215 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -59.68 -40.29 87.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.59999999999999998 111.187 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.07 -27.51 28.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.212 -0.755 . . . . 0.63 111.212 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.91 -40.51 95.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.67000000000000004 111.262 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.05 78.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.69999999999999996 111.178 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -65.0 -29.07 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.72999999999999998 111.227 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.5 t -72.66 -40.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.77000000000000002 111.188 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.87 82.18 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.234 -0.746 . . . . 0.80000000000000004 111.234 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.79 -36.88 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 111.175 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.53 -24.07 45.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.87 111.239 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.02 -32.68 70.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.90000000000000002 111.157 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -74.8 -36.95 62.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.93000000000000005 111.202 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.31 -46.06 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.96999999999999997 111.188 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.54 -58.79 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.163 -170.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -89.45 -49.27 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 1.03 111.2 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.49 21.4 3.03 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.205 -0.758 . . . . 1.0700000000000001 111.205 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.29 114.99 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 1.1000000000000001 111.191 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.25 110.08 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 1.1299999999999999 111.169 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.2 t -97.91 121.49 48.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 1.1699999999999999 111.119 -174.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.0 m -117.97 121.03 39.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.2 111.266 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 9' ' ' ILE . 46.9 t -107.36 125.38 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 1.23 111.207 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.99 172.04 12.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 1.27 111.237 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.445 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 37.2 t60 -139.97 52.73 3.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 1.3 111.168 -174.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 72.8 Cg_endo -72.01 152.67 57.42 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.649 1.566 . . . . 1.3300000000000001 111.26 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -101.92 -177.04 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.433 . . . . 1.3700000000000001 111.217 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 53.12 46.1 27.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 1.3999999999999999 111.233 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 90.3 mt -93.84 -37.75 11.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 1.4299999999999999 111.176 -174.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 pm0 -69.66 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 1.47 111.218 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -89.48 -19.58 24.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 1.5 111.19 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -110.19 -25.14 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 1.53 111.232 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.514 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.2 m-30 -58.51 -45.14 99.69 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 1.5700000000000001 111.22 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 64.8 Cg_exo -55.48 -30.96 76.16 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.656 1.57 . . . . 1.6000000000000001 111.247 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.02 -43.74 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.191 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -75.63 -23.32 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.6699999999999999 111.147 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -24.47 66.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 1.7 111.205 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.75 -8.05 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 1.73 111.167 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.0 p -114.01 -11.93 12.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 1.77 111.23 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.3 25.51 30.84 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.231 -0.748 . . . . 1.8 111.231 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -114.81 170.71 8.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 1.8300000000000001 111.244 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.48 -174.4 16.6 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.202 -0.759 . . . . 1.8700000000000001 111.202 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -74.87 -176.39 2.82 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.757 1.638 . . . . 1.8999999999999999 111.155 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -104.18 -48.12 3.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 1.9299999999999999 111.181 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.419 ' HB ' HG12 ' A' ' 9' ' ' ILE . 96.2 mt -112.4 133.16 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 1.97 111.174 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.8 mt -131.2 129.78 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 2.0 111.152 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -85.93 142.89 28.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 2.0299999999999998 111.195 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -141.21 163.95 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 2.0699999999999998 111.231 174.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.46 166.22 11.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 2.1000000000000001 111.167 164.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -61.29 -30.28 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 2.1299999999999999 111.178 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -82.07 -0.86 46.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 2.1699999999999999 111.244 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.4 -25.06 7.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 2.2000000000000002 111.179 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -58.63 -43.18 89.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 2.23 111.186 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.97 -48.24 87.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 2.27 111.204 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.88 -38.03 42.71 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.192 -0.763 . . . . 2.2999999999999998 111.192 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -69.92 -37.4 75.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 2.3300000000000001 111.192 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.85 -36.17 64.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 2.3700000000000001 111.201 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.14 -42.44 85.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 2.3999999999999999 111.195 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.7 p -71.13 -14.98 62.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 2.4300000000000002 111.12 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.17 32.21 23.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.254 -0.738 . . . . 2.4700000000000002 111.254 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.14 -6.65 25.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.842 0.353 . . . . 2.5 111.188 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 tp -114.9 133.82 55.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 2.5299999999999998 111.229 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.92 146.84 37.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 2.5699999999999998 111.218 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.57 129.27 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 2.6000000000000001 111.257 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -121.02 133.45 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 2.6299999999999999 111.179 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -120.83 101.5 45.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 2.6699999999999999 111.235 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.36 147.44 32.62 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 121.692 1.595 . . . . 2.7000000000000002 111.176 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.99 148.97 38.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 2.73 111.194 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -53.45 -47.64 69.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 2.77 111.187 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 2.7999999999999998 111.191 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.15 -51.32 64.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 2.8300000000000001 111.175 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.9 -19.94 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 2.8700000000000001 111.185 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.46 -34.96 68.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 2.8999999999999999 111.149 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.56 -22.47 56.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 2.9300000000000002 111.222 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.72 154.93 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 2.9700000000000002 111.164 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.03 136.11 87.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 3.0 111.184 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.03 -14.96 23.54 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.676 1.584 . . . . 3.0299999999999998 111.227 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -80.37 -31.78 37.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 3.0699999999999998 111.191 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.4 p -96.03 -23.17 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 3.1000000000000001 111.201 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -62.51 -40.06 95.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 3.1299999999999999 111.199 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.6 -8.22 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 3.1699999999999999 111.235 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.36 -3.71 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 3.2000000000000002 111.232 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.5 66.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 3.23 111.226 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -129.76 154.98 46.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 3.27 111.179 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -153.1 129.9 10.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.205 -0.452 . . . . 3.2999999999999998 111.214 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 t30 62.62 29.85 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 3.3300000000000001 111.202 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.23 88.34 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.166 -0.774 . . . . 3.3700000000000001 111.166 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.55 145.55 47.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.766 0.317 . . . . 3.3999999999999999 111.18 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -71.37 137.52 48.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 3.4300000000000002 111.198 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.2 pt -123.94 -2.58 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 3.4700000000000002 111.224 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.6 168.87 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 3.5 111.211 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -109.52 129.15 24.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 3.5299999999999998 111.243 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.32 133.06 20.29 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.683 1.589 . . . . 3.5699999999999998 111.185 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.6 mt -113.23 -63.43 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 3.6000000000000001 111.192 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.39 149.87 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 3.6299999999999999 111.25 -172.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.13 157.04 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 3.6699999999999999 111.222 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -115.49 151.09 35.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 3.7000000000000002 111.217 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.21 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 3.73 111.195 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -127.49 172.48 10.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 3.77 111.204 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.9 p -138.71 150.32 46.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 3.7999999999999998 111.11 -172.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 247' ' ' LEU . 2.0 tt -94.25 106.42 18.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 3.8300000000000001 111.191 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 81.7 mt -92.18 125.14 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 3.8700000000000001 111.178 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.38 158.54 43.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 3.8999999999999999 111.202 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -84.93 99.94 11.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 3.9300000000000002 111.187 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -56.01 -47.83 77.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 3.9700000000000002 111.128 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.72 -52.19 65.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 4.0 111.217 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.93 -60.11 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 4.0300000000000002 111.214 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.45 87.64 51.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 4.0700000000000003 111.237 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.27 -14.71 25.55 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.681 1.587 . . . . 4.0999999999999996 111.173 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -90.53 110.05 38.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 4.1299999999999999 111.184 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.53 157.65 25.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.661 1.574 . . . . 4.1699999999999999 111.183 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.01 141.06 79.9 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.692 1.595 . . . . 4.2000000000000002 111.153 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.91 -18.7 36.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 4.2300000000000004 111.216 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.6 t -157.67 -178.28 7.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 4.2699999999999996 111.182 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -65.65 -35.67 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 4.2999999999999998 111.215 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -74.24 -6.58 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 4.3300000000000001 111.2 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -104.63 9.94 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 4.3700000000000001 111.174 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.558 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 88.7 mt -71.47 -41.62 10.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 4.4000000000000004 111.15 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 84.2 Cg_exo -52.53 -30.52 45.02 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.715 1.61 . . . . 4.4299999999999997 111.153 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.75 -37.05 67.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 4.4699999999999998 111.205 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -67.23 -47.88 69.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 4.5 111.194 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.13 -29.33 70.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 4.5300000000000002 111.223 -171.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.9 -44.95 64.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 4.5700000000000003 111.158 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -94.01 -30.93 14.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 4.5999999999999996 111.139 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.96 -27.8 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.202 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.42 -41.62 63.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 4.6699999999999999 111.214 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.18 -5.74 59.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 4.7000000000000002 111.225 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.74 12.34 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 4.7300000000000004 111.175 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.08 24.9 70.3 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -140.2 179.78 6.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 4.7999999999999998 111.134 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -151.38 138.05 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 4.8300000000000001 111.175 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.43 -60.61 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.141 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.7 tp -135.96 119.54 17.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 4.9000000000000004 111.221 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mtm -115.48 101.51 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 4.9299999999999997 111.174 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -110.06 135.84 50.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 4.9699999999999998 111.203 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -59.99 113.97 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 5.0 111.194 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.78 -24.84 63.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 5.0300000000000002 111.245 -169.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -100.84 -39.61 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 5.0700000000000003 111.22 -171.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -78.71 128.32 77.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 5.0999999999999996 111.217 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -73.21 -20.2 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.738 1.626 . . . . 5.1299999999999999 111.149 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -54.48 -43.24 71.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 5.1699999999999999 111.131 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -79.9 -19.99 46.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 5.2000000000000002 111.234 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 64.8 p -99.35 -5.54 29.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 5.2300000000000004 111.221 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.583 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 83.1 t90 -62.24 -45.42 90.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 5.2699999999999996 111.255 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 40.7 Cg_exo -61.29 -38.54 64.59 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.731 1.621 . . . . 5.2999999999999998 111.167 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.74 -60.02 4.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 5.3300000000000001 111.201 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 167' ' ' TYR . 20.8 tt -70.18 -22.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 5.3700000000000001 111.181 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -88.78 -4.07 58.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 5.4000000000000004 111.205 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -113.1 -10.47 13.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.214 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -95.57 -31.46 13.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 5.4699999999999998 111.188 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.6 33.35 2.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 5.5 111.223 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.64 11.35 23.4 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 161' ' ' ILE . 84.1 t80 -131.84 109.77 10.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 5.5700000000000003 111.187 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 63.62 33.18 13.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 5.5999999999999996 111.234 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 74.7 m-85 -124.96 95.3 4.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 5.6299999999999999 111.205 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.6699999999999999 111.141 171.778 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 22.3 t0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.732 0.301 . . . . 5.9000000000000004 111.264 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.4 pt -114.97 29.64 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 5.9299999999999997 111.191 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.57 -59.96 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 5.9699999999999998 111.203 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -90.32 169.96 10.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 6.0 111.184 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.0 t -88.82 139.85 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 6.0300000000000002 111.217 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.33 24.07 15.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.17 -0.772 . . . . 6.0700000000000003 111.17 -169.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.55 -20.81 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 6.0999999999999996 111.23 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -105.36 23.1 14.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 6.1299999999999999 111.235 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -95.58 136.79 35.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 6.1699999999999999 111.179 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.74 -27.83 63.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 6.2000000000000002 111.209 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.77 -31.6 81.43 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.129 -0.788 . . . . 6.2300000000000004 111.129 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -45.09 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 6.2699999999999996 111.18 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -66.18 -40.97 90.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 6.2999999999999998 111.177 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.99 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.285 -0.416 . . . . 6.3300000000000001 111.165 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.24 -41.22 92.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 6.3700000000000001 111.218 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 30.2 tp -69.69 -36.18 75.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 6.4000000000000004 111.138 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.8 m -62.86 -41.68 99.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 6.4299999999999997 111.233 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.23 -44.52 95.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.193 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.7 tp -56.85 -41.32 77.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 6.5 111.136 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.401 ' HA ' HD13 ' A' ' 199' ' ' ILE . 54.1 t -70.34 -34.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 6.5300000000000002 111.205 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.9 -34.3 77.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 6.5700000000000003 111.192 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.66 -23.35 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.5999999999999996 111.198 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 196' ' ' VAL . 92.9 mt -78.85 -49.78 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 6.6299999999999999 111.151 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.67 -25.35 53.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 6.6699999999999999 111.129 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -94.65 10.77 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 6.7000000000000002 111.25 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 59.98 52.47 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 6.7300000000000004 111.194 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -107.17 -29.84 9.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.236 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 19.0 ptp -155.13 164.95 38.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 6.7999999999999998 111.198 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -145.0 -169.96 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 6.8300000000000001 111.171 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.1 82.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 6.8700000000000001 111.184 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.22 -37.86 86.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 6.9000000000000004 111.239 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.2 m -53.88 109.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.217 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -147.19 -164.34 1.98 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.257 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -50.64 -42.6 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 7.0 111.199 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.3 p -66.84 -18.27 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 7.0300000000000002 111.21 -169.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -103.35 -54.91 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 7.0700000000000003 111.194 176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.0 -61.7 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 7.0999999999999996 111.213 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -92.75 -53.63 4.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 7.1299999999999999 111.266 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.04 -52.4 49.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 7.1699999999999999 111.217 -167.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.66 95.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 7.2000000000000002 111.171 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.06 -51.08 70.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 7.2300000000000004 111.216 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.02 -32.08 73.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 7.2699999999999996 111.176 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -63.55 -43.78 96.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 7.2999999999999998 111.226 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 122.31 19.38 3.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.193 -0.763 . . . . 7.3300000000000001 111.193 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 7.3700000000000001 111.234 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.7 m -113.38 124.99 53.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 7.4000000000000004 111.198 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.63 76.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 7.4299999999999997 111.181 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -167.83 144.98 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 7.4699999999999998 111.253 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.3 t -155.96 163.79 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 7.5 111.226 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.55 130.3 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 7.5300000000000002 111.135 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -156.96 173.78 16.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 7.5700000000000003 111.229 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.0 -61.21 7.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.179 -0.769 . . . . 7.5999999999999996 111.179 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.94 144.96 98.79 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.219 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -79.61 156.53 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 7.6699999999999999 111.191 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.2 13.65 30.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 7.7000000000000002 111.183 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -62.81 -32.07 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 7.7300000000000004 111.237 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.7 p -87.61 -9.84 53.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 7.7699999999999996 111.172 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -95.42 0.99 53.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 7.7999999999999998 111.185 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.7 mt -69.19 -55.22 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 7.8300000000000001 111.201 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.78 -24.13 62.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 7.8700000000000001 111.178 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.0 m -65.03 -46.94 79.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 7.9000000000000004 111.216 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 69.0 m -100.01 -2.65 33.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 7.9299999999999997 111.191 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.04 34.91 13.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 7.9699999999999998 111.211 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.97 135.96 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 8.0 111.206 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.13 122.55 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 8.0299999999999994 111.2 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -118.35 146.34 44.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 8.0700000000000003 111.176 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -110.91 157.31 15.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.212 -0.755 . . . . 8.0999999999999996 111.212 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.72 130.03 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 8.1300000000000008 111.174 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -141.98 -169.96 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 8.1699999999999999 111.145 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 98.6 t -93.02 118.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 8.1999999999999993 111.169 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.532 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 49.9 tp -90.25 -45.0 0.4 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 8.2300000000000004 111.133 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 74.2 Cg_exo -55.28 128.1 29.06 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.706 1.604 . . . . 8.2699999999999996 111.179 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.2 m -138.88 126.6 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 8.3000000000000007 111.184 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.85 127.37 44.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 8.3300000000000001 111.197 -175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 86.3 tttt 44.62 45.14 7.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 8.3699999999999992 111.184 -170.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.04 78.78 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 254' ' ' PRO . 62.4 tp60 -130.0 109.93 16.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 8.4299999999999997 111.233 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 253' ' ' GLN . 67.2 Cg_endo -70.11 137.09 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.728 1.619 . . . . 8.4700000000000006 111.184 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 62.8 p -154.94 -75.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 8.5 111.241 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -159.95 138.51 7.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 8.5299999999999994 111.171 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.455 ' HD3' ' HG2' ' A' ' 248' ' ' PRO . 63.3 Cg_endo -74.25 168.6 24.42 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.227 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 330' ' ' MET . 16.5 t80 -54.94 116.87 2.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 8.5999999999999996 111.177 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.54 104.32 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 8.6300000000000008 111.192 -163.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.39 140.03 21.59 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.196 -0.762 . . . . 8.6699999999999999 111.196 164.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.35 108.31 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.311 . . . . 8.6999999999999993 111.193 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 51.1 tp -57.31 120.36 8.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 8.7300000000000004 111.167 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.8 m -138.29 153.54 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 8.7699999999999996 111.172 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.59 137.9 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 8.8000000000000007 111.207 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.97 -174.48 14.98 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.227 -0.749 . . . . 8.8300000000000001 111.227 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.0 mt -111.88 128.64 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 8.8699999999999992 111.191 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -57.81 123.09 14.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.251 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 8.9299999999999997 111.196 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.13 54.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 8.9700000000000006 111.272 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.99 127.98 93.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 9.0 111.206 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.7 -4.1 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.717 1.612 . . . . 9.0299999999999994 111.225 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -110.06 30.79 6.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 9.0700000000000003 111.145 -171.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -51.95 -36.71 50.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 9.0999999999999996 111.183 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.26 -49.64 75.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 9.1300000000000008 111.188 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.16 -43.3 95.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 9.1699999999999999 111.195 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 9.1999999999999993 111.131 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -68.3 -42.27 79.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 9.2300000000000004 111.154 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -56.89 -49.53 75.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 9.2699999999999996 111.209 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -57.54 -59.94 4.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 9.3000000000000007 111.179 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.81 -38.8 82.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 9.3300000000000001 111.194 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.94 -43.84 10.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 9.3699999999999992 111.218 -168.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -103.51 -6.18 22.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 9.4000000000000004 111.224 -166.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.94 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 9.4299999999999997 111.194 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.67 -60.55 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 9.4700000000000006 111.169 -166.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.17 64.9 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 9.5 111.164 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 24.5 p -130.05 -179.99 5.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 9.5299999999999994 111.275 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.96 -27.01 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 9.5700000000000003 111.158 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -92.93 -39.89 10.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 9.5999999999999996 111.173 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -64.78 -46.77 88.71 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.196 -0.762 . . . . 9.6300000000000008 111.196 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.02 -15.5 60.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 9.6699999999999999 111.202 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -65.49 -38.4 89.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 9.6999999999999993 111.201 169.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.31 37.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 9.7300000000000004 111.217 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.19 -45.45 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 9.7699999999999996 111.166 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -87.56 10.5 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 9.8000000000000007 111.235 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.59 -42.98 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 9.8300000000000001 111.193 165.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -95.61 -32.44 12.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 9.8699999999999992 111.168 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.17 158.69 43.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 9.9000000000000004 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.08 130.02 36.09 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.747 1.631 . . . . 9.9299999999999997 111.18 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 78.1 mt -58.24 -41.89 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 9.9700000000000006 111.25 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.46 -20.25 67.53 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.214 -0.754 . . . . 10.0 111.214 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.85 75.26 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 10.029999999999999 111.236 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.07 150.67 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.177 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.66 -8.96 21.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 10.1 111.237 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 307' ' ' TYR . 31.6 tp -81.77 119.99 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 10.130000000000001 111.145 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -68.83 -39.47 79.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 10.17 111.227 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.0 t -51.35 -49.53 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 10.199999999999999 111.236 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.4 ' HB2' HD21 ' A' ' 304' ' ' LEU . 60.2 t80 -70.49 -40.29 73.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 10.23 111.172 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -52.41 -39.55 61.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 10.27 111.225 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.88 -30.11 71.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 10.300000000000001 111.246 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -71.59 -34.77 70.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.33 111.192 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.79 -18.31 61.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 10.369999999999999 111.202 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.62 -18.59 62.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 10.4 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -27.2 66.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 10.43 111.176 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -100.19 110.05 58.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.243 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -55.38 -31.16 76.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.645 1.563 . . . . 10.5 111.244 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 10.529999999999999 111.211 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.33 -44.81 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 10.57 111.198 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.48 -31.76 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 10.6 111.242 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.28 73.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 10.630000000000001 111.174 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.0 p -93.09 -20.19 20.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 10.67 111.232 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.3 mmt -71.64 -31.04 66.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 10.699999999999999 111.245 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.71 -44.94 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 10.73 111.176 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -73.06 -26.19 61.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.77 111.146 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.3 90.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 10.800000000000001 111.2 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.06 -34.91 64.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 10.83 111.092 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -94.97 0.13 54.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 10.869999999999999 111.187 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.61 -164.78 40.39 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.192 -0.763 . . . . 10.9 111.192 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -124.03 138.04 54.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 10.93 111.217 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.0 mm -102.83 135.26 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 10.970000000000001 111.178 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 258' ' ' PHE . 28.6 ttt -70.13 116.24 42.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 11.0 111.141 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.13 159.23 37.4 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 11.029999999999999 111.185 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -105.83 50.01 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.489 . . . . 11.07 111.209 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 86.4 mt -85.9 124.95 70.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 11.1 111.239 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.06 -29.32 22.6 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.709 1.606 . . . . 11.130000000000001 111.248 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -69.09 -37.24 78.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 11.17 111.166 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 89.9 mtp -79.75 -27.82 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 11.199999999999999 111.223 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -57.82 -49.74 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 11.23 111.166 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.6 82.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 11.27 111.18 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -68.26 -36.77 79.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 11.300000000000001 111.196 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -68.96 -32.48 72.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 11.33 111.195 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -61.92 -41.25 97.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 11.369999999999999 111.254 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.37 90.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 11.4 111.188 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.16 -40.09 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 11.43 111.154 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -64.31 -32.49 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 11.470000000000001 111.244 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.9 m -75.32 -39.86 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.193 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.98 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.223 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.84 -16.34 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.243 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.12 -28.74 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 11.6 111.138 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.45 -29.81 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 11.630000000000001 111.191 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -88.36 -32.29 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 11.67 111.194 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.07 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 11.699999999999999 111.151 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.9 p -75.75 -16.25 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 11.73 111.15 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.95 10.06 79.48 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.202 -0.759 . . . . 11.77 111.202 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -81.6 -49.66 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 11.800000000000001 111.268 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -110.75 169.61 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 11.83 111.198 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.0 p -85.74 175.18 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 11.869999999999999 111.224 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.1 m -69.35 -14.56 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 11.9 111.215 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -95.03 -42.62 8.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 11.93 111.205 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -75.32 -35.2 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 11.970000000000001 111.16 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.95 94.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 12.0 111.193 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.03 -39.22 69.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 12.029999999999999 111.242 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -51.83 -38.89 57.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 12.07 111.185 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -49.97 -43.0 49.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.176 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.54 -35.46 27.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 12.130000000000001 111.247 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.05 -31.02 69.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 12.17 111.154 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 12.199999999999999 111.188 -177.733 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.818 0.342 . . . . 0.070000000000000007 111.22 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -67.63 142.26 56.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.10000000000000001 111.184 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.72 138.58 31.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.13 111.127 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.25 28.01 9.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.182 -0.767 . . . . 0.17000000000000001 111.182 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -146.57 145.42 30.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 0.20000000000000001 111.216 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.8 mt -111.98 98.34 7.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.23000000000000001 111.255 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.91 112.04 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.27000000000000002 111.141 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -105.89 122.35 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.29999999999999999 111.209 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -109.9 129.98 55.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.33000000000000002 111.23 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 11' ' ' ILE . 18.6 tt -149.53 123.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.37 111.222 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.02 150.01 22.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.40000000000000002 111.198 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.42 172.02 38.12 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.221 -0.752 . . . . 0.42999999999999999 111.221 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -79.87 76.88 6.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.831 0.348 . . . . 0.46999999999999997 111.224 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -103.76 179.96 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.5 111.129 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.07 63.93 4.4 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.222 -0.751 . . . . 0.53000000000000003 111.222 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -68.4 -24.11 64.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.56999999999999995 111.182 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -70.07 -49.94 46.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.59999999999999998 111.224 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.56 96.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.63 111.224 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.5 tp -69.7 -31.73 69.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.67000000000000004 111.16 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.73 72.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.183 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -63.19 -42.55 99.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.72999999999999998 111.16 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.63 -21.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.77000000000000002 111.232 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.81 68.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.19 -0.764 . . . . 0.80000000000000004 111.19 171.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -67.37 -42.61 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.745 0.307 . . . . 0.82999999999999996 111.165 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.39 -48.56 79.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.87 111.169 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.63 -44.25 85.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.90000000000000002 111.147 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.2 -37.44 87.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.93000000000000005 111.227 -176.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -75.09 -34.99 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.96999999999999997 111.233 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -70.75 -39.51 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 1.0 111.218 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.6 p -110.51 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 1.03 111.202 -170.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 5.45 75.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.229 -0.749 . . . . 1.0700000000000001 111.229 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.89 119.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 1.1000000000000001 111.199 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -64.95 123.93 20.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 1.1299999999999999 111.243 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.72 125.03 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 1.1699999999999999 111.181 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.5 m -130.38 136.33 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 1.2 111.17 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.4 t -113.79 124.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 1.23 111.171 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.86 158.62 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 1.27 111.197 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -114.3 86.49 12.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 1.3 111.154 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.25 178.11 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.697 1.598 . . . . 1.3300000000000001 111.23 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -146.96 174.78 11.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 1.3700000000000001 111.228 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 53.19 37.84 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 1.3999999999999999 111.185 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.09 -24.94 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.442 . . . . 1.4299999999999999 111.182 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.26 -12.55 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 1.47 111.182 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -110.04 -23.06 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 1.5 111.213 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -92.92 -38.81 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.53 111.168 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.502 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.6 m-30 -59.97 -46.41 98.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 1.5700000000000001 111.202 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 79.5 Cg_exo -51.75 -36.06 60.67 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.685 1.59 . . . . 1.6000000000000001 111.228 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -75.7 -48.43 21.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 47' ' ' PHE . 25.9 m -74.56 -18.38 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 1.6699999999999999 111.208 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.06 -30.59 71.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 1.7 111.175 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.67 -12.16 57.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.187 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.9 p -114.04 -14.94 12.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.77 111.167 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.92 39.7 16.2 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 1.8 111.215 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -113.23 -168.42 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 1.8300000000000001 111.196 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.48 -169.23 13.12 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.214 -0.754 . . . . 1.8700000000000001 111.214 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.86 -170.15 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.701 1.601 . . . . 1.8999999999999999 111.222 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -103.13 -38.59 7.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 1.9299999999999999 111.158 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -122.2 132.9 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 1.97 111.177 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -125.1 120.78 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 2.0 111.192 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -85.07 146.12 27.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 2.0299999999999998 111.177 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -159.92 158.4 30.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 2.0699999999999998 111.171 173.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.94 174.27 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 2.1000000000000001 111.218 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -58.06 -32.93 68.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.232 -0.44 . . . . 2.1299999999999999 111.199 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -91.56 6.67 44.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 2.1699999999999999 111.219 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -114.64 -20.02 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 2.2000000000000002 111.161 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.34 -50.82 71.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 2.23 111.192 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -46.77 75.89 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.765 . . . . 2.27 111.186 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.89 95.05 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.171 -0.771 . . . . 2.2999999999999998 111.171 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -78.89 -24.88 43.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 2.3300000000000001 111.199 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.62 -23.16 31.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 2.3700000000000001 111.242 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -62.59 -33.71 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 2.3999999999999999 111.19 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -69.22 -28.75 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 2.4300000000000002 111.15 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.99 51.32 7.76 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.22 -0.752 . . . . 2.4700000000000002 111.22 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 75' ' ' LEU . 3.8 pp -132.03 20.05 4.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 2.5 111.221 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.88 134.29 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 2.5299999999999998 111.195 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.51 158.9 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 2.5699999999999998 111.24 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -89.62 159.25 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 2.6000000000000001 111.255 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.1 mt -130.07 137.85 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 2.6299999999999999 111.15 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.5 m -95.11 114.99 64.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.6699999999999999 111.235 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.6 155.14 27.6 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.151 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -90.03 169.98 10.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 2.73 111.197 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.11 -59.91 2.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 2.77 111.255 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.96 78.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 2.7999999999999998 111.165 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -54.87 -50.34 68.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.442 . . . . 2.8300000000000001 111.207 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -57.54 -43.86 84.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 2.8700000000000001 111.147 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.03 -34.98 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 2.8999999999999999 111.162 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -79.55 -21.87 44.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 2.9300000000000002 111.153 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.417 HD21 HD21 ' A' ' 304' ' ' LEU . 90.9 mt -88.09 151.42 22.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.9700000000000002 111.188 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -67.56 156.66 88.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 3.0 111.196 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.19 3.0 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.7 1.6 . . . . 3.0299999999999998 111.167 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -122.6 10.63 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.175 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.4 p -119.52 -35.43 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 3.1000000000000001 111.247 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -70.12 -40.0 75.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 3.1299999999999999 111.139 173.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -77.85 -30.98 51.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 3.1699999999999999 111.183 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.37 65.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 3.2000000000000002 111.168 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.21 20.98 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 3.23 111.142 -172.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 44.1 mtm105 -95.21 170.38 9.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 3.27 111.18 172.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -160.42 119.61 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 3.2999999999999998 111.215 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.1 t30 60.64 34.24 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 3.3300000000000001 111.217 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.98 7.7 83.4 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.262 -0.735 . . . . 3.3700000000000001 111.262 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -131.22 130.01 42.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 3.3999999999999999 111.269 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.1 tt -70.02 129.99 40.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 3.4300000000000002 111.212 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -113.93 -25.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 3.4700000000000002 111.223 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.85 165.85 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 3.5 111.199 -171.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -111.0 140.81 23.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 3.5299999999999998 111.193 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.14 -179.77 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.678 1.585 . . . . 3.5699999999999998 111.19 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.0 tp -165.06 -21.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 3.6000000000000001 111.15 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.33 145.55 23.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 3.6299999999999999 111.188 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.52 125.73 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 111.208 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -114.93 154.98 27.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 3.7000000000000002 111.218 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.02 175.91 9.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 3.73 111.188 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 113' ' ' LEU . 1.7 pp -143.21 146.54 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 3.77 111.173 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -168.36 179.97 4.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 3.7999999999999998 111.251 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.404 ' HB2' HD23 ' A' ' 247' ' ' LEU . 55.0 tp -95.41 112.2 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 3.8300000000000001 111.206 -174.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 tt -114.21 137.28 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 3.8700000000000001 111.236 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.59 150.52 46.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 3.8999999999999999 111.174 -172.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -85.83 120.27 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 3.9300000000000002 111.264 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.85 -35.09 67.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 3.9700000000000002 111.176 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.65 -33.94 77.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 4.0 111.188 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.02 -48.63 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.111 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.7 tp -154.98 111.12 2.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 4.0700000000000003 111.219 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.99 -17.67 19.39 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.697 1.598 . . . . 4.0999999999999996 111.197 -172.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -56.46 114.07 7.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 4.1299999999999999 111.217 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.7 134.81 15.41 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.71 1.606 . . . . 4.1699999999999999 111.218 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.519 ' HG3' ' SD ' ' A' ' 224' ' ' MET . 79.5 Cg_endo -77.61 140.59 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.753 1.636 . . . . 4.2000000000000002 111.171 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -100.14 -45.01 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 4.2300000000000004 111.239 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 t -158.41 -178.64 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.161 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -62.38 -38.33 89.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 4.2999999999999998 111.165 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.01 -15.45 62.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 4.3300000000000001 111.216 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -89.06 -14.31 36.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 4.3700000000000001 111.212 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.581 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.3 mt -67.54 -44.93 46.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 4.4000000000000004 111.205 -172.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 54.3 Cg_exo -55.07 -37.74 93.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.674 1.583 . . . . 4.4299999999999997 111.171 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.95 -36.88 72.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 4.4699999999999998 111.222 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.93 -32.92 74.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 4.5 111.193 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -56.38 -36.27 68.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 4.5300000000000002 111.249 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.88 -30.52 71.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 4.5700000000000003 111.153 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.2 -24.58 32.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 4.5999999999999996 111.146 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 -3.28 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 4.6299999999999999 111.198 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.22 -29.06 70.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 4.6699999999999999 111.221 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.94 79.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 4.7000000000000002 111.183 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -107.85 -9.94 15.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 4.7300000000000004 111.218 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.4 40.47 33.04 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.216 -0.754 . . . . 4.7699999999999996 111.216 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -111.62 155.3 23.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.313 . . . . 4.7999999999999998 111.225 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 t -99.71 141.44 32.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 4.8300000000000001 111.235 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.46 ' HB2' ' HE3' ' A' ' 224' ' ' MET . . . -85.93 -6.78 59.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 4.8700000000000001 111.204 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.4 HD21 HD13 ' A' ' 198' ' ' LEU . 31.0 tp -165.37 133.41 3.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 4.9000000000000004 111.226 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 26.0 ttt -156.73 134.53 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 4.9299999999999997 111.189 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -129.03 -176.93 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 4.9699999999999998 111.183 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -84.75 120.32 26.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 5.0 111.276 168.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 tp -52.56 -38.9 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 5.0300000000000002 111.191 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -122.44 39.3 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 5.0700000000000003 111.225 -165.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 154' ' ' PRO . 14.5 tp10 -146.71 118.31 4.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 5.0999999999999996 111.175 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 153' ' ' GLU . 32.9 Cg_endo -67.09 -26.6 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.677 1.585 . . . . 5.1299999999999999 111.226 -175.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -56.7 -41.07 76.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 5.1699999999999999 111.155 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 5.2000000000000002 111.225 -174.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.1 p -98.87 -6.31 29.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 5.2300000000000004 111.174 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.558 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.6 t90 -68.49 -43.76 32.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 5.2699999999999996 111.179 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 63.9 Cg_exo -55.76 -31.67 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.702 1.601 . . . . 5.2999999999999998 111.157 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 65.6 tp -61.73 -59.94 4.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 5.3300000000000001 111.238 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.51 -25.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.3700000000000001 111.202 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.24 67.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 5.4000000000000004 111.211 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.03 77.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 5.4299999999999997 111.211 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -78.01 -29.96 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 5.4699999999999998 111.186 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 92.41 50.0 2.67 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.167 -0.773 . . . . 5.5 111.167 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -55.87 -59.47 10.54 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 5.5300000000000002 111.204 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.437 ' O ' ' HB1' ' A' ' 168' ' ' ALA . 50.4 p90 -112.58 169.84 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 5.5700000000000003 111.233 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 167' ' ' TYR . . . 65.15 20.27 11.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 5.5999999999999996 111.222 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.97 150.04 43.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 5.6299999999999999 111.195 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.1 tttp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 5.6699999999999999 111.236 174.468 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.788 0.328 . . . . 5.9000000000000004 111.195 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.2 pt -75.2 -16.94 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 5.9299999999999997 111.215 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.73 -26.67 54.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 5.9699999999999998 111.211 -172.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.29 170.21 11.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 6.0 111.195 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -72.64 125.41 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 6.0300000000000002 111.181 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.59 60.4 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.175 -0.77 . . . . 6.0700000000000003 111.175 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.64 -37.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 6.0999999999999996 111.204 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -85.12 -3.57 58.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.238 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -71.35 155.59 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 6.1699999999999999 111.248 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.34 -33.66 67.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 6.2000000000000002 111.221 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.63 -27.26 73.12 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.213 -0.755 . . . . 6.2300000000000004 111.213 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.1 78.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.718 0.294 . . . . 6.2699999999999996 111.197 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.33 -43.05 95.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 6.2999999999999998 111.24 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.24 93.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 6.3300000000000001 111.145 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.92 97.44 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.212 -0.755 . . . . 6.3700000000000001 111.212 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.56 -29.64 61.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 6.4000000000000004 111.214 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 69.9 m -61.96 -44.33 96.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 6.4299999999999997 111.158 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -64.99 -37.45 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 6.4699999999999998 111.195 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.17 -46.86 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 6.5 111.193 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.25 -39.81 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 6.5300000000000002 111.248 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.37 -31.47 72.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 6.5700000000000003 111.198 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.4 HD13 HD21 ' A' ' 147' ' ' LEU . 46.5 tp -66.94 -41.29 87.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 6.5999999999999996 111.215 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 43.1 pt -83.0 -19.47 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 6.6299999999999999 111.232 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.15 -39.84 75.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 6.6699999999999999 111.133 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.23 -9.62 59.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 6.7000000000000002 111.204 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.38 54.29 2.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 6.7300000000000004 111.178 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -79.94 -20.37 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 6.7699999999999996 111.219 172.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -141.49 150.27 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.7999999999999998 111.174 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -127.01 170.02 12.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 6.8300000000000001 111.185 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.15 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 6.8700000000000001 111.225 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.16 -30.47 71.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 6.9000000000000004 111.196 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.8 m -59.42 125.01 21.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 6.9299999999999997 111.171 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -129.97 -166.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 6.9699999999999998 111.215 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -55.74 -50.04 71.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 7.0 111.146 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.7 p -73.15 -25.23 60.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.21 -171.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.0 mm -75.04 -51.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 7.0700000000000003 111.164 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.07 -32.87 74.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 7.0999999999999996 111.237 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -70.15 -52.17 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 7.1299999999999999 111.257 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.66 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 7.1699999999999999 111.181 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.439 ' HA ' ' HB2' ' A' ' 221' ' ' GLU . . . -55.07 -36.3 65.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 7.2000000000000002 111.165 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -94.21 -41.01 9.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 7.2300000000000004 111.237 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.2 -41.91 80.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 7.2699999999999996 111.184 -173.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.17 -9.04 49.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 7.2999999999999998 111.187 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.61 27.38 59.2 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.771 . . . . 7.3300000000000001 111.171 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 216' ' ' ALA . 75.6 mm-40 -68.44 -29.88 68.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 7.3700000000000001 111.183 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.4 p -109.7 167.89 9.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 7.4000000000000004 111.132 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.63 -38.57 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4299999999999997 111.226 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.519 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 64.4 ttp -144.95 145.03 31.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 7.4699999999999998 111.159 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -163.56 174.22 12.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 7.5 111.175 170.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -100.94 128.82 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 7.5300000000000002 111.234 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -163.84 177.79 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 7.5700000000000003 111.194 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -112.09 163.5 12.19 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 230' ' ' TRP . 38.6 Cg_exo -59.62 117.2 3.91 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.632 1.555 . . . . 7.6299999999999999 111.208 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.46 ' HB3' ' O ' ' A' ' 229' ' ' PRO . . . 175.04 -35.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 7.6699999999999999 111.225 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -109.95 4.31 21.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.241 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.02 -19.98 59.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 7.7300000000000004 111.206 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 90.5 p -65.71 -20.06 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 7.7699999999999996 111.227 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -72.79 -24.57 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 7.7999999999999998 111.19 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.05 -38.01 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 7.8300000000000001 111.178 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.63 -34.96 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 7.8700000000000001 111.201 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.6 m -66.52 -41.16 89.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 7.9000000000000004 111.219 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 88.8 p -73.18 -14.68 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 7.9299999999999997 111.194 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 59.98 51.52 5.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 7.9699999999999998 111.222 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.1 m -118.16 164.43 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 8.0 111.17 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -84.61 139.27 32.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 8.0299999999999994 111.193 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -153.8 165.0 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 8.0700000000000003 111.183 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.88 163.84 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.137 -0.785 . . . . 8.0999999999999996 111.137 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.88 129.55 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 8.1300000000000008 111.225 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 34.9 p -133.15 171.6 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 8.1699999999999999 111.181 171.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.35 150.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 8.1999999999999993 111.189 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.687 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 2.7 pt? -140.96 51.58 2.53 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.199 -175.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 46.0 Cg_endo -62.57 146.94 95.44 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.737 1.624 . . . . 8.2699999999999996 111.228 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 42.6 m -139.66 117.04 11.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 8.3000000000000007 111.25 -174.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.73 73.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 8.3300000000000001 111.212 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 60.56 56.1 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 8.3699999999999992 111.235 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.33 10.47 85.95 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.212 -0.755 . . . . 8.4000000000000004 111.212 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -130.02 110.01 16.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 8.4299999999999997 111.205 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 136.7 14.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.694 1.596 . . . . 8.4700000000000006 111.265 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.2 m -125.19 -87.37 0.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 8.5 111.168 167.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -143.17 142.72 22.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 8.5299999999999994 111.194 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.37 166.33 27.71 Favored 'Trans proline' 0 C--N 1.328 -0.54 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.124 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -73.41 138.05 45.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 8.5999999999999996 111.209 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.43 168.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 8.6300000000000008 111.191 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -144.64 163.19 27.96 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.13 -0.788 . . . . 8.6699999999999999 111.13 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.3 t -125.14 134.84 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 8.6999999999999993 111.19 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 49.1 tp -89.95 133.4 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 8.7300000000000004 111.227 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 90.1 p -143.94 169.97 16.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 8.7699999999999996 111.203 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 8.8000000000000007 111.256 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.15 -169.04 12.87 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.209 -0.756 . . . . 8.8300000000000001 111.209 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 89.4 mt -116.08 135.19 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 8.8699999999999992 111.221 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -60.94 131.11 49.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.172 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.95 -21.19 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 8.9299999999999997 111.197 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -91.53 -4.94 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 8.9700000000000006 111.194 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t -64.5 122.73 80.09 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 9.0 111.165 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.15 -17.9 18.86 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.706 1.604 . . . . 9.0299999999999994 111.215 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -110.55 60.04 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 9.0700000000000003 111.251 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -72.09 -36.66 69.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 9.0999999999999996 111.201 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.56 -37.64 80.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 9.1300000000000008 111.172 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.2 mt -72.33 -40.77 67.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 9.1699999999999999 111.169 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.1 95.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 9.1999999999999993 111.221 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.82 -44.11 90.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 9.2300000000000004 111.256 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -60.04 -43.49 95.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 9.2699999999999996 111.204 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -61.59 -52.08 65.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 9.3000000000000007 111.25 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.02 -20.1 65.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 9.3300000000000001 111.193 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -87.22 -60.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 9.3699999999999992 111.198 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -102.14 -6.46 23.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 9.4000000000000004 111.212 -162.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -124.01 -27.22 3.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 9.4299999999999997 111.21 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.84 -45.83 16.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 9.4700000000000006 111.209 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.92 71.11 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 9.5 111.216 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 42.0 p -138.58 176.03 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 9.5299999999999994 111.199 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -51.78 -36.97 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 9.5700000000000003 111.235 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -92.51 -38.72 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 9.5999999999999996 111.201 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.6 -60.2 8.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.0 tp -56.86 -45.58 82.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 9.6699999999999999 111.156 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.77 -54.18 47.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 9.6999999999999993 111.198 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.53 84.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 9.7300000000000004 111.17 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.2 -43.38 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 9.7699999999999996 111.165 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -98.39 7.53 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 9.8000000000000007 111.258 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.07 -39.3 74.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 9.8300000000000001 111.174 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -97.98 10.48 40.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 9.8699999999999992 111.198 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -130.0 160.39 65.43 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 9.9000000000000004 111.184 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.96 144.96 65.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.724 1.616 . . . . 9.9299999999999997 111.171 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.8 39.18 2.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.248 -0.433 . . . . 9.9700000000000006 111.18 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -54.88 -42.06 78.41 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.21 -0.756 . . . . 10.0 111.21 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -167.07 144.3 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 10.029999999999999 111.179 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.07 173.68 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 10.07 111.13 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.14 -36.63 19.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 10.1 111.157 -172.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.417 HD21 HD21 ' A' ' 89' ' ' LEU . 96.2 mt -81.56 143.26 32.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 10.130000000000001 111.191 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.29 -45.01 23.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 10.17 111.192 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 97.2 p -65.07 -31.9 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 10.199999999999999 111.158 -173.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -75.98 -46.12 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 10.23 111.17 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.25 -31.7 71.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 10.27 111.213 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -53.88 -41.49 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 10.300000000000001 111.2 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -71.34 -37.47 71.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 10.33 111.214 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.1 mp -67.56 -20.29 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 10.369999999999999 111.244 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.03 -18.51 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 10.4 111.256 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.55 -27.88 69.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 10.43 111.177 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.65 115.15 63.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 10.470000000000001 111.213 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.53 -34.37 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.706 1.604 . . . . 10.5 111.177 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.86 -31.99 73.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.19 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 95.8 mt -78.32 -39.99 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 10.57 111.19 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.441 ' HA ' ' HB3' ' A' ' 321' ' ' MET . . . -56.24 -33.61 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 10.6 111.191 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.34 -35.04 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 10.630000000000001 111.177 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 66.4 p -105.18 -20.15 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.228 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.441 ' HB3' ' HA ' ' A' ' 318' ' ' ALA . 60.9 ttp -65.08 -58.7 5.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 10.699999999999999 111.208 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -54.12 -41.6 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.73 111.185 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.35 -29.95 60.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 10.77 111.177 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.07 -35.32 76.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 10.800000000000001 111.232 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.05 -35.04 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 10.83 111.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.17 -4.95 34.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 10.869999999999999 111.164 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.62 -178.84 52.46 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.127 -0.789 . . . . 10.9 111.127 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -119.59 157.12 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 10.93 111.207 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.6 pt -119.76 166.68 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 10.970000000000001 111.189 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.8 tpp -60.04 130.0 88.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 11.0 111.198 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.19 141.45 58.83 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.753 1.636 . . . . 11.029999999999999 111.204 174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.13 20.59 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 11.07 111.179 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.68 130.04 32.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 11.1 111.201 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.75 -41.76 53.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.667 1.578 . . . . 11.130000000000001 111.157 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -63.52 -44.61 93.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 11.17 111.135 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.96 -31.84 73.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 11.199999999999999 111.209 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.1 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 11.23 111.182 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.97 76.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 11.27 111.211 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -67.2 -27.48 67.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 11.300000000000001 111.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -60.03 -38.22 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 11.33 111.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -72.13 -30.1 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 11.369999999999999 111.172 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.4 74.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 11.4 111.201 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.44 -24.99 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 11.43 111.23 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -57.66 -50.2 73.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 11.470000000000001 111.205 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.7 m -60.68 -38.23 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 11.5 111.235 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -55.81 -40.09 72.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 11.529999999999999 111.157 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -47.95 82.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.265 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 348' ' ' ILE . 8.2 tp -74.6 -23.19 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 11.6 111.158 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.64 -27.59 45.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 11.630000000000001 111.187 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.0 -27.71 32.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 11.67 111.186 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.49 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 11.699999999999999 111.183 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.6 p -72.65 -16.22 61.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 11.73 111.272 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.05 35.24 27.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.249 -0.74 . . . . 11.77 111.249 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -99.98 -35.09 9.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 11.800000000000001 111.214 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -127.97 157.07 41.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 11.83 111.137 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -77.45 177.48 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 11.869999999999999 111.224 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.99 -21.26 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 11.9 111.237 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -92.33 -37.69 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 11.93 111.196 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -66.99 -38.18 85.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.172 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.06 -41.77 94.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 12.0 111.185 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.0 -15.29 51.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 12.029999999999999 111.173 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.99 -56.63 8.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 12.07 111.225 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.96 -32.81 74.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 12.1 111.204 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.09 -56.68 19.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 12.130000000000001 111.236 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.76 -34.27 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 12.17 111.222 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.8 m . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 12.199999999999999 111.237 173.797 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.798 0.332 . . . . 0.070000000000000007 111.22 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.62 153.77 38.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.10000000000000001 111.2 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.05 125.02 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.13 111.199 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 18.07 60.62 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -134.12 150.03 51.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.20000000000000001 111.187 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -119.57 119.94 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.23000000000000001 111.23 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.85 116.24 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.27000000000000002 111.196 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.417 ' HB ' HG23 ' A' ' 37' ' ' VAL . 74.2 mt -121.79 116.62 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.29999999999999999 111.185 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.87 107.12 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.33000000000000002 111.234 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.8 tt -115.79 139.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.37 111.186 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -76.66 109.65 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.40000000000000002 111.2 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.76 -171.75 43.04 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.212 -0.755 . . . . 0.42999999999999999 111.212 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -109.95 -43.6 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.46999999999999997 111.229 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 88.2 tttt -151.41 40.01 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.5 111.241 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -14.77 68.67 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.19 -0.764 . . . . 0.53000000000000003 111.19 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -56.71 -30.96 64.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.56999999999999995 111.225 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.96 -37.95 89.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.59999999999999998 111.194 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.48 -31.72 11.22 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.16 -0.776 . . . . 0.63 111.16 -177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.2 tp -73.48 -46.58 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.67000000000000004 111.24 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.43 68.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.69999999999999996 111.173 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.71 -38.93 64.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.72999999999999998 111.17 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -75.71 -23.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.77000000000000002 111.258 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.64 -5.54 81.55 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.206 -0.758 . . . . 0.80000000000000004 111.206 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.49 -24.13 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.327 . . . . 0.82999999999999996 111.201 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.32 -25.48 66.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.87 111.197 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.90000000000000002 111.298 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.95 -28.37 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.93000000000000005 111.205 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.26 -35.65 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.96999999999999997 111.184 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.87 -47.93 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.255 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -124.21 -20.98 5.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 1.03 111.191 -172.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.11 27.15 24.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.186 -0.765 . . . . 1.0700000000000001 111.186 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.3 mt -105.43 128.18 59.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 1.1000000000000001 111.169 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.38 124.98 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 1.1299999999999999 111.24 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -99.4 119.46 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 1.1699999999999999 111.201 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.5 m -114.76 123.81 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.2 111.199 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG23 ' HB ' ' A' ' 9' ' ' ILE . 72.5 t -114.59 131.57 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.23 111.217 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.71 170.34 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 1.27 111.227 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.96 68.74 80.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 1.3 111.206 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.94 161.64 38.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.749 1.633 . . . . 1.3300000000000001 111.227 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -120.27 171.48 8.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 1.3700000000000001 111.232 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 54.96 37.22 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 1.3999999999999999 111.215 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.0 mt -66.85 -37.0 83.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 1.4299999999999999 111.176 -174.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -70.8 -11.99 61.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 1.47 111.208 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -102.91 -6.12 22.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.5 111.197 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.88 -39.91 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.53 111.197 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.579 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 m-85 -62.46 -39.3 54.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.5700000000000001 111.232 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 76.9 Cg_exo -52.39 -24.4 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.697 1.598 . . . . 1.6000000000000001 111.172 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -109.12 -17.39 13.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 1.6299999999999999 111.186 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.9 t -105.64 -58.77 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 1.6699999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.24 -33.1 75.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 1.7 111.25 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.21 -25.64 68.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.73 111.192 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 p -96.57 5.79 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 1.77 111.192 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.82 18.1 58.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.196 -0.762 . . . . 1.8 111.196 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -110.95 172.31 6.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 1.8300000000000001 111.178 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.01 -163.4 16.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.15 -0.78 . . . . 1.8700000000000001 111.15 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.59 -172.86 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.611 1.541 . . . . 1.8999999999999999 111.206 -175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -96.83 -44.35 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 1.9299999999999999 111.176 173.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.77 135.7 58.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 1.97 111.229 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.7 mt -130.55 130.0 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 2.0 111.225 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.55 138.82 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 2.0299999999999998 111.186 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -141.76 167.94 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 2.0699999999999998 111.216 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.47 158.14 24.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 2.1000000000000001 111.192 164.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -43.83 -41.35 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 2.1299999999999999 111.17 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -83.19 -18.29 39.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 2.1699999999999999 111.21 -174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.11 -19.55 24.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 2.2000000000000002 111.199 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.05 -30.02 67.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.23 111.194 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.18 98.49 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 2.27 111.219 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.74 -44.55 80.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.172 -0.771 . . . . 2.2999999999999998 111.172 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -68.15 -33.28 74.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.234 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.34 -39.81 64.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.19 -0.459 . . . . 2.3700000000000001 111.181 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -65.11 -30.06 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 2.3999999999999999 111.141 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -74.15 -12.91 60.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 2.4300000000000002 111.2 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 27.73 50.47 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.206 -0.758 . . . . 2.4700000000000002 111.206 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -110.39 -6.05 15.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.836 0.35 . . . . 2.5 111.241 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.6 tp -98.39 130.32 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 2.5299999999999998 111.186 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 146.19 24.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.185 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -82.46 159.8 22.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.6000000000000001 111.223 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.8 102.95 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 2.6299999999999999 111.184 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -52.27 111.6 2.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 2.6699999999999999 111.26 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.31 145.64 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.665 1.577 . . . . 2.7000000000000002 111.223 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.38 169.98 9.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 2.73 111.247 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -84.36 -29.11 26.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 2.77 111.17 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.16 91.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 2.7999999999999998 111.241 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.443 ' HA ' ' HB3' ' A' ' 88' ' ' LYS . 59.1 m-85 -80.04 -22.5 42.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 2.8300000000000001 111.186 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.93 -39.95 75.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 2.8700000000000001 111.249 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -94.71 -33.19 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 2.8999999999999999 111.181 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 85' ' ' PHE . 58.1 tptt -64.8 -43.57 92.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 2.9300000000000002 111.148 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -85.23 142.3 29.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 2.9700000000000002 111.147 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -66.85 127.98 93.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 3.0 111.204 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.11 -35.05 80.72 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.656 1.571 . . . . 3.0299999999999998 111.155 -168.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -52.86 -44.6 66.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.197 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -90.91 -23.24 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.1000000000000001 111.141 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -60.0 -43.96 94.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 3.1299999999999999 111.138 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -86.06 -9.51 56.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 3.1699999999999999 111.175 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.27 48.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 3.2000000000000002 111.181 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.459 HG22 ' HD3' ' A' ' 107' ' ' PRO . 29.4 m -114.99 26.24 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 3.23 111.19 -170.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -139.74 154.72 47.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 3.27 111.192 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -148.4 127.51 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 3.2999999999999998 111.203 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 65.04 26.19 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 3.3300000000000001 111.188 -174.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.4 -42.0 2.04 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.151 -0.78 . . . . 3.3700000000000001 111.151 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.61 135.53 33.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 3.3999999999999999 111.151 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.99 143.24 43.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 3.4300000000000002 111.167 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -115.83 -13.45 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 3.4700000000000002 111.179 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.59 160.54 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 3.5 111.168 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -109.95 133.98 20.82 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 3.5299999999999998 111.256 169.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.577 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 72.6 Cg_endo -81.02 -178.46 4.4 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.692 1.595 . . . . 3.5699999999999998 111.25 -172.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.609 ' O ' HG12 ' A' ' 108' ' ' ILE . 16.3 tt 163.94 14.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 3.6000000000000001 111.23 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -171.22 144.78 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.6299999999999999 111.228 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.98 157.0 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 3.6699999999999999 111.183 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -140.02 109.94 6.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 3.7000000000000002 111.214 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.91 156.25 36.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 3.73 111.233 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.2 tp -134.24 116.73 15.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 3.77 111.184 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.0 p -161.56 169.84 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 3.7999999999999998 111.251 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.75 117.52 24.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 3.8300000000000001 111.207 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -108.09 148.48 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 3.8700000000000001 111.259 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -146.27 154.88 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 3.8999999999999999 111.212 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -83.28 122.52 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 3.9300000000000002 111.137 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.6 -19.2 65.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 3.9700000000000002 111.232 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -89.95 -26.91 20.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 4.0 111.153 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -54.71 3.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 4.0300000000000002 111.163 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.52 82.4 18.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 4.0700000000000003 111.187 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.04 -15.01 29.27 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.769 1.646 . . . . 4.0999999999999996 111.204 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -106.95 97.49 17.96 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 4.1299999999999999 111.184 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.1 163.75 34.51 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.731 1.621 . . . . 4.1699999999999999 111.158 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.82 152.09 68.88 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.662 1.575 . . . . 4.2000000000000002 111.175 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.7 -10.92 30.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 4.2300000000000004 111.168 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -156.97 -176.54 6.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.168 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -79.7 -26.55 40.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 4.2999999999999998 111.212 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.04 -22.08 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 4.3300000000000001 111.138 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.11 -15.91 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.3700000000000001 111.259 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.519 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.7 mt -66.95 -51.35 38.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 4.4000000000000004 111.142 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 96.1 Cg_endo -75.73 -22.5 13.52 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.72 1.613 . . . . 4.4299999999999997 111.193 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.56 89.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 4.4699999999999998 111.232 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.92 -38.21 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 4.5 111.219 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -46.68 -47.83 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.204 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -49.35 76.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 4.5700000000000003 111.19 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.88 -30.09 70.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 4.5999999999999996 111.147 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.2 mt -79.46 -36.1 39.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 4.6299999999999999 111.245 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.84 -20.06 64.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 4.6699999999999999 111.163 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.89 68.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 4.7000000000000002 111.24 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -107.0 8.47 30.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 4.7300000000000004 111.219 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.58 60.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.178 -0.769 . . . . 4.7699999999999996 111.178 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 72.9 mmtt -109.94 -174.15 2.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 4.7999999999999998 111.191 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.4 t -151.89 163.62 38.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 4.8300000000000001 111.178 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 224' ' ' MET . . . -66.42 -57.77 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 4.8700000000000001 111.177 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.0 pp -164.95 164.93 20.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 4.9000000000000004 111.191 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.2 mmt -110.37 100.02 8.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 4.9299999999999997 111.147 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.88 130.01 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 4.9699999999999998 111.215 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -70.27 111.93 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 5.0 111.2 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.76 7.55 44.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 5.0300000000000002 111.217 -170.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -109.83 -48.11 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 5.0700000000000003 111.263 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.7 121.22 81.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 5.0999999999999996 111.208 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.0 -31.26 8.18 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.717 1.611 . . . . 5.1299999999999999 111.224 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -73.82 -33.59 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 5.1699999999999999 111.167 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -53.03 -37.1 61.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 5.2000000000000002 111.168 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.7 p -99.06 15.31 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 5.2300000000000004 111.199 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.518 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 91.0 t90 -66.78 -46.63 55.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 5.2699999999999996 111.254 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 41.7 Cg_endo -87.94 -4.05 7.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.676 1.584 . . . . 5.2999999999999998 111.203 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.46 -51.46 68.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 5.3300000000000001 111.215 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.33 -31.42 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 5.3700000000000001 111.2 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.4 -35.15 79.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 5.4000000000000004 111.164 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.23 80.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 5.4299999999999997 111.197 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.48 -43.46 90.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.204 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.82 26.2 4.83 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.197 -0.761 . . . . 5.5 111.197 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.95 -31.69 4.67 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.257 -0.737 . . . . 5.5300000000000002 111.257 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.75 110.01 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 5.5700000000000003 111.241 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.29 35.82 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 5.5999999999999996 111.159 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -120.14 141.43 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 5.6299999999999999 111.133 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 5.6699999999999999 111.219 178.625 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.7 t0 . . . . . 0 CA--C 1.523 -0.075 0 CA-C-O 120.868 0.366 . . . . 5.9000000000000004 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 pt -72.33 -17.0 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 5.9299999999999997 111.192 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.23 -20.02 52.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 5.9699999999999998 111.196 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.75 174.42 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 6.0 111.165 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.33 152.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 6.0300000000000002 111.185 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.87 22.01 36.6 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.177 -0.769 . . . . 6.0700000000000003 111.177 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.9 p -71.04 -20.02 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 6.0999999999999996 111.25 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -113.79 22.56 13.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 6.1299999999999999 111.232 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.17 117.73 29.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 6.1699999999999999 111.196 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.91 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 6.2000000000000002 111.161 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.94 76.81 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.209 -0.756 . . . . 6.2300000000000004 111.209 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.58 80.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 6.2699999999999996 111.172 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.42 -39.05 93.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 6.2999999999999998 111.217 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 6.3300000000000001 111.207 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.84 -44.67 94.35 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.162 -0.775 . . . . 6.3700000000000001 111.162 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.506 ' O ' HD21 ' A' ' 192' ' ' LEU . 0.7 OUTLIER -65.76 -37.33 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 6.4000000000000004 111.234 176.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.8 m -61.14 -44.01 98.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 6.4299999999999997 111.173 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -55.66 -46.03 77.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 6.4699999999999998 111.205 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.88 -52.12 66.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 6.5 111.268 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.07 -21.14 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 6.5300000000000002 111.253 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.86 -40.18 79.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 6.5700000000000003 111.242 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.04 -35.61 81.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 6.5999999999999996 111.177 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.28 -52.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.195 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.58 -43.03 99.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 6.6699999999999999 111.231 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -79.94 -10.14 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 6.7000000000000002 111.149 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 59.83 58.46 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 6.7300000000000004 111.182 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -81.17 -22.57 38.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 6.7699999999999996 111.219 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.98 170.75 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.207 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -92.74 161.98 14.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 6.8300000000000001 111.197 -174.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.86 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 6.8700000000000001 111.238 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.01 -30.06 67.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 6.9000000000000004 111.18 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.8 m -51.77 130.78 29.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.206 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -157.49 176.72 12.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 6.9699999999999998 111.197 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -64.04 -21.2 66.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 7.0 111.175 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.0 p -69.7 -25.6 63.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 7.0300000000000002 111.226 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.52 -32.27 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 7.0700000000000003 111.19 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 225' ' ' THR . . . -61.04 -44.69 97.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 7.0999999999999996 111.202 177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.97 -39.55 93.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 7.1299999999999999 111.207 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.12 -47.19 86.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.219 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.94 63.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 7.2000000000000002 111.211 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.64 -38.89 92.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 7.2300000000000004 111.183 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -93.33 -39.69 10.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 7.2699999999999996 111.175 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.52 -23.06 59.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 7.2999999999999998 111.218 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.35 51.23 6.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.229 -0.748 . . . . 7.3300000000000001 111.229 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.92 3.25 25.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 7.3700000000000001 111.227 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 154.04 36.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 7.4000000000000004 111.241 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.57 -29.87 18.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 7.4299999999999997 111.212 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 21.6 ptt? -152.3 170.0 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 7.4699999999999998 111.185 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 213' ' ' ALA . 12.3 t -170.18 152.82 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 7.5 111.161 170.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 94.0 mt -91.89 120.07 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 7.5300000000000002 111.236 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -160.8 -172.12 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 7.5700000000000003 111.167 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -120.36 -165.09 12.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.165 -0.774 . . . . 7.5999999999999996 111.165 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.13 64.65 8.39 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.708 1.606 . . . . 7.6299999999999999 111.245 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -125.41 -30.07 3.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 7.6699999999999999 111.224 171.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.19 -5.22 30.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 7.7000000000000002 111.246 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -76.91 -19.15 57.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 7.7300000000000004 111.175 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 95.5 p -72.85 -10.06 59.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 7.7699999999999996 111.196 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.445 ' HA ' ' HB ' ' A' ' 237' ' ' THR . 65.8 m-80 -95.01 5.41 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 7.7999999999999998 111.187 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.9 -51.29 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 7.8300000000000001 111.198 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -77.39 -25.32 50.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 7.8700000000000001 111.199 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 234' ' ' ASN . 87.5 m -64.99 -45.95 83.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 7.9000000000000004 111.227 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 85.2 p -82.58 -14.72 54.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 7.9299999999999997 111.259 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 59.57 45.4 13.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 7.9699999999999998 111.18 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 73.6 t -128.03 142.82 42.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 8.0 111.207 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -74.75 112.57 11.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 8.0299999999999994 111.222 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -112.84 143.04 44.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 8.0700000000000003 111.177 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -118.58 167.47 13.04 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.147 -0.781 . . . . 8.0999999999999996 111.147 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.65 160.75 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 8.1300000000000008 111.17 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -135.76 -176.65 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 8.1699999999999999 111.201 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.01 120.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 8.1999999999999993 111.206 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.609 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . 91.5 mt -87.8 -42.2 0.5 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.134 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 247' ' ' LEU . 78.2 Cg_exo -53.22 112.42 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.695 1.597 . . . . 8.2699999999999996 111.156 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 88.0 m -124.48 112.11 16.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 8.3000000000000007 111.168 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -110.01 128.75 55.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 8.3300000000000001 111.126 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 85.1 tttt 45.17 46.04 9.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 8.3699999999999992 111.176 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.9 14.49 78.48 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.205 -0.758 . . . . 8.4000000000000004 111.205 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -129.98 109.99 16.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.181 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.8 130.63 38.24 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.746 1.631 . . . . 8.4700000000000006 111.187 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.6 t -105.1 -99.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 8.5 111.126 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 73.6 mmtt -136.87 151.94 73.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 8.5299999999999994 111.223 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 48.6 Cg_exo -60.4 144.57 99.52 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.737 1.624 . . . . 8.5700000000000003 111.181 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -92.96 148.31 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 8.5999999999999996 111.162 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.35 126.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 8.6300000000000008 111.213 -175.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -85.83 162.83 36.1 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -129.28 136.41 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 8.6999999999999993 111.141 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 67.1 mt -109.82 148.74 30.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 8.7300000000000004 111.165 172.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -161.63 169.98 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 8.7699999999999996 111.234 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.15 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 8.8000000000000007 111.162 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.46 179.66 16.41 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.226 -0.749 . . . . 8.8300000000000001 111.226 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.3 mt -100.98 136.01 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 8.8699999999999992 111.194 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.91 124.72 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 8.9000000000000004 111.167 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.13 -22.42 66.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 8.9299999999999997 111.231 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -5.51 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 8.9700000000000006 111.237 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -79.48 129.88 70.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 9.0 111.2 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.52 -3.33 13.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.708 1.605 . . . . 9.0299999999999994 111.233 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -120.01 60.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 9.0700000000000003 111.263 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -75.85 -30.38 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 9.0999999999999996 111.183 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -68.06 -46.46 71.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 9.1300000000000008 111.223 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 64.3 tp -62.76 -44.13 97.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 9.1699999999999999 111.18 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.29 98.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 9.1999999999999993 111.128 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -63.25 -40.22 96.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 9.2300000000000004 111.183 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.68 -54.78 42.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 9.2699999999999996 111.222 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -52.28 -50.0 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 9.3000000000000007 111.275 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.63 -43.6 93.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 9.3300000000000001 111.219 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -83.41 -61.76 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 9.3699999999999992 111.232 -168.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -92.98 -8.56 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 9.4000000000000004 111.262 -162.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.0 -50.09 2.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 9.4299999999999997 111.231 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.0 tp -78.42 -60.0 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 9.4700000000000006 111.163 -174.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 285' ' ' LEU . 3.8 mm? -75.2 69.93 2.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 9.5 111.177 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 29.5 p -136.86 178.02 7.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 9.5299999999999994 111.14 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.18 -25.75 68.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 9.5700000000000003 111.202 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -98.49 -34.59 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.5999999999999996 111.221 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.91 -48.71 59.27 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.35 -45.37 84.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 9.6699999999999999 111.186 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.32 -46.12 91.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 9.6999999999999993 111.217 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.64 74.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 9.7300000000000004 111.136 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.79 -40.65 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 9.7699999999999996 111.204 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.22 0.67 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 9.8000000000000007 111.281 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.89 -35.93 82.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 9.8300000000000001 111.152 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.2 -28.33 9.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 9.8699999999999992 111.177 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.45 164.06 19.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 9.9000000000000004 111.19 -176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.97 139.95 79.5 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.702 1.601 . . . . 9.9299999999999997 111.206 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 98.7 mt -70.12 -18.6 63.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.166 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.01 -26.53 71.44 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.197 -0.761 . . . . 10.0 111.197 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -60.13 127.09 30.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 10.029999999999999 111.189 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.9 134.25 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 10.07 111.193 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -114.42 -27.18 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 10.1 111.168 164.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.19 144.99 27.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 10.130000000000001 111.162 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -65.55 -47.35 76.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 10.17 111.224 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.8 m -62.67 -40.05 95.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 10.199999999999999 111.204 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -65.17 -40.37 94.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 10.23 111.226 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -60.75 -33.39 72.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 10.27 111.238 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.12 -33.11 71.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 10.300000000000001 111.174 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -70.31 -29.9 66.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 10.33 111.188 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.15 -29.84 61.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 10.369999999999999 111.169 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.01 73.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 10.4 111.189 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.33 -34.36 68.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 10.43 111.166 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.02 118.35 48.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 10.470000000000001 111.159 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.7 -35.51 93.34 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.744 1.629 . . . . 10.5 111.153 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -79.98 -52.58 7.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 10.529999999999999 111.156 -172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.414 HG22 ' HG2' ' A' ' 321' ' ' MET . 50.4 mm -79.17 -27.34 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 10.57 111.163 -170.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.31 -36.72 33.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 10.6 111.172 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.15 95.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.188 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.8 m -69.95 -39.85 75.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 10.67 111.107 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.414 ' HG2' HG22 ' A' ' 317' ' ' ILE . 38.8 mmt -68.37 -35.42 77.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 10.699999999999999 111.233 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.53 -42.4 87.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 10.73 111.233 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -64.91 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 10.77 111.238 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 10.800000000000001 111.232 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.49 -42.77 99.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.83 111.271 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.04 -9.83 38.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 10.869999999999999 111.262 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.97 -165.16 35.45 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.23 164.31 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 10.93 111.17 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.4 pt -111.32 162.87 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 10.970000000000001 111.214 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -84.95 164.72 40.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 11.0 111.18 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.06 138.53 82.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.72 1.614 . . . . 11.029999999999999 111.182 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -107.51 28.27 8.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 11.07 111.221 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 335' ' ' GLN . 89.3 mt -90.62 125.26 60.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 11.1 111.202 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.49 -24.36 31.01 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.736 1.624 . . . . 11.130000000000001 111.183 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.413 ' H ' HG22 ' A' ' 333' ' ' ILE . 61.7 mt-30 -80.57 -1.46 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 11.17 111.129 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.1 mmm -95.16 6.9 47.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 11.199999999999999 111.164 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.4 p -64.55 -33.78 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 11.23 111.133 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.29 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 11.27 111.163 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -60.98 -47.59 85.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 11.300000000000001 111.172 175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.38 -49.06 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 11.33 111.219 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.36 -47.01 65.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.172 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.37 86.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.244 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.97 -46.38 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 11.43 111.192 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.75 -44.85 70.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 11.470000000000001 111.233 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.8 m -65.21 -40.56 94.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.203 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.76 -34.08 77.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 11.529999999999999 111.174 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.82 -48.9 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 11.57 111.167 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 8.9 tp -74.88 -25.18 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 11.6 111.201 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.76 -48.29 55.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 11.630000000000001 111.219 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.64 76.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 11.67 111.208 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.07 87.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.175 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 11.73 111.161 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.34 27.02 8.92 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.216 -0.754 . . . . 11.77 111.216 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -82.75 -35.08 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 11.800000000000001 111.23 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -151.38 174.77 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 11.83 111.135 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -85.0 171.97 11.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 11.869999999999999 111.177 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -72.19 -24.16 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 11.9 111.237 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.01 -47.89 60.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 11.93 111.161 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -68.5 -28.45 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 11.970000000000001 111.162 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.13 -51.33 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 12.0 111.208 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.29 -20.35 48.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 12.029999999999999 111.205 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.86 -52.42 56.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 12.07 111.151 171.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.84 -37.4 86.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.429 . . . . 12.1 111.246 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.45 81.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 12.130000000000001 111.212 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -55.31 -44.5 75.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 12.17 111.208 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.8 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 12.199999999999999 111.237 177.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.8 0.333 . . . . 0.070000000000000007 111.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.0 144.93 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.10000000000000001 111.199 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.04 129.94 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.13 111.211 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.02 19.56 21.24 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.153 -0.779 . . . . 0.17000000000000001 111.153 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -140.16 146.61 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.20000000000000001 111.196 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt -112.29 140.75 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.23000000000000001 111.264 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.84 118.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.27000000000000002 111.218 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.467 HG12 ' HB ' ' A' ' 59' ' ' ILE . 89.5 mt -107.88 123.9 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.29999999999999999 111.213 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -110.09 130.66 55.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.33000000000000002 111.201 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.42 120.09 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.37 111.231 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.58 125.35 26.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.40000000000000002 111.156 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.15 -170.83 40.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.151 -0.78 . . . . 0.42999999999999999 111.151 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.04 -51.9 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.46999999999999997 111.157 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.73 158.8 42.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.5 111.254 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.99 -8.87 4.82 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.229 -0.748 . . . . 0.53000000000000003 111.229 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -64.93 -24.56 67.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 111.257 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.54 -42.73 70.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.59999999999999998 111.219 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.58 -40.41 97.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.155 -0.778 . . . . 0.63 111.155 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.17 -23.61 51.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.328 . . . . 0.67000000000000004 111.183 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -33.4 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.147 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.77 -42.85 97.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.164 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.93 -25.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.77000000000000002 111.184 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -33.52 87.45 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.13 -0.788 . . . . 0.80000000000000004 111.13 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.61 -43.91 92.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.82999999999999996 111.151 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.97 -35.98 76.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.87 111.222 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.08 -42.73 93.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.90000000000000002 111.172 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.59 -35.76 81.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.93000000000000005 111.234 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -64.35 -30.05 71.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.96999999999999997 111.182 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -99.89 -34.7 10.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.252 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -107.05 -29.03 9.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 1.03 111.239 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.95 6.55 75.56 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.186 -0.766 . . . . 1.0700000000000001 111.186 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.7 mm -89.22 127.86 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 1.1000000000000001 111.176 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.6 134.33 33.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.1299999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -115.49 124.44 71.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 1.1699999999999999 111.265 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -115.69 125.97 53.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 1.2 111.249 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.19 131.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.23 111.198 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -128.84 156.12 44.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 1.27 111.208 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -111.49 85.64 6.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 1.3 111.178 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 147.51 45.91 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.713 1.608 . . . . 1.3300000000000001 111.19 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -137.03 5.23 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 1.3700000000000001 111.182 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -124.96 35.05 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 1.3999999999999999 111.16 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.98 -35.15 74.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 1.4299999999999999 111.199 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.3 -40.04 64.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.47 111.199 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -84.66 -26.94 27.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 1.5 111.144 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.02 -19.81 43.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.217 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.453 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.2 m-30 -55.04 -57.43 19.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 1.5700000000000001 111.231 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 72.8 Cg_endo -72.96 -23.33 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.732 1.621 . . . . 1.6000000000000001 111.16 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -67.7 -36.4 80.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.302 -0.408 . . . . 1.6299999999999999 111.162 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.8 m -100.02 -28.08 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 1.6699999999999999 111.183 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 1.7 111.229 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -15.89 60.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 1.73 111.2 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 p -109.88 -18.39 13.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 1.77 111.145 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.96 42.52 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.214 -0.754 . . . . 1.8 111.214 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -111.22 -175.0 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.8300000000000001 111.154 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.07 -172.15 25.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.172 -0.771 . . . . 1.8700000000000001 111.172 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.0 -176.49 2.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.666 1.578 . . . . 1.8999999999999999 111.212 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -99.27 -48.03 4.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 1.9299999999999999 111.211 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.467 ' HB ' HG12 ' A' ' 9' ' ' ILE . 83.4 mt -117.93 134.96 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 1.97 111.195 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -121.72 137.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 2.0 111.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -105.39 137.95 42.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 2.0299999999999998 111.206 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.99 163.38 18.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 2.0699999999999998 111.173 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.22 165.93 12.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 2.1000000000000001 111.173 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -53.96 -33.52 57.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.1299999999999999 111.197 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -102.51 16.27 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 2.1699999999999999 111.206 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -110.01 -0.02 18.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 2.2000000000000002 111.165 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -69.97 -27.55 64.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 2.23 111.225 -170.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.7 -39.74 61.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 2.27 111.218 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -30.82 78.77 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.178 -0.769 . . . . 2.2999999999999998 111.178 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.64 -37.07 11.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.24 -174.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.08 64.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 2.3700000000000001 111.174 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -84.51 -28.23 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 2.3999999999999999 111.195 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 -15.62 56.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.4300000000000002 111.249 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 31.55 30.28 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.229 -0.748 . . . . 2.4700000000000002 111.229 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -118.65 33.73 5.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 2.5 111.211 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.0 tp -152.37 125.16 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 2.5299999999999998 111.158 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.68 157.67 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 2.5699999999999998 111.22 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.87 80.01 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 2.6000000000000001 111.21 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.57 114.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 2.6299999999999999 111.258 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 103' ' ' LEU . 53.0 m -100.9 121.58 51.9 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 2.6699999999999999 111.219 -168.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.45 ' HB3' ' CD2' ' A' ' 106' ' ' TYR . 58.1 Cg_endo -67.43 125.27 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.18 173.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -85.03 -168.28 2.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 2.73 111.176 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.89 -32.86 71.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 2.77 111.181 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.61 -35.05 76.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 2.7999999999999998 111.168 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.93 -24.82 21.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 2.8300000000000001 111.201 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.69 -35.03 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.8700000000000001 111.158 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -89.25 -34.96 16.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 2.8999999999999999 111.202 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -81.03 -30.08 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 2.9300000000000002 111.175 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -104.56 166.11 10.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 2.9700000000000002 111.249 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.448 ' CE2' ' HA ' ' A' ' 303' ' ' ALA . 19.7 m-85 -60.14 138.14 91.33 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 3.0 111.228 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.31 -13.56 28.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.687 1.591 . . . . 3.0299999999999998 111.214 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.71 -21.98 24.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 3.0699999999999998 111.164 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.409 ' HA ' ' HB1' ' A' ' 96' ' ' ALA . 69.6 p -107.37 -19.74 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 3.1000000000000001 111.185 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -60.14 -42.63 95.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 3.1299999999999999 111.188 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.98 -15.55 29.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 3.1699999999999999 111.137 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 93' ' ' THR . . . -86.28 13.31 8.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 3.2000000000000002 111.2 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.2 m -120.19 71.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 3.23 111.24 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -141.33 139.15 33.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 3.27 111.163 -158.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -162.44 139.85 8.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 3.2999999999999998 111.175 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 65.8 30.55 10.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 3.3300000000000001 111.186 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.72 86.78 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.149 -0.78 . . . . 3.3700000000000001 111.149 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.15 155.68 48.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.821 0.343 . . . . 3.3999999999999999 111.216 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.408 ' HB2' HG21 ' A' ' 80' ' ' THR . 90.1 mt -79.06 142.43 36.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 3.4300000000000002 111.151 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 pt -124.93 -5.01 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 3.4700000000000002 111.226 -162.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.14 160.41 39.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 3.5 111.244 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.45 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 86.9 m-85 -99.09 125.07 42.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 3.5299999999999998 111.139 166.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.66 131.16 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.702 1.601 . . . . 3.5699999999999998 111.135 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.401 HG12 HD22 ' A' ' 285' ' ' LEU . 83.9 mt -108.24 -55.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 3.6000000000000001 111.18 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.77 156.36 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 3.6299999999999999 111.206 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.04 161.01 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 3.6699999999999999 111.161 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -149.31 110.57 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 3.7000000000000002 111.132 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.44 135.85 44.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 3.73 111.227 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.13 145.07 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 3.77 111.164 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 99.0 p -150.15 169.4 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 3.7999999999999998 111.199 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -115.13 130.21 56.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 3.8300000000000001 111.221 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.75 147.79 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 3.8700000000000001 111.23 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -138.19 159.03 43.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 3.8999999999999999 111.132 167.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 122' ' ' LEU . 34.4 t-20 -107.85 104.75 14.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 3.9300000000000002 111.257 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.447 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.0 mttt -57.67 -34.8 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 3.9700000000000002 111.203 -174.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.34 -47.72 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 4.0 111.227 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.21 -58.46 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 4.0300000000000002 111.288 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 118' ' ' ASN . 68.2 mt -125.04 76.26 67.23 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 4.0700000000000003 111.285 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.43 -17.61 39.0 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.691 1.594 . . . . 4.0999999999999996 111.224 -174.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 60.1 t-20 -97.81 104.84 23.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 4.1299999999999999 111.198 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.5 Cg_endo -70.18 155.47 64.48 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.635 1.557 . . . . 4.1699999999999999 111.241 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.38 144.22 60.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 4.2000000000000002 111.238 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.18 -19.88 31.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 4.2300000000000004 111.215 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -150.07 -177.33 5.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 4.2699999999999996 111.238 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -64.58 -41.73 96.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 4.2999999999999998 111.212 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.27 -23.1 66.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 4.3300000000000001 111.185 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -87.71 -15.34 37.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 4.3700000000000001 111.174 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.495 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 82.7 mt -68.94 -50.48 22.12 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 4.4000000000000004 111.179 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.495 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 92.1 Cg_endo -75.93 -18.98 16.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.661 1.574 . . . . 4.4299999999999997 111.199 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.0 85.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 4.4699999999999998 111.201 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.75 -28.65 60.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 4.5 111.214 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.62 -42.51 98.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 4.5300000000000002 111.179 173.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.78 -48.1 72.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 4.5700000000000003 111.201 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -61.84 -40.98 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 4.5999999999999996 111.191 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.403 HD22 ' HB1' ' A' ' 223' ' ' ALA . 26.0 tp -72.25 -31.78 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 4.6299999999999999 111.215 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.73 -39.52 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 4.6699999999999999 111.158 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.76 71.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 4.7000000000000002 111.228 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.89 -14.86 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.488 . . . . 4.7300000000000004 111.222 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.13 16.49 18.64 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.277 -0.729 . . . . 4.7699999999999996 111.277 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -134.26 154.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 4.7999999999999998 111.212 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.5 t -100.96 146.92 26.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 4.8300000000000001 111.225 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -112.73 -20.61 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 4.8700000000000001 111.205 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.7 tp -125.58 114.57 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 4.9000000000000004 111.17 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.428 ' SD ' ' OG1' ' A' ' 222' ' ' THR . 97.9 mtp -145.0 110.08 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 4.9299999999999997 111.22 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -101.21 -179.97 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 4.9699999999999998 111.186 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -96.06 105.26 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 5.0 111.216 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 151' ' ' LEU . 3.2 mm? -89.21 9.38 25.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 5.0300000000000002 111.209 -173.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -110.64 -9.98 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 5.0700000000000003 111.234 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -144.6 113.28 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 5.0999999999999996 111.193 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.12 -33.56 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.719 1.613 . . . . 5.1299999999999999 111.221 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -55.24 -33.03 62.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 5.1699999999999999 111.197 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -104.99 25.57 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 5.2000000000000002 111.22 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.8 p -121.97 -14.38 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 5.2300000000000004 111.141 166.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.593 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 88.7 t90 -66.12 -40.1 34.04 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 5.2699999999999996 111.192 176.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 74.4 Cg_exo -55.45 -19.54 23.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.758 1.639 . . . . 5.2999999999999998 111.201 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.4 tp -42.77 -51.54 5.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 5.3300000000000001 111.223 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 47.7 pt -86.19 -9.99 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 5.3700000000000001 111.169 -173.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.94 -25.78 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 5.4000000000000004 111.173 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.95 98.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 5.4299999999999997 111.225 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -95.69 9.83 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.216 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.21 29.6 73.34 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.177 -0.769 . . . . 5.5 111.177 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.89 -37.89 28.41 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -71.79 131.64 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 5.5700000000000003 111.179 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 55.02 55.29 7.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 5.5999999999999996 111.202 168.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -127.38 162.45 26.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.428 . . . . 5.6299999999999999 111.223 165.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.7 pttt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 5.6699999999999999 111.237 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.2 t0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.831 0.348 . . . . 5.9000000000000004 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.39 -18.62 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 5.9299999999999997 111.2 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 5.9699999999999998 111.217 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.3 141.76 58.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 6.0 111.161 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.85 173.45 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 6.0300000000000002 111.177 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -83.8 9.0 63.87 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.242 -0.743 . . . . 6.0700000000000003 111.242 -168.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.28 -2.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 6.0999999999999996 111.187 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -131.33 10.03 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 6.1299999999999999 111.199 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.08 139.46 36.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 6.1699999999999999 111.164 174.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.66 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 6.2000000000000002 111.179 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.64 93.54 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.761 . . . . 6.2300000000000004 111.199 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.23 92.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 6.2699999999999996 111.247 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.1 -47.3 62.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 6.2999999999999998 111.22 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.27 92.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 6.3300000000000001 111.239 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -46.73 88.46 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.245 -0.742 . . . . 6.3700000000000001 111.245 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.17 -43.46 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 6.4000000000000004 111.197 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -50.95 -29.29 11.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 6.4299999999999997 111.172 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -53.29 -60.62 3.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 6.4699999999999998 111.17 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.9 mt -78.48 -25.36 45.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 6.5 111.234 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.59 -47.37 85.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 6.5300000000000002 111.243 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -75.01 -35.44 61.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 6.5700000000000003 111.222 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 204' ' ' MET . 5.1 mp -75.76 -18.97 59.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 6.5999999999999996 111.197 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 93.8 mt -91.71 -40.6 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 6.6299999999999999 111.213 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.78 -38.09 77.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 6.6699999999999999 111.22 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.96 13.57 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 6.7000000000000002 111.146 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 56.94 46.19 19.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 6.7300000000000004 111.193 172.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -94.98 -49.91 5.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 6.7699999999999996 111.26 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.469 ' HG2' ' HB3' ' A' ' 198' ' ' LEU . 97.5 mmm -74.31 144.99 44.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 6.7999999999999998 111.224 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -86.56 114.57 23.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 6.8300000000000001 111.164 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.58 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.8700000000000001 111.22 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.28 -30.3 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 6.9000000000000004 111.175 -176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 m -64.97 128.96 37.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.262 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.06 -166.76 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 6.9699999999999998 111.189 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -69.92 -48.81 57.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 7.0 111.122 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -67.49 -29.84 69.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 7.0300000000000002 111.21 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.7 mt -66.96 -44.94 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 7.0700000000000003 111.194 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.36 93.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.141 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.92 -40.04 40.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 7.1299999999999999 111.138 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.0 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.208 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.04 -9.12 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 7.2000000000000002 111.214 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.53 -25.02 56.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 7.2300000000000004 111.205 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -89.39 -24.04 22.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 7.2699999999999996 111.171 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.01 -25.42 32.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 7.2999999999999998 111.148 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.26 29.13 28.62 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.277 -0.729 . . . . 7.3300000000000001 111.277 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.55 -19.13 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 7.3700000000000001 111.233 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.428 ' OG1' ' SD ' ' A' ' 148' ' ' MET . 96.9 m -119.59 127.59 53.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 7.4000000000000004 111.142 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.403 ' HB1' HD22 ' A' ' 139' ' ' LEU . . . -93.51 -31.22 14.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 7.4299999999999997 111.135 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 17.2 ptp -157.46 159.68 37.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 7.4699999999999998 111.183 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.0 t -160.39 -173.17 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 7.5 111.181 170.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.62 122.27 58.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 7.5300000000000002 111.207 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -166.79 -178.99 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 7.5700000000000003 111.279 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.52 -165.23 41.07 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.407 ' HA ' ' CH2' ' A' ' 232' ' ' TRP . 60.3 Cg_endo -75.44 79.61 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.669 1.579 . . . . 7.6299999999999999 111.153 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -175.02 -22.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.428 . . . . 7.6699999999999999 111.231 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.75 -47.52 66.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 7.7000000000000002 111.177 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.407 ' CH2' ' HA ' ' A' ' 229' ' ' PRO . 41.2 p90 -86.33 2.17 48.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 7.7300000000000004 111.156 -170.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.3 p -84.51 -9.44 58.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 7.7699999999999996 111.188 171.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -94.85 -7.16 41.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 7.7999999999999998 111.213 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.89 -24.31 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 7.8300000000000001 111.191 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -30.9 29.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 7.8700000000000001 111.189 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.4 m -62.29 -40.12 95.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 7.9000000000000004 111.205 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 49.5 m -71.35 -24.73 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 7.9299999999999997 111.226 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 63.12 54.47 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 7.9699999999999998 111.188 174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.66 167.47 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 8.0 111.196 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -81.09 126.41 31.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 8.0299999999999994 111.266 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.447 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 53.4 p90 -145.85 164.44 31.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 8.0700000000000003 111.193 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.41 -179.38 30.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.148 -0.781 . . . . 8.0999999999999996 111.148 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.61 140.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 8.1300000000000008 111.158 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -138.18 -174.84 3.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 8.1699999999999999 111.258 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.4 ' HB ' ' HD3' ' A' ' 248' ' ' PRO . 35.7 m -121.26 159.16 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 8.1999999999999993 111.13 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.503 ' N ' HD21 ' A' ' 247' ' ' LEU . 2.4 pt? -139.93 50.01 2.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 8.2300000000000004 111.197 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 74.0 Cg_endo -73.13 149.97 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.714 1.609 . . . . 8.2699999999999996 111.184 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.9 m -148.66 117.76 6.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 8.3000000000000007 111.254 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -105.46 85.24 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 8.3300000000000001 111.152 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 86.5 mttt 57.02 35.35 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 8.3699999999999992 111.206 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.34 -14.05 28.07 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.261 -0.736 . . . . 8.4000000000000004 111.261 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.42 ' HA ' ' HD2' ' A' ' 254' ' ' PRO . 60.3 tp60 -117.92 109.98 40.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 8.4299999999999997 111.217 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 253' ' ' GLN . 58.4 Cg_endo -69.17 139.01 41.13 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.66 1.573 . . . . 8.4700000000000006 111.253 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.9 t -139.99 -75.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 8.5 111.29 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.44 ' HB3' ' HA2' ' A' ' 327' ' ' GLY . 70.1 mmtt -144.41 146.21 31.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 8.5299999999999994 111.201 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 165.97 30.6 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.742 1.628 . . . . 8.5700000000000003 111.223 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.16 139.21 44.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 8.5999999999999996 111.229 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.94 115.28 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 8.6300000000000008 111.213 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.68 151.38 32.28 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.2 -0.76 . . . . 8.6699999999999999 111.2 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.65 133.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 8.6999999999999993 111.148 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 50.0 tp -102.53 134.3 46.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 8.7300000000000004 111.141 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 98.6 p -132.99 173.78 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 8.7699999999999996 111.219 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.31 40.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 8.8000000000000007 111.211 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -157.74 -173.05 25.66 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.224 -0.751 . . . . 8.8300000000000001 111.224 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -102.41 127.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 8.8699999999999992 111.187 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.15 135.66 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 8.9000000000000004 111.211 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.27 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 8.9299999999999997 111.206 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -99.42 19.54 15.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 8.9700000000000006 111.267 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 16.5 t -69.78 121.55 82.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 9.0 111.207 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 -26.47 19.09 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.648 1.565 . . . . 9.0299999999999994 111.162 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -119.62 62.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.0700000000000003 111.219 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -65.08 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 9.0999999999999996 111.177 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.51 -49.2 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 9.1300000000000008 111.219 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 99.5 mt -68.52 -34.75 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 9.1699999999999999 111.228 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.54 99.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 9.1999999999999993 111.237 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -47.94 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 9.2300000000000004 111.183 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.95 -40.1 95.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.259 -0.428 . . . . 9.2699999999999996 111.163 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -59.8 -52.04 67.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 9.3000000000000007 111.138 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.08 -44.58 94.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 9.3300000000000001 111.191 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.57 -35.12 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 9.3699999999999992 111.18 -167.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -93.9 -23.2 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 9.4000000000000004 111.172 -170.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -122.66 -66.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 9.4299999999999997 111.224 -171.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 67.3 tp -50.41 -56.03 13.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 9.4700000000000006 111.192 -167.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.401 HD22 HG12 ' A' ' 108' ' ' ILE . 85.9 mt -104.0 38.35 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 9.5 111.192 -175.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.5 p -119.14 -165.73 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 9.5299999999999994 111.259 167.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.84 -10.87 60.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 9.5700000000000003 111.174 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -88.11 -54.41 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 9.5999999999999996 111.209 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.33 6.38 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.171 -0.772 . . . . 9.6300000000000008 111.171 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.13 -34.67 76.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 9.6699999999999999 111.189 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.55 -41.27 80.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 9.6999999999999993 111.216 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.32 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 9.7300000000000004 111.263 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.5 t -86.28 -40.3 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 9.7699999999999996 111.152 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.99 -23.62 63.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 9.8000000000000007 111.246 -172.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.71 -14.83 62.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 9.8300000000000001 111.175 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -111.16 -34.61 6.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 9.8699999999999992 111.164 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.98 162.67 20.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 9.9000000000000004 111.225 -174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.17 159.53 15.14 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.711 1.607 . . . . 9.9299999999999997 111.16 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.75 39.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 9.9700000000000006 111.241 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.06 -61.26 7.57 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.198 -0.761 . . . . 10.0 111.198 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.18 153.98 2.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 10.029999999999999 111.19 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.06 159.55 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 10.07 111.153 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 90' ' ' TYR . . . -83.84 -30.2 26.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 10.1 111.174 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -67.03 121.61 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 10.130000000000001 111.16 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -68.31 -17.49 64.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.194 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 t -58.33 -40.36 81.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 10.199999999999999 111.223 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -108.65 7.29 26.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 10.23 111.209 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -57.7 -50.0 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 10.27 111.199 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.58 -29.97 61.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 10.300000000000001 111.18 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.61 -37.06 84.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 10.33 111.219 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 9.8 mp -82.73 -37.51 24.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 10.369999999999999 111.196 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -77.99 -4.65 48.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 10.4 111.196 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.13 -41.58 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 10.43 111.151 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.27 120.71 70.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 10.470000000000001 111.168 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.13 -29.72 47.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.703 1.602 . . . . 10.5 111.255 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.22 -23.14 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 10.529999999999999 111.175 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.3 mt -98.65 -39.42 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 10.57 111.202 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.49 -34.23 70.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 10.6 111.19 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.68 62.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.630000000000001 111.202 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 94.4 m -95.23 -42.33 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.243 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.7 mtp -65.01 -41.94 94.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 10.699999999999999 111.18 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 10.73 111.183 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -76.97 -16.94 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 10.77 111.237 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.54 49.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 10.800000000000001 111.228 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -80.34 -19.93 45.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 10.83 111.235 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.43 -4.14 32.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 10.869999999999999 111.086 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 256' ' ' LYS . . . -87.83 -170.06 45.85 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -86.41 99.95 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 10.93 111.205 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.15 136.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 10.970000000000001 111.203 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.458 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 53.0 ttm -46.59 124.93 7.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 11.0 111.258 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 54.3 Cg_exo -60.28 155.58 45.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.705 1.603 . . . . 11.029999999999999 111.2 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -94.89 15.99 17.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 11.07 111.274 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 82.4 mt -80.49 125.04 81.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 11.1 111.253 -169.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.51 -40.36 79.09 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.747 1.631 . . . . 11.130000000000001 111.154 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.26 -38.97 93.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 11.17 111.24 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.437 ' HA ' ' HB2' ' A' ' 339' ' ' PHE . 96.0 mmm -75.13 -23.74 57.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 11.199999999999999 111.165 -175.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 41.6 t -62.64 -40.9 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 11.23 111.175 169.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.84 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 11.27 111.269 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.437 ' HB2' ' HA ' ' A' ' 336' ' ' MET . 26.1 m-85 -66.66 -27.38 67.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 11.300000000000001 111.235 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -54.36 -46.51 73.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 11.33 111.198 -173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -99.24 -23.0 15.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 11.369999999999999 111.213 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.57 91.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 11.4 111.214 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.58 -36.54 66.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 11.43 111.193 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.6 ttp180 -54.72 -45.1 74.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 11.470000000000001 111.208 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 95.6 m -61.66 -40.03 93.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 11.5 111.21 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.22 88.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.192 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.5 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 11.57 111.191 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.7 -48.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 11.6 111.135 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -69.03 -28.92 67.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 11.630000000000001 111.167 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.6 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 11.67 111.218 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.85 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 11.699999999999999 111.2 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -74.65 -17.41 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 11.73 111.182 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.76 26.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.231 -0.748 . . . . 11.77 111.231 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -99.99 -38.71 8.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 11.800000000000001 111.223 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -129.85 168.75 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 11.83 111.116 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 33.9 p -92.62 175.04 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 11.869999999999999 111.18 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.1 m -67.2 -14.36 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 11.9 111.19 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.69 -49.3 5.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 11.93 111.188 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.14 -39.34 75.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 11.970000000000001 111.169 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.81 96.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 12.0 111.228 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.84 -24.78 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 12.029999999999999 111.158 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.32 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 12.07 111.148 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -64.71 -39.63 93.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 12.1 111.169 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.4 80.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 12.130000000000001 111.18 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -71.95 -42.92 66.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 12.17 111.144 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.4 m . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 12.199999999999999 111.159 -175.493 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.811 0.339 . . . . 0.070000000000000007 111.22 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.97 129.92 39.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.10000000000000001 111.178 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.2 139.96 58.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.13 111.23 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.58 2.29 57.57 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.17000000000000001 111.206 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.07 155.03 45.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.816 0.341 . . . . 0.20000000000000001 111.18 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.6 tp -104.18 115.05 29.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.23000000000000001 111.167 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -117.68 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.27000000000000002 111.196 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.21 114.97 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.29999999999999999 111.195 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -102.75 113.05 26.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.33000000000000002 111.249 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 4.6 tt -125.11 139.94 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.37 111.24 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -88.48 109.9 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.40000000000000002 111.178 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.4 47.82 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.213 -0.755 . . . . 0.42999999999999999 111.213 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -77.81 -69.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.46999999999999997 111.205 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -129.98 31.4 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.5 111.217 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.92 -19.68 69.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.239 -0.744 . . . . 0.53000000000000003 111.239 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -60.56 -24.37 65.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 0.56999999999999995 111.211 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -63.12 -49.95 72.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.59999999999999998 111.193 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.95 96.47 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.203 -0.759 . . . . 0.63 111.203 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.72 -31.48 66.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.818 0.342 . . . . 0.67000000000000004 111.22 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.12 91.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.69999999999999996 111.225 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.16 -35.02 74.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.72999999999999998 111.196 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 -41.25 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.77000000000000002 111.236 174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -27.93 69.31 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.14 -0.784 . . . . 0.80000000000000004 111.14 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.45 -33.99 74.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.826 0.346 . . . . 0.82999999999999996 111.206 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.25 -39.05 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.87 111.199 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -61.02 -42.38 98.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 111.166 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.27 -41.59 99.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.93000000000000005 111.21 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.01 -35.96 69.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.96999999999999997 111.216 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.07 -40.12 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.178 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.5 p -103.27 -27.21 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.226 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.85 4.8 78.54 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.219 -0.753 . . . . 1.0700000000000001 111.219 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.5 mm -87.34 115.0 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 1.1000000000000001 111.212 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.03 124.9 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 1.1299999999999999 111.204 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.15 136.01 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.1699999999999999 111.248 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.4 t -142.56 147.84 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 1.2 111.171 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.32 132.68 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 1.23 111.217 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -140.02 176.37 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 1.27 111.262 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -119.02 75.25 14.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.3 111.149 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.15 158.32 49.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.695 1.596 . . . . 1.3300000000000001 111.217 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -123.15 -179.99 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 1.3700000000000001 111.182 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 55.09 34.63 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 1.3999999999999999 111.195 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.9 mt -74.92 -22.97 58.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 1.4299999999999999 111.284 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -70.03 -12.06 61.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.47 111.235 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.28 -36.05 5.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 1.5 111.199 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -71.33 -38.66 71.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 1.53 111.147 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.495 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.4 m-30 -61.39 -56.28 35.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 1.5700000000000001 111.206 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -66.95 -23.63 46.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.81 1.674 . . . . 1.6000000000000001 111.204 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -70.07 -45.22 67.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 111.196 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.51 -19.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 1.6699999999999999 111.192 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.0 -25.76 68.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.7 111.207 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.11 60.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 1.73 111.216 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p -109.7 -15.21 14.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 1.77 111.175 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.44 23.6 28.49 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.13 -0.788 . . . . 1.8 111.13 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.13 170.08 8.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 1.8300000000000001 111.208 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.92 179.03 21.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.233 -0.747 . . . . 1.8700000000000001 111.233 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 -174.74 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.642 1.561 . . . . 1.8999999999999999 111.267 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.25 -51.39 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 1.9299999999999999 111.244 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.94 134.22 57.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 1.97 111.245 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -129.77 127.07 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 2.0 111.236 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 27.4 m-85 -98.75 127.64 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 2.0299999999999998 111.204 178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -130.0 142.36 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 2.0699999999999998 111.118 169.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.06 145.0 56.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.218 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -46.61 -36.15 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 2.1299999999999999 111.258 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -81.66 -5.26 57.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 2.1699999999999999 111.211 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.64 -0.05 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 2.2000000000000002 111.206 174.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -65.02 -56.56 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 2.23 111.194 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.0 -33.52 74.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.185 -0.766 . . . . 2.27 111.185 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.34 -44.81 94.94 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.226 -0.749 . . . . 2.2999999999999998 111.226 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.01 -40.43 75.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.182 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.8 68.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 2.3700000000000001 111.183 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -60.39 -29.9 69.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 2.3999999999999999 111.205 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -68.12 -25.4 65.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 2.4300000000000002 111.193 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.37 32.38 22.72 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.19 -0.764 . . . . 2.4700000000000002 111.19 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -104.4 4.82 33.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 2.5 111.191 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.77 140.04 44.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 2.5299999999999998 111.191 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.71 154.51 20.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 2.5699999999999998 111.211 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -74.82 134.74 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 2.6000000000000001 111.205 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.05 130.02 63.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 2.6299999999999999 111.184 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.2 m -116.83 113.34 40.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 2.6699999999999999 111.253 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.52 156.7 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.637 1.558 . . . . 2.7000000000000002 111.186 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.21 155.65 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 2.73 111.214 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.15 -53.83 52.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 2.77 111.205 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.41 84.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.7999999999999998 111.163 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -54.87 -51.94 64.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 2.8300000000000001 111.214 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -55.9 -42.72 76.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 2.8700000000000001 111.167 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.6 -29.68 70.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 2.8999999999999999 111.199 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.26 -17.93 58.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 2.9300000000000002 111.205 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.5 mt -83.41 153.5 24.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.9700000000000002 111.191 172.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.35 148.73 97.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 3.0 111.199 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.96 -15.0 18.93 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.699 1.599 . . . . 3.0299999999999998 111.252 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -96.55 -21.01 17.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 3.0699999999999998 111.154 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -78.43 -14.83 59.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 3.1000000000000001 111.191 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.427 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 49.8 m0 -63.05 -45.49 92.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.476 . . . . 3.1299999999999999 111.254 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.4 -11.82 60.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 3.1699999999999999 111.15 -170.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.54 -1.98 57.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 3.2000000000000002 111.237 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.55 10.3 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 3.23 111.228 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 94' ' ' TRP . 71.6 mtp180 -87.63 144.75 26.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 3.27 111.196 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -142.25 123.61 14.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 3.2999999999999998 111.161 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 65.0 20.75 12.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 3.3300000000000001 111.222 -169.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.56 -2.71 74.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.245 -0.742 . . . . 3.3700000000000001 111.245 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -115.44 144.24 44.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 3.3999999999999999 111.229 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.95 126.14 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 3.4300000000000002 111.214 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.7 pt -130.12 14.96 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 3.4700000000000002 111.281 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.8 169.43 5.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 3.5 111.187 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -119.47 145.96 40.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 3.5299999999999998 111.183 170.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.94 -178.17 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.69 1.593 . . . . 3.5699999999999998 111.203 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.86 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 3.6000000000000001 111.153 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 3.6299999999999999 111.184 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -105.61 157.91 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.6699999999999999 111.168 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -87.48 179.98 6.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 3.7000000000000002 111.198 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.81 143.33 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 3.73 111.174 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.755 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.9 pp -160.03 144.37 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 3.77 111.219 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.2 t -169.96 -171.88 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 3.7999999999999998 111.171 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.1 tp -71.55 112.49 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 3.8300000000000001 111.229 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.75 125.92 71.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 3.8700000000000001 111.135 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -125.11 146.75 49.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 3.8999999999999999 111.217 -168.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -79.96 123.72 28.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 3.9300000000000002 111.237 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.53 -14.21 62.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 3.9700000000000002 111.171 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -89.98 -29.84 18.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 4.0 111.233 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.1 mt -98.55 -51.22 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 4.0300000000000002 111.164 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 46.6 tp -141.35 79.65 17.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 4.0700000000000003 111.191 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.25 -14.98 28.59 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.235 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -105.04 99.97 22.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 4.1299999999999999 111.21 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.43 156.98 45.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.255 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.19 167.18 28.0 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.686 1.59 . . . . 4.2000000000000002 111.239 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.42 -21.37 38.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 4.2300000000000004 111.206 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.2 t -161.54 172.02 17.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 4.2699999999999996 111.186 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -77.02 -12.02 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 4.2999999999999998 111.19 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.06 -8.75 57.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 4.3300000000000001 111.242 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.48 -4.28 31.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.3700000000000001 111.26 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.535 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 82.8 mt -69.69 -43.81 22.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 4.4000000000000004 111.158 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 55.4 Cg_exo -53.77 -40.15 81.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.71 1.607 . . . . 4.4299999999999997 111.171 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.8 90.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.4699999999999998 111.184 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.0 mt -64.99 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 4.5 111.255 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 4.5300000000000002 111.194 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.65 -31.57 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 4.5700000000000003 111.178 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.32 -32.83 55.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 4.5999999999999996 111.191 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.35 -5.09 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 4.6299999999999999 111.209 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.03 -39.99 75.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 4.6699999999999999 111.224 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.76 -29.31 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 4.7000000000000002 111.206 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.02 -18.74 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 4.7300000000000004 111.199 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 23.71 38.98 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.151 -0.779 . . . . 4.7699999999999996 111.151 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -100.08 149.32 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 4.7999999999999998 111.197 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -96.35 146.53 24.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 4.8300000000000001 111.191 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.412 ' HB2' ' HE3' ' A' ' 224' ' ' MET . . . -100.24 5.54 44.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 4.8700000000000001 111.178 175.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 tp -160.34 130.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 4.9000000000000004 111.2 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.404 ' O ' ' OG1' ' A' ' 225' ' ' THR . 91.4 mmm -135.02 154.93 51.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 4.9299999999999997 111.237 169.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.84 165.05 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 4.9699999999999998 111.211 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 58.1 t-20 -73.9 89.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 5.0 111.159 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.16 -38.92 82.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.272 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.36 -53.81 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 5.0700000000000003 111.222 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 155' ' ' TYR . 43.0 tp10 -79.05 122.46 84.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 5.0999999999999996 111.194 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.86 -20.18 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.653 1.569 . . . . 5.1299999999999999 111.195 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.445 ' H ' ' HG3' ' A' ' 153' ' ' GLU . 82.6 t80 -59.44 -22.63 61.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 5.1699999999999999 111.203 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 150' ' ' ASN . 94.1 m-85 -113.95 29.66 7.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 5.2000000000000002 111.247 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 -22.93 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 5.2300000000000004 111.167 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.74 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 56.5 p-90 -84.57 -23.11 0.32 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 5.2699999999999996 111.213 -173.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.74 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 59.1 Cg_exo -49.1 -40.72 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.679 1.586 . . . . 5.2999999999999998 111.169 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.02 -34.98 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.151 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.36 -32.2 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 5.3700000000000001 111.215 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.11 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 5.4000000000000004 111.17 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.66 -28.33 69.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 5.4299999999999997 111.205 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -89.11 -28.75 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 5.4699999999999998 111.22 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.74 41.88 2.41 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.202 -0.759 . . . . 5.5 111.202 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -107.84 -14.58 16.96 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.189 -0.764 . . . . 5.5300000000000002 111.189 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -105.26 99.04 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 5.5700000000000003 111.179 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.81 47.57 10.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 5.5999999999999996 111.115 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -126.06 139.99 52.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 5.6299999999999999 111.188 171.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 80.8 tttt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.155 172.738 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.3 t0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.804 0.335 . . . . 5.9000000000000004 111.163 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.46 -12.93 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 5.9299999999999997 111.155 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -74.6 -22.07 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 5.9699999999999998 111.165 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -95.62 103.27 15.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 6.0 111.182 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.14 133.84 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 6.0300000000000002 111.194 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.73 39.27 3.1 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.279 -0.728 . . . . 6.0700000000000003 111.279 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.56 -20.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 6.0999999999999996 111.164 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -111.33 14.26 21.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 6.1299999999999999 111.173 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -76.85 150.64 36.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 6.1699999999999999 111.254 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.94 83.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 6.2000000000000002 111.217 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.47 -28.94 72.02 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.9 76.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 6.2699999999999996 111.174 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -79.3 -36.48 39.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 6.2999999999999998 111.206 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.87 74.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.184 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.22 -38.69 94.04 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.175 -0.77 . . . . 6.3700000000000001 111.175 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.5 tp -69.21 -35.3 76.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 6.4000000000000004 111.163 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.0 m -58.97 -39.36 81.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 6.4299999999999997 111.247 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.25 -43.46 97.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.229 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.43 -46.24 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 6.5 111.185 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.61 -26.98 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 6.5300000000000002 111.16 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -73.3 -36.8 66.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 6.5700000000000003 111.194 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.93 -34.67 78.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 6.5999999999999996 111.202 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.99 -44.87 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.169 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.74 -37.71 82.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 6.6699999999999999 111.213 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -86.72 4.97 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 6.7000000000000002 111.188 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 59.83 40.73 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 6.7300000000000004 111.135 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -98.86 -30.63 12.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 6.7699999999999996 111.238 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 96.6 mmm -120.07 141.53 49.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 6.7999999999999998 111.211 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.04 147.2 28.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 6.8300000000000001 111.138 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.55 -30.25 68.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 6.8700000000000001 111.176 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -85.11 -9.63 57.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 6.9000000000000004 111.244 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -57.04 128.73 38.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 6.9299999999999997 111.209 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 43.6 p30 -140.03 -165.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 6.9699999999999998 111.195 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -61.22 -47.35 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 7.0 111.212 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.7 p -70.09 -27.66 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 7.0300000000000002 111.176 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.16 -45.89 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 7.0700000000000003 111.233 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.7 98.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 7.0999999999999996 111.163 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -67.92 -37.09 81.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 7.1299999999999999 111.161 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.81 82.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 7.1699999999999999 111.219 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 7.2000000000000002 111.276 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -69.79 -25.95 64.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 7.2300000000000004 111.253 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -73.07 -14.68 61.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 7.2699999999999996 111.191 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.51 -17.66 13.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 7.2999999999999998 111.18 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.95 27.75 33.37 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.206 -0.758 . . . . 7.3300000000000001 111.206 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 7.3700000000000001 111.2 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 85.8 m -128.34 124.29 36.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 7.4000000000000004 111.203 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.12 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 7.4299999999999997 111.164 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.412 ' HE3' ' HB2' ' A' ' 146' ' ' ALA . 22.7 ptt? -156.54 165.01 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 7.4699999999999998 111.207 176.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 148' ' ' MET . 14.0 t -146.56 178.96 7.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 7.5 111.221 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.6 tt -122.26 112.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 7.5300000000000002 111.147 174.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -169.98 -178.62 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 7.5700000000000003 111.224 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -108.16 -165.7 21.28 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.222 -0.751 . . . . 7.5999999999999996 111.222 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -61.9 -18.9 63.67 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.745 1.63 . . . . 7.6299999999999999 111.214 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 7.6699999999999999 111.171 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.77 -25.7 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.203 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 51.9 t90 -80.02 -10.02 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 7.7300000000000004 111.202 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -64.99 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 7.7699999999999996 111.204 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -84.79 -29.97 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 7.7999999999999998 111.218 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.59 -38.59 81.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 7.8300000000000001 111.193 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.3 -40.97 86.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 7.8700000000000001 111.148 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 93.8 m -65.05 -40.89 95.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 7.9000000000000004 111.255 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.8 p -77.92 -13.41 59.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 7.9299999999999997 111.231 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 60.02 50.15 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 7.9699999999999998 111.171 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.82 140.27 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 8.0 111.234 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -77.88 92.0 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 8.0299999999999994 111.244 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -101.08 140.84 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 8.0700000000000003 111.225 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.01 -179.64 20.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.159 -0.776 . . . . 8.0999999999999996 111.159 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 141.83 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.87 0.367 . . . . 8.1300000000000008 111.172 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.2 t -123.06 -171.54 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 8.1699999999999999 111.207 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -122.09 109.92 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 8.1999999999999993 111.247 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.555 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 88.2 mt -83.05 -40.54 0.82 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 8.2300000000000004 111.19 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 85.7 Cg_exo -52.76 110.28 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.723 1.616 . . . . 8.2699999999999996 111.197 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -139.89 130.0 25.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 8.3000000000000007 111.167 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -117.23 108.83 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 8.3300000000000001 111.263 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 58.08 35.59 25.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 8.3699999999999992 111.185 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.11 -8.56 69.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.158 -0.777 . . . . 8.4000000000000004 111.158 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -104.28 109.98 63.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.197 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.86 148.46 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.746 1.63 . . . . 8.4700000000000006 111.128 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.7 p -135.03 -105.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 8.5 111.184 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 48.8 tptt -159.52 133.58 5.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 8.5299999999999994 111.182 -170.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 77.2 Cg_exo -55.02 144.0 70.65 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.693 1.595 . . . . 8.5700000000000003 111.155 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -69.54 131.04 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 8.5999999999999996 111.249 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.05 -178.93 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 8.6300000000000008 111.152 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.23 -160.52 10.41 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.56 169.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 8.6999999999999993 111.209 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.86 119.92 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 8.7300000000000004 111.191 165.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.5 m -103.2 113.61 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 8.7699999999999996 111.2 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.28 115.44 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 8.8000000000000007 111.176 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -115.24 178.19 17.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.21 -0.756 . . . . 8.8300000000000001 111.21 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 99.1 mt -111.92 130.65 65.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 8.8699999999999992 111.267 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.29 126.06 26.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 8.9000000000000004 111.203 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.51 64.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 8.9299999999999997 111.126 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -94.35 -5.03 47.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 8.9700000000000006 111.132 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.32 132.63 95.27 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 9.0 111.185 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.6 -10.21 17.2 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.734 1.623 . . . . 9.0299999999999994 111.204 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -121.4 60.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 9.0700000000000003 111.2 -175.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.55 -29.03 52.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 9.0999999999999996 111.156 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.84 -40.03 76.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 9.1300000000000008 111.167 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.76 -35.6 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 9.1699999999999999 111.127 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.05 90.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 9.1999999999999993 111.146 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.49 -43.58 84.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 9.2300000000000004 111.246 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -56.48 -53.88 52.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 9.2699999999999996 111.214 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -54.73 -57.24 12.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 9.3000000000000007 111.163 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.1 -52.62 64.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 9.3300000000000001 111.232 -174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -79.41 -45.12 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 9.3699999999999992 111.174 -165.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -98.94 -11.8 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 9.4000000000000004 111.217 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -125.0 -65.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 9.4299999999999997 111.21 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 69.8 tp -59.62 -49.12 78.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 9.4700000000000006 111.229 -169.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 72.6 mt -97.78 40.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 9.5 111.195 -171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.0 p -105.07 176.58 5.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 9.5299999999999994 111.234 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.76 -30.33 70.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 9.5700000000000003 111.192 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -87.05 -40.08 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 9.5999999999999996 111.171 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -61.85 -46.98 93.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.245 -0.742 . . . . 9.6300000000000008 111.245 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.71 -21.97 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 9.6699999999999999 111.225 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -69.91 -39.36 76.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 9.6999999999999993 111.256 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.43 -29.55 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 9.7300000000000004 111.219 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 73.7 t -73.27 -42.85 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 9.7699999999999996 111.174 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -85.32 5.18 31.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 9.8000000000000007 111.255 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -54.25 -40.01 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 9.8300000000000001 111.208 167.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -106.88 -32.76 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 9.8699999999999992 111.163 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.93 160.04 41.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 9.9000000000000004 111.198 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.62 140.17 75.99 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.646 1.564 . . . . 9.9299999999999997 111.174 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.69 -17.74 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 9.9700000000000006 111.18 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.84 68.47 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.27 101.79 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 10.029999999999999 111.253 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.58 129.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 10.07 111.258 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -114.47 -10.62 12.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 10.1 111.258 165.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.61 117.18 27.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 10.130000000000001 111.204 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.04 -42.11 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.166 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.3 p -64.89 -30.01 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 10.199999999999999 111.179 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -72.16 -42.23 66.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 10.23 111.201 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.72 -30.02 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.205 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.15 -28.66 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 10.300000000000001 111.245 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.85 -32.06 40.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 10.33 111.172 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.25 -29.2 69.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 10.369999999999999 111.219 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.63 -18.61 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 10.4 111.173 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.97 -31.64 69.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 10.43 111.242 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.0 121.53 83.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 10.470000000000001 111.231 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.96 -34.9 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.688 1.592 . . . . 10.5 111.181 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.53 -53.5 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 10.529999999999999 111.23 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.45 -30.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 10.57 111.292 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.02 62.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 10.6 111.105 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.35 90.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.421 . . . . 10.630000000000001 111.235 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.0 m -70.27 -40.06 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 10.67 111.161 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.9 mmt -70.55 -31.36 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.149 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.58 -45.93 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 10.73 111.195 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -75.93 -31.99 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 10.77 111.213 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.96 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 10.800000000000001 111.225 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.09 -25.43 67.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 10.83 111.173 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.06 -24.71 40.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 10.869999999999999 111.162 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -74.88 158.06 50.91 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.205 -0.758 . . . . 10.9 111.205 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -127.11 163.66 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.764 0.316 . . . . 10.93 111.259 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 48.7 mm -110.4 133.29 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 10.970000000000001 111.178 -169.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.89 122.38 79.01 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 11.0 111.244 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.15 150.52 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.754 1.636 . . . . 11.029999999999999 111.166 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -113.57 -25.22 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 11.07 111.23 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 334' ' ' PRO . 97.6 mt -40.07 130.01 1.61 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 11.1 111.138 -177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 333' ' ' ILE . 83.8 Cg_exo -51.98 -37.72 68.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.708 1.605 . . . . 11.130000000000001 111.186 -172.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.05 -39.51 92.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 11.17 111.21 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 99.7 mmm -75.09 -34.23 61.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 11.199999999999999 111.135 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.2 m -69.67 -33.35 72.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 11.23 111.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 11.27 111.179 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -65.57 -35.92 82.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 11.300000000000001 111.16 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.452 ' HA ' ' CE3' ' A' ' 340' ' ' TRP . 4.2 m95 -70.01 -38.41 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 11.33 111.233 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -60.7 -40.29 91.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.176 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.41 73.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 11.4 111.175 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.84 -29.7 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 11.43 111.174 -174.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -69.94 -38.76 76.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 11.470000000000001 111.247 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.2 m -69.33 -37.3 77.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 11.5 111.208 173.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.32 94.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 11.529999999999999 111.172 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.57 -24.73 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 11.57 111.223 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.04 -45.97 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 11.6 111.177 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.23 -36.55 83.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 11.630000000000001 111.164 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.06 -43.75 61.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.452 . . . . 11.67 111.186 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.226 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.3 p -71.37 -15.02 62.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 11.73 111.231 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 92.19 25.69 20.96 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 111.24 -0.744 . . . . 11.77 111.24 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.03 -39.9 7.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 11.800000000000001 111.186 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -113.86 172.5 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 11.83 111.249 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -99.94 165.68 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 11.869999999999999 111.199 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.85 -16.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 11.9 111.227 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.85 -51.11 4.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 11.93 111.236 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -70.3 -31.42 68.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 11.970000000000001 111.129 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.79 -40.35 95.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 12.0 111.192 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.61 -30.83 61.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 12.029999999999999 111.125 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.42 -45.54 83.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 12.07 111.218 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.08 -41.92 99.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 12.1 111.197 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.79 -45.22 75.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 12.130000000000001 111.198 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -56.68 -36.58 69.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 12.17 111.224 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.3 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 12.199999999999999 111.172 -176.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.827 0.346 . . . . 0.029999999999999999 111.216 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.02 145.89 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.070000000000000007 111.189 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -53.52 136.23 38.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.10000000000000001 111.235 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.25 144.97 32.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.13 111.173 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.32 16.77 63.82 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.211 -0.756 . . . . 0.17000000000000001 111.211 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.06 149.67 52.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.20000000000000001 111.22 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -122.86 101.22 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.23000000000000001 111.171 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.1 t -98.18 125.06 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.27000000000000002 111.212 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.6 mt -121.07 112.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.29999999999999999 111.202 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -92.09 92.75 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.33000000000000002 111.221 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -71.02 150.12 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.37 111.176 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -132.13 111.98 11.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.162 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.04 174.11 26.32 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.171 -0.771 . . . . 0.42999999999999999 111.171 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 -50.18 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.46999999999999997 111.195 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -125.01 -135.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.5 111.192 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.49 -7.65 78.17 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.53000000000000003 111.224 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -64.77 -54.67 27.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.56999999999999995 111.201 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.32 -40.69 97.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.59999999999999998 111.228 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.84 -53.35 44.79 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.225 -0.75 . . . . 0.63 111.225 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.0 tp -70.68 -32.4 69.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.67000000000000004 111.239 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.76 97.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.202 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.33 -38.27 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.219 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.91 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.77000000000000002 111.193 173.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.46 -38.42 96.32 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 0.80000000000000004 111.22 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.7 -44.42 96.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.82999999999999996 111.176 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.98 -41.49 92.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.87 111.209 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -59.28 -48.35 81.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.90000000000000002 111.241 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -64.35 -34.11 77.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.93000000000000005 111.185 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -69.18 -31.64 70.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.96999999999999997 111.22 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.05 -31.36 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.221 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.5 p -101.85 -29.87 11.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 1.03 111.201 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.04 5.68 83.0 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.223 -0.751 . . . . 1.0700000000000001 111.223 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.58 121.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 1.1000000000000001 111.219 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -61.67 119.51 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 1.1299999999999999 111.176 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.02 131.08 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 1.1699999999999999 111.247 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -123.43 110.26 14.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.2 111.164 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.7 t -101.84 131.77 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 1.23 111.186 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -152.92 169.98 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 1.27 111.215 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -140.3 76.87 25.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.3 111.194 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.83 80.0 2.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.724 1.616 . . . . 1.3300000000000001 111.213 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 29.7 t0 -52.29 162.97 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 1.3700000000000001 111.215 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 93.0 mttt 68.12 43.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.3999999999999999 111.173 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.29 -21.56 64.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 1.4299999999999999 111.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.89 -27.27 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 1.47 111.204 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -114.18 -25.48 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 1.5 111.209 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -94.37 -36.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 1.53 111.13 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 85.7 t80 -63.51 -43.06 77.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 1.5700000000000001 111.199 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 88.6 Cg_exo -53.05 -31.35 53.45 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.716 1.611 . . . . 1.6000000000000001 111.213 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -64.19 -32.94 74.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 1.6299999999999999 111.206 -173.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.7 m -100.06 -26.22 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 1.6699999999999999 111.167 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.7 111.206 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.33 -4.91 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.73 111.243 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -115.0 5.0 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 1.77 111.203 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.57 58.65 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.176 -0.77 . . . . 1.8 111.176 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 56' ' ' GLY . 94.2 m-20 -120.02 -165.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 1.8300000000000001 111.193 -176.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 55' ' ' ASP . . . 117.23 -162.96 12.67 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.159 -0.776 . . . . 1.8700000000000001 111.159 170.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.88 178.17 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.711 1.607 . . . . 1.8999999999999999 111.206 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.46 -40.85 10.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.9299999999999999 111.189 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.38 138.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 1.97 111.18 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.8 tt -143.92 138.78 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 2.0 111.199 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' A' ' 264' ' ' ALA . 29.8 m-85 -105.12 142.78 34.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 2.0299999999999998 111.233 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -134.49 155.6 50.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 2.0699999999999998 111.194 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.411 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . . . -68.13 159.22 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 2.1000000000000001 111.153 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -53.98 -33.58 57.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 2.1299999999999999 111.2 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -82.11 -49.94 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 2.1699999999999999 111.205 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -65.32 -31.13 72.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 2.2000000000000002 111.19 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -56.8 -36.11 69.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.23 111.18 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.08 -39.18 49.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.15 -0.78 . . . . 2.27 111.15 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.23 64.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.772 . . . . 2.2999999999999998 111.171 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.24 -49.3 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 2.3300000000000001 111.222 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.88 78.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 2.3700000000000001 111.212 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -58.2 -41.8 84.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.214 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.0 p -66.83 -17.9 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 2.4300000000000002 111.213 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.6 25.79 37.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.228 -0.749 . . . . 2.4700000000000002 111.228 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.61 2.54 44.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 2.5 111.205 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.17 117.27 28.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 2.5299999999999998 111.225 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.82 153.36 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.235 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.62 129.19 39.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 2.6000000000000001 111.206 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.36 129.59 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 2.6299999999999999 111.227 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 p -129.36 87.08 54.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 2.6699999999999999 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -58.48 150.17 70.22 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 2.7000000000000002 111.209 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -43.78 139.68 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 2.73 111.201 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.84 -39.59 39.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 2.77 111.174 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.79 85.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 2.7999999999999998 111.197 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -66.93 -40.07 87.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 2.8300000000000001 111.215 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.39 -30.87 71.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 2.8700000000000001 111.172 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.64 -35.02 67.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 2.8999999999999999 111.212 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.99 -16.22 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 2.9300000000000002 111.224 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -75.52 121.76 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 2.9700000000000002 111.191 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -69.14 144.79 95.69 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 3.0 111.217 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.36 -34.89 72.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.666 1.577 . . . . 3.0299999999999998 111.235 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 7.6 m-30 -64.62 -32.65 74.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 3.0699999999999998 111.184 -175.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -108.1 -21.61 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 3.1000000000000001 111.175 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -70.25 -41.32 73.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 3.1299999999999999 111.188 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.86 -27.82 63.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 3.1699999999999999 111.216 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.12 -21.03 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.2000000000000002 111.213 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.0 m -111.68 25.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 3.23 111.165 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -102.71 167.88 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 3.27 111.201 171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -163.29 130.02 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 3.2999999999999998 111.152 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 65.0 21.48 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 3.3300000000000001 111.224 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.96 11.16 77.21 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.193 -0.763 . . . . 3.3700000000000001 111.193 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -122.84 143.03 50.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 3.3999999999999999 111.195 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.5 tp -75.09 118.74 18.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 3.4300000000000002 111.189 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 pt -117.53 -20.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 3.4700000000000002 111.203 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.13 177.09 9.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 3.5 111.227 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -140.84 142.62 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 3.5299999999999998 111.209 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.3 155.98 41.6 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.728 1.618 . . . . 3.5699999999999998 111.217 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 tp -134.74 -30.0 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 3.6000000000000001 111.186 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.49 149.64 29.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 3.6299999999999999 111.22 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -124.99 120.58 58.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 3.6699999999999999 111.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -124.68 157.22 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.7000000000000002 111.191 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.05 155.01 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 3.73 111.236 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.34 175.8 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 3.77 111.173 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.3 p -171.78 170.19 5.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 3.7999999999999998 111.175 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.49 ' C ' HD21 ' A' ' 115' ' ' LEU . 5.9 tt -97.1 99.94 11.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 3.8300000000000001 111.212 175.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.16 127.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 3.8700000000000001 111.194 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -140.26 160.81 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 3.8999999999999999 111.177 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -75.77 109.02 9.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 3.9300000000000002 111.183 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -81.33 -37.8 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 3.9700000000000002 111.173 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -54.97 -45.14 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 4.0 111.205 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.81 -61.25 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 4.0300000000000002 111.17 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.9 mt -127.58 92.64 42.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 4.0700000000000003 111.21 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.01 -19.0 46.21 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.665 1.577 . . . . 4.0999999999999996 111.205 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -98.47 105.83 32.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 4.1299999999999999 111.2 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.51 164.91 23.4 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.697 1.598 . . . . 4.1699999999999999 111.227 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.05 125.43 17.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.68 1.587 . . . . 4.2000000000000002 111.196 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.48 -23.64 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 4.2300000000000004 111.185 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.423 HG21 ' H ' ' A' ' 130' ' ' GLU . 14.3 t -157.48 -177.25 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 4.2699999999999996 111.186 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -71.49 -25.3 62.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 4.2999999999999998 111.163 -170.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.423 ' H ' HG21 ' A' ' 128' ' ' THR . 98.7 mt-10 -71.25 -17.26 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 4.3300000000000001 111.215 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -100.41 4.38 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 4.3700000000000001 111.226 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.51 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 24.8 mm -75.23 -51.03 3.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.4000000000000004 111.176 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.51 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 94.6 Cg_endo -74.58 -13.39 22.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.692 1.595 . . . . 4.4299999999999997 111.181 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.7 78.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 4.4699999999999998 111.178 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.03 -30.05 22.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 4.5 111.194 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.82 -33.43 75.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 4.5300000000000002 111.181 168.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.77 -45.08 72.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 4.5700000000000003 111.161 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.35 -30.48 71.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 4.5999999999999996 111.254 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.74 -14.66 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.178 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.65 -44.56 73.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 4.6699999999999999 111.226 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.93 -16.86 60.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 4.7000000000000002 111.213 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -95.11 3.01 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 4.7300000000000004 111.225 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.96 25.19 69.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.243 -0.743 . . . . 4.7699999999999996 111.243 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -136.97 -179.93 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 4.7999999999999998 111.227 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.2 t -149.9 140.29 22.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 4.8300000000000001 111.196 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.33 -45.6 19.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 4.8700000000000001 111.227 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.444 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 31.8 tp -77.79 124.84 28.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 4.9000000000000004 111.176 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 99.3 mmm -124.99 50.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 4.9299999999999997 111.214 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -76.36 147.4 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 4.9699999999999998 111.214 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -71.66 102.05 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 5.0 111.219 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.31 -19.14 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.201 -172.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -39.96 96.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 5.0700000000000003 111.157 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 154' ' ' PRO . 55.8 mt-10 -98.56 160.03 29.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.21 168.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 153' ' ' GLU . 66.7 Cg_endo -77.36 3.51 6.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.668 1.578 . . . . 5.1299999999999999 111.225 -174.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -49.41 -55.01 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 5.1699999999999999 111.248 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.67 36.54 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 5.2000000000000002 111.192 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.2 p -126.34 -22.95 3.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 5.2300000000000004 111.152 168.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 88.8 t90 -67.56 -48.26 44.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 5.2699999999999996 111.2 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 91.5 Cg_endo -76.99 -14.97 16.73 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.713 1.608 . . . . 5.2999999999999998 111.192 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.85 -44.28 93.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 5.3300000000000001 111.229 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 87.2 mt -65.45 -45.03 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 5.3700000000000001 111.189 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.19 65.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 5.4000000000000004 111.162 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.13 72.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.175 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -64.97 -27.01 68.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.231 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.41 -3.64 50.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.226 -0.75 . . . . 5.5 111.226 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.8 -12.97 70.65 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.171 -0.771 . . . . 5.5300000000000002 111.171 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.93 130.33 31.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 5.5700000000000003 111.176 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.18 21.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 5.5999999999999996 111.195 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -140.0 90.11 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 5.6299999999999999 111.194 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -125.02 166.42 16.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.199 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -166.87 140.04 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 5.7000000000000002 111.191 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -150.19 96.18 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 5.7300000000000004 111.194 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 45.62 53.87 8.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 5.7699999999999996 111.193 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.1 16.07 65.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.186 -0.765 . . . . 5.7999999999999998 111.186 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -129.91 169.23 15.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 5.8300000000000001 111.216 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -129.63 139.38 51.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 5.8700000000000001 111.207 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -94.51 106.73 18.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 5.9000000000000004 111.193 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.3 pt -112.27 16.37 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 5.9299999999999997 111.197 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.29 -28.97 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 5.9699999999999998 111.194 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -74.99 169.72 17.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 6.0 111.216 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.43 124.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 6.0300000000000002 111.206 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.99 -18.94 25.56 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.0 m -68.66 -14.58 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.75 0.309 . . . . 6.0999999999999996 111.161 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -88.26 5.0 43.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 6.1299999999999999 111.208 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -95.28 150.02 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 6.1699999999999999 111.207 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.18 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 6.2000000000000002 111.22 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.92 99.91 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.206 -0.758 . . . . 6.2300000000000004 111.206 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.24 90.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 6.2699999999999996 111.223 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.4 -35.07 79.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.2999999999999998 111.213 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.07 92.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 6.3300000000000001 111.22 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.7 -45.25 96.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.166 -0.774 . . . . 6.3700000000000001 111.166 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.7 tp -71.9 -32.57 67.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 6.4000000000000004 111.213 178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.5 m -62.29 -40.1 95.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 6.4299999999999997 111.181 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -59.75 -45.92 90.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 6.4699999999999998 111.187 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.8 tp -53.16 -59.47 4.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 6.5 111.197 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 6.5300000000000002 111.194 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.27 -41.41 94.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 6.5700000000000003 111.233 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.4 -23.01 54.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 6.5999999999999996 111.17 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.66 -43.2 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.217 168.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.91 -24.23 62.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 6.6699999999999999 111.207 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -89.73 5.46 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 6.7000000000000002 111.214 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 63.61 37.5 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 6.7300000000000004 111.193 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -110.76 -34.98 6.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 6.7699999999999996 111.253 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 76.4 mtp -108.79 154.41 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 6.7999999999999998 111.161 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -127.02 111.56 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 6.8300000000000001 111.215 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.71 -17.9 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 6.8700000000000001 111.182 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -84.51 -26.09 28.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 6.9000000000000004 111.25 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -61.23 132.25 53.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 6.9299999999999997 111.181 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -139.39 -165.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 6.9699999999999998 111.189 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -58.77 -50.06 75.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 7.0 111.144 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.0 p -69.56 -32.61 71.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.192 -171.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.75 -46.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 7.0700000000000003 111.188 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.17 93.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 7.0999999999999996 111.219 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.49 -46.04 87.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 7.1299999999999999 111.199 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.26 96.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 7.1699999999999999 111.191 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.0 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 7.2000000000000002 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -70.59 -45.03 66.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 7.2300000000000004 111.212 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.76 -32.72 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 7.2699999999999996 111.226 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -83.49 -26.11 30.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 7.2999999999999998 111.159 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.28 19.92 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.168 -0.773 . . . . 7.3300000000000001 111.168 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -70.99 -30.07 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 7.3700000000000001 111.227 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.2 p -117.08 164.18 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 7.4000000000000004 111.217 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.78 -22.28 31.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 7.4299999999999997 111.205 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.64 170.28 21.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 7.4699999999999998 111.177 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.7 t -148.0 140.0 24.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 7.5 111.195 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 147' ' ' LEU . 88.2 mt -112.82 117.01 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 7.5300000000000002 111.183 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -158.83 177.68 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 7.5700000000000003 111.169 -176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -79.6 170.46 54.19 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.227 -0.749 . . . . 7.5999999999999996 111.227 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.35 -17.08 21.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 7.6299999999999999 111.207 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -70.3 -30.08 66.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 7.6699999999999999 111.168 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.63 -4.84 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 7.7000000000000002 111.154 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.442 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 4.2 t90 -62.26 -29.52 70.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 7.7300000000000004 111.215 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 92.0 p -64.85 -21.43 66.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 7.7699999999999996 111.224 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.2 -30.1 12.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 7.7999999999999998 111.218 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 83.3 mt -65.28 -34.68 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.227 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -80.16 7.83 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 7.8700000000000001 111.219 -169.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.5 m -58.31 -32.5 68.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 7.9000000000000004 111.207 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 66.5 m -69.98 -19.0 63.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 7.9299999999999997 111.21 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 60.43 38.91 19.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 7.9699999999999998 111.217 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.45 169.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 8.0 111.204 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -73.36 107.78 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 8.0299999999999994 111.206 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -102.44 133.42 47.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 8.0700000000000003 111.176 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -104.01 179.34 25.03 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.206 -0.758 . . . . 8.0999999999999996 111.206 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.9 137.89 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.757 0.313 . . . . 8.1300000000000008 111.193 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -145.88 -175.21 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 8.1699999999999999 111.214 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.2 t -78.87 125.24 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 8.1999999999999993 111.253 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.531 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 56.7 tp -79.7 -51.37 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 8.2300000000000004 111.202 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 89.2 Cg_endo -80.38 154.94 21.65 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.696 1.597 . . . . 8.2699999999999996 111.209 -173.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 85.1 m -124.98 109.88 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 8.3000000000000007 111.164 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.78 104.78 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 8.3300000000000001 111.22 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 55.25 35.05 24.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 8.3699999999999992 111.23 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.86 76.15 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.192 -0.763 . . . . 8.4000000000000004 111.192 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -129.99 109.97 16.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 8.4299999999999997 111.209 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.77 150.3 61.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.693 1.595 . . . . 8.4700000000000006 111.168 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 83.7 p -139.34 -72.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 8.5 111.232 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 47.3 tptt -159.42 129.89 3.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 8.5299999999999994 111.193 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.431 ' HA ' ' HG3' ' A' ' 248' ' ' PRO . 51.3 Cg_exo -55.03 157.04 14.19 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.739 1.626 . . . . 8.5700000000000003 111.22 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -67.28 146.0 54.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 8.5999999999999996 111.208 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 85.7 t -109.72 113.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 8.6300000000000008 111.175 -171.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.07 115.04 5.01 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.163 -0.775 . . . . 8.6699999999999999 111.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.4 t -101.89 116.42 45.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 8.6999999999999993 111.2 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 63' ' ' ALA . 10.4 mp -73.16 144.82 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 8.7300000000000004 111.225 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 99.4 p -142.43 159.63 41.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 8.7699999999999996 111.203 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.428 ' HB3' ' CD2' ' A' ' 61' ' ' PHE . . . -130.52 156.23 45.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 8.8000000000000007 111.198 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.15 175.55 20.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.264 -0.735 . . . . 8.8300000000000001 111.264 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.8 129.97 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 8.8699999999999992 111.183 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.54 120.96 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.181 -173.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.76 -23.46 66.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 8.9299999999999997 111.186 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.0 58.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 8.9700000000000006 111.236 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.1 t -83.28 121.46 76.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 9.0 111.183 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.12 3.32 7.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.705 1.603 . . . . 9.0299999999999994 111.201 169.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.26 36.92 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 9.0700000000000003 111.241 -172.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -62.34 -24.11 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 9.0999999999999996 111.232 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.69 -30.48 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 9.1300000000000008 111.252 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -72.09 -43.37 64.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 9.1699999999999999 111.206 174.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.68 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 9.1999999999999993 111.218 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.79 -56.35 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.2300000000000004 111.2 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -65.46 -43.03 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 9.2699999999999996 111.183 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.39 -50.21 73.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 9.3000000000000007 111.19 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 284' ' ' LEU . 59.6 tp -58.76 -53.13 61.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 9.3300000000000001 111.203 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.79 -30.67 56.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 9.3699999999999992 111.181 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -97.62 -27.4 14.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 9.4000000000000004 111.238 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.71 -64.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 9.4299999999999997 111.223 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 280' ' ' LEU . 45.5 tp -60.85 -41.84 96.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 9.4700000000000006 111.242 -166.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 37.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.205 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 97.4 m -114.78 141.38 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 9.5299999999999994 111.249 170.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -49.05 -40.49 31.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 9.5700000000000003 111.221 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.06 -46.37 85.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 9.5999999999999996 111.14 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.66 -40.55 90.27 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.241 -0.744 . . . . 9.6300000000000008 111.241 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.29 -35.5 81.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 9.6699999999999999 111.185 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.75 -40.85 84.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 9.6999999999999993 111.224 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 9.7300000000000004 111.22 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.79 -37.66 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 9.7699999999999996 111.182 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -81.88 5.06 20.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.428 . . . . 9.8000000000000007 111.207 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.15 -33.22 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 9.8300000000000001 111.209 165.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -107.42 -38.73 5.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8699999999999992 111.179 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -87.78 161.44 44.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.9000000000000004 111.191 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -55.03 144.65 67.65 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.671 1.581 . . . . 9.9299999999999997 111.186 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.37 -20.6 64.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 9.9700000000000006 111.232 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.94 -26.81 67.71 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.185 -0.766 . . . . 10.0 111.185 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.18 133.99 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 10.029999999999999 111.191 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.6 138.66 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 10.07 111.191 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.49 -48.02 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 10.1 111.186 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 85.0 mt -116.82 152.54 34.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 10.130000000000001 111.242 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -54.44 -37.24 64.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 10.17 111.182 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.0 p -56.18 -29.46 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 10.199999999999999 111.195 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -88.59 -35.83 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 10.23 111.2 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -60.06 -27.44 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 10.27 111.205 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.33 -30.4 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.151 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.77 -31.65 35.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 10.33 111.193 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.45 -21.72 62.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 10.369999999999999 111.219 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.95 66.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 10.4 111.203 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.82 -30.08 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 10.43 111.145 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 119.03 75.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.178 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.49 -35.47 96.69 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.73 1.62 . . . . 10.5 111.217 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -85.08 -51.11 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 10.529999999999999 111.218 -172.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.19 -39.81 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 10.57 111.172 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.04 85.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 10.6 111.187 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.21 86.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 10.630000000000001 111.181 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -64.51 -44.87 89.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 10.67 111.187 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.8 mmm -67.07 -34.65 78.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 10.699999999999999 111.183 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.5 -45.85 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 10.73 111.194 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -73.18 -22.42 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 10.77 111.159 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.05 -31.82 65.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 10.800000000000001 111.248 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.97 -18.29 64.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 10.83 111.177 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.25 -8.89 59.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 10.869999999999999 111.202 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -104.83 -141.89 11.13 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 10.9 111.226 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -145.0 136.34 25.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 10.93 111.174 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.2 mm -77.58 128.94 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 10.970000000000001 111.194 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 37.5 mmt -79.55 116.01 57.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 11.0 111.231 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.94 155.12 57.98 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.724 1.616 . . . . 11.029999999999999 111.195 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -97.61 20.09 12.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 11.07 111.202 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.91 128.27 91.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 11.1 111.153 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.24 -43.59 52.38 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.714 1.61 . . . . 11.130000000000001 111.223 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -64.99 -40.77 95.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 11.17 111.186 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.4 mmm -64.73 -39.37 93.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 11.199999999999999 111.214 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.1 t -60.52 -45.82 92.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.179 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.3 88.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 11.27 111.211 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -64.87 -33.45 76.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 11.300000000000001 111.18 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -69.97 -39.78 75.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 11.33 111.222 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 344' ' ' ARG . 34.6 m-85 -64.97 -30.08 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 11.369999999999999 111.211 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.61 71.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.18 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 93.5 t -85.5 -29.46 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 11.43 111.202 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 341' ' ' TYR . 99.6 mtt180 -65.2 -25.3 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 11.470000000000001 111.219 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 76.0 p -85.99 -29.72 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 11.5 111.213 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.72 92.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.529999999999999 111.189 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.47 -23.43 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 11.57 111.21 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.9 mm -88.33 -38.04 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 11.6 111.206 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -65.0 -32.42 74.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 11.630000000000001 111.214 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.3 -39.8 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 11.67 111.19 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.23 86.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 11.699999999999999 111.199 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.7 p -80.73 -19.43 45.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 11.73 111.209 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 90.58 18.03 50.07 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.222 -0.751 . . . . 11.77 111.222 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -70.2 -37.98 75.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 11.800000000000001 111.228 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -147.0 168.74 20.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 11.83 111.176 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 45.0 p -81.18 175.14 10.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 11.869999999999999 111.141 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.88 -44.74 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 11.9 111.161 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.17 -48.15 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 11.93 111.18 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.59 -36.23 80.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 11.970000000000001 111.193 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.02 70.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 12.0 111.216 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.55 -15.92 55.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 12.029999999999999 111.219 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.18 -49.12 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 12.07 111.202 168.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.76 -39.04 92.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 12.1 111.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.45 -46.65 89.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 12.130000000000001 111.221 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.71 -47.63 76.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 12.17 111.178 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.6 m -59.01 -44.82 91.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 12.199999999999999 111.197 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.97 -36.93 85.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 12.23 111.239 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 92.1 mt -70.83 -39.98 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 12.27 111.231 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 75.7 p -84.54 -15.04 47.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 12.300000000000001 111.236 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.199 -1.559 0 CA-C-N 116.182 -0.463 . . . . 12.33 111.201 177.644 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.76 0.314 . . . . 0.029999999999999999 111.212 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.9 115.1 47.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 0.070000000000000007 111.252 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.15 129.93 42.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.10000000000000001 111.215 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -57.68 128.97 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.13 111.206 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.91 48.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -126.33 98.02 5.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.771 0.319 . . . . 0.20000000000000001 111.195 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.05 119.72 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.23000000000000001 111.204 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.29 118.83 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.27000000000000002 111.238 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 HG12 ' HB ' ' A' ' 59' ' ' ILE . 76.9 mt -121.21 112.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.29999999999999999 111.189 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -103.38 117.12 33.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.33000000000000002 111.222 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 7.1 tt -115.61 137.05 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.37 111.208 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.64 114.94 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.40000000000000002 111.228 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.01 -172.46 39.86 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.209 -0.756 . . . . 0.42999999999999999 111.209 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -108.47 -39.18 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.329 . . . . 0.46999999999999997 111.219 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.14 149.83 43.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.5 111.191 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.26 0.83 4.52 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.215 -0.754 . . . . 0.53000000000000003 111.215 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 37' ' ' VAL . 43.8 p90 -62.71 -20.09 64.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.56999999999999995 111.204 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.67 -30.5 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 0.59999999999999998 111.205 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.69 -47.24 91.61 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.24 -0.744 . . . . 0.63 111.24 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.58 -30.79 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.67000000000000004 111.173 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.29 83.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.69999999999999996 111.21 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.4 -39.69 91.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.173 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 82.5 t -71.23 -34.85 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.77000000000000002 111.144 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.16 -27.12 73.83 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.182 -0.767 . . . . 0.80000000000000004 111.182 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 -48.4 81.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.82999999999999996 111.197 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.0 -41.79 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.87 111.205 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.37 -51.34 69.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.90000000000000002 111.274 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.93 -38.16 90.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.93000000000000005 111.262 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.36 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.96999999999999997 111.159 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.32 -35.01 12.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.186 -173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -103.4 -29.96 10.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.03 111.234 -174.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.55 4.56 79.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.166 -0.774 . . . . 1.0700000000000001 111.166 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.2 124.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 1.1000000000000001 111.24 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.94 150.06 47.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 1.1299999999999999 111.153 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -125.02 125.12 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 1.1699999999999999 111.234 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -121.33 109.84 15.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 1.2 111.221 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 17' ' ' TYR . 35.1 t -105.07 130.12 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.187 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -151.07 166.49 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 1.27 111.198 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -100.03 123.26 47.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 1.3 111.216 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -79.6 165.03 23.11 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.617 1.545 . . . . 1.3300000000000001 111.201 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -121.0 141.03 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 1.3700000000000001 111.187 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 55.04 46.71 23.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 1.3999999999999999 111.238 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.02 -50.72 68.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 1.4299999999999999 111.211 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -52.57 -43.64 65.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 1.47 111.169 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.5 111.185 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -97.08 -7.0 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.192 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.483 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 5.2 m-30 -55.19 -54.8 46.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 1.5700000000000001 111.155 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -70.66 -12.21 30.84 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.68 1.587 . . . . 1.6000000000000001 111.21 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.98 -8.61 51.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.154 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.97 -57.68 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 1.6699999999999999 111.209 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.29 -23.11 43.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 1.7 111.199 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.58 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.73 111.172 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -104.2 -19.88 13.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.77 111.182 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.09 58.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.161 -0.775 . . . . 1.8 111.161 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -129.59 -165.43 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.8300000000000001 111.182 -170.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.42 -165.76 14.37 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.195 -0.762 . . . . 1.8700000000000001 111.195 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.49 167.16 27.78 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.665 1.577 . . . . 1.8999999999999999 111.201 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -80.04 -62.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 1.9299999999999999 111.186 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.411 ' HB ' HG12 ' A' ' 9' ' ' ILE . 92.5 mt -99.78 139.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 1.97 111.208 174.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 tt -141.53 134.91 30.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 2.0 111.225 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.42 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 64.5 m-85 -106.43 144.93 32.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 2.0299999999999998 111.315 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -156.39 148.45 23.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 2.0699999999999998 111.248 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.41 158.0 24.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 2.1000000000000001 111.175 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -60.6 -17.02 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 2.1299999999999999 111.244 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -42.91 -48.34 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 2.1699999999999999 111.159 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -134.98 27.45 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 2.2000000000000002 111.162 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.53 -42.61 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 2.23 111.176 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.77 -46.42 93.49 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.92 89.28 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.181 -0.767 . . . . 2.2999999999999998 111.181 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.05 -43.59 73.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 2.3300000000000001 111.157 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.84 -37.58 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 2.3700000000000001 111.143 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -67.07 -30.81 70.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.151 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -73.79 -13.89 61.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 2.4300000000000002 111.16 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.81 19.14 52.72 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.169 -0.772 . . . . 2.4700000000000002 111.169 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.89 -38.61 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.806 0.336 . . . . 2.5 111.234 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 tp -102.63 132.32 48.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 2.5299999999999998 111.239 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.54 137.09 32.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 2.5699999999999998 111.207 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -77.52 156.12 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 2.6000000000000001 111.203 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.2 mt -113.79 122.67 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 2.6299999999999999 111.204 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.2 m -120.58 96.74 48.88 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 2.6699999999999999 111.15 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.03 148.2 49.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.732 1.621 . . . . 2.7000000000000002 111.226 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -81.76 -179.37 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 2.73 111.188 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.73 -45.81 74.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 2.77 111.19 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.88 86.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 2.7999999999999998 111.232 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.41 -36.46 84.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 2.8300000000000001 111.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.71 -34.59 78.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 2.8700000000000001 111.235 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -71.35 -34.97 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 2.8999999999999999 111.155 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.1 -20.55 59.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 2.9300000000000002 111.186 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.6 mt -75.02 135.26 41.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 2.9700000000000002 111.193 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -63.29 138.89 97.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 3.0 111.162 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -50.15 -47.74 22.69 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.647 1.565 . . . . 3.0299999999999998 111.186 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.14 -47.66 81.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.0699999999999998 111.169 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -70.77 -21.69 62.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 3.1000000000000001 111.212 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -69.97 -41.53 74.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 3.1299999999999999 111.233 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -78.05 -24.01 47.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 3.1699999999999999 111.252 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.62 90.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 3.2000000000000002 111.197 -174.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.71 79.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.23 111.207 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HB3' HD21 ' A' ' 103' ' ' LEU . 54.4 ptt85 -156.68 161.05 39.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 3.27 111.163 175.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -159.98 136.37 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 3.2999999999999998 111.246 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 64.98 29.89 12.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 3.3300000000000001 111.216 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.77 53.89 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.187 -0.765 . . . . 3.3700000000000001 111.187 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -165.07 147.44 8.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 3.3999999999999999 111.159 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 98' ' ' ARG . 94.2 mt -64.9 136.39 56.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 3.4300000000000002 111.232 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 pt -115.2 -14.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 3.4700000000000002 111.224 -176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.0 172.92 5.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 3.5 111.226 -174.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -119.73 123.43 28.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 3.5299999999999998 111.18 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.8 139.54 33.72 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.667 1.578 . . . . 3.5699999999999998 111.2 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.32 -4.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 3.6000000000000001 111.223 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.75 144.75 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 3.6299999999999999 111.193 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.67 128.22 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 3.6699999999999999 111.242 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.68 151.21 46.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 3.7000000000000002 111.218 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.64 164.98 11.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 3.73 111.215 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 tp -143.85 124.1 13.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 3.77 111.214 172.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.9 p -163.05 -174.29 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 3.7999999999999998 111.17 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.9 tp -103.48 120.08 40.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 3.8300000000000001 111.177 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.574 ' N ' HD13 ' A' ' 116' ' ' ILE . 3.8 mp -102.93 141.36 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 3.8700000000000001 111.24 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -136.8 150.61 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 3.8999999999999999 111.159 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -91.28 117.33 29.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.9300000000000002 111.251 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.09 -34.88 79.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 3.9700000000000002 111.196 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.94 -47.6 84.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 4.0 111.205 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.2 tp -80.35 -52.36 7.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 4.0300000000000002 111.186 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.53 99.53 52.56 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 4.0700000000000003 111.174 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 -17.84 19.12 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.739 1.626 . . . . 4.0999999999999996 111.159 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 55.5 t-20 -85.01 116.81 67.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 4.1299999999999999 111.144 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 55.9 Cg_endo -67.42 117.9 5.19 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.716 1.61 . . . . 4.1699999999999999 111.232 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.97 129.62 31.17 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.718 1.612 . . . . 4.2000000000000002 111.181 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.01 -45.09 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 4.2300000000000004 111.186 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.6 t -136.3 -177.59 4.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 4.2699999999999996 111.173 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.65 -34.16 21.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 4.2999999999999998 111.207 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.77 -15.61 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 4.3300000000000001 111.215 -163.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -91.45 -9.44 44.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 4.3700000000000001 111.186 -176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.589 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 93.1 mt -74.02 -45.0 6.59 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 4.4000000000000004 111.195 -171.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.7 Cg_exo -57.0 -40.38 84.52 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.67 1.58 . . . . 4.4299999999999997 111.191 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.37 99.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 4.4699999999999998 111.183 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.411 HD21 ' HE3' ' A' ' 224' ' ' MET . 65.7 tp -63.95 -42.98 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.427 . . . . 4.5 111.268 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.95 -35.05 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.239 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.04 -37.02 75.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 4.5700000000000003 111.218 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.04 -31.91 69.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 4.5999999999999996 111.176 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.0 mt -82.18 -15.9 51.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 4.6299999999999999 111.155 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.93 -44.53 63.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 4.6699999999999999 111.156 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.37 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 4.7000000000000002 111.24 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.03 -7.29 33.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 4.7300000000000004 111.196 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.16 62.43 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.163 -0.775 . . . . 4.7699999999999996 111.163 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 74.4 mmtt -114.96 179.28 3.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.8 0.333 . . . . 4.7999999999999998 111.212 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -137.82 143.94 41.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 4.8300000000000001 111.196 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -59.78 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 4.8700000000000001 111.249 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.411 HD23 HD11 ' A' ' 132' ' ' ILE . 64.6 tp -128.13 115.64 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 4.9000000000000004 111.166 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.8 mmm -111.68 136.03 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 4.9299999999999997 111.198 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 156' ' ' PHE . 54.5 p90 -171.68 164.99 6.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 4.9699999999999998 111.27 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -79.69 112.71 17.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 5.0 111.211 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.2 tp -63.18 -32.36 73.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 5.0300000000000002 111.182 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -96.66 7.54 46.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 5.0700000000000003 111.229 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -110.04 114.23 56.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 5.0999999999999996 111.172 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.32 -39.22 81.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.697 1.598 . . . . 5.1299999999999999 111.214 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -50.49 -40.02 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 5.1699999999999999 111.154 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 31.8 m-85 -79.96 -37.52 34.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 5.2000000000000002 111.273 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.3 p -105.17 17.73 23.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 5.2300000000000004 111.156 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.558 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 88.3 t90 -66.73 -49.67 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 5.2699999999999996 111.286 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 83.6 Cg_endo -80.01 -14.92 12.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 5.2999999999999998 111.193 -174.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.9 tp -60.95 -33.99 74.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 5.3300000000000001 111.175 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.35 -30.02 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 5.3700000000000001 111.244 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.09 -43.75 10.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 5.4000000000000004 111.208 -172.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.4 -11.48 59.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 5.4299999999999997 111.213 -169.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -78.59 -4.42 48.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 5.4699999999999998 111.241 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.84 12.25 2.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.199 -0.76 . . . . 5.5 111.199 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.04 -19.66 25.74 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.241 -0.743 . . . . 5.5300000000000002 111.241 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.61 109.98 11.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 5.5700000000000003 111.172 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 176' ' ' TYR . . . 68.39 35.3 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 5.5999999999999996 111.138 173.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.78 54.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 5.6299999999999999 111.235 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -125.19 156.4 38.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 5.6699999999999999 111.157 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -149.16 124.86 10.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 5.7000000000000002 111.226 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -149.19 99.55 2.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 5.7300000000000004 111.217 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.44 34.12 23.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 5.7699999999999996 111.2 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.97 11.07 77.39 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.222 -0.751 . . . . 5.7999999999999998 111.222 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.01 155.01 40.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.789 0.328 . . . . 5.8300000000000001 111.225 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.434 ' CE1' ' HA ' ' A' ' 168' ' ' ALA . 74.0 t80 -81.9 131.25 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 5.8700000000000001 111.171 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -82.82 107.78 15.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 5.9000000000000004 111.201 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.3 pt -98.36 -2.25 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 5.9299999999999997 111.166 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.01 -33.91 38.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 5.9699999999999998 111.165 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -64.76 139.99 58.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 6.0 111.173 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.0 t -72.93 123.88 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 6.0300000000000002 111.18 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.14 93.24 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -76.0 -24.94 16.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.769 0.319 . . . . 6.0999999999999996 111.171 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -89.6 64.51 6.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 6.1299999999999999 111.13 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -138.76 160.0 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 6.1699999999999999 111.222 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.41 80.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 6.2000000000000002 111.164 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.04 -47.36 83.05 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.4 90.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 6.2699999999999996 111.183 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.55 -44.14 91.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 6.2999999999999998 111.18 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.03 79.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.18 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.53 -45.03 97.18 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.225 -0.75 . . . . 6.3700000000000001 111.225 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.94 -38.55 86.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 6.4000000000000004 111.223 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -59.96 -50.91 71.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.233 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.28 -38.18 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 6.4699999999999998 111.213 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.8 tp -49.99 -53.22 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 6.5 111.203 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.6 -33.26 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 6.5300000000000002 111.162 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -54.72 -42.86 72.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 6.5700000000000003 111.249 176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.42 -33.34 74.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 6.5999999999999996 111.132 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.91 -48.7 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 6.6299999999999999 111.125 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.92 -25.95 31.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 6.6699999999999999 111.163 -171.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.95 15.5 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 6.7000000000000002 111.202 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.01 52.3 5.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 6.7300000000000004 111.214 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -115.12 -34.47 5.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 6.7699999999999996 111.209 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 98.9 mmm -139.81 169.34 17.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.147 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -153.06 175.03 13.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 6.8300000000000001 111.215 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -86.9 2.65 48.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 6.8700000000000001 111.141 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.39 1.8 55.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 6.9000000000000004 111.186 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.6 p -80.9 164.99 22.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 6.9299999999999997 111.259 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -158.12 170.0 23.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.149 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -59.66 -48.58 81.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 7.0 111.252 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 88.7 p -70.86 -30.01 66.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 7.0300000000000002 111.201 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.25 -46.97 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 7.0700000000000003 111.227 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.8 88.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 7.0999999999999996 111.2 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.81 -42.12 88.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 7.1299999999999999 111.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.05 94.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.177 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.42 -34.27 77.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 7.2000000000000002 111.164 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -64.59 -43.17 94.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 7.2300000000000004 111.231 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.77 -35.87 81.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2699999999999996 111.223 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -77.62 -26.61 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2999999999999998 111.205 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.01 31.64 22.78 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.228 -0.749 . . . . 7.3300000000000001 111.228 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -90.08 -6.01 55.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 7.3700000000000001 111.186 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 95.8 m -106.58 132.11 52.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 7.4000000000000004 111.253 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -86.81 -44.22 11.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 7.4299999999999997 111.253 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.411 ' HE3' HD21 ' A' ' 135' ' ' LEU . 61.9 mtm -135.39 152.65 51.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 7.4699999999999998 111.157 -174.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -161.69 147.06 13.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 7.5 111.22 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.42 115.7 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 7.5300000000000002 111.244 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -154.9 166.82 32.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 7.5700000000000003 111.264 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.65 -176.46 18.38 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.219 -0.752 . . . . 7.5999999999999996 111.219 166.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -56.15 -26.73 61.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.671 1.581 . . . . 7.6299999999999999 111.218 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -60.18 -22.05 62.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 7.6699999999999999 111.21 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.03 24.98 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 7.7000000000000002 111.178 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -101.81 10.03 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 7.7300000000000004 111.241 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.8 p -70.49 -32.68 70.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 7.7699999999999996 111.213 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -89.04 -34.02 16.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 7.7999999999999998 111.212 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.46 -38.85 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 7.8300000000000001 111.207 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -72.74 -32.26 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 7.8700000000000001 111.188 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -99.31 8.72 44.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 7.9000000000000004 111.175 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 239' ' ' LYS . 85.1 p -70.71 -18.43 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 7.9299999999999997 111.171 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 238' ' ' SER . 94.9 mttt 63.92 24.02 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 7.9699999999999998 111.211 -170.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.76 131.25 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 8.0 111.18 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.13 133.78 51.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 8.0299999999999994 111.144 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -145.34 158.68 43.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 8.0700000000000003 111.197 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.01 179.69 18.01 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.178 -0.769 . . . . 8.0999999999999996 111.178 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 73.5 t -133.52 131.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 8.1300000000000008 111.188 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 46.4 p -119.74 167.82 11.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 8.1699999999999999 111.163 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.77 119.94 51.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 8.1999999999999993 111.216 -166.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.54 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . 85.9 mt -82.97 -42.97 0.87 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 8.2300000000000004 111.221 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 247' ' ' LEU . 76.5 Cg_exo -45.48 113.28 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.71 1.606 . . . . 8.2699999999999996 111.183 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 92.3 m -124.57 134.36 52.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 8.3000000000000007 111.216 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -127.17 117.74 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 8.3300000000000001 111.233 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 57.24 34.97 25.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 8.3699999999999992 111.17 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.51 13.21 82.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.168 -0.773 . . . . 8.4000000000000004 111.168 176.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.439 ' HA ' ' HD2' ' A' ' 254' ' ' PRO . 63.7 tp60 -130.0 110.01 16.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.337 . . . . 8.4299999999999997 111.192 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 253' ' ' GLN . 64.9 Cg_endo -69.48 142.04 48.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.671 1.581 . . . . 8.4700000000000006 111.222 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.6 p -125.01 -84.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 8.5 111.245 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.26 155.2 76.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 8.5299999999999994 111.266 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 155.0 72.37 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.725 1.617 . . . . 8.5700000000000003 111.247 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -76.9 132.04 38.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 8.5999999999999996 111.127 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -106.72 126.77 62.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 8.6300000000000008 111.247 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.01 149.42 16.79 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.165 -0.774 . . . . 8.6699999999999999 111.165 170.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 77.2 t -125.54 130.4 72.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 8.6999999999999993 111.216 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 56.1 tp -97.66 121.05 39.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 8.7300000000000004 111.222 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 72.4 m -123.64 146.94 47.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 8.7699999999999996 111.194 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -78.14 162.93 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 8.8000000000000007 111.192 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.29 171.51 36.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.215 -0.754 . . . . 8.8300000000000001 111.215 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.71 132.31 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 8.8699999999999992 111.196 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -59.99 120.89 10.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 8.9000000000000004 111.211 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.84 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 8.9299999999999997 111.194 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -98.9 -0.3 42.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 8.9700000000000006 111.216 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -64.95 131.09 95.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 9.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.95 -15.09 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.715 1.61 . . . . 9.0299999999999994 111.214 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -123.52 61.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 9.0700000000000003 111.175 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -72.27 -22.53 61.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 9.0999999999999996 111.25 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -33.15 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 9.1300000000000008 111.159 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.2 -41.56 90.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 9.1699999999999999 111.198 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.16 94.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 9.1999999999999993 111.215 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -55.36 -49.94 70.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 9.2300000000000004 111.2 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -62.16 -56.92 13.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 9.2699999999999996 111.258 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.55 -55.05 33.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 9.3000000000000007 111.183 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.46 -50.01 74.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 9.3300000000000001 111.24 -172.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.03 -49.73 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 9.3699999999999992 111.223 -172.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -98.39 -13.45 20.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 9.4000000000000004 111.164 -158.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.53 -49.89 1.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 9.4299999999999997 111.203 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.03 -53.45 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 9.4700000000000006 111.191 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.5 mp -76.75 59.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.23 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.3 p -139.76 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 9.5299999999999994 111.209 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -56.78 -47.5 80.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 9.5700000000000003 111.231 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.36 -33.24 69.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 9.5999999999999996 111.261 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.84 -47.89 88.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.26 -0.736 . . . . 9.6300000000000008 111.26 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.18 -50.09 62.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.767 0.318 . . . . 9.6699999999999999 111.156 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.73 -35.05 73.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 9.6999999999999993 111.187 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.16 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.7300000000000004 111.191 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.71 -44.06 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 9.7699999999999996 111.173 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.51 -0.11 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 9.8000000000000007 111.21 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -77.58 -16.36 58.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 9.8300000000000001 111.164 168.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -110.47 -33.18 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 9.8699999999999992 111.244 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -96.2 160.23 30.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 9.9000000000000004 111.189 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.97 154.06 23.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.736 1.624 . . . . 9.9299999999999997 111.216 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.16 -6.9 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 9.9700000000000006 111.142 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.54 -44.01 85.69 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.17 -0.772 . . . . 10.0 111.17 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.43 125.46 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.731 0.3 . . . . 10.029999999999999 111.205 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.3 p -152.06 141.14 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 10.07 111.189 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -139.02 35.86 2.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 10.1 111.218 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.14 148.0 46.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 10.130000000000001 111.152 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.06 -49.98 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 10.17 111.204 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.4 p -68.79 -25.36 64.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 10.199999999999999 111.209 -173.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -79.99 -50.49 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 10.23 111.23 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.98 -38.34 72.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.171 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.11 -39.85 93.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 10.300000000000001 111.167 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -75.48 -32.82 60.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 10.33 111.173 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.16 -24.3 57.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 10.369999999999999 111.168 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.78 -14.56 62.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 10.4 111.201 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.24 -30.06 70.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 10.43 111.209 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -78.52 117.65 67.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 10.470000000000001 111.148 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.71 -34.99 86.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.685 1.59 . . . . 10.5 111.146 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.74 -29.71 67.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.529999999999999 111.219 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.78 -29.96 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 10.57 111.224 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.38 94.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 10.6 111.205 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.2 99.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.206 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.3 m -68.03 -44.63 76.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.196 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 56.7 mtt -73.74 -37.11 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.22 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.77 -44.01 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 10.73 111.23 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -64.8 -36.8 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 10.77 111.179 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.49 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 10.800000000000001 111.156 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -72.03 -37.45 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 10.83 111.117 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.03 -0.02 54.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.149 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.34 -136.77 9.49 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.245 -0.742 . . . . 10.9 111.245 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -149.07 147.29 28.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 10.93 111.188 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.3 pt -117.11 162.61 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 10.970000000000001 111.205 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -59.37 117.43 22.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 11.0 111.188 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 149.36 88.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.672 1.581 . . . . 11.029999999999999 111.183 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -105.05 39.91 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 11.07 111.202 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 74.9 mt -88.74 118.76 69.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 11.1 111.255 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.83 -17.97 13.58 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.674 1.582 . . . . 11.130000000000001 111.225 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.14 -5.01 58.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 11.17 111.226 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.6 mmm -110.77 19.1 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 11.199999999999999 111.255 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.1 m -65.65 -50.94 63.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 11.23 111.181 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.15 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 11.27 111.217 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -71.13 -47.27 58.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 11.300000000000001 111.216 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -70.13 -35.77 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 11.33 111.261 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -58.15 -51.96 67.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 11.369999999999999 111.196 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -31.49 72.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 11.4 111.143 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.21 -43.07 88.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 11.43 111.181 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.31 -40.05 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 11.470000000000001 111.167 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.3 m -57.3 -41.11 79.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 11.5 111.212 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.01 71.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 11.529999999999999 111.194 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.04 -25.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.186 -172.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.79 -46.03 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 11.6 111.195 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.53 -27.39 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 11.630000000000001 111.221 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.77 -39.13 36.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 11.67 111.184 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.48 86.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 11.699999999999999 111.216 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -74.4 -14.97 60.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 11.73 111.203 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.39 31.89 40.18 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.14 -0.784 . . . . 11.77 111.14 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -100.01 -38.28 8.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.78 0.324 . . . . 11.800000000000001 111.177 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -124.96 159.18 31.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 11.83 111.207 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.3 p -81.66 176.92 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 11.869999999999999 111.204 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 10.7 m -70.59 -21.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 11.9 111.199 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -89.84 -36.71 14.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 11.93 111.187 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -69.09 -36.72 77.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.151 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.92 87.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 12.0 111.171 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.84 -32.48 73.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 12.029999999999999 111.191 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.94 -59.96 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 12.07 111.248 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.38 -41.1 89.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 12.1 111.235 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.26 85.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 12.130000000000001 111.19 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.7 -46.45 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 12.17 111.202 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.2 m -62.43 -39.96 95.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 12.199999999999999 111.208 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -65.01 -37.21 86.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 12.23 111.175 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.9 mt -73.28 -45.01 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 12.27 111.228 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 370' ' ' LYS . 81.0 p -81.99 -15.48 53.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 12.300000000000001 111.201 -176.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 369' ' ' THR . 98.8 mttt . . . . . 0 C--O 1.199 -1.553 0 CA-C-N 116.221 -0.445 . . . . 12.33 111.222 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.736 0.303 . . . . 0.029999999999999999 111.258 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.1 tp -59.59 136.7 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.070000000000000007 111.133 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.18 150.1 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.10000000000000001 111.214 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.03 125.13 22.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.13 111.217 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.74 14.29 58.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.143 -0.783 . . . . 0.17000000000000001 111.143 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -132.06 155.01 48.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 0.20000000000000001 111.23 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -116.27 109.98 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.23000000000000001 111.186 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.94 123.76 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.27000000000000002 111.179 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.29999999999999999 111.264 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.401 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.3 m0 -109.98 128.74 55.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.33000000000000002 111.175 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.5 mt -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.37 111.165 -173.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -62.34 122.17 15.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.40000000000000002 111.224 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.9 -174.31 15.14 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.14 -0.784 . . . . 0.42999999999999999 111.14 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -99.95 -19.93 16.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.46999999999999997 111.264 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.45 144.16 28.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.5 111.175 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.73 -18.81 8.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.174 -0.771 . . . . 0.53000000000000003 111.174 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -47.59 -55.12 9.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.767 0.318 . . . . 0.56999999999999995 111.197 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -94.23 -27.04 16.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.59999999999999998 111.268 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.13 -57.23 19.33 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.255 -0.738 . . . . 0.63 111.255 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.7 tp -74.57 -29.14 61.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.67000000000000004 111.229 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -32.6 63.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.69999999999999996 111.164 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -59.21 -33.54 71.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.72999999999999998 111.172 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.26 -40.16 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.77000000000000002 111.228 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.25 -28.94 71.68 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.285 -0.726 . . . . 0.80000000000000004 111.285 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.66 -42.52 99.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.82999999999999996 111.135 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.3 -48.45 70.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.87 111.165 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -56.17 -44.16 79.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.90000000000000002 111.197 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.29 -42.07 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.93000000000000005 111.178 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.89 -35.0 69.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.96999999999999997 111.257 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -78.71 -35.9 44.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.256 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -106.26 -28.31 10.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 1.03 111.212 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.75 5.06 74.94 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.24 -0.744 . . . . 1.0700000000000001 111.24 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mm -86.5 114.78 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 1.1000000000000001 111.219 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.92 124.06 19.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 111.181 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.36 126.14 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 1.1699999999999999 111.177 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -126.46 116.77 21.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 1.2 111.234 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.5 125.01 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 1.23 111.186 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.401 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.6 mt-10 -132.71 161.35 34.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 1.27 111.194 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -117.15 102.78 52.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 1.3 111.188 172.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.56 167.95 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.709 1.606 . . . . 1.3300000000000001 111.186 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.6 t0 -100.19 102.86 14.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 1.3700000000000001 111.142 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.18 70.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 1.3999999999999999 111.2 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 68.5 mt -59.98 -20.69 59.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 1.4299999999999999 111.214 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -49.23 -35.03 16.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 1.47 111.185 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -109.86 -25.58 10.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 1.5 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 43' ' ' LEU . 87.1 tttt -79.98 -24.4 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 1.53 111.141 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.473 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -50.67 -57.39 13.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 1.5700000000000001 111.2 -177.098 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -68.61 -24.65 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.663 1.575 . . . . 1.6000000000000001 111.209 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.11 -37.31 72.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.173 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -88.59 -24.16 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 1.6699999999999999 111.197 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.26 -30.82 71.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 1.7 111.158 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.0 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 1.73 111.273 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -101.53 -15.39 17.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 1.77 111.131 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.5 32.55 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.208 -0.757 . . . . 1.8 111.208 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -110.02 169.97 8.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 1.8300000000000001 111.179 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.44 179.99 31.86 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.21 -0.756 . . . . 1.8700000000000001 111.21 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.37 -178.08 3.55 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.669 1.579 . . . . 1.8999999999999999 111.154 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -84.55 -56.53 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.9299999999999999 111.241 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -114.16 138.93 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 1.97 111.283 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.68 121.07 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 2.0 111.193 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -98.2 107.89 20.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 2.0299999999999998 111.162 167.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -148.33 157.26 43.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 2.0699999999999998 111.172 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.7 140.95 53.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.1000000000000001 111.226 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -58.62 -26.19 63.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 2.1299999999999999 111.149 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -76.7 -6.7 53.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 2.1699999999999999 111.232 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -129.13 -24.94 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 111.19 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.04 -29.98 67.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 2.23 111.187 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -28.82 73.57 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.21 -0.756 . . . . 2.27 111.21 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.78 -31.89 59.77 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.159 -0.776 . . . . 2.2999999999999998 111.159 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -64.54 -36.15 83.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.203 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.77 69.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 2.3700000000000001 111.153 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -55.33 -42.59 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 2.3999999999999999 111.2 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 99.9 p -70.64 -15.05 62.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 2.4300000000000002 111.222 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.22 22.04 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.195 -0.762 . . . . 2.4700000000000002 111.195 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -107.24 -8.67 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 2.5 111.25 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -105.08 135.08 47.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 2.5299999999999998 111.214 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.96 134.97 53.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 2.5699999999999998 111.166 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -74.5 91.03 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 2.6000000000000001 111.243 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.95 98.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 2.6299999999999999 111.154 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.6 m -91.46 115.39 64.38 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 2.6699999999999999 111.224 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -56.39 144.99 81.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.702 1.601 . . . . 2.7000000000000002 111.169 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.96 163.05 28.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 2.73 111.134 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.31 -36.39 53.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 2.77 111.187 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.64 74.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 2.7999999999999998 111.263 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -70.25 -31.23 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 2.8300000000000001 111.226 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -57.56 -33.86 68.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 2.8700000000000001 111.216 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -81.72 -16.1 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 2.8999999999999999 111.245 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 305' ' ' LYS . 70.1 mmtt -85.02 -35.03 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 2.9300000000000002 111.199 -170.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.63 161.14 20.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 2.9700000000000002 111.141 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -60.02 144.67 86.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 3.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.96 -25.12 66.96 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.684 1.589 . . . . 3.0299999999999998 111.224 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -65.68 -49.05 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 3.0699999999999998 111.18 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.5 p -89.12 -24.13 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.262 -0.426 . . . . 3.1000000000000001 111.204 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -69.96 -46.79 64.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 3.1299999999999999 111.192 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.89 -15.43 61.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 3.1699999999999999 111.188 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.24 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 3.2000000000000002 111.179 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.15 78.92 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 3.23 111.227 -169.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.415 ' HB3' HD21 ' A' ' 103' ' ' LEU . 33.7 ptt-85 -149.82 165.1 33.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 3.27 111.193 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -131.97 114.43 14.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 3.2999999999999998 111.221 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 61.94 37.2 15.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 3.3300000000000001 111.163 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.8 7.68 83.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.213 -0.755 . . . . 3.3700000000000001 111.213 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.96 107.25 15.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 3.3999999999999999 111.171 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.415 HD21 ' HB3' ' A' ' 98' ' ' ARG . 58.0 mt -59.33 128.99 39.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 3.4300000000000002 111.12 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -112.36 -20.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 3.4700000000000002 111.228 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.35 176.0 6.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 3.5 111.268 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -113.25 127.32 26.96 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 3.5299999999999998 111.231 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 263' ' ' SER . 42.1 Cg_endo -67.45 138.95 47.72 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.718 1.612 . . . . 3.5699999999999998 111.273 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.4 mm -116.14 -47.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 3.6000000000000001 111.243 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.73 154.98 50.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 3.6299999999999999 111.179 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 134.96 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 3.6699999999999999 111.252 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -124.9 123.41 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 3.7000000000000002 111.186 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.26 151.18 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 3.73 111.218 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.2 tp -138.18 125.81 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 3.77 111.166 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 t -159.98 -168.54 2.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 3.7999999999999998 111.179 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.95 125.54 36.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 3.8300000000000001 111.173 -168.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.86 139.99 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 3.8700000000000001 111.267 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -136.55 144.92 44.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 3.8999999999999999 111.205 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -75.52 123.5 25.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 3.9300000000000002 111.216 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -70.97 -30.1 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 3.9700000000000002 111.185 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -77.85 -43.26 30.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 4.0 111.209 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.14 -44.64 59.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 4.0300000000000002 111.163 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -128.54 77.3 77.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 4.0700000000000003 111.238 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.69 -25.01 74.97 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.659 1.573 . . . . 4.0999999999999996 111.198 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -105.19 100.07 23.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 4.1299999999999999 111.26 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.0 155.4 52.8 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.706 1.604 . . . . 4.1699999999999999 111.196 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 154.55 59.31 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.691 1.594 . . . . 4.2000000000000002 111.253 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -85.32 -15.64 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 4.2300000000000004 111.192 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.2 t -160.0 162.66 34.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 4.2699999999999996 111.192 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -59.4 -23.25 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 4.2999999999999998 111.215 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.43 -22.83 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.3300000000000001 111.185 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -96.76 2.97 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 4.3700000000000001 111.226 -176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.519 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 70.4 mt -66.93 -54.33 21.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 4.4000000000000004 111.191 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 67.5 Cg_endo -71.78 -18.52 28.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.735 1.623 . . . . 4.4299999999999997 111.233 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.98 -24.69 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 4.4699999999999998 111.197 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.2 -6.88 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 4.5 111.162 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.37 -35.01 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 4.5300000000000002 111.174 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.03 -39.88 83.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 4.5700000000000003 111.213 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.61 -27.85 68.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 4.5999999999999996 111.158 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.01 -0.36 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 4.6299999999999999 111.207 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.15 -26.27 68.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 4.6699999999999999 111.228 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.97 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 4.7000000000000002 111.232 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -99.92 -20.01 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 4.7300000000000004 111.183 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.61 24.8 44.88 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.145 -0.782 . . . . 4.7699999999999996 111.145 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -119.04 164.94 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 4.7999999999999998 111.19 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t -111.34 158.46 19.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 4.8300000000000001 111.213 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.1 -72.86 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.178 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.3 tp -156.94 129.0 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 4.9000000000000004 111.166 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mmm -84.73 140.55 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 4.9299999999999997 111.242 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.02 138.42 53.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 4.9699999999999998 111.165 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -82.91 119.78 24.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 5.0 111.209 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.406 HD22 HD11 ' A' ' 195' ' ' LEU . 99.0 mt -114.81 -25.52 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 5.0300000000000002 111.181 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.07 -39.82 90.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 5.0700000000000003 111.184 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.97 118.4 56.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 5.0999999999999996 111.208 -172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.96 -34.91 88.34 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.654 1.569 . . . . 5.1299999999999999 111.16 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -53.5 -37.69 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 5.1699999999999999 111.215 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.28 25.63 8.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 5.2000000000000002 111.245 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.3 p -103.34 -15.23 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 5.2300000000000004 111.154 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.558 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 75.0 t90 -68.67 -48.2 32.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 5.2699999999999996 111.217 175.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 67.6 Cg_endo -74.79 -4.36 15.29 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.674 1.582 . . . . 5.2999999999999998 111.193 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.8 mt -65.3 -21.04 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 5.3300000000000001 111.176 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.7 mt -109.68 -41.46 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 5.3700000000000001 111.173 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 159' ' ' PRO . . . -65.02 -44.47 89.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 5.4000000000000004 111.232 -175.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.01 -34.33 78.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 5.4299999999999997 111.233 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -64.2 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 5.4699999999999998 111.219 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.57 23.74 6.74 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.248 -0.741 . . . . 5.5 111.248 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.53 -22.05 17.61 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.169 -0.772 . . . . 5.5300000000000002 111.169 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.44 ' O ' ' HB1' ' A' ' 168' ' ' ALA . 68.1 t80 -111.59 145.15 39.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 5.5700000000000003 111.122 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 167' ' ' TYR . . . 67.55 22.79 9.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 5.5999999999999996 111.175 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.36 173.22 11.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 5.6299999999999999 111.171 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -139.32 112.88 8.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 5.6699999999999999 111.166 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -79.14 80.11 5.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 5.7000000000000002 111.23 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -145.69 90.01 1.96 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 5.7300000000000004 111.235 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 74.12 -69.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 5.7699999999999996 111.267 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.0 25.78 0.07 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.22 -0.752 . . . . 5.7999999999999998 111.22 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -114.96 103.28 10.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 5.8300000000000001 111.201 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -110.46 77.22 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 5.8700000000000001 111.243 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -81.6 122.88 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 5.9000000000000004 111.16 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.86 -34.11 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 5.9299999999999997 111.198 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -30.04 71.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 5.9699999999999998 111.156 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -65.59 143.03 57.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 6.0 111.169 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 183' ' ' VAL . 70.9 t -47.83 124.08 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 6.0300000000000002 111.142 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -98.48 14.31 62.18 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.229 -0.749 . . . . 6.0700000000000003 111.229 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.462 ' H ' HG12 ' A' ' 181' ' ' VAL . 25.0 m -123.63 31.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 6.0999999999999996 111.189 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -127.67 9.95 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 6.1299999999999999 111.25 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.38 161.38 14.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 6.1699999999999999 111.148 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.17 72.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 6.2000000000000002 111.148 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.32 -37.09 90.43 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.177 -0.769 . . . . 6.2300000000000004 111.177 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.2 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 6.2699999999999996 111.185 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.74 -40.76 75.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 6.2999999999999998 111.254 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.55 -28.91 68.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.146 -0.479 . . . . 6.3300000000000001 111.207 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -20.13 66.74 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.154 -0.778 . . . . 6.3700000000000001 111.154 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.407 HD22 HG23 ' A' ' 347' ' ' VAL . 86.7 mt -104.99 -34.9 7.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 6.4000000000000004 111.203 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.9 m -64.56 -52.53 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 6.4299999999999997 111.233 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.62 -38.62 87.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 6.4699999999999998 111.193 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.406 HD11 HD22 ' A' ' 151' ' ' LEU . 54.1 tp -58.17 -53.33 59.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 6.5 111.203 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.77 -42.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 6.5300000000000002 111.212 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.92 -39.67 86.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 6.5700000000000003 111.204 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 84.7 mt -70.4 -35.4 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 6.5999999999999996 111.23 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.24 -40.79 89.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.188 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.79 -24.62 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 6.6699999999999999 111.205 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.71 5.18 52.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 6.7000000000000002 111.22 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 60.65 35.26 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 6.7300000000000004 111.224 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -74.88 -34.06 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.215 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -145.21 149.93 35.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 6.7999999999999998 111.17 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -94.65 151.52 19.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 6.8300000000000001 111.243 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.94 -24.53 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 6.8700000000000001 111.229 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.77 -16.75 56.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 6.9000000000000004 111.146 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -56.4 118.03 4.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 6.9299999999999997 111.232 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -119.97 -164.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 6.9699999999999998 111.22 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.09 -47.83 81.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 7.0 111.167 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 82.5 p -75.09 -25.51 58.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 7.0300000000000002 111.183 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.5 mm -67.65 -52.26 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 7.0700000000000003 111.182 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.99 90.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 7.0999999999999996 111.201 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.39 -42.46 91.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 7.1299999999999999 111.218 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.08 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.173 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -26.67 68.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 7.2000000000000002 111.224 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -81.65 -45.28 15.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 7.2300000000000004 111.197 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.66 -30.12 64.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 7.2699999999999996 111.188 -174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -9.75 56.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 7.2999999999999998 111.222 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.16 32.87 51.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.194 -0.762 . . . . 7.3300000000000001 111.194 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -81.43 -29.33 33.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.764 0.316 . . . . 7.3700000000000001 111.191 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.1 p -100.24 160.04 14.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 7.4000000000000004 111.204 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.06 -24.76 16.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 7.4299999999999997 111.189 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 90.2 mmm -109.88 149.94 29.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 7.4699999999999998 111.168 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -159.64 179.61 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 7.5 111.174 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.2 mt -121.1 124.17 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 7.5300000000000002 111.178 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -165.01 179.94 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 7.5700000000000003 111.279 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 229' ' ' PRO . . . -74.84 139.33 25.1 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.245 -0.742 . . . . 7.5999999999999996 111.245 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' A' ' 228' ' ' GLY . 53.6 Cg_exo -53.32 129.84 35.51 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.67 1.58 . . . . 7.6299999999999999 111.188 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 57.39 49.93 12.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 7.6699999999999999 111.217 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.86 75.37 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 7.7000000000000002 111.226 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.413 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 48.4 m0 -68.28 -17.13 64.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 7.7300000000000004 111.146 -170.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 97.0 p -66.18 -19.97 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 7.7699999999999996 111.208 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -118.98 -19.41 8.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 7.7999999999999998 111.105 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.8 mt -90.77 -61.33 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.195 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.97 -39.55 75.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 7.8700000000000001 111.205 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 83.9 m -52.45 -44.93 65.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 7.9000000000000004 111.159 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 84.9 p -81.27 -10.47 59.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 7.9299999999999997 111.195 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 59.99 40.23 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 7.9699999999999998 111.247 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.63 135.06 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 8.0 111.161 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -73.85 111.24 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 8.0299999999999994 111.227 -175.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.31 145.02 44.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 8.0700000000000003 111.159 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.08 178.65 17.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.189 -0.764 . . . . 8.0999999999999996 111.189 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.89 139.96 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 8.1300000000000008 111.166 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.1 t -142.5 176.55 8.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 8.1699999999999999 111.209 171.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.57 112.85 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 8.1999999999999993 111.139 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.506 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 40.6 tp -63.46 -53.76 49.47 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 8.2300000000000004 111.212 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 70.8 Cg_endo -74.81 147.34 34.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.688 1.592 . . . . 8.2699999999999996 111.191 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.4 m -116.27 125.34 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 8.3000000000000007 111.177 174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -99.98 90.08 4.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 8.3300000000000001 111.188 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 52.14 55.47 9.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 8.3699999999999992 111.19 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 99.27 -23.59 35.68 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.221 -0.752 . . . . 8.4000000000000004 111.221 171.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -129.95 109.97 16.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 8.4299999999999997 111.232 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -54.98 130.71 42.2 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.719 1.613 . . . . 8.4700000000000006 111.194 173.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.7 t -114.97 -94.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 8.5 111.188 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.94 145.53 30.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 8.5299999999999994 111.185 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.73 -176.42 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.731 1.62 . . . . 8.5700000000000003 111.175 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -86.58 156.4 20.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 8.5999999999999996 111.201 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.14 117.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 8.6300000000000008 111.179 -173.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.57 150.05 19.03 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.222 -0.751 . . . . 8.6699999999999999 111.222 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.98 121.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.894 0.378 . . . . 8.6999999999999993 111.183 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.4 tp -95.44 110.93 22.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 8.7300000000000004 111.214 172.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 89.5 p -112.51 151.7 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 8.7699999999999996 111.156 -171.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -111.48 126.93 55.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 8.8000000000000007 111.176 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.98 177.68 19.12 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.236 -0.746 . . . . 8.8300000000000001 111.236 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 80.2 mt -111.67 122.87 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 8.8699999999999992 111.184 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -60.75 128.9 38.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 8.9000000000000004 111.137 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.85 63.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 8.9299999999999997 111.232 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -87.17 -5.01 59.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 8.9700000000000006 111.108 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.9 t -80.43 132.39 58.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 9.0 111.179 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.68 -5.4 14.73 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.749 1.633 . . . . 9.0299999999999994 111.191 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -118.0 59.92 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 9.0700000000000003 111.218 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -77.76 -28.89 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 9.0999999999999996 111.243 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.45 -38.6 65.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 9.1300000000000008 111.265 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.41 -37.73 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 9.1699999999999999 111.199 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.83 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 9.1999999999999993 111.216 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.1 -48.85 70.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 9.2300000000000004 111.192 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.69 -47.6 77.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 9.2699999999999996 111.127 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.05 -41.06 74.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 9.3000000000000007 111.21 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.14 -3.76 58.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.3300000000000001 111.223 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.41 -50.01 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 9.3699999999999992 111.244 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -121.21 4.96 10.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 9.4000000000000004 111.163 -164.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -125.0 -62.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 9.4299999999999997 111.143 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.56 -53.29 58.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 9.4700000000000006 111.155 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 64.1 mt -85.03 60.8 6.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 9.5 111.199 -174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.6 p -134.94 167.53 20.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 9.5299999999999994 111.248 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.47 -34.62 78.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 9.5700000000000003 111.177 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.07 -35.18 22.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 9.5999999999999996 111.166 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.81 -48.76 63.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.69 -28.25 65.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 9.6699999999999999 111.232 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -69.41 -36.12 76.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 9.6999999999999993 111.148 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.01 78.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 9.7300000000000004 111.187 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -70.41 -39.95 77.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 9.7699999999999996 111.217 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.14 5.02 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8000000000000007 111.139 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -54.65 -50.21 68.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 9.8300000000000001 111.182 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -106.8 -18.16 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 9.8699999999999992 111.147 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -103.08 162.76 19.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 9.9000000000000004 111.277 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.45 144.93 48.67 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 121.729 1.619 . . . . 9.9299999999999997 111.198 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.23 -6.89 59.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 9.9700000000000006 111.18 -170.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -56.96 -35.9 70.95 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.139 -0.784 . . . . 10.0 111.139 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.19 127.98 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 10.029999999999999 111.12 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.77 129.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 10.07 111.236 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -125.13 26.48 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 10.1 111.168 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 36.2 tp -157.65 130.99 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 10.130000000000001 111.221 -172.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 86.7 tttt -61.78 -46.52 89.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 10.17 111.188 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 68.0 m -55.07 -38.25 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 10.199999999999999 111.16 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -71.39 -41.81 69.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 10.23 111.226 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.58 -34.27 66.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 10.27 111.237 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.48 -29.98 68.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 10.300000000000001 111.244 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -96.52 -30.02 13.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 10.33 111.142 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.45 -30.95 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 10.369999999999999 111.182 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.14 -9.12 54.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 10.4 111.196 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.93 -28.42 67.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 10.43 111.156 173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -80.62 115.59 56.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.470000000000001 111.177 173.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.52 -38.81 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.726 1.618 . . . . 10.5 111.205 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.64 -39.87 70.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.166 -172.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.67 -40.04 76.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 10.57 111.194 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.59 -43.37 89.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 10.6 111.234 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.93 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 10.630000000000001 111.158 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 90.0 m -63.37 -43.06 98.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.199 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.98 -38.32 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 10.699999999999999 111.19 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -63.27 -46.16 88.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.197 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.96 -33.79 76.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 10.77 111.212 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.05 -45.68 84.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 10.800000000000001 111.167 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.23 -39.84 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 10.83 111.174 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -95.95 6.15 49.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 10.869999999999999 111.224 -174.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.65 -156.03 26.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.234 -0.746 . . . . 10.9 111.234 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -130.6 116.18 17.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 10.93 111.249 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 97.7 mt -105.08 137.0 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 10.970000000000001 111.209 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 83.0 mtp -63.35 130.57 94.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 11.0 111.235 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 50.7 Cg_exo -55.01 144.39 68.67 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 11.029999999999999 111.204 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -120.17 55.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 11.07 111.151 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 335' ' ' GLN . 82.0 mt -126.63 130.42 23.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 11.1 111.215 -178.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.13 -29.22 74.23 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.697 1.598 . . . . 11.130000000000001 111.229 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.42 ' H ' HG22 ' A' ' 333' ' ' ILE . 90.6 mt-30 -64.02 -41.71 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 11.17 111.19 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 95.3 mmm -65.34 -37.25 86.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 11.199999999999999 111.249 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 39.4 t -59.92 -41.41 91.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 11.23 111.242 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.41 -36.65 83.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 11.27 111.252 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -64.98 -36.69 85.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 11.300000000000001 111.183 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -68.22 -29.76 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 11.33 111.177 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -62.76 -41.4 99.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 11.369999999999999 111.187 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.37 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 11.4 111.267 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.7 -42.59 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 11.43 111.153 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.5 -45.12 95.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 11.470000000000001 111.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.4 m -64.99 -39.94 94.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 11.5 111.241 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.29 -45.42 91.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 11.529999999999999 111.162 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.407 HG23 HD22 ' A' ' 192' ' ' LEU . 70.1 t -64.72 -40.52 89.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 11.57 111.243 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.1 mt -65.13 -43.82 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 11.6 111.222 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.78 -37.37 87.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 11.630000000000001 111.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.0 -44.37 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 11.67 111.203 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.03 79.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 11.699999999999999 111.218 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.4 p -82.93 -14.95 53.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 11.73 111.22 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.25 12.26 65.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.22 -0.752 . . . . 11.77 111.22 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -70.04 -40.81 74.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 11.800000000000001 111.145 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -129.89 166.92 19.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 11.83 111.248 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -83.46 174.47 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 11.869999999999999 111.181 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -44.1 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 11.9 111.187 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.92 -42.75 80.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 11.93 111.201 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -64.74 -40.35 95.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 11.970000000000001 111.211 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.91 -48.49 73.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 12.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.26 -23.18 60.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 12.029999999999999 111.198 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.12 -48.48 73.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 12.07 111.186 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.63 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 12.1 111.241 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.54 93.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 12.130000000000001 111.173 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.35 -40.62 97.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 12.17 111.16 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 95.9 m -56.96 -42.74 80.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 12.199999999999999 111.248 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 22.6 tpp85 -66.17 -44.14 84.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 12.23 111.241 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.76 -39.97 87.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 12.27 111.171 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 370' ' ' LYS . 69.5 p -88.63 -14.95 36.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 12.300000000000001 111.159 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 369' ' ' THR . 99.0 mttt . . . . . 0 C--O 1.201 -1.474 0 CA-C-N 116.188 -0.46 . . . . 12.33 111.216 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.76 0.314 . . . . 0.029999999999999999 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.7 mt -96.41 115.5 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.070000000000000007 111.223 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -95.58 139.96 31.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.243 -0.435 . . . . 0.10000000000000001 111.231 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.68 125.04 21.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.13 111.199 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.64 5.21 60.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.2 -0.76 . . . . 0.17000000000000001 111.2 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HG2' ' HB2' ' A' ' 34' ' ' LYS . 96.0 mttt -133.47 148.56 51.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.20000000000000001 111.116 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.2 mt -113.74 140.76 48.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.23000000000000001 111.152 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.93 110.89 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.27000000000000002 111.178 172.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.464 HG12 ' HB ' ' A' ' 59' ' ' ILE . 69.8 mt -113.79 116.21 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.29999999999999999 111.235 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.447 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 38.7 m0 -105.46 119.76 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.33000000000000002 111.164 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.43 139.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.37 111.208 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -67.63 119.31 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.142 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.81 -177.99 26.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.144 -0.782 . . . . 0.42999999999999999 111.144 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -102.71 -35.03 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.46999999999999997 111.138 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.83 163.26 28.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.5 111.201 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.41 -7.9 9.01 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.149 -0.781 . . . . 0.53000000000000003 111.149 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -60.75 -23.23 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.317 . . . . 0.56999999999999995 111.188 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -67.23 -36.43 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.59999999999999998 111.167 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.59 -44.86 94.46 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.28 -0.728 . . . . 0.63 111.28 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.15 -32.74 70.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.753 0.311 . . . . 0.67000000000000004 111.162 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.03 92.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.69999999999999996 111.181 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -61.41 -34.76 75.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.72999999999999998 111.207 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.95 -39.78 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.77000000000000002 111.256 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.09 79.78 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.27 -0.732 . . . . 0.80000000000000004 111.27 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.07 -37.39 84.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.337 . . . . 0.82999999999999996 111.227 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.89 -37.43 87.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.87 111.169 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -30.0 67.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.90000000000000002 111.183 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.39 -36.48 66.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.93000000000000005 111.145 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -82.79 -39.15 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.96999999999999997 111.238 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.71 -50.22 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.199 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -102.46 -49.34 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.03 111.202 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.44 21.57 3.01 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.213 -0.755 . . . . 1.0700000000000001 111.213 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.56 122.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 1.1000000000000001 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 6' ' ' LYS . 99.1 mttt -87.97 127.75 35.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 1.1299999999999999 111.182 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.22 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 1.1699999999999999 111.218 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -115.42 125.05 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 1.2 111.158 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -114.95 126.38 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.195 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -129.96 162.6 28.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.27 111.201 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -112.32 106.84 55.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.228 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.447 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 78.7 Cg_endo -75.51 175.82 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.66 1.573 . . . . 1.3300000000000001 111.194 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -131.49 109.84 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 1.3700000000000001 111.219 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 58.07 69.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 1.3999999999999999 111.183 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.02 -18.59 61.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 1.4299999999999999 111.199 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -64.54 -15.08 60.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.202 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -99.24 -34.84 10.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 1.5 111.195 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -89.89 -48.66 7.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.53 111.208 -166.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 2.6 m-30 -56.47 -47.49 98.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.19 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 80.3 Cg_exo -50.46 -35.07 44.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.731 1.62 . . . . 1.6000000000000001 111.229 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -79.86 -47.47 15.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 1.6299999999999999 111.247 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.408 HG23 ' HA ' ' A' ' 47' ' ' PHE . 22.0 m -78.42 -16.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 1.6699999999999999 111.256 -174.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 1.7 111.204 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.66 -15.49 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 1.73 111.208 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -108.5 -14.97 14.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 1.77 111.194 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.55 30.25 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.249 -0.74 . . . . 1.8 111.249 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -110.16 169.99 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.327 . . . . 1.8300000000000001 111.221 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.48 -173.83 25.72 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.201 -0.76 . . . . 1.8700000000000001 111.201 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.63 173.22 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.68 1.587 . . . . 1.8999999999999999 111.258 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -88.77 -50.93 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 1.9299999999999999 111.221 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.464 ' HB ' HG12 ' A' ' 9' ' ' ILE . 84.9 mt -116.27 132.97 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.97 111.162 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.1 mt -114.2 117.56 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 2.0 111.139 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -114.07 106.5 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 111.234 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -150.46 159.97 44.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 2.0699999999999998 111.155 -166.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.12 158.52 27.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.213 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 46.3 m170 -71.58 -2.8 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 2.1299999999999999 111.197 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.41 -30.94 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 2.1699999999999999 111.188 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mmt-85 -129.95 -27.92 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 2.2000000000000002 111.159 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -55.04 -43.34 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 2.23 111.211 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.31 -28.32 72.1 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.244 -0.742 . . . . 2.27 111.244 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.71 -11.32 81.88 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.145 -0.782 . . . . 2.2999999999999998 111.145 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -69.6 -29.94 67.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.717 0.294 . . . . 2.3300000000000001 111.188 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.71 -35.18 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 2.3700000000000001 111.242 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -70.02 -38.71 75.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 2.3999999999999999 111.202 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.3 p -69.82 -19.99 63.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 2.4300000000000002 111.221 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.31 23.98 25.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.168 -0.773 . . . . 2.4700000000000002 111.168 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.6 30.91 6.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 2.5 111.234 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.9 tp -151.1 115.32 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 2.5299999999999998 111.224 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.77 162.44 24.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 2.5699999999999998 111.184 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -85.65 86.86 7.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 2.6000000000000001 111.211 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 mm -98.47 101.93 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 2.6299999999999999 111.15 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -92.94 120.76 66.89 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 2.6699999999999999 111.203 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.14 141.27 80.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.713 1.609 . . . . 2.7000000000000002 111.194 176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -89.65 -174.28 4.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.24 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.67 -38.63 67.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 2.77 111.209 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.22 79.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 2.7999999999999998 111.187 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.82 -22.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 2.8300000000000001 111.155 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -62.52 -29.62 70.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 2.8700000000000001 111.168 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -97.61 -30.17 13.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 2.8999999999999999 111.205 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -79.98 -35.17 37.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 2.9300000000000002 111.255 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -94.57 149.49 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.9700000000000002 111.192 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -73.35 135.02 79.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 3.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.07 -46.94 29.25 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.643 1.562 . . . . 3.0299999999999998 111.208 -170.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.52 -46.82 85.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 3.0699999999999998 111.241 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.3 p -82.41 -15.92 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 3.1000000000000001 111.228 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 85.8 t90 -65.98 -52.34 50.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 3.1299999999999999 111.259 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -85.78 9.98 14.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 3.1699999999999999 111.271 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.89 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 3.2000000000000002 111.239 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -104.07 24.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 3.23 111.175 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.2 ttt180 -76.57 129.98 37.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 3.27 111.206 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -157.95 132.81 8.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 3.2999999999999998 111.241 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 68.49 35.05 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 3.3300000000000001 111.149 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.59 -35.13 4.93 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.226 -0.75 . . . . 3.3700000000000001 111.226 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -130.62 171.95 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 3.3999999999999999 111.182 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.8 mp -77.94 145.17 36.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 3.4300000000000002 111.231 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.8 14.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 3.4700000000000002 111.136 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -168.92 178.89 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 3.5 111.15 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -110.07 117.54 51.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 3.5299999999999998 111.177 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.04 136.73 76.42 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.71 1.607 . . . . 3.5699999999999998 111.204 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.1 mm -112.96 -60.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 3.6000000000000001 111.3 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -154.93 162.61 41.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 3.6299999999999999 111.145 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.01 159.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 3.6699999999999999 111.193 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.25 126.76 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 3.7000000000000002 111.137 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.02 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 3.73 111.219 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.4 tp -124.26 111.58 16.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 3.77 111.19 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 t -166.91 -171.65 1.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 3.7999999999999998 111.18 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.2 tp -53.06 108.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 3.8300000000000001 111.198 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 244' ' ' VAL . 81.0 mt -92.55 114.13 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 3.8700000000000001 111.153 165.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -124.28 153.63 41.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 3.8999999999999999 111.165 -169.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -85.05 113.46 21.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 3.9300000000000002 111.147 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.34 -30.85 69.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 3.9700000000000002 111.182 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -72.1 -30.21 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 4.0 111.135 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.2 -13.8 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 4.0300000000000002 111.24 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 38.1 tp -142.97 79.79 14.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 4.0700000000000003 111.214 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.17 -19.48 29.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.757 1.638 . . . . 4.0999999999999996 111.205 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -120.16 89.97 43.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 4.1299999999999999 111.183 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.55 157.48 48.77 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.27 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.38 154.74 45.9 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.77 1.646 . . . . 4.2000000000000002 111.172 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.56 -5.24 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 4.2300000000000004 111.217 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -164.3 156.14 16.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 4.2699999999999996 111.19 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -59.79 -18.84 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 4.2999999999999998 111.221 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.67 -14.46 60.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 4.3300000000000001 111.164 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.67 6.03 47.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 4.3700000000000001 111.202 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.5 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 30.3 mm -74.19 -44.17 6.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.2 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 89.7 Cg_exo -49.24 -41.91 41.14 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.662 1.575 . . . . 4.4299999999999997 111.217 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.26 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 4.4699999999999998 111.167 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.16 -52.75 11.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 4.5 111.261 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.96 -37.79 61.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 4.5300000000000002 111.206 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.42 -57.72 10.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 4.5700000000000003 111.191 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.94 -30.61 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 4.5999999999999996 111.233 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.0 mt -77.08 -30.44 55.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 4.6299999999999999 111.248 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.98 -37.5 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 4.6699999999999999 111.216 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.62 -28.45 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 4.7000000000000002 111.213 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.45 -1.66 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 4.7300000000000004 111.149 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.25 25.26 40.63 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -129.95 160.09 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 4.7999999999999998 111.19 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.9 t -138.82 144.86 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 4.8300000000000001 111.219 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.03 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 4.8700000000000001 111.17 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 mt -110.38 121.58 45.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 4.9000000000000004 111.118 169.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.8 tpp -150.16 115.26 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 4.9299999999999997 111.211 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.7 176.0 7.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 4.9699999999999998 111.226 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -79.91 120.26 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 5.0 111.153 160.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 151' ' ' LEU . 4.0 mm? -90.23 -37.96 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 5.0300000000000002 111.223 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -65.16 -42.34 93.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 5.0700000000000003 111.146 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.9 126.45 75.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 5.0999999999999996 111.205 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.29 -21.26 31.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.681 1.587 . . . . 5.1299999999999999 111.202 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.39 -38.2 73.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 5.1699999999999999 111.192 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -99.33 14.93 27.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 5.2000000000000002 111.2 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.2 p -103.1 -10.92 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 5.2300000000000004 111.169 173.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.545 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 51.5 t-105 -72.43 -42.74 8.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 5.2699999999999996 111.19 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 70.8 Cg_exo -55.04 -33.27 82.76 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.73 1.62 . . . . 5.2999999999999998 111.171 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.407 HD13 ' HG ' ' A' ' 195' ' ' LEU . 63.1 mt -69.26 -24.63 64.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 5.3300000000000001 111.188 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 49.0 mm -81.3 -40.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 5.3700000000000001 111.218 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.15 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 5.4000000000000004 111.162 174.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.52 76.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 5.4299999999999997 111.153 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.04 -62.03 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 5.4699999999999998 111.206 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.99 -8.34 70.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.236 -0.746 . . . . 5.5 111.236 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.44 55.1 3.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.167 -0.773 . . . . 5.5300000000000002 111.167 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.78 151.67 33.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 5.5700000000000003 111.256 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 48.19 42.26 17.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 5.5999999999999996 111.24 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -139.93 78.82 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 5.6299999999999999 111.163 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -135.42 118.16 16.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 5.6699999999999999 111.216 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -125.52 142.77 51.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 5.7000000000000002 111.169 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -127.85 96.53 4.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 5.7300000000000004 111.263 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 65.35 30.33 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 5.7699999999999996 111.236 -172.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.97 6.08 69.95 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.162 -0.775 . . . . 5.7999999999999998 111.162 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -96.04 99.78 11.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 5.8300000000000001 111.217 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -65.06 125.1 23.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 5.8700000000000001 111.143 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -84.3 113.45 21.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 5.9000000000000004 111.178 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 pt -95.28 5.45 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 5.9299999999999997 111.25 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.56 28.18 8.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 5.9699999999999998 111.191 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -82.25 169.97 15.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 6.0 111.157 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 95.6 t -112.87 124.84 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 6.0300000000000002 111.169 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -66.2 -39.36 94.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.212 -0.755 . . . . 6.0700000000000003 111.212 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.51 0.08 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 6.0999999999999996 111.156 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -106.16 -4.84 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 6.1299999999999999 111.226 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -83.31 160.04 21.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 6.1699999999999999 111.22 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.69 70.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 6.2000000000000002 111.193 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.82 -33.67 63.77 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.237 -0.745 . . . . 6.2300000000000004 111.237 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.76 -28.63 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 6.2699999999999996 111.154 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.04 -64.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 6.2999999999999998 111.157 -174.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.39 -34.78 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 6.3300000000000001 111.151 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -33.44 87.23 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.273 -0.731 . . . . 6.3700000000000001 111.273 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.0 tp -75.0 -39.58 61.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 6.4000000000000004 111.236 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.9 m -54.57 -46.47 73.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.179 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -63.19 -47.6 81.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 6.4699999999999998 111.177 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.491 ' C ' HD21 ' A' ' 195' ' ' LEU . 8.5 tt -50.0 -54.03 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 6.5 111.209 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.43 -36.47 76.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.144 -0.48 . . . . 6.5300000000000002 111.19 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.07 -35.02 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.5700000000000003 111.203 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.44 -27.14 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 6.5999999999999996 111.194 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.91 -36.91 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 6.6299999999999999 111.241 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.79 -21.66 59.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 6.6699999999999999 111.265 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -90.04 3.68 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 6.7000000000000002 111.216 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 62.26 35.09 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 6.7300000000000004 111.235 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -106.9 -30.01 9.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 6.7699999999999996 111.19 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 95.7 mtp -125.92 160.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 6.7999999999999998 111.169 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -125.2 118.92 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 6.8300000000000001 111.265 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.84 -24.07 67.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 6.8700000000000001 111.223 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -81.83 -10.09 59.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 6.9000000000000004 111.173 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.8 m -54.59 108.54 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.174 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -89.98 179.82 5.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 6.9699999999999998 111.202 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -63.28 -49.09 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 7.0 111.248 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.1 p -65.06 -24.03 67.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 7.0300000000000002 111.167 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.31 -47.95 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 7.0700000000000003 111.272 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.27 90.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.208 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.43 -51.97 63.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 7.1299999999999999 111.247 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.76 94.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 7.1699999999999999 111.201 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.45 94.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 7.2000000000000002 111.213 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.93 -45.48 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 7.2300000000000004 111.181 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -69.94 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 7.2699999999999996 111.201 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.85 -11.78 56.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.2999999999999998 111.206 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.33 26.12 48.81 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.163 -0.775 . . . . 7.3300000000000001 111.163 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -78.53 -34.44 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 7.3700000000000001 111.199 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 84.9 m -123.87 112.42 17.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 7.4000000000000004 111.172 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.29 93.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 7.4299999999999997 111.18 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 62.3 ttp -127.31 119.99 27.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 7.4699999999999998 111.226 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 41.1 p -127.58 179.97 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 7.5 111.19 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.16 118.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 7.5300000000000002 111.24 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -108.23 120.83 43.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.438 . . . . 7.5700000000000003 111.199 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 232' ' ' TRP . . . -77.87 -172.9 39.87 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.254 -0.739 . . . . 7.5999999999999996 111.254 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.13 -34.45 87.66 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.618 1.545 . . . . 7.6299999999999999 111.163 -175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -71.59 -31.54 67.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 7.6699999999999999 111.234 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.77 6.67 13.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 7.7000000000000002 111.239 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.461 ' N ' ' O ' ' A' ' 228' ' ' GLY . 92.3 t90 -54.15 -36.39 63.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 7.7300000000000004 111.227 -170.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.1 p -62.39 -17.37 58.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 7.7699999999999996 111.228 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -57.63 -49.93 74.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 7.7999999999999998 111.234 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.0 tp -74.45 -28.47 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 7.8300000000000001 111.158 -173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.75 -35.29 57.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 7.8700000000000001 111.233 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 76.1 m -67.15 -31.66 72.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 7.9000000000000004 111.163 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 60.6 p -69.62 -15.03 63.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 7.9299999999999997 111.171 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 58.44 50.24 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 7.9699999999999998 111.187 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.07 175.83 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 8.0 111.183 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -85.32 119.48 25.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 8.0299999999999994 111.15 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.44 160.07 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 8.0700000000000003 111.24 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -164.21 -168.17 25.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.245 -0.742 . . . . 8.0999999999999996 111.245 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 116' ' ' ILE . 77.6 t -131.25 140.08 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 8.1300000000000008 111.205 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -122.69 -173.76 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 8.1699999999999999 111.248 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.12 113.44 43.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 8.1999999999999993 111.188 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.544 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 74.2 mt -83.88 -45.41 0.78 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 8.2300000000000004 111.145 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 79.3 Cg_endo -80.64 156.01 21.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.694 1.596 . . . . 8.2699999999999996 111.168 -167.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 62.9 p -119.8 161.31 20.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 8.3000000000000007 111.279 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -123.36 100.94 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 8.3300000000000001 111.187 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 59.4 32.82 22.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 8.3699999999999992 111.221 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.82 62.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -122.11 110.03 33.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 8.4299999999999997 111.165 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 61.2 Cg_endo -70.37 143.74 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.669 1.579 . . . . 8.4700000000000006 111.248 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -139.54 -74.93 0.36 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 8.5 111.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.439 ' HB3' ' HD2' ' A' ' 257' ' ' PRO . 71.4 mmtt -131.26 158.55 74.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 8.5299999999999994 111.231 -177.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 256' ' ' LYS . 60.0 Cg_endo -75.56 161.76 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.662 1.575 . . . . 8.5700000000000003 111.257 -174.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -73.97 125.76 28.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 8.5999999999999996 111.198 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.2 t -111.08 124.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 8.6300000000000008 111.196 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -81.77 143.74 23.59 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.175 -0.77 . . . . 8.6699999999999999 111.175 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 65.7 t -121.11 130.03 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 8.6999999999999993 111.167 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.38 131.95 52.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 8.7300000000000004 111.176 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.5 p -145.07 154.74 42.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 8.7699999999999996 111.2 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -119.14 132.59 56.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 8.8000000000000007 111.117 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.22 -179.32 16.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.184 -0.766 . . . . 8.8300000000000001 111.184 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -108.78 130.65 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.788 0.328 . . . . 8.8699999999999992 111.237 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -60.7 134.06 56.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 8.9000000000000004 111.144 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.98 -18.43 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 8.9299999999999997 111.201 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.98 58.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 8.9700000000000006 111.248 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.0 t -65.0 127.93 93.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 9.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.01 -14.97 20.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.743 1.629 . . . . 9.0299999999999994 111.234 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -130.02 74.95 1.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 9.0700000000000003 111.202 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -80.08 -22.91 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 9.0999999999999996 111.22 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -74.12 -35.56 64.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 9.1300000000000008 111.215 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.7 -42.48 77.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 9.1699999999999999 111.259 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -38.98 92.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 9.1999999999999993 111.189 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -56.19 -51.45 67.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 9.2300000000000004 111.204 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.33 -42.12 99.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 9.2699999999999996 111.115 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.92 -42.45 80.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 9.3000000000000007 111.225 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.1 -3.55 58.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 9.3300000000000001 111.167 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -103.21 -50.83 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 9.3699999999999992 111.169 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -124.73 4.88 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 9.4000000000000004 111.266 -164.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -125.07 -70.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 9.4299999999999997 111.143 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 66.3 tp -65.43 -57.58 7.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 9.4700000000000006 111.246 -172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.96 61.78 7.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 9.5 111.218 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 31.4 p -129.94 -171.13 2.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 9.5299999999999994 111.223 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -75.5 -9.91 58.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 9.5700000000000003 111.196 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -116.13 -33.81 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 9.5999999999999996 111.214 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.78 -51.04 31.94 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.158 -0.777 . . . . 9.6300000000000008 111.158 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.02 -20.69 59.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.74 0.305 . . . . 9.6699999999999999 111.135 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.1 -47.17 84.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 9.6999999999999993 111.186 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.13 80.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 9.7300000000000004 111.218 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.54 -39.72 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 9.7699999999999996 111.177 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.92 7.27 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 9.8000000000000007 111.252 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.89 -43.04 80.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 9.8300000000000001 111.237 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -98.45 -20.41 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.8699999999999992 111.248 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.96 155.24 47.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 9.9000000000000004 111.202 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.21 144.98 79.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.714 1.609 . . . . 9.9299999999999997 111.251 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 24.51 12.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.168 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -66.95 -27.2 73.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.205 -0.758 . . . . 10.0 111.205 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.98 27.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 10.029999999999999 111.203 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.6 p -159.0 141.02 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 10.07 111.19 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.68 60.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 10.1 111.168 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 38.5 tp -60.25 125.06 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 10.130000000000001 111.157 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.64 -34.85 72.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 10.17 111.261 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 47.0 t -53.78 -52.2 60.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 10.199999999999999 111.184 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -66.46 -44.14 83.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 10.23 111.199 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -52.78 -42.45 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 10.27 111.261 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.81 -40.59 79.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.228 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -29.96 63.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 10.33 111.26 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.32 -17.86 33.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 10.369999999999999 111.226 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.81 -17.45 63.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 10.4 111.216 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.7 -30.67 71.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 10.43 111.177 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -77.93 118.25 70.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 10.470000000000001 111.221 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -57.6 -39.89 84.64 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.704 1.603 . . . . 10.5 111.181 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.66 -40.04 69.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 10.529999999999999 111.255 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.3 mt -69.97 -40.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 10.57 111.163 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.96 78.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 10.6 111.223 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.78 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 10.630000000000001 111.162 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -68.57 -42.84 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 10.67 111.216 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.0 mtt -66.51 -34.39 77.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 10.699999999999999 111.244 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.65 -47.08 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.152 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -76.05 -31.66 58.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 10.77 111.218 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.5 93.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 10.800000000000001 111.277 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 10.83 111.221 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.43 13.69 17.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.216 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.6 -175.02 40.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.162 -0.775 . . . . 10.9 111.162 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.469 ' HA ' ' OE1' ' A' ' 328' ' ' GLU . 5.2 tp10 -99.96 139.65 35.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 10.93 111.226 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 94.3 mt -94.75 130.43 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 10.970000000000001 111.165 -171.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 47.2 ttm -60.0 116.64 18.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 11.0 111.17 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.61 160.16 18.17 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.764 1.643 . . . . 11.029999999999999 111.246 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -109.85 20.21 18.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 11.07 111.113 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 333' ' ' ILE . 3.8 mp -86.12 122.93 72.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 11.1 111.171 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.99 -47.02 29.82 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.669 1.579 . . . . 11.130000000000001 111.269 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.81 -46.31 90.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 11.17 111.293 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.424 ' H ' HG22 ' A' ' 333' ' ' ILE . 67.1 mtt -60.06 -43.05 95.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 11.199999999999999 111.129 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.3 m -57.23 -41.14 78.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 11.23 111.117 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.63 94.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 11.27 111.213 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -71.7 -29.63 64.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.300000000000001 111.226 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -59.94 -51.98 67.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 11.33 111.163 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.73 -38.44 86.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 11.369999999999999 111.132 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -54.8 -37.72 66.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 11.4 111.211 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.4 t -71.7 -40.69 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 11.43 111.182 174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -51.06 -37.68 47.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 11.470000000000001 111.148 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.5 p -94.24 -26.98 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 11.5 111.184 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.08 -38.03 89.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 11.529999999999999 111.152 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.61 -21.6 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 11.57 111.203 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.95 -45.54 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 11.6 111.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 11.630000000000001 111.268 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.06 -39.59 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 11.67 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.28 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 11.699999999999999 111.161 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.9 p -78.31 -13.66 59.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 11.73 111.163 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.94 25.87 33.29 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.213 -0.755 . . . . 11.77 111.213 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -90.07 -48.55 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 11.800000000000001 111.178 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -124.99 165.22 18.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 11.83 111.242 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -84.77 175.06 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 11.869999999999999 111.131 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.7 t -59.31 -44.86 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 11.9 111.185 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 11.93 111.254 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.13 -44.67 87.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 11.970000000000001 111.221 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.67 94.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 12.0 111.226 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.75 -24.99 48.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 12.029999999999999 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.43 -48.31 78.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 12.07 111.178 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -69.46 -33.91 73.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 12.1 111.118 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.5 75.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 12.130000000000001 111.184 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -70.02 -56.66 6.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 12.17 111.151 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.2 m -51.55 -43.45 62.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 12.199999999999999 111.171 -173.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.65 -29.91 70.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 12.23 111.193 -171.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 48.0 pt -105.01 -4.37 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 12.27 111.253 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.4 p -115.0 1.71 14.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 12.300000000000001 111.168 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.534 0 CA-C-N 116.245 -0.434 . . . . 12.33 111.152 178.381 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.808 0.337 . . . . 0.029999999999999999 111.167 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -99.1 124.77 52.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.070000000000000007 111.229 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -98.15 155.09 17.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.10000000000000001 111.139 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -93.67 155.05 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.13 111.212 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.24 16.82 54.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.235 -0.746 . . . . 0.17000000000000001 111.235 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.81 160.0 21.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.746 0.308 . . . . 0.20000000000000001 111.237 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.448 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.6 pp -145.89 153.95 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.254 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.35 135.26 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.27000000000000002 111.187 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.418 HD13 HG23 ' A' ' 37' ' ' VAL . 83.5 mt -115.6 124.97 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.29999999999999999 111.222 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -103.61 105.15 15.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.33000000000000002 111.233 172.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.454 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.8 tt -115.48 137.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.37 111.187 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -81.03 108.94 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 111.195 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.0 -173.15 46.07 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.217 -0.753 . . . . 0.42999999999999999 111.217 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -104.98 -53.04 2.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.819 0.343 . . . . 0.46999999999999997 111.186 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.12 18.71 5.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.5 111.156 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.96 -23.65 69.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.183 -0.767 . . . . 0.53000000000000003 111.183 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -53.81 -32.71 53.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.56999999999999995 111.184 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.45 -41.56 96.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.59999999999999998 111.214 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -34.88 83.39 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.218 -0.753 . . . . 0.63 111.218 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 284' ' ' LEU . 83.1 mt -81.95 -25.87 34.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 0.67000000000000004 111.197 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.63 47.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.69999999999999996 111.207 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.72999999999999998 111.246 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.56 -17.85 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.77000000000000002 111.182 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.77 -31.94 81.37 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.207 -0.757 . . . . 0.80000000000000004 111.207 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.67 -46.15 80.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.82999999999999996 111.178 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.68 -50.03 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.87 111.235 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.90000000000000002 111.199 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.79 -39.09 80.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.93000000000000005 111.223 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.23 -32.22 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.96999999999999997 111.24 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -71.31 -40.53 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.248 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.4 p -113.91 -29.97 6.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 1.03 111.181 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.62 -0.3 63.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 1.0700000000000001 111.22 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.3 mm -76.57 110.99 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.1000000000000001 111.211 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.0 124.99 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 1.1299999999999999 111.225 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.54 121.49 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 1.1699999999999999 111.171 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.16 121.31 37.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 1.2 111.241 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.418 HG23 HD13 ' A' ' 9' ' ' ILE . 40.7 t -118.18 125.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 1.23 111.136 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.27 165.73 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 1.27 111.172 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -121.45 70.07 23.45 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.215 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.42 161.99 33.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.687 1.591 . . . . 1.3300000000000001 111.231 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -124.82 -178.32 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.3700000000000001 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 54.99 39.73 31.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 1.3999999999999999 111.217 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.95 -9.17 59.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 1.4299999999999999 111.186 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.24 -27.98 69.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 1.47 111.209 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.07 -34.59 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.5 111.212 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.25 -46.43 80.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 1.53 111.183 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.537 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 81.1 t80 -62.56 -53.41 57.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 1.5700000000000001 111.132 -173.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 46.8 Cg_endo -67.76 -25.73 39.45 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.686 1.591 . . . . 1.6000000000000001 111.172 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -65.21 -35.27 80.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 1.6299999999999999 111.271 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -97.29 -26.17 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.6699999999999999 111.213 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.96 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 1.7 111.242 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.72 67.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.73 111.152 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 p -96.69 3.54 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.77 111.162 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.72 20.24 56.48 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.21 -0.756 . . . . 1.8 111.21 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' ' 56' ' ' GLY . 87.7 m-20 -119.99 -166.02 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 1.8300000000000001 111.222 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' H ' ' HB3' ' A' ' 55' ' ' ASP . . . 113.53 -164.87 12.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.205 -0.758 . . . . 1.8700000000000001 111.205 175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.17 -176.32 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.714 1.609 . . . . 1.8999999999999999 111.221 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 276' ' ' ALA . 43.4 m-20 -103.33 -40.26 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.9299999999999999 111.252 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.37 138.36 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 1.97 111.226 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 42.0 mm -113.96 122.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.0 111.267 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.454 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 27.1 m-85 -100.02 110.96 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 2.0299999999999998 111.242 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.485 ' C ' ' CD1' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -145.03 -175.0 4.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 2.0699999999999998 111.228 -173.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.12 176.75 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 2.1000000000000001 111.16 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -87.43 14.58 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 2.1299999999999999 111.18 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -96.75 -29.97 13.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 111.193 172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -118.28 12.35 13.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 2.2000000000000002 111.164 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -70.01 -21.15 63.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 2.23 111.242 -172.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.97 -12.74 83.14 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.51 -54.34 37.94 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.26 -0.736 . . . . 2.2999999999999998 111.26 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 5.2 m-30 -88.89 -20.43 24.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.3300000000000001 111.196 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.48 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 2.3700000000000001 111.236 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -68.67 -31.03 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 2.3999999999999999 111.166 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -75.18 -28.96 60.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 2.4300000000000002 111.192 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.28 31.56 33.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.253 -0.739 . . . . 2.4700000000000002 111.253 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -99.58 1.16 43.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.75 0.31 . . . . 2.5 111.199 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.76 131.53 34.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 2.5299999999999998 111.26 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 149.23 34.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 2.5699999999999998 111.194 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.07 124.37 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 2.6000000000000001 111.224 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.6 mt -115.05 129.4 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 2.6299999999999999 111.212 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -125.03 104.63 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 2.6699999999999999 111.152 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.98 148.52 45.36 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.714 1.609 . . . . 2.7000000000000002 111.207 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -84.91 179.99 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.215 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.4 -49.89 74.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 2.77 111.212 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.2 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 2.7999999999999998 111.194 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.02 -45.06 83.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 2.8300000000000001 111.216 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.31 -27.93 69.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.199 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -94.64 -19.71 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 2.8999999999999999 111.204 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -79.92 -29.99 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 2.9300000000000002 111.247 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.412 ' HA ' ' H ' ' A' ' 305' ' ' LYS . 6.7 mp -96.12 150.52 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 2.9700000000000002 111.169 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.19 135.66 96.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 3.0 111.154 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.1 -47.64 24.81 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.73 1.62 . . . . 3.0299999999999998 111.161 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.8 -54.96 23.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 3.0699999999999998 111.239 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.7 m -60.06 -36.87 78.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 3.1000000000000001 111.161 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -65.65 -42.73 91.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 3.1299999999999999 111.182 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.19 -19.92 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 3.1699999999999999 111.242 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -30.0 67.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 3.2000000000000002 111.219 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.406 HG22 ' HD3' ' A' ' 107' ' ' PRO . 27.4 m -106.07 18.78 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 3.23 111.182 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -100.01 130.06 46.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 3.27 111.206 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -141.6 119.8 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 3.2999999999999998 111.148 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 65.55 43.85 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 3.3300000000000001 111.233 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.51 -42.27 2.35 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.178 -0.769 . . . . 3.3700000000000001 111.178 171.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -109.97 -178.78 3.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.807 0.336 . . . . 3.3999999999999999 111.216 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.47 154.47 18.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 3.4300000000000002 111.213 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.7 pt -113.99 -4.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 3.4700000000000002 111.157 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 167.22 21.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 3.5 111.181 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.3 m-30 -110.61 137.88 20.86 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 3.5299999999999998 111.17 170.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 46.9 Cg_exo -61.59 143.7 97.08 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.652 1.568 . . . . 3.5699999999999998 111.213 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.1 mt -109.2 -58.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 3.6000000000000001 111.195 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.62 160.9 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 3.6299999999999999 111.217 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -107.77 145.87 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 3.6699999999999999 111.191 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -120.04 -179.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 3.7000000000000002 111.196 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.55 167.89 16.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 3.73 111.198 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.512 HD22 ' HD3' ' A' ' 159' ' ' PRO . 65.1 tp -161.55 118.47 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 3.77 111.175 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -162.15 -178.02 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 3.7999999999999998 111.206 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.2 tp -95.09 126.72 40.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 3.8300000000000001 111.15 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.2 mt -109.27 132.66 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 3.8700000000000001 111.173 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -148.7 159.16 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 3.8999999999999999 111.17 -172.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.33 117.55 30.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 3.9300000000000002 111.177 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -68.72 -47.49 66.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 3.9700000000000002 111.23 -175.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.69 -39.13 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 4.0 111.269 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.7 tp -65.48 -42.54 92.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.154 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.1 mt -125.02 73.46 65.59 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 4.0700000000000003 111.111 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.58 142.3 16.19 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.195 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -70.64 149.76 95.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 4.1299999999999999 111.222 -12.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 89.4 Cg_exo -52.21 132.48 43.96 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.676 1.584 . . . . 4.1699999999999999 111.222 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 76.2 Cg_exo -53.08 133.55 52.56 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.723 1.615 . . . . 4.2000000000000002 111.223 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -112.68 -17.11 12.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 4.2300000000000004 111.198 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -157.33 176.92 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 4.2699999999999996 111.186 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -75.13 -19.96 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 4.2999999999999998 111.221 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.1 -13.19 61.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 4.3300000000000001 111.205 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -107.29 13.69 26.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 4.3700000000000001 111.2 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.572 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 94.3 mt -76.63 -41.26 2.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.197 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 85.8 Cg_exo -53.37 -28.39 43.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.739 1.626 . . . . 4.4299999999999997 111.167 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.96 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 4.4699999999999998 111.166 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.8 tp -79.15 -43.92 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 4.5 111.241 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -31.81 71.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 4.5300000000000002 111.21 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.67 -28.73 58.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 4.5700000000000003 111.206 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -80.12 -32.07 39.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 4.5999999999999996 111.261 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 91.7 mt -86.13 -7.67 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 4.6299999999999999 111.182 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.95 -44.94 78.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 4.6699999999999999 111.133 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.74 68.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 4.7000000000000002 111.144 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.61 -8.8 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 4.7300000000000004 111.211 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 27.53 60.25 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.206 -0.758 . . . . 4.7699999999999996 111.206 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 75.1 mmtt -115.55 159.13 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.873 0.368 . . . . 4.7999999999999998 111.177 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.9 t -98.86 153.92 18.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 4.8300000000000001 111.229 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.74 -26.75 64.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 4.8700000000000001 111.167 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.16 154.92 34.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 4.9000000000000004 111.16 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.8 mtm -108.11 115.7 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 4.9299999999999997 111.256 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.479 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 93.8 m-85 -95.5 130.81 42.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 4.9699999999999998 111.244 -154.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -117.69 77.29 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 5.0 111.152 164.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 149' ' ' PHE . 96.6 mt -97.86 -0.83 44.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 5.0300000000000002 111.139 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -71.54 -22.04 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 5.0700000000000003 111.224 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.44 150.96 53.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.269 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.17 -15.03 18.47 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.679 1.586 . . . . 5.1299999999999999 111.205 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.18 -29.21 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 5.1699999999999999 111.146 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -74.11 -41.03 62.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 5.2000000000000002 111.199 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -96.34 -8.56 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 5.2300000000000004 111.187 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.495 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 77.2 t90 -58.04 -46.0 99.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 5.2699999999999996 111.186 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.512 ' HD3' HD22 ' A' ' 113' ' ' LEU . 98.4 Cg_endo -84.05 -20.08 4.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.65 1.567 . . . . 5.2999999999999998 111.197 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.35 -45.86 75.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.164 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.96 -33.61 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 5.3700000000000001 111.198 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.46 -4.16 59.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 5.4000000000000004 111.217 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.02 72.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.4299999999999997 111.245 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -91.08 -10.06 43.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.179 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.25 25.12 49.37 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.153 -0.779 . . . . 5.5 111.153 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.82 -1.99 36.74 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.214 -0.755 . . . . 5.5300000000000002 111.214 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.13 106.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 5.5700000000000003 111.237 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 64.55 22.25 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 5.5999999999999996 111.211 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.37 147.29 28.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 5.6299999999999999 111.166 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -57.28 120.13 7.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 5.6699999999999999 111.194 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -76.38 73.81 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 5.7000000000000002 111.163 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -150.03 99.27 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 5.7300000000000004 111.182 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 58.85 -119.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 5.7699999999999996 111.222 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.01 23.31 19.39 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.144 -0.782 . . . . 5.7999999999999998 111.144 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.69 140.13 38.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 5.8300000000000001 111.227 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -128.15 75.02 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 5.8700000000000001 111.196 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.6 t0 -96.1 103.86 15.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 5.9000000000000004 111.22 176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.9 tt -69.97 -17.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 5.9299999999999997 111.203 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -80.04 -17.45 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 5.9699999999999998 111.17 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.82 169.92 16.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 6.0 111.2 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.57 91.23 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 6.0300000000000002 111.167 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.07 32.1 7.86 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.162 -0.775 . . . . 6.0700000000000003 111.162 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.45 -22.58 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.759 0.314 . . . . 6.0999999999999996 111.143 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -99.6 12.51 36.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.197 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.44 141.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 6.1699999999999999 111.177 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.43 -37.01 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 6.2000000000000002 111.179 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.63 -32.73 45.21 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.15 -0.78 . . . . 6.2300000000000004 111.15 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.82 -48.51 58.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.339 . . . . 6.2699999999999996 111.196 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -69.8 -24.17 63.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 6.2999999999999998 111.172 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 6.3300000000000001 111.187 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.07 -39.73 96.52 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.232 -0.747 . . . . 6.3700000000000001 111.232 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.5 tp -72.33 -30.62 64.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 6.4000000000000004 111.227 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.1 m -64.41 -42.69 95.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 6.4299999999999997 111.22 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -58.72 -47.18 85.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 6.4699999999999998 111.207 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.3 tp -46.56 -45.04 18.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 6.5 111.18 174.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -74.02 -36.85 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 6.5300000000000002 111.175 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.97 -36.84 68.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 6.5700000000000003 111.171 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.13 -32.86 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 6.5999999999999996 111.195 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.43 -40.03 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 6.6299999999999999 111.104 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.85 -29.63 70.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 6.6699999999999999 111.151 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -76.19 -8.96 58.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 6.7000000000000002 111.225 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 64.85 35.09 8.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 6.7300000000000004 111.174 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -129.15 53.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 6.7699999999999996 111.173 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 47.5 ttm -159.15 147.63 18.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 6.7999999999999998 111.224 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -146.5 114.63 6.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.429 . . . . 6.8300000000000001 111.159 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.42 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 6.8700000000000001 111.183 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.38 -25.89 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 6.9000000000000004 111.211 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.8 p -75.24 149.89 38.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 6.9299999999999997 111.213 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.78 -165.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 6.9699999999999998 111.211 -170.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.86 -51.87 67.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.0 111.165 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.1 p -70.83 -29.71 65.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 7.0300000000000002 111.244 -171.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.99 -45.03 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 7.0700000000000003 111.223 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 7.0999999999999996 111.171 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.24 -41.45 94.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 7.1299999999999999 111.22 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.0 -36.29 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 7.1699999999999999 111.158 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.06 93.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 7.2000000000000002 111.167 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.38 -33.44 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 7.2300000000000004 111.212 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -60.06 -39.35 85.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 7.2699999999999996 111.236 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 -30.22 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 7.2999999999999998 111.2 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.1 34.99 13.08 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.259 -0.737 . . . . 7.3300000000000001 111.259 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.14 -35.0 68.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 7.3700000000000001 111.204 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.9 m -129.99 139.18 51.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 7.4000000000000004 111.189 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.35 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 7.4299999999999997 111.143 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -85.09 153.68 22.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 7.4699999999999998 111.241 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.1 t -169.3 179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 7.5 111.287 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.34 118.63 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 7.5300000000000002 111.17 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -160.69 177.89 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 7.5700000000000003 111.189 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.79 -134.38 7.83 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.168 -0.773 . . . . 7.5999999999999996 111.168 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.77 -177.11 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.169 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 69.87 17.95 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 7.6699999999999999 111.161 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.66 -24.09 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 7.7000000000000002 111.188 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 97.9 m95 -69.52 -14.95 63.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 7.7300000000000004 111.123 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.6 p -64.96 -20.95 66.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 7.7699999999999996 111.216 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.05 -28.56 8.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 7.7999999999999998 111.225 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.2 mt -64.85 -45.11 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 7.8300000000000001 111.254 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -74.55 -33.8 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 7.8700000000000001 111.198 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.7 m -64.14 -44.6 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 7.9000000000000004 111.234 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.9 p -78.18 -15.04 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 7.9299999999999997 111.235 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.63 45.97 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 7.9699999999999998 111.217 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.84 141.21 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 8.0 111.157 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -74.87 78.69 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 8.0299999999999994 111.209 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -89.96 127.65 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 8.0700000000000003 111.183 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -100.4 166.39 19.72 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.223 -0.751 . . . . 8.0999999999999996 111.223 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 88.5 t -139.6 134.98 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.773 0.32 . . . . 8.1300000000000008 111.253 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.2 t -135.06 150.17 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 8.1699999999999999 111.21 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.4 t -70.29 110.81 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 8.1999999999999993 111.16 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.507 ' N ' ' HD2' ' A' ' 248' ' ' PRO . 53.0 tp -75.38 -47.82 4.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 8.2300000000000004 111.282 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 247' ' ' LEU . 85.7 Cg_endo -78.41 143.2 19.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.764 1.642 . . . . 8.2699999999999996 111.228 -173.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 78.8 m -107.74 133.59 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 8.3000000000000007 111.182 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -108.46 99.71 9.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 8.3300000000000001 111.221 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 57.69 35.14 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 8.3699999999999992 111.12 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 98.6 -15.57 60.84 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.175 -0.77 . . . . 8.4000000000000004 111.175 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -130.06 110.0 16.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 8.4299999999999997 111.161 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.8 151.69 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.7 1.6 . . . . 8.4700000000000006 111.268 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 98.9 p -137.6 -75.01 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 8.5 111.201 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -134.07 163.35 51.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 8.5299999999999994 111.163 -174.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.97 144.47 56.5 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.721 1.614 . . . . 8.5700000000000003 111.173 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -73.81 140.59 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 8.5999999999999996 111.185 -175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.441 HG12 HG21 ' A' ' 261' ' ' VAL . 61.6 t -107.1 106.76 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 8.6300000000000008 111.221 -170.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -84.93 85.08 1.58 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.169 -0.773 . . . . 8.6699999999999999 111.169 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 259' ' ' VAL . 36.9 t -68.18 142.35 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 8.6999999999999993 111.188 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.87 154.9 18.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 8.7300000000000004 111.257 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 91.2 p -143.71 155.13 44.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 8.7699999999999996 111.199 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' ILE . . . -121.76 124.3 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 8.8000000000000007 111.245 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -103.97 177.29 24.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.177 -0.769 . . . . 8.8300000000000001 111.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 87.5 mt -124.14 132.0 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 8.8699999999999992 111.2 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -69.32 114.28 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.148 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.54 -24.72 66.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 8.9299999999999997 111.163 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 8.9700000000000006 111.217 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -66.06 136.74 95.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 9.0 111.235 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.79 -12.1 26.24 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.727 1.618 . . . . 9.0299999999999994 111.206 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.59 21.51 8.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 9.0700000000000003 111.201 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -62.78 -21.88 66.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 9.0999999999999996 111.174 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.36 -34.5 77.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 9.1300000000000008 111.194 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 9.1699999999999999 111.155 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . . . -65.03 -41.86 94.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 9.1999999999999993 111.168 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.75 -44.55 81.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 9.2300000000000004 111.234 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -80.11 -52.75 7.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 9.2699999999999996 111.227 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -63.8 -37.05 85.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 9.3000000000000007 111.224 -171.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 284' ' ' LEU . 40.1 tp -68.12 -48.16 66.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 9.3300000000000001 111.187 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -72.08 -28.98 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 9.3699999999999992 111.182 -173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -99.56 -40.2 7.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 9.4000000000000004 111.181 -166.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.17 -54.84 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 9.4299999999999997 111.15 -169.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 20' ' ' LEU . 95.1 mt -64.1 -49.59 71.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 9.4700000000000006 111.148 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.85 51.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 9.5 111.165 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 76.7 p -124.97 -175.94 3.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 9.5299999999999994 111.153 170.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -53.29 -40.56 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 9.5700000000000003 111.197 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.35 -37.95 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 9.5999999999999996 111.134 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.37 -43.24 93.09 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.99 -36.23 83.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 9.6699999999999999 111.231 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -69.04 -41.86 77.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 9.6999999999999993 111.204 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.26 87.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 9.7300000000000004 111.154 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 68.0 t -74.91 -40.83 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 9.7699999999999996 111.17 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -75.93 -2.93 32.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 9.8000000000000007 111.203 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.05 -38.14 67.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 9.8300000000000001 111.195 165.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -108.5 -34.03 6.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 9.8699999999999992 111.158 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.03 160.63 40.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 9.9000000000000004 111.205 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.65 139.38 67.29 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.667 1.578 . . . . 9.9299999999999997 111.167 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.38 -24.19 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 9.9700000000000006 111.153 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.77 -28.84 70.71 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.153 -0.779 . . . . 10.0 111.153 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.91 122.83 13.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.779 0.323 . . . . 10.029999999999999 111.228 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.85 136.6 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.16 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -103.36 -34.79 8.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 10.1 111.188 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.16 138.72 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 10.130000000000001 111.176 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.412 ' H ' ' HA ' ' A' ' 89' ' ' LEU . 59.8 tttm -61.36 -39.04 89.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 10.17 111.222 168.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 44.6 t -56.05 -48.62 75.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 10.199999999999999 111.175 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.55 -37.71 83.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 10.23 111.224 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.67 -36.74 77.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 10.27 111.173 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.73 -30.03 70.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 10.300000000000001 111.248 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.4 -32.16 62.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 10.33 111.198 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.22 -26.18 62.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 10.369999999999999 111.226 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.88 -19.22 65.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 10.4 111.324 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.48 -24.93 67.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 10.43 111.221 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -101.92 109.99 61.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 10.470000000000001 111.205 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.97 -32.92 80.78 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.659 1.573 . . . . 10.5 111.188 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.55 -28.09 67.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 10.529999999999999 111.264 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -91.01 -38.5 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 10.57 111.218 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.02 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 10.6 111.254 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.48 -35.5 74.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 10.630000000000001 111.231 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.1 p -91.33 -19.95 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 10.67 111.211 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.0 mmt -74.21 -35.92 63.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 10.699999999999999 111.205 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.5 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 10.73 111.285 171.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.32 -42.75 99.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 10.77 111.2 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.42 93.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 10.800000000000001 111.21 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.05 -42.5 99.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 10.83 111.179 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -94.95 7.53 45.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 10.869999999999999 111.198 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.88 -162.66 35.9 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.268 -0.733 . . . . 10.9 111.268 172.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -119.8 132.38 55.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 10.93 111.213 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.17 136.22 25.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 10.970000000000001 111.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 50.0 tpp -59.93 114.41 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 11.0 111.247 173.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 38.7 Cg_exo -60.31 133.74 51.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.678 1.585 . . . . 11.029999999999999 111.221 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -94.18 72.81 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 11.07 111.207 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 80.4 mt -123.15 116.11 28.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 11.1 111.185 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.06 -33.45 73.6 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.632 1.555 . . . . 11.130000000000001 111.26 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -71.46 -27.86 63.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 11.17 111.23 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -86.88 -20.62 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 11.199999999999999 111.157 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 98.2 p -64.15 -29.98 71.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.178 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.97 -49.51 70.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 11.27 111.247 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -56.76 -48.74 77.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 11.300000000000001 111.173 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -68.75 -43.58 75.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 11.33 111.176 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 -73.89 -30.55 62.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 11.369999999999999 111.259 -176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.65 75.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 11.4 111.188 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.28 -21.82 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 11.43 111.279 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -56.56 -48.93 76.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 11.470000000000001 111.186 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 71.0 p -65.2 -29.7 70.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 11.5 111.175 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.03 -44.22 89.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 11.529999999999999 111.173 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.77 -38.52 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.173 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.92 -42.69 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 11.6 111.208 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -65.0 -39.17 93.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 11.630000000000001 111.21 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.45 -21.96 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 11.67 111.206 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.52 -30.39 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 11.699999999999999 111.22 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.5 p -86.16 -22.16 27.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 11.73 111.181 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.85 30.35 26.56 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.233 -0.747 . . . . 11.77 111.233 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -109.94 2.61 19.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 11.800000000000001 111.238 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -159.58 137.01 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 11.83 111.212 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 62.1 p -70.0 164.97 22.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 11.869999999999999 111.255 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.5 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 11.9 111.233 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.19 -46.99 88.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 11.93 111.207 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.87 -37.53 79.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 11.970000000000001 111.191 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.69 92.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 12.0 111.214 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 94.5 mt -74.98 -24.89 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 12.029999999999999 111.18 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.71 -49.3 73.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 12.07 111.167 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.84 -34.21 77.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.208 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.01 -59.56 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 12.130000000000001 111.2 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -54.94 -43.25 73.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 12.17 111.209 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 83.7 m -58.15 -49.05 78.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 12.199999999999999 111.26 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.03 -30.0 67.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 12.23 111.232 -177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.6 mt -67.37 -40.74 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 12.27 111.136 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.8 p -89.22 -15.69 33.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 12.300000000000001 111.234 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.511 0 CA-C-N 116.171 -0.468 . . . . 12.33 111.217 178.149 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.823 0.344 . . . . 0.029999999999999999 111.196 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.15 134.98 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.070000000000000007 111.204 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -55.01 130.04 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.10000000000000001 111.226 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.27 129.44 40.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.13 111.194 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.62 27.94 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.258 -0.737 . . . . 0.17000000000000001 111.258 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.98 132.53 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.20000000000000001 111.252 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.71 120.02 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.23000000000000001 111.211 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.34 115.04 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.27000000000000002 111.212 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.419 HG12 ' HB ' ' A' ' 59' ' ' ILE . 73.6 mt -115.05 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.29999999999999999 111.197 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -110.09 129.06 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.33000000000000002 111.194 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.0 mt -101.42 115.08 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.37 111.158 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -97.7 89.24 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.40000000000000002 111.225 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.5 -145.65 7.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.264 -0.735 . . . . 0.42999999999999999 111.264 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.47 22.77 8.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.46999999999999997 111.195 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -102.29 156.87 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.5 111.248 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.95 -164.98 38.01 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.185 -0.766 . . . . 0.53000000000000003 111.185 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -158.98 25.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.56999999999999995 111.215 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -59.68 -40.29 87.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.59999999999999998 111.187 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.07 -27.51 28.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.212 -0.755 . . . . 0.63 111.212 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.91 -40.51 95.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.67000000000000004 111.262 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.05 78.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.69999999999999996 111.178 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -65.0 -29.07 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.72999999999999998 111.227 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.5 t -72.66 -40.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.77000000000000002 111.188 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.87 82.18 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.234 -0.746 . . . . 0.80000000000000004 111.234 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.79 -36.88 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 111.175 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.53 -24.07 45.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.87 111.239 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.02 -32.68 70.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.90000000000000002 111.157 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -74.8 -36.95 62.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.93000000000000005 111.202 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.31 -46.06 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.96999999999999997 111.188 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.54 -58.79 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.163 -170.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -89.45 -49.27 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 1.03 111.2 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.49 21.4 3.03 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.205 -0.758 . . . . 1.0700000000000001 111.205 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.29 114.99 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 1.1000000000000001 111.191 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.25 110.08 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 1.1299999999999999 111.169 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.2 t -97.91 121.49 48.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 1.1699999999999999 111.119 -174.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.0 m -117.97 121.03 39.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.2 111.266 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 9' ' ' ILE . 46.9 t -107.36 125.38 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 1.23 111.207 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.99 172.04 12.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 1.27 111.237 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.445 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 37.2 t60 -139.97 52.73 3.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 1.3 111.168 -174.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 72.8 Cg_endo -72.01 152.67 57.42 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.649 1.566 . . . . 1.3300000000000001 111.26 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -101.92 -177.04 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.433 . . . . 1.3700000000000001 111.217 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 53.12 46.1 27.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 1.3999999999999999 111.233 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 90.3 mt -93.84 -37.75 11.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 1.4299999999999999 111.176 -174.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 pm0 -69.66 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 1.47 111.218 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -89.48 -19.58 24.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 1.5 111.19 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -110.19 -25.14 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 1.53 111.232 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.514 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.2 m-30 -58.51 -45.14 99.69 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 1.5700000000000001 111.22 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 64.8 Cg_exo -55.48 -30.96 76.16 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.656 1.57 . . . . 1.6000000000000001 111.247 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.02 -43.74 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.191 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -75.63 -23.32 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.6699999999999999 111.147 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -24.47 66.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 1.7 111.205 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.75 -8.05 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 1.73 111.167 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.0 p -114.01 -11.93 12.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 1.77 111.23 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.3 25.51 30.84 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.231 -0.748 . . . . 1.8 111.231 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -114.81 170.71 8.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 1.8300000000000001 111.244 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.48 -174.4 16.6 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.202 -0.759 . . . . 1.8700000000000001 111.202 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -74.87 -176.39 2.82 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.757 1.638 . . . . 1.8999999999999999 111.155 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -104.18 -48.12 3.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 1.9299999999999999 111.181 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.419 ' HB ' HG12 ' A' ' 9' ' ' ILE . 96.2 mt -112.4 133.16 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 1.97 111.174 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.8 mt -131.2 129.78 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 2.0 111.152 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -85.93 142.89 28.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 2.0299999999999998 111.195 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -141.21 163.95 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 2.0699999999999998 111.231 174.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.46 166.22 11.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 2.1000000000000001 111.167 164.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -61.29 -30.28 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 2.1299999999999999 111.178 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -82.07 -0.86 46.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 2.1699999999999999 111.244 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.4 -25.06 7.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 2.2000000000000002 111.179 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -58.63 -43.18 89.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 2.23 111.186 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.97 -48.24 87.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 2.27 111.204 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.88 -38.03 42.71 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.192 -0.763 . . . . 2.2999999999999998 111.192 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -69.92 -37.4 75.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 2.3300000000000001 111.192 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.85 -36.17 64.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 2.3700000000000001 111.201 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.14 -42.44 85.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 2.3999999999999999 111.195 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.7 p -71.13 -14.98 62.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 2.4300000000000002 111.12 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.17 32.21 23.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.254 -0.738 . . . . 2.4700000000000002 111.254 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.14 -6.65 25.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.842 0.353 . . . . 2.5 111.188 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 tp -114.9 133.82 55.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 2.5299999999999998 111.229 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.92 146.84 37.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 2.5699999999999998 111.218 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.57 129.27 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 2.6000000000000001 111.257 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -121.02 133.45 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 2.6299999999999999 111.179 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -120.83 101.5 45.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 2.6699999999999999 111.235 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.36 147.44 32.62 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 121.692 1.595 . . . . 2.7000000000000002 111.176 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.99 148.97 38.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 2.73 111.194 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -53.45 -47.64 69.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 2.77 111.187 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 2.7999999999999998 111.191 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.15 -51.32 64.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 2.8300000000000001 111.175 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.9 -19.94 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 2.8700000000000001 111.185 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.46 -34.96 68.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 2.8999999999999999 111.149 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.56 -22.47 56.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 2.9300000000000002 111.222 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.72 154.93 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 2.9700000000000002 111.164 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.03 136.11 87.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 3.0 111.184 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.03 -14.96 23.54 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.676 1.584 . . . . 3.0299999999999998 111.227 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -80.37 -31.78 37.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 3.0699999999999998 111.191 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.4 p -96.03 -23.17 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 3.1000000000000001 111.201 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -62.51 -40.06 95.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 3.1299999999999999 111.199 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.6 -8.22 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 3.1699999999999999 111.235 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.36 -3.71 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 3.2000000000000002 111.232 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.5 66.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 3.23 111.226 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -129.76 154.98 46.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 3.27 111.179 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -153.1 129.9 10.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.205 -0.452 . . . . 3.2999999999999998 111.214 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 t30 62.62 29.85 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 3.3300000000000001 111.202 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.23 88.34 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.166 -0.774 . . . . 3.3700000000000001 111.166 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.55 145.55 47.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.766 0.317 . . . . 3.3999999999999999 111.18 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -71.37 137.52 48.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 3.4300000000000002 111.198 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.2 pt -123.94 -2.58 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 3.4700000000000002 111.224 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.6 168.87 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 3.5 111.211 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -109.52 129.15 24.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 3.5299999999999998 111.243 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.32 133.06 20.29 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.683 1.589 . . . . 3.5699999999999998 111.185 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.6 mt -113.23 -63.43 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 3.6000000000000001 111.192 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.39 149.87 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 3.6299999999999999 111.25 -172.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.13 157.04 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 3.6699999999999999 111.222 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -115.49 151.09 35.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 3.7000000000000002 111.217 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.21 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 3.73 111.195 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -127.49 172.48 10.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 3.77 111.204 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.9 p -138.71 150.32 46.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 3.7999999999999998 111.11 -172.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 247' ' ' LEU . 2.0 tt -94.25 106.42 18.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 3.8300000000000001 111.191 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 81.7 mt -92.18 125.14 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 3.8700000000000001 111.178 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.38 158.54 43.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 3.8999999999999999 111.202 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -84.93 99.94 11.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 3.9300000000000002 111.187 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -56.01 -47.83 77.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 3.9700000000000002 111.128 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.72 -52.19 65.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 4.0 111.217 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.93 -60.11 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 4.0300000000000002 111.214 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.45 87.64 51.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 4.0700000000000003 111.237 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.27 -14.71 25.55 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.681 1.587 . . . . 4.0999999999999996 111.173 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -90.53 110.05 38.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 4.1299999999999999 111.184 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.53 157.65 25.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.661 1.574 . . . . 4.1699999999999999 111.183 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.01 141.06 79.9 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.692 1.595 . . . . 4.2000000000000002 111.153 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.91 -18.7 36.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 4.2300000000000004 111.216 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.6 t -157.67 -178.28 7.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 4.2699999999999996 111.182 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -65.65 -35.67 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 4.2999999999999998 111.215 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -74.24 -6.58 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 4.3300000000000001 111.2 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -104.63 9.94 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 4.3700000000000001 111.174 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.558 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 88.7 mt -71.47 -41.62 10.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 4.4000000000000004 111.15 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 84.2 Cg_exo -52.53 -30.52 45.02 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.715 1.61 . . . . 4.4299999999999997 111.153 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.75 -37.05 67.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 4.4699999999999998 111.205 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -67.23 -47.88 69.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 4.5 111.194 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.13 -29.33 70.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 4.5300000000000002 111.223 -171.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.9 -44.95 64.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 4.5700000000000003 111.158 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -94.01 -30.93 14.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 4.5999999999999996 111.139 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.96 -27.8 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.202 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.42 -41.62 63.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 4.6699999999999999 111.214 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.18 -5.74 59.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 4.7000000000000002 111.225 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.74 12.34 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 4.7300000000000004 111.175 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.08 24.9 70.3 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -140.2 179.78 6.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 4.7999999999999998 111.134 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -151.38 138.05 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 4.8300000000000001 111.175 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.43 -60.61 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.141 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.7 tp -135.96 119.54 17.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 4.9000000000000004 111.221 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mtm -115.48 101.51 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 4.9299999999999997 111.174 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -110.06 135.84 50.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 4.9699999999999998 111.203 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -59.99 113.97 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 5.0 111.194 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.78 -24.84 63.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 5.0300000000000002 111.245 -169.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -100.84 -39.61 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 5.0700000000000003 111.22 -171.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -78.71 128.32 77.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 5.0999999999999996 111.217 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -73.21 -20.2 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.738 1.626 . . . . 5.1299999999999999 111.149 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -54.48 -43.24 71.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 5.1699999999999999 111.131 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -79.9 -19.99 46.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 5.2000000000000002 111.234 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 64.8 p -99.35 -5.54 29.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 5.2300000000000004 111.221 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.583 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 83.1 t90 -62.24 -45.42 90.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 5.2699999999999996 111.255 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 40.7 Cg_exo -61.29 -38.54 64.59 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.731 1.621 . . . . 5.2999999999999998 111.167 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.74 -60.02 4.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 5.3300000000000001 111.201 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 167' ' ' TYR . 20.8 tt -70.18 -22.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 5.3700000000000001 111.181 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -88.78 -4.07 58.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 5.4000000000000004 111.205 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -113.1 -10.47 13.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.214 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -95.57 -31.46 13.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 5.4699999999999998 111.188 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.6 33.35 2.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 5.5 111.223 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.64 11.35 23.4 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 161' ' ' ILE . 84.1 t80 -131.84 109.77 10.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 5.5700000000000003 111.187 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 63.62 33.18 13.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 5.5999999999999996 111.234 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 74.7 m-85 -124.96 95.3 4.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 5.6299999999999999 111.205 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -51.7 125.03 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.6699999999999999 111.141 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -93.68 126.85 39.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 5.7000000000000002 111.242 -172.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -140.01 73.01 1.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 5.7300000000000004 111.21 169.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 80.3 -65.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 5.7699999999999996 111.165 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.02 15.0 1.93 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.18 -0.768 . . . . 5.7999999999999998 111.18 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -92.19 144.66 25.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.82 0.343 . . . . 5.8300000000000001 111.198 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.85 73.83 1.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 5.8700000000000001 111.187 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 169' ' ' PHE . 22.3 t0 -90.07 161.55 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 5.9000000000000004 111.264 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.4 pt -114.97 29.64 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 5.9299999999999997 111.191 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.57 -59.96 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 5.9699999999999998 111.203 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -90.32 169.96 10.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 6.0 111.184 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.0 t -88.82 139.85 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 6.0300000000000002 111.217 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.33 24.07 15.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.17 -0.772 . . . . 6.0700000000000003 111.17 -169.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.55 -20.81 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 6.0999999999999996 111.23 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -105.36 23.1 14.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 6.1299999999999999 111.235 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -95.58 136.79 35.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 6.1699999999999999 111.179 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.74 -27.83 63.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 6.2000000000000002 111.209 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.77 -31.6 81.43 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.129 -0.788 . . . . 6.2300000000000004 111.129 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -45.09 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 6.2699999999999996 111.18 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -66.18 -40.97 90.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 6.2999999999999998 111.177 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.99 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.285 -0.416 . . . . 6.3300000000000001 111.165 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.24 -41.22 92.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 6.3700000000000001 111.218 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 30.2 tp -69.69 -36.18 75.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 6.4000000000000004 111.138 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.8 m -62.86 -41.68 99.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 6.4299999999999997 111.233 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.23 -44.52 95.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.193 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.7 tp -56.85 -41.32 77.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 6.5 111.136 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.401 ' HA ' HD13 ' A' ' 199' ' ' ILE . 54.1 t -70.34 -34.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 6.5300000000000002 111.205 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.9 -34.3 77.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 6.5700000000000003 111.192 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.66 -23.35 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.5999999999999996 111.198 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 196' ' ' VAL . 92.9 mt -78.85 -49.78 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 6.6299999999999999 111.151 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.67 -25.35 53.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 6.6699999999999999 111.129 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -94.65 10.77 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 6.7000000000000002 111.25 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 59.98 52.47 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 6.7300000000000004 111.194 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -107.17 -29.84 9.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.236 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 19.0 ptp -155.13 164.95 38.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 6.7999999999999998 111.198 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -145.0 -169.96 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 6.8300000000000001 111.171 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.1 82.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 6.8700000000000001 111.184 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.22 -37.86 86.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 6.9000000000000004 111.239 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.2 m -53.88 109.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.217 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -147.19 -164.34 1.98 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.257 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -50.64 -42.6 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 7.0 111.199 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.3 p -66.84 -18.27 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 7.0300000000000002 111.21 -169.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -103.35 -54.91 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 7.0700000000000003 111.194 176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.0 -61.7 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 7.0999999999999996 111.213 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -92.75 -53.63 4.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 7.1299999999999999 111.266 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.04 -52.4 49.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 7.1699999999999999 111.217 -167.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.66 95.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 7.2000000000000002 111.171 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.06 -51.08 70.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 7.2300000000000004 111.216 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.02 -32.08 73.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 7.2699999999999996 111.176 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -63.55 -43.78 96.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 7.2999999999999998 111.226 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 122.31 19.38 3.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.193 -0.763 . . . . 7.3300000000000001 111.193 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 7.3700000000000001 111.234 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.7 m -113.38 124.99 53.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 7.4000000000000004 111.198 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.63 76.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 7.4299999999999997 111.181 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -167.83 144.98 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 7.4699999999999998 111.253 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.3 t -155.96 163.79 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 7.5 111.226 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.55 130.3 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 7.5300000000000002 111.135 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -156.96 173.78 16.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 7.5700000000000003 111.229 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.0 -61.21 7.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.179 -0.769 . . . . 7.5999999999999996 111.179 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.94 144.96 98.79 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.219 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -79.61 156.53 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 7.6699999999999999 111.191 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.2 13.65 30.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 7.7000000000000002 111.183 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -62.81 -32.07 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 7.7300000000000004 111.237 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.7 p -87.61 -9.84 53.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 7.7699999999999996 111.172 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -95.42 0.99 53.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 7.7999999999999998 111.185 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.7 mt -69.19 -55.22 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 7.8300000000000001 111.201 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.78 -24.13 62.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 7.8700000000000001 111.178 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.0 m -65.03 -46.94 79.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 7.9000000000000004 111.216 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 69.0 m -100.01 -2.65 33.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 7.9299999999999997 111.191 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.04 34.91 13.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 7.9699999999999998 111.211 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.97 135.96 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 8.0 111.206 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.13 122.55 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 8.0299999999999994 111.2 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -118.35 146.34 44.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 8.0700000000000003 111.176 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -110.91 157.31 15.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.212 -0.755 . . . . 8.0999999999999996 111.212 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.72 130.03 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 8.1300000000000008 111.174 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -141.98 -169.96 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 8.1699999999999999 111.145 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 98.6 t -93.02 118.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 8.1999999999999993 111.169 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.532 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 49.9 tp -90.25 -45.0 0.4 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 8.2300000000000004 111.133 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 74.2 Cg_exo -55.28 128.1 29.06 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.706 1.604 . . . . 8.2699999999999996 111.179 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.2 m -138.88 126.6 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 8.3000000000000007 111.184 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.85 127.37 44.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 8.3300000000000001 111.197 -175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 86.3 tttt 44.62 45.14 7.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 8.3699999999999992 111.184 -170.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.04 78.78 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 254' ' ' PRO . 62.4 tp60 -130.0 109.93 16.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 8.4299999999999997 111.233 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 253' ' ' GLN . 67.2 Cg_endo -70.11 137.09 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.728 1.619 . . . . 8.4700000000000006 111.184 175.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 62.8 p -154.94 -75.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 8.5 111.241 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -159.95 138.51 7.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 8.5299999999999994 111.171 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.455 ' HD3' ' HG2' ' A' ' 248' ' ' PRO . 63.3 Cg_endo -74.25 168.6 24.42 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.227 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 330' ' ' MET . 16.5 t80 -54.94 116.87 2.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 8.5999999999999996 111.177 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.54 104.32 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 8.6300000000000008 111.192 -163.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.39 140.03 21.59 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.196 -0.762 . . . . 8.6699999999999999 111.196 164.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.35 108.31 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.311 . . . . 8.6999999999999993 111.193 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 51.1 tp -57.31 120.36 8.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 8.7300000000000004 111.167 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.8 m -138.29 153.54 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 8.7699999999999996 111.172 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.59 137.9 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 8.8000000000000007 111.207 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.97 -174.48 14.98 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.227 -0.749 . . . . 8.8300000000000001 111.227 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.0 mt -111.88 128.64 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 8.8699999999999992 111.191 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -57.81 123.09 14.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.251 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 8.9299999999999997 111.196 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.13 54.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 8.9700000000000006 111.272 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.99 127.98 93.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 9.0 111.206 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.7 -4.1 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.717 1.612 . . . . 9.0299999999999994 111.225 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -110.06 30.79 6.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 9.0700000000000003 111.145 -171.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -51.95 -36.71 50.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 9.0999999999999996 111.183 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.26 -49.64 75.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 9.1300000000000008 111.188 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.16 -43.3 95.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 9.1699999999999999 111.195 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 9.1999999999999993 111.131 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -68.3 -42.27 79.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 9.2300000000000004 111.154 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -56.89 -49.53 75.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 9.2699999999999996 111.209 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -57.54 -59.94 4.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 9.3000000000000007 111.179 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.81 -38.8 82.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 9.3300000000000001 111.194 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.94 -43.84 10.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 9.3699999999999992 111.218 -168.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -103.51 -6.18 22.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 9.4000000000000004 111.224 -166.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.94 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 9.4299999999999997 111.194 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.67 -60.55 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 9.4700000000000006 111.169 -166.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.17 64.9 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 9.5 111.164 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 24.5 p -130.05 -179.99 5.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 9.5299999999999994 111.275 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.96 -27.01 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 9.5700000000000003 111.158 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -92.93 -39.89 10.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 9.5999999999999996 111.173 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -64.78 -46.77 88.71 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.196 -0.762 . . . . 9.6300000000000008 111.196 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.02 -15.5 60.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 9.6699999999999999 111.202 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -65.49 -38.4 89.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 9.6999999999999993 111.201 169.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.31 37.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 9.7300000000000004 111.217 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.19 -45.45 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 9.7699999999999996 111.166 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -87.56 10.5 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 9.8000000000000007 111.235 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.59 -42.98 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 9.8300000000000001 111.193 165.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -95.61 -32.44 12.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 9.8699999999999992 111.168 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.17 158.69 43.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 9.9000000000000004 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.08 130.02 36.09 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.747 1.631 . . . . 9.9299999999999997 111.18 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 78.1 mt -58.24 -41.89 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 9.9700000000000006 111.25 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.46 -20.25 67.53 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.214 -0.754 . . . . 10.0 111.214 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.85 75.26 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 10.029999999999999 111.236 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.07 150.67 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.177 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.66 -8.96 21.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 10.1 111.237 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 307' ' ' TYR . 31.6 tp -81.77 119.99 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 10.130000000000001 111.145 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -68.83 -39.47 79.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 10.17 111.227 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.0 t -51.35 -49.53 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 10.199999999999999 111.236 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.4 ' HB2' HD21 ' A' ' 304' ' ' LEU . 60.2 t80 -70.49 -40.29 73.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 10.23 111.172 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -52.41 -39.55 61.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 10.27 111.225 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.88 -30.11 71.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 10.300000000000001 111.246 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -71.59 -34.77 70.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.33 111.192 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.79 -18.31 61.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 10.369999999999999 111.202 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.62 -18.59 62.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 10.4 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -27.2 66.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 10.43 111.176 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -100.19 110.05 58.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.243 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -55.38 -31.16 76.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.645 1.563 . . . . 10.5 111.244 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 10.529999999999999 111.211 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.33 -44.81 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 10.57 111.198 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.48 -31.76 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 10.6 111.242 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.28 73.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 10.630000000000001 111.174 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.0 p -93.09 -20.19 20.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 10.67 111.232 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.3 mmt -71.64 -31.04 66.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 10.699999999999999 111.245 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.71 -44.94 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 10.73 111.176 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -73.06 -26.19 61.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.77 111.146 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.3 90.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 10.800000000000001 111.2 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.06 -34.91 64.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 10.83 111.092 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -94.97 0.13 54.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 10.869999999999999 111.187 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.61 -164.78 40.39 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.192 -0.763 . . . . 10.9 111.192 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -124.03 138.04 54.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 10.93 111.217 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.0 mm -102.83 135.26 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 10.970000000000001 111.178 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 258' ' ' PHE . 28.6 ttt -70.13 116.24 42.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 11.0 111.141 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.13 159.23 37.4 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 11.029999999999999 111.185 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -105.83 50.01 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.489 . . . . 11.07 111.209 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 86.4 mt -85.9 124.95 70.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 11.1 111.239 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.06 -29.32 22.6 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.709 1.606 . . . . 11.130000000000001 111.248 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -69.09 -37.24 78.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 11.17 111.166 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 89.9 mtp -79.75 -27.82 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 11.199999999999999 111.223 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -57.82 -49.74 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 11.23 111.166 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.6 82.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 11.27 111.18 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -68.26 -36.77 79.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 11.300000000000001 111.196 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -68.96 -32.48 72.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 11.33 111.195 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -61.92 -41.25 97.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 11.369999999999999 111.254 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.37 90.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 11.4 111.188 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.16 -40.09 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 11.43 111.154 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -64.31 -32.49 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 11.470000000000001 111.244 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.9 m -75.32 -39.86 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.193 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.98 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.223 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.84 -16.34 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.243 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.12 -28.74 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 11.6 111.138 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.45 -29.81 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 11.630000000000001 111.191 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -88.36 -32.29 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 11.67 111.194 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.07 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 11.699999999999999 111.151 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.9 p -75.75 -16.25 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 11.73 111.15 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.95 10.06 79.48 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.202 -0.759 . . . . 11.77 111.202 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -81.6 -49.66 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 11.800000000000001 111.268 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -110.75 169.61 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 11.83 111.198 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.0 p -85.74 175.18 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 11.869999999999999 111.224 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.1 m -69.35 -14.56 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 11.9 111.215 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -95.03 -42.62 8.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 11.93 111.205 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -75.32 -35.2 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 11.970000000000001 111.16 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.95 94.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 12.0 111.193 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.03 -39.22 69.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 12.029999999999999 111.242 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -51.83 -38.89 57.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 12.07 111.185 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -49.97 -43.0 49.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.176 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.54 -35.46 27.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 12.130000000000001 111.247 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.05 -31.02 69.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 12.17 111.154 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.4 m -52.08 -38.8 58.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 12.199999999999999 111.188 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -102.6 -35.53 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 12.23 111.142 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.05 -47.16 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 12.27 111.172 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.4 p -109.63 -31.94 7.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 12.300000000000001 111.207 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.2 -1.516 0 CA-C-N 116.172 -0.467 . . . . 12.33 111.172 177.146 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.774 0.321 . . . . 0.029999999999999999 111.214 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.3 mt -78.58 126.99 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.070000000000000007 111.22 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -67.63 142.26 56.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.10000000000000001 111.184 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.72 138.58 31.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.13 111.127 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.25 28.01 9.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.182 -0.767 . . . . 0.17000000000000001 111.182 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -146.57 145.42 30.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 0.20000000000000001 111.216 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.8 mt -111.98 98.34 7.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.23000000000000001 111.255 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.91 112.04 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.27000000000000002 111.141 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -105.89 122.35 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.29999999999999999 111.209 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -109.9 129.98 55.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.33000000000000002 111.23 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 11' ' ' ILE . 18.6 tt -149.53 123.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.37 111.222 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.02 150.01 22.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.40000000000000002 111.198 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.42 172.02 38.12 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.221 -0.752 . . . . 0.42999999999999999 111.221 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -79.87 76.88 6.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.831 0.348 . . . . 0.46999999999999997 111.224 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -103.76 179.96 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.5 111.129 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.07 63.93 4.4 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.222 -0.751 . . . . 0.53000000000000003 111.222 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -68.4 -24.11 64.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.56999999999999995 111.182 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -70.07 -49.94 46.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.59999999999999998 111.224 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.56 96.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.63 111.224 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.5 tp -69.7 -31.73 69.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.67000000000000004 111.16 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.73 72.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.183 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -63.19 -42.55 99.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.72999999999999998 111.16 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.63 -21.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.77000000000000002 111.232 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.81 68.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.19 -0.764 . . . . 0.80000000000000004 111.19 171.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -67.37 -42.61 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.745 0.307 . . . . 0.82999999999999996 111.165 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.39 -48.56 79.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.87 111.169 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.63 -44.25 85.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.90000000000000002 111.147 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.2 -37.44 87.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.93000000000000005 111.227 -176.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -75.09 -34.99 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.96999999999999997 111.233 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -70.75 -39.51 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 1.0 111.218 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.6 p -110.51 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 1.03 111.202 -170.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 5.45 75.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.229 -0.749 . . . . 1.0700000000000001 111.229 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.89 119.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 1.1000000000000001 111.199 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -64.95 123.93 20.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 1.1299999999999999 111.243 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.72 125.03 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 1.1699999999999999 111.181 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.5 m -130.38 136.33 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 1.2 111.17 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.4 t -113.79 124.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 1.23 111.171 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.86 158.62 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 1.27 111.197 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -114.3 86.49 12.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 1.3 111.154 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.25 178.11 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.697 1.598 . . . . 1.3300000000000001 111.23 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -146.96 174.78 11.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 1.3700000000000001 111.228 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 53.19 37.84 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 1.3999999999999999 111.185 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.09 -24.94 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.442 . . . . 1.4299999999999999 111.182 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.26 -12.55 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 1.47 111.182 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -110.04 -23.06 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 1.5 111.213 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -92.92 -38.81 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.53 111.168 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.502 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.6 m-30 -59.97 -46.41 98.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 1.5700000000000001 111.202 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 79.5 Cg_exo -51.75 -36.06 60.67 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.685 1.59 . . . . 1.6000000000000001 111.228 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -75.7 -48.43 21.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 47' ' ' PHE . 25.9 m -74.56 -18.38 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 1.6699999999999999 111.208 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.06 -30.59 71.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 1.7 111.175 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.67 -12.16 57.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.187 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.9 p -114.04 -14.94 12.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.77 111.167 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.92 39.7 16.2 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 1.8 111.215 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -113.23 -168.42 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 1.8300000000000001 111.196 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.48 -169.23 13.12 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.214 -0.754 . . . . 1.8700000000000001 111.214 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.86 -170.15 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.701 1.601 . . . . 1.8999999999999999 111.222 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -103.13 -38.59 7.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 1.9299999999999999 111.158 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -122.2 132.9 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 1.97 111.177 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -125.1 120.78 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 2.0 111.192 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -85.07 146.12 27.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 2.0299999999999998 111.177 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -159.92 158.4 30.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 2.0699999999999998 111.171 173.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.94 174.27 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 2.1000000000000001 111.218 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -58.06 -32.93 68.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.232 -0.44 . . . . 2.1299999999999999 111.199 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -91.56 6.67 44.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 2.1699999999999999 111.219 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -114.64 -20.02 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 2.2000000000000002 111.161 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.34 -50.82 71.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 2.23 111.192 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -46.77 75.89 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.765 . . . . 2.27 111.186 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.89 95.05 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.171 -0.771 . . . . 2.2999999999999998 111.171 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -78.89 -24.88 43.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 2.3300000000000001 111.199 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.62 -23.16 31.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 2.3700000000000001 111.242 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -62.59 -33.71 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 2.3999999999999999 111.19 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -69.22 -28.75 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 2.4300000000000002 111.15 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.99 51.32 7.76 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.22 -0.752 . . . . 2.4700000000000002 111.22 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 75' ' ' LEU . 3.8 pp -132.03 20.05 4.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 2.5 111.221 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.88 134.29 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 2.5299999999999998 111.195 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.51 158.9 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 2.5699999999999998 111.24 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -89.62 159.25 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 2.6000000000000001 111.255 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.1 mt -130.07 137.85 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 2.6299999999999999 111.15 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.5 m -95.11 114.99 64.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.6699999999999999 111.235 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.6 155.14 27.6 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.151 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -90.03 169.98 10.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 2.73 111.197 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.11 -59.91 2.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 2.77 111.255 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.96 78.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 2.7999999999999998 111.165 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -54.87 -50.34 68.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.442 . . . . 2.8300000000000001 111.207 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -57.54 -43.86 84.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 2.8700000000000001 111.147 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.03 -34.98 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 2.8999999999999999 111.162 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -79.55 -21.87 44.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 2.9300000000000002 111.153 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.417 HD21 HD21 ' A' ' 304' ' ' LEU . 90.9 mt -88.09 151.42 22.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.9700000000000002 111.188 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -67.56 156.66 88.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 3.0 111.196 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.19 3.0 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.7 1.6 . . . . 3.0299999999999998 111.167 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -122.6 10.63 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.175 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.4 p -119.52 -35.43 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 3.1000000000000001 111.247 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -70.12 -40.0 75.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 3.1299999999999999 111.139 173.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -77.85 -30.98 51.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 3.1699999999999999 111.183 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.37 65.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 3.2000000000000002 111.168 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.21 20.98 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 3.23 111.142 -172.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 44.1 mtm105 -95.21 170.38 9.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 3.27 111.18 172.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -160.42 119.61 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 3.2999999999999998 111.215 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.1 t30 60.64 34.24 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 3.3300000000000001 111.217 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.98 7.7 83.4 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.262 -0.735 . . . . 3.3700000000000001 111.262 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -131.22 130.01 42.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 3.3999999999999999 111.269 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.1 tt -70.02 129.99 40.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 3.4300000000000002 111.212 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -113.93 -25.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 3.4700000000000002 111.223 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.85 165.85 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 3.5 111.199 -171.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -111.0 140.81 23.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 3.5299999999999998 111.193 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.14 -179.77 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.678 1.585 . . . . 3.5699999999999998 111.19 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.0 tp -165.06 -21.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 3.6000000000000001 111.15 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.33 145.55 23.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 3.6299999999999999 111.188 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.52 125.73 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 111.208 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -114.93 154.98 27.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 3.7000000000000002 111.218 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.02 175.91 9.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 3.73 111.188 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 113' ' ' LEU . 1.7 pp -143.21 146.54 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 3.77 111.173 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -168.36 179.97 4.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 3.7999999999999998 111.251 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.404 ' HB2' HD23 ' A' ' 247' ' ' LEU . 55.0 tp -95.41 112.2 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 3.8300000000000001 111.206 -174.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 tt -114.21 137.28 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 3.8700000000000001 111.236 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.59 150.52 46.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 3.8999999999999999 111.174 -172.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -85.83 120.27 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 3.9300000000000002 111.264 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.85 -35.09 67.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 3.9700000000000002 111.176 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.65 -33.94 77.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 4.0 111.188 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.02 -48.63 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.111 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.7 tp -154.98 111.12 2.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 4.0700000000000003 111.219 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.99 -17.67 19.39 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.697 1.598 . . . . 4.0999999999999996 111.197 -172.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -56.46 114.07 7.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 4.1299999999999999 111.217 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.7 134.81 15.41 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.71 1.606 . . . . 4.1699999999999999 111.218 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.519 ' HG3' ' SD ' ' A' ' 224' ' ' MET . 79.5 Cg_endo -77.61 140.59 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.753 1.636 . . . . 4.2000000000000002 111.171 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -100.14 -45.01 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 4.2300000000000004 111.239 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 t -158.41 -178.64 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.161 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -62.38 -38.33 89.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 4.2999999999999998 111.165 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.01 -15.45 62.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 4.3300000000000001 111.216 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -89.06 -14.31 36.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 4.3700000000000001 111.212 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.581 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.3 mt -67.54 -44.93 46.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 4.4000000000000004 111.205 -172.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 54.3 Cg_exo -55.07 -37.74 93.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.674 1.583 . . . . 4.4299999999999997 111.171 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.95 -36.88 72.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 4.4699999999999998 111.222 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.93 -32.92 74.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 4.5 111.193 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -56.38 -36.27 68.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 4.5300000000000002 111.249 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.88 -30.52 71.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 4.5700000000000003 111.153 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.2 -24.58 32.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 4.5999999999999996 111.146 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 -3.28 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 4.6299999999999999 111.198 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.22 -29.06 70.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 4.6699999999999999 111.221 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.94 79.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 4.7000000000000002 111.183 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -107.85 -9.94 15.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 4.7300000000000004 111.218 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.4 40.47 33.04 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.216 -0.754 . . . . 4.7699999999999996 111.216 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -111.62 155.3 23.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.313 . . . . 4.7999999999999998 111.225 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 t -99.71 141.44 32.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 4.8300000000000001 111.235 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.46 ' HB2' ' HE3' ' A' ' 224' ' ' MET . . . -85.93 -6.78 59.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 4.8700000000000001 111.204 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.4 HD21 HD13 ' A' ' 198' ' ' LEU . 31.0 tp -165.37 133.41 3.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 4.9000000000000004 111.226 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 26.0 ttt -156.73 134.53 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 4.9299999999999997 111.189 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -129.03 -176.93 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 4.9699999999999998 111.183 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -84.75 120.32 26.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 5.0 111.276 168.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 tp -52.56 -38.9 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 5.0300000000000002 111.191 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -122.44 39.3 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 5.0700000000000003 111.225 -165.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 154' ' ' PRO . 14.5 tp10 -146.71 118.31 4.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 5.0999999999999996 111.175 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 153' ' ' GLU . 32.9 Cg_endo -67.09 -26.6 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.677 1.585 . . . . 5.1299999999999999 111.226 -175.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -56.7 -41.07 76.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 5.1699999999999999 111.155 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 5.2000000000000002 111.225 -174.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.1 p -98.87 -6.31 29.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 5.2300000000000004 111.174 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.558 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.6 t90 -68.49 -43.76 32.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 5.2699999999999996 111.179 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 63.9 Cg_exo -55.76 -31.67 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.702 1.601 . . . . 5.2999999999999998 111.157 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 65.6 tp -61.73 -59.94 4.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 5.3300000000000001 111.238 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.51 -25.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.3700000000000001 111.202 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.24 67.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 5.4000000000000004 111.211 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.03 77.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 5.4299999999999997 111.211 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -78.01 -29.96 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 5.4699999999999998 111.186 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 92.41 50.0 2.67 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.167 -0.773 . . . . 5.5 111.167 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -55.87 -59.47 10.54 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 5.5300000000000002 111.204 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.437 ' O ' ' HB1' ' A' ' 168' ' ' ALA . 50.4 p90 -112.58 169.84 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 5.5700000000000003 111.233 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 167' ' ' TYR . . . 65.15 20.27 11.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 5.5999999999999996 111.222 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.97 150.04 43.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 5.6299999999999999 111.195 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -135.92 83.38 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 5.6699999999999999 111.236 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -54.93 107.95 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 5.7000000000000002 111.184 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -149.94 92.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 5.7300000000000004 111.222 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 58.05 35.0 24.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 5.7699999999999996 111.249 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.36 -2.26 77.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.197 -0.761 . . . . 5.7999999999999998 111.197 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -99.97 154.42 18.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 5.8300000000000001 111.162 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -142.05 156.98 45.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 5.8700000000000001 111.171 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -152.49 120.58 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 5.9000000000000004 111.195 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.2 pt -75.2 -16.94 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 5.9299999999999997 111.215 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.73 -26.67 54.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 5.9699999999999998 111.211 -172.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.29 170.21 11.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 6.0 111.195 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -72.64 125.41 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 6.0300000000000002 111.181 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.59 60.4 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.175 -0.77 . . . . 6.0700000000000003 111.175 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.64 -37.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 6.0999999999999996 111.204 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -85.12 -3.57 58.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.238 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -71.35 155.59 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 6.1699999999999999 111.248 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.34 -33.66 67.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 6.2000000000000002 111.221 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.63 -27.26 73.12 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.213 -0.755 . . . . 6.2300000000000004 111.213 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.1 78.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.718 0.294 . . . . 6.2699999999999996 111.197 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.33 -43.05 95.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 6.2999999999999998 111.24 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.24 93.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 6.3300000000000001 111.145 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.92 97.44 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.212 -0.755 . . . . 6.3700000000000001 111.212 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.56 -29.64 61.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 6.4000000000000004 111.214 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 69.9 m -61.96 -44.33 96.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 6.4299999999999997 111.158 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -64.99 -37.45 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 6.4699999999999998 111.195 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.17 -46.86 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 6.5 111.193 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.25 -39.81 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 6.5300000000000002 111.248 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.37 -31.47 72.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 6.5700000000000003 111.198 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.4 HD13 HD21 ' A' ' 147' ' ' LEU . 46.5 tp -66.94 -41.29 87.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 6.5999999999999996 111.215 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 43.1 pt -83.0 -19.47 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 6.6299999999999999 111.232 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.15 -39.84 75.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 6.6699999999999999 111.133 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.23 -9.62 59.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 6.7000000000000002 111.204 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.38 54.29 2.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 6.7300000000000004 111.178 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -79.94 -20.37 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 6.7699999999999996 111.219 172.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -141.49 150.27 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.7999999999999998 111.174 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -127.01 170.02 12.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 6.8300000000000001 111.185 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.15 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 6.8700000000000001 111.225 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.16 -30.47 71.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 6.9000000000000004 111.196 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.8 m -59.42 125.01 21.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 6.9299999999999997 111.171 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -129.97 -166.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 6.9699999999999998 111.215 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -55.74 -50.04 71.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 7.0 111.146 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.7 p -73.15 -25.23 60.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.21 -171.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.0 mm -75.04 -51.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 7.0700000000000003 111.164 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.07 -32.87 74.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 7.0999999999999996 111.237 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -70.15 -52.17 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 7.1299999999999999 111.257 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.66 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 7.1699999999999999 111.181 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.439 ' HA ' ' HB2' ' A' ' 221' ' ' GLU . . . -55.07 -36.3 65.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 7.2000000000000002 111.165 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -94.21 -41.01 9.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 7.2300000000000004 111.237 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.2 -41.91 80.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 7.2699999999999996 111.184 -173.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.17 -9.04 49.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 7.2999999999999998 111.187 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.61 27.38 59.2 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.771 . . . . 7.3300000000000001 111.171 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 216' ' ' ALA . 75.6 mm-40 -68.44 -29.88 68.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 7.3700000000000001 111.183 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.4 p -109.7 167.89 9.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 7.4000000000000004 111.132 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.63 -38.57 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4299999999999997 111.226 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.519 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 64.4 ttp -144.95 145.03 31.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 7.4699999999999998 111.159 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -163.56 174.22 12.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 7.5 111.175 170.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -100.94 128.82 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 7.5300000000000002 111.234 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -163.84 177.79 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 7.5700000000000003 111.194 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -112.09 163.5 12.19 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 230' ' ' TRP . 38.6 Cg_exo -59.62 117.2 3.91 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.632 1.555 . . . . 7.6299999999999999 111.208 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.46 ' HB3' ' O ' ' A' ' 229' ' ' PRO . . . 175.04 -35.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 7.6699999999999999 111.225 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -109.95 4.31 21.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.241 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.02 -19.98 59.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 7.7300000000000004 111.206 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 90.5 p -65.71 -20.06 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 7.7699999999999996 111.227 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -72.79 -24.57 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 7.7999999999999998 111.19 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.05 -38.01 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 7.8300000000000001 111.178 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.63 -34.96 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 7.8700000000000001 111.201 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.6 m -66.52 -41.16 89.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 7.9000000000000004 111.219 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 88.8 p -73.18 -14.68 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 7.9299999999999997 111.194 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 59.98 51.52 5.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 7.9699999999999998 111.222 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.1 m -118.16 164.43 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 8.0 111.17 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -84.61 139.27 32.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 8.0299999999999994 111.193 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -153.8 165.0 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 8.0700000000000003 111.183 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.88 163.84 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.137 -0.785 . . . . 8.0999999999999996 111.137 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.88 129.55 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 8.1300000000000008 111.225 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 34.9 p -133.15 171.6 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 8.1699999999999999 111.181 171.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.35 150.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 8.1999999999999993 111.189 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.687 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 2.7 pt? -140.96 51.58 2.53 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.199 -175.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 46.0 Cg_endo -62.57 146.94 95.44 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.737 1.624 . . . . 8.2699999999999996 111.228 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 42.6 m -139.66 117.04 11.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 8.3000000000000007 111.25 -174.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.73 73.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 8.3300000000000001 111.212 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 60.56 56.1 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 8.3699999999999992 111.235 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.33 10.47 85.95 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.212 -0.755 . . . . 8.4000000000000004 111.212 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -130.02 110.01 16.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 8.4299999999999997 111.205 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 136.7 14.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.694 1.596 . . . . 8.4700000000000006 111.265 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.2 m -125.19 -87.37 0.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 8.5 111.168 167.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -143.17 142.72 22.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 8.5299999999999994 111.194 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.37 166.33 27.71 Favored 'Trans proline' 0 C--N 1.328 -0.54 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.124 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -73.41 138.05 45.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 8.5999999999999996 111.209 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.43 168.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 8.6300000000000008 111.191 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -144.64 163.19 27.96 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.13 -0.788 . . . . 8.6699999999999999 111.13 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.3 t -125.14 134.84 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 8.6999999999999993 111.19 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 49.1 tp -89.95 133.4 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 8.7300000000000004 111.227 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 90.1 p -143.94 169.97 16.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 8.7699999999999996 111.203 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 8.8000000000000007 111.256 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.15 -169.04 12.87 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.209 -0.756 . . . . 8.8300000000000001 111.209 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 89.4 mt -116.08 135.19 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 8.8699999999999992 111.221 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -60.94 131.11 49.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.172 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.95 -21.19 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 8.9299999999999997 111.197 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -91.53 -4.94 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 8.9700000000000006 111.194 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t -64.5 122.73 80.09 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 9.0 111.165 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.15 -17.9 18.86 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.706 1.604 . . . . 9.0299999999999994 111.215 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -110.55 60.04 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 9.0700000000000003 111.251 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -72.09 -36.66 69.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 9.0999999999999996 111.201 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.56 -37.64 80.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 9.1300000000000008 111.172 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.2 mt -72.33 -40.77 67.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 9.1699999999999999 111.169 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.1 95.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 9.1999999999999993 111.221 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.82 -44.11 90.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 9.2300000000000004 111.256 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -60.04 -43.49 95.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 9.2699999999999996 111.204 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -61.59 -52.08 65.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 9.3000000000000007 111.25 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.02 -20.1 65.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 9.3300000000000001 111.193 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -87.22 -60.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 9.3699999999999992 111.198 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -102.14 -6.46 23.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 9.4000000000000004 111.212 -162.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -124.01 -27.22 3.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 9.4299999999999997 111.21 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.84 -45.83 16.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 9.4700000000000006 111.209 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.92 71.11 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 9.5 111.216 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 42.0 p -138.58 176.03 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 9.5299999999999994 111.199 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -51.78 -36.97 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 9.5700000000000003 111.235 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -92.51 -38.72 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 9.5999999999999996 111.201 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.6 -60.2 8.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.0 tp -56.86 -45.58 82.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 9.6699999999999999 111.156 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.77 -54.18 47.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 9.6999999999999993 111.198 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.53 84.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 9.7300000000000004 111.17 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.2 -43.38 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 9.7699999999999996 111.165 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -98.39 7.53 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 9.8000000000000007 111.258 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.07 -39.3 74.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 9.8300000000000001 111.174 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -97.98 10.48 40.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 9.8699999999999992 111.198 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -130.0 160.39 65.43 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 9.9000000000000004 111.184 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.96 144.96 65.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.724 1.616 . . . . 9.9299999999999997 111.171 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.8 39.18 2.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.248 -0.433 . . . . 9.9700000000000006 111.18 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -54.88 -42.06 78.41 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.21 -0.756 . . . . 10.0 111.21 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -167.07 144.3 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 10.029999999999999 111.179 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.07 173.68 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 10.07 111.13 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.14 -36.63 19.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 10.1 111.157 -172.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.417 HD21 HD21 ' A' ' 89' ' ' LEU . 96.2 mt -81.56 143.26 32.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 10.130000000000001 111.191 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.29 -45.01 23.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 10.17 111.192 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 97.2 p -65.07 -31.9 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 10.199999999999999 111.158 -173.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -75.98 -46.12 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 10.23 111.17 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.25 -31.7 71.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 10.27 111.213 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -53.88 -41.49 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 10.300000000000001 111.2 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -71.34 -37.47 71.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 10.33 111.214 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.1 mp -67.56 -20.29 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 10.369999999999999 111.244 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.03 -18.51 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 10.4 111.256 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.55 -27.88 69.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 10.43 111.177 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.65 115.15 63.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 10.470000000000001 111.213 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.53 -34.37 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.706 1.604 . . . . 10.5 111.177 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.86 -31.99 73.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.19 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 95.8 mt -78.32 -39.99 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 10.57 111.19 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.441 ' HA ' ' HB3' ' A' ' 321' ' ' MET . . . -56.24 -33.61 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 10.6 111.191 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.34 -35.04 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 10.630000000000001 111.177 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 66.4 p -105.18 -20.15 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.228 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.441 ' HB3' ' HA ' ' A' ' 318' ' ' ALA . 60.9 ttp -65.08 -58.7 5.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 10.699999999999999 111.208 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -54.12 -41.6 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.73 111.185 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.35 -29.95 60.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 10.77 111.177 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.07 -35.32 76.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 10.800000000000001 111.232 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.05 -35.04 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 10.83 111.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.17 -4.95 34.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 10.869999999999999 111.164 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.62 -178.84 52.46 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.127 -0.789 . . . . 10.9 111.127 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -119.59 157.12 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 10.93 111.207 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.6 pt -119.76 166.68 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 10.970000000000001 111.189 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.8 tpp -60.04 130.0 88.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 11.0 111.198 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.19 141.45 58.83 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.753 1.636 . . . . 11.029999999999999 111.204 174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.13 20.59 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 11.07 111.179 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.68 130.04 32.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 11.1 111.201 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.75 -41.76 53.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.667 1.578 . . . . 11.130000000000001 111.157 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -63.52 -44.61 93.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 11.17 111.135 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.96 -31.84 73.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 11.199999999999999 111.209 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.1 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 11.23 111.182 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.97 76.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 11.27 111.211 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -67.2 -27.48 67.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 11.300000000000001 111.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -60.03 -38.22 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 11.33 111.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -72.13 -30.1 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 11.369999999999999 111.172 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.4 74.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 11.4 111.201 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.44 -24.99 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 11.43 111.23 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -57.66 -50.2 73.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 11.470000000000001 111.205 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.7 m -60.68 -38.23 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 11.5 111.235 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -55.81 -40.09 72.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 11.529999999999999 111.157 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -47.95 82.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.265 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 348' ' ' ILE . 8.2 tp -74.6 -23.19 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 11.6 111.158 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.64 -27.59 45.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 11.630000000000001 111.187 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.0 -27.71 32.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 11.67 111.186 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.49 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 11.699999999999999 111.183 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.6 p -72.65 -16.22 61.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 11.73 111.272 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.05 35.24 27.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.249 -0.74 . . . . 11.77 111.249 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -99.98 -35.09 9.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 11.800000000000001 111.214 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -127.97 157.07 41.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 11.83 111.137 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -77.45 177.48 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 11.869999999999999 111.224 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.99 -21.26 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 11.9 111.237 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -92.33 -37.69 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 11.93 111.196 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -66.99 -38.18 85.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.172 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.06 -41.77 94.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 12.0 111.185 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.0 -15.29 51.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 12.029999999999999 111.173 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.99 -56.63 8.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 12.07 111.225 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.96 -32.81 74.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 12.1 111.204 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.485 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -59.09 -56.68 19.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 12.130000000000001 111.236 171.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.76 -34.27 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 12.17 111.222 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.8 m -59.57 -35.91 75.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 12.199999999999999 111.237 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.45 -24.13 56.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 12.23 111.131 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 364' ' ' ALA . 39.1 mm -77.39 -61.01 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 12.27 111.201 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.7 p -122.27 -25.41 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 12.300000000000001 111.146 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--O 1.201 -1.495 0 CA-C-N 116.157 -0.474 . . . . 12.33 111.155 -178.656 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.783 0.325 . . . . 0.029999999999999999 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.12 124.95 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.070000000000000007 111.22 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.62 153.77 38.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.10000000000000001 111.2 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.05 125.02 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.13 111.199 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 18.07 60.62 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -134.12 150.03 51.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.20000000000000001 111.187 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -119.57 119.94 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.23000000000000001 111.23 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.85 116.24 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.27000000000000002 111.196 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.417 ' HB ' HG23 ' A' ' 37' ' ' VAL . 74.2 mt -121.79 116.62 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.29999999999999999 111.185 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.87 107.12 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.33000000000000002 111.234 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.8 tt -115.79 139.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.37 111.186 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -76.66 109.65 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.40000000000000002 111.2 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.76 -171.75 43.04 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.212 -0.755 . . . . 0.42999999999999999 111.212 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -109.95 -43.6 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.46999999999999997 111.229 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 88.2 tttt -151.41 40.01 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.5 111.241 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -14.77 68.67 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.19 -0.764 . . . . 0.53000000000000003 111.19 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -56.71 -30.96 64.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.56999999999999995 111.225 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.96 -37.95 89.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.59999999999999998 111.194 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.48 -31.72 11.22 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.16 -0.776 . . . . 0.63 111.16 -177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.2 tp -73.48 -46.58 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.67000000000000004 111.24 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.43 68.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.69999999999999996 111.173 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.71 -38.93 64.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.72999999999999998 111.17 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -75.71 -23.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.77000000000000002 111.258 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.64 -5.54 81.55 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.206 -0.758 . . . . 0.80000000000000004 111.206 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.49 -24.13 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.327 . . . . 0.82999999999999996 111.201 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.32 -25.48 66.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.87 111.197 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.90000000000000002 111.298 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.95 -28.37 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.93000000000000005 111.205 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.26 -35.65 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.96999999999999997 111.184 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.87 -47.93 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.255 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -124.21 -20.98 5.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 1.03 111.191 -172.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.11 27.15 24.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.186 -0.765 . . . . 1.0700000000000001 111.186 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.3 mt -105.43 128.18 59.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 1.1000000000000001 111.169 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.38 124.98 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 1.1299999999999999 111.24 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -99.4 119.46 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 1.1699999999999999 111.201 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.5 m -114.76 123.81 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.2 111.199 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG23 ' HB ' ' A' ' 9' ' ' ILE . 72.5 t -114.59 131.57 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.23 111.217 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.71 170.34 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 1.27 111.227 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.96 68.74 80.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 1.3 111.206 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.94 161.64 38.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.749 1.633 . . . . 1.3300000000000001 111.227 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -120.27 171.48 8.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 1.3700000000000001 111.232 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 54.96 37.22 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 1.3999999999999999 111.215 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.0 mt -66.85 -37.0 83.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 1.4299999999999999 111.176 -174.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -70.8 -11.99 61.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 1.47 111.208 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -102.91 -6.12 22.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.5 111.197 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.88 -39.91 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.53 111.197 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.579 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 m-85 -62.46 -39.3 54.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.5700000000000001 111.232 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 76.9 Cg_exo -52.39 -24.4 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.697 1.598 . . . . 1.6000000000000001 111.172 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -109.12 -17.39 13.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 1.6299999999999999 111.186 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.9 t -105.64 -58.77 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 1.6699999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.24 -33.1 75.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 1.7 111.25 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.21 -25.64 68.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.73 111.192 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 p -96.57 5.79 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 1.77 111.192 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.82 18.1 58.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.196 -0.762 . . . . 1.8 111.196 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -110.95 172.31 6.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 1.8300000000000001 111.178 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.01 -163.4 16.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.15 -0.78 . . . . 1.8700000000000001 111.15 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.59 -172.86 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.611 1.541 . . . . 1.8999999999999999 111.206 -175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -96.83 -44.35 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 1.9299999999999999 111.176 173.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.77 135.7 58.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 1.97 111.229 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.7 mt -130.55 130.0 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 2.0 111.225 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.55 138.82 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 2.0299999999999998 111.186 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -141.76 167.94 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 2.0699999999999998 111.216 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.47 158.14 24.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 2.1000000000000001 111.192 164.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -43.83 -41.35 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 2.1299999999999999 111.17 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -83.19 -18.29 39.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 2.1699999999999999 111.21 -174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.11 -19.55 24.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 2.2000000000000002 111.199 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.05 -30.02 67.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.23 111.194 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.18 98.49 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 2.27 111.219 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.74 -44.55 80.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.172 -0.771 . . . . 2.2999999999999998 111.172 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -68.15 -33.28 74.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.234 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.34 -39.81 64.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.19 -0.459 . . . . 2.3700000000000001 111.181 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -65.11 -30.06 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 2.3999999999999999 111.141 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -74.15 -12.91 60.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 2.4300000000000002 111.2 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 27.73 50.47 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.206 -0.758 . . . . 2.4700000000000002 111.206 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -110.39 -6.05 15.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.836 0.35 . . . . 2.5 111.241 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.6 tp -98.39 130.32 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 2.5299999999999998 111.186 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 146.19 24.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.185 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -82.46 159.8 22.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.6000000000000001 111.223 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.8 102.95 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 2.6299999999999999 111.184 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -52.27 111.6 2.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 2.6699999999999999 111.26 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.31 145.64 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.665 1.577 . . . . 2.7000000000000002 111.223 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.38 169.98 9.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 2.73 111.247 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -84.36 -29.11 26.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 2.77 111.17 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.16 91.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 2.7999999999999998 111.241 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.443 ' HA ' ' HB3' ' A' ' 88' ' ' LYS . 59.1 m-85 -80.04 -22.5 42.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 2.8300000000000001 111.186 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.93 -39.95 75.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 2.8700000000000001 111.249 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -94.71 -33.19 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 2.8999999999999999 111.181 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 85' ' ' PHE . 58.1 tptt -64.8 -43.57 92.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 2.9300000000000002 111.148 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -85.23 142.3 29.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 2.9700000000000002 111.147 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -66.85 127.98 93.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 3.0 111.204 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.11 -35.05 80.72 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.656 1.571 . . . . 3.0299999999999998 111.155 -168.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -52.86 -44.6 66.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.197 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -90.91 -23.24 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.1000000000000001 111.141 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -60.0 -43.96 94.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 3.1299999999999999 111.138 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -86.06 -9.51 56.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 3.1699999999999999 111.175 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.27 48.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 3.2000000000000002 111.181 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.459 HG22 ' HD3' ' A' ' 107' ' ' PRO . 29.4 m -114.99 26.24 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 3.23 111.19 -170.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -139.74 154.72 47.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 3.27 111.192 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -148.4 127.51 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 3.2999999999999998 111.203 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 65.04 26.19 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 3.3300000000000001 111.188 -174.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.4 -42.0 2.04 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.151 -0.78 . . . . 3.3700000000000001 111.151 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.61 135.53 33.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 3.3999999999999999 111.151 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.99 143.24 43.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 3.4300000000000002 111.167 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -115.83 -13.45 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 3.4700000000000002 111.179 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.59 160.54 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 3.5 111.168 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -109.95 133.98 20.82 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 3.5299999999999998 111.256 169.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.577 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 72.6 Cg_endo -81.02 -178.46 4.4 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.692 1.595 . . . . 3.5699999999999998 111.25 -172.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.609 ' O ' HG12 ' A' ' 108' ' ' ILE . 16.3 tt 163.94 14.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 3.6000000000000001 111.23 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -171.22 144.78 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.6299999999999999 111.228 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.98 157.0 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 3.6699999999999999 111.183 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -140.02 109.94 6.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 3.7000000000000002 111.214 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.91 156.25 36.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 3.73 111.233 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.2 tp -134.24 116.73 15.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 3.77 111.184 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.0 p -161.56 169.84 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 3.7999999999999998 111.251 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.75 117.52 24.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 3.8300000000000001 111.207 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -108.09 148.48 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 3.8700000000000001 111.259 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -146.27 154.88 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 3.8999999999999999 111.212 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -83.28 122.52 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 3.9300000000000002 111.137 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.6 -19.2 65.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 3.9700000000000002 111.232 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -89.95 -26.91 20.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 4.0 111.153 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -54.71 3.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 4.0300000000000002 111.163 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.52 82.4 18.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 4.0700000000000003 111.187 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.04 -15.01 29.27 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.769 1.646 . . . . 4.0999999999999996 111.204 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -106.95 97.49 17.96 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 4.1299999999999999 111.184 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.1 163.75 34.51 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.731 1.621 . . . . 4.1699999999999999 111.158 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.82 152.09 68.88 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.662 1.575 . . . . 4.2000000000000002 111.175 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.7 -10.92 30.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 4.2300000000000004 111.168 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -156.97 -176.54 6.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.168 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -79.7 -26.55 40.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 4.2999999999999998 111.212 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.04 -22.08 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 4.3300000000000001 111.138 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.11 -15.91 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.3700000000000001 111.259 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.519 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.7 mt -66.95 -51.35 38.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 4.4000000000000004 111.142 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 96.1 Cg_endo -75.73 -22.5 13.52 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.72 1.613 . . . . 4.4299999999999997 111.193 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.56 89.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 4.4699999999999998 111.232 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.92 -38.21 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 4.5 111.219 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -46.68 -47.83 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.204 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -49.35 76.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 4.5700000000000003 111.19 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.88 -30.09 70.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 4.5999999999999996 111.147 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.2 mt -79.46 -36.1 39.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 4.6299999999999999 111.245 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.84 -20.06 64.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 4.6699999999999999 111.163 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.89 68.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 4.7000000000000002 111.24 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -107.0 8.47 30.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 4.7300000000000004 111.219 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.58 60.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.178 -0.769 . . . . 4.7699999999999996 111.178 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 72.9 mmtt -109.94 -174.15 2.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 4.7999999999999998 111.191 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.4 t -151.89 163.62 38.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 4.8300000000000001 111.178 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 224' ' ' MET . . . -66.42 -57.77 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 4.8700000000000001 111.177 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.0 pp -164.95 164.93 20.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 4.9000000000000004 111.191 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.2 mmt -110.37 100.02 8.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 4.9299999999999997 111.147 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.88 130.01 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 4.9699999999999998 111.215 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -70.27 111.93 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 5.0 111.2 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.76 7.55 44.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 5.0300000000000002 111.217 -170.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -109.83 -48.11 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 5.0700000000000003 111.263 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.7 121.22 81.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 5.0999999999999996 111.208 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.0 -31.26 8.18 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.717 1.611 . . . . 5.1299999999999999 111.224 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -73.82 -33.59 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 5.1699999999999999 111.167 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -53.03 -37.1 61.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 5.2000000000000002 111.168 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.7 p -99.06 15.31 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 5.2300000000000004 111.199 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.518 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 91.0 t90 -66.78 -46.63 55.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 5.2699999999999996 111.254 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 41.7 Cg_endo -87.94 -4.05 7.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.676 1.584 . . . . 5.2999999999999998 111.203 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.46 -51.46 68.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 5.3300000000000001 111.215 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.33 -31.42 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 5.3700000000000001 111.2 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.4 -35.15 79.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 5.4000000000000004 111.164 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.23 80.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 5.4299999999999997 111.197 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.48 -43.46 90.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.204 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.82 26.2 4.83 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.197 -0.761 . . . . 5.5 111.197 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.95 -31.69 4.67 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.257 -0.737 . . . . 5.5300000000000002 111.257 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.75 110.01 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 5.5700000000000003 111.241 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.29 35.82 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 5.5999999999999996 111.159 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -120.14 141.43 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 5.6299999999999999 111.133 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -70.06 128.17 35.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 5.6699999999999999 111.219 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -100.0 89.26 3.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 5.7000000000000002 111.216 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -152.14 95.07 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 5.7300000000000004 111.199 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 73.26 -67.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 5.7699999999999996 111.179 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.92 25.0 0.07 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.246 -0.742 . . . . 5.7999999999999998 111.246 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -107.92 120.01 41.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.331 . . . . 5.8300000000000001 111.153 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -122.24 88.08 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 5.8700000000000001 111.175 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -86.49 128.66 34.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 5.9000000000000004 111.159 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 pt -72.33 -17.0 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 5.9299999999999997 111.192 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.23 -20.02 52.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 5.9699999999999998 111.196 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.75 174.42 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 6.0 111.165 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.33 152.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 6.0300000000000002 111.185 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.87 22.01 36.6 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.177 -0.769 . . . . 6.0700000000000003 111.177 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.9 p -71.04 -20.02 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 6.0999999999999996 111.25 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -113.79 22.56 13.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 6.1299999999999999 111.232 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.17 117.73 29.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 6.1699999999999999 111.196 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.91 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 6.2000000000000002 111.161 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.94 76.81 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.209 -0.756 . . . . 6.2300000000000004 111.209 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.58 80.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 6.2699999999999996 111.172 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.42 -39.05 93.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 6.2999999999999998 111.217 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 6.3300000000000001 111.207 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.84 -44.67 94.35 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.162 -0.775 . . . . 6.3700000000000001 111.162 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.506 ' O ' HD21 ' A' ' 192' ' ' LEU . 0.7 OUTLIER -65.76 -37.33 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 6.4000000000000004 111.234 176.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.8 m -61.14 -44.01 98.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 6.4299999999999997 111.173 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -55.66 -46.03 77.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 6.4699999999999998 111.205 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.88 -52.12 66.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 6.5 111.268 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.07 -21.14 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 6.5300000000000002 111.253 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.86 -40.18 79.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 6.5700000000000003 111.242 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.04 -35.61 81.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 6.5999999999999996 111.177 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.28 -52.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.195 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.58 -43.03 99.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 6.6699999999999999 111.231 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -79.94 -10.14 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 6.7000000000000002 111.149 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 59.83 58.46 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 6.7300000000000004 111.182 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -81.17 -22.57 38.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 6.7699999999999996 111.219 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.98 170.75 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.207 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -92.74 161.98 14.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 6.8300000000000001 111.197 -174.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.86 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 6.8700000000000001 111.238 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.01 -30.06 67.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 6.9000000000000004 111.18 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.8 m -51.77 130.78 29.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.206 175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -157.49 176.72 12.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 6.9699999999999998 111.197 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -64.04 -21.2 66.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 7.0 111.175 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.0 p -69.7 -25.6 63.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 7.0300000000000002 111.226 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.52 -32.27 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 7.0700000000000003 111.19 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 225' ' ' THR . . . -61.04 -44.69 97.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 7.0999999999999996 111.202 177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.97 -39.55 93.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 7.1299999999999999 111.207 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.12 -47.19 86.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.219 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.94 63.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 7.2000000000000002 111.211 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.64 -38.89 92.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 7.2300000000000004 111.183 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -93.33 -39.69 10.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 7.2699999999999996 111.175 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.52 -23.06 59.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 7.2999999999999998 111.218 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.35 51.23 6.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.229 -0.748 . . . . 7.3300000000000001 111.229 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.92 3.25 25.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 7.3700000000000001 111.227 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 154.04 36.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 7.4000000000000004 111.241 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.57 -29.87 18.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 7.4299999999999997 111.212 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 21.6 ptt? -152.3 170.0 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 7.4699999999999998 111.185 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 213' ' ' ALA . 12.3 t -170.18 152.82 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 7.5 111.161 170.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 94.0 mt -91.89 120.07 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 7.5300000000000002 111.236 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -160.8 -172.12 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 7.5700000000000003 111.167 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -120.36 -165.09 12.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.165 -0.774 . . . . 7.5999999999999996 111.165 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.13 64.65 8.39 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.708 1.606 . . . . 7.6299999999999999 111.245 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -125.41 -30.07 3.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 7.6699999999999999 111.224 171.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.19 -5.22 30.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 7.7000000000000002 111.246 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -76.91 -19.15 57.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 7.7300000000000004 111.175 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 95.5 p -72.85 -10.06 59.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 7.7699999999999996 111.196 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.445 ' HA ' ' HB ' ' A' ' 237' ' ' THR . 65.8 m-80 -95.01 5.41 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 7.7999999999999998 111.187 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.9 -51.29 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 7.8300000000000001 111.198 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -77.39 -25.32 50.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 7.8700000000000001 111.199 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.445 ' HB ' ' HA ' ' A' ' 234' ' ' ASN . 87.5 m -64.99 -45.95 83.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 7.9000000000000004 111.227 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 85.2 p -82.58 -14.72 54.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 7.9299999999999997 111.259 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 59.57 45.4 13.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 7.9699999999999998 111.18 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 73.6 t -128.03 142.82 42.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 8.0 111.207 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -74.75 112.57 11.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 8.0299999999999994 111.222 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -112.84 143.04 44.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 8.0700000000000003 111.177 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -118.58 167.47 13.04 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.147 -0.781 . . . . 8.0999999999999996 111.147 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.65 160.75 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 8.1300000000000008 111.17 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -135.76 -176.65 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 8.1699999999999999 111.201 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.01 120.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 8.1999999999999993 111.206 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.609 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . 91.5 mt -87.8 -42.2 0.5 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.134 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 247' ' ' LEU . 78.2 Cg_exo -53.22 112.42 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.695 1.597 . . . . 8.2699999999999996 111.156 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 88.0 m -124.48 112.11 16.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 8.3000000000000007 111.168 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -110.01 128.75 55.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 8.3300000000000001 111.126 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 85.1 tttt 45.17 46.04 9.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 8.3699999999999992 111.176 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.9 14.49 78.48 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.205 -0.758 . . . . 8.4000000000000004 111.205 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -129.98 109.99 16.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.181 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.8 130.63 38.24 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.746 1.631 . . . . 8.4700000000000006 111.187 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.6 t -105.1 -99.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 8.5 111.126 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 73.6 mmtt -136.87 151.94 73.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 8.5299999999999994 111.223 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 48.6 Cg_exo -60.4 144.57 99.52 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.737 1.624 . . . . 8.5700000000000003 111.181 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -92.96 148.31 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 8.5999999999999996 111.162 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.35 126.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 8.6300000000000008 111.213 -175.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -85.83 162.83 36.1 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -129.28 136.41 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 8.6999999999999993 111.141 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 67.1 mt -109.82 148.74 30.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 8.7300000000000004 111.165 172.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -161.63 169.98 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 8.7699999999999996 111.234 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.15 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 8.8000000000000007 111.162 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.46 179.66 16.41 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.226 -0.749 . . . . 8.8300000000000001 111.226 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.3 mt -100.98 136.01 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 8.8699999999999992 111.194 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.91 124.72 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 8.9000000000000004 111.167 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.13 -22.42 66.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 8.9299999999999997 111.231 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -5.51 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 8.9700000000000006 111.237 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -79.48 129.88 70.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 9.0 111.2 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.52 -3.33 13.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.708 1.605 . . . . 9.0299999999999994 111.233 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -120.01 60.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 9.0700000000000003 111.263 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -75.85 -30.38 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 9.0999999999999996 111.183 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -68.06 -46.46 71.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 9.1300000000000008 111.223 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 64.3 tp -62.76 -44.13 97.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 9.1699999999999999 111.18 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.29 98.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 9.1999999999999993 111.128 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -63.25 -40.22 96.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 9.2300000000000004 111.183 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.68 -54.78 42.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 9.2699999999999996 111.222 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -52.28 -50.0 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 9.3000000000000007 111.275 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.63 -43.6 93.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 9.3300000000000001 111.219 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -83.41 -61.76 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 9.3699999999999992 111.232 -168.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -92.98 -8.56 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 9.4000000000000004 111.262 -162.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.0 -50.09 2.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 9.4299999999999997 111.231 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.0 tp -78.42 -60.0 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 9.4700000000000006 111.163 -174.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 285' ' ' LEU . 3.8 mm? -75.2 69.93 2.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 9.5 111.177 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 29.5 p -136.86 178.02 7.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 9.5299999999999994 111.14 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.18 -25.75 68.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 9.5700000000000003 111.202 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -98.49 -34.59 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.5999999999999996 111.221 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.91 -48.71 59.27 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.35 -45.37 84.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 9.6699999999999999 111.186 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.32 -46.12 91.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 9.6999999999999993 111.217 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.64 74.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 9.7300000000000004 111.136 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.79 -40.65 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 9.7699999999999996 111.204 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.22 0.67 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 9.8000000000000007 111.281 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.89 -35.93 82.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 9.8300000000000001 111.152 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.2 -28.33 9.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 9.8699999999999992 111.177 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.45 164.06 19.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 9.9000000000000004 111.19 -176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.97 139.95 79.5 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.702 1.601 . . . . 9.9299999999999997 111.206 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 98.7 mt -70.12 -18.6 63.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.166 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.01 -26.53 71.44 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.197 -0.761 . . . . 10.0 111.197 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -60.13 127.09 30.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 10.029999999999999 111.189 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.9 134.25 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 10.07 111.193 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -114.42 -27.18 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 10.1 111.168 164.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.19 144.99 27.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 10.130000000000001 111.162 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -65.55 -47.35 76.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 10.17 111.224 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.8 m -62.67 -40.05 95.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 10.199999999999999 111.204 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -65.17 -40.37 94.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 10.23 111.226 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -60.75 -33.39 72.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 10.27 111.238 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.12 -33.11 71.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 10.300000000000001 111.174 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -70.31 -29.9 66.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 10.33 111.188 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.15 -29.84 61.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 10.369999999999999 111.169 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.01 73.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 10.4 111.189 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.33 -34.36 68.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 10.43 111.166 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.02 118.35 48.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 10.470000000000001 111.159 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.7 -35.51 93.34 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.744 1.629 . . . . 10.5 111.153 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -79.98 -52.58 7.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 10.529999999999999 111.156 -172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.414 HG22 ' HG2' ' A' ' 321' ' ' MET . 50.4 mm -79.17 -27.34 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 10.57 111.163 -170.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.31 -36.72 33.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 10.6 111.172 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.15 95.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.188 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.8 m -69.95 -39.85 75.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 10.67 111.107 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.414 ' HG2' HG22 ' A' ' 317' ' ' ILE . 38.8 mmt -68.37 -35.42 77.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 10.699999999999999 111.233 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.53 -42.4 87.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 10.73 111.233 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -64.91 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 10.77 111.238 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 10.800000000000001 111.232 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.49 -42.77 99.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.83 111.271 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.04 -9.83 38.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 10.869999999999999 111.262 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.97 -165.16 35.45 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.23 164.31 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 10.93 111.17 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.4 pt -111.32 162.87 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 10.970000000000001 111.214 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -84.95 164.72 40.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 11.0 111.18 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.06 138.53 82.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.72 1.614 . . . . 11.029999999999999 111.182 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -107.51 28.27 8.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 11.07 111.221 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 335' ' ' GLN . 89.3 mt -90.62 125.26 60.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 11.1 111.202 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.49 -24.36 31.01 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.736 1.624 . . . . 11.130000000000001 111.183 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.413 ' H ' HG22 ' A' ' 333' ' ' ILE . 61.7 mt-30 -80.57 -1.46 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 11.17 111.129 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.1 mmm -95.16 6.9 47.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 11.199999999999999 111.164 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.4 p -64.55 -33.78 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 11.23 111.133 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.29 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 11.27 111.163 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -60.98 -47.59 85.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 11.300000000000001 111.172 175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.38 -49.06 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 11.33 111.219 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.36 -47.01 65.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.172 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.37 86.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.244 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.97 -46.38 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 11.43 111.192 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.75 -44.85 70.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 11.470000000000001 111.233 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.8 m -65.21 -40.56 94.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.203 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.76 -34.08 77.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 11.529999999999999 111.174 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.82 -48.9 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 11.57 111.167 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 8.9 tp -74.88 -25.18 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 11.6 111.201 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.76 -48.29 55.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 11.630000000000001 111.219 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.64 76.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 11.67 111.208 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.07 87.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.175 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 11.73 111.161 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.34 27.02 8.92 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.216 -0.754 . . . . 11.77 111.216 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -82.75 -35.08 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 11.800000000000001 111.23 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -151.38 174.77 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 11.83 111.135 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -85.0 171.97 11.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 11.869999999999999 111.177 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -72.19 -24.16 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 11.9 111.237 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.01 -47.89 60.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 11.93 111.161 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -68.5 -28.45 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 11.970000000000001 111.162 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.13 -51.33 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 12.0 111.208 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.29 -20.35 48.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 12.029999999999999 111.205 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.86 -52.42 56.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 12.07 111.151 171.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.84 -37.4 86.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.429 . . . . 12.1 111.246 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.45 81.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 12.130000000000001 111.212 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -55.31 -44.5 75.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 12.17 111.208 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.8 m -59.31 -44.54 92.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 12.199999999999999 111.237 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.85 -30.13 67.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 12.23 111.151 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 86.8 mt -69.06 -41.09 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 12.27 111.22 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.9 p -86.8 -15.08 40.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 12.300000000000001 111.258 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.508 0 CA-C-N 116.148 -0.478 . . . . 12.33 111.209 177.728 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.762 0.315 . . . . 0.029999999999999999 111.191 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt -116.27 125.57 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.070000000000000007 111.175 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.0 144.93 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.10000000000000001 111.199 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.04 129.94 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.13 111.211 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.02 19.56 21.24 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.153 -0.779 . . . . 0.17000000000000001 111.153 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -140.16 146.61 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.20000000000000001 111.196 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt -112.29 140.75 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.23000000000000001 111.264 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.84 118.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.27000000000000002 111.218 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.467 HG12 ' HB ' ' A' ' 59' ' ' ILE . 89.5 mt -107.88 123.9 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.29999999999999999 111.213 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -110.09 130.66 55.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.33000000000000002 111.201 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.42 120.09 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.37 111.231 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.58 125.35 26.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.40000000000000002 111.156 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.15 -170.83 40.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.151 -0.78 . . . . 0.42999999999999999 111.151 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.04 -51.9 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.46999999999999997 111.157 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.73 158.8 42.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.5 111.254 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.99 -8.87 4.82 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.229 -0.748 . . . . 0.53000000000000003 111.229 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -64.93 -24.56 67.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 111.257 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.54 -42.73 70.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.59999999999999998 111.219 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.58 -40.41 97.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.155 -0.778 . . . . 0.63 111.155 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.17 -23.61 51.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.328 . . . . 0.67000000000000004 111.183 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -33.4 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.147 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.77 -42.85 97.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.164 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.93 -25.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.77000000000000002 111.184 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -33.52 87.45 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.13 -0.788 . . . . 0.80000000000000004 111.13 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.61 -43.91 92.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.82999999999999996 111.151 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.97 -35.98 76.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.87 111.222 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.08 -42.73 93.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.90000000000000002 111.172 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.59 -35.76 81.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.93000000000000005 111.234 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -64.35 -30.05 71.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.96999999999999997 111.182 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -99.89 -34.7 10.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.252 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -107.05 -29.03 9.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 1.03 111.239 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.95 6.55 75.56 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.186 -0.766 . . . . 1.0700000000000001 111.186 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.7 mm -89.22 127.86 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 1.1000000000000001 111.176 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.6 134.33 33.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.1299999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -115.49 124.44 71.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 1.1699999999999999 111.265 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -115.69 125.97 53.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 1.2 111.249 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.19 131.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.23 111.198 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -128.84 156.12 44.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 1.27 111.208 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -111.49 85.64 6.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 1.3 111.178 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 147.51 45.91 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.713 1.608 . . . . 1.3300000000000001 111.19 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -137.03 5.23 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 1.3700000000000001 111.182 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -124.96 35.05 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 1.3999999999999999 111.16 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.98 -35.15 74.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 1.4299999999999999 111.199 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.3 -40.04 64.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.47 111.199 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -84.66 -26.94 27.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 1.5 111.144 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.02 -19.81 43.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.217 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.453 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.2 m-30 -55.04 -57.43 19.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 1.5700000000000001 111.231 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 72.8 Cg_endo -72.96 -23.33 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.732 1.621 . . . . 1.6000000000000001 111.16 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -67.7 -36.4 80.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.302 -0.408 . . . . 1.6299999999999999 111.162 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.8 m -100.02 -28.08 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 1.6699999999999999 111.183 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 1.7 111.229 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -15.89 60.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 1.73 111.2 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 p -109.88 -18.39 13.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 1.77 111.145 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.96 42.52 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.214 -0.754 . . . . 1.8 111.214 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -111.22 -175.0 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.8300000000000001 111.154 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.07 -172.15 25.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.172 -0.771 . . . . 1.8700000000000001 111.172 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.0 -176.49 2.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.666 1.578 . . . . 1.8999999999999999 111.212 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -99.27 -48.03 4.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 1.9299999999999999 111.211 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.467 ' HB ' HG12 ' A' ' 9' ' ' ILE . 83.4 mt -117.93 134.96 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 1.97 111.195 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -121.72 137.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 2.0 111.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -105.39 137.95 42.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 2.0299999999999998 111.206 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.99 163.38 18.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 2.0699999999999998 111.173 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.22 165.93 12.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 2.1000000000000001 111.173 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -53.96 -33.52 57.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.1299999999999999 111.197 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -102.51 16.27 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 2.1699999999999999 111.206 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -110.01 -0.02 18.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 2.2000000000000002 111.165 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -69.97 -27.55 64.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 2.23 111.225 -170.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.7 -39.74 61.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 2.27 111.218 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -30.82 78.77 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.178 -0.769 . . . . 2.2999999999999998 111.178 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.64 -37.07 11.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.24 -174.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.08 64.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 2.3700000000000001 111.174 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -84.51 -28.23 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 2.3999999999999999 111.195 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 -15.62 56.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.4300000000000002 111.249 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 31.55 30.28 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.229 -0.748 . . . . 2.4700000000000002 111.229 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -118.65 33.73 5.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 2.5 111.211 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.0 tp -152.37 125.16 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 2.5299999999999998 111.158 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.68 157.67 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 2.5699999999999998 111.22 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.87 80.01 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 2.6000000000000001 111.21 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.57 114.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 2.6299999999999999 111.258 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 103' ' ' LEU . 53.0 m -100.9 121.58 51.9 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 2.6699999999999999 111.219 -168.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.45 ' HB3' ' CD2' ' A' ' 106' ' ' TYR . 58.1 Cg_endo -67.43 125.27 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.18 173.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -85.03 -168.28 2.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 2.73 111.176 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.89 -32.86 71.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 2.77 111.181 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.61 -35.05 76.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 2.7999999999999998 111.168 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.93 -24.82 21.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 2.8300000000000001 111.201 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.69 -35.03 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.8700000000000001 111.158 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -89.25 -34.96 16.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 2.8999999999999999 111.202 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -81.03 -30.08 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 2.9300000000000002 111.175 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -104.56 166.11 10.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 2.9700000000000002 111.249 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.448 ' CE2' ' HA ' ' A' ' 303' ' ' ALA . 19.7 m-85 -60.14 138.14 91.33 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 3.0 111.228 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.31 -13.56 28.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.687 1.591 . . . . 3.0299999999999998 111.214 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.71 -21.98 24.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 3.0699999999999998 111.164 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.409 ' HA ' ' HB1' ' A' ' 96' ' ' ALA . 69.6 p -107.37 -19.74 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 3.1000000000000001 111.185 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -60.14 -42.63 95.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 3.1299999999999999 111.188 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.98 -15.55 29.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 3.1699999999999999 111.137 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 93' ' ' THR . . . -86.28 13.31 8.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 3.2000000000000002 111.2 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.2 m -120.19 71.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 3.23 111.24 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -141.33 139.15 33.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 3.27 111.163 -158.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -162.44 139.85 8.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 3.2999999999999998 111.175 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 65.8 30.55 10.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 3.3300000000000001 111.186 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.72 86.78 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.149 -0.78 . . . . 3.3700000000000001 111.149 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.15 155.68 48.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.821 0.343 . . . . 3.3999999999999999 111.216 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.408 ' HB2' HG21 ' A' ' 80' ' ' THR . 90.1 mt -79.06 142.43 36.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 3.4300000000000002 111.151 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 pt -124.93 -5.01 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 3.4700000000000002 111.226 -162.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.14 160.41 39.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 3.5 111.244 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.45 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 86.9 m-85 -99.09 125.07 42.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 3.5299999999999998 111.139 166.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.66 131.16 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.702 1.601 . . . . 3.5699999999999998 111.135 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.401 HG12 HD22 ' A' ' 285' ' ' LEU . 83.9 mt -108.24 -55.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 3.6000000000000001 111.18 -169.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.77 156.36 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 3.6299999999999999 111.206 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.04 161.01 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 3.6699999999999999 111.161 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -149.31 110.57 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 3.7000000000000002 111.132 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.44 135.85 44.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 3.73 111.227 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.13 145.07 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 3.77 111.164 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 99.0 p -150.15 169.4 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 3.7999999999999998 111.199 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -115.13 130.21 56.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 3.8300000000000001 111.221 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.75 147.79 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 3.8700000000000001 111.23 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -138.19 159.03 43.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 3.8999999999999999 111.132 167.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 122' ' ' LEU . 34.4 t-20 -107.85 104.75 14.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 3.9300000000000002 111.257 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.447 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.0 mttt -57.67 -34.8 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 3.9700000000000002 111.203 -174.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.34 -47.72 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 4.0 111.227 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.21 -58.46 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 4.0300000000000002 111.288 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 118' ' ' ASN . 68.2 mt -125.04 76.26 67.23 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 4.0700000000000003 111.285 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.43 -17.61 39.0 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.691 1.594 . . . . 4.0999999999999996 111.224 -174.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 60.1 t-20 -97.81 104.84 23.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 4.1299999999999999 111.198 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.5 Cg_endo -70.18 155.47 64.48 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.635 1.557 . . . . 4.1699999999999999 111.241 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.38 144.22 60.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 4.2000000000000002 111.238 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.18 -19.88 31.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 4.2300000000000004 111.215 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -150.07 -177.33 5.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 4.2699999999999996 111.238 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -64.58 -41.73 96.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 4.2999999999999998 111.212 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.27 -23.1 66.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 4.3300000000000001 111.185 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -87.71 -15.34 37.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 4.3700000000000001 111.174 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.495 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 82.7 mt -68.94 -50.48 22.12 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 4.4000000000000004 111.179 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.495 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 92.1 Cg_endo -75.93 -18.98 16.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.661 1.574 . . . . 4.4299999999999997 111.199 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.0 85.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 4.4699999999999998 111.201 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.75 -28.65 60.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 4.5 111.214 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.62 -42.51 98.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 4.5300000000000002 111.179 173.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.78 -48.1 72.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 4.5700000000000003 111.201 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -61.84 -40.98 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 4.5999999999999996 111.191 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.403 HD22 ' HB1' ' A' ' 223' ' ' ALA . 26.0 tp -72.25 -31.78 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 4.6299999999999999 111.215 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.73 -39.52 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 4.6699999999999999 111.158 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.76 71.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 4.7000000000000002 111.228 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.89 -14.86 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.488 . . . . 4.7300000000000004 111.222 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.13 16.49 18.64 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.277 -0.729 . . . . 4.7699999999999996 111.277 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -134.26 154.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 4.7999999999999998 111.212 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.5 t -100.96 146.92 26.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 4.8300000000000001 111.225 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -112.73 -20.61 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 4.8700000000000001 111.205 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.7 tp -125.58 114.57 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 4.9000000000000004 111.17 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.428 ' SD ' ' OG1' ' A' ' 222' ' ' THR . 97.9 mtp -145.0 110.08 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 4.9299999999999997 111.22 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -101.21 -179.97 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 4.9699999999999998 111.186 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -96.06 105.26 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 5.0 111.216 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 151' ' ' LEU . 3.2 mm? -89.21 9.38 25.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 5.0300000000000002 111.209 -173.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -110.64 -9.98 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 5.0700000000000003 111.234 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -144.6 113.28 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 5.0999999999999996 111.193 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.12 -33.56 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.719 1.613 . . . . 5.1299999999999999 111.221 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -55.24 -33.03 62.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 5.1699999999999999 111.197 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -104.99 25.57 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 5.2000000000000002 111.22 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.8 p -121.97 -14.38 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 5.2300000000000004 111.141 166.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.593 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 88.7 t90 -66.12 -40.1 34.04 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 5.2699999999999996 111.192 176.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 74.4 Cg_exo -55.45 -19.54 23.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.758 1.639 . . . . 5.2999999999999998 111.201 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.4 tp -42.77 -51.54 5.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 5.3300000000000001 111.223 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 47.7 pt -86.19 -9.99 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 5.3700000000000001 111.169 -173.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.94 -25.78 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 5.4000000000000004 111.173 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.95 98.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 5.4299999999999997 111.225 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -95.69 9.83 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.216 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.21 29.6 73.34 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.177 -0.769 . . . . 5.5 111.177 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.89 -37.89 28.41 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -71.79 131.64 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 5.5700000000000003 111.179 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 55.02 55.29 7.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 5.5999999999999996 111.202 168.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -127.38 162.45 26.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.428 . . . . 5.6299999999999999 111.223 165.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -125.33 147.55 49.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 5.6699999999999999 111.237 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -164.82 136.66 4.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 5.7000000000000002 111.191 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -149.88 90.05 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 5.7300000000000004 111.165 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 53.87 40.37 31.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 5.7699999999999996 111.15 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.61 -26.04 22.54 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.153 -0.779 . . . . 5.7999999999999998 111.153 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.03 -180.0 7.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 5.8300000000000001 111.208 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.54 103.35 8.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 5.8700000000000001 111.237 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -99.83 114.09 27.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 5.9000000000000004 111.169 -175.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.39 -18.62 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 5.9299999999999997 111.2 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 5.9699999999999998 111.217 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.3 141.76 58.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 6.0 111.161 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.85 173.45 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 6.0300000000000002 111.177 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -83.8 9.0 63.87 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.242 -0.743 . . . . 6.0700000000000003 111.242 -168.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.28 -2.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 6.0999999999999996 111.187 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -131.33 10.03 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 6.1299999999999999 111.199 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.08 139.46 36.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 6.1699999999999999 111.164 174.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.66 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 6.2000000000000002 111.179 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.64 93.54 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.761 . . . . 6.2300000000000004 111.199 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.23 92.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 6.2699999999999996 111.247 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.1 -47.3 62.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 6.2999999999999998 111.22 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.27 92.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 6.3300000000000001 111.239 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -46.73 88.46 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.245 -0.742 . . . . 6.3700000000000001 111.245 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.17 -43.46 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 6.4000000000000004 111.197 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -50.95 -29.29 11.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 6.4299999999999997 111.172 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -53.29 -60.62 3.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 6.4699999999999998 111.17 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.9 mt -78.48 -25.36 45.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 6.5 111.234 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.59 -47.37 85.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 6.5300000000000002 111.243 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -75.01 -35.44 61.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 6.5700000000000003 111.222 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 204' ' ' MET . 5.1 mp -75.76 -18.97 59.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 6.5999999999999996 111.197 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 93.8 mt -91.71 -40.6 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 6.6299999999999999 111.213 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.78 -38.09 77.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 6.6699999999999999 111.22 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.96 13.57 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 6.7000000000000002 111.146 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 56.94 46.19 19.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 6.7300000000000004 111.193 172.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -94.98 -49.91 5.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 6.7699999999999996 111.26 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.469 ' HG2' ' HB3' ' A' ' 198' ' ' LEU . 97.5 mmm -74.31 144.99 44.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 6.7999999999999998 111.224 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -86.56 114.57 23.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 6.8300000000000001 111.164 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.58 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.8700000000000001 111.22 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.28 -30.3 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 6.9000000000000004 111.175 -176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 m -64.97 128.96 37.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.262 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.06 -166.76 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 6.9699999999999998 111.189 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -69.92 -48.81 57.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 7.0 111.122 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -67.49 -29.84 69.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 7.0300000000000002 111.21 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.7 mt -66.96 -44.94 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 7.0700000000000003 111.194 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.36 93.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.141 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.92 -40.04 40.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 7.1299999999999999 111.138 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.0 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.208 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.04 -9.12 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 7.2000000000000002 111.214 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.53 -25.02 56.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 7.2300000000000004 111.205 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -89.39 -24.04 22.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 7.2699999999999996 111.171 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.01 -25.42 32.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 7.2999999999999998 111.148 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.26 29.13 28.62 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.277 -0.729 . . . . 7.3300000000000001 111.277 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.55 -19.13 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 7.3700000000000001 111.233 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.428 ' OG1' ' SD ' ' A' ' 148' ' ' MET . 96.9 m -119.59 127.59 53.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 7.4000000000000004 111.142 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.403 ' HB1' HD22 ' A' ' 139' ' ' LEU . . . -93.51 -31.22 14.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 7.4299999999999997 111.135 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 17.2 ptp -157.46 159.68 37.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 7.4699999999999998 111.183 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.0 t -160.39 -173.17 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 7.5 111.181 170.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.62 122.27 58.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 7.5300000000000002 111.207 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -166.79 -178.99 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 7.5700000000000003 111.279 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.52 -165.23 41.07 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.407 ' HA ' ' CH2' ' A' ' 232' ' ' TRP . 60.3 Cg_endo -75.44 79.61 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.669 1.579 . . . . 7.6299999999999999 111.153 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -175.02 -22.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.428 . . . . 7.6699999999999999 111.231 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.75 -47.52 66.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 7.7000000000000002 111.177 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.407 ' CH2' ' HA ' ' A' ' 229' ' ' PRO . 41.2 p90 -86.33 2.17 48.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 7.7300000000000004 111.156 -170.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.3 p -84.51 -9.44 58.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 7.7699999999999996 111.188 171.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -94.85 -7.16 41.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 7.7999999999999998 111.213 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.89 -24.31 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 7.8300000000000001 111.191 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -30.9 29.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 7.8700000000000001 111.189 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.4 m -62.29 -40.12 95.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 7.9000000000000004 111.205 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 49.5 m -71.35 -24.73 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 7.9299999999999997 111.226 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 63.12 54.47 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 7.9699999999999998 111.188 174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.66 167.47 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 8.0 111.196 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -81.09 126.41 31.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 8.0299999999999994 111.266 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.447 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 53.4 p90 -145.85 164.44 31.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 8.0700000000000003 111.193 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.41 -179.38 30.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.148 -0.781 . . . . 8.0999999999999996 111.148 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.61 140.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 8.1300000000000008 111.158 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -138.18 -174.84 3.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 8.1699999999999999 111.258 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.4 ' HB ' ' HD3' ' A' ' 248' ' ' PRO . 35.7 m -121.26 159.16 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 8.1999999999999993 111.13 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.503 ' N ' HD21 ' A' ' 247' ' ' LEU . 2.4 pt? -139.93 50.01 2.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 8.2300000000000004 111.197 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 74.0 Cg_endo -73.13 149.97 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.714 1.609 . . . . 8.2699999999999996 111.184 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.9 m -148.66 117.76 6.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 8.3000000000000007 111.254 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -105.46 85.24 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 8.3300000000000001 111.152 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 86.5 mttt 57.02 35.35 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 8.3699999999999992 111.206 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.34 -14.05 28.07 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.261 -0.736 . . . . 8.4000000000000004 111.261 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.42 ' HA ' ' HD2' ' A' ' 254' ' ' PRO . 60.3 tp60 -117.92 109.98 40.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 8.4299999999999997 111.217 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 253' ' ' GLN . 58.4 Cg_endo -69.17 139.01 41.13 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.66 1.573 . . . . 8.4700000000000006 111.253 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.9 t -139.99 -75.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 8.5 111.29 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.44 ' HB3' ' HA2' ' A' ' 327' ' ' GLY . 70.1 mmtt -144.41 146.21 31.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 8.5299999999999994 111.201 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 165.97 30.6 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.742 1.628 . . . . 8.5700000000000003 111.223 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.16 139.21 44.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 8.5999999999999996 111.229 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.94 115.28 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 8.6300000000000008 111.213 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.68 151.38 32.28 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.2 -0.76 . . . . 8.6699999999999999 111.2 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.65 133.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 8.6999999999999993 111.148 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 50.0 tp -102.53 134.3 46.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 8.7300000000000004 111.141 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 98.6 p -132.99 173.78 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 8.7699999999999996 111.219 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.31 40.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 8.8000000000000007 111.211 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -157.74 -173.05 25.66 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.224 -0.751 . . . . 8.8300000000000001 111.224 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -102.41 127.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 8.8699999999999992 111.187 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.15 135.66 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 8.9000000000000004 111.211 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.27 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 8.9299999999999997 111.206 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -99.42 19.54 15.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 8.9700000000000006 111.267 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 16.5 t -69.78 121.55 82.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 9.0 111.207 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 -26.47 19.09 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.648 1.565 . . . . 9.0299999999999994 111.162 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -119.62 62.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.0700000000000003 111.219 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -65.08 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 9.0999999999999996 111.177 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.51 -49.2 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 9.1300000000000008 111.219 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 99.5 mt -68.52 -34.75 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 9.1699999999999999 111.228 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.54 99.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 9.1999999999999993 111.237 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -47.94 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 9.2300000000000004 111.183 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.95 -40.1 95.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.259 -0.428 . . . . 9.2699999999999996 111.163 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -59.8 -52.04 67.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 9.3000000000000007 111.138 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.08 -44.58 94.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 9.3300000000000001 111.191 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.57 -35.12 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 9.3699999999999992 111.18 -167.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -93.9 -23.2 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 9.4000000000000004 111.172 -170.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -122.66 -66.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 9.4299999999999997 111.224 -171.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 67.3 tp -50.41 -56.03 13.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 9.4700000000000006 111.192 -167.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.401 HD22 HG12 ' A' ' 108' ' ' ILE . 85.9 mt -104.0 38.35 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 9.5 111.192 -175.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.5 p -119.14 -165.73 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 9.5299999999999994 111.259 167.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.84 -10.87 60.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 9.5700000000000003 111.174 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -88.11 -54.41 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 9.5999999999999996 111.209 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.33 6.38 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.171 -0.772 . . . . 9.6300000000000008 111.171 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.13 -34.67 76.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 9.6699999999999999 111.189 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.55 -41.27 80.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 9.6999999999999993 111.216 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.32 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 9.7300000000000004 111.263 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.5 t -86.28 -40.3 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 9.7699999999999996 111.152 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.99 -23.62 63.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 9.8000000000000007 111.246 -172.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.71 -14.83 62.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 9.8300000000000001 111.175 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -111.16 -34.61 6.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 9.8699999999999992 111.164 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.98 162.67 20.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 9.9000000000000004 111.225 -174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.17 159.53 15.14 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.711 1.607 . . . . 9.9299999999999997 111.16 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.75 39.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 9.9700000000000006 111.241 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.06 -61.26 7.57 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.198 -0.761 . . . . 10.0 111.198 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.18 153.98 2.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 10.029999999999999 111.19 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.06 159.55 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 10.07 111.153 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 90' ' ' TYR . . . -83.84 -30.2 26.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 10.1 111.174 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -67.03 121.61 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 10.130000000000001 111.16 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -68.31 -17.49 64.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.194 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 t -58.33 -40.36 81.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 10.199999999999999 111.223 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -108.65 7.29 26.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 10.23 111.209 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -57.7 -50.0 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 10.27 111.199 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.58 -29.97 61.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 10.300000000000001 111.18 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.61 -37.06 84.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 10.33 111.219 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 9.8 mp -82.73 -37.51 24.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 10.369999999999999 111.196 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -77.99 -4.65 48.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 10.4 111.196 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.13 -41.58 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 10.43 111.151 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.27 120.71 70.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 10.470000000000001 111.168 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.13 -29.72 47.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.703 1.602 . . . . 10.5 111.255 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.22 -23.14 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 10.529999999999999 111.175 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.3 mt -98.65 -39.42 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 10.57 111.202 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.49 -34.23 70.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 10.6 111.19 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.68 62.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.630000000000001 111.202 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 94.4 m -95.23 -42.33 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.243 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.7 mtp -65.01 -41.94 94.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 10.699999999999999 111.18 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 10.73 111.183 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -76.97 -16.94 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 10.77 111.237 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.54 49.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 10.800000000000001 111.228 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -80.34 -19.93 45.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 10.83 111.235 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.43 -4.14 32.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 10.869999999999999 111.086 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 256' ' ' LYS . . . -87.83 -170.06 45.85 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -86.41 99.95 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 10.93 111.205 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.15 136.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 10.970000000000001 111.203 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.458 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 53.0 ttm -46.59 124.93 7.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 11.0 111.258 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 54.3 Cg_exo -60.28 155.58 45.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.705 1.603 . . . . 11.029999999999999 111.2 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -94.89 15.99 17.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 11.07 111.274 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 82.4 mt -80.49 125.04 81.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 11.1 111.253 -169.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.51 -40.36 79.09 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.747 1.631 . . . . 11.130000000000001 111.154 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.26 -38.97 93.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 11.17 111.24 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.437 ' HA ' ' HB2' ' A' ' 339' ' ' PHE . 96.0 mmm -75.13 -23.74 57.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 11.199999999999999 111.165 -175.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 41.6 t -62.64 -40.9 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 11.23 111.175 169.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.84 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 11.27 111.269 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.437 ' HB2' ' HA ' ' A' ' 336' ' ' MET . 26.1 m-85 -66.66 -27.38 67.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 11.300000000000001 111.235 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -54.36 -46.51 73.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 11.33 111.198 -173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -99.24 -23.0 15.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 11.369999999999999 111.213 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.57 91.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 11.4 111.214 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.58 -36.54 66.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 11.43 111.193 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.6 ttp180 -54.72 -45.1 74.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 11.470000000000001 111.208 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 95.6 m -61.66 -40.03 93.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 11.5 111.21 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.22 88.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.192 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.5 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 11.57 111.191 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.7 -48.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 11.6 111.135 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -69.03 -28.92 67.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 11.630000000000001 111.167 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.6 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 11.67 111.218 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.85 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 11.699999999999999 111.2 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -74.65 -17.41 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 11.73 111.182 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.76 26.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.231 -0.748 . . . . 11.77 111.231 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -99.99 -38.71 8.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 11.800000000000001 111.223 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -129.85 168.75 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 11.83 111.116 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 33.9 p -92.62 175.04 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 11.869999999999999 111.18 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.1 m -67.2 -14.36 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 11.9 111.19 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.69 -49.3 5.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 11.93 111.188 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.14 -39.34 75.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 11.970000000000001 111.169 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.81 96.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 12.0 111.228 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.84 -24.78 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 12.029999999999999 111.158 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.32 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 12.07 111.148 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -64.71 -39.63 93.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 12.1 111.169 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.4 80.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 12.130000000000001 111.18 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -71.95 -42.92 66.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 12.17 111.144 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.4 m -60.04 -36.91 78.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 12.199999999999999 111.159 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -80.13 -11.44 59.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 12.23 111.172 -173.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.3 mt -115.01 -66.81 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 12.27 111.211 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 370' ' ' LYS . 58.9 p -96.1 -20.42 18.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 12.300000000000001 111.213 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 369' ' ' THR . 98.6 mttt . . . . . 0 C--O 1.2 -1.545 0 CA-C-N 116.194 -0.457 . . . . 12.33 111.225 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.821 0.343 . . . . 0.029999999999999999 111.156 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm -88.26 110.18 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.070000000000000007 111.22 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.97 129.92 39.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.10000000000000001 111.178 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.2 139.96 58.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.13 111.23 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.58 2.29 57.57 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.17000000000000001 111.206 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.07 155.03 45.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.816 0.341 . . . . 0.20000000000000001 111.18 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.6 tp -104.18 115.05 29.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.23000000000000001 111.167 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -117.68 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.27000000000000002 111.196 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.21 114.97 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.29999999999999999 111.195 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -102.75 113.05 26.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.33000000000000002 111.249 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 4.6 tt -125.11 139.94 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.37 111.24 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -88.48 109.9 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.40000000000000002 111.178 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.4 47.82 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.213 -0.755 . . . . 0.42999999999999999 111.213 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -77.81 -69.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.46999999999999997 111.205 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -129.98 31.4 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.5 111.217 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.92 -19.68 69.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.239 -0.744 . . . . 0.53000000000000003 111.239 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -60.56 -24.37 65.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 0.56999999999999995 111.211 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -63.12 -49.95 72.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.59999999999999998 111.193 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.95 96.47 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.203 -0.759 . . . . 0.63 111.203 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.72 -31.48 66.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.818 0.342 . . . . 0.67000000000000004 111.22 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.12 91.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.69999999999999996 111.225 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.16 -35.02 74.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.72999999999999998 111.196 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 -41.25 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.77000000000000002 111.236 174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -27.93 69.31 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.14 -0.784 . . . . 0.80000000000000004 111.14 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.45 -33.99 74.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.826 0.346 . . . . 0.82999999999999996 111.206 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.25 -39.05 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.87 111.199 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -61.02 -42.38 98.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 111.166 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.27 -41.59 99.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.93000000000000005 111.21 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.01 -35.96 69.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.96999999999999997 111.216 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.07 -40.12 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.178 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.5 p -103.27 -27.21 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.226 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.85 4.8 78.54 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.219 -0.753 . . . . 1.0700000000000001 111.219 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.5 mm -87.34 115.0 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 1.1000000000000001 111.212 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.03 124.9 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 1.1299999999999999 111.204 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.15 136.01 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.1699999999999999 111.248 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.4 t -142.56 147.84 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 1.2 111.171 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.32 132.68 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 1.23 111.217 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -140.02 176.37 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 1.27 111.262 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -119.02 75.25 14.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.3 111.149 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.15 158.32 49.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.695 1.596 . . . . 1.3300000000000001 111.217 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -123.15 -179.99 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 1.3700000000000001 111.182 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 55.09 34.63 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 1.3999999999999999 111.195 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.9 mt -74.92 -22.97 58.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 1.4299999999999999 111.284 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -70.03 -12.06 61.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.47 111.235 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.28 -36.05 5.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 1.5 111.199 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -71.33 -38.66 71.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 1.53 111.147 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.495 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.4 m-30 -61.39 -56.28 35.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 1.5700000000000001 111.206 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -66.95 -23.63 46.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.81 1.674 . . . . 1.6000000000000001 111.204 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -70.07 -45.22 67.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 111.196 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.51 -19.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 1.6699999999999999 111.192 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.0 -25.76 68.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.7 111.207 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.11 60.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 1.73 111.216 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p -109.7 -15.21 14.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 1.77 111.175 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.44 23.6 28.49 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.13 -0.788 . . . . 1.8 111.13 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.13 170.08 8.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 1.8300000000000001 111.208 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.92 179.03 21.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.233 -0.747 . . . . 1.8700000000000001 111.233 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 -174.74 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.642 1.561 . . . . 1.8999999999999999 111.267 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.25 -51.39 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 1.9299999999999999 111.244 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.94 134.22 57.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 1.97 111.245 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -129.77 127.07 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 2.0 111.236 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 27.4 m-85 -98.75 127.64 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 2.0299999999999998 111.204 178.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -130.0 142.36 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 2.0699999999999998 111.118 169.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.06 145.0 56.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.218 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -46.61 -36.15 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 2.1299999999999999 111.258 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -81.66 -5.26 57.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 2.1699999999999999 111.211 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.64 -0.05 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 2.2000000000000002 111.206 174.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -65.02 -56.56 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 2.23 111.194 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.0 -33.52 74.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.185 -0.766 . . . . 2.27 111.185 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.34 -44.81 94.94 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.226 -0.749 . . . . 2.2999999999999998 111.226 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.01 -40.43 75.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.182 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.8 68.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 2.3700000000000001 111.183 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -60.39 -29.9 69.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 2.3999999999999999 111.205 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -68.12 -25.4 65.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 2.4300000000000002 111.193 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.37 32.38 22.72 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.19 -0.764 . . . . 2.4700000000000002 111.19 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -104.4 4.82 33.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 2.5 111.191 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.77 140.04 44.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 2.5299999999999998 111.191 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.71 154.51 20.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 2.5699999999999998 111.211 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -74.82 134.74 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 2.6000000000000001 111.205 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.05 130.02 63.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 2.6299999999999999 111.184 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.2 m -116.83 113.34 40.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 2.6699999999999999 111.253 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.52 156.7 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.637 1.558 . . . . 2.7000000000000002 111.186 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.21 155.65 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 2.73 111.214 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.15 -53.83 52.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 2.77 111.205 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.41 84.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.7999999999999998 111.163 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -54.87 -51.94 64.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 2.8300000000000001 111.214 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -55.9 -42.72 76.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 2.8700000000000001 111.167 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.6 -29.68 70.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 2.8999999999999999 111.199 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.26 -17.93 58.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 2.9300000000000002 111.205 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.5 mt -83.41 153.5 24.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.9700000000000002 111.191 172.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.35 148.73 97.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 3.0 111.199 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.96 -15.0 18.93 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.699 1.599 . . . . 3.0299999999999998 111.252 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -96.55 -21.01 17.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 3.0699999999999998 111.154 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -78.43 -14.83 59.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 3.1000000000000001 111.191 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.427 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 49.8 m0 -63.05 -45.49 92.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.476 . . . . 3.1299999999999999 111.254 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.4 -11.82 60.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 3.1699999999999999 111.15 -170.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.54 -1.98 57.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 3.2000000000000002 111.237 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.55 10.3 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 3.23 111.228 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 94' ' ' TRP . 71.6 mtp180 -87.63 144.75 26.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 3.27 111.196 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.4 t80 -142.25 123.61 14.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 3.2999999999999998 111.161 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 65.0 20.75 12.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 3.3300000000000001 111.222 -169.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.56 -2.71 74.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.245 -0.742 . . . . 3.3700000000000001 111.245 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -115.44 144.24 44.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 3.3999999999999999 111.229 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.95 126.14 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 3.4300000000000002 111.214 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.7 pt -130.12 14.96 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 3.4700000000000002 111.281 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.8 169.43 5.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 3.5 111.187 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -119.47 145.96 40.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 3.5299999999999998 111.183 170.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.94 -178.17 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.69 1.593 . . . . 3.5699999999999998 111.203 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.86 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 3.6000000000000001 111.153 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 3.6299999999999999 111.184 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -105.61 157.91 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.6699999999999999 111.168 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -87.48 179.98 6.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 3.7000000000000002 111.198 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.81 143.33 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 3.73 111.174 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.755 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.9 pp -160.03 144.37 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 3.77 111.219 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.2 t -169.96 -171.88 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 3.7999999999999998 111.171 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.1 tp -71.55 112.49 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 3.8300000000000001 111.229 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.75 125.92 71.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 3.8700000000000001 111.135 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -125.11 146.75 49.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 3.8999999999999999 111.217 -168.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -79.96 123.72 28.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 3.9300000000000002 111.237 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.53 -14.21 62.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 3.9700000000000002 111.171 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -89.98 -29.84 18.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 4.0 111.233 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.1 mt -98.55 -51.22 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 4.0300000000000002 111.164 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 46.6 tp -141.35 79.65 17.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 4.0700000000000003 111.191 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.25 -14.98 28.59 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.235 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -105.04 99.97 22.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 4.1299999999999999 111.21 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.43 156.98 45.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.255 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.19 167.18 28.0 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.686 1.59 . . . . 4.2000000000000002 111.239 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.42 -21.37 38.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 4.2300000000000004 111.206 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.2 t -161.54 172.02 17.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 4.2699999999999996 111.186 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -77.02 -12.02 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 4.2999999999999998 111.19 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.06 -8.75 57.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 4.3300000000000001 111.242 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.48 -4.28 31.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.3700000000000001 111.26 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.535 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 82.8 mt -69.69 -43.81 22.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 4.4000000000000004 111.158 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 55.4 Cg_exo -53.77 -40.15 81.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.71 1.607 . . . . 4.4299999999999997 111.171 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.8 90.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.4699999999999998 111.184 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.0 mt -64.99 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 4.5 111.255 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 4.5300000000000002 111.194 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.65 -31.57 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 4.5700000000000003 111.178 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.32 -32.83 55.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 4.5999999999999996 111.191 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.35 -5.09 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 4.6299999999999999 111.209 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.03 -39.99 75.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 4.6699999999999999 111.224 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.76 -29.31 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 4.7000000000000002 111.206 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.02 -18.74 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 4.7300000000000004 111.199 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 23.71 38.98 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.151 -0.779 . . . . 4.7699999999999996 111.151 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -100.08 149.32 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 4.7999999999999998 111.197 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -96.35 146.53 24.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 4.8300000000000001 111.191 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.412 ' HB2' ' HE3' ' A' ' 224' ' ' MET . . . -100.24 5.54 44.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 4.8700000000000001 111.178 175.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 tp -160.34 130.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 4.9000000000000004 111.2 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.404 ' O ' ' OG1' ' A' ' 225' ' ' THR . 91.4 mmm -135.02 154.93 51.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 4.9299999999999997 111.237 169.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.84 165.05 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 4.9699999999999998 111.211 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 58.1 t-20 -73.9 89.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 5.0 111.159 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.16 -38.92 82.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.272 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.36 -53.81 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 5.0700000000000003 111.222 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 155' ' ' TYR . 43.0 tp10 -79.05 122.46 84.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 5.0999999999999996 111.194 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.86 -20.18 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.653 1.569 . . . . 5.1299999999999999 111.195 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.445 ' H ' ' HG3' ' A' ' 153' ' ' GLU . 82.6 t80 -59.44 -22.63 61.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 5.1699999999999999 111.203 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 150' ' ' ASN . 94.1 m-85 -113.95 29.66 7.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 5.2000000000000002 111.247 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 -22.93 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 5.2300000000000004 111.167 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.74 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 56.5 p-90 -84.57 -23.11 0.32 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 5.2699999999999996 111.213 -173.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.74 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 59.1 Cg_exo -49.1 -40.72 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.679 1.586 . . . . 5.2999999999999998 111.169 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.02 -34.98 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.151 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.36 -32.2 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 5.3700000000000001 111.215 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.11 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 5.4000000000000004 111.17 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.66 -28.33 69.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 5.4299999999999997 111.205 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -89.11 -28.75 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 5.4699999999999998 111.22 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.74 41.88 2.41 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.202 -0.759 . . . . 5.5 111.202 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -107.84 -14.58 16.96 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.189 -0.764 . . . . 5.5300000000000002 111.189 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -105.26 99.04 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 5.5700000000000003 111.179 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.81 47.57 10.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 5.5999999999999996 111.115 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -126.06 139.99 52.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 5.6299999999999999 111.188 171.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.17 134.36 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.155 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -87.34 79.92 8.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 5.7000000000000002 111.173 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -137.98 66.02 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 5.7300000000000004 111.217 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 73.38 -72.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 5.7699999999999996 111.154 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -147.34 13.82 1.43 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.167 -0.773 . . . . 5.7999999999999998 111.167 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.08 114.31 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 5.8300000000000001 111.225 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -118.39 77.06 1.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 5.8700000000000001 111.241 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -65.03 127.32 31.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 5.9000000000000004 111.163 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.46 -12.93 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 5.9299999999999997 111.155 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -74.6 -22.07 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 5.9699999999999998 111.165 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -95.62 103.27 15.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 6.0 111.182 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.14 133.84 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 6.0300000000000002 111.194 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.73 39.27 3.1 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.279 -0.728 . . . . 6.0700000000000003 111.279 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.56 -20.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 6.0999999999999996 111.164 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -111.33 14.26 21.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 6.1299999999999999 111.173 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -76.85 150.64 36.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 6.1699999999999999 111.254 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.94 83.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 6.2000000000000002 111.217 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.47 -28.94 72.02 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.9 76.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 6.2699999999999996 111.174 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -79.3 -36.48 39.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 6.2999999999999998 111.206 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.87 74.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.184 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.22 -38.69 94.04 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.175 -0.77 . . . . 6.3700000000000001 111.175 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.5 tp -69.21 -35.3 76.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 6.4000000000000004 111.163 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.0 m -58.97 -39.36 81.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 6.4299999999999997 111.247 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.25 -43.46 97.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.229 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.43 -46.24 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 6.5 111.185 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.61 -26.98 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 6.5300000000000002 111.16 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -73.3 -36.8 66.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 6.5700000000000003 111.194 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.93 -34.67 78.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 6.5999999999999996 111.202 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.99 -44.87 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.169 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.74 -37.71 82.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 6.6699999999999999 111.213 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -86.72 4.97 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 6.7000000000000002 111.188 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 59.83 40.73 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 6.7300000000000004 111.135 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -98.86 -30.63 12.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 6.7699999999999996 111.238 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 96.6 mmm -120.07 141.53 49.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 6.7999999999999998 111.211 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.04 147.2 28.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 6.8300000000000001 111.138 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.55 -30.25 68.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 6.8700000000000001 111.176 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -85.11 -9.63 57.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 6.9000000000000004 111.244 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -57.04 128.73 38.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 6.9299999999999997 111.209 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 43.6 p30 -140.03 -165.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 6.9699999999999998 111.195 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -61.22 -47.35 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 7.0 111.212 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.7 p -70.09 -27.66 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 7.0300000000000002 111.176 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.16 -45.89 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 7.0700000000000003 111.233 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.7 98.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 7.0999999999999996 111.163 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -67.92 -37.09 81.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 7.1299999999999999 111.161 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.81 82.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 7.1699999999999999 111.219 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 7.2000000000000002 111.276 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -69.79 -25.95 64.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 7.2300000000000004 111.253 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -73.07 -14.68 61.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 7.2699999999999996 111.191 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.51 -17.66 13.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 7.2999999999999998 111.18 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.95 27.75 33.37 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.206 -0.758 . . . . 7.3300000000000001 111.206 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 7.3700000000000001 111.2 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 85.8 m -128.34 124.29 36.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 7.4000000000000004 111.203 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.12 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 7.4299999999999997 111.164 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.412 ' HE3' ' HB2' ' A' ' 146' ' ' ALA . 22.7 ptt? -156.54 165.01 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 7.4699999999999998 111.207 176.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 148' ' ' MET . 14.0 t -146.56 178.96 7.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 7.5 111.221 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.6 tt -122.26 112.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 7.5300000000000002 111.147 174.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -169.98 -178.62 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 7.5700000000000003 111.224 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -108.16 -165.7 21.28 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.222 -0.751 . . . . 7.5999999999999996 111.222 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -61.9 -18.9 63.67 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.745 1.63 . . . . 7.6299999999999999 111.214 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 7.6699999999999999 111.171 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.77 -25.7 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.203 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 51.9 t90 -80.02 -10.02 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 7.7300000000000004 111.202 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -64.99 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 7.7699999999999996 111.204 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -84.79 -29.97 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 7.7999999999999998 111.218 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 88.8 mt -66.59 -38.59 81.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 7.8300000000000001 111.193 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.3 -40.97 86.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 7.8700000000000001 111.148 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 93.8 m -65.05 -40.89 95.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 7.9000000000000004 111.255 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.8 p -77.92 -13.41 59.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 7.9299999999999997 111.231 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 60.02 50.15 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 7.9699999999999998 111.171 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.82 140.27 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 8.0 111.234 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -77.88 92.0 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 8.0299999999999994 111.244 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -101.08 140.84 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 8.0700000000000003 111.225 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.01 -179.64 20.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.159 -0.776 . . . . 8.0999999999999996 111.159 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 141.83 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.87 0.367 . . . . 8.1300000000000008 111.172 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.2 t -123.06 -171.54 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 8.1699999999999999 111.207 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -122.09 109.92 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 8.1999999999999993 111.247 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.555 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 88.2 mt -83.05 -40.54 0.82 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 8.2300000000000004 111.19 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 85.7 Cg_exo -52.76 110.28 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.723 1.616 . . . . 8.2699999999999996 111.197 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -139.89 130.0 25.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 8.3000000000000007 111.167 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -117.23 108.83 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 8.3300000000000001 111.263 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 58.08 35.59 25.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 8.3699999999999992 111.185 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.11 -8.56 69.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.158 -0.777 . . . . 8.4000000000000004 111.158 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -104.28 109.98 63.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.197 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.86 148.46 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.746 1.63 . . . . 8.4700000000000006 111.128 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.7 p -135.03 -105.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 8.5 111.184 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 48.8 tptt -159.52 133.58 5.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 8.5299999999999994 111.182 -170.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 77.2 Cg_exo -55.02 144.0 70.65 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.693 1.595 . . . . 8.5700000000000003 111.155 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -69.54 131.04 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 8.5999999999999996 111.249 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.05 -178.93 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 8.6300000000000008 111.152 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.23 -160.52 10.41 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.56 169.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 8.6999999999999993 111.209 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.86 119.92 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 8.7300000000000004 111.191 165.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.5 m -103.2 113.61 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 8.7699999999999996 111.2 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.28 115.44 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 8.8000000000000007 111.176 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -115.24 178.19 17.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.21 -0.756 . . . . 8.8300000000000001 111.21 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 99.1 mt -111.92 130.65 65.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 8.8699999999999992 111.267 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.29 126.06 26.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 8.9000000000000004 111.203 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.51 64.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 8.9299999999999997 111.126 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -94.35 -5.03 47.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 8.9700000000000006 111.132 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.32 132.63 95.27 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 9.0 111.185 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.6 -10.21 17.2 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.734 1.623 . . . . 9.0299999999999994 111.204 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -121.4 60.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 9.0700000000000003 111.2 -175.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.55 -29.03 52.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 9.0999999999999996 111.156 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.84 -40.03 76.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 9.1300000000000008 111.167 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.76 -35.6 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 9.1699999999999999 111.127 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.05 90.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 9.1999999999999993 111.146 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.49 -43.58 84.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 9.2300000000000004 111.246 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -56.48 -53.88 52.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 9.2699999999999996 111.214 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -54.73 -57.24 12.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 9.3000000000000007 111.163 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.1 -52.62 64.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 9.3300000000000001 111.232 -174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -79.41 -45.12 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 9.3699999999999992 111.174 -165.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -98.94 -11.8 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 9.4000000000000004 111.217 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -125.0 -65.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 9.4299999999999997 111.21 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 69.8 tp -59.62 -49.12 78.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 9.4700000000000006 111.229 -169.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 72.6 mt -97.78 40.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 9.5 111.195 -171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.0 p -105.07 176.58 5.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 9.5299999999999994 111.234 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.76 -30.33 70.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 9.5700000000000003 111.192 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -87.05 -40.08 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 9.5999999999999996 111.171 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -61.85 -46.98 93.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.245 -0.742 . . . . 9.6300000000000008 111.245 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.71 -21.97 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 9.6699999999999999 111.225 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -69.91 -39.36 76.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 9.6999999999999993 111.256 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.43 -29.55 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 9.7300000000000004 111.219 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 73.7 t -73.27 -42.85 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 9.7699999999999996 111.174 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -85.32 5.18 31.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 9.8000000000000007 111.255 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -54.25 -40.01 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 9.8300000000000001 111.208 167.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -106.88 -32.76 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 9.8699999999999992 111.163 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.93 160.04 41.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 9.9000000000000004 111.198 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.62 140.17 75.99 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.646 1.564 . . . . 9.9299999999999997 111.174 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.69 -17.74 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 9.9700000000000006 111.18 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.84 68.47 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.27 101.79 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 10.029999999999999 111.253 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.58 129.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 10.07 111.258 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -114.47 -10.62 12.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 10.1 111.258 165.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.61 117.18 27.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 10.130000000000001 111.204 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.04 -42.11 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.166 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.3 p -64.89 -30.01 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 10.199999999999999 111.179 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -72.16 -42.23 66.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 10.23 111.201 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.72 -30.02 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.205 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.15 -28.66 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 10.300000000000001 111.245 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.85 -32.06 40.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 10.33 111.172 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.25 -29.2 69.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 10.369999999999999 111.219 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.63 -18.61 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 10.4 111.173 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.97 -31.64 69.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 10.43 111.242 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -70.0 121.53 83.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 10.470000000000001 111.231 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.96 -34.9 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.688 1.592 . . . . 10.5 111.181 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.53 -53.5 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 10.529999999999999 111.23 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.45 -30.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 10.57 111.292 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.02 62.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 10.6 111.105 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.35 90.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.421 . . . . 10.630000000000001 111.235 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.0 m -70.27 -40.06 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 10.67 111.161 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.9 mmt -70.55 -31.36 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.149 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.58 -45.93 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 10.73 111.195 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -75.93 -31.99 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 10.77 111.213 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.96 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 10.800000000000001 111.225 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.09 -25.43 67.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 10.83 111.173 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.06 -24.71 40.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 10.869999999999999 111.162 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -74.88 158.06 50.91 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.205 -0.758 . . . . 10.9 111.205 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -127.11 163.66 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.764 0.316 . . . . 10.93 111.259 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 48.7 mm -110.4 133.29 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 10.970000000000001 111.178 -169.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.89 122.38 79.01 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 11.0 111.244 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.15 150.52 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.754 1.636 . . . . 11.029999999999999 111.166 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -113.57 -25.22 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 11.07 111.23 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 334' ' ' PRO . 97.6 mt -40.07 130.01 1.61 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 11.1 111.138 -177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 333' ' ' ILE . 83.8 Cg_exo -51.98 -37.72 68.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.708 1.605 . . . . 11.130000000000001 111.186 -172.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.05 -39.51 92.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 11.17 111.21 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 99.7 mmm -75.09 -34.23 61.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 11.199999999999999 111.135 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.2 m -69.67 -33.35 72.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 11.23 111.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 11.27 111.179 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -65.57 -35.92 82.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 11.300000000000001 111.16 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.452 ' HA ' ' CE3' ' A' ' 340' ' ' TRP . 4.2 m95 -70.01 -38.41 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 11.33 111.233 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -60.7 -40.29 91.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.176 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.41 73.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 11.4 111.175 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.84 -29.7 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 11.43 111.174 -174.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -69.94 -38.76 76.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 11.470000000000001 111.247 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.2 m -69.33 -37.3 77.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 11.5 111.208 173.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.32 94.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 11.529999999999999 111.172 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.57 -24.73 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 11.57 111.223 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.04 -45.97 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 11.6 111.177 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.23 -36.55 83.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 11.630000000000001 111.164 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.06 -43.75 61.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.452 . . . . 11.67 111.186 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.226 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.3 p -71.37 -15.02 62.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 11.73 111.231 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 92.19 25.69 20.96 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 111.24 -0.744 . . . . 11.77 111.24 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.03 -39.9 7.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 11.800000000000001 111.186 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -113.86 172.5 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 11.83 111.249 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -99.94 165.68 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 11.869999999999999 111.199 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.85 -16.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 11.9 111.227 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.85 -51.11 4.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 11.93 111.236 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -70.3 -31.42 68.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 11.970000000000001 111.129 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.79 -40.35 95.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 12.0 111.192 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.61 -30.83 61.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 12.029999999999999 111.125 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.42 -45.54 83.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 12.07 111.218 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.08 -41.92 99.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 12.1 111.197 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.79 -45.22 75.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 12.130000000000001 111.198 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -56.68 -36.58 69.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 12.17 111.224 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.3 m -47.86 -35.09 9.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 12.199999999999999 111.172 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -104.29 -34.99 8.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 12.23 111.161 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.13 -48.72 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 12.27 111.166 -174.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 370' ' ' LYS . 62.4 p -112.92 -29.78 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 12.300000000000001 111.268 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 369' ' ' THR . 98.8 mttt . . . . . 0 C--O 1.2 -1.501 0 CA-C-N 116.163 -0.471 . . . . 12.33 111.259 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.817 0.342 . . . . 0.070000000000000007 111.189 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -53.52 136.23 38.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.10000000000000001 111.235 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.25 144.97 32.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.13 111.173 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.32 16.77 63.82 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.211 -0.756 . . . . 0.17000000000000001 111.211 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.06 149.67 52.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.20000000000000001 111.22 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -122.86 101.22 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.23000000000000001 111.171 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.1 t -98.18 125.06 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.27000000000000002 111.212 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.6 mt -121.07 112.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.29999999999999999 111.202 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -92.09 92.75 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.33000000000000002 111.221 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -71.02 150.12 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.37 111.176 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -132.13 111.98 11.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.162 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.04 174.11 26.32 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.171 -0.771 . . . . 0.42999999999999999 111.171 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 -50.18 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.46999999999999997 111.195 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -125.01 -135.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.5 111.192 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.49 -7.65 78.17 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.53000000000000003 111.224 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -64.77 -54.67 27.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.56999999999999995 111.201 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.32 -40.69 97.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.59999999999999998 111.228 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.84 -53.35 44.79 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.225 -0.75 . . . . 0.63 111.225 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.0 tp -70.68 -32.4 69.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.67000000000000004 111.239 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.76 97.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.202 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.33 -38.27 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.219 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.91 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.77000000000000002 111.193 173.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.46 -38.42 96.32 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 0.80000000000000004 111.22 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.7 -44.42 96.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.82999999999999996 111.176 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.98 -41.49 92.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.87 111.209 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -59.28 -48.35 81.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.90000000000000002 111.241 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -64.35 -34.11 77.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.93000000000000005 111.185 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -69.18 -31.64 70.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.96999999999999997 111.22 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.05 -31.36 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.221 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.5 p -101.85 -29.87 11.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 1.03 111.201 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.04 5.68 83.0 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.223 -0.751 . . . . 1.0700000000000001 111.223 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.58 121.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 1.1000000000000001 111.219 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -61.67 119.51 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 1.1299999999999999 111.176 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.02 131.08 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 1.1699999999999999 111.247 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -123.43 110.26 14.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.2 111.164 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.7 t -101.84 131.77 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 1.23 111.186 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -152.92 169.98 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 1.27 111.215 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -140.3 76.87 25.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.3 111.194 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.83 80.0 2.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.724 1.616 . . . . 1.3300000000000001 111.213 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 29.7 t0 -52.29 162.97 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 1.3700000000000001 111.215 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 93.0 mttt 68.12 43.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.3999999999999999 111.173 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.29 -21.56 64.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 1.4299999999999999 111.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.89 -27.27 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 1.47 111.204 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -114.18 -25.48 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 1.5 111.209 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -94.37 -36.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 1.53 111.13 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 85.7 t80 -63.51 -43.06 77.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 1.5700000000000001 111.199 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 88.6 Cg_exo -53.05 -31.35 53.45 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.716 1.611 . . . . 1.6000000000000001 111.213 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -64.19 -32.94 74.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 1.6299999999999999 111.206 -173.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.7 m -100.06 -26.22 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 1.6699999999999999 111.167 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.7 111.206 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.33 -4.91 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.73 111.243 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -115.0 5.0 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 1.77 111.203 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.57 58.65 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.176 -0.77 . . . . 1.8 111.176 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -120.02 -165.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 1.8300000000000001 111.193 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.23 -162.96 12.67 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.159 -0.776 . . . . 1.8700000000000001 111.159 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.88 178.17 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.711 1.607 . . . . 1.8999999999999999 111.206 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.46 -40.85 10.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.9299999999999999 111.189 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.38 138.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 1.97 111.18 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.8 tt -143.92 138.78 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 2.0 111.199 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 29.8 m-85 -105.12 142.78 34.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 2.0299999999999998 111.233 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -134.49 155.6 50.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 2.0699999999999998 111.194 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . . . -68.13 159.22 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 2.1000000000000001 111.153 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -53.98 -33.58 57.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 2.1299999999999999 111.2 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -82.11 -49.94 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 2.1699999999999999 111.205 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -65.32 -31.13 72.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 2.2000000000000002 111.19 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -56.8 -36.11 69.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.23 111.18 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.08 -39.18 49.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.15 -0.78 . . . . 2.27 111.15 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.23 64.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.772 . . . . 2.2999999999999998 111.171 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.24 -49.3 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 2.3300000000000001 111.222 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.88 78.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 2.3700000000000001 111.212 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -58.2 -41.8 84.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.214 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.0 p -66.83 -17.9 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 2.4300000000000002 111.213 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.6 25.79 37.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.228 -0.749 . . . . 2.4700000000000002 111.228 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.61 2.54 44.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 2.5 111.205 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.17 117.27 28.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 2.5299999999999998 111.225 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.82 153.36 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.235 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.62 129.19 39.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 2.6000000000000001 111.206 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.36 129.59 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 2.6299999999999999 111.227 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 p -129.36 87.08 54.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 2.6699999999999999 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -58.48 150.17 70.22 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 2.7000000000000002 111.209 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -43.78 139.68 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 2.73 111.201 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.84 -39.59 39.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 2.77 111.174 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.79 85.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 2.7999999999999998 111.197 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -66.93 -40.07 87.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 2.8300000000000001 111.215 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.39 -30.87 71.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 2.8700000000000001 111.172 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.64 -35.02 67.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 2.8999999999999999 111.212 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.99 -16.22 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 2.9300000000000002 111.224 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -75.52 121.76 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 2.9700000000000002 111.191 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -69.14 144.79 95.69 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 3.0 111.217 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.36 -34.89 72.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.666 1.577 . . . . 3.0299999999999998 111.235 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 7.6 m-30 -64.62 -32.65 74.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 3.0699999999999998 111.184 -175.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -108.1 -21.61 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 3.1000000000000001 111.175 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -70.25 -41.32 73.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 3.1299999999999999 111.188 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.86 -27.82 63.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 3.1699999999999999 111.216 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.12 -21.03 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.2000000000000002 111.213 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.0 m -111.68 25.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 3.23 111.165 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -102.71 167.88 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 3.27 111.201 171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 37.1 t80 -163.29 130.02 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 3.2999999999999998 111.152 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 95.7 m-20 65.0 21.48 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 3.3300000000000001 111.224 -173.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.96 11.16 77.21 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.193 -0.763 . . . . 3.3700000000000001 111.193 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -122.84 143.03 50.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 3.3999999999999999 111.195 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.5 tp -75.09 118.74 18.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 3.4300000000000002 111.189 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 pt -117.53 -20.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 3.4700000000000002 111.203 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.13 177.09 9.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 3.5 111.227 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -140.84 142.62 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 3.5299999999999998 111.209 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.3 155.98 41.6 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.728 1.618 . . . . 3.5699999999999998 111.217 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 tp -134.74 -30.0 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 3.6000000000000001 111.186 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.49 149.64 29.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 3.6299999999999999 111.22 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -124.99 120.58 58.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 3.6699999999999999 111.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -124.68 157.22 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.7000000000000002 111.191 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.05 155.01 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 3.73 111.236 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.34 175.8 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 3.77 111.173 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.3 p -171.78 170.19 5.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 3.7999999999999998 111.175 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.492 HD23 ' C ' ' A' ' 115' ' ' LEU . 5.9 tt -97.1 99.94 11.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 3.8300000000000001 111.212 175.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.16 127.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 3.8700000000000001 111.194 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -140.26 160.81 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 3.8999999999999999 111.177 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -75.77 109.02 9.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 3.9300000000000002 111.183 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -81.33 -37.8 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 3.9700000000000002 111.173 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -54.97 -45.14 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 4.0 111.205 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.81 -61.25 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 4.0300000000000002 111.17 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.9 mt -127.58 92.64 42.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 4.0700000000000003 111.21 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.01 -19.0 46.21 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.665 1.577 . . . . 4.0999999999999996 111.205 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -98.47 105.83 32.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 4.1299999999999999 111.2 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.51 164.91 23.4 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.697 1.598 . . . . 4.1699999999999999 111.227 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.05 125.43 17.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.68 1.587 . . . . 4.2000000000000002 111.196 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.48 -23.64 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 4.2300000000000004 111.185 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 130' ' ' GLU . 14.3 t -157.48 -177.25 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 4.2699999999999996 111.186 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -71.49 -25.3 62.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 4.2999999999999998 111.163 -170.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.453 ' H ' HG23 ' A' ' 128' ' ' THR . 98.7 mt-10 -71.25 -17.26 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 4.3300000000000001 111.215 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -100.41 4.38 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 4.3700000000000001 111.226 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.515 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 24.8 mm -75.23 -51.03 3.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.4000000000000004 111.176 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.515 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 94.6 Cg_endo -74.58 -13.39 22.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.692 1.595 . . . . 4.4299999999999997 111.181 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.7 78.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 4.4699999999999998 111.178 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.03 -30.05 22.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 4.5 111.194 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.82 -33.43 75.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 4.5300000000000002 111.181 168.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.77 -45.08 72.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 4.5700000000000003 111.161 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.35 -30.48 71.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 4.5999999999999996 111.254 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.74 -14.66 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.178 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.65 -44.56 73.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 4.6699999999999999 111.226 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.93 -16.86 60.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 4.7000000000000002 111.213 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -95.11 3.01 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 4.7300000000000004 111.225 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.96 25.19 69.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.243 -0.743 . . . . 4.7699999999999996 111.243 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -136.97 -179.93 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 4.7999999999999998 111.227 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.2 t -149.9 140.29 22.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 4.8300000000000001 111.196 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.33 -45.6 19.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 4.8700000000000001 111.227 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.453 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 31.8 tp -77.79 124.84 28.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 4.9000000000000004 111.176 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 99.3 mmm -124.99 50.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 4.9299999999999997 111.214 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -76.36 147.4 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 4.9699999999999998 111.214 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -71.66 102.05 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 5.0 111.219 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.31 -19.14 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.201 -172.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -39.96 96.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 5.0700000000000003 111.157 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -98.56 160.03 29.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.21 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.36 3.51 6.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.668 1.578 . . . . 5.1299999999999999 111.225 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -49.41 -55.01 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 5.1699999999999999 111.248 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.67 36.54 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 5.2000000000000002 111.192 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.2 p -126.34 -22.95 3.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 5.2300000000000004 111.152 168.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.487 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 88.8 t90 -67.56 -48.26 44.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 5.2699999999999996 111.2 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 91.5 Cg_endo -76.99 -14.97 16.73 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.713 1.608 . . . . 5.2999999999999998 111.192 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.85 -44.28 93.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 5.3300000000000001 111.229 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 87.2 mt -65.45 -45.03 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 5.3700000000000001 111.189 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.19 65.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 5.4000000000000004 111.162 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.13 72.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.175 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -64.97 -27.01 68.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.231 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.41 -3.64 50.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.226 -0.75 . . . . 5.5 111.226 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.8 -12.97 70.65 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.171 -0.771 . . . . 5.5300000000000002 111.171 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.93 130.33 31.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 5.5700000000000003 111.176 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.18 21.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 5.5999999999999996 111.195 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -140.0 90.11 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 5.6299999999999999 111.194 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.199 -178.214 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 57.1 t0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.814 0.34 . . . . 5.9000000000000004 111.193 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.3 pt -112.27 16.37 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 5.9299999999999997 111.197 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.29 -28.97 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 5.9699999999999998 111.194 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -74.99 169.72 17.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 6.0 111.216 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.43 124.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 6.0300000000000002 111.206 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.99 -18.94 25.56 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.0 m -68.66 -14.58 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.75 0.309 . . . . 6.0999999999999996 111.161 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -88.26 5.0 43.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 6.1299999999999999 111.208 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -95.28 150.02 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 6.1699999999999999 111.207 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.18 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 6.2000000000000002 111.22 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.92 99.91 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.206 -0.758 . . . . 6.2300000000000004 111.206 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.24 90.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 6.2699999999999996 111.223 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.4 -35.07 79.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.2999999999999998 111.213 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.07 92.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 6.3300000000000001 111.22 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.7 -45.25 96.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.166 -0.774 . . . . 6.3700000000000001 111.166 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.7 tp -71.9 -32.57 67.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 6.4000000000000004 111.213 178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.5 m -62.29 -40.1 95.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 6.4299999999999997 111.181 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -59.75 -45.92 90.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 6.4699999999999998 111.187 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.8 tp -53.16 -59.47 4.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 6.5 111.197 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 6.5300000000000002 111.194 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.27 -41.41 94.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 6.5700000000000003 111.233 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.419 ' HB2' ' SD ' ' A' ' 204' ' ' MET . 79.8 mt -76.4 -23.01 54.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 6.5999999999999996 111.17 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.66 -43.2 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.217 168.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.91 -24.23 62.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 6.6699999999999999 111.207 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -89.73 5.46 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 6.7000000000000002 111.214 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 63.61 37.5 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 6.7300000000000004 111.193 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -110.76 -34.98 6.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 6.7699999999999996 111.253 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 198' ' ' LEU . 76.4 mtp -108.79 154.41 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 6.7999999999999998 111.161 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -127.02 111.56 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 6.8300000000000001 111.215 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.71 -17.9 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 6.8700000000000001 111.182 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -84.51 -26.09 28.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 6.9000000000000004 111.25 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -61.23 132.25 53.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 6.9299999999999997 111.181 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -139.39 -165.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 6.9699999999999998 111.189 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -58.77 -50.06 75.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 7.0 111.144 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.0 p -69.56 -32.61 71.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.192 -171.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.75 -46.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 7.0700000000000003 111.188 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.17 93.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 7.0999999999999996 111.219 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.49 -46.04 87.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 7.1299999999999999 111.199 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.26 96.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 7.1699999999999999 111.191 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.0 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 7.2000000000000002 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -70.59 -45.03 66.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 7.2300000000000004 111.212 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.76 -32.72 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 7.2699999999999996 111.226 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -83.49 -26.11 30.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 7.2999999999999998 111.159 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.28 19.92 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.168 -0.773 . . . . 7.3300000000000001 111.168 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -70.99 -30.07 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 7.3700000000000001 111.227 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.2 p -117.08 164.18 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 7.4000000000000004 111.217 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.78 -22.28 31.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 7.4299999999999997 111.205 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.64 170.28 21.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 7.4699999999999998 111.177 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.7 t -148.0 140.0 24.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 7.5 111.195 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 147' ' ' LEU . 88.2 mt -112.82 117.01 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 7.5300000000000002 111.183 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' A' ' 235' ' ' ILE . 7.4 t-20 -158.83 177.68 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 7.5700000000000003 111.169 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -79.6 170.46 54.19 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.227 -0.749 . . . . 7.5999999999999996 111.227 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.35 -17.08 21.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 7.6299999999999999 111.207 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -70.3 -30.08 66.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 7.6699999999999999 111.168 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.63 -4.84 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 7.7000000000000002 111.154 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 4.2 t90 -62.26 -29.52 70.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 7.7300000000000004 111.215 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 92.0 p -64.85 -21.43 66.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 7.7699999999999996 111.224 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.2 -30.1 12.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 7.7999999999999998 111.218 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 227' ' ' ASN . 83.3 mt -65.28 -34.68 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.227 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -80.16 7.83 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 7.8700000000000001 111.219 -169.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.5 m -58.31 -32.5 68.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 7.9000000000000004 111.207 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 66.5 m -69.98 -19.0 63.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 7.9299999999999997 111.21 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 60.43 38.91 19.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 7.9699999999999998 111.217 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.45 169.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 8.0 111.204 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -73.36 107.78 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 8.0299999999999994 111.206 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -102.44 133.42 47.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 8.0700000000000003 111.176 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -104.01 179.34 25.03 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.206 -0.758 . . . . 8.0999999999999996 111.206 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.9 137.89 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.757 0.313 . . . . 8.1300000000000008 111.193 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -145.88 -175.21 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 8.1699999999999999 111.214 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.2 t -78.87 125.24 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 8.1999999999999993 111.253 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.582 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 56.7 tp -79.7 -51.37 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 8.2300000000000004 111.202 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 89.2 Cg_endo -80.38 154.94 21.65 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.696 1.597 . . . . 8.2699999999999996 111.209 -173.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 85.1 m -124.98 109.88 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 8.3000000000000007 111.164 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.78 104.78 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 8.3300000000000001 111.22 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 55.25 35.05 24.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 8.3699999999999992 111.23 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.86 76.15 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.192 -0.763 . . . . 8.4000000000000004 111.192 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -129.99 109.97 16.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 8.4299999999999997 111.209 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.77 150.3 61.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.693 1.595 . . . . 8.4700000000000006 111.168 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 83.7 p -139.34 -72.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 8.5 111.232 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 47.3 tptt -159.42 129.89 3.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 8.5299999999999994 111.193 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.413 ' HA ' ' HG3' ' A' ' 248' ' ' PRO . 51.3 Cg_exo -55.03 157.04 14.19 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.739 1.626 . . . . 8.5700000000000003 111.22 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -67.28 146.0 54.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 8.5999999999999996 111.208 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.402 ' HB ' HD13 ' A' ' 329' ' ' ILE . 85.7 t -109.72 113.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 8.6300000000000008 111.175 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.07 115.04 5.01 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.163 -0.775 . . . . 8.6699999999999999 111.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.4 t -101.89 116.42 45.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 8.6999999999999993 111.2 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 63' ' ' ALA . 10.4 mp -73.16 144.82 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 8.7300000000000004 111.225 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 99.4 p -142.43 159.63 41.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 8.7699999999999996 111.203 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -130.52 156.23 45.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 8.8000000000000007 111.198 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.15 175.55 20.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.264 -0.735 . . . . 8.8300000000000001 111.264 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.8 129.97 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 8.8699999999999992 111.183 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.54 120.96 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.181 -173.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.76 -23.46 66.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 8.9299999999999997 111.186 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.0 58.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 8.9700000000000006 111.236 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.1 t -83.28 121.46 76.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 9.0 111.183 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.12 3.32 7.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.705 1.603 . . . . 9.0299999999999994 111.201 169.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.26 36.92 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 9.0700000000000003 111.241 -172.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -62.34 -24.11 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 9.0999999999999996 111.232 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.69 -30.48 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 9.1300000000000008 111.252 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -72.09 -43.37 64.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 9.1699999999999999 111.206 174.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.68 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 9.1999999999999993 111.218 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.79 -56.35 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.2300000000000004 111.2 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -65.46 -43.03 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 9.2699999999999996 111.183 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.39 -50.21 73.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 9.3000000000000007 111.19 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.76 -53.13 61.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 9.3300000000000001 111.203 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.79 -30.67 56.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 9.3699999999999992 111.181 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -97.62 -27.4 14.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 9.4000000000000004 111.238 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.71 -64.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 9.4299999999999997 111.223 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 45.5 tp -60.85 -41.84 96.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 9.4700000000000006 111.242 -166.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 37.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.205 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 97.4 m -114.78 141.38 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 9.5299999999999994 111.249 170.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -49.05 -40.49 31.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 9.5700000000000003 111.221 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.06 -46.37 85.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 9.5999999999999996 111.14 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.66 -40.55 90.27 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.241 -0.744 . . . . 9.6300000000000008 111.241 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.29 -35.5 81.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 9.6699999999999999 111.185 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.75 -40.85 84.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 9.6999999999999993 111.224 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 9.7300000000000004 111.22 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.79 -37.66 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 9.7699999999999996 111.182 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.573 ' HB3' HD23 ' A' ' 299' ' ' LEU . 98.1 m-20 -81.88 5.06 20.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.428 . . . . 9.8000000000000007 111.207 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.15 -33.22 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 9.8300000000000001 111.209 165.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -107.42 -38.73 5.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8699999999999992 111.179 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -87.78 161.44 44.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.9000000000000004 111.191 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -55.03 144.65 67.65 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.671 1.581 . . . . 9.9299999999999997 111.186 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.573 HD23 ' HB3' ' A' ' 294' ' ' ASN . 93.7 mt -68.37 -20.6 64.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 9.9700000000000006 111.232 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.94 -26.81 67.71 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.185 -0.766 . . . . 10.0 111.185 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.18 133.99 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 10.029999999999999 111.191 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.6 138.66 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 10.07 111.191 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.49 -48.02 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 10.1 111.186 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 85.0 mt -116.82 152.54 34.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 10.130000000000001 111.242 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -54.44 -37.24 64.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 10.17 111.182 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.0 p -56.18 -29.46 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 10.199999999999999 111.195 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -88.59 -35.83 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 10.23 111.2 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -60.06 -27.44 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 10.27 111.205 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.33 -30.4 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.151 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.77 -31.65 35.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 10.33 111.193 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.45 -21.72 62.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 10.369999999999999 111.219 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.95 66.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 10.4 111.203 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.82 -30.08 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 10.43 111.145 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 119.03 75.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.178 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.49 -35.47 96.69 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.73 1.62 . . . . 10.5 111.217 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -85.08 -51.11 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 10.529999999999999 111.218 -172.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.19 -39.81 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 10.57 111.172 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.04 85.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 10.6 111.187 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.21 86.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 10.630000000000001 111.181 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -64.51 -44.87 89.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 10.67 111.187 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.8 mmm -67.07 -34.65 78.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 10.699999999999999 111.183 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.5 -45.85 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 10.73 111.194 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 256' ' ' LYS . 99.3 m-20 -73.18 -22.42 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 10.77 111.159 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.05 -31.82 65.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 10.800000000000001 111.248 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.97 -18.29 64.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 10.83 111.177 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.25 -8.89 59.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 10.869999999999999 111.202 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -104.83 -141.89 11.13 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 10.9 111.226 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -145.0 136.34 25.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 10.93 111.174 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.402 HD13 ' HB ' ' A' ' 259' ' ' VAL . 49.2 mm -77.58 128.94 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 10.970000000000001 111.194 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 37.5 mmt -79.55 116.01 57.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 11.0 111.231 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.94 155.12 57.98 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.724 1.616 . . . . 11.029999999999999 111.195 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -97.61 20.09 12.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 11.07 111.202 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.91 128.27 91.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 11.1 111.153 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.24 -43.59 52.38 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.714 1.61 . . . . 11.130000000000001 111.223 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -64.99 -40.77 95.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 11.17 111.186 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.4 mmm -64.73 -39.37 93.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 11.199999999999999 111.214 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.1 t -60.52 -45.82 92.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.179 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.3 88.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 11.27 111.211 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -64.87 -33.45 76.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 11.300000000000001 111.18 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -69.97 -39.78 75.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 11.33 111.222 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.97 -30.08 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 11.369999999999999 111.211 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.61 71.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.18 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 93.5 t -85.5 -29.46 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 11.43 111.202 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.2 -25.3 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 11.470000000000001 111.219 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 76.0 p -85.99 -29.72 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 11.5 111.213 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.72 92.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.529999999999999 111.189 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.47 -23.43 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 11.57 111.21 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.9 mm -88.33 -38.04 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 11.6 111.206 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.531 ' HB3' ' HG2' ' A' ' 355' ' ' GLN . 96.0 m-20 -65.0 -32.42 74.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 11.630000000000001 111.214 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.3 -39.8 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 11.67 111.19 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.23 86.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 11.699999999999999 111.199 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.7 p -80.73 -19.43 45.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 11.73 111.209 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 90.58 18.03 50.07 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.222 -0.751 . . . . 11.77 111.222 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -70.2 -37.98 75.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 11.800000000000001 111.228 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.531 ' HG2' ' HB3' ' A' ' 349' ' ' ASN . 2.6 pt20 -147.0 168.74 20.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 11.83 111.176 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 45.0 p -81.18 175.14 10.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 11.869999999999999 111.141 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.88 -44.74 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 11.9 111.161 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.17 -48.15 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 11.93 111.18 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.59 -36.23 80.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 11.970000000000001 111.193 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.02 70.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 12.0 111.216 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.55 -15.92 55.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 12.029999999999999 111.219 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.18 -49.12 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 12.07 111.202 168.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.76 -39.04 92.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 12.1 111.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.45 -46.65 89.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 12.130000000000001 111.221 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.71 -47.63 76.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 12.17 111.178 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 12.199999999999999 111.197 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.6 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.779 0.323 . . . . 0.070000000000000007 111.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.15 129.93 42.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.10000000000000001 111.215 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -57.68 128.97 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.13 111.206 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.91 48.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -126.33 98.02 5.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.771 0.319 . . . . 0.20000000000000001 111.195 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.05 119.72 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.23000000000000001 111.204 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.29 118.83 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.27000000000000002 111.238 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.9 mt -121.21 112.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.29999999999999999 111.189 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -103.38 117.12 33.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.33000000000000002 111.222 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.1 tt -115.61 137.05 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.37 111.208 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.64 114.94 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.40000000000000002 111.228 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.01 -172.46 39.86 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.209 -0.756 . . . . 0.42999999999999999 111.209 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -108.47 -39.18 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.329 . . . . 0.46999999999999997 111.219 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.14 149.83 43.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.5 111.191 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.26 0.83 4.52 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.215 -0.754 . . . . 0.53000000000000003 111.215 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 37' ' ' VAL . 43.8 p90 -62.71 -20.09 64.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.56999999999999995 111.204 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.67 -30.5 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 0.59999999999999998 111.205 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.69 -47.24 91.61 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.24 -0.744 . . . . 0.63 111.24 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HB2' HG11 ' A' ' 37' ' ' VAL . 82.2 mt -72.58 -30.79 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.67000000000000004 111.173 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.29 83.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.69999999999999996 111.21 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.4 -39.69 91.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.173 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 82.5 t -71.23 -34.85 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.77000000000000002 111.144 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.16 -27.12 73.83 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.182 -0.767 . . . . 0.80000000000000004 111.182 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 -48.4 81.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.82999999999999996 111.197 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.0 -41.79 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.87 111.205 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.37 -51.34 69.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.90000000000000002 111.274 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.93 -38.16 90.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.93000000000000005 111.262 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.36 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.96999999999999997 111.159 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.32 -35.01 12.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.186 -173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -103.4 -29.96 10.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.03 111.234 -174.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.55 4.56 79.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.166 -0.774 . . . . 1.0700000000000001 111.166 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.2 124.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 1.1000000000000001 111.24 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.94 150.06 47.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 1.1299999999999999 111.153 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -125.02 125.12 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 1.1699999999999999 111.234 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -121.33 109.84 15.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 1.2 111.221 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' A' ' 20' ' ' LEU . 35.1 t -105.07 130.12 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.187 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -151.07 166.49 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 1.27 111.198 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -100.03 123.26 47.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 1.3 111.216 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -79.6 165.03 23.11 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.617 1.545 . . . . 1.3300000000000001 111.201 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -121.0 141.03 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 1.3700000000000001 111.187 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 55.04 46.71 23.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 1.3999999999999999 111.238 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.02 -50.72 68.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 1.4299999999999999 111.211 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -52.57 -43.64 65.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 1.47 111.169 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.5 111.185 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -97.08 -7.0 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.192 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.474 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 5.2 m-30 -55.19 -54.8 46.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 1.5700000000000001 111.155 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -70.66 -12.21 30.84 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.68 1.587 . . . . 1.6000000000000001 111.21 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.98 -8.61 51.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.154 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.97 -57.68 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 1.6699999999999999 111.209 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.29 -23.11 43.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 1.7 111.199 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.58 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.73 111.172 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -104.2 -19.88 13.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.77 111.182 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.09 58.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.161 -0.775 . . . . 1.8 111.161 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -129.59 -165.43 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.8300000000000001 111.182 -170.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.42 -165.76 14.37 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.195 -0.762 . . . . 1.8700000000000001 111.195 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.49 167.16 27.78 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.665 1.577 . . . . 1.8999999999999999 111.201 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -80.04 -62.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 1.9299999999999999 111.186 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -99.78 139.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 1.97 111.208 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 tt -141.53 134.91 30.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 2.0 111.225 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.43 144.93 32.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 2.0299999999999998 111.315 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -156.39 148.45 23.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 2.0699999999999998 111.248 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.41 158.0 24.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 2.1000000000000001 111.175 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -60.6 -17.02 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 2.1299999999999999 111.244 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -42.91 -48.34 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 2.1699999999999999 111.159 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -134.98 27.45 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 2.2000000000000002 111.162 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.53 -42.61 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 2.23 111.176 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.77 -46.42 93.49 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.92 89.28 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.181 -0.767 . . . . 2.2999999999999998 111.181 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.05 -43.59 73.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 2.3300000000000001 111.157 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.84 -37.58 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 2.3700000000000001 111.143 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -67.07 -30.81 70.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.151 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -73.79 -13.89 61.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 2.4300000000000002 111.16 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.81 19.14 52.72 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.169 -0.772 . . . . 2.4700000000000002 111.169 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.89 -38.61 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.806 0.336 . . . . 2.5 111.234 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 tp -102.63 132.32 48.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 2.5299999999999998 111.239 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.54 137.09 32.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 2.5699999999999998 111.207 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -77.52 156.12 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 2.6000000000000001 111.203 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.2 mt -113.79 122.67 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 2.6299999999999999 111.204 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.2 m -120.58 96.74 48.88 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 2.6699999999999999 111.15 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.03 148.2 49.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.732 1.621 . . . . 2.7000000000000002 111.226 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -81.76 -179.37 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 2.73 111.188 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.73 -45.81 74.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 2.77 111.19 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.88 86.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 2.7999999999999998 111.232 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.41 -36.46 84.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 2.8300000000000001 111.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.71 -34.59 78.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 2.8700000000000001 111.235 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -71.35 -34.97 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 2.8999999999999999 111.155 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.1 -20.55 59.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 2.9300000000000002 111.186 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.6 mt -75.02 135.26 41.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 2.9700000000000002 111.193 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -63.29 138.89 97.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 3.0 111.162 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -50.15 -47.74 22.69 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.647 1.565 . . . . 3.0299999999999998 111.186 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.14 -47.66 81.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.0699999999999998 111.169 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -70.77 -21.69 62.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 3.1000000000000001 111.212 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -69.97 -41.53 74.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 3.1299999999999999 111.233 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -78.05 -24.01 47.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 3.1699999999999999 111.252 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.62 90.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 3.2000000000000002 111.197 -174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.71 79.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.23 111.207 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HB3' HD23 ' A' ' 103' ' ' LEU . 54.4 ptt85 -156.68 161.05 39.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 3.27 111.163 175.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 44.3 t80 -159.98 136.37 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 3.2999999999999998 111.246 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 95.0 m-20 64.98 29.89 12.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 3.3300000000000001 111.216 -175.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.77 53.89 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.187 -0.765 . . . . 3.3700000000000001 111.187 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -165.07 147.44 8.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 3.3999999999999999 111.159 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 98' ' ' ARG . 94.2 mt -64.9 136.39 56.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 3.4300000000000002 111.232 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 pt -115.2 -14.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 3.4700000000000002 111.224 -176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.0 172.92 5.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 3.5 111.226 -174.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -119.73 123.43 28.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 3.5299999999999998 111.18 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.8 139.54 33.72 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.667 1.578 . . . . 3.5699999999999998 111.2 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.32 -4.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 3.6000000000000001 111.223 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.75 144.75 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 3.6299999999999999 111.193 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.67 128.22 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 3.6699999999999999 111.242 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.68 151.21 46.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 3.7000000000000002 111.218 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.64 164.98 11.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 3.73 111.215 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 tp -143.85 124.1 13.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 3.77 111.214 172.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.9 p -163.05 -174.29 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 3.7999999999999998 111.17 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.9 tp -103.48 120.08 40.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 3.8300000000000001 111.177 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 116' ' ' ILE . 3.8 mp -102.93 141.36 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 3.8700000000000001 111.24 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -136.8 150.61 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 3.8999999999999999 111.159 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -91.28 117.33 29.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.9300000000000002 111.251 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.09 -34.88 79.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 3.9700000000000002 111.196 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.94 -47.6 84.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 4.0 111.205 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.2 tp -80.35 -52.36 7.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 4.0300000000000002 111.186 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.53 99.53 52.56 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 4.0700000000000003 111.174 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 -17.84 19.12 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.739 1.626 . . . . 4.0999999999999996 111.159 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -85.01 116.81 67.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 4.1299999999999999 111.144 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.42 117.9 5.19 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.716 1.61 . . . . 4.1699999999999999 111.232 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.97 129.62 31.17 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.718 1.612 . . . . 4.2000000000000002 111.181 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.01 -45.09 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 4.2300000000000004 111.186 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.6 t -136.3 -177.59 4.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 4.2699999999999996 111.173 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.65 -34.16 21.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 4.2999999999999998 111.207 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.77 -15.61 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 4.3300000000000001 111.215 -163.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -91.45 -9.44 44.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 4.3700000000000001 111.186 -176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.594 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 93.1 mt -74.02 -45.0 6.59 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 4.4000000000000004 111.195 -171.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.7 Cg_exo -57.0 -40.38 84.52 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.67 1.58 . . . . 4.4299999999999997 111.191 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.37 99.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 4.4699999999999998 111.183 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.7 tp -63.95 -42.98 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.427 . . . . 4.5 111.268 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.95 -35.05 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.239 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.04 -37.02 75.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 4.5700000000000003 111.218 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.04 -31.91 69.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 4.5999999999999996 111.176 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.0 mt -82.18 -15.9 51.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 4.6299999999999999 111.155 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.93 -44.53 63.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 4.6699999999999999 111.156 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.37 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 4.7000000000000002 111.24 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.03 -7.29 33.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 4.7300000000000004 111.196 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.16 62.43 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.163 -0.775 . . . . 4.7699999999999996 111.163 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 74.4 mmtt -114.96 179.28 3.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.8 0.333 . . . . 4.7999999999999998 111.212 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -137.82 143.94 41.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 4.8300000000000001 111.196 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -59.78 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 4.8700000000000001 111.249 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 132' ' ' ILE . 64.6 tp -128.13 115.64 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 4.9000000000000004 111.166 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.8 mmm -111.68 136.03 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 4.9299999999999997 111.198 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -171.68 164.99 6.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 4.9699999999999998 111.27 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -79.69 112.71 17.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 5.0 111.211 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.2 tp -63.18 -32.36 73.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 5.0300000000000002 111.182 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -96.66 7.54 46.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 5.0700000000000003 111.229 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -110.04 114.23 56.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 5.0999999999999996 111.172 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.32 -39.22 81.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.697 1.598 . . . . 5.1299999999999999 111.214 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -50.49 -40.02 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 5.1699999999999999 111.154 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -79.96 -37.52 34.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 5.2000000000000002 111.273 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.3 p -105.17 17.73 23.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 5.2300000000000004 111.156 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.557 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 88.3 t90 -66.73 -49.67 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 5.2699999999999996 111.286 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 83.6 Cg_endo -80.01 -14.92 12.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 5.2999999999999998 111.193 -174.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.9 tp -60.95 -33.99 74.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 5.3300000000000001 111.175 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.35 -30.02 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 5.3700000000000001 111.244 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.09 -43.75 10.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 5.4000000000000004 111.208 -172.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.4 -11.48 59.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 5.4299999999999997 111.213 -169.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -78.59 -4.42 48.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 5.4699999999999998 111.241 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.84 12.25 2.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.199 -0.76 . . . . 5.5 111.199 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.04 -19.66 25.74 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.241 -0.743 . . . . 5.5300000000000002 111.241 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.61 109.98 11.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 5.5700000000000003 111.172 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 68.39 35.3 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 5.5999999999999996 111.138 173.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.78 54.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 5.6299999999999999 111.235 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 177' ' ' ASP . 73.0 mmtt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 5.6699999999999999 111.157 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 170' ' ' LYS . 53.7 t0 . . . . . 0 CA--C 1.523 -0.074 0 CA-C-O 120.804 0.335 . . . . 5.9000000000000004 111.201 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.3 pt -98.36 -2.25 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 5.9299999999999997 111.166 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.01 -33.91 38.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 5.9699999999999998 111.165 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -64.76 139.99 58.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 6.0 111.173 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 184' ' ' ASP . 85.0 t -72.93 123.88 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 6.0300000000000002 111.18 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.14 93.24 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -76.0 -24.94 16.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.769 0.319 . . . . 6.0999999999999996 111.171 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . 51.2 t0 -89.6 64.51 6.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 6.1299999999999999 111.13 -177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -138.76 160.0 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 6.1699999999999999 111.222 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.41 80.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 6.2000000000000002 111.164 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.04 -47.36 83.05 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.4 90.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 6.2699999999999996 111.183 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.55 -44.14 91.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 6.2999999999999998 111.18 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.03 79.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.18 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.53 -45.03 97.18 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.225 -0.75 . . . . 6.3700000000000001 111.225 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.94 -38.55 86.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 6.4000000000000004 111.223 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -59.96 -50.91 71.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.233 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.28 -38.18 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 6.4699999999999998 111.213 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.8 tp -49.99 -53.22 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 6.5 111.203 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.6 -33.26 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 6.5300000000000002 111.162 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 94.4 m-20 -54.72 -42.86 72.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 6.5700000000000003 111.249 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.42 -33.34 74.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 6.5999999999999996 111.132 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.91 -48.7 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 6.6299999999999999 111.125 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.92 -25.95 31.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 6.6699999999999999 111.163 -171.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 96.1 m-20 -94.95 15.5 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 6.7000000000000002 111.202 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.01 52.3 5.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 6.7300000000000004 111.214 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -115.12 -34.47 5.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 6.7699999999999996 111.209 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 98.9 mmm -139.81 169.34 17.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.147 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -153.06 175.03 13.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 6.8300000000000001 111.215 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -86.9 2.65 48.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 6.8700000000000001 111.141 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.39 1.8 55.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 6.9000000000000004 111.186 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.6 p -80.9 164.99 22.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 6.9299999999999997 111.259 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -158.12 170.0 23.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.149 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -59.66 -48.58 81.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 7.0 111.252 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 88.7 p -70.86 -30.01 66.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 7.0300000000000002 111.201 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.25 -46.97 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 7.0700000000000003 111.227 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.8 88.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 7.0999999999999996 111.2 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.81 -42.12 88.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 7.1299999999999999 111.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.05 94.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.177 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.42 -34.27 77.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 7.2000000000000002 111.164 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -64.59 -43.17 94.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 7.2300000000000004 111.231 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.77 -35.87 81.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2699999999999996 111.223 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -77.62 -26.61 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2999999999999998 111.205 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.01 31.64 22.78 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.228 -0.749 . . . . 7.3300000000000001 111.228 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -90.08 -6.01 55.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 7.3700000000000001 111.186 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 95.8 m -106.58 132.11 52.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 7.4000000000000004 111.253 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -86.81 -44.22 11.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 7.4299999999999997 111.253 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 61.9 mtm -135.39 152.65 51.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 7.4699999999999998 111.157 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -161.69 147.06 13.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 7.5 111.22 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.42 115.7 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 7.5300000000000002 111.244 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -154.9 166.82 32.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 7.5700000000000003 111.264 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.65 -176.46 18.38 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.219 -0.752 . . . . 7.5999999999999996 111.219 166.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -56.15 -26.73 61.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.671 1.581 . . . . 7.6299999999999999 111.218 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -60.18 -22.05 62.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 7.6699999999999999 111.21 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.03 24.98 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 7.7000000000000002 111.178 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -101.81 10.03 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 7.7300000000000004 111.241 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.8 p -70.49 -32.68 70.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 7.7699999999999996 111.213 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -89.04 -34.02 16.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 7.7999999999999998 111.212 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.46 -38.85 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 7.8300000000000001 111.207 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -72.74 -32.26 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 7.8700000000000001 111.188 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -99.31 8.72 44.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 7.9000000000000004 111.175 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 85.1 p -70.71 -18.43 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 7.9299999999999997 111.171 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 63.92 24.02 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 7.9699999999999998 111.211 -170.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.76 131.25 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 8.0 111.18 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.13 133.78 51.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 8.0299999999999994 111.144 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -145.34 158.68 43.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 8.0700000000000003 111.197 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.01 179.69 18.01 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.178 -0.769 . . . . 8.0999999999999996 111.178 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 73.5 t -133.52 131.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 8.1300000000000008 111.188 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 46.4 p -119.74 167.82 11.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 8.1699999999999999 111.163 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.77 119.94 51.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 8.1999999999999993 111.216 -166.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.493 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 85.9 mt -82.97 -42.97 0.87 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 8.2300000000000004 111.221 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 76.5 Cg_exo -45.48 113.28 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.71 1.606 . . . . 8.2699999999999996 111.183 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 92.3 m -124.57 134.36 52.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 8.3000000000000007 111.216 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -127.17 117.74 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 8.3300000000000001 111.233 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 57.24 34.97 25.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 8.3699999999999992 111.17 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.51 13.21 82.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.168 -0.773 . . . . 8.4000000000000004 111.168 176.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -130.0 110.01 16.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.337 . . . . 8.4299999999999997 111.192 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.48 142.04 48.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.671 1.581 . . . . 8.4700000000000006 111.222 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.6 p -125.01 -84.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 8.5 111.245 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.26 155.2 76.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 8.5299999999999994 111.266 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 155.0 72.37 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.725 1.617 . . . . 8.5700000000000003 111.247 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -76.9 132.04 38.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 8.5999999999999996 111.127 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -106.72 126.77 62.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 8.6300000000000008 111.247 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.01 149.42 16.79 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.165 -0.774 . . . . 8.6699999999999999 111.165 170.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 77.2 t -125.54 130.4 72.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 8.6999999999999993 111.216 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 56.1 tp -97.66 121.05 39.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 8.7300000000000004 111.222 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 72.4 m -123.64 146.94 47.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 8.7699999999999996 111.194 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -78.14 162.93 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 8.8000000000000007 111.192 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.29 171.51 36.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.215 -0.754 . . . . 8.8300000000000001 111.215 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.71 132.31 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 8.8699999999999992 111.196 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -59.99 120.89 10.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 8.9000000000000004 111.211 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.84 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 8.9299999999999997 111.194 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -98.9 -0.3 42.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 8.9700000000000006 111.216 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -64.95 131.09 95.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 9.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.95 -15.09 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.715 1.61 . . . . 9.0299999999999994 111.214 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -123.52 61.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 9.0700000000000003 111.175 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -72.27 -22.53 61.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 9.0999999999999996 111.25 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -33.15 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 9.1300000000000008 111.159 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.2 -41.56 90.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 9.1699999999999999 111.198 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.16 94.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 9.1999999999999993 111.215 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -55.36 -49.94 70.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 9.2300000000000004 111.2 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -62.16 -56.92 13.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 9.2699999999999996 111.258 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.55 -55.05 33.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 9.3000000000000007 111.183 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.46 -50.01 74.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 9.3300000000000001 111.24 -172.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.03 -49.73 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 9.3699999999999992 111.223 -172.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -98.39 -13.45 20.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 9.4000000000000004 111.164 -158.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.53 -49.89 1.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 9.4299999999999997 111.203 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.03 -53.45 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 9.4700000000000006 111.191 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.5 mp -76.75 59.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.23 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.3 p -139.76 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 9.5299999999999994 111.209 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -56.78 -47.5 80.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 9.5700000000000003 111.231 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.36 -33.24 69.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 9.5999999999999996 111.261 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.84 -47.89 88.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.26 -0.736 . . . . 9.6300000000000008 111.26 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.18 -50.09 62.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.767 0.318 . . . . 9.6699999999999999 111.156 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.73 -35.05 73.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 9.6999999999999993 111.187 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.16 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.7300000000000004 111.191 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.71 -44.06 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 9.7699999999999996 111.173 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.51 -0.11 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 9.8000000000000007 111.21 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -77.58 -16.36 58.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 9.8300000000000001 111.164 168.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -110.47 -33.18 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 9.8699999999999992 111.244 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -96.2 160.23 30.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 9.9000000000000004 111.189 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.97 154.06 23.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.736 1.624 . . . . 9.9299999999999997 111.216 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.16 -6.9 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 9.9700000000000006 111.142 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.54 -44.01 85.69 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.17 -0.772 . . . . 10.0 111.17 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.43 125.46 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.731 0.3 . . . . 10.029999999999999 111.205 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.3 p -152.06 141.14 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 10.07 111.189 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -139.02 35.86 2.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 10.1 111.218 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.14 148.0 46.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 10.130000000000001 111.152 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.06 -49.98 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 10.17 111.204 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.4 p -68.79 -25.36 64.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 10.199999999999999 111.209 -173.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -79.99 -50.49 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 10.23 111.23 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.98 -38.34 72.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.171 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.11 -39.85 93.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 10.300000000000001 111.167 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -75.48 -32.82 60.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 10.33 111.173 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.16 -24.3 57.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 10.369999999999999 111.168 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.78 -14.56 62.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 10.4 111.201 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.24 -30.06 70.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 10.43 111.209 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -78.52 117.65 67.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 10.470000000000001 111.148 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.71 -34.99 86.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.685 1.59 . . . . 10.5 111.146 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.74 -29.71 67.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.529999999999999 111.219 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.78 -29.96 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 10.57 111.224 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.38 94.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 10.6 111.205 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.2 99.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.206 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.3 m -68.03 -44.63 76.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.196 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 56.7 mtt -73.74 -37.11 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.22 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.77 -44.01 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 10.73 111.23 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -64.8 -36.8 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 10.77 111.179 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.49 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 10.800000000000001 111.156 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -72.03 -37.45 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 10.83 111.117 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.03 -0.02 54.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.149 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.34 -136.77 9.49 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.245 -0.742 . . . . 10.9 111.245 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -149.07 147.29 28.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 10.93 111.188 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.3 pt -117.11 162.61 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 10.970000000000001 111.205 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -59.37 117.43 22.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 11.0 111.188 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 149.36 88.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.672 1.581 . . . . 11.029999999999999 111.183 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -105.05 39.91 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 11.07 111.202 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 74.9 mt -88.74 118.76 69.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 11.1 111.255 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.83 -17.97 13.58 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.674 1.582 . . . . 11.130000000000001 111.225 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.14 -5.01 58.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 11.17 111.226 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.6 mmm -110.77 19.1 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 11.199999999999999 111.255 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.1 m -65.65 -50.94 63.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 11.23 111.181 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.15 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 11.27 111.217 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -71.13 -47.27 58.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 11.300000000000001 111.216 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -70.13 -35.77 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 11.33 111.261 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -58.15 -51.96 67.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 11.369999999999999 111.196 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -31.49 72.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 11.4 111.143 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.21 -43.07 88.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 11.43 111.181 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.31 -40.05 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 11.470000000000001 111.167 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.3 m -57.3 -41.11 79.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 11.5 111.212 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.01 71.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 11.529999999999999 111.194 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.04 -25.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.186 -172.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.79 -46.03 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 11.6 111.195 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.53 -27.39 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 11.630000000000001 111.221 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.77 -39.13 36.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 11.67 111.184 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.48 86.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 11.699999999999999 111.216 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -74.4 -14.97 60.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 11.73 111.203 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.39 31.89 40.18 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.14 -0.784 . . . . 11.77 111.14 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -100.01 -38.28 8.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.78 0.324 . . . . 11.800000000000001 111.177 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -124.96 159.18 31.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 11.83 111.207 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.3 p -81.66 176.92 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 11.869999999999999 111.204 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 10.7 m -70.59 -21.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 11.9 111.199 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -89.84 -36.71 14.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 11.93 111.187 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -69.09 -36.72 77.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.151 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.92 87.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 12.0 111.171 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.84 -32.48 73.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 12.029999999999999 111.191 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.94 -59.96 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 12.07 111.248 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.38 -41.1 89.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 12.1 111.235 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.26 85.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 12.130000000000001 111.19 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.7 -46.45 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 12.17 111.202 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.2 m . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 12.199999999999999 111.208 -177.952 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.862 0.363 . . . . 0.070000000000000007 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.18 150.1 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.10000000000000001 111.214 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.03 125.13 22.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.13 111.217 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.74 14.29 58.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.143 -0.783 . . . . 0.17000000000000001 111.143 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -132.06 155.01 48.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 0.20000000000000001 111.23 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -116.27 109.98 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.23000000000000001 111.186 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.94 123.76 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.27000000000000002 111.179 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.29999999999999999 111.264 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.404 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.3 m0 -109.98 128.74 55.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.33000000000000002 111.175 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 86.5 mt -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.37 111.165 -173.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' HB2' ' CE3' ' A' ' 62' ' ' TRP . 57.0 t-20 -62.34 122.17 15.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.40000000000000002 111.224 172.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.9 -174.31 15.14 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.14 -0.784 . . . . 0.42999999999999999 111.14 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -99.95 -19.93 16.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.46999999999999997 111.264 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.45 144.16 28.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.5 111.175 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.73 -18.81 8.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.174 -0.771 . . . . 0.53000000000000003 111.174 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -47.59 -55.12 9.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.767 0.318 . . . . 0.56999999999999995 111.197 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -94.23 -27.04 16.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.59999999999999998 111.268 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.13 -57.23 19.33 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.255 -0.738 . . . . 0.63 111.255 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.7 tp -74.57 -29.14 61.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.67000000000000004 111.229 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -32.6 63.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.69999999999999996 111.164 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -59.21 -33.54 71.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.72999999999999998 111.172 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.26 -40.16 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.77000000000000002 111.228 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.25 -28.94 71.68 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.285 -0.726 . . . . 0.80000000000000004 111.285 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.66 -42.52 99.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.82999999999999996 111.135 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.3 -48.45 70.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.87 111.165 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -56.17 -44.16 79.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.90000000000000002 111.197 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.29 -42.07 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.93000000000000005 111.178 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.89 -35.0 69.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.96999999999999997 111.257 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -78.71 -35.9 44.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.256 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -106.26 -28.31 10.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 1.03 111.212 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.75 5.06 74.94 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.24 -0.744 . . . . 1.0700000000000001 111.24 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mm -86.5 114.78 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 1.1000000000000001 111.219 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.92 124.06 19.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 111.181 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.36 126.14 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 1.1699999999999999 111.177 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -126.46 116.77 21.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 1.2 111.234 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.5 125.01 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 1.23 111.186 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.6 mt-10 -132.71 161.35 34.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 1.27 111.194 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -117.15 102.78 52.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 1.3 111.188 172.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.56 167.95 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.709 1.606 . . . . 1.3300000000000001 111.186 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.6 t0 -100.19 102.86 14.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 1.3700000000000001 111.142 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.18 70.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 1.3999999999999999 111.2 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 68.5 mt -59.98 -20.69 59.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 1.4299999999999999 111.214 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -49.23 -35.03 16.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 1.47 111.185 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -109.86 -25.58 10.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 1.5 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 43' ' ' LEU . 87.1 tttt -79.98 -24.4 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 1.53 111.141 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.467 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -50.67 -57.39 13.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 1.5700000000000001 111.2 -177.098 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -68.61 -24.65 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.663 1.575 . . . . 1.6000000000000001 111.209 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.11 -37.31 72.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.173 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -88.59 -24.16 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 1.6699999999999999 111.197 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.26 -30.82 71.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 1.7 111.158 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.0 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 1.73 111.273 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -101.53 -15.39 17.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 1.77 111.131 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.5 32.55 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.208 -0.757 . . . . 1.8 111.208 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -110.02 169.97 8.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 1.8300000000000001 111.179 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.44 179.99 31.86 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.21 -0.756 . . . . 1.8700000000000001 111.21 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.37 -178.08 3.55 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.669 1.579 . . . . 1.8999999999999999 111.154 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -84.55 -56.53 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.9299999999999999 111.241 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -114.16 138.93 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 1.97 111.283 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.68 121.07 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 2.0 111.193 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 22.0 m-85 -98.2 107.89 20.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 2.0299999999999998 111.162 167.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.513 ' CE3' ' HB2' ' A' ' 12' ' ' ASN . 24.3 t-105 -148.33 157.26 43.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 2.0699999999999998 111.172 -172.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.7 140.95 53.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.1000000000000001 111.226 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -58.62 -26.19 63.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 2.1299999999999999 111.149 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -76.7 -6.7 53.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 2.1699999999999999 111.232 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -129.13 -24.94 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 111.19 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.04 -29.98 67.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 2.23 111.187 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -28.82 73.57 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.21 -0.756 . . . . 2.27 111.21 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.78 -31.89 59.77 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.159 -0.776 . . . . 2.2999999999999998 111.159 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -64.54 -36.15 83.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.203 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.77 69.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 2.3700000000000001 111.153 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -55.33 -42.59 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 2.3999999999999999 111.2 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 99.9 p -70.64 -15.05 62.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 2.4300000000000002 111.222 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.22 22.04 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.195 -0.762 . . . . 2.4700000000000002 111.195 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -107.24 -8.67 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 2.5 111.25 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -105.08 135.08 47.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 2.5299999999999998 111.214 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.96 134.97 53.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 2.5699999999999998 111.166 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -74.5 91.03 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 2.6000000000000001 111.243 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.95 98.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 2.6299999999999999 111.154 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.6 m -91.46 115.39 64.38 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 2.6699999999999999 111.224 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -56.39 144.99 81.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.702 1.601 . . . . 2.7000000000000002 111.169 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.96 163.05 28.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 2.73 111.134 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.31 -36.39 53.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 2.77 111.187 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.64 74.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 2.7999999999999998 111.263 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -70.25 -31.23 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 2.8300000000000001 111.226 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -57.56 -33.86 68.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 2.8700000000000001 111.216 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -81.72 -16.1 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 2.8999999999999999 111.245 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 305' ' ' LYS . 70.1 mmtt -85.02 -35.03 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 2.9300000000000002 111.199 -170.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.63 161.14 20.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 2.9700000000000002 111.141 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -60.02 144.67 86.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 3.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.96 -25.12 66.96 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.684 1.589 . . . . 3.0299999999999998 111.224 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -65.68 -49.05 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 3.0699999999999998 111.18 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.5 p -89.12 -24.13 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.262 -0.426 . . . . 3.1000000000000001 111.204 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -69.96 -46.79 64.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 3.1299999999999999 111.192 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.89 -15.43 61.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 3.1699999999999999 111.188 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.24 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 3.2000000000000002 111.179 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.15 78.92 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 3.23 111.227 -169.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HB3' HD23 ' A' ' 103' ' ' LEU . 33.7 ptt-85 -149.82 165.1 33.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 3.27 111.193 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -131.97 114.43 14.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 3.2999999999999998 111.221 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 61.94 37.2 15.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 3.3300000000000001 111.163 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.8 7.68 83.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.213 -0.755 . . . . 3.3700000000000001 111.213 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.96 107.25 15.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 3.3999999999999999 111.171 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.409 HD23 ' HB3' ' A' ' 98' ' ' ARG . 58.0 mt -59.33 128.99 39.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 3.4300000000000002 111.12 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -112.36 -20.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 3.4700000000000002 111.228 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.35 176.0 6.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 3.5 111.268 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -113.25 127.32 26.96 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 3.5299999999999998 111.231 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.45 138.95 47.72 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.718 1.612 . . . . 3.5699999999999998 111.273 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.4 mm -116.14 -47.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 3.6000000000000001 111.243 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.73 154.98 50.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 3.6299999999999999 111.179 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 134.96 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 3.6699999999999999 111.252 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -124.9 123.41 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 3.7000000000000002 111.186 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.26 151.18 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 3.73 111.218 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.2 tp -138.18 125.81 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 3.77 111.166 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 t -159.98 -168.54 2.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 3.7999999999999998 111.179 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.95 125.54 36.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 3.8300000000000001 111.173 -168.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.86 139.99 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 3.8700000000000001 111.267 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -136.55 144.92 44.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 3.8999999999999999 111.205 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -75.52 123.5 25.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 3.9300000000000002 111.216 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -70.97 -30.1 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 3.9700000000000002 111.185 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -77.85 -43.26 30.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 4.0 111.209 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.14 -44.64 59.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 4.0300000000000002 111.163 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -128.54 77.3 77.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 4.0700000000000003 111.238 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.69 -25.01 74.97 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.659 1.573 . . . . 4.0999999999999996 111.198 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -105.19 100.07 23.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 4.1299999999999999 111.26 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.0 155.4 52.8 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.706 1.604 . . . . 4.1699999999999999 111.196 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 154.55 59.31 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.691 1.594 . . . . 4.2000000000000002 111.253 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -85.32 -15.64 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 4.2300000000000004 111.192 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.2 t -160.0 162.66 34.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 4.2699999999999996 111.192 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -59.4 -23.25 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 4.2999999999999998 111.215 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.43 -22.83 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.3300000000000001 111.185 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -96.76 2.97 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 4.3700000000000001 111.226 -176.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.528 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 70.4 mt -66.93 -54.33 21.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 4.4000000000000004 111.191 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 67.5 Cg_endo -71.78 -18.52 28.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.735 1.623 . . . . 4.4299999999999997 111.233 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.98 -24.69 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 4.4699999999999998 111.197 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.2 -6.88 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 4.5 111.162 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.37 -35.01 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 4.5300000000000002 111.174 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.03 -39.88 83.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 4.5700000000000003 111.213 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.61 -27.85 68.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 4.5999999999999996 111.158 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.01 -0.36 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 4.6299999999999999 111.207 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.15 -26.27 68.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 4.6699999999999999 111.228 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.97 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 4.7000000000000002 111.232 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -99.92 -20.01 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 4.7300000000000004 111.183 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.61 24.8 44.88 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.145 -0.782 . . . . 4.7699999999999996 111.145 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -119.04 164.94 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 4.7999999999999998 111.19 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t -111.34 158.46 19.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 4.8300000000000001 111.213 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.1 -72.86 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.178 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.3 tp -156.94 129.0 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 4.9000000000000004 111.166 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mmm -84.73 140.55 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 4.9299999999999997 111.242 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.02 138.42 53.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 4.9699999999999998 111.165 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -82.91 119.78 24.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 5.0 111.209 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.407 HD21 HD11 ' A' ' 195' ' ' LEU . 99.0 mt -114.81 -25.52 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 5.0300000000000002 111.181 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.07 -39.82 90.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 5.0700000000000003 111.184 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.97 118.4 56.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 5.0999999999999996 111.208 -172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.96 -34.91 88.34 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.654 1.569 . . . . 5.1299999999999999 111.16 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -53.5 -37.69 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 5.1699999999999999 111.215 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.28 25.63 8.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 5.2000000000000002 111.245 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.3 p -103.34 -15.23 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 5.2300000000000004 111.154 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 75.0 t90 -68.67 -48.2 32.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 5.2699999999999996 111.217 175.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 67.6 Cg_endo -74.79 -4.36 15.29 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.674 1.582 . . . . 5.2999999999999998 111.193 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.8 mt -65.3 -21.04 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 5.3300000000000001 111.176 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.7 mt -109.68 -41.46 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 5.3700000000000001 111.173 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.02 -44.47 89.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 5.4000000000000004 111.232 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.01 -34.33 78.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 5.4299999999999997 111.233 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -64.2 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 5.4699999999999998 111.219 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.57 23.74 6.74 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.248 -0.741 . . . . 5.5 111.248 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.53 -22.05 17.61 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.169 -0.772 . . . . 5.5300000000000002 111.169 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 68.1 t80 -111.59 145.15 39.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 5.5700000000000003 111.122 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 67.55 22.79 9.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 5.5999999999999996 111.175 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.36 173.22 11.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 5.6299999999999999 111.171 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 5.6699999999999999 111.166 175.42 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.5 t0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.781 0.324 . . . . 5.9000000000000004 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.86 -34.11 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 5.9299999999999997 111.198 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -30.04 71.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 5.9699999999999998 111.156 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -65.59 143.03 57.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 6.0 111.169 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 183' ' ' VAL . 70.9 t -47.83 124.08 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 6.0300000000000002 111.142 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -98.48 14.31 62.18 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.229 -0.749 . . . . 6.0700000000000003 111.229 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.483 ' H ' HG12 ' A' ' 181' ' ' VAL . 25.0 m -123.63 31.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 6.0999999999999996 111.189 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -127.67 9.95 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 6.1299999999999999 111.25 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.38 161.38 14.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 6.1699999999999999 111.148 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.17 72.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 6.2000000000000002 111.148 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.32 -37.09 90.43 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.177 -0.769 . . . . 6.2300000000000004 111.177 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.2 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 6.2699999999999996 111.185 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.74 -40.76 75.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 6.2999999999999998 111.254 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.55 -28.91 68.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.146 -0.479 . . . . 6.3300000000000001 111.207 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -20.13 66.74 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.154 -0.778 . . . . 6.3700000000000001 111.154 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 347' ' ' VAL . 86.7 mt -104.99 -34.9 7.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 6.4000000000000004 111.203 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.9 m -64.56 -52.53 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 6.4299999999999997 111.233 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.62 -38.62 87.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 6.4699999999999998 111.193 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 151' ' ' LEU . 54.1 tp -58.17 -53.33 59.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 6.5 111.203 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.77 -42.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 6.5300000000000002 111.212 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.92 -39.67 86.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 6.5700000000000003 111.204 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 84.7 mt -70.4 -35.4 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 6.5999999999999996 111.23 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.24 -40.79 89.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.188 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.79 -24.62 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 6.6699999999999999 111.205 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.71 5.18 52.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 6.7000000000000002 111.22 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 60.65 35.26 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 6.7300000000000004 111.224 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -74.88 -34.06 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.215 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -145.21 149.93 35.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 6.7999999999999998 111.17 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -94.65 151.52 19.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 6.8300000000000001 111.243 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.94 -24.53 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 6.8700000000000001 111.229 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.77 -16.75 56.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 6.9000000000000004 111.146 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -56.4 118.03 4.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 6.9299999999999997 111.232 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -119.97 -164.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 6.9699999999999998 111.22 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.09 -47.83 81.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 7.0 111.167 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 82.5 p -75.09 -25.51 58.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 7.0300000000000002 111.183 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.5 mm -67.65 -52.26 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 7.0700000000000003 111.182 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.99 90.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 7.0999999999999996 111.201 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.39 -42.46 91.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 7.1299999999999999 111.218 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.08 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.173 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -26.67 68.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 7.2000000000000002 111.224 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -81.65 -45.28 15.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 7.2300000000000004 111.197 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.66 -30.12 64.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 7.2699999999999996 111.188 -174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -9.75 56.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 7.2999999999999998 111.222 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.16 32.87 51.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.194 -0.762 . . . . 7.3300000000000001 111.194 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -81.43 -29.33 33.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.764 0.316 . . . . 7.3700000000000001 111.191 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.1 p -100.24 160.04 14.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 7.4000000000000004 111.204 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.06 -24.76 16.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 7.4299999999999997 111.189 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 90.2 mmm -109.88 149.94 29.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 7.4699999999999998 111.168 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -159.64 179.61 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 7.5 111.174 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.2 mt -121.1 124.17 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 7.5300000000000002 111.178 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -165.01 179.94 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 7.5700000000000003 111.279 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -74.84 139.33 25.1 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.245 -0.742 . . . . 7.5999999999999996 111.245 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.32 129.84 35.51 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.67 1.58 . . . . 7.6299999999999999 111.188 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 57.39 49.93 12.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 7.6699999999999999 111.217 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.86 75.37 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 7.7000000000000002 111.226 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.427 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 48.4 m0 -68.28 -17.13 64.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 7.7300000000000004 111.146 -170.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 97.0 p -66.18 -19.97 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 7.7699999999999996 111.208 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -118.98 -19.41 8.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 7.7999999999999998 111.105 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.8 mt -90.77 -61.33 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.195 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.97 -39.55 75.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 7.8700000000000001 111.205 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 83.9 m -52.45 -44.93 65.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 7.9000000000000004 111.159 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 84.9 p -81.27 -10.47 59.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 7.9299999999999997 111.195 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 59.99 40.23 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 7.9699999999999998 111.247 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.63 135.06 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 8.0 111.161 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -73.85 111.24 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 8.0299999999999994 111.227 -175.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.31 145.02 44.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 8.0700000000000003 111.159 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.08 178.65 17.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.189 -0.764 . . . . 8.0999999999999996 111.189 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.89 139.96 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 8.1300000000000008 111.166 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.1 t -142.5 176.55 8.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 8.1699999999999999 111.209 171.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.57 112.85 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 8.1999999999999993 111.139 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.57 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 40.6 tp -63.46 -53.76 49.47 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 8.2300000000000004 111.212 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 70.8 Cg_endo -74.81 147.34 34.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.688 1.592 . . . . 8.2699999999999996 111.191 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.4 m -116.27 125.34 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 8.3000000000000007 111.177 174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -99.98 90.08 4.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 8.3300000000000001 111.188 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 52.14 55.47 9.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 8.3699999999999992 111.19 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 99.27 -23.59 35.68 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.221 -0.752 . . . . 8.4000000000000004 111.221 171.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -129.95 109.97 16.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 8.4299999999999997 111.232 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -54.98 130.71 42.2 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.719 1.613 . . . . 8.4700000000000006 111.194 173.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.7 t -114.97 -94.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 8.5 111.188 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.94 145.53 30.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 8.5299999999999994 111.185 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.73 -176.42 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.731 1.62 . . . . 8.5700000000000003 111.175 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -86.58 156.4 20.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 8.5999999999999996 111.201 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.14 117.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 8.6300000000000008 111.179 -173.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.57 150.05 19.03 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.222 -0.751 . . . . 8.6699999999999999 111.222 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.98 121.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.894 0.378 . . . . 8.6999999999999993 111.183 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.4 tp -95.44 110.93 22.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 8.7300000000000004 111.214 172.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 89.5 p -112.51 151.7 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 8.7699999999999996 111.156 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -111.48 126.93 55.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 8.8000000000000007 111.176 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.98 177.68 19.12 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.236 -0.746 . . . . 8.8300000000000001 111.236 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 80.2 mt -111.67 122.87 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 8.8699999999999992 111.184 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -60.75 128.9 38.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 8.9000000000000004 111.137 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.85 63.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 8.9299999999999997 111.232 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -87.17 -5.01 59.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 8.9700000000000006 111.108 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.9 t -80.43 132.39 58.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 9.0 111.179 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.68 -5.4 14.73 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.749 1.633 . . . . 9.0299999999999994 111.191 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -118.0 59.92 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 9.0700000000000003 111.218 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -77.76 -28.89 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 9.0999999999999996 111.243 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.45 -38.6 65.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 9.1300000000000008 111.265 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.41 -37.73 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 9.1699999999999999 111.199 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.83 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 9.1999999999999993 111.216 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.1 -48.85 70.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 9.2300000000000004 111.192 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.69 -47.6 77.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 9.2699999999999996 111.127 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.05 -41.06 74.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 9.3000000000000007 111.21 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.14 -3.76 58.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.3300000000000001 111.223 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.41 -50.01 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 9.3699999999999992 111.244 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -121.21 4.96 10.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 9.4000000000000004 111.163 -164.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -125.0 -62.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 9.4299999999999997 111.143 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.56 -53.29 58.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 9.4700000000000006 111.155 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 64.1 mt -85.03 60.8 6.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 9.5 111.199 -174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.6 p -134.94 167.53 20.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 9.5299999999999994 111.248 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.47 -34.62 78.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 9.5700000000000003 111.177 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.07 -35.18 22.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 9.5999999999999996 111.166 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.81 -48.76 63.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.69 -28.25 65.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 9.6699999999999999 111.232 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -69.41 -36.12 76.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 9.6999999999999993 111.148 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.01 78.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 9.7300000000000004 111.187 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -70.41 -39.95 77.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 9.7699999999999996 111.217 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.14 5.02 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8000000000000007 111.139 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -54.65 -50.21 68.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 9.8300000000000001 111.182 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -106.8 -18.16 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 9.8699999999999992 111.147 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -103.08 162.76 19.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 9.9000000000000004 111.277 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.45 144.93 48.67 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 121.729 1.619 . . . . 9.9299999999999997 111.198 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.23 -6.89 59.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 9.9700000000000006 111.18 -170.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -56.96 -35.9 70.95 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.139 -0.784 . . . . 10.0 111.139 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.19 127.98 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 10.029999999999999 111.12 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 304' ' ' LEU . 7.6 p -152.77 129.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 10.07 111.236 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -125.13 26.48 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 10.1 111.168 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.405 ' H ' HG22 ' A' ' 302' ' ' VAL . 36.2 tp -157.65 130.99 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 10.130000000000001 111.221 -172.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 86.7 tttt -61.78 -46.52 89.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 10.17 111.188 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 68.0 m -55.07 -38.25 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 10.199999999999999 111.16 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -71.39 -41.81 69.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 10.23 111.226 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.58 -34.27 66.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 10.27 111.237 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.48 -29.98 68.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 10.300000000000001 111.244 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -96.52 -30.02 13.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 10.33 111.142 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.45 -30.95 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 10.369999999999999 111.182 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.14 -9.12 54.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 10.4 111.196 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.93 -28.42 67.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 10.43 111.156 173.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -80.62 115.59 56.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.470000000000001 111.177 173.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.52 -38.81 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.726 1.618 . . . . 10.5 111.205 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.64 -39.87 70.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.166 -172.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.67 -40.04 76.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 10.57 111.194 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.59 -43.37 89.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 10.6 111.234 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.93 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 10.630000000000001 111.158 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 90.0 m -63.37 -43.06 98.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.199 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.98 -38.32 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 10.699999999999999 111.19 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -63.27 -46.16 88.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.197 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.96 -33.79 76.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 10.77 111.212 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.05 -45.68 84.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 10.800000000000001 111.167 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.23 -39.84 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 10.83 111.174 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -95.95 6.15 49.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 10.869999999999999 111.224 -174.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.65 -156.03 26.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.234 -0.746 . . . . 10.9 111.234 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -130.6 116.18 17.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 10.93 111.249 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 97.7 mt -105.08 137.0 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 10.970000000000001 111.209 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 83.0 mtp -63.35 130.57 94.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 11.0 111.235 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 50.7 Cg_exo -55.01 144.39 68.67 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 11.029999999999999 111.204 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -120.17 55.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 11.07 111.151 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 335' ' ' GLN . 82.0 mt -126.63 130.42 23.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 11.1 111.215 -178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.13 -29.22 74.23 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.697 1.598 . . . . 11.130000000000001 111.229 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 333' ' ' ILE . 90.6 mt-30 -64.02 -41.71 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 11.17 111.19 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 95.3 mmm -65.34 -37.25 86.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 11.199999999999999 111.249 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 39.4 t -59.92 -41.41 91.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 11.23 111.242 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.41 -36.65 83.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 11.27 111.252 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -64.98 -36.69 85.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 11.300000000000001 111.183 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -68.22 -29.76 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 11.33 111.177 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -62.76 -41.4 99.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 11.369999999999999 111.187 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.37 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 11.4 111.267 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.7 -42.59 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 11.43 111.153 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.5 -45.12 95.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 11.470000000000001 111.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.4 m -64.99 -39.94 94.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 11.5 111.241 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.29 -45.42 91.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 11.529999999999999 111.162 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 192' ' ' LEU . 70.1 t -64.72 -40.52 89.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 11.57 111.243 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.1 mt -65.13 -43.82 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 11.6 111.222 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.78 -37.37 87.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 11.630000000000001 111.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.0 -44.37 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 11.67 111.203 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.03 79.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 11.699999999999999 111.218 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.4 p -82.93 -14.95 53.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 11.73 111.22 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.25 12.26 65.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.22 -0.752 . . . . 11.77 111.22 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -70.04 -40.81 74.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 11.800000000000001 111.145 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -129.89 166.92 19.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 11.83 111.248 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -83.46 174.47 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 11.869999999999999 111.181 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -44.1 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 11.9 111.187 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.92 -42.75 80.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 11.93 111.201 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -64.74 -40.35 95.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 11.970000000000001 111.211 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.91 -48.49 73.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 12.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.26 -23.18 60.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 12.029999999999999 111.198 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.12 -48.48 73.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 12.07 111.186 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.63 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 12.1 111.241 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.54 93.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 12.130000000000001 111.173 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.35 -40.62 97.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 12.17 111.16 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 95.9 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 12.199999999999999 111.248 178.782 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.763 0.316 . . . . 0.070000000000000007 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -95.58 139.96 31.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.243 -0.435 . . . . 0.10000000000000001 111.231 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.68 125.04 21.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.13 111.199 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.64 5.21 60.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.2 -0.76 . . . . 0.17000000000000001 111.2 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HG2' ' HB2' ' A' ' 34' ' ' LYS . 96.0 mttt -133.47 148.56 51.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.20000000000000001 111.116 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.2 mt -113.74 140.76 48.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.23000000000000001 111.152 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.93 110.89 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.27000000000000002 111.178 172.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.445 HG12 ' HB ' ' A' ' 59' ' ' ILE . 69.8 mt -113.79 116.21 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.29999999999999999 111.235 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.417 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 38.7 m0 -105.46 119.76 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.33000000000000002 111.164 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.43 139.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.37 111.208 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -67.63 119.31 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.142 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.81 -177.99 26.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.144 -0.782 . . . . 0.42999999999999999 111.144 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -102.71 -35.03 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.46999999999999997 111.138 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.83 163.26 28.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.5 111.201 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.41 -7.9 9.01 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.149 -0.781 . . . . 0.53000000000000003 111.149 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -60.75 -23.23 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.317 . . . . 0.56999999999999995 111.188 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -67.23 -36.43 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.59999999999999998 111.167 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.59 -44.86 94.46 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.28 -0.728 . . . . 0.63 111.28 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 37' ' ' VAL . 80.4 mt -70.15 -32.74 70.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.753 0.311 . . . . 0.67000000000000004 111.162 175.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.03 92.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.69999999999999996 111.181 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -61.41 -34.76 75.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.72999999999999998 111.207 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.95 -39.78 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.77000000000000002 111.256 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.09 79.78 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.27 -0.732 . . . . 0.80000000000000004 111.27 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.07 -37.39 84.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.337 . . . . 0.82999999999999996 111.227 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.89 -37.43 87.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.87 111.169 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -30.0 67.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.90000000000000002 111.183 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.39 -36.48 66.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.93000000000000005 111.145 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -82.79 -39.15 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.96999999999999997 111.238 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.71 -50.22 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.199 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -102.46 -49.34 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.03 111.202 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.44 21.57 3.01 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.213 -0.755 . . . . 1.0700000000000001 111.213 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.56 122.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 1.1000000000000001 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HB2' ' HG2' ' A' ' 6' ' ' LYS . 99.1 mttt -87.97 127.75 35.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 1.1299999999999999 111.182 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.22 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 1.1699999999999999 111.218 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -115.42 125.05 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 1.2 111.158 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 20' ' ' LEU . 40.2 t -114.95 126.38 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.195 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -129.96 162.6 28.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.27 111.201 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -112.32 106.84 55.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.228 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 78.7 Cg_endo -75.51 175.82 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.66 1.573 . . . . 1.3300000000000001 111.194 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -131.49 109.84 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 1.3700000000000001 111.219 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 58.07 69.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 1.3999999999999999 111.183 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.02 -18.59 61.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 1.4299999999999999 111.199 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -64.54 -15.08 60.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.202 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -99.24 -34.84 10.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 1.5 111.195 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -89.89 -48.66 7.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.53 111.208 -166.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 2.6 m-30 -56.47 -47.49 98.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.19 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 80.3 Cg_exo -50.46 -35.07 44.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.731 1.62 . . . . 1.6000000000000001 111.229 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -79.86 -47.47 15.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 1.6299999999999999 111.247 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -78.42 -16.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 1.6699999999999999 111.256 -174.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 1.7 111.204 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.66 -15.49 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 1.73 111.208 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -108.5 -14.97 14.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 1.77 111.194 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.55 30.25 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.249 -0.74 . . . . 1.8 111.249 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -110.16 169.99 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.327 . . . . 1.8300000000000001 111.221 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.48 -173.83 25.72 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.201 -0.76 . . . . 1.8700000000000001 111.201 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.63 173.22 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.68 1.587 . . . . 1.8999999999999999 111.258 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -88.77 -50.93 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 1.9299999999999999 111.221 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HB ' HG12 ' A' ' 9' ' ' ILE . 84.9 mt -116.27 132.97 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.97 111.162 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.1 mt -114.2 117.56 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 2.0 111.139 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -114.07 106.5 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 111.234 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -150.46 159.97 44.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 2.0699999999999998 111.155 -166.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.12 158.52 27.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.213 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.408 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 46.3 m170 -71.58 -2.8 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 2.1299999999999999 111.197 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.41 -30.94 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 2.1699999999999999 111.188 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mmt-85 -129.95 -27.92 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 2.2000000000000002 111.159 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -55.04 -43.34 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 2.23 111.211 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.31 -28.32 72.1 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.244 -0.742 . . . . 2.27 111.244 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.71 -11.32 81.88 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.145 -0.782 . . . . 2.2999999999999998 111.145 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -69.6 -29.94 67.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.717 0.294 . . . . 2.3300000000000001 111.188 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.71 -35.18 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 2.3700000000000001 111.242 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -70.02 -38.71 75.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 2.3999999999999999 111.202 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.3 p -69.82 -19.99 63.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 2.4300000000000002 111.221 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.31 23.98 25.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.168 -0.773 . . . . 2.4700000000000002 111.168 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.6 30.91 6.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 2.5 111.234 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.9 tp -151.1 115.32 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 2.5299999999999998 111.224 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.77 162.44 24.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 2.5699999999999998 111.184 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -85.65 86.86 7.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 2.6000000000000001 111.211 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 mm -98.47 101.93 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 2.6299999999999999 111.15 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -92.94 120.76 66.89 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 2.6699999999999999 111.203 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.14 141.27 80.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.713 1.609 . . . . 2.7000000000000002 111.194 176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -89.65 -174.28 4.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.24 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.67 -38.63 67.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 2.77 111.209 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.22 79.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 2.7999999999999998 111.187 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.82 -22.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 2.8300000000000001 111.155 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -62.52 -29.62 70.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 2.8700000000000001 111.168 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -97.61 -30.17 13.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 2.8999999999999999 111.205 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -79.98 -35.17 37.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 2.9300000000000002 111.255 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -94.57 149.49 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.9700000000000002 111.192 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -73.35 135.02 79.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 3.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.07 -46.94 29.25 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.643 1.562 . . . . 3.0299999999999998 111.208 -170.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.52 -46.82 85.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 3.0699999999999998 111.241 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.3 p -82.41 -15.92 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 3.1000000000000001 111.228 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 85.8 t90 -65.98 -52.34 50.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 3.1299999999999999 111.259 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -85.78 9.98 14.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 3.1699999999999999 111.271 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.89 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 3.2000000000000002 111.239 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -104.07 24.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 3.23 111.175 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.2 ttt180 -76.57 129.98 37.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 3.27 111.206 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -157.95 132.81 8.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 3.2999999999999998 111.241 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 68.49 35.05 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 3.3300000000000001 111.149 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.59 -35.13 4.93 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.226 -0.75 . . . . 3.3700000000000001 111.226 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -130.62 171.95 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 3.3999999999999999 111.182 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.8 mp -77.94 145.17 36.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 3.4300000000000002 111.231 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.8 14.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 3.4700000000000002 111.136 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -168.92 178.89 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 3.5 111.15 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -110.07 117.54 51.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 3.5299999999999998 111.177 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.04 136.73 76.42 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.71 1.607 . . . . 3.5699999999999998 111.204 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.1 mm -112.96 -60.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 3.6000000000000001 111.3 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -154.93 162.61 41.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 3.6299999999999999 111.145 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.01 159.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 3.6699999999999999 111.193 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.25 126.76 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 3.7000000000000002 111.137 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.02 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 3.73 111.219 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.4 tp -124.26 111.58 16.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 3.77 111.19 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 t -166.91 -171.65 1.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 3.7999999999999998 111.18 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.2 tp -53.06 108.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 3.8300000000000001 111.198 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 244' ' ' VAL . 81.0 mt -92.55 114.13 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 3.8700000000000001 111.153 165.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -124.28 153.63 41.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 3.8999999999999999 111.165 -169.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -85.05 113.46 21.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 3.9300000000000002 111.147 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.34 -30.85 69.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 3.9700000000000002 111.182 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -72.1 -30.21 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 4.0 111.135 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.2 -13.8 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 4.0300000000000002 111.24 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 38.1 tp -142.97 79.79 14.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 4.0700000000000003 111.214 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.17 -19.48 29.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.757 1.638 . . . . 4.0999999999999996 111.205 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -120.16 89.97 43.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 4.1299999999999999 111.183 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.55 157.48 48.77 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.27 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.38 154.74 45.9 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.77 1.646 . . . . 4.2000000000000002 111.172 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.56 -5.24 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 4.2300000000000004 111.217 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -164.3 156.14 16.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 4.2699999999999996 111.19 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -59.79 -18.84 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 4.2999999999999998 111.221 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.67 -14.46 60.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 4.3300000000000001 111.164 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.67 6.03 47.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 4.3700000000000001 111.202 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.5 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 30.3 mm -74.19 -44.17 6.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.2 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 89.7 Cg_exo -49.24 -41.91 41.14 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.662 1.575 . . . . 4.4299999999999997 111.217 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.26 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 4.4699999999999998 111.167 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.16 -52.75 11.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 4.5 111.261 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.96 -37.79 61.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 4.5300000000000002 111.206 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.42 -57.72 10.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 4.5700000000000003 111.191 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.94 -30.61 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 4.5999999999999996 111.233 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.4 ' HB3' ' HG3' ' A' ' 144' ' ' LYS . 95.0 mt -77.08 -30.44 55.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 4.6299999999999999 111.248 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.98 -37.5 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 4.6699999999999999 111.216 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.62 -28.45 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 4.7000000000000002 111.213 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.45 -1.66 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 4.7300000000000004 111.149 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.25 25.26 40.63 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' A' ' 139' ' ' LEU . 29.9 pttt -129.95 160.09 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 4.7999999999999998 111.19 175.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.9 t -138.82 144.86 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 4.8300000000000001 111.219 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.03 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 4.8700000000000001 111.17 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 mt -110.38 121.58 45.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 4.9000000000000004 111.118 169.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.8 tpp -150.16 115.26 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 4.9299999999999997 111.211 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.7 176.0 7.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 4.9699999999999998 111.226 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -79.91 120.26 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 5.0 111.153 160.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 151' ' ' LEU . 4.0 mm? -90.23 -37.96 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 5.0300000000000002 111.223 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -65.16 -42.34 93.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 5.0700000000000003 111.146 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.9 126.45 75.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 5.0999999999999996 111.205 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.29 -21.26 31.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.681 1.587 . . . . 5.1299999999999999 111.202 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.39 -38.2 73.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 5.1699999999999999 111.192 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -99.33 14.93 27.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 5.2000000000000002 111.2 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.2 p -103.1 -10.92 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 5.2300000000000004 111.169 173.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.545 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 51.5 t-105 -72.43 -42.74 8.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 5.2699999999999996 111.19 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 70.8 Cg_exo -55.04 -33.27 82.76 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.73 1.62 . . . . 5.2999999999999998 111.171 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.455 HD13 ' HG ' ' A' ' 195' ' ' LEU . 63.1 mt -69.26 -24.63 64.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 5.3300000000000001 111.188 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 49.0 mm -81.3 -40.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 5.3700000000000001 111.218 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.15 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 5.4000000000000004 111.162 174.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.52 76.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 5.4299999999999997 111.153 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.04 -62.03 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 5.4699999999999998 111.206 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.99 -8.34 70.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.236 -0.746 . . . . 5.5 111.236 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.44 55.1 3.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.167 -0.773 . . . . 5.5300000000000002 111.167 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.78 151.67 33.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 5.5700000000000003 111.256 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 48.19 42.26 17.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 5.5999999999999996 111.24 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -139.93 78.82 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 5.6299999999999999 111.163 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 5.6699999999999999 111.216 -174.507 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.79 0.329 . . . . 5.9000000000000004 111.178 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 pt -95.28 5.45 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 5.9299999999999997 111.25 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.56 28.18 8.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 5.9699999999999998 111.191 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -82.25 169.97 15.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 6.0 111.157 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 95.6 t -112.87 124.84 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 6.0300000000000002 111.169 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -66.2 -39.36 94.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.212 -0.755 . . . . 6.0700000000000003 111.212 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.51 0.08 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 6.0999999999999996 111.156 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -106.16 -4.84 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 6.1299999999999999 111.226 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -83.31 160.04 21.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 6.1699999999999999 111.22 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.69 70.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 6.2000000000000002 111.193 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.82 -33.67 63.77 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.237 -0.745 . . . . 6.2300000000000004 111.237 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.76 -28.63 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 6.2699999999999996 111.154 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.04 -64.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 6.2999999999999998 111.157 -174.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.39 -34.78 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 6.3300000000000001 111.151 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -33.44 87.23 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.273 -0.731 . . . . 6.3700000000000001 111.273 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.0 tp -75.0 -39.58 61.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 6.4000000000000004 111.236 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.9 m -54.57 -46.47 73.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.179 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -63.19 -47.6 81.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 6.4699999999999998 111.177 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.5 tt -50.0 -54.03 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 6.5 111.209 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.43 -36.47 76.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.144 -0.48 . . . . 6.5300000000000002 111.19 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.07 -35.02 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.5700000000000003 111.203 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.44 -27.14 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 6.5999999999999996 111.194 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.91 -36.91 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 6.6299999999999999 111.241 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.79 -21.66 59.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 6.6699999999999999 111.265 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -90.04 3.68 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 6.7000000000000002 111.216 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 62.26 35.09 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 6.7300000000000004 111.235 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -106.9 -30.01 9.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 6.7699999999999996 111.19 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 95.7 mtp -125.92 160.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 6.7999999999999998 111.169 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -125.2 118.92 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 6.8300000000000001 111.265 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.84 -24.07 67.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 6.8700000000000001 111.223 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -81.83 -10.09 59.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 6.9000000000000004 111.173 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.8 m -54.59 108.54 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.174 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -89.98 179.82 5.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 6.9699999999999998 111.202 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -63.28 -49.09 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 7.0 111.248 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.1 p -65.06 -24.03 67.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 7.0300000000000002 111.167 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.31 -47.95 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 7.0700000000000003 111.272 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.27 90.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.208 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.43 -51.97 63.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 7.1299999999999999 111.247 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.76 94.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 7.1699999999999999 111.201 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.45 94.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 7.2000000000000002 111.213 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.93 -45.48 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 7.2300000000000004 111.181 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -69.94 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 7.2699999999999996 111.201 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.85 -11.78 56.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.2999999999999998 111.206 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.33 26.12 48.81 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.163 -0.775 . . . . 7.3300000000000001 111.163 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -78.53 -34.44 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 7.3700000000000001 111.199 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 84.9 m -123.87 112.42 17.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 7.4000000000000004 111.172 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.29 93.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 7.4299999999999997 111.18 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 62.3 ttp -127.31 119.99 27.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 7.4699999999999998 111.226 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 41.1 p -127.58 179.97 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 7.5 111.19 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.16 118.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 7.5300000000000002 111.24 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -108.23 120.83 43.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.438 . . . . 7.5700000000000003 111.199 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 232' ' ' TRP . . . -77.87 -172.9 39.87 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.254 -0.739 . . . . 7.5999999999999996 111.254 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.13 -34.45 87.66 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.618 1.545 . . . . 7.6299999999999999 111.163 -175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -71.59 -31.54 67.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 7.6699999999999999 111.234 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.77 6.67 13.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 7.7000000000000002 111.239 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.461 ' N ' ' O ' ' A' ' 228' ' ' GLY . 92.3 t90 -54.15 -36.39 63.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 7.7300000000000004 111.227 -170.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.1 p -62.39 -17.37 58.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 7.7699999999999996 111.228 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -57.63 -49.93 74.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 7.7999999999999998 111.234 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.0 tp -74.45 -28.47 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 7.8300000000000001 111.158 -173.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.75 -35.29 57.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 7.8700000000000001 111.233 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 76.1 m -67.15 -31.66 72.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 7.9000000000000004 111.163 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 60.6 p -69.62 -15.03 63.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 7.9299999999999997 111.171 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 58.44 50.24 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 7.9699999999999998 111.187 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.07 175.83 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 8.0 111.183 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -85.32 119.48 25.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 8.0299999999999994 111.15 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.44 160.07 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 8.0700000000000003 111.24 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -164.21 -168.17 25.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.245 -0.742 . . . . 8.0999999999999996 111.245 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 116' ' ' ILE . 77.6 t -131.25 140.08 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 8.1300000000000008 111.205 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -122.69 -173.76 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 8.1699999999999999 111.248 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.12 113.44 43.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 8.1999999999999993 111.188 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.544 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 74.2 mt -83.88 -45.41 0.78 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 8.2300000000000004 111.145 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 79.3 Cg_endo -80.64 156.01 21.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.694 1.596 . . . . 8.2699999999999996 111.168 -167.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.9 p -119.8 161.31 20.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 8.3000000000000007 111.279 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -123.36 100.94 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 8.3300000000000001 111.187 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 59.4 32.82 22.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 8.3699999999999992 111.221 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.82 62.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -122.11 110.03 33.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 8.4299999999999997 111.165 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.37 143.74 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.669 1.579 . . . . 8.4700000000000006 111.248 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -139.54 -74.93 0.36 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 8.5 111.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -131.26 158.55 74.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 8.5299999999999994 111.231 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.56 161.76 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.662 1.575 . . . . 8.5700000000000003 111.257 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -73.97 125.76 28.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 8.5999999999999996 111.198 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.2 t -111.08 124.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 8.6300000000000008 111.196 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -81.77 143.74 23.59 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.175 -0.77 . . . . 8.6699999999999999 111.175 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 65.7 t -121.11 130.03 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 8.6999999999999993 111.167 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.38 131.95 52.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 8.7300000000000004 111.176 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.5 p -145.07 154.74 42.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 8.7699999999999996 111.2 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -119.14 132.59 56.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 8.8000000000000007 111.117 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.22 -179.32 16.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.184 -0.766 . . . . 8.8300000000000001 111.184 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -108.78 130.65 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.788 0.328 . . . . 8.8699999999999992 111.237 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -60.7 134.06 56.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 8.9000000000000004 111.144 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.98 -18.43 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 8.9299999999999997 111.201 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.98 58.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 8.9700000000000006 111.248 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.0 t -65.0 127.93 93.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 9.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.01 -14.97 20.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.743 1.629 . . . . 9.0299999999999994 111.234 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -130.02 74.95 1.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 9.0700000000000003 111.202 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -80.08 -22.91 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 9.0999999999999996 111.22 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -74.12 -35.56 64.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 9.1300000000000008 111.215 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.7 -42.48 77.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 9.1699999999999999 111.259 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -38.98 92.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 9.1999999999999993 111.189 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -56.19 -51.45 67.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 9.2300000000000004 111.204 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.33 -42.12 99.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 9.2699999999999996 111.115 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.92 -42.45 80.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 9.3000000000000007 111.225 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.1 -3.55 58.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 9.3300000000000001 111.167 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -103.21 -50.83 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 9.3699999999999992 111.169 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -124.73 4.88 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 9.4000000000000004 111.266 -164.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -125.07 -70.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 9.4299999999999997 111.143 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 66.3 tp -65.43 -57.58 7.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 9.4700000000000006 111.246 -172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.96 61.78 7.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 9.5 111.218 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 31.4 p -129.94 -171.13 2.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 9.5299999999999994 111.223 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -75.5 -9.91 58.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 9.5700000000000003 111.196 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -116.13 -33.81 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 9.5999999999999996 111.214 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.78 -51.04 31.94 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.158 -0.777 . . . . 9.6300000000000008 111.158 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.02 -20.69 59.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.74 0.305 . . . . 9.6699999999999999 111.135 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.1 -47.17 84.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 9.6999999999999993 111.186 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.13 80.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 9.7300000000000004 111.218 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.54 -39.72 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 9.7699999999999996 111.177 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.92 7.27 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 9.8000000000000007 111.252 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.89 -43.04 80.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 9.8300000000000001 111.237 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -98.45 -20.41 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.8699999999999992 111.248 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.96 155.24 47.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 9.9000000000000004 111.202 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.21 144.98 79.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.714 1.609 . . . . 9.9299999999999997 111.251 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 24.51 12.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.168 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -66.95 -27.2 73.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.205 -0.758 . . . . 10.0 111.205 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.98 27.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 10.029999999999999 111.203 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.6 p -159.0 141.02 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 10.07 111.19 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.68 60.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 10.1 111.168 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 38.5 tp -60.25 125.06 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 10.130000000000001 111.157 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.64 -34.85 72.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 10.17 111.261 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 47.0 t -53.78 -52.2 60.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 10.199999999999999 111.184 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -66.46 -44.14 83.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 10.23 111.199 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -52.78 -42.45 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 10.27 111.261 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.81 -40.59 79.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.228 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -29.96 63.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 10.33 111.26 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.32 -17.86 33.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 10.369999999999999 111.226 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.81 -17.45 63.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 10.4 111.216 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.7 -30.67 71.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 10.43 111.177 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -77.93 118.25 70.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 10.470000000000001 111.221 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -57.6 -39.89 84.64 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.704 1.603 . . . . 10.5 111.181 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.66 -40.04 69.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 10.529999999999999 111.255 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.3 mt -69.97 -40.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 10.57 111.163 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.96 78.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 10.6 111.223 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.78 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 10.630000000000001 111.162 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -68.57 -42.84 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 10.67 111.216 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.0 mtt -66.51 -34.39 77.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 10.699999999999999 111.244 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.65 -47.08 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.152 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -76.05 -31.66 58.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 10.77 111.218 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.5 93.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 10.800000000000001 111.277 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 10.83 111.221 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.43 13.69 17.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.216 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.6 -175.02 40.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.162 -0.775 . . . . 10.9 111.162 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.443 ' HA ' ' OE1' ' A' ' 328' ' ' GLU . 5.2 tp10 -99.96 139.65 35.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 10.93 111.226 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 94.3 mt -94.75 130.43 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 10.970000000000001 111.165 -171.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.408 ' SD ' ' HB2' ' A' ' 64' ' ' HIS . 47.2 ttm -60.0 116.64 18.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 11.0 111.17 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.61 160.16 18.17 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.764 1.643 . . . . 11.029999999999999 111.246 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -109.85 20.21 18.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 11.07 111.113 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 333' ' ' ILE . 3.8 mp -86.12 122.93 72.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 11.1 111.171 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.99 -47.02 29.82 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.669 1.579 . . . . 11.130000000000001 111.269 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.81 -46.31 90.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 11.17 111.293 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.406 ' H ' HG22 ' A' ' 333' ' ' ILE . 67.1 mtt -60.06 -43.05 95.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 11.199999999999999 111.129 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.3 m -57.23 -41.14 78.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 11.23 111.117 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.63 94.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 11.27 111.213 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -71.7 -29.63 64.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.300000000000001 111.226 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -59.94 -51.98 67.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 11.33 111.163 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.73 -38.44 86.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 11.369999999999999 111.132 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -54.8 -37.72 66.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 11.4 111.211 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.4 t -71.7 -40.69 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 11.43 111.182 174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -51.06 -37.68 47.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 11.470000000000001 111.148 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.5 p -94.24 -26.98 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 11.5 111.184 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.08 -38.03 89.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 11.529999999999999 111.152 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.61 -21.6 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 11.57 111.203 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.95 -45.54 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 11.6 111.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 11.630000000000001 111.268 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.06 -39.59 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 11.67 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.28 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 11.699999999999999 111.161 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.9 p -78.31 -13.66 59.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 11.73 111.163 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.94 25.87 33.29 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.213 -0.755 . . . . 11.77 111.213 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -90.07 -48.55 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 11.800000000000001 111.178 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -124.99 165.22 18.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 11.83 111.242 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -84.77 175.06 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 11.869999999999999 111.131 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.7 t -59.31 -44.86 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 11.9 111.185 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 11.93 111.254 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.13 -44.67 87.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 11.970000000000001 111.221 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.67 94.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 12.0 111.226 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.75 -24.99 48.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 12.029999999999999 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.43 -48.31 78.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 12.07 111.178 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -69.46 -33.91 73.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 12.1 111.118 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.5 75.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 12.130000000000001 111.184 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -70.02 -56.66 6.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 12.17 111.151 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 12.199999999999999 111.171 -173.003 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.837 0.351 . . . . 0.070000000000000007 111.229 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -98.15 155.09 17.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.10000000000000001 111.139 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -93.67 155.05 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.13 111.212 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.24 16.82 54.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.235 -0.746 . . . . 0.17000000000000001 111.235 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.81 160.0 21.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.746 0.308 . . . . 0.20000000000000001 111.237 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.6 pp -145.89 153.95 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.254 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.35 135.26 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.27000000000000002 111.187 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 37' ' ' VAL . 83.5 mt -115.6 124.97 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.29999999999999999 111.222 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -103.61 105.15 15.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.33000000000000002 111.233 172.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.8 tt -115.48 137.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.37 111.187 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -81.03 108.94 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 111.195 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.0 -173.15 46.07 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.217 -0.753 . . . . 0.42999999999999999 111.217 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -104.98 -53.04 2.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.819 0.343 . . . . 0.46999999999999997 111.186 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.12 18.71 5.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.5 111.156 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.96 -23.65 69.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.183 -0.767 . . . . 0.53000000000000003 111.183 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -53.81 -32.71 53.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.56999999999999995 111.184 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.45 -41.56 96.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.59999999999999998 111.214 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -34.88 83.39 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.218 -0.753 . . . . 0.63 111.218 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 284' ' ' LEU . 83.1 mt -81.95 -25.87 34.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 0.67000000000000004 111.197 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.63 47.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.69999999999999996 111.207 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.72999999999999998 111.246 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.56 -17.85 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.77000000000000002 111.182 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.77 -31.94 81.37 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.207 -0.757 . . . . 0.80000000000000004 111.207 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.67 -46.15 80.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.82999999999999996 111.178 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.68 -50.03 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.87 111.235 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.90000000000000002 111.199 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.79 -39.09 80.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.93000000000000005 111.223 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.23 -32.22 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.96999999999999997 111.24 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -71.31 -40.53 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.248 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.4 p -113.91 -29.97 6.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 1.03 111.181 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.62 -0.3 63.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 1.0700000000000001 111.22 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.3 mm -76.57 110.99 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.1000000000000001 111.211 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.0 124.99 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 1.1299999999999999 111.225 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.54 121.49 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 1.1699999999999999 111.171 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.16 121.31 37.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 1.2 111.241 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 9' ' ' ILE . 40.7 t -118.18 125.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 1.23 111.136 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.27 165.73 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 1.27 111.172 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -121.45 70.07 23.45 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.215 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.42 161.99 33.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.687 1.591 . . . . 1.3300000000000001 111.231 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -124.82 -178.32 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.3700000000000001 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 54.99 39.73 31.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 1.3999999999999999 111.217 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.95 -9.17 59.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 1.4299999999999999 111.186 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.24 -27.98 69.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 1.47 111.209 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.07 -34.59 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.5 111.212 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.25 -46.43 80.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 1.53 111.183 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.535 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 81.1 t80 -62.56 -53.41 57.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 1.5700000000000001 111.132 -173.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 46.8 Cg_endo -67.76 -25.73 39.45 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.686 1.591 . . . . 1.6000000000000001 111.172 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -65.21 -35.27 80.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 1.6299999999999999 111.271 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -97.29 -26.17 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.6699999999999999 111.213 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.96 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 1.7 111.242 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.72 67.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.73 111.152 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 p -96.69 3.54 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.77 111.162 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.72 20.24 56.48 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.21 -0.756 . . . . 1.8 111.21 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -119.99 -166.02 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 1.8300000000000001 111.222 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.53 -164.87 12.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.205 -0.758 . . . . 1.8700000000000001 111.205 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.17 -176.32 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.714 1.609 . . . . 1.8999999999999999 111.221 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 276' ' ' ALA . 43.4 m-20 -103.33 -40.26 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.9299999999999999 111.252 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.37 138.36 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 1.97 111.226 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 42.0 mm -113.96 122.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.0 111.267 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 27.1 m-85 -100.02 110.96 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 2.0299999999999998 111.242 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.485 ' C ' ' CD1' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -145.03 -175.0 4.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 2.0699999999999998 111.228 -173.072 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.12 176.75 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 2.1000000000000001 111.16 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -87.43 14.58 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 2.1299999999999999 111.18 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -96.75 -29.97 13.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 111.193 172.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -118.28 12.35 13.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 2.2000000000000002 111.164 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -70.01 -21.15 63.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 2.23 111.242 -172.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.97 -12.74 83.14 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.51 -54.34 37.94 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.26 -0.736 . . . . 2.2999999999999998 111.26 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 5.2 m-30 -88.89 -20.43 24.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.3300000000000001 111.196 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.48 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 2.3700000000000001 111.236 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -68.67 -31.03 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 2.3999999999999999 111.166 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -75.18 -28.96 60.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 2.4300000000000002 111.192 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.28 31.56 33.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.253 -0.739 . . . . 2.4700000000000002 111.253 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -99.58 1.16 43.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.75 0.31 . . . . 2.5 111.199 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.76 131.53 34.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 2.5299999999999998 111.26 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 149.23 34.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 2.5699999999999998 111.194 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.07 124.37 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 2.6000000000000001 111.224 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.6 mt -115.05 129.4 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 2.6299999999999999 111.212 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -125.03 104.63 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 2.6699999999999999 111.152 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.98 148.52 45.36 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.714 1.609 . . . . 2.7000000000000002 111.207 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -84.91 179.99 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.215 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.4 -49.89 74.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 2.77 111.212 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.2 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 2.7999999999999998 111.194 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.02 -45.06 83.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 2.8300000000000001 111.216 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.31 -27.93 69.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.199 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -94.64 -19.71 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 2.8999999999999999 111.204 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -79.92 -29.99 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 2.9300000000000002 111.247 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.12 150.52 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 2.9700000000000002 111.169 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.19 135.66 96.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 3.0 111.154 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.1 -47.64 24.81 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.73 1.62 . . . . 3.0299999999999998 111.161 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.8 -54.96 23.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 3.0699999999999998 111.239 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.7 m -60.06 -36.87 78.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 3.1000000000000001 111.161 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -65.65 -42.73 91.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 3.1299999999999999 111.182 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.19 -19.92 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 3.1699999999999999 111.242 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -30.0 67.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 3.2000000000000002 111.219 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 332' ' ' ASN . 27.4 m -106.07 18.78 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 3.23 111.182 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -100.01 130.06 46.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 3.27 111.206 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -141.6 119.8 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 3.2999999999999998 111.148 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 65.55 43.85 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 3.3300000000000001 111.233 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.51 -42.27 2.35 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.178 -0.769 . . . . 3.3700000000000001 111.178 171.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -109.97 -178.78 3.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.807 0.336 . . . . 3.3999999999999999 111.216 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.47 154.47 18.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 3.4300000000000002 111.213 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.7 pt -113.99 -4.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 3.4700000000000002 111.157 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 167.22 21.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 3.5 111.181 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.3 m-30 -110.61 137.88 20.86 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 3.5299999999999998 111.17 170.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 46.9 Cg_exo -61.59 143.7 97.08 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.652 1.568 . . . . 3.5699999999999998 111.213 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 262' ' ' LEU . 95.1 mt -109.2 -58.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 3.6000000000000001 111.195 178.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.62 160.9 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 3.6299999999999999 111.217 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -107.77 145.87 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 3.6699999999999999 111.191 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -120.04 -179.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 3.7000000000000002 111.196 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.421 ' H ' ' HD3' ' A' ' 229' ' ' PRO . . . -128.55 167.89 16.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 3.73 111.198 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.522 HD21 ' HD3' ' A' ' 159' ' ' PRO . 65.1 tp -161.55 118.47 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 3.77 111.175 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -162.15 -178.02 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 3.7999999999999998 111.206 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 247' ' ' LEU . 52.2 tp -95.09 126.72 40.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 3.8300000000000001 111.15 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.2 mt -109.27 132.66 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 3.8700000000000001 111.173 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -148.7 159.16 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 3.8999999999999999 111.17 -172.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.33 117.55 30.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 3.9300000000000002 111.177 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 94.8 mttt -68.72 -47.49 66.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 3.9700000000000002 111.23 -175.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.69 -39.13 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 4.0 111.269 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.7 tp -65.48 -42.54 92.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.154 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.1 mt -125.02 73.46 65.59 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 4.0700000000000003 111.111 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 75.4 Cg_endo -79.58 142.3 16.19 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.195 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' PRO . 99.1 m-20 -70.64 149.76 95.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 4.1299999999999999 111.222 -12.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 89.4 Cg_exo -52.21 132.48 43.96 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.676 1.584 . . . . 4.1699999999999999 111.222 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 76.2 Cg_exo -53.08 133.55 52.56 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.723 1.615 . . . . 4.2000000000000002 111.223 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -112.68 -17.11 12.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 4.2300000000000004 111.198 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -157.33 176.92 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 4.2699999999999996 111.186 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -75.13 -19.96 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 4.2999999999999998 111.221 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.1 -13.19 61.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 4.3300000000000001 111.205 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -107.29 13.69 26.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 4.3700000000000001 111.2 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.572 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 94.3 mt -76.63 -41.26 2.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.197 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 85.8 Cg_exo -53.37 -28.39 43.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.739 1.626 . . . . 4.4299999999999997 111.167 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.96 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 4.4699999999999998 111.166 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.8 tp -79.15 -43.92 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 4.5 111.241 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -31.81 71.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 4.5300000000000002 111.21 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.67 -28.73 58.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 4.5700000000000003 111.206 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -80.12 -32.07 39.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 4.5999999999999996 111.261 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 91.7 mt -86.13 -7.67 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 4.6299999999999999 111.182 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.95 -44.94 78.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 4.6699999999999999 111.133 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.74 68.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 4.7000000000000002 111.144 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.61 -8.8 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 4.7300000000000004 111.211 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 27.53 60.25 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.206 -0.758 . . . . 4.7699999999999996 111.206 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 75.1 mmtt -115.55 159.13 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.873 0.368 . . . . 4.7999999999999998 111.177 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.9 t -98.86 153.92 18.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 4.8300000000000001 111.229 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.74 -26.75 64.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 4.8700000000000001 111.167 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.16 154.92 34.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 4.9000000000000004 111.16 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.8 mtm -108.11 115.7 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 4.9299999999999997 111.256 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.525 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 93.8 m-85 -95.5 130.81 42.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 4.9699999999999998 111.244 -154.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -117.69 77.29 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 5.0 111.152 164.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 149' ' ' PHE . 96.6 mt -97.86 -0.83 44.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 5.0300000000000002 111.139 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -71.54 -22.04 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 5.0700000000000003 111.224 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.44 150.96 53.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.269 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.17 -15.03 18.47 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.679 1.586 . . . . 5.1299999999999999 111.205 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.18 -29.21 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 5.1699999999999999 111.146 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -74.11 -41.03 62.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 5.2000000000000002 111.199 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -96.34 -8.56 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 5.2300000000000004 111.187 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.49 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 77.2 t90 -58.04 -46.0 99.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 5.2699999999999996 111.186 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD3' HD21 ' A' ' 113' ' ' LEU . 98.4 Cg_endo -84.05 -20.08 4.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.65 1.567 . . . . 5.2999999999999998 111.197 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.35 -45.86 75.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.164 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.96 -33.61 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 5.3700000000000001 111.198 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.46 -4.16 59.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 5.4000000000000004 111.217 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.02 72.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.4299999999999997 111.245 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -91.08 -10.06 43.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.179 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.25 25.12 49.37 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.153 -0.779 . . . . 5.5 111.153 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.82 -1.99 36.74 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.214 -0.755 . . . . 5.5300000000000002 111.214 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.13 106.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 5.5700000000000003 111.237 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 64.55 22.25 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 5.5999999999999996 111.211 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.37 147.29 28.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 5.6299999999999999 111.166 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 177' ' ' ASP . 24.1 ttmm . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 5.6699999999999999 111.194 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 170' ' ' LYS . 68.6 t0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.797 0.332 . . . . 5.9000000000000004 111.22 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.9 tt -69.97 -17.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 5.9299999999999997 111.203 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -80.04 -17.45 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 5.9699999999999998 111.17 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.82 169.92 16.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 6.0 111.2 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.57 91.23 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 6.0300000000000002 111.167 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.07 32.1 7.86 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.162 -0.775 . . . . 6.0700000000000003 111.162 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.45 -22.58 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.759 0.314 . . . . 6.0999999999999996 111.143 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -99.6 12.51 36.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.197 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.44 141.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 6.1699999999999999 111.177 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.43 -37.01 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 6.2000000000000002 111.179 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.63 -32.73 45.21 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.15 -0.78 . . . . 6.2300000000000004 111.15 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.82 -48.51 58.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.339 . . . . 6.2699999999999996 111.196 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -69.8 -24.17 63.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 6.2999999999999998 111.172 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 6.3300000000000001 111.187 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.07 -39.73 96.52 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.232 -0.747 . . . . 6.3700000000000001 111.232 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.5 tp -72.33 -30.62 64.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 6.4000000000000004 111.227 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.1 m -64.41 -42.69 95.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 6.4299999999999997 111.22 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -58.72 -47.18 85.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 6.4699999999999998 111.207 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.3 tp -46.56 -45.04 18.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 6.5 111.18 174.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -74.02 -36.85 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 6.5300000000000002 111.175 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.97 -36.84 68.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 6.5700000000000003 111.171 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.13 -32.86 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 6.5999999999999996 111.195 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.43 -40.03 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 6.6299999999999999 111.104 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.85 -29.63 70.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 6.6699999999999999 111.151 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -76.19 -8.96 58.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 6.7000000000000002 111.225 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 64.85 35.09 8.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 6.7300000000000004 111.174 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -129.15 53.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 6.7699999999999996 111.173 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 47.5 ttm -159.15 147.63 18.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 6.7999999999999998 111.224 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -146.5 114.63 6.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.429 . . . . 6.8300000000000001 111.159 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.42 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 6.8700000000000001 111.183 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.38 -25.89 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 6.9000000000000004 111.211 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.8 p -75.24 149.89 38.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 6.9299999999999997 111.213 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.78 -165.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 6.9699999999999998 111.211 -170.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.86 -51.87 67.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.0 111.165 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.1 p -70.83 -29.71 65.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 7.0300000000000002 111.244 -171.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.99 -45.03 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 7.0700000000000003 111.223 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 7.0999999999999996 111.171 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.24 -41.45 94.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 7.1299999999999999 111.22 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.0 -36.29 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 7.1699999999999999 111.158 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.06 93.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 7.2000000000000002 111.167 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.38 -33.44 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 7.2300000000000004 111.212 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -60.06 -39.35 85.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 7.2699999999999996 111.236 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 -30.22 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 7.2999999999999998 111.2 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.1 34.99 13.08 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.259 -0.737 . . . . 7.3300000000000001 111.259 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.14 -35.0 68.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 7.3700000000000001 111.204 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.9 m -129.99 139.18 51.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 7.4000000000000004 111.189 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.35 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 7.4299999999999997 111.143 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -85.09 153.68 22.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 7.4699999999999998 111.241 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.1 t -169.3 179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 7.5 111.287 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.34 118.63 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 7.5300000000000002 111.17 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -160.69 177.89 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 7.5700000000000003 111.189 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.79 -134.38 7.83 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.168 -0.773 . . . . 7.5999999999999996 111.168 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.421 ' HD3' ' H ' ' A' ' 112' ' ' ALA . 83.7 Cg_endo -81.77 -177.11 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.169 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 69.87 17.95 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 7.6699999999999999 111.161 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.66 -24.09 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 7.7000000000000002 111.188 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.455 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 97.9 m95 -69.52 -14.95 63.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 7.7300000000000004 111.123 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.6 p -64.96 -20.95 66.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 7.7699999999999996 111.216 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.05 -28.56 8.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 7.7999999999999998 111.225 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.2 mt -64.85 -45.11 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 7.8300000000000001 111.254 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -74.55 -33.8 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 7.8700000000000001 111.198 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.7 m -64.14 -44.6 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 7.9000000000000004 111.234 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.9 p -78.18 -15.04 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 7.9299999999999997 111.235 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.63 45.97 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 7.9699999999999998 111.217 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.84 141.21 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 8.0 111.157 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -74.87 78.69 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 8.0299999999999994 111.209 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -89.96 127.65 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 8.0700000000000003 111.183 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.407 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -100.4 166.39 19.72 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.223 -0.751 . . . . 8.0999999999999996 111.223 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 88.5 t -139.6 134.98 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.773 0.32 . . . . 8.1300000000000008 111.253 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.2 t -135.06 150.17 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 8.1699999999999999 111.21 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.4 t -70.29 110.81 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 8.1999999999999993 111.16 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 53.0 tp -75.38 -47.82 4.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 8.2300000000000004 111.282 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 85.7 Cg_endo -78.41 143.2 19.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.764 1.642 . . . . 8.2699999999999996 111.228 -173.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 78.8 m -107.74 133.59 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 8.3000000000000007 111.182 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -108.46 99.71 9.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 8.3300000000000001 111.221 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 57.69 35.14 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 8.3699999999999992 111.12 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 98.6 -15.57 60.84 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.175 -0.77 . . . . 8.4000000000000004 111.175 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -130.06 110.0 16.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 8.4299999999999997 111.161 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.8 151.69 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.7 1.6 . . . . 8.4700000000000006 111.268 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 98.9 p -137.6 -75.01 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 8.5 111.201 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 326' ' ' LYS . 74.5 mmtt -134.07 163.35 51.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 8.5299999999999994 111.163 -174.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.97 144.47 56.5 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.721 1.614 . . . . 8.5700000000000003 111.173 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.41 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 86.3 t80 -73.81 140.59 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 8.5999999999999996 111.185 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 261' ' ' VAL . 61.6 t -107.1 106.76 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 8.6300000000000008 111.221 -170.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -84.93 85.08 1.58 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.169 -0.773 . . . . 8.6699999999999999 111.169 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 259' ' ' VAL . 36.9 t -68.18 142.35 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 8.6999999999999993 111.188 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 74.1 mt -91.87 154.9 18.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 8.7300000000000004 111.257 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 91.2 p -143.71 155.13 44.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 8.7699999999999996 111.199 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 60' ' ' ILE . . . -121.76 124.3 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 8.8000000000000007 111.245 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -103.97 177.29 24.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.177 -0.769 . . . . 8.8300000000000001 111.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 87.5 mt -124.14 132.0 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 8.8699999999999992 111.2 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -69.32 114.28 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.148 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.54 -24.72 66.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 8.9299999999999997 111.163 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 8.9700000000000006 111.217 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -66.06 136.74 95.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 9.0 111.235 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.79 -12.1 26.24 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.727 1.618 . . . . 9.0299999999999994 111.206 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.59 21.51 8.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 9.0700000000000003 111.201 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -62.78 -21.88 66.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 9.0999999999999996 111.174 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.36 -34.5 77.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 9.1300000000000008 111.194 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 9.1699999999999999 111.155 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . . . -65.03 -41.86 94.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 9.1999999999999993 111.168 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.75 -44.55 81.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 9.2300000000000004 111.234 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -80.11 -52.75 7.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 9.2699999999999996 111.227 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -63.8 -37.05 85.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 9.3000000000000007 111.224 -171.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 284' ' ' LEU . 40.1 tp -68.12 -48.16 66.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 9.3300000000000001 111.187 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -72.08 -28.98 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 9.3699999999999992 111.182 -173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -99.56 -40.2 7.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 9.4000000000000004 111.181 -166.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.17 -54.84 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 9.4299999999999997 111.15 -169.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 20' ' ' LEU . 95.1 mt -64.1 -49.59 71.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 9.4700000000000006 111.148 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.85 51.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 9.5 111.165 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 76.7 p -124.97 -175.94 3.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 9.5299999999999994 111.153 170.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -53.29 -40.56 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 9.5700000000000003 111.197 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.35 -37.95 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 9.5999999999999996 111.134 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.37 -43.24 93.09 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.99 -36.23 83.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 9.6699999999999999 111.231 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -69.04 -41.86 77.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 9.6999999999999993 111.204 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.26 87.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 9.7300000000000004 111.154 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 68.0 t -74.91 -40.83 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 9.7699999999999996 111.17 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.563 ' HB3' HD23 ' A' ' 299' ' ' LEU . 96.7 m-20 -75.93 -2.93 32.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 9.8000000000000007 111.203 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.05 -38.14 67.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 9.8300000000000001 111.195 165.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -108.5 -34.03 6.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 9.8699999999999992 111.158 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.03 160.63 40.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 9.9000000000000004 111.205 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.65 139.38 67.29 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.667 1.578 . . . . 9.9299999999999997 111.167 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 294' ' ' ASN . 95.0 mt -66.38 -24.19 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 9.9700000000000006 111.153 -175.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.77 -28.84 70.71 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.153 -0.779 . . . . 10.0 111.153 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.91 122.83 13.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.779 0.323 . . . . 10.029999999999999 111.228 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.85 136.6 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.16 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -103.36 -34.79 8.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 10.1 111.188 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.16 138.72 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 10.130000000000001 111.176 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -61.36 -39.04 89.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 10.17 111.222 168.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 44.6 t -56.05 -48.62 75.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 10.199999999999999 111.175 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.55 -37.71 83.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 10.23 111.224 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.67 -36.74 77.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 10.27 111.173 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.73 -30.03 70.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 10.300000000000001 111.248 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.4 -32.16 62.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 10.33 111.198 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.22 -26.18 62.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 10.369999999999999 111.226 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.88 -19.22 65.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 10.4 111.324 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.48 -24.93 67.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 10.43 111.221 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -101.92 109.99 61.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 10.470000000000001 111.205 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.97 -32.92 80.78 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.659 1.573 . . . . 10.5 111.188 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.55 -28.09 67.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 10.529999999999999 111.264 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -91.01 -38.5 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 10.57 111.218 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.02 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 10.6 111.254 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.48 -35.5 74.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 10.630000000000001 111.231 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.1 p -91.33 -19.95 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 10.67 111.211 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.0 mmt -74.21 -35.92 63.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 10.699999999999999 111.205 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.5 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 10.73 111.285 171.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.32 -42.75 99.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 10.77 111.2 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.42 93.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 10.800000000000001 111.21 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.05 -42.5 99.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 10.83 111.179 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.407 ' HB2' ' HG3' ' A' ' 256' ' ' LYS . 99.7 mttt -94.95 7.53 45.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 10.869999999999999 111.198 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.88 -162.66 35.9 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.268 -0.733 . . . . 10.9 111.268 172.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -119.8 132.38 55.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 10.93 111.213 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.17 136.22 25.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 10.970000000000001 111.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 50.0 tpp -59.93 114.41 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 11.0 111.247 173.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.31 133.74 51.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.678 1.585 . . . . 11.029999999999999 111.221 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 97' ' ' VAL . 42.5 t-20 -94.18 72.81 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 11.07 111.207 173.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 80.4 mt -123.15 116.11 28.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 11.1 111.185 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.06 -33.45 73.6 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.632 1.555 . . . . 11.130000000000001 111.26 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -71.46 -27.86 63.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 11.17 111.23 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -86.88 -20.62 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 11.199999999999999 111.157 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 98.2 p -64.15 -29.98 71.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.178 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.97 -49.51 70.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 11.27 111.247 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -56.76 -48.74 77.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 11.300000000000001 111.173 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -68.75 -43.58 75.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 11.33 111.176 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 -73.89 -30.55 62.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 11.369999999999999 111.259 -176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.65 75.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 11.4 111.188 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.28 -21.82 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 11.43 111.279 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -56.56 -48.93 76.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 11.470000000000001 111.186 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 71.0 p -65.2 -29.7 70.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 11.5 111.175 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.03 -44.22 89.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 11.529999999999999 111.173 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.77 -38.52 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.173 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.92 -42.69 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 11.6 111.208 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -65.0 -39.17 93.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 11.630000000000001 111.21 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.45 -21.96 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 11.67 111.206 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.52 -30.39 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 11.699999999999999 111.22 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.5 p -86.16 -22.16 27.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 11.73 111.181 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.85 30.35 26.56 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.233 -0.747 . . . . 11.77 111.233 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -109.94 2.61 19.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 11.800000000000001 111.238 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -159.58 137.01 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 11.83 111.212 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 62.1 p -70.0 164.97 22.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 11.869999999999999 111.255 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.5 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 11.9 111.233 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.19 -46.99 88.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 11.93 111.207 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.87 -37.53 79.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 11.970000000000001 111.191 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.69 92.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 12.0 111.214 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 94.5 mt -74.98 -24.89 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 12.029999999999999 111.18 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.71 -49.3 73.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 12.07 111.167 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.84 -34.21 77.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.208 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.01 -59.56 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 12.130000000000001 111.2 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -54.94 -43.25 73.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 12.17 111.209 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 83.7 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 12.199999999999999 111.26 178.871 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.1 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.777 0.323 . . . . 0.070000000000000007 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -55.01 130.04 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.10000000000000001 111.226 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.27 129.44 40.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.13 111.194 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.62 27.94 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.258 -0.737 . . . . 0.17000000000000001 111.258 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.98 132.53 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.20000000000000001 111.252 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.71 120.02 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.23000000000000001 111.211 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.34 115.04 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.27000000000000002 111.212 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 37' ' ' VAL . 73.6 mt -115.05 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.29999999999999999 111.197 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -110.09 129.06 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.33000000000000002 111.194 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.0 mt -101.42 115.08 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.37 111.158 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -97.7 89.24 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.40000000000000002 111.225 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.5 -145.65 7.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.264 -0.735 . . . . 0.42999999999999999 111.264 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.47 22.77 8.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.46999999999999997 111.195 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -102.29 156.87 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.5 111.248 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.95 -164.98 38.01 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.185 -0.766 . . . . 0.53000000000000003 111.185 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -158.98 25.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.56999999999999995 111.215 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -59.68 -40.29 87.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.59999999999999998 111.187 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.07 -27.51 28.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.212 -0.755 . . . . 0.63 111.212 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.91 -40.51 95.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.67000000000000004 111.262 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.05 78.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.69999999999999996 111.178 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -65.0 -29.07 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.72999999999999998 111.227 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.5 t -72.66 -40.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.77000000000000002 111.188 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.87 82.18 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.234 -0.746 . . . . 0.80000000000000004 111.234 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.79 -36.88 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 111.175 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.53 -24.07 45.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.87 111.239 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.02 -32.68 70.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.90000000000000002 111.157 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -74.8 -36.95 62.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.93000000000000005 111.202 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.31 -46.06 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.96999999999999997 111.188 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.54 -58.79 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.163 -170.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -89.45 -49.27 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 1.03 111.2 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.49 21.4 3.03 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.205 -0.758 . . . . 1.0700000000000001 111.205 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.29 114.99 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 1.1000000000000001 111.191 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.25 110.08 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 1.1299999999999999 111.169 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.2 t -97.91 121.49 48.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 1.1699999999999999 111.119 -174.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.0 m -117.97 121.03 39.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.2 111.266 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 9' ' ' ILE . 46.9 t -107.36 125.38 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 1.23 111.207 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.99 172.04 12.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 1.27 111.237 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.445 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 37.2 t60 -139.97 52.73 3.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 1.3 111.168 -174.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 72.8 Cg_endo -72.01 152.67 57.42 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.649 1.566 . . . . 1.3300000000000001 111.26 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -101.92 -177.04 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.433 . . . . 1.3700000000000001 111.217 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 53.12 46.1 27.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 1.3999999999999999 111.233 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 90.3 mt -93.84 -37.75 11.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 1.4299999999999999 111.176 -174.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 pm0 -69.66 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 1.47 111.218 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -89.48 -19.58 24.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 1.5 111.19 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -110.19 -25.14 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 1.53 111.232 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.2 m-30 -58.51 -45.14 99.69 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 1.5700000000000001 111.22 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 64.8 Cg_exo -55.48 -30.96 76.16 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.656 1.57 . . . . 1.6000000000000001 111.247 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.02 -43.74 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.191 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -75.63 -23.32 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.6699999999999999 111.147 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -24.47 66.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 1.7 111.205 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.75 -8.05 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 1.73 111.167 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.0 p -114.01 -11.93 12.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 1.77 111.23 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.3 25.51 30.84 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.231 -0.748 . . . . 1.8 111.231 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -114.81 170.71 8.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 1.8300000000000001 111.244 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.48 -174.4 16.6 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.202 -0.759 . . . . 1.8700000000000001 111.202 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -74.87 -176.39 2.82 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.757 1.638 . . . . 1.8999999999999999 111.155 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -104.18 -48.12 3.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 1.9299999999999999 111.181 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -112.4 133.16 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 1.97 111.174 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.8 mt -131.2 129.78 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 2.0 111.152 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -85.93 142.89 28.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 2.0299999999999998 111.195 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 98.4 m95 -141.21 163.95 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 2.0699999999999998 111.231 174.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.46 166.22 11.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 2.1000000000000001 111.167 164.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -61.29 -30.28 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 2.1299999999999999 111.178 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -82.07 -0.86 46.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 2.1699999999999999 111.244 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.4 -25.06 7.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 2.2000000000000002 111.179 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 62' ' ' TRP . 8.8 m-85 -58.63 -43.18 89.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 2.23 111.186 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.97 -48.24 87.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 2.27 111.204 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.88 -38.03 42.71 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.192 -0.763 . . . . 2.2999999999999998 111.192 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -69.92 -37.4 75.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 2.3300000000000001 111.192 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.85 -36.17 64.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 2.3700000000000001 111.201 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.14 -42.44 85.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 2.3999999999999999 111.195 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.7 p -71.13 -14.98 62.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 2.4300000000000002 111.12 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.17 32.21 23.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.254 -0.738 . . . . 2.4700000000000002 111.254 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.14 -6.65 25.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.842 0.353 . . . . 2.5 111.188 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 tp -114.9 133.82 55.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 2.5299999999999998 111.229 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.92 146.84 37.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 2.5699999999999998 111.218 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.57 129.27 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 2.6000000000000001 111.257 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -121.02 133.45 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 2.6299999999999999 111.179 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -120.83 101.5 45.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 2.6699999999999999 111.235 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.36 147.44 32.62 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 121.692 1.595 . . . . 2.7000000000000002 111.176 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.99 148.97 38.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 2.73 111.194 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -53.45 -47.64 69.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 2.77 111.187 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 2.7999999999999998 111.191 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.15 -51.32 64.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 2.8300000000000001 111.175 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.9 -19.94 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 2.8700000000000001 111.185 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.46 -34.96 68.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 2.8999999999999999 111.149 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.56 -22.47 56.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 2.9300000000000002 111.222 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.72 154.93 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 2.9700000000000002 111.164 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.03 136.11 87.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 3.0 111.184 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.03 -14.96 23.54 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.676 1.584 . . . . 3.0299999999999998 111.227 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -80.37 -31.78 37.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 3.0699999999999998 111.191 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.4 p -96.03 -23.17 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 3.1000000000000001 111.201 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -62.51 -40.06 95.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 3.1299999999999999 111.199 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.6 -8.22 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 3.1699999999999999 111.235 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.36 -3.71 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 3.2000000000000002 111.232 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.5 66.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 3.23 111.226 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -129.76 154.98 46.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 3.27 111.179 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -153.1 129.9 10.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.205 -0.452 . . . . 3.2999999999999998 111.214 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 t30 62.62 29.85 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 3.3300000000000001 111.202 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.23 88.34 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.166 -0.774 . . . . 3.3700000000000001 111.166 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.55 145.55 47.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.766 0.317 . . . . 3.3999999999999999 111.18 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -71.37 137.52 48.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 3.4300000000000002 111.198 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.2 pt -123.94 -2.58 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 3.4700000000000002 111.224 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.6 168.87 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 3.5 111.211 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -109.52 129.15 24.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 3.5299999999999998 111.243 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.32 133.06 20.29 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.683 1.589 . . . . 3.5699999999999998 111.185 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.6 mt -113.23 -63.43 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 3.6000000000000001 111.192 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.39 149.87 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 3.6299999999999999 111.25 -172.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.13 157.04 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 3.6699999999999999 111.222 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -115.49 151.09 35.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 3.7000000000000002 111.217 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.21 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 3.73 111.195 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -127.49 172.48 10.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 3.77 111.204 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.9 p -138.71 150.32 46.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 3.7999999999999998 111.11 -172.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tt -94.25 106.42 18.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 3.8300000000000001 111.191 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 81.7 mt -92.18 125.14 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 3.8700000000000001 111.178 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.38 158.54 43.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 3.8999999999999999 111.202 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -84.93 99.94 11.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 3.9300000000000002 111.187 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -56.01 -47.83 77.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 3.9700000000000002 111.128 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.72 -52.19 65.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 4.0 111.217 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.93 -60.11 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 4.0300000000000002 111.214 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.45 87.64 51.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 4.0700000000000003 111.237 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.27 -14.71 25.55 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.681 1.587 . . . . 4.0999999999999996 111.173 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -90.53 110.05 38.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 4.1299999999999999 111.184 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.53 157.65 25.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.661 1.574 . . . . 4.1699999999999999 111.183 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.01 141.06 79.9 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.692 1.595 . . . . 4.2000000000000002 111.153 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.91 -18.7 36.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 4.2300000000000004 111.216 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 130' ' ' GLU . 14.6 t -157.67 -178.28 7.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 4.2699999999999996 111.182 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -65.65 -35.67 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 4.2999999999999998 111.215 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.411 ' H ' HG23 ' A' ' 128' ' ' THR . 98.3 mt-10 -74.24 -6.58 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 4.3300000000000001 111.2 -174.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -104.63 9.94 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 4.3700000000000001 111.174 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.558 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 88.7 mt -71.47 -41.62 10.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 4.4000000000000004 111.15 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 84.2 Cg_exo -52.53 -30.52 45.02 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.715 1.61 . . . . 4.4299999999999997 111.153 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.75 -37.05 67.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 4.4699999999999998 111.205 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -67.23 -47.88 69.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 4.5 111.194 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.13 -29.33 70.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 4.5300000000000002 111.223 -171.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.9 -44.95 64.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 4.5700000000000003 111.158 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -94.01 -30.93 14.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 4.5999999999999996 111.139 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.96 -27.8 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.202 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.42 -41.62 63.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 4.6699999999999999 111.214 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.18 -5.74 59.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 4.7000000000000002 111.225 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.74 12.34 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 4.7300000000000004 111.175 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.08 24.9 70.3 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -140.2 179.78 6.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 4.7999999999999998 111.134 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -151.38 138.05 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 4.8300000000000001 111.175 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.43 -60.61 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.141 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.7 tp -135.96 119.54 17.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 4.9000000000000004 111.221 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mtm -115.48 101.51 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 4.9299999999999997 111.174 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -110.06 135.84 50.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 4.9699999999999998 111.203 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -59.99 113.97 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 5.0 111.194 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.78 -24.84 63.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 5.0300000000000002 111.245 -169.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -100.84 -39.61 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 5.0700000000000003 111.22 -171.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 155' ' ' TYR . 87.8 tt0 -78.71 128.32 77.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 5.0999999999999996 111.217 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -73.21 -20.2 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.738 1.626 . . . . 5.1299999999999999 111.149 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.406 ' H ' ' HG2' ' A' ' 153' ' ' GLU . 74.0 t80 -54.48 -43.24 71.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 5.1699999999999999 111.131 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -79.9 -19.99 46.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 5.2000000000000002 111.234 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 64.8 p -99.35 -5.54 29.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 5.2300000000000004 111.221 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.61 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 83.1 t90 -62.24 -45.42 90.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 5.2699999999999996 111.255 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 40.7 Cg_exo -61.29 -38.54 64.59 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.731 1.621 . . . . 5.2999999999999998 111.167 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.74 -60.02 4.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 5.3300000000000001 111.201 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 167' ' ' TYR . 20.8 tt -70.18 -22.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 5.3700000000000001 111.181 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -88.78 -4.07 58.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 5.4000000000000004 111.205 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -113.1 -10.47 13.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.214 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -95.57 -31.46 13.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 5.4699999999999998 111.188 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.6 33.35 2.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 5.5 111.223 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.64 11.35 23.4 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.443 ' HB2' HG23 ' A' ' 161' ' ' ILE . 84.1 t80 -131.84 109.77 10.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 5.5700000000000003 111.187 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 63.62 33.18 13.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 5.5999999999999996 111.234 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -124.96 95.3 4.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 5.6299999999999999 111.205 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.6699999999999999 111.141 171.778 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.3 t0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.732 0.301 . . . . 5.9000000000000004 111.264 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.4 pt -114.97 29.64 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 5.9299999999999997 111.191 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.57 -59.96 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 5.9699999999999998 111.203 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -90.32 169.96 10.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 6.0 111.184 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 183' ' ' VAL . 97.0 t -88.82 139.85 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 6.0300000000000002 111.217 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.33 24.07 15.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.17 -0.772 . . . . 6.0700000000000003 111.17 -169.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 181' ' ' VAL . 7.8 p -65.55 -20.81 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 6.0999999999999996 111.23 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -105.36 23.1 14.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 6.1299999999999999 111.235 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -95.58 136.79 35.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 6.1699999999999999 111.179 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.74 -27.83 63.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 6.2000000000000002 111.209 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.77 -31.6 81.43 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.129 -0.788 . . . . 6.2300000000000004 111.129 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -45.09 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 6.2699999999999996 111.18 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -66.18 -40.97 90.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 6.2999999999999998 111.177 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.99 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.285 -0.416 . . . . 6.3300000000000001 111.165 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.24 -41.22 92.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 6.3700000000000001 111.218 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 30.2 tp -69.69 -36.18 75.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 6.4000000000000004 111.138 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.8 m -62.86 -41.68 99.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 6.4299999999999997 111.233 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.23 -44.52 95.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.193 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.7 tp -56.85 -41.32 77.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 6.5 111.136 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 199' ' ' ILE . 54.1 t -70.34 -34.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 6.5300000000000002 111.205 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.9 -34.3 77.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 6.5700000000000003 111.192 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.66 -23.35 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.5999999999999996 111.198 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 196' ' ' VAL . 92.9 mt -78.85 -49.78 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 6.6299999999999999 111.151 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.67 -25.35 53.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 6.6699999999999999 111.129 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -94.65 10.77 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 6.7000000000000002 111.25 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 59.98 52.47 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 6.7300000000000004 111.194 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -107.17 -29.84 9.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.236 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 19.0 ptp -155.13 164.95 38.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 6.7999999999999998 111.198 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -145.0 -169.96 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 6.8300000000000001 111.171 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.1 82.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 6.8700000000000001 111.184 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.22 -37.86 86.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 6.9000000000000004 111.239 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.2 m -53.88 109.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.217 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -147.19 -164.34 1.98 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.257 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -50.64 -42.6 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 7.0 111.199 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.3 p -66.84 -18.27 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 7.0300000000000002 111.21 -169.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -103.35 -54.91 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 7.0700000000000003 111.194 176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.0 -61.7 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 7.0999999999999996 111.213 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -92.75 -53.63 4.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 7.1299999999999999 111.266 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.04 -52.4 49.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 7.1699999999999999 111.217 -167.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.66 95.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 7.2000000000000002 111.171 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.06 -51.08 70.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 7.2300000000000004 111.216 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.02 -32.08 73.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 7.2699999999999996 111.176 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -63.55 -43.78 96.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 7.2999999999999998 111.226 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 122.31 19.38 3.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.193 -0.763 . . . . 7.3300000000000001 111.193 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 7.3700000000000001 111.234 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.7 m -113.38 124.99 53.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 7.4000000000000004 111.198 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.63 76.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 7.4299999999999997 111.181 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -167.83 144.98 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 7.4699999999999998 111.253 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.3 t -155.96 163.79 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 7.5 111.226 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.55 130.3 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 7.5300000000000002 111.135 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -156.96 173.78 16.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 7.5700000000000003 111.229 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.0 -61.21 7.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.179 -0.769 . . . . 7.5999999999999996 111.179 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.94 144.96 98.79 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.219 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -79.61 156.53 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 7.6699999999999999 111.191 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.2 13.65 30.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 7.7000000000000002 111.183 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -62.81 -32.07 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 7.7300000000000004 111.237 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.7 p -87.61 -9.84 53.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 7.7699999999999996 111.172 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -95.42 0.99 53.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 7.7999999999999998 111.185 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 242' ' ' TYR . 83.7 mt -69.19 -55.22 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 7.8300000000000001 111.201 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.78 -24.13 62.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 7.8700000000000001 111.178 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.0 m -65.03 -46.94 79.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 7.9000000000000004 111.216 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 69.0 m -100.01 -2.65 33.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 7.9299999999999997 111.191 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.04 34.91 13.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 7.9699999999999998 111.211 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.97 135.96 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 8.0 111.206 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.13 122.55 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 8.0299999999999994 111.2 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.41 ' H ' HG12 ' A' ' 235' ' ' ILE . 76.0 m-85 -118.35 146.34 44.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 8.0700000000000003 111.176 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -110.91 157.31 15.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.212 -0.755 . . . . 8.0999999999999996 111.212 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.72 130.03 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 8.1300000000000008 111.174 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -141.98 -169.96 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 8.1699999999999999 111.145 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 98.6 t -93.02 118.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 8.1999999999999993 111.169 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.574 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 49.9 tp -90.25 -45.0 0.4 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 8.2300000000000004 111.133 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 74.2 Cg_exo -55.28 128.1 29.06 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.706 1.604 . . . . 8.2699999999999996 111.179 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.2 m -138.88 126.6 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 8.3000000000000007 111.184 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.85 127.37 44.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 8.3300000000000001 111.197 -175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 86.3 tttt 44.62 45.14 7.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 8.3699999999999992 111.184 -170.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.04 78.78 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -130.0 109.93 16.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 8.4299999999999997 111.233 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.11 137.09 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.728 1.619 . . . . 8.4700000000000006 111.184 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 62.8 p -154.94 -75.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 8.5 111.241 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 323' ' ' ASN . 48.7 tttp -159.95 138.51 7.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 8.5299999999999994 111.171 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' A' ' 248' ' ' PRO . 63.3 Cg_endo -74.25 168.6 24.42 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.227 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 330' ' ' MET . 16.5 t80 -54.94 116.87 2.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 8.5999999999999996 111.177 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.54 104.32 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 8.6300000000000008 111.192 -163.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.39 140.03 21.59 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.196 -0.762 . . . . 8.6699999999999999 111.196 164.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.35 108.31 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.311 . . . . 8.6999999999999993 111.193 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 51.1 tp -57.31 120.36 8.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 8.7300000000000004 111.167 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.8 m -138.29 153.54 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 8.7699999999999996 111.172 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.59 137.9 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 8.8000000000000007 111.207 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.97 -174.48 14.98 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.227 -0.749 . . . . 8.8300000000000001 111.227 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.0 mt -111.88 128.64 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 8.8699999999999992 111.191 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -57.81 123.09 14.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.251 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 8.9299999999999997 111.196 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.13 54.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 8.9700000000000006 111.272 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.99 127.98 93.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 9.0 111.206 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.7 -4.1 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.717 1.612 . . . . 9.0299999999999994 111.225 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -110.06 30.79 6.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 9.0700000000000003 111.145 -171.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -51.95 -36.71 50.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 9.0999999999999996 111.183 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.26 -49.64 75.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 9.1300000000000008 111.188 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.16 -43.3 95.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 9.1699999999999999 111.195 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 9.1999999999999993 111.131 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -68.3 -42.27 79.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 9.2300000000000004 111.154 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -56.89 -49.53 75.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 9.2699999999999996 111.209 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -57.54 -59.94 4.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 9.3000000000000007 111.179 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.81 -38.8 82.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 9.3300000000000001 111.194 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.94 -43.84 10.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 9.3699999999999992 111.218 -168.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -103.51 -6.18 22.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 9.4000000000000004 111.224 -166.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.94 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 9.4299999999999997 111.194 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.67 -60.55 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 9.4700000000000006 111.169 -166.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.17 64.9 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 9.5 111.164 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 24.5 p -130.05 -179.99 5.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 9.5299999999999994 111.275 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.96 -27.01 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 9.5700000000000003 111.158 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -92.93 -39.89 10.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 9.5999999999999996 111.173 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -64.78 -46.77 88.71 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.196 -0.762 . . . . 9.6300000000000008 111.196 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.02 -15.5 60.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 9.6699999999999999 111.202 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -65.49 -38.4 89.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 9.6999999999999993 111.201 169.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.31 37.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 9.7300000000000004 111.217 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.19 -45.45 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 9.7699999999999996 111.166 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -87.56 10.5 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 9.8000000000000007 111.235 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.59 -42.98 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 9.8300000000000001 111.193 165.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -95.61 -32.44 12.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 9.8699999999999992 111.168 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.17 158.69 43.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 9.9000000000000004 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.08 130.02 36.09 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.747 1.631 . . . . 9.9299999999999997 111.18 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 78.1 mt -58.24 -41.89 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 9.9700000000000006 111.25 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.46 -20.25 67.53 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.214 -0.754 . . . . 10.0 111.214 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.85 75.26 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 10.029999999999999 111.236 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.07 150.67 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.177 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.66 -8.96 21.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 10.1 111.237 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.403 HD23 ' HB2' ' A' ' 307' ' ' TYR . 31.6 tp -81.77 119.99 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 10.130000000000001 111.145 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -68.83 -39.47 79.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 10.17 111.227 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.0 t -51.35 -49.53 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 10.199999999999999 111.236 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.403 ' HB2' HD23 ' A' ' 304' ' ' LEU . 60.2 t80 -70.49 -40.29 73.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 10.23 111.172 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -52.41 -39.55 61.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 10.27 111.225 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.88 -30.11 71.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 10.300000000000001 111.246 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -71.59 -34.77 70.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.33 111.192 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.79 -18.31 61.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 10.369999999999999 111.202 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.62 -18.59 62.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 10.4 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -27.2 66.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 10.43 111.176 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -100.19 110.05 58.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.243 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -55.38 -31.16 76.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.645 1.563 . . . . 10.5 111.244 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 10.529999999999999 111.211 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.33 -44.81 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 10.57 111.198 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.48 -31.76 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 10.6 111.242 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.28 73.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 10.630000000000001 111.174 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.0 p -93.09 -20.19 20.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 10.67 111.232 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.3 mmt -71.64 -31.04 66.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 10.699999999999999 111.245 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.71 -44.94 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 10.73 111.176 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . 90.5 m-20 -73.06 -26.19 61.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.77 111.146 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.3 90.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 10.800000000000001 111.2 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.06 -34.91 64.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 10.83 111.092 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -94.97 0.13 54.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 10.869999999999999 111.187 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.61 -164.78 40.39 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.192 -0.763 . . . . 10.9 111.192 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -124.03 138.04 54.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 10.93 111.217 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.0 mm -102.83 135.26 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 10.970000000000001 111.178 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 258' ' ' PHE . 28.6 ttt -70.13 116.24 42.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 11.0 111.141 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.13 159.23 37.4 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 11.029999999999999 111.185 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -105.83 50.01 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.489 . . . . 11.07 111.209 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 86.4 mt -85.9 124.95 70.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 11.1 111.239 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.06 -29.32 22.6 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.709 1.606 . . . . 11.130000000000001 111.248 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -69.09 -37.24 78.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 11.17 111.166 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 89.9 mtp -79.75 -27.82 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 11.199999999999999 111.223 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -57.82 -49.74 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 11.23 111.166 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.6 82.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 11.27 111.18 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -68.26 -36.77 79.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 11.300000000000001 111.196 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -68.96 -32.48 72.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 11.33 111.195 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -61.92 -41.25 97.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 11.369999999999999 111.254 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.37 90.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 11.4 111.188 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.16 -40.09 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 11.43 111.154 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -64.31 -32.49 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 11.470000000000001 111.244 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.9 m -75.32 -39.86 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.193 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.98 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.223 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.84 -16.34 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.243 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.12 -28.74 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 11.6 111.138 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.45 -29.81 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 11.630000000000001 111.191 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -88.36 -32.29 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 11.67 111.194 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.07 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 11.699999999999999 111.151 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.9 p -75.75 -16.25 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 11.73 111.15 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.95 10.06 79.48 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.202 -0.759 . . . . 11.77 111.202 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -81.6 -49.66 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 11.800000000000001 111.268 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -110.75 169.61 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 11.83 111.198 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.0 p -85.74 175.18 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 11.869999999999999 111.224 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.1 m -69.35 -14.56 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 11.9 111.215 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -95.03 -42.62 8.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 11.93 111.205 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -75.32 -35.2 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 11.970000000000001 111.16 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.95 94.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 12.0 111.193 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.03 -39.22 69.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 12.029999999999999 111.242 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -51.83 -38.89 57.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 12.07 111.185 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -49.97 -43.0 49.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.176 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.54 -35.46 27.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 12.130000000000001 111.247 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.05 -31.02 69.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 12.17 111.154 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 12.199999999999999 111.188 -177.733 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.818 0.342 . . . . 0.070000000000000007 111.22 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -67.63 142.26 56.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.10000000000000001 111.184 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.72 138.58 31.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.13 111.127 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.25 28.01 9.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.182 -0.767 . . . . 0.17000000000000001 111.182 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -146.57 145.42 30.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 0.20000000000000001 111.216 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.8 mt -111.98 98.34 7.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.23000000000000001 111.255 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.91 112.04 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.27000000000000002 111.141 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -105.89 122.35 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.29999999999999999 111.209 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -109.9 129.98 55.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.33000000000000002 111.23 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 11' ' ' ILE . 18.6 tt -149.53 123.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.37 111.222 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.02 150.01 22.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.40000000000000002 111.198 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.42 172.02 38.12 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.221 -0.752 . . . . 0.42999999999999999 111.221 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -79.87 76.88 6.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.831 0.348 . . . . 0.46999999999999997 111.224 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -103.76 179.96 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.5 111.129 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.07 63.93 4.4 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.222 -0.751 . . . . 0.53000000000000003 111.222 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -68.4 -24.11 64.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.56999999999999995 111.182 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -70.07 -49.94 46.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.59999999999999998 111.224 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.56 96.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.63 111.224 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.5 tp -69.7 -31.73 69.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.67000000000000004 111.16 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.73 72.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.183 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -63.19 -42.55 99.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.72999999999999998 111.16 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.63 -21.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.77000000000000002 111.232 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.81 68.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.19 -0.764 . . . . 0.80000000000000004 111.19 171.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -67.37 -42.61 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.745 0.307 . . . . 0.82999999999999996 111.165 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.39 -48.56 79.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.87 111.169 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.63 -44.25 85.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.90000000000000002 111.147 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.2 -37.44 87.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.93000000000000005 111.227 -176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -75.09 -34.99 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.96999999999999997 111.233 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -70.75 -39.51 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 1.0 111.218 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.6 p -110.51 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 1.03 111.202 -170.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 5.45 75.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.229 -0.749 . . . . 1.0700000000000001 111.229 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.89 119.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 1.1000000000000001 111.199 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -64.95 123.93 20.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 1.1299999999999999 111.243 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.72 125.03 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 1.1699999999999999 111.181 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.5 m -130.38 136.33 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 1.2 111.17 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.4 t -113.79 124.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 1.23 111.171 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.86 158.62 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 1.27 111.197 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -114.3 86.49 12.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 1.3 111.154 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.25 178.11 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.697 1.598 . . . . 1.3300000000000001 111.23 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -146.96 174.78 11.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 1.3700000000000001 111.228 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 53.19 37.84 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 1.3999999999999999 111.185 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.09 -24.94 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.442 . . . . 1.4299999999999999 111.182 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.26 -12.55 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 1.47 111.182 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -110.04 -23.06 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 1.5 111.213 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -92.92 -38.81 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.53 111.168 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.6 m-30 -59.97 -46.41 98.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 1.5700000000000001 111.202 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 79.5 Cg_exo -51.75 -36.06 60.67 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.685 1.59 . . . . 1.6000000000000001 111.228 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -75.7 -48.43 21.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 47' ' ' PHE . 25.9 m -74.56 -18.38 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 1.6699999999999999 111.208 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.06 -30.59 71.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 1.7 111.175 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.67 -12.16 57.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.187 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.9 p -114.04 -14.94 12.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.77 111.167 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.92 39.7 16.2 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 1.8 111.215 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -113.23 -168.42 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 1.8300000000000001 111.196 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.48 -169.23 13.12 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.214 -0.754 . . . . 1.8700000000000001 111.214 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.86 -170.15 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.701 1.601 . . . . 1.8999999999999999 111.222 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -103.13 -38.59 7.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 1.9299999999999999 111.158 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -122.2 132.9 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 1.97 111.177 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -125.1 120.78 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 2.0 111.192 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -85.07 146.12 27.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 2.0299999999999998 111.177 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -159.92 158.4 30.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 2.0699999999999998 111.171 173.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.94 174.27 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 2.1000000000000001 111.218 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -58.06 -32.93 68.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.232 -0.44 . . . . 2.1299999999999999 111.199 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -91.56 6.67 44.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 2.1699999999999999 111.219 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -114.64 -20.02 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 2.2000000000000002 111.161 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.34 -50.82 71.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 2.23 111.192 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -46.77 75.89 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.765 . . . . 2.27 111.186 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.89 95.05 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.171 -0.771 . . . . 2.2999999999999998 111.171 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -78.89 -24.88 43.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 2.3300000000000001 111.199 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.62 -23.16 31.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 2.3700000000000001 111.242 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -62.59 -33.71 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 2.3999999999999999 111.19 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -69.22 -28.75 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 2.4300000000000002 111.15 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.99 51.32 7.76 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.22 -0.752 . . . . 2.4700000000000002 111.22 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 75' ' ' LEU . 3.8 pp -132.03 20.05 4.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 2.5 111.221 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.88 134.29 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 2.5299999999999998 111.195 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.51 158.9 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 2.5699999999999998 111.24 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -89.62 159.25 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 2.6000000000000001 111.255 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.1 mt -130.07 137.85 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 2.6299999999999999 111.15 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.5 m -95.11 114.99 64.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.6699999999999999 111.235 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.6 155.14 27.6 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.151 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -90.03 169.98 10.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 2.73 111.197 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.11 -59.91 2.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 2.77 111.255 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.96 78.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 2.7999999999999998 111.165 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -54.87 -50.34 68.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.442 . . . . 2.8300000000000001 111.207 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -57.54 -43.86 84.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 2.8700000000000001 111.147 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.03 -34.98 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 2.8999999999999999 111.162 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -79.55 -21.87 44.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 2.9300000000000002 111.153 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.416 HD23 HD23 ' A' ' 304' ' ' LEU . 90.9 mt -88.09 151.42 22.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.9700000000000002 111.188 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -67.56 156.66 88.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 3.0 111.196 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.19 3.0 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.7 1.6 . . . . 3.0299999999999998 111.167 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -122.6 10.63 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.175 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.4 p -119.52 -35.43 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 3.1000000000000001 111.247 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -70.12 -40.0 75.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 3.1299999999999999 111.139 173.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -77.85 -30.98 51.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 3.1699999999999999 111.183 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.37 65.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 3.2000000000000002 111.168 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.21 20.98 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 3.23 111.142 -172.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 44.1 mtm105 -95.21 170.38 9.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 3.27 111.18 172.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -160.42 119.61 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 3.2999999999999998 111.215 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.1 t30 60.64 34.24 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 3.3300000000000001 111.217 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.98 7.7 83.4 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.262 -0.735 . . . . 3.3700000000000001 111.262 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -131.22 130.01 42.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 3.3999999999999999 111.269 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.1 tt -70.02 129.99 40.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 3.4300000000000002 111.212 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -113.93 -25.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 3.4700000000000002 111.223 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.85 165.85 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 3.5 111.199 -171.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -111.0 140.81 23.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 3.5299999999999998 111.193 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.14 -179.77 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.678 1.585 . . . . 3.5699999999999998 111.19 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.0 tp -165.06 -21.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 3.6000000000000001 111.15 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.33 145.55 23.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 3.6299999999999999 111.188 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.52 125.73 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 111.208 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -114.93 154.98 27.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 3.7000000000000002 111.218 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.02 175.91 9.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 3.73 111.188 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 113' ' ' LEU . 1.7 pp -143.21 146.54 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 3.77 111.173 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -168.36 179.97 4.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 3.7999999999999998 111.251 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.525 ' HB2' HD22 ' A' ' 247' ' ' LEU . 55.0 tp -95.41 112.2 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 3.8300000000000001 111.206 -174.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 tt -114.21 137.28 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 3.8700000000000001 111.236 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.59 150.52 46.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 3.8999999999999999 111.174 -172.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -85.83 120.27 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 3.9300000000000002 111.264 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.85 -35.09 67.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 3.9700000000000002 111.176 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.65 -33.94 77.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 4.0 111.188 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.02 -48.63 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.111 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.7 tp -154.98 111.12 2.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 4.0700000000000003 111.219 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.99 -17.67 19.39 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.697 1.598 . . . . 4.0999999999999996 111.197 -172.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -56.46 114.07 7.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 4.1299999999999999 111.217 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.7 134.81 15.41 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.71 1.606 . . . . 4.1699999999999999 111.218 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.511 ' HG3' ' SD ' ' A' ' 224' ' ' MET . 79.5 Cg_endo -77.61 140.59 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.753 1.636 . . . . 4.2000000000000002 111.171 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -100.14 -45.01 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 4.2300000000000004 111.239 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 t -158.41 -178.64 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.161 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -62.38 -38.33 89.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 4.2999999999999998 111.165 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.01 -15.45 62.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 4.3300000000000001 111.216 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -89.06 -14.31 36.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 4.3700000000000001 111.212 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.59 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.3 mt -67.54 -44.93 46.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 4.4000000000000004 111.205 -172.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 54.3 Cg_exo -55.07 -37.74 93.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.674 1.583 . . . . 4.4299999999999997 111.171 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.95 -36.88 72.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 4.4699999999999998 111.222 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.93 -32.92 74.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 4.5 111.193 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -56.38 -36.27 68.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 4.5300000000000002 111.249 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.88 -30.52 71.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 4.5700000000000003 111.153 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.2 -24.58 32.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 4.5999999999999996 111.146 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 -3.28 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 4.6299999999999999 111.198 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.22 -29.06 70.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 4.6699999999999999 111.221 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.94 79.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 4.7000000000000002 111.183 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -107.85 -9.94 15.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 4.7300000000000004 111.218 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.4 40.47 33.04 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.216 -0.754 . . . . 4.7699999999999996 111.216 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -111.62 155.3 23.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.313 . . . . 4.7999999999999998 111.225 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 t -99.71 141.44 32.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 4.8300000000000001 111.235 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.476 ' HB1' ' HE2' ' A' ' 224' ' ' MET . . . -85.93 -6.78 59.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 4.8700000000000001 111.204 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 198' ' ' LEU . 31.0 tp -165.37 133.41 3.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 4.9000000000000004 111.226 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 26.0 ttt -156.73 134.53 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 4.9299999999999997 111.189 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -129.03 -176.93 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 4.9699999999999998 111.183 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -84.75 120.32 26.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 5.0 111.276 168.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 tp -52.56 -38.9 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 5.0300000000000002 111.191 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -122.44 39.3 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 5.0700000000000003 111.225 -165.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -146.71 118.31 4.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 5.0999999999999996 111.175 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.09 -26.6 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.677 1.585 . . . . 5.1299999999999999 111.226 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -56.7 -41.07 76.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 5.1699999999999999 111.155 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 5.2000000000000002 111.225 -174.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.1 p -98.87 -6.31 29.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 5.2300000000000004 111.174 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.565 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.6 t90 -68.49 -43.76 32.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 5.2699999999999996 111.179 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 63.9 Cg_exo -55.76 -31.67 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.702 1.601 . . . . 5.2999999999999998 111.157 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 65.6 tp -61.73 -59.94 4.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 5.3300000000000001 111.238 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.51 -25.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.3700000000000001 111.202 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.24 67.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 5.4000000000000004 111.211 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.03 77.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 5.4299999999999997 111.211 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -78.01 -29.96 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 5.4699999999999998 111.186 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 92.41 50.0 2.67 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.167 -0.773 . . . . 5.5 111.167 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -55.87 -59.47 10.54 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 5.5300000000000002 111.204 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 50.4 p90 -112.58 169.84 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 5.5700000000000003 111.233 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 65.15 20.27 11.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 5.5999999999999996 111.222 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.97 150.04 43.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 5.6299999999999999 111.195 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.1 tttp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 5.6699999999999999 111.236 174.468 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.788 0.328 . . . . 5.9000000000000004 111.195 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.2 pt -75.2 -16.94 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 5.9299999999999997 111.215 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.73 -26.67 54.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 5.9699999999999998 111.211 -172.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.29 170.21 11.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 6.0 111.195 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -72.64 125.41 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 6.0300000000000002 111.181 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.59 60.4 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.175 -0.77 . . . . 6.0700000000000003 111.175 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.64 -37.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 6.0999999999999996 111.204 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -85.12 -3.57 58.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.238 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -71.35 155.59 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 6.1699999999999999 111.248 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.34 -33.66 67.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 6.2000000000000002 111.221 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.63 -27.26 73.12 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.213 -0.755 . . . . 6.2300000000000004 111.213 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.1 78.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.718 0.294 . . . . 6.2699999999999996 111.197 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.33 -43.05 95.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 6.2999999999999998 111.24 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.24 93.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 6.3300000000000001 111.145 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.92 97.44 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.212 -0.755 . . . . 6.3700000000000001 111.212 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.56 -29.64 61.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 6.4000000000000004 111.214 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 69.9 m -61.96 -44.33 96.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 6.4299999999999997 111.158 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -64.99 -37.45 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 6.4699999999999998 111.195 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.17 -46.86 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 6.5 111.193 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.25 -39.81 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 6.5300000000000002 111.248 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.37 -31.47 72.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 6.5700000000000003 111.198 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.402 HD13 HD23 ' A' ' 147' ' ' LEU . 46.5 tp -66.94 -41.29 87.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 6.5999999999999996 111.215 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 43.1 pt -83.0 -19.47 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 6.6299999999999999 111.232 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.15 -39.84 75.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 6.6699999999999999 111.133 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.23 -9.62 59.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 6.7000000000000002 111.204 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.38 54.29 2.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 6.7300000000000004 111.178 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -79.94 -20.37 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 6.7699999999999996 111.219 172.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -141.49 150.27 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.7999999999999998 111.174 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -127.01 170.02 12.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 6.8300000000000001 111.185 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.15 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 6.8700000000000001 111.225 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.16 -30.47 71.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 6.9000000000000004 111.196 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.8 m -59.42 125.01 21.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 6.9299999999999997 111.171 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -129.97 -166.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 6.9699999999999998 111.215 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -55.74 -50.04 71.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 7.0 111.146 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.7 p -73.15 -25.23 60.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.21 -171.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.0 mm -75.04 -51.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 7.0700000000000003 111.164 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.07 -32.87 74.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 7.0999999999999996 111.237 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -70.15 -52.17 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 7.1299999999999999 111.257 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.66 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 7.1699999999999999 111.181 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 221' ' ' GLU . . . -55.07 -36.3 65.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 7.2000000000000002 111.165 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -94.21 -41.01 9.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 7.2300000000000004 111.237 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.2 -41.91 80.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 7.2699999999999996 111.184 -173.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.17 -9.04 49.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 7.2999999999999998 111.187 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.61 27.38 59.2 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.771 . . . . 7.3300000000000001 111.171 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 216' ' ' ALA . 75.6 mm-40 -68.44 -29.88 68.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 7.3700000000000001 111.183 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.4 p -109.7 167.89 9.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 7.4000000000000004 111.132 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.63 -38.57 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4299999999999997 111.226 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.511 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 64.4 ttp -144.95 145.03 31.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 7.4699999999999998 111.159 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -163.56 174.22 12.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 7.5 111.175 170.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -100.94 128.82 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 7.5300000000000002 111.234 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -163.84 177.79 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 7.5700000000000003 111.194 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -112.09 163.5 12.19 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.62 117.2 3.91 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.632 1.555 . . . . 7.6299999999999999 111.208 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 175.04 -35.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 7.6699999999999999 111.225 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -109.95 4.31 21.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.241 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.02 -19.98 59.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 7.7300000000000004 111.206 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 90.5 p -65.71 -20.06 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 7.7699999999999996 111.227 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -72.79 -24.57 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 7.7999999999999998 111.19 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.05 -38.01 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 7.8300000000000001 111.178 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.63 -34.96 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 7.8700000000000001 111.201 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.6 m -66.52 -41.16 89.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 7.9000000000000004 111.219 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 88.8 p -73.18 -14.68 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 7.9299999999999997 111.194 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 59.98 51.52 5.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 7.9699999999999998 111.222 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.1 m -118.16 164.43 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 8.0 111.17 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -84.61 139.27 32.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 8.0299999999999994 111.193 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -153.8 165.0 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 8.0700000000000003 111.183 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.88 163.84 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.137 -0.785 . . . . 8.0999999999999996 111.137 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.88 129.55 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 8.1300000000000008 111.225 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 34.9 p -133.15 171.6 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 8.1699999999999999 111.181 171.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.35 150.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 8.1999999999999993 111.189 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.655 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 2.7 pt? -140.96 51.58 2.53 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.199 -175.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 46.0 Cg_endo -62.57 146.94 95.44 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.737 1.624 . . . . 8.2699999999999996 111.228 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 42.6 m -139.66 117.04 11.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 8.3000000000000007 111.25 -174.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.73 73.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 8.3300000000000001 111.212 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 60.56 56.1 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 8.3699999999999992 111.235 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.33 10.47 85.95 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.212 -0.755 . . . . 8.4000000000000004 111.212 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -130.02 110.01 16.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 8.4299999999999997 111.205 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 136.7 14.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.694 1.596 . . . . 8.4700000000000006 111.265 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.2 m -125.19 -87.37 0.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 8.5 111.168 167.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -143.17 142.72 22.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 8.5299999999999994 111.194 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.37 166.33 27.71 Favored 'Trans proline' 0 C--N 1.328 -0.54 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.124 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -73.41 138.05 45.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 8.5999999999999996 111.209 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.43 168.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 8.6300000000000008 111.191 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -144.64 163.19 27.96 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.13 -0.788 . . . . 8.6699999999999999 111.13 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.3 t -125.14 134.84 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 8.6999999999999993 111.19 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 49.1 tp -89.95 133.4 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 8.7300000000000004 111.227 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 90.1 p -143.94 169.97 16.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 8.7699999999999996 111.203 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 8.8000000000000007 111.256 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.15 -169.04 12.87 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.209 -0.756 . . . . 8.8300000000000001 111.209 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 89.4 mt -116.08 135.19 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 8.8699999999999992 111.221 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -60.94 131.11 49.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.172 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.95 -21.19 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 8.9299999999999997 111.197 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -91.53 -4.94 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 8.9700000000000006 111.194 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t -64.5 122.73 80.09 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 9.0 111.165 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.15 -17.9 18.86 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.706 1.604 . . . . 9.0299999999999994 111.215 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -110.55 60.04 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 9.0700000000000003 111.251 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -72.09 -36.66 69.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 9.0999999999999996 111.201 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.56 -37.64 80.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 9.1300000000000008 111.172 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.2 mt -72.33 -40.77 67.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 9.1699999999999999 111.169 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.1 95.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 9.1999999999999993 111.221 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.82 -44.11 90.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 9.2300000000000004 111.256 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -60.04 -43.49 95.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 9.2699999999999996 111.204 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -61.59 -52.08 65.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 9.3000000000000007 111.25 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.02 -20.1 65.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 9.3300000000000001 111.193 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -87.22 -60.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 9.3699999999999992 111.198 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -102.14 -6.46 23.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 9.4000000000000004 111.212 -162.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -124.01 -27.22 3.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 9.4299999999999997 111.21 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.84 -45.83 16.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 9.4700000000000006 111.209 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.92 71.11 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 9.5 111.216 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 42.0 p -138.58 176.03 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 9.5299999999999994 111.199 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -51.78 -36.97 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 9.5700000000000003 111.235 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -92.51 -38.72 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 9.5999999999999996 111.201 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.6 -60.2 8.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.0 tp -56.86 -45.58 82.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 9.6699999999999999 111.156 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.77 -54.18 47.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 9.6999999999999993 111.198 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.53 84.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 9.7300000000000004 111.17 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.2 -43.38 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 9.7699999999999996 111.165 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -98.39 7.53 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 9.8000000000000007 111.258 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.07 -39.3 74.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 9.8300000000000001 111.174 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -97.98 10.48 40.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 9.8699999999999992 111.198 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -130.0 160.39 65.43 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 9.9000000000000004 111.184 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.96 144.96 65.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.724 1.616 . . . . 9.9299999999999997 111.171 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.8 39.18 2.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.248 -0.433 . . . . 9.9700000000000006 111.18 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -54.88 -42.06 78.41 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.21 -0.756 . . . . 10.0 111.21 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -167.07 144.3 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 10.029999999999999 111.179 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.07 173.68 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 10.07 111.13 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.14 -36.63 19.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 10.1 111.157 -172.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.416 HD23 HD23 ' A' ' 89' ' ' LEU . 96.2 mt -81.56 143.26 32.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 10.130000000000001 111.191 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.29 -45.01 23.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 10.17 111.192 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 97.2 p -65.07 -31.9 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 10.199999999999999 111.158 -173.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -75.98 -46.12 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 10.23 111.17 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.25 -31.7 71.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 10.27 111.213 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -53.88 -41.49 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 10.300000000000001 111.2 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -71.34 -37.47 71.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 10.33 111.214 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.1 mp -67.56 -20.29 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 10.369999999999999 111.244 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.03 -18.51 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 10.4 111.256 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.55 -27.88 69.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 10.43 111.177 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.65 115.15 63.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 10.470000000000001 111.213 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.53 -34.37 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.706 1.604 . . . . 10.5 111.177 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.86 -31.99 73.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.19 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 95.8 mt -78.32 -39.99 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 10.57 111.19 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 321' ' ' MET . . . -56.24 -33.61 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 10.6 111.191 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.34 -35.04 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 10.630000000000001 111.177 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 66.4 p -105.18 -20.15 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.228 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.453 ' HB3' ' HA ' ' A' ' 318' ' ' ALA . 60.9 ttp -65.08 -58.7 5.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 10.699999999999999 111.208 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -54.12 -41.6 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.73 111.185 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.35 -29.95 60.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 10.77 111.177 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.07 -35.32 76.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 10.800000000000001 111.232 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.05 -35.04 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 10.83 111.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.17 -4.95 34.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 10.869999999999999 111.164 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.62 -178.84 52.46 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.127 -0.789 . . . . 10.9 111.127 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -119.59 157.12 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 10.93 111.207 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.6 pt -119.76 166.68 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 10.970000000000001 111.189 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.8 tpp -60.04 130.0 88.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 11.0 111.198 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.19 141.45 58.83 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.753 1.636 . . . . 11.029999999999999 111.204 174.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.13 20.59 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 11.07 111.179 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 335' ' ' GLN . 83.8 mt -95.68 130.04 32.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 11.1 111.201 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.75 -41.76 53.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.667 1.578 . . . . 11.130000000000001 111.157 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.4 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.4 mt-30 -63.52 -44.61 93.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 11.17 111.135 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.96 -31.84 73.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 11.199999999999999 111.209 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.1 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 11.23 111.182 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.97 76.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 11.27 111.211 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -67.2 -27.48 67.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 11.300000000000001 111.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -60.03 -38.22 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 11.33 111.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -72.13 -30.1 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 11.369999999999999 111.172 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.4 74.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 11.4 111.201 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.44 -24.99 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 11.43 111.23 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -57.66 -50.2 73.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 11.470000000000001 111.205 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.7 m -60.68 -38.23 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 11.5 111.235 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -55.81 -40.09 72.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 11.529999999999999 111.157 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -47.95 82.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.265 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 348' ' ' ILE . 8.2 tp -74.6 -23.19 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 11.6 111.158 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.64 -27.59 45.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 11.630000000000001 111.187 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.0 -27.71 32.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 11.67 111.186 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.49 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 11.699999999999999 111.183 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.6 p -72.65 -16.22 61.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 11.73 111.272 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.05 35.24 27.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.249 -0.74 . . . . 11.77 111.249 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -99.98 -35.09 9.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 11.800000000000001 111.214 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -127.97 157.07 41.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 11.83 111.137 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -77.45 177.48 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 11.869999999999999 111.224 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.99 -21.26 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 11.9 111.237 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -92.33 -37.69 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 11.93 111.196 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -66.99 -38.18 85.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.172 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.06 -41.77 94.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 12.0 111.185 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.0 -15.29 51.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 12.029999999999999 111.173 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.99 -56.63 8.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 12.07 111.225 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.96 -32.81 74.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 12.1 111.204 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.09 -56.68 19.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 12.130000000000001 111.236 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.76 -34.27 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 12.17 111.222 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.8 m . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 12.199999999999999 111.237 173.797 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.798 0.332 . . . . 0.070000000000000007 111.22 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.62 153.77 38.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.10000000000000001 111.2 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.05 125.02 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.13 111.199 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 18.07 60.62 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -134.12 150.03 51.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.20000000000000001 111.187 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -119.57 119.94 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.23000000000000001 111.23 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.85 116.24 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.27000000000000002 111.196 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.415 ' HB ' HG22 ' A' ' 37' ' ' VAL . 74.2 mt -121.79 116.62 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.29999999999999999 111.185 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.87 107.12 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.33000000000000002 111.234 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.8 tt -115.79 139.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.37 111.186 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -76.66 109.65 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.40000000000000002 111.2 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.76 -171.75 43.04 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.212 -0.755 . . . . 0.42999999999999999 111.212 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -109.95 -43.6 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.46999999999999997 111.229 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 88.2 tttt -151.41 40.01 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.5 111.241 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -14.77 68.67 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.19 -0.764 . . . . 0.53000000000000003 111.19 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -56.71 -30.96 64.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.56999999999999995 111.225 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.96 -37.95 89.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.59999999999999998 111.194 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.48 -31.72 11.22 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.16 -0.776 . . . . 0.63 111.16 -177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.2 tp -73.48 -46.58 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.67000000000000004 111.24 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.43 68.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.69999999999999996 111.173 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.71 -38.93 64.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.72999999999999998 111.17 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -75.71 -23.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.77000000000000002 111.258 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.64 -5.54 81.55 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.206 -0.758 . . . . 0.80000000000000004 111.206 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.49 -24.13 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.327 . . . . 0.82999999999999996 111.201 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.32 -25.48 66.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.87 111.197 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.90000000000000002 111.298 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.95 -28.37 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.93000000000000005 111.205 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.26 -35.65 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.96999999999999997 111.184 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.87 -47.93 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.255 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -124.21 -20.98 5.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 1.03 111.191 -172.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.11 27.15 24.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.186 -0.765 . . . . 1.0700000000000001 111.186 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.3 mt -105.43 128.18 59.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 1.1000000000000001 111.169 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.38 124.98 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 1.1299999999999999 111.24 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -99.4 119.46 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 1.1699999999999999 111.201 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.5 m -114.76 123.81 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.2 111.199 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' ' 9' ' ' ILE . 72.5 t -114.59 131.57 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.23 111.217 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.71 170.34 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 1.27 111.227 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.96 68.74 80.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 1.3 111.206 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.94 161.64 38.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.749 1.633 . . . . 1.3300000000000001 111.227 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -120.27 171.48 8.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 1.3700000000000001 111.232 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 54.96 37.22 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 1.3999999999999999 111.215 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.0 mt -66.85 -37.0 83.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 1.4299999999999999 111.176 -174.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -70.8 -11.99 61.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 1.47 111.208 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -102.91 -6.12 22.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.5 111.197 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.88 -39.91 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.53 111.197 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.579 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 m-85 -62.46 -39.3 54.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.5700000000000001 111.232 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 76.9 Cg_exo -52.39 -24.4 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.697 1.598 . . . . 1.6000000000000001 111.172 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -109.12 -17.39 13.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 1.6299999999999999 111.186 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.9 t -105.64 -58.77 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 1.6699999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.24 -33.1 75.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 1.7 111.25 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.21 -25.64 68.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.73 111.192 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 p -96.57 5.79 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 1.77 111.192 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.82 18.1 58.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.196 -0.762 . . . . 1.8 111.196 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -110.95 172.31 6.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 1.8300000000000001 111.178 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.01 -163.4 16.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.15 -0.78 . . . . 1.8700000000000001 111.15 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.59 -172.86 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.611 1.541 . . . . 1.8999999999999999 111.206 -175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -96.83 -44.35 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 1.9299999999999999 111.176 173.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.77 135.7 58.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 1.97 111.229 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.7 mt -130.55 130.0 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 2.0 111.225 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.55 138.82 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 2.0299999999999998 111.186 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -141.76 167.94 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 2.0699999999999998 111.216 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.47 158.14 24.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 2.1000000000000001 111.192 164.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -43.83 -41.35 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 2.1299999999999999 111.17 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -83.19 -18.29 39.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 2.1699999999999999 111.21 -174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.11 -19.55 24.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 2.2000000000000002 111.199 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.05 -30.02 67.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.23 111.194 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.18 98.49 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 2.27 111.219 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.74 -44.55 80.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.172 -0.771 . . . . 2.2999999999999998 111.172 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -68.15 -33.28 74.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.234 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.34 -39.81 64.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.19 -0.459 . . . . 2.3700000000000001 111.181 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -65.11 -30.06 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 2.3999999999999999 111.141 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -74.15 -12.91 60.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 2.4300000000000002 111.2 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 27.73 50.47 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.206 -0.758 . . . . 2.4700000000000002 111.206 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -110.39 -6.05 15.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.836 0.35 . . . . 2.5 111.241 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.6 tp -98.39 130.32 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 2.5299999999999998 111.186 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 146.19 24.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.185 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -82.46 159.8 22.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.6000000000000001 111.223 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.8 102.95 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 2.6299999999999999 111.184 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -52.27 111.6 2.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 2.6699999999999999 111.26 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.31 145.64 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.665 1.577 . . . . 2.7000000000000002 111.223 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.38 169.98 9.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 2.73 111.247 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -84.36 -29.11 26.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 2.77 111.17 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.16 91.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 2.7999999999999998 111.241 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.444 ' HA ' ' HB3' ' A' ' 88' ' ' LYS . 59.1 m-85 -80.04 -22.5 42.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 2.8300000000000001 111.186 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.93 -39.95 75.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 2.8700000000000001 111.249 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -94.71 -33.19 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 2.8999999999999999 111.181 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 85' ' ' PHE . 58.1 tptt -64.8 -43.57 92.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 2.9300000000000002 111.148 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -85.23 142.3 29.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 2.9700000000000002 111.147 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -66.85 127.98 93.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 3.0 111.204 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.11 -35.05 80.72 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.656 1.571 . . . . 3.0299999999999998 111.155 -168.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -52.86 -44.6 66.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.197 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -90.91 -23.24 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.1000000000000001 111.141 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -60.0 -43.96 94.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 3.1299999999999999 111.138 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -86.06 -9.51 56.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 3.1699999999999999 111.175 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.27 48.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 3.2000000000000002 111.181 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.452 HG21 ' HD3' ' A' ' 107' ' ' PRO . 29.4 m -114.99 26.24 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 3.23 111.19 -170.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -139.74 154.72 47.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 3.27 111.192 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 66.3 t80 -148.4 127.51 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 3.2999999999999998 111.203 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 97.8 m-20 65.04 26.19 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 3.3300000000000001 111.188 -174.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.4 -42.0 2.04 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.151 -0.78 . . . . 3.3700000000000001 111.151 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.61 135.53 33.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 3.3999999999999999 111.151 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.99 143.24 43.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 3.4300000000000002 111.167 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -115.83 -13.45 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 3.4700000000000002 111.179 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.59 160.54 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 3.5 111.168 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -109.95 133.98 20.82 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 3.5299999999999998 111.256 169.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.604 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 72.6 Cg_endo -81.02 -178.46 4.4 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.692 1.595 . . . . 3.5699999999999998 111.25 -172.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 107' ' ' PRO . 16.3 tt 163.94 14.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 3.6000000000000001 111.23 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -171.22 144.78 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.6299999999999999 111.228 174.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.98 157.0 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 3.6699999999999999 111.183 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -140.02 109.94 6.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 3.7000000000000002 111.214 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.91 156.25 36.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 3.73 111.233 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.2 tp -134.24 116.73 15.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 3.77 111.184 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.0 p -161.56 169.84 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 3.7999999999999998 111.251 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.75 117.52 24.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 3.8300000000000001 111.207 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -108.09 148.48 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 3.8700000000000001 111.259 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -146.27 154.88 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 3.8999999999999999 111.212 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -83.28 122.52 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 3.9300000000000002 111.137 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 241' ' ' ASN . 97.9 mttt -64.6 -19.2 65.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 3.9700000000000002 111.232 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -89.95 -26.91 20.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 4.0 111.153 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -54.71 3.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 4.0300000000000002 111.163 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.52 82.4 18.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 4.0700000000000003 111.187 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.04 -15.01 29.27 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.769 1.646 . . . . 4.0999999999999996 111.204 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -106.95 97.49 17.96 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 4.1299999999999999 111.184 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.1 163.75 34.51 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.731 1.621 . . . . 4.1699999999999999 111.158 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.82 152.09 68.88 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.662 1.575 . . . . 4.2000000000000002 111.175 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.7 -10.92 30.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 4.2300000000000004 111.168 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -156.97 -176.54 6.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.168 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -79.7 -26.55 40.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 4.2999999999999998 111.212 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.04 -22.08 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 4.3300000000000001 111.138 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.11 -15.91 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.3700000000000001 111.259 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.519 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.7 mt -66.95 -51.35 38.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 4.4000000000000004 111.142 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 96.1 Cg_endo -75.73 -22.5 13.52 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.72 1.613 . . . . 4.4299999999999997 111.193 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.56 89.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 4.4699999999999998 111.232 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.92 -38.21 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 4.5 111.219 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 34.8 t70 -46.68 -47.83 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.204 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -49.35 76.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 4.5700000000000003 111.19 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.88 -30.09 70.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 4.5999999999999996 111.147 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.2 mt -79.46 -36.1 39.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 4.6299999999999999 111.245 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.84 -20.06 64.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 4.6699999999999999 111.163 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.89 68.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 4.7000000000000002 111.24 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -107.0 8.47 30.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 4.7300000000000004 111.219 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.58 60.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.178 -0.769 . . . . 4.7699999999999996 111.178 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 72.9 mmtt -109.94 -174.15 2.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 4.7999999999999998 111.191 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.4 t -151.89 163.62 38.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 4.8300000000000001 111.178 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 136' ' ' ASP . . . -66.42 -57.77 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 4.8700000000000001 111.177 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.53 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.0 pp -164.95 164.93 20.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 4.9000000000000004 111.191 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.2 mmt -110.37 100.02 8.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 4.9299999999999997 111.147 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.88 130.01 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 4.9699999999999998 111.215 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 208' ' ' THR . 39.5 t-20 -70.27 111.93 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 5.0 111.2 169.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.76 7.55 44.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 5.0300000000000002 111.217 -170.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -109.83 -48.11 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 5.0700000000000003 111.263 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.7 121.22 81.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 5.0999999999999996 111.208 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.0 -31.26 8.18 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.717 1.611 . . . . 5.1299999999999999 111.224 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -73.82 -33.59 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 5.1699999999999999 111.167 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -53.03 -37.1 61.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 5.2000000000000002 111.168 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.7 p -99.06 15.31 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 5.2300000000000004 111.199 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 91.0 t90 -66.78 -46.63 55.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 5.2699999999999996 111.254 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 41.7 Cg_endo -87.94 -4.05 7.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.676 1.584 . . . . 5.2999999999999998 111.203 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.46 -51.46 68.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 5.3300000000000001 111.215 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.33 -31.42 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 5.3700000000000001 111.2 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.4 -35.15 79.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 5.4000000000000004 111.164 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.23 80.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 5.4299999999999997 111.197 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.48 -43.46 90.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.204 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.82 26.2 4.83 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.197 -0.761 . . . . 5.5 111.197 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.95 -31.69 4.67 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.257 -0.737 . . . . 5.5300000000000002 111.257 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.75 110.01 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 5.5700000000000003 111.241 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.29 35.82 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 5.5999999999999996 111.159 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -120.14 141.43 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 5.6299999999999999 111.133 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 5.6699999999999999 111.219 178.625 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.7 t0 . . . . . 0 CA--C 1.523 -0.075 0 CA-C-O 120.868 0.366 . . . . 5.9000000000000004 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 pt -72.33 -17.0 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 5.9299999999999997 111.192 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.23 -20.02 52.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 5.9699999999999998 111.196 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.75 174.42 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 6.0 111.165 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.33 152.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 6.0300000000000002 111.185 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.87 22.01 36.6 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.177 -0.769 . . . . 6.0700000000000003 111.177 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.9 p -71.04 -20.02 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 6.0999999999999996 111.25 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -113.79 22.56 13.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 6.1299999999999999 111.232 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.17 117.73 29.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 6.1699999999999999 111.196 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.91 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 6.2000000000000002 111.161 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.94 76.81 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.209 -0.756 . . . . 6.2300000000000004 111.209 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.58 80.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 6.2699999999999996 111.172 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.42 -39.05 93.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 6.2999999999999998 111.217 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 6.3300000000000001 111.207 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.84 -44.67 94.35 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.162 -0.775 . . . . 6.3700000000000001 111.162 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 192' ' ' LEU . 0.7 OUTLIER -65.76 -37.33 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 6.4000000000000004 111.234 176.078 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.8 m -61.14 -44.01 98.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 6.4299999999999997 111.173 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -55.66 -46.03 77.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 6.4699999999999998 111.205 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.88 -52.12 66.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 6.5 111.268 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.07 -21.14 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 6.5300000000000002 111.253 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.86 -40.18 79.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 6.5700000000000003 111.242 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.04 -35.61 81.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 6.5999999999999996 111.177 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.28 -52.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.195 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.58 -43.03 99.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 6.6699999999999999 111.231 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -79.94 -10.14 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 6.7000000000000002 111.149 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 59.83 58.46 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 6.7300000000000004 111.182 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -81.17 -22.57 38.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 6.7699999999999996 111.219 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.98 170.75 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.207 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -92.74 161.98 14.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 6.8300000000000001 111.197 -174.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.86 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 6.8700000000000001 111.238 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.01 -30.06 67.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 6.9000000000000004 111.18 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 150' ' ' ASN . 49.8 m -51.77 130.78 29.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.206 175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -157.49 176.72 12.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 6.9699999999999998 111.197 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -64.04 -21.2 66.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 7.0 111.175 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.0 p -69.7 -25.6 63.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 7.0300000000000002 111.226 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.52 -32.27 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 7.0700000000000003 111.19 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 225' ' ' THR . . . -61.04 -44.69 97.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 7.0999999999999996 111.202 177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.97 -39.55 93.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 7.1299999999999999 111.207 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.12 -47.19 86.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.219 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.94 63.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 7.2000000000000002 111.211 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.64 -38.89 92.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 7.2300000000000004 111.183 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 234' ' ' ASN . 97.7 m-20 -93.33 -39.69 10.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 7.2699999999999996 111.175 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.52 -23.06 59.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 7.2999999999999998 111.218 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.35 51.23 6.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.229 -0.748 . . . . 7.3300000000000001 111.229 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.92 3.25 25.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 7.3700000000000001 111.227 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 154.04 36.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 7.4000000000000004 111.241 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.57 -29.87 18.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 7.4299999999999997 111.212 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 21.6 ptt? -152.3 170.0 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 7.4699999999999998 111.185 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.413 HG21 ' HB1' ' A' ' 213' ' ' ALA . 12.3 t -170.18 152.82 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 7.5 111.161 170.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 94.0 mt -91.89 120.07 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 7.5300000000000002 111.236 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -160.8 -172.12 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 7.5700000000000003 111.167 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -120.36 -165.09 12.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.165 -0.774 . . . . 7.5999999999999996 111.165 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.13 64.65 8.39 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.708 1.606 . . . . 7.6299999999999999 111.245 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -125.41 -30.07 3.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 7.6699999999999999 111.224 171.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.19 -5.22 30.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 7.7000000000000002 111.246 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -76.91 -19.15 57.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 7.7300000000000004 111.175 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 95.5 p -72.85 -10.06 59.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 7.7699999999999996 111.196 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 218' ' ' ASN . 65.8 m-80 -95.01 5.41 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 7.7999999999999998 111.187 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.9 -51.29 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 7.8300000000000001 111.198 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -77.39 -25.32 50.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 7.8700000000000001 111.199 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 87.5 m -64.99 -45.95 83.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 7.9000000000000004 111.227 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 85.2 p -82.58 -14.72 54.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 7.9299999999999997 111.259 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 59.57 45.4 13.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 7.9699999999999998 111.18 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 73.6 t -128.03 142.82 42.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 8.0 111.207 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 119' ' ' LYS . 97.4 m-20 -74.75 112.57 11.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 8.0299999999999994 111.222 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -112.84 143.04 44.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 8.0700000000000003 111.177 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -118.58 167.47 13.04 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.147 -0.781 . . . . 8.0999999999999996 111.147 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.65 160.75 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 8.1300000000000008 111.17 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -135.76 -176.65 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 8.1699999999999999 111.201 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.01 120.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 8.1999999999999993 111.206 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.535 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 91.5 mt -87.8 -42.2 0.5 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.134 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 78.2 Cg_exo -53.22 112.42 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.695 1.597 . . . . 8.2699999999999996 111.156 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 88.0 m -124.48 112.11 16.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 8.3000000000000007 111.168 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -110.01 128.75 55.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 8.3300000000000001 111.126 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 85.1 tttt 45.17 46.04 9.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 8.3699999999999992 111.176 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.9 14.49 78.48 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.205 -0.758 . . . . 8.4000000000000004 111.205 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -129.98 109.99 16.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.181 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.8 130.63 38.24 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.746 1.631 . . . . 8.4700000000000006 111.187 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.6 t -105.1 -99.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 8.5 111.126 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -136.87 151.94 73.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 8.5299999999999994 111.223 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -60.4 144.57 99.52 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.737 1.624 . . . . 8.5700000000000003 111.181 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -92.96 148.31 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 8.5999999999999996 111.162 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.35 126.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 8.6300000000000008 111.213 -175.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -85.83 162.83 36.1 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -129.28 136.41 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 8.6999999999999993 111.141 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 67.1 mt -109.82 148.74 30.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 8.7300000000000004 111.165 172.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -161.63 169.98 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 8.7699999999999996 111.234 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.15 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 8.8000000000000007 111.162 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.46 179.66 16.41 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.226 -0.749 . . . . 8.8300000000000001 111.226 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.3 mt -100.98 136.01 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 8.8699999999999992 111.194 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.91 124.72 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 8.9000000000000004 111.167 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.13 -22.42 66.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 8.9299999999999997 111.231 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -5.51 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 8.9700000000000006 111.237 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -79.48 129.88 70.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 9.0 111.2 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.52 -3.33 13.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.708 1.605 . . . . 9.0299999999999994 111.233 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -120.01 60.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 9.0700000000000003 111.263 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -75.85 -30.38 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 9.0999999999999996 111.183 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -68.06 -46.46 71.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 9.1300000000000008 111.223 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 64.3 tp -62.76 -44.13 97.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 9.1699999999999999 111.18 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.29 98.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 9.1999999999999993 111.128 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -63.25 -40.22 96.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 9.2300000000000004 111.183 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.68 -54.78 42.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 9.2699999999999996 111.222 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -52.28 -50.0 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 9.3000000000000007 111.275 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.63 -43.6 93.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 9.3300000000000001 111.219 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -83.41 -61.76 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 9.3699999999999992 111.232 -168.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -92.98 -8.56 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 9.4000000000000004 111.262 -162.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.0 -50.09 2.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 9.4299999999999997 111.231 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.0 tp -78.42 -60.0 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 9.4700000000000006 111.163 -174.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.8 mm? -75.2 69.93 2.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 9.5 111.177 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 29.5 p -136.86 178.02 7.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 9.5299999999999994 111.14 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.18 -25.75 68.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 9.5700000000000003 111.202 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -98.49 -34.59 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.5999999999999996 111.221 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.91 -48.71 59.27 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.35 -45.37 84.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 9.6699999999999999 111.186 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.32 -46.12 91.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 9.6999999999999993 111.217 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.64 74.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 9.7300000000000004 111.136 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.79 -40.65 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 9.7699999999999996 111.204 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.516 ' HB3' HD23 ' A' ' 299' ' ' LEU . 91.9 m-20 -78.22 0.67 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 9.8000000000000007 111.281 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.89 -35.93 82.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 9.8300000000000001 111.152 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.2 -28.33 9.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 9.8699999999999992 111.177 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.45 164.06 19.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 9.9000000000000004 111.19 -176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.97 139.95 79.5 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.702 1.601 . . . . 9.9299999999999997 111.206 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 294' ' ' ASN . 98.7 mt -70.12 -18.6 63.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.166 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.01 -26.53 71.44 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.197 -0.761 . . . . 10.0 111.197 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -60.13 127.09 30.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 10.029999999999999 111.189 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.9 134.25 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 10.07 111.193 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 108' ' ' ILE . . . -114.42 -27.18 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 10.1 111.168 164.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.19 144.99 27.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 10.130000000000001 111.162 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -65.55 -47.35 76.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 10.17 111.224 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.8 m -62.67 -40.05 95.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 10.199999999999999 111.204 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -65.17 -40.37 94.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 10.23 111.226 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -60.75 -33.39 72.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 10.27 111.238 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.12 -33.11 71.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 10.300000000000001 111.174 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -70.31 -29.9 66.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 10.33 111.188 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.15 -29.84 61.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 10.369999999999999 111.169 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.01 73.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 10.4 111.189 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.33 -34.36 68.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 10.43 111.166 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.02 118.35 48.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 10.470000000000001 111.159 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.7 -35.51 93.34 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.744 1.629 . . . . 10.5 111.153 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -79.98 -52.58 7.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 10.529999999999999 111.156 -172.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.428 HG22 ' HG2' ' A' ' 321' ' ' MET . 50.4 mm -79.17 -27.34 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 10.57 111.163 -170.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.31 -36.72 33.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 10.6 111.172 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.15 95.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.188 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.8 m -69.95 -39.85 75.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 10.67 111.107 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.428 ' HG2' HG22 ' A' ' 317' ' ' ILE . 38.8 mmt -68.37 -35.42 77.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 10.699999999999999 111.233 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.53 -42.4 87.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 10.73 111.233 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -64.91 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 10.77 111.238 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 10.800000000000001 111.232 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.49 -42.77 99.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.83 111.271 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.04 -9.83 38.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 10.869999999999999 111.262 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.97 -165.16 35.45 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.23 164.31 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 10.93 111.17 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.4 pt -111.32 162.87 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 10.970000000000001 111.214 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -84.95 164.72 40.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 11.0 111.18 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.06 138.53 82.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.72 1.614 . . . . 11.029999999999999 111.182 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -107.51 28.27 8.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 11.07 111.221 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 335' ' ' GLN . 89.3 mt -90.62 125.26 60.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 11.1 111.202 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.49 -24.36 31.01 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.736 1.624 . . . . 11.130000000000001 111.183 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.438 ' H ' HG22 ' A' ' 333' ' ' ILE . 61.7 mt-30 -80.57 -1.46 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 11.17 111.129 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.1 mmm -95.16 6.9 47.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 11.199999999999999 111.164 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.4 p -64.55 -33.78 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 11.23 111.133 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.29 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 11.27 111.163 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -60.98 -47.59 85.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 11.300000000000001 111.172 175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.38 -49.06 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 11.33 111.219 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.36 -47.01 65.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.172 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.37 86.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.244 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.97 -46.38 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 11.43 111.192 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.75 -44.85 70.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 11.470000000000001 111.233 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.8 m -65.21 -40.56 94.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.203 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.76 -34.08 77.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 11.529999999999999 111.174 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.82 -48.9 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 11.57 111.167 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 8.9 tp -74.88 -25.18 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 11.6 111.201 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.76 -48.29 55.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 11.630000000000001 111.219 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.64 76.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 11.67 111.208 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.07 87.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.175 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 11.73 111.161 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.34 27.02 8.92 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.216 -0.754 . . . . 11.77 111.216 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -82.75 -35.08 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 11.800000000000001 111.23 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -151.38 174.77 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 11.83 111.135 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -85.0 171.97 11.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 11.869999999999999 111.177 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -72.19 -24.16 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 11.9 111.237 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.01 -47.89 60.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 11.93 111.161 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -68.5 -28.45 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 11.970000000000001 111.162 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.13 -51.33 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 12.0 111.208 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.29 -20.35 48.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 12.029999999999999 111.205 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.86 -52.42 56.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 12.07 111.151 171.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.84 -37.4 86.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.429 . . . . 12.1 111.246 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.45 81.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 12.130000000000001 111.212 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -55.31 -44.5 75.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 12.17 111.208 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.8 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 12.199999999999999 111.237 177.896 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.8 0.333 . . . . 0.070000000000000007 111.175 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.0 144.93 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.10000000000000001 111.199 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.04 129.94 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.13 111.211 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.02 19.56 21.24 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.153 -0.779 . . . . 0.17000000000000001 111.153 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -140.16 146.61 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.20000000000000001 111.196 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 275' ' ' LEU . 88.2 mt -112.29 140.75 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.23000000000000001 111.264 172.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.84 118.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.27000000000000002 111.218 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 59' ' ' ILE . 89.5 mt -107.88 123.9 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.29999999999999999 111.213 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -110.09 130.66 55.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.33000000000000002 111.201 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.42 120.09 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.37 111.231 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.58 125.35 26.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.40000000000000002 111.156 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.15 -170.83 40.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.151 -0.78 . . . . 0.42999999999999999 111.151 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.04 -51.9 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.46999999999999997 111.157 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.73 158.8 42.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.5 111.254 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.99 -8.87 4.82 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.229 -0.748 . . . . 0.53000000000000003 111.229 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -64.93 -24.56 67.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 111.257 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.54 -42.73 70.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.59999999999999998 111.219 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.58 -40.41 97.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.155 -0.778 . . . . 0.63 111.155 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.17 -23.61 51.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.328 . . . . 0.67000000000000004 111.183 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -33.4 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.147 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.77 -42.85 97.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.164 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.93 -25.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.77000000000000002 111.184 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -33.52 87.45 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.13 -0.788 . . . . 0.80000000000000004 111.13 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.61 -43.91 92.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.82999999999999996 111.151 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.97 -35.98 76.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.87 111.222 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.08 -42.73 93.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.90000000000000002 111.172 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.59 -35.76 81.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.93000000000000005 111.234 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -64.35 -30.05 71.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.96999999999999997 111.182 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -99.89 -34.7 10.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.252 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -107.05 -29.03 9.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 1.03 111.239 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.95 6.55 75.56 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.186 -0.766 . . . . 1.0700000000000001 111.186 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.7 mm -89.22 127.86 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 1.1000000000000001 111.176 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.6 134.33 33.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.1299999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -115.49 124.44 71.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 1.1699999999999999 111.265 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -115.69 125.97 53.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 1.2 111.249 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.19 131.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.23 111.198 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -128.84 156.12 44.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 1.27 111.208 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -111.49 85.64 6.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 1.3 111.178 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 147.51 45.91 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.713 1.608 . . . . 1.3300000000000001 111.19 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -137.03 5.23 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 1.3700000000000001 111.182 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -124.96 35.05 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 1.3999999999999999 111.16 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.98 -35.15 74.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 1.4299999999999999 111.199 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.3 -40.04 64.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.47 111.199 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -84.66 -26.94 27.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 1.5 111.144 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.02 -19.81 43.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.217 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.481 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.2 m-30 -55.04 -57.43 19.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 1.5700000000000001 111.231 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 72.8 Cg_endo -72.96 -23.33 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.732 1.621 . . . . 1.6000000000000001 111.16 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -67.7 -36.4 80.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.302 -0.408 . . . . 1.6299999999999999 111.162 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.8 m -100.02 -28.08 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 1.6699999999999999 111.183 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 1.7 111.229 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -15.89 60.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 1.73 111.2 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 p -109.88 -18.39 13.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 1.77 111.145 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.96 42.52 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.214 -0.754 . . . . 1.8 111.214 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -111.22 -175.0 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.8300000000000001 111.154 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.07 -172.15 25.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.172 -0.771 . . . . 1.8700000000000001 111.172 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.0 -176.49 2.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.666 1.578 . . . . 1.8999999999999999 111.212 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -99.27 -48.03 4.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 1.9299999999999999 111.211 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.441 ' HB ' HG12 ' A' ' 9' ' ' ILE . 83.4 mt -117.93 134.96 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 1.97 111.195 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -121.72 137.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 2.0 111.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -105.39 137.95 42.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 2.0299999999999998 111.206 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.99 163.38 18.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 2.0699999999999998 111.173 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.22 165.93 12.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 2.1000000000000001 111.173 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -53.96 -33.52 57.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.1299999999999999 111.197 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 340' ' ' TRP . 76.1 m-20 -102.51 16.27 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 2.1699999999999999 111.206 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -110.01 -0.02 18.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 2.2000000000000002 111.165 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -69.97 -27.55 64.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 2.23 111.225 -170.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.7 -39.74 61.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 2.27 111.218 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -30.82 78.77 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.178 -0.769 . . . . 2.2999999999999998 111.178 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.64 -37.07 11.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.24 -174.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.08 64.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 2.3700000000000001 111.174 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -84.51 -28.23 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 2.3999999999999999 111.195 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 -15.62 56.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.4300000000000002 111.249 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 31.55 30.28 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.229 -0.748 . . . . 2.4700000000000002 111.229 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -118.65 33.73 5.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 2.5 111.211 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.0 tp -152.37 125.16 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 2.5299999999999998 111.158 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.68 157.67 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 2.5699999999999998 111.22 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.87 80.01 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 2.6000000000000001 111.21 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.57 114.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 2.6299999999999999 111.258 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.469 HG23 ' HB2' ' A' ' 103' ' ' LEU . 53.0 m -100.9 121.58 51.9 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 2.6699999999999999 111.219 -168.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HB3' ' CD2' ' A' ' 106' ' ' TYR . 58.1 Cg_endo -67.43 125.27 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.18 173.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -85.03 -168.28 2.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 2.73 111.176 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.89 -32.86 71.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 2.77 111.181 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.61 -35.05 76.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 2.7999999999999998 111.168 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.93 -24.82 21.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 2.8300000000000001 111.201 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.69 -35.03 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.8700000000000001 111.158 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -89.25 -34.96 16.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 2.8999999999999999 111.202 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -81.03 -30.08 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 2.9300000000000002 111.175 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -104.56 166.11 10.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 2.9700000000000002 111.249 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.448 ' CE2' ' HA ' ' A' ' 303' ' ' ALA . 19.7 m-85 -60.14 138.14 91.33 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 3.0 111.228 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.31 -13.56 28.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.687 1.591 . . . . 3.0299999999999998 111.214 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.71 -21.98 24.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 3.0699999999999998 111.164 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -107.37 -19.74 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 3.1000000000000001 111.185 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -60.14 -42.63 95.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 3.1299999999999999 111.188 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.98 -15.55 29.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 3.1699999999999999 111.137 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.28 13.31 8.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 3.2000000000000002 111.2 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.2 m -120.19 71.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 3.23 111.24 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -141.33 139.15 33.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 3.27 111.163 -158.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -162.44 139.85 8.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 3.2999999999999998 111.175 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 65.8 30.55 10.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 3.3300000000000001 111.186 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.72 86.78 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.149 -0.78 . . . . 3.3700000000000001 111.149 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.15 155.68 48.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.821 0.343 . . . . 3.3999999999999999 111.216 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.469 ' HB2' HG23 ' A' ' 80' ' ' THR . 90.1 mt -79.06 142.43 36.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 3.4300000000000002 111.151 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 pt -124.93 -5.01 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 3.4700000000000002 111.226 -162.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.14 160.41 39.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 3.5 111.244 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 86.9 m-85 -99.09 125.07 42.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 3.5299999999999998 111.139 166.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.66 131.16 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.702 1.601 . . . . 3.5699999999999998 111.135 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.24 -55.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 3.6000000000000001 111.18 -169.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.77 156.36 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 3.6299999999999999 111.206 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.04 161.01 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 3.6699999999999999 111.161 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -149.31 110.57 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 3.7000000000000002 111.132 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.44 135.85 44.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 3.73 111.227 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.13 145.07 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 3.77 111.164 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 99.0 p -150.15 169.4 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 3.7999999999999998 111.199 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -115.13 130.21 56.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 3.8300000000000001 111.221 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.75 147.79 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 3.8700000000000001 111.23 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -138.19 159.03 43.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 3.8999999999999999 111.132 167.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 122' ' ' LEU . 34.4 t-20 -107.85 104.75 14.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 3.9300000000000002 111.257 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.0 mttt -57.67 -34.8 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 3.9700000000000002 111.203 -174.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.34 -47.72 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 4.0 111.227 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.21 -58.46 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 4.0300000000000002 111.288 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 118' ' ' ASN . 68.2 mt -125.04 76.26 67.23 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 4.0700000000000003 111.285 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.43 -17.61 39.0 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.691 1.594 . . . . 4.0999999999999996 111.224 -174.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -97.81 104.84 23.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 4.1299999999999999 111.198 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.18 155.47 64.48 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.635 1.557 . . . . 4.1699999999999999 111.241 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.38 144.22 60.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 4.2000000000000002 111.238 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.18 -19.88 31.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 4.2300000000000004 111.215 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -150.07 -177.33 5.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 4.2699999999999996 111.238 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -64.58 -41.73 96.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 4.2999999999999998 111.212 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.27 -23.1 66.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 4.3300000000000001 111.185 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -87.71 -15.34 37.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 4.3700000000000001 111.174 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 82.7 mt -68.94 -50.48 22.12 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 4.4000000000000004 111.179 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 92.1 Cg_endo -75.93 -18.98 16.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.661 1.574 . . . . 4.4299999999999997 111.199 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.0 85.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 4.4699999999999998 111.201 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.75 -28.65 60.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 4.5 111.214 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.62 -42.51 98.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 4.5300000000000002 111.179 173.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.78 -48.1 72.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 4.5700000000000003 111.201 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -61.84 -40.98 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 4.5999999999999996 111.191 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 223' ' ' ALA . 26.0 tp -72.25 -31.78 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 4.6299999999999999 111.215 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.73 -39.52 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 4.6699999999999999 111.158 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.76 71.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 4.7000000000000002 111.228 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.89 -14.86 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.488 . . . . 4.7300000000000004 111.222 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.13 16.49 18.64 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.277 -0.729 . . . . 4.7699999999999996 111.277 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -134.26 154.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 4.7999999999999998 111.212 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.5 t -100.96 146.92 26.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 4.8300000000000001 111.225 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -112.73 -20.61 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 4.8700000000000001 111.205 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.7 tp -125.58 114.57 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 4.9000000000000004 111.17 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.402 ' SD ' ' OG1' ' A' ' 222' ' ' THR . 97.9 mtp -145.0 110.08 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 4.9299999999999997 111.22 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -101.21 -179.97 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 4.9699999999999998 111.186 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.649 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . 61.0 t-20 -96.06 105.26 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 5.0 111.216 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 151' ' ' LEU . 3.2 mm? -89.21 9.38 25.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 5.0300000000000002 111.209 -173.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -110.64 -9.98 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 5.0700000000000003 111.234 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -144.6 113.28 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 5.0999999999999996 111.193 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.12 -33.56 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.719 1.613 . . . . 5.1299999999999999 111.221 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -55.24 -33.03 62.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 5.1699999999999999 111.197 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.649 ' HB2' ' HB3' ' A' ' 150' ' ' ASN . 77.9 m-85 -104.99 25.57 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 5.2000000000000002 111.22 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.8 p -121.97 -14.38 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 5.2300000000000004 111.141 166.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.593 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 88.7 t90 -66.12 -40.1 34.04 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 5.2699999999999996 111.192 176.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 74.4 Cg_exo -55.45 -19.54 23.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.758 1.639 . . . . 5.2999999999999998 111.201 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.4 tp -42.77 -51.54 5.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 5.3300000000000001 111.223 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 47.7 pt -86.19 -9.99 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 5.3700000000000001 111.169 -173.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.94 -25.78 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 5.4000000000000004 111.173 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.95 98.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 5.4299999999999997 111.225 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -95.69 9.83 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.216 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.21 29.6 73.34 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.177 -0.769 . . . . 5.5 111.177 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.89 -37.89 28.41 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -71.79 131.64 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 5.5700000000000003 111.179 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 55.02 55.29 7.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 5.5999999999999996 111.202 168.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -127.38 162.45 26.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.428 . . . . 5.6299999999999999 111.223 165.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.7 pttt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 5.6699999999999999 111.237 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.2 t0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.831 0.348 . . . . 5.9000000000000004 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.39 -18.62 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 5.9299999999999997 111.2 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 5.9699999999999998 111.217 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.3 141.76 58.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 6.0 111.161 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.85 173.45 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 6.0300000000000002 111.177 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -83.8 9.0 63.87 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.242 -0.743 . . . . 6.0700000000000003 111.242 -168.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.28 -2.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 6.0999999999999996 111.187 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -131.33 10.03 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 6.1299999999999999 111.199 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.08 139.46 36.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 6.1699999999999999 111.164 174.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.66 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 6.2000000000000002 111.179 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.64 93.54 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.761 . . . . 6.2300000000000004 111.199 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.23 92.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 6.2699999999999996 111.247 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.1 -47.3 62.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 6.2999999999999998 111.22 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.27 92.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 6.3300000000000001 111.239 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -46.73 88.46 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.245 -0.742 . . . . 6.3700000000000001 111.245 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.17 -43.46 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 6.4000000000000004 111.197 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -50.95 -29.29 11.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 6.4299999999999997 111.172 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -53.29 -60.62 3.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 6.4699999999999998 111.17 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.9 mt -78.48 -25.36 45.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 6.5 111.234 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.59 -47.37 85.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 6.5300000000000002 111.243 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -75.01 -35.44 61.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 6.5700000000000003 111.222 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.483 ' HB3' ' HG2' ' A' ' 204' ' ' MET . 5.1 mp -75.76 -18.97 59.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 6.5999999999999996 111.197 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 93.8 mt -91.71 -40.6 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 6.6299999999999999 111.213 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.78 -38.09 77.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 6.6699999999999999 111.22 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.96 13.57 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 6.7000000000000002 111.146 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 56.94 46.19 19.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 6.7300000000000004 111.193 172.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -94.98 -49.91 5.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 6.7699999999999996 111.26 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.483 ' HG2' ' HB3' ' A' ' 198' ' ' LEU . 97.5 mmm -74.31 144.99 44.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 6.7999999999999998 111.224 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -86.56 114.57 23.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 6.8300000000000001 111.164 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.58 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.8700000000000001 111.22 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.28 -30.3 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 6.9000000000000004 111.175 -176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 m -64.97 128.96 37.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.262 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.06 -166.76 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 6.9699999999999998 111.189 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -69.92 -48.81 57.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 7.0 111.122 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -67.49 -29.84 69.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 7.0300000000000002 111.21 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.7 mt -66.96 -44.94 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 7.0700000000000003 111.194 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.36 93.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.141 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.92 -40.04 40.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 7.1299999999999999 111.138 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.0 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.208 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.04 -9.12 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 7.2000000000000002 111.214 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.53 -25.02 56.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 7.2300000000000004 111.205 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -89.39 -24.04 22.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 7.2699999999999996 111.171 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.01 -25.42 32.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 7.2999999999999998 111.148 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.26 29.13 28.62 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.277 -0.729 . . . . 7.3300000000000001 111.277 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.55 -19.13 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 7.3700000000000001 111.233 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.402 ' OG1' ' SD ' ' A' ' 148' ' ' MET . 96.9 m -119.59 127.59 53.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 7.4000000000000004 111.142 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 139' ' ' LEU . . . -93.51 -31.22 14.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 7.4299999999999997 111.135 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 17.2 ptp -157.46 159.68 37.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 7.4699999999999998 111.183 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.0 t -160.39 -173.17 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 7.5 111.181 170.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.62 122.27 58.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 7.5300000000000002 111.207 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 9.5 t-20 -166.79 -178.99 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 7.5700000000000003 111.279 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.52 -165.23 41.07 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.44 79.61 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.669 1.579 . . . . 7.6299999999999999 111.153 -174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -175.02 -22.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.428 . . . . 7.6699999999999999 111.231 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -68.75 -47.52 66.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 7.7000000000000002 111.177 -172.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -86.33 2.17 48.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 7.7300000000000004 111.156 -170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.3 p -84.51 -9.44 58.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 7.7699999999999996 111.188 171.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -94.85 -7.16 41.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 7.7999999999999998 111.213 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.89 -24.31 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 7.8300000000000001 111.191 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -30.9 29.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 7.8700000000000001 111.189 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.4 m -62.29 -40.12 95.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 7.9000000000000004 111.205 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 49.5 m -71.35 -24.73 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 7.9299999999999997 111.226 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 63.12 54.47 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 7.9699999999999998 111.188 174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.66 167.47 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 8.0 111.196 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -81.09 126.41 31.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 8.0299999999999994 111.266 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.434 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 53.4 p90 -145.85 164.44 31.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 8.0700000000000003 111.193 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.41 -179.38 30.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.148 -0.781 . . . . 8.0999999999999996 111.148 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.61 140.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 8.1300000000000008 111.158 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -138.18 -174.84 3.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 8.1699999999999999 111.258 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.26 159.16 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 8.1999999999999993 111.13 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 247' ' ' LEU . 2.4 pt? -139.93 50.01 2.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 8.2300000000000004 111.197 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 74.0 Cg_endo -73.13 149.97 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.714 1.609 . . . . 8.2699999999999996 111.184 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.9 m -148.66 117.76 6.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 8.3000000000000007 111.254 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -105.46 85.24 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 8.3300000000000001 111.152 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 86.5 mttt 57.02 35.35 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 8.3699999999999992 111.206 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.34 -14.05 28.07 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.261 -0.736 . . . . 8.4000000000000004 111.261 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -117.92 109.98 40.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 8.4299999999999997 111.217 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.17 139.01 41.13 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.66 1.573 . . . . 8.4700000000000006 111.253 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.9 t -139.99 -75.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 8.5 111.29 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.474 ' HB3' ' HA2' ' A' ' 327' ' ' GLY . 70.1 mmtt -144.41 146.21 31.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 8.5299999999999994 111.201 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 165.97 30.6 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.742 1.628 . . . . 8.5700000000000003 111.223 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.16 139.21 44.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 8.5999999999999996 111.229 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.94 115.28 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 8.6300000000000008 111.213 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.68 151.38 32.28 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.2 -0.76 . . . . 8.6699999999999999 111.2 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.65 133.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 8.6999999999999993 111.148 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 50.0 tp -102.53 134.3 46.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 8.7300000000000004 111.141 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 98.6 p -132.99 173.78 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 8.7699999999999996 111.219 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.31 40.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 8.8000000000000007 111.211 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -157.74 -173.05 25.66 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.224 -0.751 . . . . 8.8300000000000001 111.224 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -102.41 127.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 8.8699999999999992 111.187 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.15 135.66 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 8.9000000000000004 111.211 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.27 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 8.9299999999999997 111.206 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -99.42 19.54 15.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 8.9700000000000006 111.267 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 16.5 t -69.78 121.55 82.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 9.0 111.207 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 -26.47 19.09 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.648 1.565 . . . . 9.0299999999999994 111.162 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -119.62 62.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.0700000000000003 111.219 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -65.08 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 9.0999999999999996 111.177 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.51 -49.2 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 9.1300000000000008 111.219 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.44 ' HB2' HD21 ' A' ' 7' ' ' LEU . 99.5 mt -68.52 -34.75 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 9.1699999999999999 111.228 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.54 99.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 9.1999999999999993 111.237 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -47.94 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 9.2300000000000004 111.183 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.95 -40.1 95.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.259 -0.428 . . . . 9.2699999999999996 111.163 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -59.8 -52.04 67.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 9.3000000000000007 111.138 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.08 -44.58 94.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 9.3300000000000001 111.191 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.57 -35.12 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 9.3699999999999992 111.18 -167.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -93.9 -23.2 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 9.4000000000000004 111.172 -170.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -122.66 -66.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 9.4299999999999997 111.224 -171.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 67.3 tp -50.41 -56.03 13.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 9.4700000000000006 111.192 -167.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.9 mt -104.0 38.35 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 9.5 111.192 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.5 p -119.14 -165.73 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 9.5299999999999994 111.259 167.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.84 -10.87 60.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 9.5700000000000003 111.174 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -88.11 -54.41 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 9.5999999999999996 111.209 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.33 6.38 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.171 -0.772 . . . . 9.6300000000000008 111.171 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.13 -34.67 76.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 9.6699999999999999 111.189 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.55 -41.27 80.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 9.6999999999999993 111.216 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.32 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 9.7300000000000004 111.263 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.5 t -86.28 -40.3 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 9.7699999999999996 111.152 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.99 -23.62 63.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 9.8000000000000007 111.246 -172.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.71 -14.83 62.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 9.8300000000000001 111.175 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -111.16 -34.61 6.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 9.8699999999999992 111.164 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.98 162.67 20.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 9.9000000000000004 111.225 -174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.17 159.53 15.14 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.711 1.607 . . . . 9.9299999999999997 111.16 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.441 ' HB3' ' HG ' ' A' ' 311' ' ' LEU . 94.7 mt -99.75 39.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 9.9700000000000006 111.241 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.06 -61.26 7.57 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.198 -0.761 . . . . 10.0 111.198 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.18 153.98 2.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 10.029999999999999 111.19 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.06 159.55 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 10.07 111.153 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 90' ' ' TYR . . . -83.84 -30.2 26.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 10.1 111.174 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -67.03 121.61 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 10.130000000000001 111.16 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -68.31 -17.49 64.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.194 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 t -58.33 -40.36 81.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 10.199999999999999 111.223 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -108.65 7.29 26.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 10.23 111.209 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -57.7 -50.0 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 10.27 111.199 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.58 -29.97 61.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 10.300000000000001 111.18 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.61 -37.06 84.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 10.33 111.219 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' A' ' 299' ' ' LEU . 9.8 mp -82.73 -37.51 24.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 10.369999999999999 111.196 175.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -77.99 -4.65 48.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 10.4 111.196 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.13 -41.58 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 10.43 111.151 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.27 120.71 70.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 10.470000000000001 111.168 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.13 -29.72 47.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.703 1.602 . . . . 10.5 111.255 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.22 -23.14 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 10.529999999999999 111.175 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.3 mt -98.65 -39.42 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 10.57 111.202 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.49 -34.23 70.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 10.6 111.19 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.68 62.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.630000000000001 111.202 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 94.4 m -95.23 -42.33 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.243 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.7 mtp -65.01 -41.94 94.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 10.699999999999999 111.18 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 10.73 111.183 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -76.97 -16.94 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 10.77 111.237 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.54 49.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 10.800000000000001 111.228 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -80.34 -19.93 45.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 10.83 111.235 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.43 -4.14 32.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 10.869999999999999 111.086 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 256' ' ' LYS . . . -87.83 -170.06 45.85 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -86.41 99.95 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 10.93 111.205 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.15 136.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 10.970000000000001 111.203 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 53.0 ttm -46.59 124.93 7.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 11.0 111.258 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 54.3 Cg_exo -60.28 155.58 45.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.705 1.603 . . . . 11.029999999999999 111.2 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -94.89 15.99 17.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 11.07 111.274 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 82.4 mt -80.49 125.04 81.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 11.1 111.253 -169.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.51 -40.36 79.09 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.747 1.631 . . . . 11.130000000000001 111.154 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.26 -38.97 93.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 11.17 111.24 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.0 mmm -75.13 -23.74 57.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 11.199999999999999 111.165 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 41.6 t -62.64 -40.9 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 11.23 111.175 169.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.84 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 11.27 111.269 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -66.66 -27.38 67.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 11.300000000000001 111.235 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 65' ' ' ASP . 87.4 t90 -54.36 -46.51 73.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 11.33 111.198 -173.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -99.24 -23.0 15.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 11.369999999999999 111.213 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.57 91.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 11.4 111.214 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.58 -36.54 66.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 11.43 111.193 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.6 ttp180 -54.72 -45.1 74.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 11.470000000000001 111.208 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 95.6 m -61.66 -40.03 93.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 11.5 111.21 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.22 88.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.192 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.5 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 11.57 111.191 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.7 -48.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 11.6 111.135 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -69.03 -28.92 67.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 11.630000000000001 111.167 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.6 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 11.67 111.218 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.85 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 11.699999999999999 111.2 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -74.65 -17.41 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 11.73 111.182 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.76 26.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.231 -0.748 . . . . 11.77 111.231 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -99.99 -38.71 8.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 11.800000000000001 111.223 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -129.85 168.75 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 11.83 111.116 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 33.9 p -92.62 175.04 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 11.869999999999999 111.18 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.1 m -67.2 -14.36 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 11.9 111.19 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.69 -49.3 5.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 11.93 111.188 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.14 -39.34 75.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 11.970000000000001 111.169 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.81 96.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 12.0 111.228 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.84 -24.78 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 12.029999999999999 111.158 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.32 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 12.07 111.148 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -64.71 -39.63 93.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 12.1 111.169 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.4 80.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 12.130000000000001 111.18 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -71.95 -42.92 66.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 12.17 111.144 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.4 m . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 12.199999999999999 111.159 -175.493 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.811 0.339 . . . . 0.070000000000000007 111.22 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.97 129.92 39.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.10000000000000001 111.178 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.2 139.96 58.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.13 111.23 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.58 2.29 57.57 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.17000000000000001 111.206 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.07 155.03 45.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.816 0.341 . . . . 0.20000000000000001 111.18 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.6 tp -104.18 115.05 29.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.23000000000000001 111.167 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -117.68 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.27000000000000002 111.196 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.21 114.97 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.29999999999999999 111.195 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -102.75 113.05 26.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.33000000000000002 111.249 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.6 tt -125.11 139.94 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.37 111.24 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -88.48 109.9 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.40000000000000002 111.178 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.4 47.82 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.213 -0.755 . . . . 0.42999999999999999 111.213 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -77.81 -69.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.46999999999999997 111.205 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -129.98 31.4 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.5 111.217 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.92 -19.68 69.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.239 -0.744 . . . . 0.53000000000000003 111.239 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -60.56 -24.37 65.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 0.56999999999999995 111.211 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -63.12 -49.95 72.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.59999999999999998 111.193 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.95 96.47 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.203 -0.759 . . . . 0.63 111.203 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.72 -31.48 66.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.818 0.342 . . . . 0.67000000000000004 111.22 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.12 91.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.69999999999999996 111.225 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.16 -35.02 74.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.72999999999999998 111.196 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 -41.25 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.77000000000000002 111.236 174.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -27.93 69.31 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.14 -0.784 . . . . 0.80000000000000004 111.14 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.45 -33.99 74.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.826 0.346 . . . . 0.82999999999999996 111.206 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.25 -39.05 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.87 111.199 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -61.02 -42.38 98.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 111.166 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.27 -41.59 99.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.93000000000000005 111.21 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.01 -35.96 69.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.96999999999999997 111.216 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.07 -40.12 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.178 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.5 p -103.27 -27.21 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.226 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.85 4.8 78.54 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.219 -0.753 . . . . 1.0700000000000001 111.219 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.5 mm -87.34 115.0 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 1.1000000000000001 111.212 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.03 124.9 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 1.1299999999999999 111.204 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.15 136.01 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.1699999999999999 111.248 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.4 t -142.56 147.84 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 1.2 111.171 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.32 132.68 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 1.23 111.217 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -140.02 176.37 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 1.27 111.262 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -119.02 75.25 14.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.3 111.149 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.15 158.32 49.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.695 1.596 . . . . 1.3300000000000001 111.217 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -123.15 -179.99 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 1.3700000000000001 111.182 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 55.09 34.63 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 1.3999999999999999 111.195 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.9 mt -74.92 -22.97 58.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 1.4299999999999999 111.284 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -70.03 -12.06 61.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.47 111.235 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.28 -36.05 5.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 1.5 111.199 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -71.33 -38.66 71.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 1.53 111.147 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.489 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.4 m-30 -61.39 -56.28 35.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 1.5700000000000001 111.206 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -66.95 -23.63 46.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.81 1.674 . . . . 1.6000000000000001 111.204 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -70.07 -45.22 67.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 111.196 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.51 -19.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 1.6699999999999999 111.192 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.0 -25.76 68.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.7 111.207 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.11 60.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 1.73 111.216 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p -109.7 -15.21 14.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 1.77 111.175 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.44 23.6 28.49 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.13 -0.788 . . . . 1.8 111.13 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.13 170.08 8.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 1.8300000000000001 111.208 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.92 179.03 21.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.233 -0.747 . . . . 1.8700000000000001 111.233 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 -174.74 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.642 1.561 . . . . 1.8999999999999999 111.267 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.25 -51.39 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 1.9299999999999999 111.244 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.94 134.22 57.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 1.97 111.245 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -129.77 127.07 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 2.0 111.236 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -98.75 127.64 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 2.0299999999999998 111.204 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -130.0 142.36 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 2.0699999999999998 111.118 169.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.06 145.0 56.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.218 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -46.61 -36.15 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 2.1299999999999999 111.258 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -81.66 -5.26 57.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 2.1699999999999999 111.211 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.64 -0.05 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 2.2000000000000002 111.206 174.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -65.02 -56.56 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 2.23 111.194 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.0 -33.52 74.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.185 -0.766 . . . . 2.27 111.185 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.34 -44.81 94.94 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.226 -0.749 . . . . 2.2999999999999998 111.226 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.01 -40.43 75.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.182 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.8 68.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 2.3700000000000001 111.183 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -60.39 -29.9 69.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 2.3999999999999999 111.205 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -68.12 -25.4 65.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 2.4300000000000002 111.193 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.37 32.38 22.72 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.19 -0.764 . . . . 2.4700000000000002 111.19 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -104.4 4.82 33.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 2.5 111.191 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.77 140.04 44.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 2.5299999999999998 111.191 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.71 154.51 20.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 2.5699999999999998 111.211 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.402 ' HA ' HG22 ' A' ' 104' ' ' ILE . 88.6 tt0 -74.82 134.74 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 2.6000000000000001 111.205 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.05 130.02 63.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 2.6299999999999999 111.184 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.2 m -116.83 113.34 40.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 2.6699999999999999 111.253 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.52 156.7 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.637 1.558 . . . . 2.7000000000000002 111.186 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.21 155.65 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 2.73 111.214 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.15 -53.83 52.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 2.77 111.205 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.41 84.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.7999999999999998 111.163 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -54.87 -51.94 64.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 2.8300000000000001 111.214 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -55.9 -42.72 76.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 2.8700000000000001 111.167 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.6 -29.68 70.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 2.8999999999999999 111.199 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.26 -17.93 58.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 2.9300000000000002 111.205 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 97.5 mt -83.41 153.5 24.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.9700000000000002 111.191 172.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.35 148.73 97.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 3.0 111.199 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.96 -15.0 18.93 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.699 1.599 . . . . 3.0299999999999998 111.252 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -96.55 -21.01 17.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 3.0699999999999998 111.154 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -78.43 -14.83 59.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 3.1000000000000001 111.191 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.419 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 49.8 m0 -63.05 -45.49 92.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.476 . . . . 3.1299999999999999 111.254 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.4 -11.82 60.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 3.1699999999999999 111.15 -170.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.54 -1.98 57.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 3.2000000000000002 111.237 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.55 10.3 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 3.23 111.228 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 94' ' ' TRP . 71.6 mtp180 -87.63 144.75 26.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 3.27 111.196 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 94.4 t80 -142.25 123.61 14.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 3.2999999999999998 111.161 171.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 97.5 m-20 65.0 20.75 12.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 3.3300000000000001 111.222 -169.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.56 -2.71 74.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.245 -0.742 . . . . 3.3700000000000001 111.245 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -115.44 144.24 44.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 3.3999999999999999 111.229 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.95 126.14 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 3.4300000000000002 111.214 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 78' ' ' GLU . 28.7 pt -130.12 14.96 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 3.4700000000000002 111.281 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.8 169.43 5.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 3.5 111.187 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -119.47 145.96 40.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 3.5299999999999998 111.183 170.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.94 -178.17 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.69 1.593 . . . . 3.5699999999999998 111.203 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.86 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 3.6000000000000001 111.153 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 3.6299999999999999 111.184 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -105.61 157.91 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.6699999999999999 111.168 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -87.48 179.98 6.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 3.7000000000000002 111.198 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.81 143.33 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 3.73 111.174 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.754 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.9 pp -160.03 144.37 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 3.77 111.219 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.2 t -169.96 -171.88 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 3.7999999999999998 111.171 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.1 tp -71.55 112.49 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 3.8300000000000001 111.229 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.75 125.92 71.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 3.8700000000000001 111.135 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -125.11 146.75 49.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 3.8999999999999999 111.217 -168.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -79.96 123.72 28.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 3.9300000000000002 111.237 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.53 -14.21 62.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 3.9700000000000002 111.171 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -89.98 -29.84 18.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 4.0 111.233 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.1 mt -98.55 -51.22 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 4.0300000000000002 111.164 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 46.6 tp -141.35 79.65 17.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 4.0700000000000003 111.191 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.25 -14.98 28.59 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.235 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -105.04 99.97 22.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 4.1299999999999999 111.21 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.43 156.98 45.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.255 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.19 167.18 28.0 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.686 1.59 . . . . 4.2000000000000002 111.239 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.42 -21.37 38.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 4.2300000000000004 111.206 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.2 t -161.54 172.02 17.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 4.2699999999999996 111.186 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -77.02 -12.02 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 4.2999999999999998 111.19 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.06 -8.75 57.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 4.3300000000000001 111.242 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.48 -4.28 31.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.3700000000000001 111.26 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.542 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 82.8 mt -69.69 -43.81 22.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 4.4000000000000004 111.158 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 55.4 Cg_exo -53.77 -40.15 81.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.71 1.607 . . . . 4.4299999999999997 111.171 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.8 90.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.4699999999999998 111.184 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.0 mt -64.99 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 4.5 111.255 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 4.5300000000000002 111.194 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.65 -31.57 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 4.5700000000000003 111.178 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.32 -32.83 55.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 4.5999999999999996 111.191 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.35 -5.09 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 4.6299999999999999 111.209 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.03 -39.99 75.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 4.6699999999999999 111.224 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.76 -29.31 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 4.7000000000000002 111.206 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.02 -18.74 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 4.7300000000000004 111.199 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 23.71 38.98 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.151 -0.779 . . . . 4.7699999999999996 111.151 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -100.08 149.32 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 4.7999999999999998 111.197 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -96.35 146.53 24.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 4.8300000000000001 111.191 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -100.24 5.54 44.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 4.8700000000000001 111.178 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 tp -160.34 130.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 4.9000000000000004 111.2 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 91.4 mmm -135.02 154.93 51.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 4.9299999999999997 111.237 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.84 165.05 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 4.9699999999999998 111.211 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 58.1 t-20 -73.9 89.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 5.0 111.159 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.16 -38.92 82.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.272 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.36 -53.81 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 5.0700000000000003 111.222 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 155' ' ' TYR . 43.0 tp10 -79.05 122.46 84.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 5.0999999999999996 111.194 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.86 -20.18 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.653 1.569 . . . . 5.1299999999999999 111.195 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.473 ' H ' ' HG3' ' A' ' 153' ' ' GLU . 82.6 t80 -59.44 -22.63 61.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 5.1699999999999999 111.203 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -113.95 29.66 7.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 5.2000000000000002 111.247 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 -22.93 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 5.2300000000000004 111.167 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.74 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 56.5 p-90 -84.57 -23.11 0.32 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 5.2699999999999996 111.213 -173.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.74 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 59.1 Cg_exo -49.1 -40.72 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.679 1.586 . . . . 5.2999999999999998 111.169 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.02 -34.98 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.151 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.36 -32.2 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 5.3700000000000001 111.215 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.11 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 5.4000000000000004 111.17 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.66 -28.33 69.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 5.4299999999999997 111.205 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -89.11 -28.75 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 5.4699999999999998 111.22 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.74 41.88 2.41 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.202 -0.759 . . . . 5.5 111.202 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -107.84 -14.58 16.96 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.189 -0.764 . . . . 5.5300000000000002 111.189 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -105.26 99.04 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 5.5700000000000003 111.179 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.81 47.57 10.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 5.5999999999999996 111.115 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -126.06 139.99 52.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 5.6299999999999999 111.188 171.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 80.8 tttt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.155 172.738 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.3 t0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.804 0.335 . . . . 5.9000000000000004 111.163 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.46 -12.93 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 5.9299999999999997 111.155 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -74.6 -22.07 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 5.9699999999999998 111.165 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -95.62 103.27 15.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 6.0 111.182 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.14 133.84 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 6.0300000000000002 111.194 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.73 39.27 3.1 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.279 -0.728 . . . . 6.0700000000000003 111.279 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.56 -20.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 6.0999999999999996 111.164 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -111.33 14.26 21.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 6.1299999999999999 111.173 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -76.85 150.64 36.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 6.1699999999999999 111.254 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.94 83.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 6.2000000000000002 111.217 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.47 -28.94 72.02 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.9 76.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 6.2699999999999996 111.174 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -79.3 -36.48 39.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 6.2999999999999998 111.206 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.87 74.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.184 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.22 -38.69 94.04 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.175 -0.77 . . . . 6.3700000000000001 111.175 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.5 tp -69.21 -35.3 76.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 6.4000000000000004 111.163 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.0 m -58.97 -39.36 81.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 6.4299999999999997 111.247 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.25 -43.46 97.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.229 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.43 -46.24 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 6.5 111.185 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.61 -26.98 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 6.5300000000000002 111.16 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -73.3 -36.8 66.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 6.5700000000000003 111.194 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.93 -34.67 78.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 6.5999999999999996 111.202 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.99 -44.87 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.169 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.74 -37.71 82.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 6.6699999999999999 111.213 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -86.72 4.97 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 6.7000000000000002 111.188 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 59.83 40.73 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 6.7300000000000004 111.135 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -98.86 -30.63 12.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 6.7699999999999996 111.238 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 96.6 mmm -120.07 141.53 49.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 6.7999999999999998 111.211 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.04 147.2 28.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 6.8300000000000001 111.138 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.55 -30.25 68.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 6.8700000000000001 111.176 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -85.11 -9.63 57.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 6.9000000000000004 111.244 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -57.04 128.73 38.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 6.9299999999999997 111.209 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 43.6 p30 -140.03 -165.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 6.9699999999999998 111.195 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -61.22 -47.35 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 7.0 111.212 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.7 p -70.09 -27.66 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 7.0300000000000002 111.176 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.16 -45.89 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 7.0700000000000003 111.233 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.7 98.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 7.0999999999999996 111.163 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -67.92 -37.09 81.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 7.1299999999999999 111.161 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.81 82.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 7.1699999999999999 111.219 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 7.2000000000000002 111.276 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -69.79 -25.95 64.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 7.2300000000000004 111.253 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -73.07 -14.68 61.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 7.2699999999999996 111.191 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.51 -17.66 13.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 7.2999999999999998 111.18 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.95 27.75 33.37 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.206 -0.758 . . . . 7.3300000000000001 111.206 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 7.3700000000000001 111.2 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 85.8 m -128.34 124.29 36.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 7.4000000000000004 111.203 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.12 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 7.4299999999999997 111.164 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -156.54 165.01 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 7.4699999999999998 111.207 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.0 t -146.56 178.96 7.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 7.5 111.221 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.6 tt -122.26 112.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 7.5300000000000002 111.147 174.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -169.98 -178.62 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 7.5700000000000003 111.224 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -108.16 -165.7 21.28 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.222 -0.751 . . . . 7.5999999999999996 111.222 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -61.9 -18.9 63.67 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.745 1.63 . . . . 7.6299999999999999 111.214 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 7.6699999999999999 111.171 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.77 -25.7 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.203 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.415 ' HA ' HD12 ' A' ' 235' ' ' ILE . 51.9 t90 -80.02 -10.02 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 7.7300000000000004 111.202 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -64.99 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 7.7699999999999996 111.204 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -84.79 -29.97 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 7.7999999999999998 111.218 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 232' ' ' TRP . 88.8 mt -66.59 -38.59 81.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 7.8300000000000001 111.193 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.3 -40.97 86.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 7.8700000000000001 111.148 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 93.8 m -65.05 -40.89 95.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 7.9000000000000004 111.255 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.8 p -77.92 -13.41 59.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 7.9299999999999997 111.231 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 60.02 50.15 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 7.9699999999999998 111.171 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.82 140.27 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 8.0 111.234 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -77.88 92.0 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 8.0299999999999994 111.244 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -101.08 140.84 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 8.0700000000000003 111.225 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.01 -179.64 20.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.159 -0.776 . . . . 8.0999999999999996 111.159 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 141.83 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.87 0.367 . . . . 8.1300000000000008 111.172 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.2 t -123.06 -171.54 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 8.1699999999999999 111.207 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -122.09 109.92 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 8.1999999999999993 111.247 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.555 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 88.2 mt -83.05 -40.54 0.82 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 8.2300000000000004 111.19 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 85.7 Cg_exo -52.76 110.28 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.723 1.616 . . . . 8.2699999999999996 111.197 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -139.89 130.0 25.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 8.3000000000000007 111.167 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -117.23 108.83 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 8.3300000000000001 111.263 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 58.08 35.59 25.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 8.3699999999999992 111.185 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.11 -8.56 69.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.158 -0.777 . . . . 8.4000000000000004 111.158 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -104.28 109.98 63.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.197 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.86 148.46 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.746 1.63 . . . . 8.4700000000000006 111.128 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.7 p -135.03 -105.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 8.5 111.184 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 48.8 tptt -159.52 133.58 5.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 8.5299999999999994 111.182 -170.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 77.2 Cg_exo -55.02 144.0 70.65 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.693 1.595 . . . . 8.5700000000000003 111.155 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -69.54 131.04 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 8.5999999999999996 111.249 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.05 -178.93 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 8.6300000000000008 111.152 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.23 -160.52 10.41 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.56 169.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 8.6999999999999993 111.209 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.86 119.92 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 8.7300000000000004 111.191 165.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.5 m -103.2 113.61 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 8.7699999999999996 111.2 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.28 115.44 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 8.8000000000000007 111.176 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -115.24 178.19 17.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.21 -0.756 . . . . 8.8300000000000001 111.21 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 99.1 mt -111.92 130.65 65.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 8.8699999999999992 111.267 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.29 126.06 26.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 8.9000000000000004 111.203 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.51 64.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 8.9299999999999997 111.126 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -94.35 -5.03 47.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 8.9700000000000006 111.132 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.32 132.63 95.27 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 9.0 111.185 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.6 -10.21 17.2 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.734 1.623 . . . . 9.0299999999999994 111.204 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -121.4 60.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 9.0700000000000003 111.2 -175.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.55 -29.03 52.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 9.0999999999999996 111.156 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.84 -40.03 76.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 9.1300000000000008 111.167 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.76 -35.6 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 9.1699999999999999 111.127 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.05 90.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 9.1999999999999993 111.146 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.49 -43.58 84.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 9.2300000000000004 111.246 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -56.48 -53.88 52.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 9.2699999999999996 111.214 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -54.73 -57.24 12.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 9.3000000000000007 111.163 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.1 -52.62 64.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 9.3300000000000001 111.232 -174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -79.41 -45.12 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 9.3699999999999992 111.174 -165.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -98.94 -11.8 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 9.4000000000000004 111.217 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -125.0 -65.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 9.4299999999999997 111.21 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 69.8 tp -59.62 -49.12 78.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 9.4700000000000006 111.229 -169.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 72.6 mt -97.78 40.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 9.5 111.195 -171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.0 p -105.07 176.58 5.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 9.5299999999999994 111.234 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.76 -30.33 70.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 9.5700000000000003 111.192 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -87.05 -40.08 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 9.5999999999999996 111.171 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -61.85 -46.98 93.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.245 -0.742 . . . . 9.6300000000000008 111.245 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.71 -21.97 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 9.6699999999999999 111.225 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -69.91 -39.36 76.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 9.6999999999999993 111.256 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.43 -29.55 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 9.7300000000000004 111.219 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 73.7 t -73.27 -42.85 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 9.7699999999999996 111.174 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -85.32 5.18 31.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 9.8000000000000007 111.255 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -54.25 -40.01 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 9.8300000000000001 111.208 167.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -106.88 -32.76 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 9.8699999999999992 111.163 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.93 160.04 41.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 9.9000000000000004 111.198 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.62 140.17 75.99 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.646 1.564 . . . . 9.9299999999999997 111.174 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.69 -17.74 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 9.9700000000000006 111.18 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.84 68.47 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.27 101.79 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 10.029999999999999 111.253 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.58 129.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 10.07 111.258 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -114.47 -10.62 12.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 10.1 111.258 165.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.61 117.18 27.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 10.130000000000001 111.204 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.04 -42.11 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.166 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.3 p -64.89 -30.01 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 10.199999999999999 111.179 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -72.16 -42.23 66.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 10.23 111.201 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.72 -30.02 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.205 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.15 -28.66 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 10.300000000000001 111.245 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.85 -32.06 40.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 10.33 111.172 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.25 -29.2 69.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 10.369999999999999 111.219 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.63 -18.61 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 10.4 111.173 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.97 -31.64 69.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 10.43 111.242 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 317' ' ' ILE . 10.1 t70 -70.0 121.53 83.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 10.470000000000001 111.231 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.96 -34.9 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.688 1.592 . . . . 10.5 111.181 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.53 -53.5 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 10.529999999999999 111.23 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 314' ' ' ASP . 94.9 mt -64.45 -30.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 10.57 111.292 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.02 62.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 10.6 111.105 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.35 90.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.421 . . . . 10.630000000000001 111.235 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.0 m -70.27 -40.06 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 10.67 111.161 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.9 mmt -70.55 -31.36 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.149 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.58 -45.93 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 10.73 111.195 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -75.93 -31.99 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 10.77 111.213 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.96 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 10.800000000000001 111.225 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.09 -25.43 67.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 10.83 111.173 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.06 -24.71 40.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 10.869999999999999 111.162 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -74.88 158.06 50.91 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.205 -0.758 . . . . 10.9 111.205 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -127.11 163.66 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.764 0.316 . . . . 10.93 111.259 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 48.7 mm -110.4 133.29 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 10.970000000000001 111.178 -169.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.89 122.38 79.01 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 11.0 111.244 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.15 150.52 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.754 1.636 . . . . 11.029999999999999 111.166 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -113.57 -25.22 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 11.07 111.23 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 97.6 mt -40.07 130.01 1.61 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 11.1 111.138 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.98 -37.72 68.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.708 1.605 . . . . 11.130000000000001 111.186 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.05 -39.51 92.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 11.17 111.21 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 99.7 mmm -75.09 -34.23 61.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 11.199999999999999 111.135 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.2 m -69.67 -33.35 72.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 11.23 111.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 11.27 111.179 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -65.57 -35.92 82.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 11.300000000000001 111.16 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.488 ' HE3' ' HA ' ' A' ' 340' ' ' TRP . 4.2 m95 -70.01 -38.41 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 11.33 111.233 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -60.7 -40.29 91.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.176 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.41 73.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 11.4 111.175 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.84 -29.7 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 11.43 111.174 -174.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -69.94 -38.76 76.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 11.470000000000001 111.247 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.2 m -69.33 -37.3 77.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 11.5 111.208 173.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.32 94.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 11.529999999999999 111.172 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.57 -24.73 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 11.57 111.223 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.04 -45.97 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 11.6 111.177 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.23 -36.55 83.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 11.630000000000001 111.164 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.06 -43.75 61.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.452 . . . . 11.67 111.186 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.226 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.3 p -71.37 -15.02 62.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 11.73 111.231 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 92.19 25.69 20.96 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 111.24 -0.744 . . . . 11.77 111.24 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.03 -39.9 7.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 11.800000000000001 111.186 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -113.86 172.5 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 11.83 111.249 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -99.94 165.68 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 11.869999999999999 111.199 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.85 -16.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 11.9 111.227 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.85 -51.11 4.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 11.93 111.236 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -70.3 -31.42 68.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 11.970000000000001 111.129 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.79 -40.35 95.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 12.0 111.192 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.61 -30.83 61.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 12.029999999999999 111.125 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.42 -45.54 83.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 12.07 111.218 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.08 -41.92 99.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 12.1 111.197 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.79 -45.22 75.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 12.130000000000001 111.198 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -56.68 -36.58 69.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 12.17 111.224 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.3 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 12.199999999999999 111.172 -176.988 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.827 0.346 . . . . 0.029999999999999999 111.216 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.02 145.89 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.070000000000000007 111.189 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -53.52 136.23 38.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.10000000000000001 111.235 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.25 144.97 32.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.13 111.173 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.32 16.77 63.82 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.211 -0.756 . . . . 0.17000000000000001 111.211 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.06 149.67 52.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.20000000000000001 111.22 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -122.86 101.22 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.23000000000000001 111.171 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.1 t -98.18 125.06 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.27000000000000002 111.212 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.6 mt -121.07 112.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.29999999999999999 111.202 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -92.09 92.75 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.33000000000000002 111.221 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -71.02 150.12 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.37 111.176 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -132.13 111.98 11.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.162 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.04 174.11 26.32 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.171 -0.771 . . . . 0.42999999999999999 111.171 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 -50.18 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.46999999999999997 111.195 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -125.01 -135.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.5 111.192 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.49 -7.65 78.17 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.53000000000000003 111.224 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -64.77 -54.67 27.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.56999999999999995 111.201 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.32 -40.69 97.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.59999999999999998 111.228 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.84 -53.35 44.79 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.225 -0.75 . . . . 0.63 111.225 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.0 tp -70.68 -32.4 69.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.67000000000000004 111.239 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.76 97.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.202 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.33 -38.27 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.219 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.91 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.77000000000000002 111.193 173.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.46 -38.42 96.32 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 0.80000000000000004 111.22 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.7 -44.42 96.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.82999999999999996 111.176 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.98 -41.49 92.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.87 111.209 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -59.28 -48.35 81.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.90000000000000002 111.241 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -64.35 -34.11 77.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.93000000000000005 111.185 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -69.18 -31.64 70.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.96999999999999997 111.22 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.05 -31.36 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.221 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.5 p -101.85 -29.87 11.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 1.03 111.201 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.04 5.68 83.0 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.223 -0.751 . . . . 1.0700000000000001 111.223 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.58 121.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 1.1000000000000001 111.219 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -61.67 119.51 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 1.1299999999999999 111.176 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.02 131.08 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 1.1699999999999999 111.247 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -123.43 110.26 14.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.2 111.164 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.7 t -101.84 131.77 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 1.23 111.186 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -152.92 169.98 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 1.27 111.215 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -140.3 76.87 25.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.3 111.194 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.83 80.0 2.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.724 1.616 . . . . 1.3300000000000001 111.213 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 29.7 t0 -52.29 162.97 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 1.3700000000000001 111.215 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 93.0 mttt 68.12 43.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.3999999999999999 111.173 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.29 -21.56 64.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 1.4299999999999999 111.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.89 -27.27 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 1.47 111.204 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -114.18 -25.48 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 1.5 111.209 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -94.37 -36.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 1.53 111.13 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 85.7 t80 -63.51 -43.06 77.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 1.5700000000000001 111.199 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 88.6 Cg_exo -53.05 -31.35 53.45 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.716 1.611 . . . . 1.6000000000000001 111.213 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -64.19 -32.94 74.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 1.6299999999999999 111.206 -173.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.7 m -100.06 -26.22 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 1.6699999999999999 111.167 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.7 111.206 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.33 -4.91 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.73 111.243 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -115.0 5.0 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 1.77 111.203 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.57 58.65 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.176 -0.77 . . . . 1.8 111.176 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -120.02 -165.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 1.8300000000000001 111.193 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.23 -162.96 12.67 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.159 -0.776 . . . . 1.8700000000000001 111.159 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.88 178.17 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.711 1.607 . . . . 1.8999999999999999 111.206 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.46 -40.85 10.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.9299999999999999 111.189 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.38 138.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 1.97 111.18 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.8 tt -143.92 138.78 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 2.0 111.199 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 29.8 m-85 -105.12 142.78 34.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 2.0299999999999998 111.233 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -134.49 155.6 50.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 2.0699999999999998 111.194 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . . . -68.13 159.22 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 2.1000000000000001 111.153 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -53.98 -33.58 57.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 2.1299999999999999 111.2 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -82.11 -49.94 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 2.1699999999999999 111.205 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -65.32 -31.13 72.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 2.2000000000000002 111.19 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -56.8 -36.11 69.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.23 111.18 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.08 -39.18 49.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.15 -0.78 . . . . 2.27 111.15 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.23 64.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.772 . . . . 2.2999999999999998 111.171 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.24 -49.3 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 2.3300000000000001 111.222 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.88 78.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 2.3700000000000001 111.212 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -58.2 -41.8 84.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.214 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.0 p -66.83 -17.9 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 2.4300000000000002 111.213 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.6 25.79 37.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.228 -0.749 . . . . 2.4700000000000002 111.228 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.61 2.54 44.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 2.5 111.205 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.17 117.27 28.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 2.5299999999999998 111.225 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.82 153.36 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.235 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.62 129.19 39.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 2.6000000000000001 111.206 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.36 129.59 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 2.6299999999999999 111.227 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 p -129.36 87.08 54.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 2.6699999999999999 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -58.48 150.17 70.22 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 2.7000000000000002 111.209 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -43.78 139.68 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 2.73 111.201 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.84 -39.59 39.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 2.77 111.174 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.79 85.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 2.7999999999999998 111.197 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -66.93 -40.07 87.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 2.8300000000000001 111.215 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.39 -30.87 71.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 2.8700000000000001 111.172 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.64 -35.02 67.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 2.8999999999999999 111.212 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.99 -16.22 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 2.9300000000000002 111.224 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -75.52 121.76 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 2.9700000000000002 111.191 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -69.14 144.79 95.69 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 3.0 111.217 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.36 -34.89 72.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.666 1.577 . . . . 3.0299999999999998 111.235 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 7.6 m-30 -64.62 -32.65 74.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 3.0699999999999998 111.184 -175.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -108.1 -21.61 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 3.1000000000000001 111.175 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -70.25 -41.32 73.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 3.1299999999999999 111.188 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.86 -27.82 63.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 3.1699999999999999 111.216 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.12 -21.03 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.2000000000000002 111.213 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.0 m -111.68 25.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 3.23 111.165 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -102.71 167.88 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 3.27 111.201 171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 37.1 t80 -163.29 130.02 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 3.2999999999999998 111.152 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 95.7 m-20 65.0 21.48 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 3.3300000000000001 111.224 -173.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.96 11.16 77.21 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.193 -0.763 . . . . 3.3700000000000001 111.193 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -122.84 143.03 50.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 3.3999999999999999 111.195 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.5 tp -75.09 118.74 18.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 3.4300000000000002 111.189 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 pt -117.53 -20.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 3.4700000000000002 111.203 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.13 177.09 9.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 3.5 111.227 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -140.84 142.62 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 3.5299999999999998 111.209 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.3 155.98 41.6 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.728 1.618 . . . . 3.5699999999999998 111.217 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 tp -134.74 -30.0 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 3.6000000000000001 111.186 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.49 149.64 29.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 3.6299999999999999 111.22 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -124.99 120.58 58.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 3.6699999999999999 111.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -124.68 157.22 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.7000000000000002 111.191 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.05 155.01 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 3.73 111.236 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.34 175.8 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 3.77 111.173 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.3 p -171.78 170.19 5.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 3.7999999999999998 111.175 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.492 HD23 ' C ' ' A' ' 115' ' ' LEU . 5.9 tt -97.1 99.94 11.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 3.8300000000000001 111.212 175.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.16 127.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 3.8700000000000001 111.194 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -140.26 160.81 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 3.8999999999999999 111.177 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -75.77 109.02 9.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 3.9300000000000002 111.183 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -81.33 -37.8 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 3.9700000000000002 111.173 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -54.97 -45.14 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 4.0 111.205 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.81 -61.25 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 4.0300000000000002 111.17 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.9 mt -127.58 92.64 42.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 4.0700000000000003 111.21 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.01 -19.0 46.21 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.665 1.577 . . . . 4.0999999999999996 111.205 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -98.47 105.83 32.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 4.1299999999999999 111.2 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.51 164.91 23.4 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.697 1.598 . . . . 4.1699999999999999 111.227 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.05 125.43 17.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.68 1.587 . . . . 4.2000000000000002 111.196 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.48 -23.64 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 4.2300000000000004 111.185 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 130' ' ' GLU . 14.3 t -157.48 -177.25 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 4.2699999999999996 111.186 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -71.49 -25.3 62.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 4.2999999999999998 111.163 -170.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.453 ' H ' HG23 ' A' ' 128' ' ' THR . 98.7 mt-10 -71.25 -17.26 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 4.3300000000000001 111.215 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -100.41 4.38 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 4.3700000000000001 111.226 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.515 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 24.8 mm -75.23 -51.03 3.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.4000000000000004 111.176 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.515 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 94.6 Cg_endo -74.58 -13.39 22.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.692 1.595 . . . . 4.4299999999999997 111.181 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.7 78.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 4.4699999999999998 111.178 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.03 -30.05 22.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 4.5 111.194 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.82 -33.43 75.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 4.5300000000000002 111.181 168.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.77 -45.08 72.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 4.5700000000000003 111.161 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.35 -30.48 71.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 4.5999999999999996 111.254 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.74 -14.66 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.178 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.65 -44.56 73.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 4.6699999999999999 111.226 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.93 -16.86 60.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 4.7000000000000002 111.213 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -95.11 3.01 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 4.7300000000000004 111.225 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.96 25.19 69.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.243 -0.743 . . . . 4.7699999999999996 111.243 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -136.97 -179.93 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 4.7999999999999998 111.227 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.2 t -149.9 140.29 22.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 4.8300000000000001 111.196 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.33 -45.6 19.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 4.8700000000000001 111.227 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.453 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 31.8 tp -77.79 124.84 28.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 4.9000000000000004 111.176 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 99.3 mmm -124.99 50.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 4.9299999999999997 111.214 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -76.36 147.4 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 4.9699999999999998 111.214 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -71.66 102.05 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 5.0 111.219 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.31 -19.14 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.201 -172.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -39.96 96.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 5.0700000000000003 111.157 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -98.56 160.03 29.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.21 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.36 3.51 6.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.668 1.578 . . . . 5.1299999999999999 111.225 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -49.41 -55.01 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 5.1699999999999999 111.248 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.67 36.54 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 5.2000000000000002 111.192 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.2 p -126.34 -22.95 3.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 5.2300000000000004 111.152 168.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.487 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 88.8 t90 -67.56 -48.26 44.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 5.2699999999999996 111.2 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 91.5 Cg_endo -76.99 -14.97 16.73 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.713 1.608 . . . . 5.2999999999999998 111.192 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.85 -44.28 93.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 5.3300000000000001 111.229 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 87.2 mt -65.45 -45.03 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 5.3700000000000001 111.189 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.19 65.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 5.4000000000000004 111.162 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.13 72.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.175 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -64.97 -27.01 68.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.231 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.41 -3.64 50.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.226 -0.75 . . . . 5.5 111.226 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.8 -12.97 70.65 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.171 -0.771 . . . . 5.5300000000000002 111.171 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.93 130.33 31.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 5.5700000000000003 111.176 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.18 21.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 5.5999999999999996 111.195 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -140.0 90.11 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 5.6299999999999999 111.194 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -125.02 166.42 16.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.199 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -166.87 140.04 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 5.7000000000000002 111.191 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -150.19 96.18 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 5.7300000000000004 111.194 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 45.62 53.87 8.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 5.7699999999999996 111.193 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.1 16.07 65.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.186 -0.765 . . . . 5.7999999999999998 111.186 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -129.91 169.23 15.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 5.8300000000000001 111.216 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -129.63 139.38 51.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 5.8700000000000001 111.207 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -94.51 106.73 18.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 5.9000000000000004 111.193 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.3 pt -112.27 16.37 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 5.9299999999999997 111.197 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.29 -28.97 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 5.9699999999999998 111.194 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -74.99 169.72 17.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 6.0 111.216 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.43 124.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 6.0300000000000002 111.206 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.99 -18.94 25.56 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.0 m -68.66 -14.58 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.75 0.309 . . . . 6.0999999999999996 111.161 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -88.26 5.0 43.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 6.1299999999999999 111.208 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -95.28 150.02 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 6.1699999999999999 111.207 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.18 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 6.2000000000000002 111.22 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.92 99.91 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.206 -0.758 . . . . 6.2300000000000004 111.206 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.24 90.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 6.2699999999999996 111.223 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.4 -35.07 79.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.2999999999999998 111.213 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.07 92.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 6.3300000000000001 111.22 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.7 -45.25 96.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.166 -0.774 . . . . 6.3700000000000001 111.166 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.7 tp -71.9 -32.57 67.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 6.4000000000000004 111.213 178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.5 m -62.29 -40.1 95.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 6.4299999999999997 111.181 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -59.75 -45.92 90.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 6.4699999999999998 111.187 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.8 tp -53.16 -59.47 4.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 6.5 111.197 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 6.5300000000000002 111.194 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.27 -41.41 94.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 6.5700000000000003 111.233 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.419 ' HB2' ' SD ' ' A' ' 204' ' ' MET . 79.8 mt -76.4 -23.01 54.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 6.5999999999999996 111.17 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.66 -43.2 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.217 168.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.91 -24.23 62.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 6.6699999999999999 111.207 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -89.73 5.46 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 6.7000000000000002 111.214 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 63.61 37.5 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 6.7300000000000004 111.193 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -110.76 -34.98 6.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 6.7699999999999996 111.253 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 198' ' ' LEU . 76.4 mtp -108.79 154.41 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 6.7999999999999998 111.161 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -127.02 111.56 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 6.8300000000000001 111.215 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.71 -17.9 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 6.8700000000000001 111.182 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -84.51 -26.09 28.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 6.9000000000000004 111.25 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -61.23 132.25 53.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 6.9299999999999997 111.181 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -139.39 -165.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 6.9699999999999998 111.189 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -58.77 -50.06 75.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 7.0 111.144 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.0 p -69.56 -32.61 71.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.192 -171.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.75 -46.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 7.0700000000000003 111.188 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.17 93.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 7.0999999999999996 111.219 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.49 -46.04 87.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 7.1299999999999999 111.199 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.26 96.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 7.1699999999999999 111.191 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.0 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 7.2000000000000002 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -70.59 -45.03 66.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 7.2300000000000004 111.212 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.76 -32.72 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 7.2699999999999996 111.226 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -83.49 -26.11 30.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 7.2999999999999998 111.159 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.28 19.92 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.168 -0.773 . . . . 7.3300000000000001 111.168 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -70.99 -30.07 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 7.3700000000000001 111.227 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.2 p -117.08 164.18 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 7.4000000000000004 111.217 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.78 -22.28 31.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 7.4299999999999997 111.205 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.64 170.28 21.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 7.4699999999999998 111.177 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.7 t -148.0 140.0 24.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 7.5 111.195 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 147' ' ' LEU . 88.2 mt -112.82 117.01 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 7.5300000000000002 111.183 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' A' ' 235' ' ' ILE . 7.4 t-20 -158.83 177.68 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 7.5700000000000003 111.169 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -79.6 170.46 54.19 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.227 -0.749 . . . . 7.5999999999999996 111.227 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.35 -17.08 21.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 7.6299999999999999 111.207 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -70.3 -30.08 66.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 7.6699999999999999 111.168 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.63 -4.84 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 7.7000000000000002 111.154 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 4.2 t90 -62.26 -29.52 70.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 7.7300000000000004 111.215 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 92.0 p -64.85 -21.43 66.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 7.7699999999999996 111.224 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.2 -30.1 12.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 7.7999999999999998 111.218 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 227' ' ' ASN . 83.3 mt -65.28 -34.68 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.227 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -80.16 7.83 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 7.8700000000000001 111.219 -169.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.5 m -58.31 -32.5 68.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 7.9000000000000004 111.207 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 66.5 m -69.98 -19.0 63.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 7.9299999999999997 111.21 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 60.43 38.91 19.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 7.9699999999999998 111.217 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.45 169.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 8.0 111.204 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -73.36 107.78 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 8.0299999999999994 111.206 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -102.44 133.42 47.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 8.0700000000000003 111.176 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -104.01 179.34 25.03 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.206 -0.758 . . . . 8.0999999999999996 111.206 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.9 137.89 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.757 0.313 . . . . 8.1300000000000008 111.193 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -145.88 -175.21 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 8.1699999999999999 111.214 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.2 t -78.87 125.24 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 8.1999999999999993 111.253 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.582 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 56.7 tp -79.7 -51.37 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 8.2300000000000004 111.202 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 89.2 Cg_endo -80.38 154.94 21.65 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.696 1.597 . . . . 8.2699999999999996 111.209 -173.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 85.1 m -124.98 109.88 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 8.3000000000000007 111.164 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.78 104.78 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 8.3300000000000001 111.22 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 55.25 35.05 24.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 8.3699999999999992 111.23 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.86 76.15 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.192 -0.763 . . . . 8.4000000000000004 111.192 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -129.99 109.97 16.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 8.4299999999999997 111.209 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.77 150.3 61.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.693 1.595 . . . . 8.4700000000000006 111.168 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 83.7 p -139.34 -72.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 8.5 111.232 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 47.3 tptt -159.42 129.89 3.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 8.5299999999999994 111.193 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.413 ' HA ' ' HG3' ' A' ' 248' ' ' PRO . 51.3 Cg_exo -55.03 157.04 14.19 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.739 1.626 . . . . 8.5700000000000003 111.22 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -67.28 146.0 54.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 8.5999999999999996 111.208 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.402 ' HB ' HD13 ' A' ' 329' ' ' ILE . 85.7 t -109.72 113.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 8.6300000000000008 111.175 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.07 115.04 5.01 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.163 -0.775 . . . . 8.6699999999999999 111.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.4 t -101.89 116.42 45.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 8.6999999999999993 111.2 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 63' ' ' ALA . 10.4 mp -73.16 144.82 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 8.7300000000000004 111.225 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 99.4 p -142.43 159.63 41.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 8.7699999999999996 111.203 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -130.52 156.23 45.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 8.8000000000000007 111.198 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.15 175.55 20.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.264 -0.735 . . . . 8.8300000000000001 111.264 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.8 129.97 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 8.8699999999999992 111.183 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.54 120.96 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.181 -173.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.76 -23.46 66.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 8.9299999999999997 111.186 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.0 58.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 8.9700000000000006 111.236 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.1 t -83.28 121.46 76.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 9.0 111.183 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.12 3.32 7.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.705 1.603 . . . . 9.0299999999999994 111.201 169.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.26 36.92 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 9.0700000000000003 111.241 -172.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -62.34 -24.11 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 9.0999999999999996 111.232 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.69 -30.48 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 9.1300000000000008 111.252 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -72.09 -43.37 64.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 9.1699999999999999 111.206 174.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.68 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 9.1999999999999993 111.218 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.79 -56.35 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.2300000000000004 111.2 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -65.46 -43.03 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 9.2699999999999996 111.183 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.39 -50.21 73.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 9.3000000000000007 111.19 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.76 -53.13 61.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 9.3300000000000001 111.203 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.79 -30.67 56.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 9.3699999999999992 111.181 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -97.62 -27.4 14.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 9.4000000000000004 111.238 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.71 -64.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 9.4299999999999997 111.223 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 45.5 tp -60.85 -41.84 96.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 9.4700000000000006 111.242 -166.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 37.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.205 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 97.4 m -114.78 141.38 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 9.5299999999999994 111.249 170.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -49.05 -40.49 31.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 9.5700000000000003 111.221 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.06 -46.37 85.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 9.5999999999999996 111.14 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.66 -40.55 90.27 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.241 -0.744 . . . . 9.6300000000000008 111.241 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.29 -35.5 81.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 9.6699999999999999 111.185 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.75 -40.85 84.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 9.6999999999999993 111.224 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 9.7300000000000004 111.22 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.79 -37.66 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 9.7699999999999996 111.182 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.573 ' HB3' HD23 ' A' ' 299' ' ' LEU . 98.1 m-20 -81.88 5.06 20.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.428 . . . . 9.8000000000000007 111.207 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.15 -33.22 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 9.8300000000000001 111.209 165.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -107.42 -38.73 5.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8699999999999992 111.179 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -87.78 161.44 44.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.9000000000000004 111.191 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -55.03 144.65 67.65 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.671 1.581 . . . . 9.9299999999999997 111.186 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.573 HD23 ' HB3' ' A' ' 294' ' ' ASN . 93.7 mt -68.37 -20.6 64.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 9.9700000000000006 111.232 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.94 -26.81 67.71 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.185 -0.766 . . . . 10.0 111.185 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.18 133.99 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 10.029999999999999 111.191 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.6 138.66 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 10.07 111.191 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.49 -48.02 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 10.1 111.186 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 85.0 mt -116.82 152.54 34.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 10.130000000000001 111.242 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -54.44 -37.24 64.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 10.17 111.182 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.0 p -56.18 -29.46 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 10.199999999999999 111.195 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -88.59 -35.83 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 10.23 111.2 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -60.06 -27.44 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 10.27 111.205 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.33 -30.4 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.151 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.77 -31.65 35.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 10.33 111.193 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.45 -21.72 62.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 10.369999999999999 111.219 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.95 66.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 10.4 111.203 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.82 -30.08 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 10.43 111.145 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 119.03 75.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.178 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.49 -35.47 96.69 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.73 1.62 . . . . 10.5 111.217 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -85.08 -51.11 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 10.529999999999999 111.218 -172.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.19 -39.81 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 10.57 111.172 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.04 85.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 10.6 111.187 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.21 86.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 10.630000000000001 111.181 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -64.51 -44.87 89.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 10.67 111.187 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.8 mmm -67.07 -34.65 78.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 10.699999999999999 111.183 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.5 -45.85 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 10.73 111.194 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 256' ' ' LYS . 99.3 m-20 -73.18 -22.42 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 10.77 111.159 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.05 -31.82 65.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 10.800000000000001 111.248 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.97 -18.29 64.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 10.83 111.177 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.25 -8.89 59.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 10.869999999999999 111.202 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -104.83 -141.89 11.13 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 10.9 111.226 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -145.0 136.34 25.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 10.93 111.174 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.402 HD13 ' HB ' ' A' ' 259' ' ' VAL . 49.2 mm -77.58 128.94 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 10.970000000000001 111.194 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 37.5 mmt -79.55 116.01 57.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 11.0 111.231 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.94 155.12 57.98 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.724 1.616 . . . . 11.029999999999999 111.195 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -97.61 20.09 12.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 11.07 111.202 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.91 128.27 91.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 11.1 111.153 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.24 -43.59 52.38 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.714 1.61 . . . . 11.130000000000001 111.223 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -64.99 -40.77 95.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 11.17 111.186 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.4 mmm -64.73 -39.37 93.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 11.199999999999999 111.214 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.1 t -60.52 -45.82 92.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.179 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.3 88.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 11.27 111.211 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -64.87 -33.45 76.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 11.300000000000001 111.18 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -69.97 -39.78 75.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 11.33 111.222 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.97 -30.08 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 11.369999999999999 111.211 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.61 71.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.18 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 93.5 t -85.5 -29.46 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 11.43 111.202 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.2 -25.3 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 11.470000000000001 111.219 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 76.0 p -85.99 -29.72 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 11.5 111.213 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.72 92.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.529999999999999 111.189 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.47 -23.43 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 11.57 111.21 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.9 mm -88.33 -38.04 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 11.6 111.206 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.531 ' HB3' ' HG2' ' A' ' 355' ' ' GLN . 96.0 m-20 -65.0 -32.42 74.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 11.630000000000001 111.214 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.3 -39.8 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 11.67 111.19 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.23 86.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 11.699999999999999 111.199 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.7 p -80.73 -19.43 45.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 11.73 111.209 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 90.58 18.03 50.07 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.222 -0.751 . . . . 11.77 111.222 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -70.2 -37.98 75.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 11.800000000000001 111.228 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.531 ' HG2' ' HB3' ' A' ' 349' ' ' ASN . 2.6 pt20 -147.0 168.74 20.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 11.83 111.176 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 45.0 p -81.18 175.14 10.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 11.869999999999999 111.141 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.88 -44.74 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 11.9 111.161 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.17 -48.15 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 11.93 111.18 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.59 -36.23 80.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 11.970000000000001 111.193 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.02 70.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 12.0 111.216 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.55 -15.92 55.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 12.029999999999999 111.219 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.18 -49.12 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 12.07 111.202 168.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.76 -39.04 92.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 12.1 111.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.45 -46.65 89.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 12.130000000000001 111.221 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.71 -47.63 76.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 12.17 111.178 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.6 m -59.01 -44.82 91.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 12.199999999999999 111.197 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.97 -36.93 85.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 12.23 111.239 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 92.1 mt -70.83 -39.98 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 12.27 111.231 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 75.7 p -84.54 -15.04 47.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 12.300000000000001 111.236 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.199 -1.559 0 CA-C-N 116.182 -0.463 . . . . 12.33 111.201 177.644 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.76 0.314 . . . . 0.029999999999999999 111.212 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.9 115.1 47.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 0.070000000000000007 111.252 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.15 129.93 42.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.10000000000000001 111.215 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -57.68 128.97 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.13 111.206 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.91 48.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -126.33 98.02 5.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.771 0.319 . . . . 0.20000000000000001 111.195 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.05 119.72 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.23000000000000001 111.204 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.29 118.83 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.27000000000000002 111.238 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.9 mt -121.21 112.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.29999999999999999 111.189 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -103.38 117.12 33.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.33000000000000002 111.222 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.1 tt -115.61 137.05 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.37 111.208 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.64 114.94 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.40000000000000002 111.228 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.01 -172.46 39.86 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.209 -0.756 . . . . 0.42999999999999999 111.209 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -108.47 -39.18 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.329 . . . . 0.46999999999999997 111.219 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.14 149.83 43.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.5 111.191 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.26 0.83 4.52 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.215 -0.754 . . . . 0.53000000000000003 111.215 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 37' ' ' VAL . 43.8 p90 -62.71 -20.09 64.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.56999999999999995 111.204 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.67 -30.5 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 0.59999999999999998 111.205 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.69 -47.24 91.61 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.24 -0.744 . . . . 0.63 111.24 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HB2' HG11 ' A' ' 37' ' ' VAL . 82.2 mt -72.58 -30.79 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.67000000000000004 111.173 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.29 83.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.69999999999999996 111.21 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.4 -39.69 91.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.173 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 82.5 t -71.23 -34.85 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.77000000000000002 111.144 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.16 -27.12 73.83 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.182 -0.767 . . . . 0.80000000000000004 111.182 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 -48.4 81.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.82999999999999996 111.197 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.0 -41.79 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.87 111.205 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.37 -51.34 69.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.90000000000000002 111.274 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.93 -38.16 90.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.93000000000000005 111.262 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.36 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.96999999999999997 111.159 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.32 -35.01 12.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.186 -173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -103.4 -29.96 10.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.03 111.234 -174.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.55 4.56 79.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.166 -0.774 . . . . 1.0700000000000001 111.166 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.2 124.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 1.1000000000000001 111.24 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.94 150.06 47.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 1.1299999999999999 111.153 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -125.02 125.12 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 1.1699999999999999 111.234 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -121.33 109.84 15.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 1.2 111.221 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' A' ' 20' ' ' LEU . 35.1 t -105.07 130.12 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.187 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -151.07 166.49 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 1.27 111.198 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -100.03 123.26 47.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 1.3 111.216 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -79.6 165.03 23.11 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.617 1.545 . . . . 1.3300000000000001 111.201 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -121.0 141.03 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 1.3700000000000001 111.187 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 55.04 46.71 23.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 1.3999999999999999 111.238 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.02 -50.72 68.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 1.4299999999999999 111.211 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -52.57 -43.64 65.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 1.47 111.169 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.5 111.185 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -97.08 -7.0 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.192 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.474 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 5.2 m-30 -55.19 -54.8 46.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 1.5700000000000001 111.155 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -70.66 -12.21 30.84 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.68 1.587 . . . . 1.6000000000000001 111.21 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.98 -8.61 51.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.154 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.97 -57.68 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 1.6699999999999999 111.209 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.29 -23.11 43.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 1.7 111.199 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.58 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.73 111.172 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -104.2 -19.88 13.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.77 111.182 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.09 58.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.161 -0.775 . . . . 1.8 111.161 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -129.59 -165.43 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.8300000000000001 111.182 -170.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.42 -165.76 14.37 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.195 -0.762 . . . . 1.8700000000000001 111.195 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.49 167.16 27.78 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.665 1.577 . . . . 1.8999999999999999 111.201 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -80.04 -62.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 1.9299999999999999 111.186 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -99.78 139.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 1.97 111.208 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 tt -141.53 134.91 30.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 2.0 111.225 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.43 144.93 32.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 2.0299999999999998 111.315 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -156.39 148.45 23.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 2.0699999999999998 111.248 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.41 158.0 24.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 2.1000000000000001 111.175 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -60.6 -17.02 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 2.1299999999999999 111.244 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -42.91 -48.34 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 2.1699999999999999 111.159 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -134.98 27.45 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 2.2000000000000002 111.162 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.53 -42.61 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 2.23 111.176 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.77 -46.42 93.49 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.92 89.28 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.181 -0.767 . . . . 2.2999999999999998 111.181 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.05 -43.59 73.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 2.3300000000000001 111.157 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.84 -37.58 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 2.3700000000000001 111.143 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -67.07 -30.81 70.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.151 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -73.79 -13.89 61.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 2.4300000000000002 111.16 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.81 19.14 52.72 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.169 -0.772 . . . . 2.4700000000000002 111.169 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.89 -38.61 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.806 0.336 . . . . 2.5 111.234 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 tp -102.63 132.32 48.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 2.5299999999999998 111.239 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.54 137.09 32.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 2.5699999999999998 111.207 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -77.52 156.12 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 2.6000000000000001 111.203 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.2 mt -113.79 122.67 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 2.6299999999999999 111.204 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.2 m -120.58 96.74 48.88 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 2.6699999999999999 111.15 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.03 148.2 49.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.732 1.621 . . . . 2.7000000000000002 111.226 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -81.76 -179.37 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 2.73 111.188 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.73 -45.81 74.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 2.77 111.19 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.88 86.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 2.7999999999999998 111.232 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.41 -36.46 84.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 2.8300000000000001 111.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.71 -34.59 78.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 2.8700000000000001 111.235 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -71.35 -34.97 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 2.8999999999999999 111.155 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.1 -20.55 59.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 2.9300000000000002 111.186 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.6 mt -75.02 135.26 41.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 2.9700000000000002 111.193 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -63.29 138.89 97.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 3.0 111.162 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -50.15 -47.74 22.69 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.647 1.565 . . . . 3.0299999999999998 111.186 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.14 -47.66 81.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.0699999999999998 111.169 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -70.77 -21.69 62.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 3.1000000000000001 111.212 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -69.97 -41.53 74.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 3.1299999999999999 111.233 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -78.05 -24.01 47.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 3.1699999999999999 111.252 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.62 90.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 3.2000000000000002 111.197 -174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.71 79.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.23 111.207 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HB3' HD23 ' A' ' 103' ' ' LEU . 54.4 ptt85 -156.68 161.05 39.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 3.27 111.163 175.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 44.3 t80 -159.98 136.37 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 3.2999999999999998 111.246 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 95.0 m-20 64.98 29.89 12.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 3.3300000000000001 111.216 -175.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.77 53.89 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.187 -0.765 . . . . 3.3700000000000001 111.187 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -165.07 147.44 8.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 3.3999999999999999 111.159 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 98' ' ' ARG . 94.2 mt -64.9 136.39 56.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 3.4300000000000002 111.232 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 pt -115.2 -14.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 3.4700000000000002 111.224 -176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.0 172.92 5.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 3.5 111.226 -174.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -119.73 123.43 28.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 3.5299999999999998 111.18 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.8 139.54 33.72 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.667 1.578 . . . . 3.5699999999999998 111.2 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.32 -4.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 3.6000000000000001 111.223 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.75 144.75 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 3.6299999999999999 111.193 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.67 128.22 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 3.6699999999999999 111.242 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.68 151.21 46.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 3.7000000000000002 111.218 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.64 164.98 11.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 3.73 111.215 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 tp -143.85 124.1 13.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 3.77 111.214 172.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.9 p -163.05 -174.29 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 3.7999999999999998 111.17 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.9 tp -103.48 120.08 40.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 3.8300000000000001 111.177 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 116' ' ' ILE . 3.8 mp -102.93 141.36 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 3.8700000000000001 111.24 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -136.8 150.61 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 3.8999999999999999 111.159 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -91.28 117.33 29.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.9300000000000002 111.251 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.09 -34.88 79.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 3.9700000000000002 111.196 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.94 -47.6 84.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 4.0 111.205 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.2 tp -80.35 -52.36 7.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 4.0300000000000002 111.186 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.53 99.53 52.56 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 4.0700000000000003 111.174 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 -17.84 19.12 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.739 1.626 . . . . 4.0999999999999996 111.159 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -85.01 116.81 67.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 4.1299999999999999 111.144 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.42 117.9 5.19 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.716 1.61 . . . . 4.1699999999999999 111.232 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.97 129.62 31.17 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.718 1.612 . . . . 4.2000000000000002 111.181 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.01 -45.09 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 4.2300000000000004 111.186 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.6 t -136.3 -177.59 4.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 4.2699999999999996 111.173 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.65 -34.16 21.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 4.2999999999999998 111.207 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.77 -15.61 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 4.3300000000000001 111.215 -163.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -91.45 -9.44 44.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 4.3700000000000001 111.186 -176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.594 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 93.1 mt -74.02 -45.0 6.59 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 4.4000000000000004 111.195 -171.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.7 Cg_exo -57.0 -40.38 84.52 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.67 1.58 . . . . 4.4299999999999997 111.191 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.37 99.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 4.4699999999999998 111.183 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.7 tp -63.95 -42.98 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.427 . . . . 4.5 111.268 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.95 -35.05 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.239 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.04 -37.02 75.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 4.5700000000000003 111.218 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.04 -31.91 69.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 4.5999999999999996 111.176 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.0 mt -82.18 -15.9 51.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 4.6299999999999999 111.155 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.93 -44.53 63.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 4.6699999999999999 111.156 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.37 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 4.7000000000000002 111.24 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.03 -7.29 33.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 4.7300000000000004 111.196 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.16 62.43 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.163 -0.775 . . . . 4.7699999999999996 111.163 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 74.4 mmtt -114.96 179.28 3.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.8 0.333 . . . . 4.7999999999999998 111.212 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -137.82 143.94 41.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 4.8300000000000001 111.196 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -59.78 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 4.8700000000000001 111.249 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 132' ' ' ILE . 64.6 tp -128.13 115.64 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 4.9000000000000004 111.166 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.8 mmm -111.68 136.03 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 4.9299999999999997 111.198 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -171.68 164.99 6.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 4.9699999999999998 111.27 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -79.69 112.71 17.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 5.0 111.211 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.2 tp -63.18 -32.36 73.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 5.0300000000000002 111.182 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -96.66 7.54 46.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 5.0700000000000003 111.229 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -110.04 114.23 56.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 5.0999999999999996 111.172 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.32 -39.22 81.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.697 1.598 . . . . 5.1299999999999999 111.214 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -50.49 -40.02 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 5.1699999999999999 111.154 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -79.96 -37.52 34.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 5.2000000000000002 111.273 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.3 p -105.17 17.73 23.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 5.2300000000000004 111.156 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.557 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 88.3 t90 -66.73 -49.67 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 5.2699999999999996 111.286 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 83.6 Cg_endo -80.01 -14.92 12.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 5.2999999999999998 111.193 -174.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.9 tp -60.95 -33.99 74.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 5.3300000000000001 111.175 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.35 -30.02 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 5.3700000000000001 111.244 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.09 -43.75 10.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 5.4000000000000004 111.208 -172.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.4 -11.48 59.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 5.4299999999999997 111.213 -169.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -78.59 -4.42 48.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 5.4699999999999998 111.241 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.84 12.25 2.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.199 -0.76 . . . . 5.5 111.199 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.04 -19.66 25.74 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.241 -0.743 . . . . 5.5300000000000002 111.241 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.61 109.98 11.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 5.5700000000000003 111.172 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.431 ' HA ' ' CE1' ' A' ' 176' ' ' TYR . . . 68.39 35.3 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 5.5999999999999996 111.138 173.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.78 54.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 5.6299999999999999 111.235 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 177' ' ' ASP . 73.0 mmtt -125.19 156.4 38.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 5.6699999999999999 111.157 174.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -149.16 124.86 10.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 5.7000000000000002 111.226 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -149.19 99.55 2.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 5.7300000000000004 111.217 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.44 34.12 23.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 5.7699999999999996 111.2 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.97 11.07 77.39 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.222 -0.751 . . . . 5.7999999999999998 111.222 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.01 155.01 40.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.789 0.328 . . . . 5.8300000000000001 111.225 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CE1' ' HA ' ' A' ' 168' ' ' ALA . 74.0 t80 -81.9 131.25 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 5.8700000000000001 111.171 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 170' ' ' LYS . 53.7 t0 -82.82 107.78 15.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 5.9000000000000004 111.201 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.3 pt -98.36 -2.25 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 5.9299999999999997 111.166 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.01 -33.91 38.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 5.9699999999999998 111.165 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -64.76 139.99 58.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 6.0 111.173 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 184' ' ' ASP . 85.0 t -72.93 123.88 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 6.0300000000000002 111.18 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.14 93.24 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -76.0 -24.94 16.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.769 0.319 . . . . 6.0999999999999996 111.171 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . 51.2 t0 -89.6 64.51 6.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 6.1299999999999999 111.13 -177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -138.76 160.0 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 6.1699999999999999 111.222 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.41 80.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 6.2000000000000002 111.164 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.04 -47.36 83.05 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.4 90.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 6.2699999999999996 111.183 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.55 -44.14 91.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 6.2999999999999998 111.18 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.03 79.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.18 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.53 -45.03 97.18 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.225 -0.75 . . . . 6.3700000000000001 111.225 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.94 -38.55 86.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 6.4000000000000004 111.223 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -59.96 -50.91 71.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.233 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.28 -38.18 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 6.4699999999999998 111.213 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.8 tp -49.99 -53.22 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 6.5 111.203 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.6 -33.26 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 6.5300000000000002 111.162 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 94.4 m-20 -54.72 -42.86 72.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 6.5700000000000003 111.249 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.42 -33.34 74.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 6.5999999999999996 111.132 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.91 -48.7 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 6.6299999999999999 111.125 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.92 -25.95 31.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 6.6699999999999999 111.163 -171.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 96.1 m-20 -94.95 15.5 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 6.7000000000000002 111.202 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.01 52.3 5.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 6.7300000000000004 111.214 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -115.12 -34.47 5.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 6.7699999999999996 111.209 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 98.9 mmm -139.81 169.34 17.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.147 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -153.06 175.03 13.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 6.8300000000000001 111.215 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -86.9 2.65 48.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 6.8700000000000001 111.141 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.39 1.8 55.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 6.9000000000000004 111.186 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.6 p -80.9 164.99 22.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 6.9299999999999997 111.259 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -158.12 170.0 23.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.149 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -59.66 -48.58 81.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 7.0 111.252 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 88.7 p -70.86 -30.01 66.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 7.0300000000000002 111.201 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.25 -46.97 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 7.0700000000000003 111.227 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.8 88.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 7.0999999999999996 111.2 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.81 -42.12 88.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 7.1299999999999999 111.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.05 94.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.177 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.42 -34.27 77.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 7.2000000000000002 111.164 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -64.59 -43.17 94.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 7.2300000000000004 111.231 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.77 -35.87 81.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2699999999999996 111.223 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -77.62 -26.61 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2999999999999998 111.205 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.01 31.64 22.78 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.228 -0.749 . . . . 7.3300000000000001 111.228 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -90.08 -6.01 55.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 7.3700000000000001 111.186 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 95.8 m -106.58 132.11 52.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 7.4000000000000004 111.253 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -86.81 -44.22 11.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 7.4299999999999997 111.253 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 61.9 mtm -135.39 152.65 51.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 7.4699999999999998 111.157 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -161.69 147.06 13.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 7.5 111.22 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.42 115.7 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 7.5300000000000002 111.244 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -154.9 166.82 32.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 7.5700000000000003 111.264 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.65 -176.46 18.38 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.219 -0.752 . . . . 7.5999999999999996 111.219 166.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -56.15 -26.73 61.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.671 1.581 . . . . 7.6299999999999999 111.218 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -60.18 -22.05 62.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 7.6699999999999999 111.21 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.03 24.98 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 7.7000000000000002 111.178 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -101.81 10.03 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 7.7300000000000004 111.241 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.8 p -70.49 -32.68 70.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 7.7699999999999996 111.213 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -89.04 -34.02 16.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 7.7999999999999998 111.212 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.46 -38.85 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 7.8300000000000001 111.207 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -72.74 -32.26 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 7.8700000000000001 111.188 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -99.31 8.72 44.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 7.9000000000000004 111.175 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 85.1 p -70.71 -18.43 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 7.9299999999999997 111.171 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 63.92 24.02 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 7.9699999999999998 111.211 -170.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.76 131.25 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 8.0 111.18 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.13 133.78 51.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 8.0299999999999994 111.144 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -145.34 158.68 43.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 8.0700000000000003 111.197 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.01 179.69 18.01 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.178 -0.769 . . . . 8.0999999999999996 111.178 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 73.5 t -133.52 131.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 8.1300000000000008 111.188 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 46.4 p -119.74 167.82 11.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 8.1699999999999999 111.163 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.77 119.94 51.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 8.1999999999999993 111.216 -166.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.493 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 85.9 mt -82.97 -42.97 0.87 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 8.2300000000000004 111.221 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 76.5 Cg_exo -45.48 113.28 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.71 1.606 . . . . 8.2699999999999996 111.183 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 92.3 m -124.57 134.36 52.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 8.3000000000000007 111.216 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -127.17 117.74 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 8.3300000000000001 111.233 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 57.24 34.97 25.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 8.3699999999999992 111.17 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.51 13.21 82.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.168 -0.773 . . . . 8.4000000000000004 111.168 176.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -130.0 110.01 16.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.337 . . . . 8.4299999999999997 111.192 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.48 142.04 48.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.671 1.581 . . . . 8.4700000000000006 111.222 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.6 p -125.01 -84.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 8.5 111.245 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.26 155.2 76.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 8.5299999999999994 111.266 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 155.0 72.37 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.725 1.617 . . . . 8.5700000000000003 111.247 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -76.9 132.04 38.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 8.5999999999999996 111.127 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -106.72 126.77 62.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 8.6300000000000008 111.247 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.01 149.42 16.79 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.165 -0.774 . . . . 8.6699999999999999 111.165 170.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 77.2 t -125.54 130.4 72.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 8.6999999999999993 111.216 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 56.1 tp -97.66 121.05 39.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 8.7300000000000004 111.222 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 72.4 m -123.64 146.94 47.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 8.7699999999999996 111.194 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -78.14 162.93 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 8.8000000000000007 111.192 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.29 171.51 36.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.215 -0.754 . . . . 8.8300000000000001 111.215 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.71 132.31 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 8.8699999999999992 111.196 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -59.99 120.89 10.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 8.9000000000000004 111.211 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.84 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 8.9299999999999997 111.194 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -98.9 -0.3 42.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 8.9700000000000006 111.216 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -64.95 131.09 95.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 9.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.95 -15.09 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.715 1.61 . . . . 9.0299999999999994 111.214 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -123.52 61.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 9.0700000000000003 111.175 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -72.27 -22.53 61.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 9.0999999999999996 111.25 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -33.15 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 9.1300000000000008 111.159 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.2 -41.56 90.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 9.1699999999999999 111.198 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.16 94.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 9.1999999999999993 111.215 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -55.36 -49.94 70.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 9.2300000000000004 111.2 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -62.16 -56.92 13.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 9.2699999999999996 111.258 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.55 -55.05 33.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 9.3000000000000007 111.183 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.46 -50.01 74.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 9.3300000000000001 111.24 -172.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.03 -49.73 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 9.3699999999999992 111.223 -172.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -98.39 -13.45 20.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 9.4000000000000004 111.164 -158.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.53 -49.89 1.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 9.4299999999999997 111.203 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.03 -53.45 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 9.4700000000000006 111.191 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.5 mp -76.75 59.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.23 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.3 p -139.76 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 9.5299999999999994 111.209 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -56.78 -47.5 80.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 9.5700000000000003 111.231 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.36 -33.24 69.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 9.5999999999999996 111.261 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.84 -47.89 88.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.26 -0.736 . . . . 9.6300000000000008 111.26 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.18 -50.09 62.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.767 0.318 . . . . 9.6699999999999999 111.156 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.73 -35.05 73.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 9.6999999999999993 111.187 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.16 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.7300000000000004 111.191 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.71 -44.06 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 9.7699999999999996 111.173 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.51 -0.11 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 9.8000000000000007 111.21 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -77.58 -16.36 58.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 9.8300000000000001 111.164 168.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -110.47 -33.18 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 9.8699999999999992 111.244 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -96.2 160.23 30.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 9.9000000000000004 111.189 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.97 154.06 23.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.736 1.624 . . . . 9.9299999999999997 111.216 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.16 -6.9 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 9.9700000000000006 111.142 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.54 -44.01 85.69 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.17 -0.772 . . . . 10.0 111.17 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.43 125.46 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.731 0.3 . . . . 10.029999999999999 111.205 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.3 p -152.06 141.14 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 10.07 111.189 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -139.02 35.86 2.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 10.1 111.218 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.14 148.0 46.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 10.130000000000001 111.152 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.06 -49.98 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 10.17 111.204 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.4 p -68.79 -25.36 64.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 10.199999999999999 111.209 -173.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -79.99 -50.49 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 10.23 111.23 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.98 -38.34 72.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.171 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.11 -39.85 93.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 10.300000000000001 111.167 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -75.48 -32.82 60.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 10.33 111.173 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.16 -24.3 57.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 10.369999999999999 111.168 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.78 -14.56 62.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 10.4 111.201 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.24 -30.06 70.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 10.43 111.209 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -78.52 117.65 67.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 10.470000000000001 111.148 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.71 -34.99 86.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.685 1.59 . . . . 10.5 111.146 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.74 -29.71 67.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.529999999999999 111.219 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.78 -29.96 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 10.57 111.224 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.38 94.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 10.6 111.205 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.2 99.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.206 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.3 m -68.03 -44.63 76.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.196 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 56.7 mtt -73.74 -37.11 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.22 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.77 -44.01 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 10.73 111.23 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -64.8 -36.8 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 10.77 111.179 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.49 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 10.800000000000001 111.156 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -72.03 -37.45 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 10.83 111.117 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.03 -0.02 54.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.149 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.34 -136.77 9.49 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.245 -0.742 . . . . 10.9 111.245 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -149.07 147.29 28.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 10.93 111.188 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.3 pt -117.11 162.61 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 10.970000000000001 111.205 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -59.37 117.43 22.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 11.0 111.188 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 149.36 88.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.672 1.581 . . . . 11.029999999999999 111.183 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -105.05 39.91 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 11.07 111.202 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 74.9 mt -88.74 118.76 69.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 11.1 111.255 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.83 -17.97 13.58 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.674 1.582 . . . . 11.130000000000001 111.225 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.14 -5.01 58.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 11.17 111.226 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.6 mmm -110.77 19.1 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 11.199999999999999 111.255 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.1 m -65.65 -50.94 63.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 11.23 111.181 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.15 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 11.27 111.217 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -71.13 -47.27 58.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 11.300000000000001 111.216 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -70.13 -35.77 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 11.33 111.261 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -58.15 -51.96 67.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 11.369999999999999 111.196 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -31.49 72.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 11.4 111.143 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.21 -43.07 88.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 11.43 111.181 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.31 -40.05 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 11.470000000000001 111.167 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.3 m -57.3 -41.11 79.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 11.5 111.212 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.01 71.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 11.529999999999999 111.194 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.04 -25.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.186 -172.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.79 -46.03 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 11.6 111.195 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.53 -27.39 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 11.630000000000001 111.221 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.77 -39.13 36.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 11.67 111.184 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.48 86.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 11.699999999999999 111.216 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -74.4 -14.97 60.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 11.73 111.203 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.39 31.89 40.18 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.14 -0.784 . . . . 11.77 111.14 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -100.01 -38.28 8.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.78 0.324 . . . . 11.800000000000001 111.177 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -124.96 159.18 31.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 11.83 111.207 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.3 p -81.66 176.92 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 11.869999999999999 111.204 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 10.7 m -70.59 -21.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 11.9 111.199 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -89.84 -36.71 14.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 11.93 111.187 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -69.09 -36.72 77.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.151 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.92 87.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 12.0 111.171 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.84 -32.48 73.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 12.029999999999999 111.191 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.94 -59.96 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 12.07 111.248 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.38 -41.1 89.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 12.1 111.235 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.26 85.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 12.130000000000001 111.19 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.7 -46.45 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 12.17 111.202 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.2 m -62.43 -39.96 95.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 12.199999999999999 111.208 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -65.01 -37.21 86.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 12.23 111.175 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.9 mt -73.28 -45.01 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 12.27 111.228 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.0 p -81.99 -15.48 53.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 12.300000000000001 111.201 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.199 -1.553 0 CA-C-N 116.221 -0.445 . . . . 12.33 111.222 177.299 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.736 0.303 . . . . 0.029999999999999999 111.258 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.1 tp -59.59 136.7 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.070000000000000007 111.133 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.18 150.1 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.10000000000000001 111.214 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.03 125.13 22.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.13 111.217 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.74 14.29 58.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.143 -0.783 . . . . 0.17000000000000001 111.143 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -132.06 155.01 48.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 0.20000000000000001 111.23 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -116.27 109.98 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.23000000000000001 111.186 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.94 123.76 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.27000000000000002 111.179 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.29999999999999999 111.264 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.404 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.3 m0 -109.98 128.74 55.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.33000000000000002 111.175 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 86.5 mt -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.37 111.165 -173.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' HB2' ' CE3' ' A' ' 62' ' ' TRP . 57.0 t-20 -62.34 122.17 15.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.40000000000000002 111.224 172.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.9 -174.31 15.14 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.14 -0.784 . . . . 0.42999999999999999 111.14 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -99.95 -19.93 16.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.46999999999999997 111.264 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.45 144.16 28.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.5 111.175 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.73 -18.81 8.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.174 -0.771 . . . . 0.53000000000000003 111.174 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -47.59 -55.12 9.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.767 0.318 . . . . 0.56999999999999995 111.197 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -94.23 -27.04 16.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.59999999999999998 111.268 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.13 -57.23 19.33 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.255 -0.738 . . . . 0.63 111.255 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.7 tp -74.57 -29.14 61.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.67000000000000004 111.229 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -32.6 63.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.69999999999999996 111.164 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -59.21 -33.54 71.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.72999999999999998 111.172 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.26 -40.16 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.77000000000000002 111.228 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.25 -28.94 71.68 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.285 -0.726 . . . . 0.80000000000000004 111.285 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.66 -42.52 99.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.82999999999999996 111.135 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.3 -48.45 70.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.87 111.165 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -56.17 -44.16 79.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.90000000000000002 111.197 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.29 -42.07 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.93000000000000005 111.178 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.89 -35.0 69.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.96999999999999997 111.257 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -78.71 -35.9 44.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.256 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -106.26 -28.31 10.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 1.03 111.212 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.75 5.06 74.94 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.24 -0.744 . . . . 1.0700000000000001 111.24 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mm -86.5 114.78 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 1.1000000000000001 111.219 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.92 124.06 19.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 111.181 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.36 126.14 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 1.1699999999999999 111.177 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -126.46 116.77 21.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 1.2 111.234 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.5 125.01 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 1.23 111.186 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.6 mt-10 -132.71 161.35 34.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 1.27 111.194 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -117.15 102.78 52.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 1.3 111.188 172.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.56 167.95 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.709 1.606 . . . . 1.3300000000000001 111.186 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.6 t0 -100.19 102.86 14.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 1.3700000000000001 111.142 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.18 70.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 1.3999999999999999 111.2 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 68.5 mt -59.98 -20.69 59.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 1.4299999999999999 111.214 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -49.23 -35.03 16.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 1.47 111.185 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -109.86 -25.58 10.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 1.5 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 43' ' ' LEU . 87.1 tttt -79.98 -24.4 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 1.53 111.141 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.467 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -50.67 -57.39 13.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 1.5700000000000001 111.2 -177.098 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -68.61 -24.65 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.663 1.575 . . . . 1.6000000000000001 111.209 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.11 -37.31 72.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.173 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -88.59 -24.16 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 1.6699999999999999 111.197 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.26 -30.82 71.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 1.7 111.158 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.0 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 1.73 111.273 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -101.53 -15.39 17.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 1.77 111.131 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.5 32.55 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.208 -0.757 . . . . 1.8 111.208 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -110.02 169.97 8.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 1.8300000000000001 111.179 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.44 179.99 31.86 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.21 -0.756 . . . . 1.8700000000000001 111.21 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.37 -178.08 3.55 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.669 1.579 . . . . 1.8999999999999999 111.154 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -84.55 -56.53 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.9299999999999999 111.241 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -114.16 138.93 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 1.97 111.283 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.68 121.07 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 2.0 111.193 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 22.0 m-85 -98.2 107.89 20.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 2.0299999999999998 111.162 167.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.513 ' CE3' ' HB2' ' A' ' 12' ' ' ASN . 24.3 t-105 -148.33 157.26 43.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 2.0699999999999998 111.172 -172.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.7 140.95 53.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.1000000000000001 111.226 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -58.62 -26.19 63.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 2.1299999999999999 111.149 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -76.7 -6.7 53.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 2.1699999999999999 111.232 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -129.13 -24.94 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 111.19 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.04 -29.98 67.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 2.23 111.187 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -28.82 73.57 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.21 -0.756 . . . . 2.27 111.21 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.78 -31.89 59.77 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.159 -0.776 . . . . 2.2999999999999998 111.159 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -64.54 -36.15 83.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.203 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.77 69.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 2.3700000000000001 111.153 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -55.33 -42.59 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 2.3999999999999999 111.2 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 99.9 p -70.64 -15.05 62.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 2.4300000000000002 111.222 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.22 22.04 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.195 -0.762 . . . . 2.4700000000000002 111.195 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -107.24 -8.67 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 2.5 111.25 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -105.08 135.08 47.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 2.5299999999999998 111.214 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.96 134.97 53.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 2.5699999999999998 111.166 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -74.5 91.03 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 2.6000000000000001 111.243 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.95 98.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 2.6299999999999999 111.154 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.6 m -91.46 115.39 64.38 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 2.6699999999999999 111.224 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -56.39 144.99 81.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.702 1.601 . . . . 2.7000000000000002 111.169 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.96 163.05 28.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 2.73 111.134 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.31 -36.39 53.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 2.77 111.187 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.64 74.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 2.7999999999999998 111.263 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -70.25 -31.23 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 2.8300000000000001 111.226 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -57.56 -33.86 68.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 2.8700000000000001 111.216 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -81.72 -16.1 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 2.8999999999999999 111.245 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 305' ' ' LYS . 70.1 mmtt -85.02 -35.03 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 2.9300000000000002 111.199 -170.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.63 161.14 20.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 2.9700000000000002 111.141 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -60.02 144.67 86.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 3.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.96 -25.12 66.96 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.684 1.589 . . . . 3.0299999999999998 111.224 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -65.68 -49.05 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 3.0699999999999998 111.18 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.5 p -89.12 -24.13 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.262 -0.426 . . . . 3.1000000000000001 111.204 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -69.96 -46.79 64.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 3.1299999999999999 111.192 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.89 -15.43 61.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 3.1699999999999999 111.188 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.24 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 3.2000000000000002 111.179 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.15 78.92 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 3.23 111.227 -169.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HB3' HD23 ' A' ' 103' ' ' LEU . 33.7 ptt-85 -149.82 165.1 33.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 3.27 111.193 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -131.97 114.43 14.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 3.2999999999999998 111.221 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 61.94 37.2 15.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 3.3300000000000001 111.163 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.8 7.68 83.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.213 -0.755 . . . . 3.3700000000000001 111.213 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.96 107.25 15.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 3.3999999999999999 111.171 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.409 HD23 ' HB3' ' A' ' 98' ' ' ARG . 58.0 mt -59.33 128.99 39.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 3.4300000000000002 111.12 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -112.36 -20.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 3.4700000000000002 111.228 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.35 176.0 6.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 3.5 111.268 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -113.25 127.32 26.96 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 3.5299999999999998 111.231 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.45 138.95 47.72 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.718 1.612 . . . . 3.5699999999999998 111.273 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.4 mm -116.14 -47.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 3.6000000000000001 111.243 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.73 154.98 50.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 3.6299999999999999 111.179 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 134.96 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 3.6699999999999999 111.252 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -124.9 123.41 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 3.7000000000000002 111.186 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.26 151.18 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 3.73 111.218 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.2 tp -138.18 125.81 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 3.77 111.166 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 t -159.98 -168.54 2.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 3.7999999999999998 111.179 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.95 125.54 36.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 3.8300000000000001 111.173 -168.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.86 139.99 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 3.8700000000000001 111.267 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -136.55 144.92 44.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 3.8999999999999999 111.205 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -75.52 123.5 25.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 3.9300000000000002 111.216 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -70.97 -30.1 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 3.9700000000000002 111.185 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -77.85 -43.26 30.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 4.0 111.209 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.14 -44.64 59.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 4.0300000000000002 111.163 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -128.54 77.3 77.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 4.0700000000000003 111.238 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.69 -25.01 74.97 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.659 1.573 . . . . 4.0999999999999996 111.198 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -105.19 100.07 23.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 4.1299999999999999 111.26 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.0 155.4 52.8 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.706 1.604 . . . . 4.1699999999999999 111.196 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 154.55 59.31 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.691 1.594 . . . . 4.2000000000000002 111.253 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -85.32 -15.64 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 4.2300000000000004 111.192 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.2 t -160.0 162.66 34.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 4.2699999999999996 111.192 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -59.4 -23.25 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 4.2999999999999998 111.215 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.43 -22.83 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.3300000000000001 111.185 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -96.76 2.97 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 4.3700000000000001 111.226 -176.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.528 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 70.4 mt -66.93 -54.33 21.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 4.4000000000000004 111.191 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 67.5 Cg_endo -71.78 -18.52 28.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.735 1.623 . . . . 4.4299999999999997 111.233 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.98 -24.69 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 4.4699999999999998 111.197 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.2 -6.88 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 4.5 111.162 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.37 -35.01 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 4.5300000000000002 111.174 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.03 -39.88 83.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 4.5700000000000003 111.213 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.61 -27.85 68.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 4.5999999999999996 111.158 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.01 -0.36 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 4.6299999999999999 111.207 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.15 -26.27 68.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 4.6699999999999999 111.228 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.97 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 4.7000000000000002 111.232 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -99.92 -20.01 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 4.7300000000000004 111.183 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.61 24.8 44.88 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.145 -0.782 . . . . 4.7699999999999996 111.145 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -119.04 164.94 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 4.7999999999999998 111.19 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t -111.34 158.46 19.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 4.8300000000000001 111.213 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.1 -72.86 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.178 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.3 tp -156.94 129.0 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 4.9000000000000004 111.166 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mmm -84.73 140.55 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 4.9299999999999997 111.242 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.02 138.42 53.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 4.9699999999999998 111.165 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -82.91 119.78 24.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 5.0 111.209 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.407 HD21 HD11 ' A' ' 195' ' ' LEU . 99.0 mt -114.81 -25.52 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 5.0300000000000002 111.181 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.07 -39.82 90.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 5.0700000000000003 111.184 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.97 118.4 56.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 5.0999999999999996 111.208 -172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.96 -34.91 88.34 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.654 1.569 . . . . 5.1299999999999999 111.16 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -53.5 -37.69 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 5.1699999999999999 111.215 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.28 25.63 8.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 5.2000000000000002 111.245 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.3 p -103.34 -15.23 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 5.2300000000000004 111.154 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 75.0 t90 -68.67 -48.2 32.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 5.2699999999999996 111.217 175.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 67.6 Cg_endo -74.79 -4.36 15.29 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.674 1.582 . . . . 5.2999999999999998 111.193 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.8 mt -65.3 -21.04 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 5.3300000000000001 111.176 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.7 mt -109.68 -41.46 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 5.3700000000000001 111.173 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.02 -44.47 89.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 5.4000000000000004 111.232 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.01 -34.33 78.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 5.4299999999999997 111.233 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -64.2 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 5.4699999999999998 111.219 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.57 23.74 6.74 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.248 -0.741 . . . . 5.5 111.248 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.53 -22.05 17.61 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.169 -0.772 . . . . 5.5300000000000002 111.169 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 68.1 t80 -111.59 145.15 39.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 5.5700000000000003 111.122 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 67.55 22.79 9.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 5.5999999999999996 111.175 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.36 173.22 11.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 5.6299999999999999 111.171 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -139.32 112.88 8.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 5.6699999999999999 111.166 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -79.14 80.11 5.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 5.7000000000000002 111.23 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 25.5 tt0 -145.69 90.01 1.96 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 5.7300000000000004 111.235 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 79.7 m-20 74.12 -69.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 5.7699999999999996 111.267 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.0 25.78 0.07 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.22 -0.752 . . . . 5.7999999999999998 111.22 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -114.96 103.28 10.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 5.8300000000000001 111.201 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -110.46 77.22 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 5.8700000000000001 111.243 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -81.6 122.88 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 5.9000000000000004 111.16 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.86 -34.11 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 5.9299999999999997 111.198 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -30.04 71.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 5.9699999999999998 111.156 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -65.59 143.03 57.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 6.0 111.169 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 183' ' ' VAL . 70.9 t -47.83 124.08 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 6.0300000000000002 111.142 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -98.48 14.31 62.18 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.229 -0.749 . . . . 6.0700000000000003 111.229 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.483 ' H ' HG12 ' A' ' 181' ' ' VAL . 25.0 m -123.63 31.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 6.0999999999999996 111.189 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -127.67 9.95 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 6.1299999999999999 111.25 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.38 161.38 14.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 6.1699999999999999 111.148 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.17 72.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 6.2000000000000002 111.148 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.32 -37.09 90.43 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.177 -0.769 . . . . 6.2300000000000004 111.177 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.2 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 6.2699999999999996 111.185 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.74 -40.76 75.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 6.2999999999999998 111.254 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.55 -28.91 68.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.146 -0.479 . . . . 6.3300000000000001 111.207 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -20.13 66.74 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.154 -0.778 . . . . 6.3700000000000001 111.154 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 347' ' ' VAL . 86.7 mt -104.99 -34.9 7.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 6.4000000000000004 111.203 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.9 m -64.56 -52.53 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 6.4299999999999997 111.233 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.62 -38.62 87.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 6.4699999999999998 111.193 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 151' ' ' LEU . 54.1 tp -58.17 -53.33 59.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 6.5 111.203 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.77 -42.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 6.5300000000000002 111.212 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.92 -39.67 86.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 6.5700000000000003 111.204 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 84.7 mt -70.4 -35.4 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 6.5999999999999996 111.23 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.24 -40.79 89.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.188 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.79 -24.62 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 6.6699999999999999 111.205 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.71 5.18 52.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 6.7000000000000002 111.22 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 60.65 35.26 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 6.7300000000000004 111.224 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -74.88 -34.06 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.215 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -145.21 149.93 35.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 6.7999999999999998 111.17 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -94.65 151.52 19.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 6.8300000000000001 111.243 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.94 -24.53 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 6.8700000000000001 111.229 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.77 -16.75 56.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 6.9000000000000004 111.146 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -56.4 118.03 4.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 6.9299999999999997 111.232 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -119.97 -164.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 6.9699999999999998 111.22 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.09 -47.83 81.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 7.0 111.167 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 82.5 p -75.09 -25.51 58.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 7.0300000000000002 111.183 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.5 mm -67.65 -52.26 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 7.0700000000000003 111.182 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.99 90.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 7.0999999999999996 111.201 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.39 -42.46 91.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 7.1299999999999999 111.218 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.08 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.173 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -26.67 68.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 7.2000000000000002 111.224 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -81.65 -45.28 15.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 7.2300000000000004 111.197 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.66 -30.12 64.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 7.2699999999999996 111.188 -174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -9.75 56.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 7.2999999999999998 111.222 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.16 32.87 51.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.194 -0.762 . . . . 7.3300000000000001 111.194 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -81.43 -29.33 33.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.764 0.316 . . . . 7.3700000000000001 111.191 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.1 p -100.24 160.04 14.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 7.4000000000000004 111.204 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.06 -24.76 16.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 7.4299999999999997 111.189 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 90.2 mmm -109.88 149.94 29.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 7.4699999999999998 111.168 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -159.64 179.61 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 7.5 111.174 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.2 mt -121.1 124.17 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 7.5300000000000002 111.178 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -165.01 179.94 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 7.5700000000000003 111.279 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -74.84 139.33 25.1 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.245 -0.742 . . . . 7.5999999999999996 111.245 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.32 129.84 35.51 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.67 1.58 . . . . 7.6299999999999999 111.188 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 57.39 49.93 12.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 7.6699999999999999 111.217 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.86 75.37 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 7.7000000000000002 111.226 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.427 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 48.4 m0 -68.28 -17.13 64.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 7.7300000000000004 111.146 -170.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 97.0 p -66.18 -19.97 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 7.7699999999999996 111.208 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -118.98 -19.41 8.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 7.7999999999999998 111.105 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.8 mt -90.77 -61.33 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.195 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.97 -39.55 75.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 7.8700000000000001 111.205 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 83.9 m -52.45 -44.93 65.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 7.9000000000000004 111.159 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 84.9 p -81.27 -10.47 59.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 7.9299999999999997 111.195 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 59.99 40.23 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 7.9699999999999998 111.247 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.63 135.06 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 8.0 111.161 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -73.85 111.24 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 8.0299999999999994 111.227 -175.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.31 145.02 44.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 8.0700000000000003 111.159 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.08 178.65 17.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.189 -0.764 . . . . 8.0999999999999996 111.189 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.89 139.96 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 8.1300000000000008 111.166 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.1 t -142.5 176.55 8.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 8.1699999999999999 111.209 171.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.57 112.85 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 8.1999999999999993 111.139 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.57 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 40.6 tp -63.46 -53.76 49.47 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 8.2300000000000004 111.212 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 70.8 Cg_endo -74.81 147.34 34.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.688 1.592 . . . . 8.2699999999999996 111.191 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.4 m -116.27 125.34 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 8.3000000000000007 111.177 174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -99.98 90.08 4.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 8.3300000000000001 111.188 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 52.14 55.47 9.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 8.3699999999999992 111.19 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 99.27 -23.59 35.68 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.221 -0.752 . . . . 8.4000000000000004 111.221 171.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -129.95 109.97 16.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 8.4299999999999997 111.232 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -54.98 130.71 42.2 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.719 1.613 . . . . 8.4700000000000006 111.194 173.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.7 t -114.97 -94.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 8.5 111.188 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.94 145.53 30.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 8.5299999999999994 111.185 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.73 -176.42 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.731 1.62 . . . . 8.5700000000000003 111.175 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -86.58 156.4 20.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 8.5999999999999996 111.201 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.14 117.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 8.6300000000000008 111.179 -173.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.57 150.05 19.03 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.222 -0.751 . . . . 8.6699999999999999 111.222 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.98 121.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.894 0.378 . . . . 8.6999999999999993 111.183 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.4 tp -95.44 110.93 22.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 8.7300000000000004 111.214 172.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 89.5 p -112.51 151.7 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 8.7699999999999996 111.156 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -111.48 126.93 55.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 8.8000000000000007 111.176 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.98 177.68 19.12 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.236 -0.746 . . . . 8.8300000000000001 111.236 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 80.2 mt -111.67 122.87 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 8.8699999999999992 111.184 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -60.75 128.9 38.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 8.9000000000000004 111.137 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.85 63.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 8.9299999999999997 111.232 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -87.17 -5.01 59.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 8.9700000000000006 111.108 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.9 t -80.43 132.39 58.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 9.0 111.179 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.68 -5.4 14.73 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.749 1.633 . . . . 9.0299999999999994 111.191 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -118.0 59.92 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 9.0700000000000003 111.218 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -77.76 -28.89 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 9.0999999999999996 111.243 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.45 -38.6 65.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 9.1300000000000008 111.265 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.41 -37.73 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 9.1699999999999999 111.199 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.83 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 9.1999999999999993 111.216 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.1 -48.85 70.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 9.2300000000000004 111.192 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.69 -47.6 77.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 9.2699999999999996 111.127 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.05 -41.06 74.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 9.3000000000000007 111.21 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.14 -3.76 58.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.3300000000000001 111.223 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.41 -50.01 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 9.3699999999999992 111.244 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -121.21 4.96 10.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 9.4000000000000004 111.163 -164.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -125.0 -62.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 9.4299999999999997 111.143 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.56 -53.29 58.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 9.4700000000000006 111.155 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 64.1 mt -85.03 60.8 6.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 9.5 111.199 -174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.6 p -134.94 167.53 20.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 9.5299999999999994 111.248 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.47 -34.62 78.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 9.5700000000000003 111.177 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.07 -35.18 22.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 9.5999999999999996 111.166 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.81 -48.76 63.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.69 -28.25 65.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 9.6699999999999999 111.232 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -69.41 -36.12 76.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 9.6999999999999993 111.148 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.01 78.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 9.7300000000000004 111.187 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -70.41 -39.95 77.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 9.7699999999999996 111.217 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.14 5.02 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8000000000000007 111.139 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -54.65 -50.21 68.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 9.8300000000000001 111.182 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -106.8 -18.16 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 9.8699999999999992 111.147 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -103.08 162.76 19.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 9.9000000000000004 111.277 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.45 144.93 48.67 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 121.729 1.619 . . . . 9.9299999999999997 111.198 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.23 -6.89 59.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 9.9700000000000006 111.18 -170.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -56.96 -35.9 70.95 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.139 -0.784 . . . . 10.0 111.139 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.19 127.98 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 10.029999999999999 111.12 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 304' ' ' LEU . 7.6 p -152.77 129.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 10.07 111.236 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -125.13 26.48 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 10.1 111.168 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.405 ' H ' HG22 ' A' ' 302' ' ' VAL . 36.2 tp -157.65 130.99 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 10.130000000000001 111.221 -172.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 86.7 tttt -61.78 -46.52 89.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 10.17 111.188 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 68.0 m -55.07 -38.25 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 10.199999999999999 111.16 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -71.39 -41.81 69.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 10.23 111.226 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.58 -34.27 66.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 10.27 111.237 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.48 -29.98 68.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 10.300000000000001 111.244 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -96.52 -30.02 13.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 10.33 111.142 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.45 -30.95 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 10.369999999999999 111.182 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.14 -9.12 54.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 10.4 111.196 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.93 -28.42 67.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 10.43 111.156 173.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -80.62 115.59 56.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.470000000000001 111.177 173.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.52 -38.81 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.726 1.618 . . . . 10.5 111.205 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.64 -39.87 70.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.166 -172.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.67 -40.04 76.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 10.57 111.194 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.59 -43.37 89.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 10.6 111.234 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.93 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 10.630000000000001 111.158 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 90.0 m -63.37 -43.06 98.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.199 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.98 -38.32 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 10.699999999999999 111.19 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -63.27 -46.16 88.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.197 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.96 -33.79 76.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 10.77 111.212 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.05 -45.68 84.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 10.800000000000001 111.167 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.23 -39.84 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 10.83 111.174 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -95.95 6.15 49.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 10.869999999999999 111.224 -174.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.65 -156.03 26.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.234 -0.746 . . . . 10.9 111.234 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -130.6 116.18 17.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 10.93 111.249 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 97.7 mt -105.08 137.0 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 10.970000000000001 111.209 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 83.0 mtp -63.35 130.57 94.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 11.0 111.235 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 50.7 Cg_exo -55.01 144.39 68.67 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 11.029999999999999 111.204 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -120.17 55.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 11.07 111.151 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 335' ' ' GLN . 82.0 mt -126.63 130.42 23.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 11.1 111.215 -178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.13 -29.22 74.23 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.697 1.598 . . . . 11.130000000000001 111.229 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 333' ' ' ILE . 90.6 mt-30 -64.02 -41.71 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 11.17 111.19 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 95.3 mmm -65.34 -37.25 86.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 11.199999999999999 111.249 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 39.4 t -59.92 -41.41 91.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 11.23 111.242 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.41 -36.65 83.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 11.27 111.252 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -64.98 -36.69 85.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 11.300000000000001 111.183 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -68.22 -29.76 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 11.33 111.177 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -62.76 -41.4 99.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 11.369999999999999 111.187 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.37 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 11.4 111.267 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.7 -42.59 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 11.43 111.153 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.5 -45.12 95.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 11.470000000000001 111.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.4 m -64.99 -39.94 94.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 11.5 111.241 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.29 -45.42 91.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 11.529999999999999 111.162 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 192' ' ' LEU . 70.1 t -64.72 -40.52 89.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 11.57 111.243 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.1 mt -65.13 -43.82 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 11.6 111.222 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.78 -37.37 87.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 11.630000000000001 111.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.0 -44.37 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 11.67 111.203 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.03 79.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 11.699999999999999 111.218 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.4 p -82.93 -14.95 53.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 11.73 111.22 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.25 12.26 65.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.22 -0.752 . . . . 11.77 111.22 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -70.04 -40.81 74.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 11.800000000000001 111.145 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -129.89 166.92 19.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 11.83 111.248 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -83.46 174.47 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 11.869999999999999 111.181 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -44.1 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 11.9 111.187 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.92 -42.75 80.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 11.93 111.201 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -64.74 -40.35 95.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 11.970000000000001 111.211 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.91 -48.49 73.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 12.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.26 -23.18 60.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 12.029999999999999 111.198 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.12 -48.48 73.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 12.07 111.186 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.63 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 12.1 111.241 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.54 93.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 12.130000000000001 111.173 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.35 -40.62 97.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 12.17 111.16 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 95.9 m -56.96 -42.74 80.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 12.199999999999999 111.248 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 22.6 tpp85 -66.17 -44.14 84.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 12.23 111.241 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.76 -39.97 87.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 12.27 111.171 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.5 p -88.63 -14.95 36.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 12.300000000000001 111.159 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.201 -1.474 0 CA-C-N 116.188 -0.46 . . . . 12.33 111.216 178.726 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.76 0.314 . . . . 0.029999999999999999 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.7 mt -96.41 115.5 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.070000000000000007 111.223 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -95.58 139.96 31.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.243 -0.435 . . . . 0.10000000000000001 111.231 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.68 125.04 21.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.13 111.199 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.64 5.21 60.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.2 -0.76 . . . . 0.17000000000000001 111.2 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HG2' ' HB2' ' A' ' 34' ' ' LYS . 96.0 mttt -133.47 148.56 51.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.20000000000000001 111.116 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.2 mt -113.74 140.76 48.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.23000000000000001 111.152 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.93 110.89 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.27000000000000002 111.178 172.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.445 HG12 ' HB ' ' A' ' 59' ' ' ILE . 69.8 mt -113.79 116.21 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.29999999999999999 111.235 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.417 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 38.7 m0 -105.46 119.76 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.33000000000000002 111.164 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.43 139.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.37 111.208 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -67.63 119.31 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.142 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.81 -177.99 26.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.144 -0.782 . . . . 0.42999999999999999 111.144 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -102.71 -35.03 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.46999999999999997 111.138 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.83 163.26 28.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.5 111.201 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.41 -7.9 9.01 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.149 -0.781 . . . . 0.53000000000000003 111.149 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -60.75 -23.23 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.317 . . . . 0.56999999999999995 111.188 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -67.23 -36.43 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.59999999999999998 111.167 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.59 -44.86 94.46 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.28 -0.728 . . . . 0.63 111.28 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 37' ' ' VAL . 80.4 mt -70.15 -32.74 70.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.753 0.311 . . . . 0.67000000000000004 111.162 175.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.03 92.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.69999999999999996 111.181 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -61.41 -34.76 75.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.72999999999999998 111.207 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.95 -39.78 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.77000000000000002 111.256 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.09 79.78 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.27 -0.732 . . . . 0.80000000000000004 111.27 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.07 -37.39 84.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.337 . . . . 0.82999999999999996 111.227 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.89 -37.43 87.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.87 111.169 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -30.0 67.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.90000000000000002 111.183 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.39 -36.48 66.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.93000000000000005 111.145 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -82.79 -39.15 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.96999999999999997 111.238 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.71 -50.22 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.199 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -102.46 -49.34 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.03 111.202 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.44 21.57 3.01 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.213 -0.755 . . . . 1.0700000000000001 111.213 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.56 122.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 1.1000000000000001 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HB2' ' HG2' ' A' ' 6' ' ' LYS . 99.1 mttt -87.97 127.75 35.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 1.1299999999999999 111.182 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.22 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 1.1699999999999999 111.218 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -115.42 125.05 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 1.2 111.158 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 20' ' ' LEU . 40.2 t -114.95 126.38 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.195 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -129.96 162.6 28.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.27 111.201 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -112.32 106.84 55.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.228 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 78.7 Cg_endo -75.51 175.82 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.66 1.573 . . . . 1.3300000000000001 111.194 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -131.49 109.84 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 1.3700000000000001 111.219 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 58.07 69.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 1.3999999999999999 111.183 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.02 -18.59 61.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 1.4299999999999999 111.199 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -64.54 -15.08 60.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.202 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -99.24 -34.84 10.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 1.5 111.195 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -89.89 -48.66 7.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.53 111.208 -166.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 2.6 m-30 -56.47 -47.49 98.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.19 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 80.3 Cg_exo -50.46 -35.07 44.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.731 1.62 . . . . 1.6000000000000001 111.229 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -79.86 -47.47 15.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 1.6299999999999999 111.247 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -78.42 -16.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 1.6699999999999999 111.256 -174.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 1.7 111.204 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.66 -15.49 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 1.73 111.208 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -108.5 -14.97 14.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 1.77 111.194 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.55 30.25 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.249 -0.74 . . . . 1.8 111.249 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -110.16 169.99 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.327 . . . . 1.8300000000000001 111.221 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.48 -173.83 25.72 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.201 -0.76 . . . . 1.8700000000000001 111.201 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.63 173.22 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.68 1.587 . . . . 1.8999999999999999 111.258 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -88.77 -50.93 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 1.9299999999999999 111.221 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HB ' HG12 ' A' ' 9' ' ' ILE . 84.9 mt -116.27 132.97 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.97 111.162 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.1 mt -114.2 117.56 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 2.0 111.139 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -114.07 106.5 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 111.234 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -150.46 159.97 44.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 2.0699999999999998 111.155 -166.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.12 158.52 27.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.213 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.408 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 46.3 m170 -71.58 -2.8 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 2.1299999999999999 111.197 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.41 -30.94 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 2.1699999999999999 111.188 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mmt-85 -129.95 -27.92 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 2.2000000000000002 111.159 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -55.04 -43.34 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 2.23 111.211 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.31 -28.32 72.1 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.244 -0.742 . . . . 2.27 111.244 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.71 -11.32 81.88 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.145 -0.782 . . . . 2.2999999999999998 111.145 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -69.6 -29.94 67.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.717 0.294 . . . . 2.3300000000000001 111.188 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.71 -35.18 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 2.3700000000000001 111.242 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -70.02 -38.71 75.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 2.3999999999999999 111.202 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.3 p -69.82 -19.99 63.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 2.4300000000000002 111.221 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.31 23.98 25.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.168 -0.773 . . . . 2.4700000000000002 111.168 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.6 30.91 6.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 2.5 111.234 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.9 tp -151.1 115.32 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 2.5299999999999998 111.224 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.77 162.44 24.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 2.5699999999999998 111.184 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -85.65 86.86 7.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 2.6000000000000001 111.211 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 mm -98.47 101.93 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 2.6299999999999999 111.15 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -92.94 120.76 66.89 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 2.6699999999999999 111.203 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.14 141.27 80.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.713 1.609 . . . . 2.7000000000000002 111.194 176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -89.65 -174.28 4.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.24 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.67 -38.63 67.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 2.77 111.209 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.22 79.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 2.7999999999999998 111.187 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.82 -22.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 2.8300000000000001 111.155 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -62.52 -29.62 70.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 2.8700000000000001 111.168 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -97.61 -30.17 13.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 2.8999999999999999 111.205 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -79.98 -35.17 37.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 2.9300000000000002 111.255 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -94.57 149.49 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.9700000000000002 111.192 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -73.35 135.02 79.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 3.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.07 -46.94 29.25 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.643 1.562 . . . . 3.0299999999999998 111.208 -170.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.52 -46.82 85.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 3.0699999999999998 111.241 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.3 p -82.41 -15.92 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 3.1000000000000001 111.228 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 85.8 t90 -65.98 -52.34 50.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 3.1299999999999999 111.259 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -85.78 9.98 14.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 3.1699999999999999 111.271 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.89 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 3.2000000000000002 111.239 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -104.07 24.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 3.23 111.175 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.2 ttt180 -76.57 129.98 37.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 3.27 111.206 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -157.95 132.81 8.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 3.2999999999999998 111.241 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 68.49 35.05 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 3.3300000000000001 111.149 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.59 -35.13 4.93 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.226 -0.75 . . . . 3.3700000000000001 111.226 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -130.62 171.95 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 3.3999999999999999 111.182 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.8 mp -77.94 145.17 36.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 3.4300000000000002 111.231 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.8 14.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 3.4700000000000002 111.136 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -168.92 178.89 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 3.5 111.15 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -110.07 117.54 51.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 3.5299999999999998 111.177 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.04 136.73 76.42 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.71 1.607 . . . . 3.5699999999999998 111.204 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.1 mm -112.96 -60.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 3.6000000000000001 111.3 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -154.93 162.61 41.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 3.6299999999999999 111.145 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.01 159.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 3.6699999999999999 111.193 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.25 126.76 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 3.7000000000000002 111.137 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.02 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 3.73 111.219 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.4 tp -124.26 111.58 16.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 3.77 111.19 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 t -166.91 -171.65 1.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 3.7999999999999998 111.18 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.2 tp -53.06 108.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 3.8300000000000001 111.198 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 244' ' ' VAL . 81.0 mt -92.55 114.13 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 3.8700000000000001 111.153 165.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -124.28 153.63 41.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 3.8999999999999999 111.165 -169.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -85.05 113.46 21.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 3.9300000000000002 111.147 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.34 -30.85 69.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 3.9700000000000002 111.182 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -72.1 -30.21 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 4.0 111.135 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.2 -13.8 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 4.0300000000000002 111.24 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 38.1 tp -142.97 79.79 14.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 4.0700000000000003 111.214 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.17 -19.48 29.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.757 1.638 . . . . 4.0999999999999996 111.205 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -120.16 89.97 43.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 4.1299999999999999 111.183 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.55 157.48 48.77 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.27 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.38 154.74 45.9 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.77 1.646 . . . . 4.2000000000000002 111.172 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.56 -5.24 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 4.2300000000000004 111.217 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -164.3 156.14 16.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 4.2699999999999996 111.19 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -59.79 -18.84 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 4.2999999999999998 111.221 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.67 -14.46 60.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 4.3300000000000001 111.164 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.67 6.03 47.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 4.3700000000000001 111.202 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.5 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 30.3 mm -74.19 -44.17 6.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.2 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 89.7 Cg_exo -49.24 -41.91 41.14 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.662 1.575 . . . . 4.4299999999999997 111.217 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.26 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 4.4699999999999998 111.167 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.16 -52.75 11.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 4.5 111.261 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.96 -37.79 61.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 4.5300000000000002 111.206 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.42 -57.72 10.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 4.5700000000000003 111.191 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.94 -30.61 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 4.5999999999999996 111.233 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.4 ' HB3' ' HG3' ' A' ' 144' ' ' LYS . 95.0 mt -77.08 -30.44 55.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 4.6299999999999999 111.248 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.98 -37.5 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 4.6699999999999999 111.216 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.62 -28.45 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 4.7000000000000002 111.213 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.45 -1.66 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 4.7300000000000004 111.149 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.25 25.26 40.63 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' A' ' 139' ' ' LEU . 29.9 pttt -129.95 160.09 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 4.7999999999999998 111.19 175.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.9 t -138.82 144.86 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 4.8300000000000001 111.219 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.03 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 4.8700000000000001 111.17 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 mt -110.38 121.58 45.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 4.9000000000000004 111.118 169.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.8 tpp -150.16 115.26 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 4.9299999999999997 111.211 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.7 176.0 7.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 4.9699999999999998 111.226 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -79.91 120.26 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 5.0 111.153 160.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 151' ' ' LEU . 4.0 mm? -90.23 -37.96 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 5.0300000000000002 111.223 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -65.16 -42.34 93.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 5.0700000000000003 111.146 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.9 126.45 75.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 5.0999999999999996 111.205 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.29 -21.26 31.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.681 1.587 . . . . 5.1299999999999999 111.202 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.39 -38.2 73.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 5.1699999999999999 111.192 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -99.33 14.93 27.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 5.2000000000000002 111.2 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.2 p -103.1 -10.92 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 5.2300000000000004 111.169 173.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.545 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 51.5 t-105 -72.43 -42.74 8.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 5.2699999999999996 111.19 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 70.8 Cg_exo -55.04 -33.27 82.76 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.73 1.62 . . . . 5.2999999999999998 111.171 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.455 HD13 ' HG ' ' A' ' 195' ' ' LEU . 63.1 mt -69.26 -24.63 64.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 5.3300000000000001 111.188 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 49.0 mm -81.3 -40.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 5.3700000000000001 111.218 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.15 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 5.4000000000000004 111.162 174.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.52 76.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 5.4299999999999997 111.153 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.04 -62.03 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 5.4699999999999998 111.206 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.99 -8.34 70.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.236 -0.746 . . . . 5.5 111.236 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.44 55.1 3.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.167 -0.773 . . . . 5.5300000000000002 111.167 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.78 151.67 33.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 5.5700000000000003 111.256 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 48.19 42.26 17.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 5.5999999999999996 111.24 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -139.93 78.82 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 5.6299999999999999 111.163 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -135.42 118.16 16.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 5.6699999999999999 111.216 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -125.52 142.77 51.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 5.7000000000000002 111.169 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 87.3 tt0 -127.85 96.53 4.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 5.7300000000000004 111.263 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 96.3 m-20 65.35 30.33 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 5.7699999999999996 111.236 -172.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.97 6.08 69.95 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.162 -0.775 . . . . 5.7999999999999998 111.162 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -96.04 99.78 11.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 5.8300000000000001 111.217 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -65.06 125.1 23.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 5.8700000000000001 111.143 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -84.3 113.45 21.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 5.9000000000000004 111.178 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 pt -95.28 5.45 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 5.9299999999999997 111.25 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.56 28.18 8.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 5.9699999999999998 111.191 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -82.25 169.97 15.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 6.0 111.157 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 95.6 t -112.87 124.84 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 6.0300000000000002 111.169 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -66.2 -39.36 94.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.212 -0.755 . . . . 6.0700000000000003 111.212 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.51 0.08 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 6.0999999999999996 111.156 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -106.16 -4.84 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 6.1299999999999999 111.226 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -83.31 160.04 21.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 6.1699999999999999 111.22 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.69 70.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 6.2000000000000002 111.193 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.82 -33.67 63.77 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.237 -0.745 . . . . 6.2300000000000004 111.237 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.76 -28.63 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 6.2699999999999996 111.154 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.04 -64.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 6.2999999999999998 111.157 -174.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.39 -34.78 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 6.3300000000000001 111.151 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -33.44 87.23 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.273 -0.731 . . . . 6.3700000000000001 111.273 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.0 tp -75.0 -39.58 61.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 6.4000000000000004 111.236 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.9 m -54.57 -46.47 73.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.179 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -63.19 -47.6 81.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 6.4699999999999998 111.177 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.5 tt -50.0 -54.03 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 6.5 111.209 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.43 -36.47 76.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.144 -0.48 . . . . 6.5300000000000002 111.19 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.07 -35.02 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.5700000000000003 111.203 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.44 -27.14 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 6.5999999999999996 111.194 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.91 -36.91 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 6.6299999999999999 111.241 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.79 -21.66 59.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 6.6699999999999999 111.265 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -90.04 3.68 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 6.7000000000000002 111.216 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 62.26 35.09 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 6.7300000000000004 111.235 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -106.9 -30.01 9.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 6.7699999999999996 111.19 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 95.7 mtp -125.92 160.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 6.7999999999999998 111.169 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -125.2 118.92 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 6.8300000000000001 111.265 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.84 -24.07 67.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 6.8700000000000001 111.223 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -81.83 -10.09 59.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 6.9000000000000004 111.173 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.8 m -54.59 108.54 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.174 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -89.98 179.82 5.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 6.9699999999999998 111.202 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -63.28 -49.09 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 7.0 111.248 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.1 p -65.06 -24.03 67.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 7.0300000000000002 111.167 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.31 -47.95 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 7.0700000000000003 111.272 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.27 90.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.208 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.43 -51.97 63.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 7.1299999999999999 111.247 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.76 94.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 7.1699999999999999 111.201 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.45 94.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 7.2000000000000002 111.213 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.93 -45.48 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 7.2300000000000004 111.181 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -69.94 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 7.2699999999999996 111.201 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.85 -11.78 56.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.2999999999999998 111.206 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.33 26.12 48.81 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.163 -0.775 . . . . 7.3300000000000001 111.163 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -78.53 -34.44 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 7.3700000000000001 111.199 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 84.9 m -123.87 112.42 17.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 7.4000000000000004 111.172 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.29 93.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 7.4299999999999997 111.18 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 62.3 ttp -127.31 119.99 27.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 7.4699999999999998 111.226 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 41.1 p -127.58 179.97 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 7.5 111.19 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.16 118.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 7.5300000000000002 111.24 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -108.23 120.83 43.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.438 . . . . 7.5700000000000003 111.199 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 232' ' ' TRP . . . -77.87 -172.9 39.87 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.254 -0.739 . . . . 7.5999999999999996 111.254 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.13 -34.45 87.66 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.618 1.545 . . . . 7.6299999999999999 111.163 -175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -71.59 -31.54 67.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 7.6699999999999999 111.234 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.77 6.67 13.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 7.7000000000000002 111.239 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.461 ' N ' ' O ' ' A' ' 228' ' ' GLY . 92.3 t90 -54.15 -36.39 63.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 7.7300000000000004 111.227 -170.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.1 p -62.39 -17.37 58.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 7.7699999999999996 111.228 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -57.63 -49.93 74.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 7.7999999999999998 111.234 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.0 tp -74.45 -28.47 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 7.8300000000000001 111.158 -173.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.75 -35.29 57.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 7.8700000000000001 111.233 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 76.1 m -67.15 -31.66 72.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 7.9000000000000004 111.163 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 60.6 p -69.62 -15.03 63.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 7.9299999999999997 111.171 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 58.44 50.24 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 7.9699999999999998 111.187 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.07 175.83 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 8.0 111.183 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -85.32 119.48 25.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 8.0299999999999994 111.15 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.44 160.07 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 8.0700000000000003 111.24 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -164.21 -168.17 25.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.245 -0.742 . . . . 8.0999999999999996 111.245 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 116' ' ' ILE . 77.6 t -131.25 140.08 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 8.1300000000000008 111.205 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -122.69 -173.76 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 8.1699999999999999 111.248 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.12 113.44 43.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 8.1999999999999993 111.188 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.544 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 74.2 mt -83.88 -45.41 0.78 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 8.2300000000000004 111.145 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 79.3 Cg_endo -80.64 156.01 21.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.694 1.596 . . . . 8.2699999999999996 111.168 -167.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.9 p -119.8 161.31 20.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 8.3000000000000007 111.279 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -123.36 100.94 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 8.3300000000000001 111.187 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 59.4 32.82 22.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 8.3699999999999992 111.221 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.82 62.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -122.11 110.03 33.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 8.4299999999999997 111.165 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.37 143.74 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.669 1.579 . . . . 8.4700000000000006 111.248 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -139.54 -74.93 0.36 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 8.5 111.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -131.26 158.55 74.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 8.5299999999999994 111.231 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.56 161.76 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.662 1.575 . . . . 8.5700000000000003 111.257 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -73.97 125.76 28.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 8.5999999999999996 111.198 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.2 t -111.08 124.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 8.6300000000000008 111.196 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -81.77 143.74 23.59 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.175 -0.77 . . . . 8.6699999999999999 111.175 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 65.7 t -121.11 130.03 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 8.6999999999999993 111.167 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.38 131.95 52.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 8.7300000000000004 111.176 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.5 p -145.07 154.74 42.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 8.7699999999999996 111.2 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -119.14 132.59 56.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 8.8000000000000007 111.117 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.22 -179.32 16.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.184 -0.766 . . . . 8.8300000000000001 111.184 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -108.78 130.65 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.788 0.328 . . . . 8.8699999999999992 111.237 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -60.7 134.06 56.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 8.9000000000000004 111.144 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.98 -18.43 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 8.9299999999999997 111.201 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.98 58.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 8.9700000000000006 111.248 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.0 t -65.0 127.93 93.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 9.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.01 -14.97 20.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.743 1.629 . . . . 9.0299999999999994 111.234 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -130.02 74.95 1.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 9.0700000000000003 111.202 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -80.08 -22.91 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 9.0999999999999996 111.22 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -74.12 -35.56 64.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 9.1300000000000008 111.215 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.7 -42.48 77.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 9.1699999999999999 111.259 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -38.98 92.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 9.1999999999999993 111.189 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -56.19 -51.45 67.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 9.2300000000000004 111.204 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.33 -42.12 99.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 9.2699999999999996 111.115 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.92 -42.45 80.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 9.3000000000000007 111.225 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.1 -3.55 58.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 9.3300000000000001 111.167 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -103.21 -50.83 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 9.3699999999999992 111.169 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -124.73 4.88 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 9.4000000000000004 111.266 -164.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -125.07 -70.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 9.4299999999999997 111.143 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 66.3 tp -65.43 -57.58 7.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 9.4700000000000006 111.246 -172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.96 61.78 7.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 9.5 111.218 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 31.4 p -129.94 -171.13 2.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 9.5299999999999994 111.223 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -75.5 -9.91 58.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 9.5700000000000003 111.196 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -116.13 -33.81 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 9.5999999999999996 111.214 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.78 -51.04 31.94 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.158 -0.777 . . . . 9.6300000000000008 111.158 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.02 -20.69 59.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.74 0.305 . . . . 9.6699999999999999 111.135 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.1 -47.17 84.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 9.6999999999999993 111.186 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.13 80.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 9.7300000000000004 111.218 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.54 -39.72 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 9.7699999999999996 111.177 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.92 7.27 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 9.8000000000000007 111.252 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.89 -43.04 80.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 9.8300000000000001 111.237 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -98.45 -20.41 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.8699999999999992 111.248 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.96 155.24 47.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 9.9000000000000004 111.202 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.21 144.98 79.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.714 1.609 . . . . 9.9299999999999997 111.251 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 24.51 12.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.168 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -66.95 -27.2 73.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.205 -0.758 . . . . 10.0 111.205 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.98 27.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 10.029999999999999 111.203 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.6 p -159.0 141.02 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 10.07 111.19 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.68 60.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 10.1 111.168 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 38.5 tp -60.25 125.06 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 10.130000000000001 111.157 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.64 -34.85 72.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 10.17 111.261 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 47.0 t -53.78 -52.2 60.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 10.199999999999999 111.184 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -66.46 -44.14 83.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 10.23 111.199 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -52.78 -42.45 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 10.27 111.261 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.81 -40.59 79.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.228 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -29.96 63.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 10.33 111.26 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.32 -17.86 33.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 10.369999999999999 111.226 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.81 -17.45 63.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 10.4 111.216 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.7 -30.67 71.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 10.43 111.177 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -77.93 118.25 70.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 10.470000000000001 111.221 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -57.6 -39.89 84.64 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.704 1.603 . . . . 10.5 111.181 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.66 -40.04 69.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 10.529999999999999 111.255 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.3 mt -69.97 -40.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 10.57 111.163 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.96 78.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 10.6 111.223 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.78 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 10.630000000000001 111.162 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -68.57 -42.84 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 10.67 111.216 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.0 mtt -66.51 -34.39 77.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 10.699999999999999 111.244 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.65 -47.08 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.152 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -76.05 -31.66 58.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 10.77 111.218 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.5 93.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 10.800000000000001 111.277 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 10.83 111.221 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.43 13.69 17.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.216 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.6 -175.02 40.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.162 -0.775 . . . . 10.9 111.162 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.443 ' HA ' ' OE1' ' A' ' 328' ' ' GLU . 5.2 tp10 -99.96 139.65 35.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 10.93 111.226 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 94.3 mt -94.75 130.43 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 10.970000000000001 111.165 -171.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.408 ' SD ' ' HB2' ' A' ' 64' ' ' HIS . 47.2 ttm -60.0 116.64 18.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 11.0 111.17 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.61 160.16 18.17 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.764 1.643 . . . . 11.029999999999999 111.246 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -109.85 20.21 18.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 11.07 111.113 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 333' ' ' ILE . 3.8 mp -86.12 122.93 72.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 11.1 111.171 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.99 -47.02 29.82 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.669 1.579 . . . . 11.130000000000001 111.269 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.81 -46.31 90.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 11.17 111.293 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.406 ' H ' HG22 ' A' ' 333' ' ' ILE . 67.1 mtt -60.06 -43.05 95.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 11.199999999999999 111.129 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.3 m -57.23 -41.14 78.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 11.23 111.117 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.63 94.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 11.27 111.213 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -71.7 -29.63 64.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.300000000000001 111.226 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -59.94 -51.98 67.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 11.33 111.163 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.73 -38.44 86.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 11.369999999999999 111.132 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -54.8 -37.72 66.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 11.4 111.211 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.4 t -71.7 -40.69 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 11.43 111.182 174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -51.06 -37.68 47.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 11.470000000000001 111.148 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.5 p -94.24 -26.98 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 11.5 111.184 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.08 -38.03 89.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 11.529999999999999 111.152 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.61 -21.6 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 11.57 111.203 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.95 -45.54 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 11.6 111.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 11.630000000000001 111.268 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.06 -39.59 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 11.67 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.28 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 11.699999999999999 111.161 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.9 p -78.31 -13.66 59.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 11.73 111.163 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.94 25.87 33.29 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.213 -0.755 . . . . 11.77 111.213 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -90.07 -48.55 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 11.800000000000001 111.178 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -124.99 165.22 18.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 11.83 111.242 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -84.77 175.06 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 11.869999999999999 111.131 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.7 t -59.31 -44.86 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 11.9 111.185 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 11.93 111.254 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.13 -44.67 87.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 11.970000000000001 111.221 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.67 94.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 12.0 111.226 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.75 -24.99 48.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 12.029999999999999 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.43 -48.31 78.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 12.07 111.178 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -69.46 -33.91 73.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 12.1 111.118 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.5 75.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 12.130000000000001 111.184 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -70.02 -56.66 6.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 12.17 111.151 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.2 m -51.55 -43.45 62.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 12.199999999999999 111.171 -173.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.65 -29.91 70.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 12.23 111.193 -171.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 48.0 pt -105.01 -4.37 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 12.27 111.253 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.4 p -115.0 1.71 14.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 12.300000000000001 111.168 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.534 0 CA-C-N 116.245 -0.434 . . . . 12.33 111.152 178.381 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.808 0.337 . . . . 0.029999999999999999 111.167 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -99.1 124.77 52.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.070000000000000007 111.229 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -98.15 155.09 17.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.10000000000000001 111.139 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -93.67 155.05 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.13 111.212 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.24 16.82 54.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.235 -0.746 . . . . 0.17000000000000001 111.235 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.81 160.0 21.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.746 0.308 . . . . 0.20000000000000001 111.237 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.6 pp -145.89 153.95 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.254 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.35 135.26 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.27000000000000002 111.187 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 37' ' ' VAL . 83.5 mt -115.6 124.97 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.29999999999999999 111.222 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -103.61 105.15 15.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.33000000000000002 111.233 172.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.8 tt -115.48 137.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.37 111.187 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -81.03 108.94 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 111.195 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.0 -173.15 46.07 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.217 -0.753 . . . . 0.42999999999999999 111.217 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -104.98 -53.04 2.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.819 0.343 . . . . 0.46999999999999997 111.186 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.12 18.71 5.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.5 111.156 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.96 -23.65 69.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.183 -0.767 . . . . 0.53000000000000003 111.183 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -53.81 -32.71 53.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.56999999999999995 111.184 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.45 -41.56 96.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.59999999999999998 111.214 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -34.88 83.39 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.218 -0.753 . . . . 0.63 111.218 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 284' ' ' LEU . 83.1 mt -81.95 -25.87 34.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 0.67000000000000004 111.197 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.63 47.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.69999999999999996 111.207 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.72999999999999998 111.246 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.56 -17.85 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.77000000000000002 111.182 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.77 -31.94 81.37 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.207 -0.757 . . . . 0.80000000000000004 111.207 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.67 -46.15 80.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.82999999999999996 111.178 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.68 -50.03 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.87 111.235 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.90000000000000002 111.199 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.79 -39.09 80.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.93000000000000005 111.223 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.23 -32.22 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.96999999999999997 111.24 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -71.31 -40.53 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.248 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.4 p -113.91 -29.97 6.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 1.03 111.181 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.62 -0.3 63.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 1.0700000000000001 111.22 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.3 mm -76.57 110.99 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.1000000000000001 111.211 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.0 124.99 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 1.1299999999999999 111.225 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.54 121.49 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 1.1699999999999999 111.171 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.16 121.31 37.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 1.2 111.241 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 9' ' ' ILE . 40.7 t -118.18 125.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 1.23 111.136 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.27 165.73 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 1.27 111.172 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -121.45 70.07 23.45 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.215 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.42 161.99 33.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.687 1.591 . . . . 1.3300000000000001 111.231 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -124.82 -178.32 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.3700000000000001 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 54.99 39.73 31.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 1.3999999999999999 111.217 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.95 -9.17 59.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 1.4299999999999999 111.186 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.24 -27.98 69.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 1.47 111.209 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.07 -34.59 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.5 111.212 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.25 -46.43 80.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 1.53 111.183 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.535 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 81.1 t80 -62.56 -53.41 57.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 1.5700000000000001 111.132 -173.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 46.8 Cg_endo -67.76 -25.73 39.45 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.686 1.591 . . . . 1.6000000000000001 111.172 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -65.21 -35.27 80.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 1.6299999999999999 111.271 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -97.29 -26.17 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.6699999999999999 111.213 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.96 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 1.7 111.242 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.72 67.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.73 111.152 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 p -96.69 3.54 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.77 111.162 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.72 20.24 56.48 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.21 -0.756 . . . . 1.8 111.21 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -119.99 -166.02 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 1.8300000000000001 111.222 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.53 -164.87 12.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.205 -0.758 . . . . 1.8700000000000001 111.205 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.17 -176.32 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.714 1.609 . . . . 1.8999999999999999 111.221 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 276' ' ' ALA . 43.4 m-20 -103.33 -40.26 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.9299999999999999 111.252 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.37 138.36 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 1.97 111.226 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 42.0 mm -113.96 122.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.0 111.267 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 27.1 m-85 -100.02 110.96 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 2.0299999999999998 111.242 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.485 ' C ' ' CD1' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -145.03 -175.0 4.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 2.0699999999999998 111.228 -173.072 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.12 176.75 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 2.1000000000000001 111.16 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -87.43 14.58 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 2.1299999999999999 111.18 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -96.75 -29.97 13.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 111.193 172.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -118.28 12.35 13.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 2.2000000000000002 111.164 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -70.01 -21.15 63.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 2.23 111.242 -172.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.97 -12.74 83.14 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.51 -54.34 37.94 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.26 -0.736 . . . . 2.2999999999999998 111.26 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 5.2 m-30 -88.89 -20.43 24.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.3300000000000001 111.196 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.48 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 2.3700000000000001 111.236 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -68.67 -31.03 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 2.3999999999999999 111.166 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -75.18 -28.96 60.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 2.4300000000000002 111.192 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.28 31.56 33.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.253 -0.739 . . . . 2.4700000000000002 111.253 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -99.58 1.16 43.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.75 0.31 . . . . 2.5 111.199 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.76 131.53 34.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 2.5299999999999998 111.26 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 149.23 34.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 2.5699999999999998 111.194 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.07 124.37 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 2.6000000000000001 111.224 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.6 mt -115.05 129.4 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 2.6299999999999999 111.212 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -125.03 104.63 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 2.6699999999999999 111.152 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.98 148.52 45.36 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.714 1.609 . . . . 2.7000000000000002 111.207 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -84.91 179.99 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.215 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.4 -49.89 74.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 2.77 111.212 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.2 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 2.7999999999999998 111.194 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.02 -45.06 83.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 2.8300000000000001 111.216 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.31 -27.93 69.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.199 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -94.64 -19.71 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 2.8999999999999999 111.204 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -79.92 -29.99 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 2.9300000000000002 111.247 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.12 150.52 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 2.9700000000000002 111.169 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.19 135.66 96.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 3.0 111.154 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.1 -47.64 24.81 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.73 1.62 . . . . 3.0299999999999998 111.161 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.8 -54.96 23.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 3.0699999999999998 111.239 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.7 m -60.06 -36.87 78.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 3.1000000000000001 111.161 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -65.65 -42.73 91.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 3.1299999999999999 111.182 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.19 -19.92 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 3.1699999999999999 111.242 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -30.0 67.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 3.2000000000000002 111.219 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 332' ' ' ASN . 27.4 m -106.07 18.78 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 3.23 111.182 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -100.01 130.06 46.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 3.27 111.206 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -141.6 119.8 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 3.2999999999999998 111.148 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 65.55 43.85 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 3.3300000000000001 111.233 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.51 -42.27 2.35 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.178 -0.769 . . . . 3.3700000000000001 111.178 171.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -109.97 -178.78 3.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.807 0.336 . . . . 3.3999999999999999 111.216 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.47 154.47 18.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 3.4300000000000002 111.213 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.7 pt -113.99 -4.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 3.4700000000000002 111.157 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 167.22 21.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 3.5 111.181 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.3 m-30 -110.61 137.88 20.86 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 3.5299999999999998 111.17 170.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 46.9 Cg_exo -61.59 143.7 97.08 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.652 1.568 . . . . 3.5699999999999998 111.213 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 262' ' ' LEU . 95.1 mt -109.2 -58.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 3.6000000000000001 111.195 178.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.62 160.9 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 3.6299999999999999 111.217 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -107.77 145.87 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 3.6699999999999999 111.191 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -120.04 -179.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 3.7000000000000002 111.196 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.421 ' H ' ' HD3' ' A' ' 229' ' ' PRO . . . -128.55 167.89 16.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 3.73 111.198 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.522 HD21 ' HD3' ' A' ' 159' ' ' PRO . 65.1 tp -161.55 118.47 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 3.77 111.175 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -162.15 -178.02 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 3.7999999999999998 111.206 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 247' ' ' LEU . 52.2 tp -95.09 126.72 40.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 3.8300000000000001 111.15 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.2 mt -109.27 132.66 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 3.8700000000000001 111.173 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -148.7 159.16 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 3.8999999999999999 111.17 -172.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.33 117.55 30.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 3.9300000000000002 111.177 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 94.8 mttt -68.72 -47.49 66.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 3.9700000000000002 111.23 -175.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.69 -39.13 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 4.0 111.269 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.7 tp -65.48 -42.54 92.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.154 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.1 mt -125.02 73.46 65.59 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 4.0700000000000003 111.111 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 75.4 Cg_endo -79.58 142.3 16.19 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.195 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' PRO . 99.1 m-20 -70.64 149.76 95.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 4.1299999999999999 111.222 -12.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 89.4 Cg_exo -52.21 132.48 43.96 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.676 1.584 . . . . 4.1699999999999999 111.222 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 76.2 Cg_exo -53.08 133.55 52.56 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.723 1.615 . . . . 4.2000000000000002 111.223 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -112.68 -17.11 12.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 4.2300000000000004 111.198 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -157.33 176.92 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 4.2699999999999996 111.186 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -75.13 -19.96 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 4.2999999999999998 111.221 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.1 -13.19 61.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 4.3300000000000001 111.205 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -107.29 13.69 26.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 4.3700000000000001 111.2 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.572 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 94.3 mt -76.63 -41.26 2.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.197 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 85.8 Cg_exo -53.37 -28.39 43.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.739 1.626 . . . . 4.4299999999999997 111.167 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.96 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 4.4699999999999998 111.166 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.8 tp -79.15 -43.92 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 4.5 111.241 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -31.81 71.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 4.5300000000000002 111.21 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.67 -28.73 58.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 4.5700000000000003 111.206 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -80.12 -32.07 39.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 4.5999999999999996 111.261 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 91.7 mt -86.13 -7.67 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 4.6299999999999999 111.182 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.95 -44.94 78.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 4.6699999999999999 111.133 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.74 68.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 4.7000000000000002 111.144 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.61 -8.8 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 4.7300000000000004 111.211 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 27.53 60.25 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.206 -0.758 . . . . 4.7699999999999996 111.206 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 75.1 mmtt -115.55 159.13 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.873 0.368 . . . . 4.7999999999999998 111.177 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.9 t -98.86 153.92 18.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 4.8300000000000001 111.229 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.74 -26.75 64.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 4.8700000000000001 111.167 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.16 154.92 34.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 4.9000000000000004 111.16 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.8 mtm -108.11 115.7 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 4.9299999999999997 111.256 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.525 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 93.8 m-85 -95.5 130.81 42.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 4.9699999999999998 111.244 -154.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -117.69 77.29 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 5.0 111.152 164.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 149' ' ' PHE . 96.6 mt -97.86 -0.83 44.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 5.0300000000000002 111.139 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -71.54 -22.04 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 5.0700000000000003 111.224 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.44 150.96 53.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.269 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.17 -15.03 18.47 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.679 1.586 . . . . 5.1299999999999999 111.205 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.18 -29.21 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 5.1699999999999999 111.146 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -74.11 -41.03 62.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 5.2000000000000002 111.199 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -96.34 -8.56 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 5.2300000000000004 111.187 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.49 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 77.2 t90 -58.04 -46.0 99.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 5.2699999999999996 111.186 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD3' HD21 ' A' ' 113' ' ' LEU . 98.4 Cg_endo -84.05 -20.08 4.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.65 1.567 . . . . 5.2999999999999998 111.197 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.35 -45.86 75.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.164 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.96 -33.61 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 5.3700000000000001 111.198 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.46 -4.16 59.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 5.4000000000000004 111.217 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.02 72.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.4299999999999997 111.245 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -91.08 -10.06 43.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.179 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.25 25.12 49.37 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.153 -0.779 . . . . 5.5 111.153 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.82 -1.99 36.74 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.214 -0.755 . . . . 5.5300000000000002 111.214 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.13 106.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 5.5700000000000003 111.237 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 64.55 22.25 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 5.5999999999999996 111.211 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.37 147.29 28.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 5.6299999999999999 111.166 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 177' ' ' ASP . 24.1 ttmm -57.28 120.13 7.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 5.6699999999999999 111.194 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -76.38 73.81 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 5.7000000000000002 111.163 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -150.03 99.27 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 5.7300000000000004 111.182 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 58.85 -119.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 5.7699999999999996 111.222 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.01 23.31 19.39 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.144 -0.782 . . . . 5.7999999999999998 111.144 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.69 140.13 38.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 5.8300000000000001 111.227 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -128.15 75.02 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 5.8700000000000001 111.196 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 170' ' ' LYS . 68.6 t0 -96.1 103.86 15.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 5.9000000000000004 111.22 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.9 tt -69.97 -17.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 5.9299999999999997 111.203 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -80.04 -17.45 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 5.9699999999999998 111.17 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.82 169.92 16.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 6.0 111.2 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.57 91.23 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 6.0300000000000002 111.167 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.07 32.1 7.86 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.162 -0.775 . . . . 6.0700000000000003 111.162 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.45 -22.58 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.759 0.314 . . . . 6.0999999999999996 111.143 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -99.6 12.51 36.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.197 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.44 141.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 6.1699999999999999 111.177 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.43 -37.01 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 6.2000000000000002 111.179 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.63 -32.73 45.21 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.15 -0.78 . . . . 6.2300000000000004 111.15 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.82 -48.51 58.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.339 . . . . 6.2699999999999996 111.196 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -69.8 -24.17 63.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 6.2999999999999998 111.172 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 6.3300000000000001 111.187 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.07 -39.73 96.52 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.232 -0.747 . . . . 6.3700000000000001 111.232 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.5 tp -72.33 -30.62 64.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 6.4000000000000004 111.227 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.1 m -64.41 -42.69 95.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 6.4299999999999997 111.22 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -58.72 -47.18 85.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 6.4699999999999998 111.207 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.3 tp -46.56 -45.04 18.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 6.5 111.18 174.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -74.02 -36.85 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 6.5300000000000002 111.175 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.97 -36.84 68.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 6.5700000000000003 111.171 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.13 -32.86 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 6.5999999999999996 111.195 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.43 -40.03 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 6.6299999999999999 111.104 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.85 -29.63 70.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 6.6699999999999999 111.151 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -76.19 -8.96 58.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 6.7000000000000002 111.225 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 64.85 35.09 8.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 6.7300000000000004 111.174 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -129.15 53.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 6.7699999999999996 111.173 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 47.5 ttm -159.15 147.63 18.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 6.7999999999999998 111.224 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -146.5 114.63 6.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.429 . . . . 6.8300000000000001 111.159 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.42 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 6.8700000000000001 111.183 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.38 -25.89 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 6.9000000000000004 111.211 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.8 p -75.24 149.89 38.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 6.9299999999999997 111.213 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.78 -165.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 6.9699999999999998 111.211 -170.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.86 -51.87 67.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.0 111.165 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.1 p -70.83 -29.71 65.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 7.0300000000000002 111.244 -171.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.99 -45.03 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 7.0700000000000003 111.223 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 7.0999999999999996 111.171 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.24 -41.45 94.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 7.1299999999999999 111.22 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.0 -36.29 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 7.1699999999999999 111.158 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.06 93.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 7.2000000000000002 111.167 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.38 -33.44 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 7.2300000000000004 111.212 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -60.06 -39.35 85.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 7.2699999999999996 111.236 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 -30.22 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 7.2999999999999998 111.2 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.1 34.99 13.08 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.259 -0.737 . . . . 7.3300000000000001 111.259 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.14 -35.0 68.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 7.3700000000000001 111.204 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.9 m -129.99 139.18 51.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 7.4000000000000004 111.189 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.35 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 7.4299999999999997 111.143 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -85.09 153.68 22.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 7.4699999999999998 111.241 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.1 t -169.3 179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 7.5 111.287 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.34 118.63 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 7.5300000000000002 111.17 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -160.69 177.89 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 7.5700000000000003 111.189 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.79 -134.38 7.83 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.168 -0.773 . . . . 7.5999999999999996 111.168 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.421 ' HD3' ' H ' ' A' ' 112' ' ' ALA . 83.7 Cg_endo -81.77 -177.11 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.169 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 69.87 17.95 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 7.6699999999999999 111.161 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.66 -24.09 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 7.7000000000000002 111.188 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.455 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 97.9 m95 -69.52 -14.95 63.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 7.7300000000000004 111.123 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.6 p -64.96 -20.95 66.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 7.7699999999999996 111.216 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.05 -28.56 8.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 7.7999999999999998 111.225 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.2 mt -64.85 -45.11 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 7.8300000000000001 111.254 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -74.55 -33.8 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 7.8700000000000001 111.198 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.7 m -64.14 -44.6 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 7.9000000000000004 111.234 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.9 p -78.18 -15.04 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 7.9299999999999997 111.235 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.63 45.97 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 7.9699999999999998 111.217 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.84 141.21 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 8.0 111.157 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -74.87 78.69 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 8.0299999999999994 111.209 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -89.96 127.65 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 8.0700000000000003 111.183 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.407 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -100.4 166.39 19.72 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.223 -0.751 . . . . 8.0999999999999996 111.223 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 88.5 t -139.6 134.98 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.773 0.32 . . . . 8.1300000000000008 111.253 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.2 t -135.06 150.17 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 8.1699999999999999 111.21 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.4 t -70.29 110.81 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 8.1999999999999993 111.16 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 53.0 tp -75.38 -47.82 4.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 8.2300000000000004 111.282 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 85.7 Cg_endo -78.41 143.2 19.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.764 1.642 . . . . 8.2699999999999996 111.228 -173.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 78.8 m -107.74 133.59 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 8.3000000000000007 111.182 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -108.46 99.71 9.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 8.3300000000000001 111.221 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 57.69 35.14 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 8.3699999999999992 111.12 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 98.6 -15.57 60.84 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.175 -0.77 . . . . 8.4000000000000004 111.175 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -130.06 110.0 16.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 8.4299999999999997 111.161 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.8 151.69 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.7 1.6 . . . . 8.4700000000000006 111.268 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 98.9 p -137.6 -75.01 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 8.5 111.201 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 326' ' ' LYS . 74.5 mmtt -134.07 163.35 51.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 8.5299999999999994 111.163 -174.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.97 144.47 56.5 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.721 1.614 . . . . 8.5700000000000003 111.173 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.41 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 86.3 t80 -73.81 140.59 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 8.5999999999999996 111.185 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 261' ' ' VAL . 61.6 t -107.1 106.76 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 8.6300000000000008 111.221 -170.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -84.93 85.08 1.58 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.169 -0.773 . . . . 8.6699999999999999 111.169 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 259' ' ' VAL . 36.9 t -68.18 142.35 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 8.6999999999999993 111.188 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 74.1 mt -91.87 154.9 18.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 8.7300000000000004 111.257 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 91.2 p -143.71 155.13 44.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 8.7699999999999996 111.199 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 60' ' ' ILE . . . -121.76 124.3 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 8.8000000000000007 111.245 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -103.97 177.29 24.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.177 -0.769 . . . . 8.8300000000000001 111.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 87.5 mt -124.14 132.0 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 8.8699999999999992 111.2 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -69.32 114.28 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.148 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.54 -24.72 66.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 8.9299999999999997 111.163 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 8.9700000000000006 111.217 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -66.06 136.74 95.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 9.0 111.235 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.79 -12.1 26.24 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.727 1.618 . . . . 9.0299999999999994 111.206 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.59 21.51 8.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 9.0700000000000003 111.201 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -62.78 -21.88 66.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 9.0999999999999996 111.174 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.36 -34.5 77.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 9.1300000000000008 111.194 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 9.1699999999999999 111.155 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . . . -65.03 -41.86 94.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 9.1999999999999993 111.168 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.75 -44.55 81.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 9.2300000000000004 111.234 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -80.11 -52.75 7.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 9.2699999999999996 111.227 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -63.8 -37.05 85.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 9.3000000000000007 111.224 -171.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 284' ' ' LEU . 40.1 tp -68.12 -48.16 66.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 9.3300000000000001 111.187 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -72.08 -28.98 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 9.3699999999999992 111.182 -173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -99.56 -40.2 7.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 9.4000000000000004 111.181 -166.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.17 -54.84 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 9.4299999999999997 111.15 -169.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 20' ' ' LEU . 95.1 mt -64.1 -49.59 71.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 9.4700000000000006 111.148 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.85 51.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 9.5 111.165 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 76.7 p -124.97 -175.94 3.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 9.5299999999999994 111.153 170.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -53.29 -40.56 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 9.5700000000000003 111.197 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.35 -37.95 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 9.5999999999999996 111.134 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.37 -43.24 93.09 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.99 -36.23 83.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 9.6699999999999999 111.231 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -69.04 -41.86 77.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 9.6999999999999993 111.204 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.26 87.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 9.7300000000000004 111.154 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 68.0 t -74.91 -40.83 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 9.7699999999999996 111.17 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.563 ' HB3' HD23 ' A' ' 299' ' ' LEU . 96.7 m-20 -75.93 -2.93 32.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 9.8000000000000007 111.203 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.05 -38.14 67.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 9.8300000000000001 111.195 165.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -108.5 -34.03 6.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 9.8699999999999992 111.158 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.03 160.63 40.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 9.9000000000000004 111.205 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.65 139.38 67.29 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.667 1.578 . . . . 9.9299999999999997 111.167 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 294' ' ' ASN . 95.0 mt -66.38 -24.19 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 9.9700000000000006 111.153 -175.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.77 -28.84 70.71 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.153 -0.779 . . . . 10.0 111.153 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.91 122.83 13.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.779 0.323 . . . . 10.029999999999999 111.228 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.85 136.6 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.16 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -103.36 -34.79 8.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 10.1 111.188 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.16 138.72 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 10.130000000000001 111.176 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -61.36 -39.04 89.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 10.17 111.222 168.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 44.6 t -56.05 -48.62 75.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 10.199999999999999 111.175 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.55 -37.71 83.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 10.23 111.224 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.67 -36.74 77.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 10.27 111.173 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.73 -30.03 70.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 10.300000000000001 111.248 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.4 -32.16 62.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 10.33 111.198 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.22 -26.18 62.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 10.369999999999999 111.226 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.88 -19.22 65.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 10.4 111.324 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.48 -24.93 67.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 10.43 111.221 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -101.92 109.99 61.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 10.470000000000001 111.205 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.97 -32.92 80.78 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.659 1.573 . . . . 10.5 111.188 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.55 -28.09 67.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 10.529999999999999 111.264 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -91.01 -38.5 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 10.57 111.218 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.02 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 10.6 111.254 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.48 -35.5 74.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 10.630000000000001 111.231 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.1 p -91.33 -19.95 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 10.67 111.211 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.0 mmt -74.21 -35.92 63.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 10.699999999999999 111.205 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.5 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 10.73 111.285 171.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.32 -42.75 99.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 10.77 111.2 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.42 93.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 10.800000000000001 111.21 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.05 -42.5 99.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 10.83 111.179 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.407 ' HB2' ' HG3' ' A' ' 256' ' ' LYS . 99.7 mttt -94.95 7.53 45.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 10.869999999999999 111.198 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.88 -162.66 35.9 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.268 -0.733 . . . . 10.9 111.268 172.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -119.8 132.38 55.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 10.93 111.213 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.17 136.22 25.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 10.970000000000001 111.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 50.0 tpp -59.93 114.41 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 11.0 111.247 173.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.31 133.74 51.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.678 1.585 . . . . 11.029999999999999 111.221 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 97' ' ' VAL . 42.5 t-20 -94.18 72.81 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 11.07 111.207 173.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 80.4 mt -123.15 116.11 28.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 11.1 111.185 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.06 -33.45 73.6 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.632 1.555 . . . . 11.130000000000001 111.26 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -71.46 -27.86 63.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 11.17 111.23 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -86.88 -20.62 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 11.199999999999999 111.157 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 98.2 p -64.15 -29.98 71.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.178 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.97 -49.51 70.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 11.27 111.247 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -56.76 -48.74 77.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 11.300000000000001 111.173 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -68.75 -43.58 75.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 11.33 111.176 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 -73.89 -30.55 62.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 11.369999999999999 111.259 -176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.65 75.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 11.4 111.188 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.28 -21.82 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 11.43 111.279 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -56.56 -48.93 76.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 11.470000000000001 111.186 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 71.0 p -65.2 -29.7 70.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 11.5 111.175 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.03 -44.22 89.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 11.529999999999999 111.173 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.77 -38.52 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.173 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.92 -42.69 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 11.6 111.208 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -65.0 -39.17 93.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 11.630000000000001 111.21 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.45 -21.96 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 11.67 111.206 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.52 -30.39 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 11.699999999999999 111.22 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.5 p -86.16 -22.16 27.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 11.73 111.181 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.85 30.35 26.56 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.233 -0.747 . . . . 11.77 111.233 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -109.94 2.61 19.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 11.800000000000001 111.238 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -159.58 137.01 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 11.83 111.212 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 62.1 p -70.0 164.97 22.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 11.869999999999999 111.255 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.5 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 11.9 111.233 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.19 -46.99 88.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 11.93 111.207 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.87 -37.53 79.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 11.970000000000001 111.191 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.69 92.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 12.0 111.214 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 94.5 mt -74.98 -24.89 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 12.029999999999999 111.18 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.71 -49.3 73.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 12.07 111.167 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.84 -34.21 77.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.208 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.01 -59.56 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 12.130000000000001 111.2 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -54.94 -43.25 73.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 12.17 111.209 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 83.7 m -58.15 -49.05 78.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 12.199999999999999 111.26 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.03 -30.0 67.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 12.23 111.232 -177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.6 mt -67.37 -40.74 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 12.27 111.136 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.8 p -89.22 -15.69 33.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 12.300000000000001 111.234 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.511 0 CA-C-N 116.171 -0.468 . . . . 12.33 111.217 178.149 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.823 0.344 . . . . 0.029999999999999999 111.196 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.15 134.98 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.070000000000000007 111.204 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -55.01 130.04 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.10000000000000001 111.226 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.27 129.44 40.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.13 111.194 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.62 27.94 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.258 -0.737 . . . . 0.17000000000000001 111.258 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.98 132.53 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.20000000000000001 111.252 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.71 120.02 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.23000000000000001 111.211 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.34 115.04 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.27000000000000002 111.212 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 37' ' ' VAL . 73.6 mt -115.05 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.29999999999999999 111.197 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -110.09 129.06 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.33000000000000002 111.194 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.0 mt -101.42 115.08 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.37 111.158 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -97.7 89.24 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.40000000000000002 111.225 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.5 -145.65 7.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.264 -0.735 . . . . 0.42999999999999999 111.264 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.47 22.77 8.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.46999999999999997 111.195 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -102.29 156.87 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.5 111.248 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.95 -164.98 38.01 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.185 -0.766 . . . . 0.53000000000000003 111.185 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -158.98 25.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.56999999999999995 111.215 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -59.68 -40.29 87.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.59999999999999998 111.187 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.07 -27.51 28.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.212 -0.755 . . . . 0.63 111.212 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.91 -40.51 95.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.67000000000000004 111.262 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.05 78.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.69999999999999996 111.178 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -65.0 -29.07 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.72999999999999998 111.227 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.5 t -72.66 -40.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.77000000000000002 111.188 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.87 82.18 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.234 -0.746 . . . . 0.80000000000000004 111.234 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.79 -36.88 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 111.175 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.53 -24.07 45.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.87 111.239 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.02 -32.68 70.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.90000000000000002 111.157 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -74.8 -36.95 62.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.93000000000000005 111.202 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.31 -46.06 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.96999999999999997 111.188 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.54 -58.79 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.163 -170.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -89.45 -49.27 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 1.03 111.2 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.49 21.4 3.03 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.205 -0.758 . . . . 1.0700000000000001 111.205 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.29 114.99 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 1.1000000000000001 111.191 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.25 110.08 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 1.1299999999999999 111.169 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.2 t -97.91 121.49 48.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 1.1699999999999999 111.119 -174.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.0 m -117.97 121.03 39.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.2 111.266 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 9' ' ' ILE . 46.9 t -107.36 125.38 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 1.23 111.207 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.99 172.04 12.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 1.27 111.237 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.445 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 37.2 t60 -139.97 52.73 3.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 1.3 111.168 -174.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 72.8 Cg_endo -72.01 152.67 57.42 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.649 1.566 . . . . 1.3300000000000001 111.26 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -101.92 -177.04 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.433 . . . . 1.3700000000000001 111.217 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 53.12 46.1 27.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 1.3999999999999999 111.233 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 90.3 mt -93.84 -37.75 11.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 1.4299999999999999 111.176 -174.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 pm0 -69.66 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 1.47 111.218 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -89.48 -19.58 24.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 1.5 111.19 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -110.19 -25.14 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 1.53 111.232 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.2 m-30 -58.51 -45.14 99.69 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 1.5700000000000001 111.22 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 64.8 Cg_exo -55.48 -30.96 76.16 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.656 1.57 . . . . 1.6000000000000001 111.247 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.02 -43.74 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.191 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -75.63 -23.32 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.6699999999999999 111.147 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -24.47 66.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 1.7 111.205 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.75 -8.05 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 1.73 111.167 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.0 p -114.01 -11.93 12.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 1.77 111.23 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.3 25.51 30.84 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.231 -0.748 . . . . 1.8 111.231 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -114.81 170.71 8.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 1.8300000000000001 111.244 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.48 -174.4 16.6 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.202 -0.759 . . . . 1.8700000000000001 111.202 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -74.87 -176.39 2.82 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.757 1.638 . . . . 1.8999999999999999 111.155 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -104.18 -48.12 3.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 1.9299999999999999 111.181 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -112.4 133.16 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 1.97 111.174 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.8 mt -131.2 129.78 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 2.0 111.152 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -85.93 142.89 28.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 2.0299999999999998 111.195 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 98.4 m95 -141.21 163.95 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 2.0699999999999998 111.231 174.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.46 166.22 11.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 2.1000000000000001 111.167 164.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -61.29 -30.28 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 2.1299999999999999 111.178 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -82.07 -0.86 46.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 2.1699999999999999 111.244 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.4 -25.06 7.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 2.2000000000000002 111.179 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 62' ' ' TRP . 8.8 m-85 -58.63 -43.18 89.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 2.23 111.186 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.97 -48.24 87.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 2.27 111.204 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.88 -38.03 42.71 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.192 -0.763 . . . . 2.2999999999999998 111.192 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -69.92 -37.4 75.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 2.3300000000000001 111.192 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.85 -36.17 64.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 2.3700000000000001 111.201 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.14 -42.44 85.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 2.3999999999999999 111.195 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.7 p -71.13 -14.98 62.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 2.4300000000000002 111.12 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.17 32.21 23.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.254 -0.738 . . . . 2.4700000000000002 111.254 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.14 -6.65 25.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.842 0.353 . . . . 2.5 111.188 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 tp -114.9 133.82 55.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 2.5299999999999998 111.229 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.92 146.84 37.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 2.5699999999999998 111.218 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.57 129.27 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 2.6000000000000001 111.257 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -121.02 133.45 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 2.6299999999999999 111.179 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -120.83 101.5 45.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 2.6699999999999999 111.235 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.36 147.44 32.62 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 121.692 1.595 . . . . 2.7000000000000002 111.176 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.99 148.97 38.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 2.73 111.194 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -53.45 -47.64 69.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 2.77 111.187 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 2.7999999999999998 111.191 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.15 -51.32 64.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 2.8300000000000001 111.175 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.9 -19.94 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 2.8700000000000001 111.185 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.46 -34.96 68.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 2.8999999999999999 111.149 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.56 -22.47 56.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 2.9300000000000002 111.222 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.72 154.93 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 2.9700000000000002 111.164 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.03 136.11 87.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 3.0 111.184 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.03 -14.96 23.54 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.676 1.584 . . . . 3.0299999999999998 111.227 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -80.37 -31.78 37.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 3.0699999999999998 111.191 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.4 p -96.03 -23.17 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 3.1000000000000001 111.201 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -62.51 -40.06 95.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 3.1299999999999999 111.199 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.6 -8.22 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 3.1699999999999999 111.235 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.36 -3.71 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 3.2000000000000002 111.232 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.5 66.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 3.23 111.226 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -129.76 154.98 46.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 3.27 111.179 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -153.1 129.9 10.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.205 -0.452 . . . . 3.2999999999999998 111.214 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 t30 62.62 29.85 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 3.3300000000000001 111.202 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.23 88.34 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.166 -0.774 . . . . 3.3700000000000001 111.166 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.55 145.55 47.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.766 0.317 . . . . 3.3999999999999999 111.18 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -71.37 137.52 48.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 3.4300000000000002 111.198 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.2 pt -123.94 -2.58 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 3.4700000000000002 111.224 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.6 168.87 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 3.5 111.211 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -109.52 129.15 24.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 3.5299999999999998 111.243 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.32 133.06 20.29 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.683 1.589 . . . . 3.5699999999999998 111.185 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.6 mt -113.23 -63.43 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 3.6000000000000001 111.192 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.39 149.87 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 3.6299999999999999 111.25 -172.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.13 157.04 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 3.6699999999999999 111.222 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -115.49 151.09 35.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 3.7000000000000002 111.217 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.21 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 3.73 111.195 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -127.49 172.48 10.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 3.77 111.204 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.9 p -138.71 150.32 46.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 3.7999999999999998 111.11 -172.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tt -94.25 106.42 18.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 3.8300000000000001 111.191 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 81.7 mt -92.18 125.14 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 3.8700000000000001 111.178 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.38 158.54 43.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 3.8999999999999999 111.202 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -84.93 99.94 11.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 3.9300000000000002 111.187 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -56.01 -47.83 77.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 3.9700000000000002 111.128 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.72 -52.19 65.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 4.0 111.217 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.93 -60.11 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 4.0300000000000002 111.214 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.45 87.64 51.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 4.0700000000000003 111.237 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.27 -14.71 25.55 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.681 1.587 . . . . 4.0999999999999996 111.173 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -90.53 110.05 38.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 4.1299999999999999 111.184 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.53 157.65 25.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.661 1.574 . . . . 4.1699999999999999 111.183 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.01 141.06 79.9 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.692 1.595 . . . . 4.2000000000000002 111.153 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.91 -18.7 36.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 4.2300000000000004 111.216 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 130' ' ' GLU . 14.6 t -157.67 -178.28 7.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 4.2699999999999996 111.182 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -65.65 -35.67 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 4.2999999999999998 111.215 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.411 ' H ' HG23 ' A' ' 128' ' ' THR . 98.3 mt-10 -74.24 -6.58 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 4.3300000000000001 111.2 -174.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -104.63 9.94 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 4.3700000000000001 111.174 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.558 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 88.7 mt -71.47 -41.62 10.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 4.4000000000000004 111.15 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 84.2 Cg_exo -52.53 -30.52 45.02 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.715 1.61 . . . . 4.4299999999999997 111.153 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.75 -37.05 67.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 4.4699999999999998 111.205 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -67.23 -47.88 69.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 4.5 111.194 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.13 -29.33 70.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 4.5300000000000002 111.223 -171.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.9 -44.95 64.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 4.5700000000000003 111.158 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -94.01 -30.93 14.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 4.5999999999999996 111.139 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.96 -27.8 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.202 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.42 -41.62 63.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 4.6699999999999999 111.214 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.18 -5.74 59.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 4.7000000000000002 111.225 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.74 12.34 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 4.7300000000000004 111.175 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.08 24.9 70.3 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -140.2 179.78 6.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 4.7999999999999998 111.134 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -151.38 138.05 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 4.8300000000000001 111.175 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.43 -60.61 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.141 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.7 tp -135.96 119.54 17.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 4.9000000000000004 111.221 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mtm -115.48 101.51 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 4.9299999999999997 111.174 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -110.06 135.84 50.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 4.9699999999999998 111.203 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -59.99 113.97 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 5.0 111.194 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.78 -24.84 63.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 5.0300000000000002 111.245 -169.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -100.84 -39.61 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 5.0700000000000003 111.22 -171.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 155' ' ' TYR . 87.8 tt0 -78.71 128.32 77.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 5.0999999999999996 111.217 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -73.21 -20.2 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.738 1.626 . . . . 5.1299999999999999 111.149 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.406 ' H ' ' HG2' ' A' ' 153' ' ' GLU . 74.0 t80 -54.48 -43.24 71.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 5.1699999999999999 111.131 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -79.9 -19.99 46.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 5.2000000000000002 111.234 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 64.8 p -99.35 -5.54 29.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 5.2300000000000004 111.221 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.61 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 83.1 t90 -62.24 -45.42 90.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 5.2699999999999996 111.255 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 40.7 Cg_exo -61.29 -38.54 64.59 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.731 1.621 . . . . 5.2999999999999998 111.167 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.74 -60.02 4.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 5.3300000000000001 111.201 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 167' ' ' TYR . 20.8 tt -70.18 -22.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 5.3700000000000001 111.181 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -88.78 -4.07 58.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 5.4000000000000004 111.205 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -113.1 -10.47 13.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.214 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -95.57 -31.46 13.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 5.4699999999999998 111.188 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.6 33.35 2.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 5.5 111.223 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.64 11.35 23.4 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.443 ' HB2' HG23 ' A' ' 161' ' ' ILE . 84.1 t80 -131.84 109.77 10.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 5.5700000000000003 111.187 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 63.62 33.18 13.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 5.5999999999999996 111.234 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -124.96 95.3 4.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 5.6299999999999999 111.205 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -51.7 125.03 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.6699999999999999 111.141 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -93.68 126.85 39.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 5.7000000000000002 111.242 -172.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 78.5 tt0 -140.01 73.01 1.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 5.7300000000000004 111.21 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 77.7 m-20 80.3 -65.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 5.7699999999999996 111.165 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.02 15.0 1.93 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.18 -0.768 . . . . 5.7999999999999998 111.18 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -92.19 144.66 25.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.82 0.343 . . . . 5.8300000000000001 111.198 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.85 73.83 1.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 5.8700000000000001 111.187 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -90.07 161.55 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 5.9000000000000004 111.264 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.4 pt -114.97 29.64 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 5.9299999999999997 111.191 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.57 -59.96 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 5.9699999999999998 111.203 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -90.32 169.96 10.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 6.0 111.184 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 183' ' ' VAL . 97.0 t -88.82 139.85 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 6.0300000000000002 111.217 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.33 24.07 15.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.17 -0.772 . . . . 6.0700000000000003 111.17 -169.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 181' ' ' VAL . 7.8 p -65.55 -20.81 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 6.0999999999999996 111.23 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -105.36 23.1 14.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 6.1299999999999999 111.235 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -95.58 136.79 35.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 6.1699999999999999 111.179 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.74 -27.83 63.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 6.2000000000000002 111.209 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.77 -31.6 81.43 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.129 -0.788 . . . . 6.2300000000000004 111.129 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -45.09 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 6.2699999999999996 111.18 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -66.18 -40.97 90.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 6.2999999999999998 111.177 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.99 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.285 -0.416 . . . . 6.3300000000000001 111.165 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.24 -41.22 92.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 6.3700000000000001 111.218 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 30.2 tp -69.69 -36.18 75.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 6.4000000000000004 111.138 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.8 m -62.86 -41.68 99.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 6.4299999999999997 111.233 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.23 -44.52 95.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.193 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.7 tp -56.85 -41.32 77.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 6.5 111.136 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 199' ' ' ILE . 54.1 t -70.34 -34.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 6.5300000000000002 111.205 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.9 -34.3 77.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 6.5700000000000003 111.192 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.66 -23.35 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.5999999999999996 111.198 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 196' ' ' VAL . 92.9 mt -78.85 -49.78 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 6.6299999999999999 111.151 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.67 -25.35 53.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 6.6699999999999999 111.129 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -94.65 10.77 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 6.7000000000000002 111.25 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 59.98 52.47 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 6.7300000000000004 111.194 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -107.17 -29.84 9.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.236 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 19.0 ptp -155.13 164.95 38.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 6.7999999999999998 111.198 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -145.0 -169.96 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 6.8300000000000001 111.171 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.1 82.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 6.8700000000000001 111.184 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.22 -37.86 86.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 6.9000000000000004 111.239 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.2 m -53.88 109.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.217 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -147.19 -164.34 1.98 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.257 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -50.64 -42.6 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 7.0 111.199 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.3 p -66.84 -18.27 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 7.0300000000000002 111.21 -169.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -103.35 -54.91 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 7.0700000000000003 111.194 176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.0 -61.7 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 7.0999999999999996 111.213 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -92.75 -53.63 4.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 7.1299999999999999 111.266 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.04 -52.4 49.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 7.1699999999999999 111.217 -167.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.66 95.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 7.2000000000000002 111.171 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.06 -51.08 70.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 7.2300000000000004 111.216 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.02 -32.08 73.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 7.2699999999999996 111.176 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -63.55 -43.78 96.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 7.2999999999999998 111.226 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 122.31 19.38 3.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.193 -0.763 . . . . 7.3300000000000001 111.193 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 7.3700000000000001 111.234 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.7 m -113.38 124.99 53.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 7.4000000000000004 111.198 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.63 76.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 7.4299999999999997 111.181 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -167.83 144.98 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 7.4699999999999998 111.253 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.3 t -155.96 163.79 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 7.5 111.226 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.55 130.3 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 7.5300000000000002 111.135 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -156.96 173.78 16.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 7.5700000000000003 111.229 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.0 -61.21 7.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.179 -0.769 . . . . 7.5999999999999996 111.179 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.94 144.96 98.79 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.219 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -79.61 156.53 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 7.6699999999999999 111.191 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.2 13.65 30.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 7.7000000000000002 111.183 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -62.81 -32.07 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 7.7300000000000004 111.237 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.7 p -87.61 -9.84 53.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 7.7699999999999996 111.172 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -95.42 0.99 53.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 7.7999999999999998 111.185 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 242' ' ' TYR . 83.7 mt -69.19 -55.22 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 7.8300000000000001 111.201 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.78 -24.13 62.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 7.8700000000000001 111.178 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.0 m -65.03 -46.94 79.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 7.9000000000000004 111.216 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 69.0 m -100.01 -2.65 33.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 7.9299999999999997 111.191 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.04 34.91 13.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 7.9699999999999998 111.211 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.97 135.96 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 8.0 111.206 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.13 122.55 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 8.0299999999999994 111.2 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.41 ' H ' HG12 ' A' ' 235' ' ' ILE . 76.0 m-85 -118.35 146.34 44.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 8.0700000000000003 111.176 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -110.91 157.31 15.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.212 -0.755 . . . . 8.0999999999999996 111.212 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.72 130.03 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 8.1300000000000008 111.174 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -141.98 -169.96 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 8.1699999999999999 111.145 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 98.6 t -93.02 118.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 8.1999999999999993 111.169 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.574 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 49.9 tp -90.25 -45.0 0.4 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 8.2300000000000004 111.133 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 74.2 Cg_exo -55.28 128.1 29.06 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.706 1.604 . . . . 8.2699999999999996 111.179 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.2 m -138.88 126.6 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 8.3000000000000007 111.184 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.85 127.37 44.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 8.3300000000000001 111.197 -175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 86.3 tttt 44.62 45.14 7.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 8.3699999999999992 111.184 -170.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.04 78.78 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -130.0 109.93 16.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 8.4299999999999997 111.233 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.11 137.09 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.728 1.619 . . . . 8.4700000000000006 111.184 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 62.8 p -154.94 -75.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 8.5 111.241 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 323' ' ' ASN . 48.7 tttp -159.95 138.51 7.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 8.5299999999999994 111.171 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' A' ' 248' ' ' PRO . 63.3 Cg_endo -74.25 168.6 24.42 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.227 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 330' ' ' MET . 16.5 t80 -54.94 116.87 2.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 8.5999999999999996 111.177 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.54 104.32 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 8.6300000000000008 111.192 -163.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.39 140.03 21.59 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.196 -0.762 . . . . 8.6699999999999999 111.196 164.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.35 108.31 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.311 . . . . 8.6999999999999993 111.193 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 51.1 tp -57.31 120.36 8.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 8.7300000000000004 111.167 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.8 m -138.29 153.54 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 8.7699999999999996 111.172 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.59 137.9 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 8.8000000000000007 111.207 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.97 -174.48 14.98 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.227 -0.749 . . . . 8.8300000000000001 111.227 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.0 mt -111.88 128.64 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 8.8699999999999992 111.191 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -57.81 123.09 14.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.251 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 8.9299999999999997 111.196 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.13 54.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 8.9700000000000006 111.272 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.99 127.98 93.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 9.0 111.206 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.7 -4.1 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.717 1.612 . . . . 9.0299999999999994 111.225 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -110.06 30.79 6.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 9.0700000000000003 111.145 -171.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -51.95 -36.71 50.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 9.0999999999999996 111.183 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.26 -49.64 75.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 9.1300000000000008 111.188 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.16 -43.3 95.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 9.1699999999999999 111.195 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 9.1999999999999993 111.131 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -68.3 -42.27 79.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 9.2300000000000004 111.154 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -56.89 -49.53 75.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 9.2699999999999996 111.209 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -57.54 -59.94 4.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 9.3000000000000007 111.179 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.81 -38.8 82.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 9.3300000000000001 111.194 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.94 -43.84 10.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 9.3699999999999992 111.218 -168.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -103.51 -6.18 22.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 9.4000000000000004 111.224 -166.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.94 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 9.4299999999999997 111.194 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.67 -60.55 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 9.4700000000000006 111.169 -166.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.17 64.9 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 9.5 111.164 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 24.5 p -130.05 -179.99 5.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 9.5299999999999994 111.275 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.96 -27.01 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 9.5700000000000003 111.158 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -92.93 -39.89 10.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 9.5999999999999996 111.173 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -64.78 -46.77 88.71 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.196 -0.762 . . . . 9.6300000000000008 111.196 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.02 -15.5 60.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 9.6699999999999999 111.202 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -65.49 -38.4 89.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 9.6999999999999993 111.201 169.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.31 37.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 9.7300000000000004 111.217 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.19 -45.45 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 9.7699999999999996 111.166 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -87.56 10.5 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 9.8000000000000007 111.235 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.59 -42.98 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 9.8300000000000001 111.193 165.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -95.61 -32.44 12.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 9.8699999999999992 111.168 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.17 158.69 43.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 9.9000000000000004 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.08 130.02 36.09 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.747 1.631 . . . . 9.9299999999999997 111.18 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 78.1 mt -58.24 -41.89 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 9.9700000000000006 111.25 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.46 -20.25 67.53 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.214 -0.754 . . . . 10.0 111.214 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.85 75.26 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 10.029999999999999 111.236 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.07 150.67 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.177 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.66 -8.96 21.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 10.1 111.237 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.403 HD23 ' HB2' ' A' ' 307' ' ' TYR . 31.6 tp -81.77 119.99 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 10.130000000000001 111.145 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -68.83 -39.47 79.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 10.17 111.227 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.0 t -51.35 -49.53 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 10.199999999999999 111.236 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.403 ' HB2' HD23 ' A' ' 304' ' ' LEU . 60.2 t80 -70.49 -40.29 73.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 10.23 111.172 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -52.41 -39.55 61.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 10.27 111.225 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.88 -30.11 71.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 10.300000000000001 111.246 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -71.59 -34.77 70.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.33 111.192 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.79 -18.31 61.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 10.369999999999999 111.202 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.62 -18.59 62.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 10.4 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -27.2 66.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 10.43 111.176 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -100.19 110.05 58.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.243 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -55.38 -31.16 76.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.645 1.563 . . . . 10.5 111.244 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 10.529999999999999 111.211 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.33 -44.81 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 10.57 111.198 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.48 -31.76 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 10.6 111.242 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.28 73.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 10.630000000000001 111.174 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.0 p -93.09 -20.19 20.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 10.67 111.232 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.3 mmt -71.64 -31.04 66.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 10.699999999999999 111.245 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.71 -44.94 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 10.73 111.176 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . 90.5 m-20 -73.06 -26.19 61.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.77 111.146 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.3 90.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 10.800000000000001 111.2 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.06 -34.91 64.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 10.83 111.092 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -94.97 0.13 54.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 10.869999999999999 111.187 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.61 -164.78 40.39 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.192 -0.763 . . . . 10.9 111.192 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -124.03 138.04 54.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 10.93 111.217 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.0 mm -102.83 135.26 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 10.970000000000001 111.178 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 258' ' ' PHE . 28.6 ttt -70.13 116.24 42.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 11.0 111.141 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.13 159.23 37.4 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 11.029999999999999 111.185 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -105.83 50.01 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.489 . . . . 11.07 111.209 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 86.4 mt -85.9 124.95 70.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 11.1 111.239 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.06 -29.32 22.6 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.709 1.606 . . . . 11.130000000000001 111.248 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -69.09 -37.24 78.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 11.17 111.166 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 89.9 mtp -79.75 -27.82 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 11.199999999999999 111.223 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -57.82 -49.74 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 11.23 111.166 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.6 82.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 11.27 111.18 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -68.26 -36.77 79.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 11.300000000000001 111.196 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -68.96 -32.48 72.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 11.33 111.195 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -61.92 -41.25 97.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 11.369999999999999 111.254 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.37 90.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 11.4 111.188 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.16 -40.09 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 11.43 111.154 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -64.31 -32.49 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 11.470000000000001 111.244 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.9 m -75.32 -39.86 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.193 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.98 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.223 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.84 -16.34 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.243 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.12 -28.74 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 11.6 111.138 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.45 -29.81 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 11.630000000000001 111.191 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -88.36 -32.29 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 11.67 111.194 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.07 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 11.699999999999999 111.151 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.9 p -75.75 -16.25 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 11.73 111.15 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.95 10.06 79.48 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.202 -0.759 . . . . 11.77 111.202 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -81.6 -49.66 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 11.800000000000001 111.268 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -110.75 169.61 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 11.83 111.198 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.0 p -85.74 175.18 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 11.869999999999999 111.224 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.1 m -69.35 -14.56 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 11.9 111.215 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -95.03 -42.62 8.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 11.93 111.205 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -75.32 -35.2 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 11.970000000000001 111.16 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.95 94.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 12.0 111.193 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.03 -39.22 69.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 12.029999999999999 111.242 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -51.83 -38.89 57.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 12.07 111.185 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -49.97 -43.0 49.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.176 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.54 -35.46 27.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 12.130000000000001 111.247 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.05 -31.02 69.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 12.17 111.154 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.4 m -52.08 -38.8 58.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 12.199999999999999 111.188 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -102.6 -35.53 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 12.23 111.142 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.05 -47.16 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 12.27 111.172 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.4 p -109.63 -31.94 7.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 12.300000000000001 111.207 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.2 -1.516 0 CA-C-N 116.172 -0.467 . . . . 12.33 111.172 177.146 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.774 0.321 . . . . 0.029999999999999999 111.214 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.3 mt -78.58 126.99 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.070000000000000007 111.22 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -67.63 142.26 56.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.10000000000000001 111.184 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.72 138.58 31.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.13 111.127 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.25 28.01 9.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.182 -0.767 . . . . 0.17000000000000001 111.182 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -146.57 145.42 30.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 0.20000000000000001 111.216 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.8 mt -111.98 98.34 7.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.23000000000000001 111.255 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.91 112.04 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.27000000000000002 111.141 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -105.89 122.35 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.29999999999999999 111.209 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -109.9 129.98 55.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.33000000000000002 111.23 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 11' ' ' ILE . 18.6 tt -149.53 123.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.37 111.222 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.02 150.01 22.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.40000000000000002 111.198 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.42 172.02 38.12 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.221 -0.752 . . . . 0.42999999999999999 111.221 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -79.87 76.88 6.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.831 0.348 . . . . 0.46999999999999997 111.224 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -103.76 179.96 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.5 111.129 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.07 63.93 4.4 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.222 -0.751 . . . . 0.53000000000000003 111.222 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -68.4 -24.11 64.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.56999999999999995 111.182 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -70.07 -49.94 46.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.59999999999999998 111.224 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.56 96.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.63 111.224 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.5 tp -69.7 -31.73 69.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.67000000000000004 111.16 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.73 72.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.183 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -63.19 -42.55 99.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.72999999999999998 111.16 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.63 -21.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.77000000000000002 111.232 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.81 68.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.19 -0.764 . . . . 0.80000000000000004 111.19 171.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -67.37 -42.61 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.745 0.307 . . . . 0.82999999999999996 111.165 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.39 -48.56 79.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.87 111.169 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.63 -44.25 85.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.90000000000000002 111.147 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.2 -37.44 87.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.93000000000000005 111.227 -176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -75.09 -34.99 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.96999999999999997 111.233 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -70.75 -39.51 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 1.0 111.218 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.6 p -110.51 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 1.03 111.202 -170.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 5.45 75.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.229 -0.749 . . . . 1.0700000000000001 111.229 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.89 119.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 1.1000000000000001 111.199 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -64.95 123.93 20.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 1.1299999999999999 111.243 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.72 125.03 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 1.1699999999999999 111.181 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.5 m -130.38 136.33 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 1.2 111.17 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.4 t -113.79 124.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 1.23 111.171 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.86 158.62 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 1.27 111.197 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -114.3 86.49 12.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 1.3 111.154 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.25 178.11 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.697 1.598 . . . . 1.3300000000000001 111.23 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -146.96 174.78 11.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 1.3700000000000001 111.228 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 53.19 37.84 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 1.3999999999999999 111.185 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.09 -24.94 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.442 . . . . 1.4299999999999999 111.182 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.26 -12.55 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 1.47 111.182 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -110.04 -23.06 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 1.5 111.213 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -92.92 -38.81 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.53 111.168 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.6 m-30 -59.97 -46.41 98.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 1.5700000000000001 111.202 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 79.5 Cg_exo -51.75 -36.06 60.67 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.685 1.59 . . . . 1.6000000000000001 111.228 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -75.7 -48.43 21.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 47' ' ' PHE . 25.9 m -74.56 -18.38 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 1.6699999999999999 111.208 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.06 -30.59 71.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 1.7 111.175 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.67 -12.16 57.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.187 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.9 p -114.04 -14.94 12.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.77 111.167 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.92 39.7 16.2 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 1.8 111.215 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -113.23 -168.42 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 1.8300000000000001 111.196 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.48 -169.23 13.12 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.214 -0.754 . . . . 1.8700000000000001 111.214 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.86 -170.15 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.701 1.601 . . . . 1.8999999999999999 111.222 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -103.13 -38.59 7.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 1.9299999999999999 111.158 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -122.2 132.9 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 1.97 111.177 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -125.1 120.78 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 2.0 111.192 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -85.07 146.12 27.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 2.0299999999999998 111.177 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -159.92 158.4 30.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 2.0699999999999998 111.171 173.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.94 174.27 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 2.1000000000000001 111.218 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -58.06 -32.93 68.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.232 -0.44 . . . . 2.1299999999999999 111.199 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -91.56 6.67 44.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 2.1699999999999999 111.219 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -114.64 -20.02 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 2.2000000000000002 111.161 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.34 -50.82 71.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 2.23 111.192 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -46.77 75.89 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.765 . . . . 2.27 111.186 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.89 95.05 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.171 -0.771 . . . . 2.2999999999999998 111.171 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -78.89 -24.88 43.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 2.3300000000000001 111.199 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.62 -23.16 31.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 2.3700000000000001 111.242 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -62.59 -33.71 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 2.3999999999999999 111.19 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -69.22 -28.75 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 2.4300000000000002 111.15 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.99 51.32 7.76 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.22 -0.752 . . . . 2.4700000000000002 111.22 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 75' ' ' LEU . 3.8 pp -132.03 20.05 4.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 2.5 111.221 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.88 134.29 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 2.5299999999999998 111.195 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.51 158.9 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 2.5699999999999998 111.24 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -89.62 159.25 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 2.6000000000000001 111.255 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.1 mt -130.07 137.85 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 2.6299999999999999 111.15 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.5 m -95.11 114.99 64.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.6699999999999999 111.235 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.6 155.14 27.6 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.151 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -90.03 169.98 10.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 2.73 111.197 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.11 -59.91 2.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 2.77 111.255 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.96 78.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 2.7999999999999998 111.165 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -54.87 -50.34 68.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.442 . . . . 2.8300000000000001 111.207 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -57.54 -43.86 84.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 2.8700000000000001 111.147 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.03 -34.98 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 2.8999999999999999 111.162 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -79.55 -21.87 44.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 2.9300000000000002 111.153 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.416 HD23 HD23 ' A' ' 304' ' ' LEU . 90.9 mt -88.09 151.42 22.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.9700000000000002 111.188 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -67.56 156.66 88.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 3.0 111.196 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.19 3.0 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.7 1.6 . . . . 3.0299999999999998 111.167 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -122.6 10.63 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.175 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.4 p -119.52 -35.43 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 3.1000000000000001 111.247 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -70.12 -40.0 75.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 3.1299999999999999 111.139 173.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -77.85 -30.98 51.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 3.1699999999999999 111.183 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.37 65.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 3.2000000000000002 111.168 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.21 20.98 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 3.23 111.142 -172.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 44.1 mtm105 -95.21 170.38 9.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 3.27 111.18 172.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -160.42 119.61 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 3.2999999999999998 111.215 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.1 t30 60.64 34.24 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 3.3300000000000001 111.217 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.98 7.7 83.4 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.262 -0.735 . . . . 3.3700000000000001 111.262 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -131.22 130.01 42.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 3.3999999999999999 111.269 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.1 tt -70.02 129.99 40.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 3.4300000000000002 111.212 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -113.93 -25.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 3.4700000000000002 111.223 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.85 165.85 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 3.5 111.199 -171.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -111.0 140.81 23.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 3.5299999999999998 111.193 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.14 -179.77 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.678 1.585 . . . . 3.5699999999999998 111.19 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.0 tp -165.06 -21.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 3.6000000000000001 111.15 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.33 145.55 23.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 3.6299999999999999 111.188 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.52 125.73 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 111.208 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -114.93 154.98 27.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 3.7000000000000002 111.218 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.02 175.91 9.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 3.73 111.188 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 113' ' ' LEU . 1.7 pp -143.21 146.54 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 3.77 111.173 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -168.36 179.97 4.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 3.7999999999999998 111.251 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.525 ' HB2' HD22 ' A' ' 247' ' ' LEU . 55.0 tp -95.41 112.2 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 3.8300000000000001 111.206 -174.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 tt -114.21 137.28 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 3.8700000000000001 111.236 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.59 150.52 46.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 3.8999999999999999 111.174 -172.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -85.83 120.27 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 3.9300000000000002 111.264 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.85 -35.09 67.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 3.9700000000000002 111.176 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.65 -33.94 77.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 4.0 111.188 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.02 -48.63 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.111 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.7 tp -154.98 111.12 2.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 4.0700000000000003 111.219 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.99 -17.67 19.39 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.697 1.598 . . . . 4.0999999999999996 111.197 -172.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -56.46 114.07 7.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 4.1299999999999999 111.217 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.7 134.81 15.41 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.71 1.606 . . . . 4.1699999999999999 111.218 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.511 ' HG3' ' SD ' ' A' ' 224' ' ' MET . 79.5 Cg_endo -77.61 140.59 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.753 1.636 . . . . 4.2000000000000002 111.171 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -100.14 -45.01 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 4.2300000000000004 111.239 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 t -158.41 -178.64 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.161 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -62.38 -38.33 89.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 4.2999999999999998 111.165 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.01 -15.45 62.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 4.3300000000000001 111.216 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -89.06 -14.31 36.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 4.3700000000000001 111.212 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.59 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.3 mt -67.54 -44.93 46.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 4.4000000000000004 111.205 -172.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 54.3 Cg_exo -55.07 -37.74 93.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.674 1.583 . . . . 4.4299999999999997 111.171 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.95 -36.88 72.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 4.4699999999999998 111.222 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.93 -32.92 74.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 4.5 111.193 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -56.38 -36.27 68.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 4.5300000000000002 111.249 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.88 -30.52 71.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 4.5700000000000003 111.153 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.2 -24.58 32.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 4.5999999999999996 111.146 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 -3.28 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 4.6299999999999999 111.198 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.22 -29.06 70.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 4.6699999999999999 111.221 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.94 79.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 4.7000000000000002 111.183 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -107.85 -9.94 15.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 4.7300000000000004 111.218 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.4 40.47 33.04 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.216 -0.754 . . . . 4.7699999999999996 111.216 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -111.62 155.3 23.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.313 . . . . 4.7999999999999998 111.225 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 t -99.71 141.44 32.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 4.8300000000000001 111.235 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.476 ' HB1' ' HE2' ' A' ' 224' ' ' MET . . . -85.93 -6.78 59.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 4.8700000000000001 111.204 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 198' ' ' LEU . 31.0 tp -165.37 133.41 3.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 4.9000000000000004 111.226 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 26.0 ttt -156.73 134.53 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 4.9299999999999997 111.189 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -129.03 -176.93 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 4.9699999999999998 111.183 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -84.75 120.32 26.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 5.0 111.276 168.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 tp -52.56 -38.9 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 5.0300000000000002 111.191 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -122.44 39.3 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 5.0700000000000003 111.225 -165.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -146.71 118.31 4.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 5.0999999999999996 111.175 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.09 -26.6 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.677 1.585 . . . . 5.1299999999999999 111.226 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -56.7 -41.07 76.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 5.1699999999999999 111.155 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 5.2000000000000002 111.225 -174.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.1 p -98.87 -6.31 29.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 5.2300000000000004 111.174 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.565 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.6 t90 -68.49 -43.76 32.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 5.2699999999999996 111.179 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 63.9 Cg_exo -55.76 -31.67 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.702 1.601 . . . . 5.2999999999999998 111.157 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 65.6 tp -61.73 -59.94 4.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 5.3300000000000001 111.238 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.51 -25.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.3700000000000001 111.202 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.24 67.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 5.4000000000000004 111.211 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.03 77.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 5.4299999999999997 111.211 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -78.01 -29.96 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 5.4699999999999998 111.186 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 92.41 50.0 2.67 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.167 -0.773 . . . . 5.5 111.167 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -55.87 -59.47 10.54 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 5.5300000000000002 111.204 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 50.4 p90 -112.58 169.84 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 5.5700000000000003 111.233 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 65.15 20.27 11.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 5.5999999999999996 111.222 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.97 150.04 43.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 5.6299999999999999 111.195 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -135.92 83.38 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 5.6699999999999999 111.236 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -54.93 107.95 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 5.7000000000000002 111.184 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -149.94 92.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 5.7300000000000004 111.222 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 58.05 35.0 24.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 5.7699999999999996 111.249 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.36 -2.26 77.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.197 -0.761 . . . . 5.7999999999999998 111.197 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -99.97 154.42 18.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 5.8300000000000001 111.162 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -142.05 156.98 45.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 5.8700000000000001 111.171 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -152.49 120.58 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 5.9000000000000004 111.195 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.2 pt -75.2 -16.94 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 5.9299999999999997 111.215 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.73 -26.67 54.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 5.9699999999999998 111.211 -172.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.29 170.21 11.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 6.0 111.195 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -72.64 125.41 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 6.0300000000000002 111.181 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.59 60.4 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.175 -0.77 . . . . 6.0700000000000003 111.175 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.64 -37.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 6.0999999999999996 111.204 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -85.12 -3.57 58.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.238 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -71.35 155.59 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 6.1699999999999999 111.248 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.34 -33.66 67.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 6.2000000000000002 111.221 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.63 -27.26 73.12 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.213 -0.755 . . . . 6.2300000000000004 111.213 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.1 78.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.718 0.294 . . . . 6.2699999999999996 111.197 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.33 -43.05 95.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 6.2999999999999998 111.24 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.24 93.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 6.3300000000000001 111.145 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.92 97.44 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.212 -0.755 . . . . 6.3700000000000001 111.212 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.56 -29.64 61.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 6.4000000000000004 111.214 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 69.9 m -61.96 -44.33 96.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 6.4299999999999997 111.158 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -64.99 -37.45 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 6.4699999999999998 111.195 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.17 -46.86 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 6.5 111.193 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.25 -39.81 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 6.5300000000000002 111.248 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.37 -31.47 72.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 6.5700000000000003 111.198 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.402 HD13 HD23 ' A' ' 147' ' ' LEU . 46.5 tp -66.94 -41.29 87.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 6.5999999999999996 111.215 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 43.1 pt -83.0 -19.47 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 6.6299999999999999 111.232 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.15 -39.84 75.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 6.6699999999999999 111.133 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.23 -9.62 59.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 6.7000000000000002 111.204 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.38 54.29 2.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 6.7300000000000004 111.178 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -79.94 -20.37 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 6.7699999999999996 111.219 172.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -141.49 150.27 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.7999999999999998 111.174 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -127.01 170.02 12.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 6.8300000000000001 111.185 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.15 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 6.8700000000000001 111.225 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.16 -30.47 71.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 6.9000000000000004 111.196 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.8 m -59.42 125.01 21.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 6.9299999999999997 111.171 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -129.97 -166.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 6.9699999999999998 111.215 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -55.74 -50.04 71.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 7.0 111.146 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.7 p -73.15 -25.23 60.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.21 -171.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.0 mm -75.04 -51.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 7.0700000000000003 111.164 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.07 -32.87 74.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 7.0999999999999996 111.237 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -70.15 -52.17 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 7.1299999999999999 111.257 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.66 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 7.1699999999999999 111.181 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 221' ' ' GLU . . . -55.07 -36.3 65.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 7.2000000000000002 111.165 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -94.21 -41.01 9.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 7.2300000000000004 111.237 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.2 -41.91 80.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 7.2699999999999996 111.184 -173.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.17 -9.04 49.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 7.2999999999999998 111.187 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.61 27.38 59.2 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.771 . . . . 7.3300000000000001 111.171 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 216' ' ' ALA . 75.6 mm-40 -68.44 -29.88 68.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 7.3700000000000001 111.183 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.4 p -109.7 167.89 9.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 7.4000000000000004 111.132 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.63 -38.57 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4299999999999997 111.226 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.511 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 64.4 ttp -144.95 145.03 31.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 7.4699999999999998 111.159 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -163.56 174.22 12.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 7.5 111.175 170.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -100.94 128.82 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 7.5300000000000002 111.234 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -163.84 177.79 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 7.5700000000000003 111.194 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -112.09 163.5 12.19 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.62 117.2 3.91 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.632 1.555 . . . . 7.6299999999999999 111.208 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 175.04 -35.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 7.6699999999999999 111.225 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -109.95 4.31 21.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.241 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.02 -19.98 59.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 7.7300000000000004 111.206 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 90.5 p -65.71 -20.06 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 7.7699999999999996 111.227 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -72.79 -24.57 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 7.7999999999999998 111.19 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.05 -38.01 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 7.8300000000000001 111.178 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.63 -34.96 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 7.8700000000000001 111.201 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.6 m -66.52 -41.16 89.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 7.9000000000000004 111.219 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 88.8 p -73.18 -14.68 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 7.9299999999999997 111.194 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 59.98 51.52 5.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 7.9699999999999998 111.222 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.1 m -118.16 164.43 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 8.0 111.17 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -84.61 139.27 32.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 8.0299999999999994 111.193 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -153.8 165.0 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 8.0700000000000003 111.183 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.88 163.84 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.137 -0.785 . . . . 8.0999999999999996 111.137 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.88 129.55 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 8.1300000000000008 111.225 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 34.9 p -133.15 171.6 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 8.1699999999999999 111.181 171.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.35 150.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 8.1999999999999993 111.189 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.655 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 2.7 pt? -140.96 51.58 2.53 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.199 -175.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 46.0 Cg_endo -62.57 146.94 95.44 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.737 1.624 . . . . 8.2699999999999996 111.228 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 42.6 m -139.66 117.04 11.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 8.3000000000000007 111.25 -174.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.73 73.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 8.3300000000000001 111.212 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 60.56 56.1 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 8.3699999999999992 111.235 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.33 10.47 85.95 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.212 -0.755 . . . . 8.4000000000000004 111.212 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -130.02 110.01 16.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 8.4299999999999997 111.205 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 136.7 14.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.694 1.596 . . . . 8.4700000000000006 111.265 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.2 m -125.19 -87.37 0.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 8.5 111.168 167.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -143.17 142.72 22.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 8.5299999999999994 111.194 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.37 166.33 27.71 Favored 'Trans proline' 0 C--N 1.328 -0.54 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.124 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -73.41 138.05 45.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 8.5999999999999996 111.209 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.43 168.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 8.6300000000000008 111.191 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -144.64 163.19 27.96 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.13 -0.788 . . . . 8.6699999999999999 111.13 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.3 t -125.14 134.84 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 8.6999999999999993 111.19 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 49.1 tp -89.95 133.4 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 8.7300000000000004 111.227 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 90.1 p -143.94 169.97 16.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 8.7699999999999996 111.203 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 8.8000000000000007 111.256 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.15 -169.04 12.87 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.209 -0.756 . . . . 8.8300000000000001 111.209 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 89.4 mt -116.08 135.19 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 8.8699999999999992 111.221 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -60.94 131.11 49.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.172 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.95 -21.19 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 8.9299999999999997 111.197 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -91.53 -4.94 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 8.9700000000000006 111.194 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t -64.5 122.73 80.09 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 9.0 111.165 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.15 -17.9 18.86 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.706 1.604 . . . . 9.0299999999999994 111.215 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -110.55 60.04 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 9.0700000000000003 111.251 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -72.09 -36.66 69.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 9.0999999999999996 111.201 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.56 -37.64 80.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 9.1300000000000008 111.172 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.2 mt -72.33 -40.77 67.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 9.1699999999999999 111.169 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.1 95.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 9.1999999999999993 111.221 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.82 -44.11 90.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 9.2300000000000004 111.256 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -60.04 -43.49 95.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 9.2699999999999996 111.204 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -61.59 -52.08 65.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 9.3000000000000007 111.25 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.02 -20.1 65.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 9.3300000000000001 111.193 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -87.22 -60.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 9.3699999999999992 111.198 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -102.14 -6.46 23.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 9.4000000000000004 111.212 -162.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -124.01 -27.22 3.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 9.4299999999999997 111.21 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.84 -45.83 16.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 9.4700000000000006 111.209 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.92 71.11 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 9.5 111.216 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 42.0 p -138.58 176.03 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 9.5299999999999994 111.199 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -51.78 -36.97 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 9.5700000000000003 111.235 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -92.51 -38.72 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 9.5999999999999996 111.201 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.6 -60.2 8.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.0 tp -56.86 -45.58 82.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 9.6699999999999999 111.156 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.77 -54.18 47.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 9.6999999999999993 111.198 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.53 84.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 9.7300000000000004 111.17 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.2 -43.38 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 9.7699999999999996 111.165 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -98.39 7.53 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 9.8000000000000007 111.258 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.07 -39.3 74.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 9.8300000000000001 111.174 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -97.98 10.48 40.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 9.8699999999999992 111.198 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -130.0 160.39 65.43 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 9.9000000000000004 111.184 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.96 144.96 65.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.724 1.616 . . . . 9.9299999999999997 111.171 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.8 39.18 2.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.248 -0.433 . . . . 9.9700000000000006 111.18 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -54.88 -42.06 78.41 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.21 -0.756 . . . . 10.0 111.21 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -167.07 144.3 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 10.029999999999999 111.179 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.07 173.68 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 10.07 111.13 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.14 -36.63 19.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 10.1 111.157 -172.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.416 HD23 HD23 ' A' ' 89' ' ' LEU . 96.2 mt -81.56 143.26 32.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 10.130000000000001 111.191 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.29 -45.01 23.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 10.17 111.192 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 97.2 p -65.07 -31.9 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 10.199999999999999 111.158 -173.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -75.98 -46.12 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 10.23 111.17 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.25 -31.7 71.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 10.27 111.213 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -53.88 -41.49 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 10.300000000000001 111.2 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -71.34 -37.47 71.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 10.33 111.214 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.1 mp -67.56 -20.29 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 10.369999999999999 111.244 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.03 -18.51 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 10.4 111.256 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.55 -27.88 69.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 10.43 111.177 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.65 115.15 63.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 10.470000000000001 111.213 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.53 -34.37 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.706 1.604 . . . . 10.5 111.177 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.86 -31.99 73.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.19 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 95.8 mt -78.32 -39.99 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 10.57 111.19 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 321' ' ' MET . . . -56.24 -33.61 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 10.6 111.191 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.34 -35.04 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 10.630000000000001 111.177 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 66.4 p -105.18 -20.15 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.228 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.453 ' HB3' ' HA ' ' A' ' 318' ' ' ALA . 60.9 ttp -65.08 -58.7 5.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 10.699999999999999 111.208 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -54.12 -41.6 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.73 111.185 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.35 -29.95 60.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 10.77 111.177 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.07 -35.32 76.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 10.800000000000001 111.232 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.05 -35.04 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 10.83 111.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.17 -4.95 34.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 10.869999999999999 111.164 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.62 -178.84 52.46 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.127 -0.789 . . . . 10.9 111.127 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -119.59 157.12 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 10.93 111.207 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.6 pt -119.76 166.68 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 10.970000000000001 111.189 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.8 tpp -60.04 130.0 88.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 11.0 111.198 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.19 141.45 58.83 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.753 1.636 . . . . 11.029999999999999 111.204 174.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.13 20.59 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 11.07 111.179 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 335' ' ' GLN . 83.8 mt -95.68 130.04 32.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 11.1 111.201 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.75 -41.76 53.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.667 1.578 . . . . 11.130000000000001 111.157 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.4 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.4 mt-30 -63.52 -44.61 93.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 11.17 111.135 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.96 -31.84 73.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 11.199999999999999 111.209 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.1 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 11.23 111.182 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.97 76.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 11.27 111.211 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -67.2 -27.48 67.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 11.300000000000001 111.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -60.03 -38.22 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 11.33 111.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -72.13 -30.1 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 11.369999999999999 111.172 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.4 74.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 11.4 111.201 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.44 -24.99 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 11.43 111.23 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -57.66 -50.2 73.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 11.470000000000001 111.205 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.7 m -60.68 -38.23 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 11.5 111.235 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -55.81 -40.09 72.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 11.529999999999999 111.157 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -47.95 82.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.265 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 348' ' ' ILE . 8.2 tp -74.6 -23.19 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 11.6 111.158 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.64 -27.59 45.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 11.630000000000001 111.187 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.0 -27.71 32.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 11.67 111.186 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.49 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 11.699999999999999 111.183 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.6 p -72.65 -16.22 61.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 11.73 111.272 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.05 35.24 27.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.249 -0.74 . . . . 11.77 111.249 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -99.98 -35.09 9.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 11.800000000000001 111.214 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -127.97 157.07 41.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 11.83 111.137 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -77.45 177.48 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 11.869999999999999 111.224 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.99 -21.26 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 11.9 111.237 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -92.33 -37.69 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 11.93 111.196 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -66.99 -38.18 85.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.172 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.06 -41.77 94.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 12.0 111.185 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.0 -15.29 51.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 12.029999999999999 111.173 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.99 -56.63 8.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 12.07 111.225 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.96 -32.81 74.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 12.1 111.204 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -59.09 -56.68 19.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 12.130000000000001 111.236 171.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.76 -34.27 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 12.17 111.222 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.8 m -59.57 -35.91 75.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 12.199999999999999 111.237 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.45 -24.13 56.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 12.23 111.131 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 364' ' ' ALA . 39.1 mm -77.39 -61.01 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 12.27 111.201 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.7 p -122.27 -25.41 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 12.300000000000001 111.146 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--O 1.201 -1.495 0 CA-C-N 116.157 -0.474 . . . . 12.33 111.155 -178.656 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.783 0.325 . . . . 0.029999999999999999 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.12 124.95 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.070000000000000007 111.22 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.62 153.77 38.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.10000000000000001 111.2 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.05 125.02 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.13 111.199 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 18.07 60.62 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -134.12 150.03 51.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.20000000000000001 111.187 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -119.57 119.94 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.23000000000000001 111.23 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.85 116.24 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.27000000000000002 111.196 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.415 ' HB ' HG22 ' A' ' 37' ' ' VAL . 74.2 mt -121.79 116.62 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.29999999999999999 111.185 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.87 107.12 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.33000000000000002 111.234 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.8 tt -115.79 139.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.37 111.186 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -76.66 109.65 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.40000000000000002 111.2 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.76 -171.75 43.04 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.212 -0.755 . . . . 0.42999999999999999 111.212 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -109.95 -43.6 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.46999999999999997 111.229 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 88.2 tttt -151.41 40.01 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.5 111.241 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -14.77 68.67 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.19 -0.764 . . . . 0.53000000000000003 111.19 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -56.71 -30.96 64.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.56999999999999995 111.225 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.96 -37.95 89.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.59999999999999998 111.194 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.48 -31.72 11.22 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.16 -0.776 . . . . 0.63 111.16 -177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.2 tp -73.48 -46.58 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.67000000000000004 111.24 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.43 68.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.69999999999999996 111.173 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.71 -38.93 64.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.72999999999999998 111.17 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -75.71 -23.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.77000000000000002 111.258 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.64 -5.54 81.55 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.206 -0.758 . . . . 0.80000000000000004 111.206 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.49 -24.13 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.327 . . . . 0.82999999999999996 111.201 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.32 -25.48 66.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.87 111.197 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.90000000000000002 111.298 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.95 -28.37 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.93000000000000005 111.205 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.26 -35.65 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.96999999999999997 111.184 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.87 -47.93 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.255 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -124.21 -20.98 5.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 1.03 111.191 -172.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.11 27.15 24.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.186 -0.765 . . . . 1.0700000000000001 111.186 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.3 mt -105.43 128.18 59.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 1.1000000000000001 111.169 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.38 124.98 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 1.1299999999999999 111.24 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -99.4 119.46 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 1.1699999999999999 111.201 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.5 m -114.76 123.81 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.2 111.199 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' ' 9' ' ' ILE . 72.5 t -114.59 131.57 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.23 111.217 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.71 170.34 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 1.27 111.227 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.96 68.74 80.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 1.3 111.206 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.94 161.64 38.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.749 1.633 . . . . 1.3300000000000001 111.227 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -120.27 171.48 8.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 1.3700000000000001 111.232 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 54.96 37.22 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 1.3999999999999999 111.215 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.0 mt -66.85 -37.0 83.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 1.4299999999999999 111.176 -174.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -70.8 -11.99 61.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 1.47 111.208 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -102.91 -6.12 22.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.5 111.197 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.88 -39.91 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.53 111.197 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.579 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 m-85 -62.46 -39.3 54.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.5700000000000001 111.232 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 76.9 Cg_exo -52.39 -24.4 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.697 1.598 . . . . 1.6000000000000001 111.172 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -109.12 -17.39 13.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 1.6299999999999999 111.186 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.9 t -105.64 -58.77 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 1.6699999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.24 -33.1 75.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 1.7 111.25 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.21 -25.64 68.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.73 111.192 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 p -96.57 5.79 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 1.77 111.192 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.82 18.1 58.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.196 -0.762 . . . . 1.8 111.196 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -110.95 172.31 6.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 1.8300000000000001 111.178 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.01 -163.4 16.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.15 -0.78 . . . . 1.8700000000000001 111.15 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.59 -172.86 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.611 1.541 . . . . 1.8999999999999999 111.206 -175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -96.83 -44.35 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 1.9299999999999999 111.176 173.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.77 135.7 58.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 1.97 111.229 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.7 mt -130.55 130.0 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 2.0 111.225 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.55 138.82 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 2.0299999999999998 111.186 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -141.76 167.94 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 2.0699999999999998 111.216 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.47 158.14 24.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 2.1000000000000001 111.192 164.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -43.83 -41.35 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 2.1299999999999999 111.17 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -83.19 -18.29 39.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 2.1699999999999999 111.21 -174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.11 -19.55 24.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 2.2000000000000002 111.199 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.05 -30.02 67.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.23 111.194 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.18 98.49 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 2.27 111.219 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.74 -44.55 80.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.172 -0.771 . . . . 2.2999999999999998 111.172 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -68.15 -33.28 74.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.234 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.34 -39.81 64.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.19 -0.459 . . . . 2.3700000000000001 111.181 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -65.11 -30.06 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 2.3999999999999999 111.141 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -74.15 -12.91 60.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 2.4300000000000002 111.2 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 27.73 50.47 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.206 -0.758 . . . . 2.4700000000000002 111.206 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -110.39 -6.05 15.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.836 0.35 . . . . 2.5 111.241 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.6 tp -98.39 130.32 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 2.5299999999999998 111.186 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 146.19 24.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.185 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -82.46 159.8 22.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.6000000000000001 111.223 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.8 102.95 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 2.6299999999999999 111.184 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -52.27 111.6 2.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 2.6699999999999999 111.26 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.31 145.64 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.665 1.577 . . . . 2.7000000000000002 111.223 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.38 169.98 9.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 2.73 111.247 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -84.36 -29.11 26.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 2.77 111.17 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.16 91.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 2.7999999999999998 111.241 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.444 ' HA ' ' HB3' ' A' ' 88' ' ' LYS . 59.1 m-85 -80.04 -22.5 42.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 2.8300000000000001 111.186 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.93 -39.95 75.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 2.8700000000000001 111.249 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -94.71 -33.19 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 2.8999999999999999 111.181 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 85' ' ' PHE . 58.1 tptt -64.8 -43.57 92.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 2.9300000000000002 111.148 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -85.23 142.3 29.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 2.9700000000000002 111.147 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -66.85 127.98 93.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 3.0 111.204 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.11 -35.05 80.72 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.656 1.571 . . . . 3.0299999999999998 111.155 -168.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -52.86 -44.6 66.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.197 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -90.91 -23.24 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.1000000000000001 111.141 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -60.0 -43.96 94.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 3.1299999999999999 111.138 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -86.06 -9.51 56.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 3.1699999999999999 111.175 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.27 48.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 3.2000000000000002 111.181 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.452 HG21 ' HD3' ' A' ' 107' ' ' PRO . 29.4 m -114.99 26.24 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 3.23 111.19 -170.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -139.74 154.72 47.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 3.27 111.192 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 66.3 t80 -148.4 127.51 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 3.2999999999999998 111.203 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 97.8 m-20 65.04 26.19 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 3.3300000000000001 111.188 -174.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.4 -42.0 2.04 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.151 -0.78 . . . . 3.3700000000000001 111.151 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.61 135.53 33.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 3.3999999999999999 111.151 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.99 143.24 43.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 3.4300000000000002 111.167 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -115.83 -13.45 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 3.4700000000000002 111.179 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.59 160.54 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 3.5 111.168 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -109.95 133.98 20.82 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 3.5299999999999998 111.256 169.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.604 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 72.6 Cg_endo -81.02 -178.46 4.4 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.692 1.595 . . . . 3.5699999999999998 111.25 -172.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 107' ' ' PRO . 16.3 tt 163.94 14.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 3.6000000000000001 111.23 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -171.22 144.78 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.6299999999999999 111.228 174.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.98 157.0 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 3.6699999999999999 111.183 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -140.02 109.94 6.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 3.7000000000000002 111.214 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.91 156.25 36.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 3.73 111.233 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.2 tp -134.24 116.73 15.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 3.77 111.184 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.0 p -161.56 169.84 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 3.7999999999999998 111.251 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.75 117.52 24.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 3.8300000000000001 111.207 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -108.09 148.48 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 3.8700000000000001 111.259 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -146.27 154.88 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 3.8999999999999999 111.212 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -83.28 122.52 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 3.9300000000000002 111.137 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 241' ' ' ASN . 97.9 mttt -64.6 -19.2 65.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 3.9700000000000002 111.232 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -89.95 -26.91 20.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 4.0 111.153 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -54.71 3.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 4.0300000000000002 111.163 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.52 82.4 18.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 4.0700000000000003 111.187 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.04 -15.01 29.27 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.769 1.646 . . . . 4.0999999999999996 111.204 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -106.95 97.49 17.96 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 4.1299999999999999 111.184 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.1 163.75 34.51 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.731 1.621 . . . . 4.1699999999999999 111.158 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.82 152.09 68.88 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.662 1.575 . . . . 4.2000000000000002 111.175 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.7 -10.92 30.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 4.2300000000000004 111.168 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -156.97 -176.54 6.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.168 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -79.7 -26.55 40.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 4.2999999999999998 111.212 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.04 -22.08 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 4.3300000000000001 111.138 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.11 -15.91 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.3700000000000001 111.259 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.519 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.7 mt -66.95 -51.35 38.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 4.4000000000000004 111.142 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 96.1 Cg_endo -75.73 -22.5 13.52 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.72 1.613 . . . . 4.4299999999999997 111.193 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.56 89.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 4.4699999999999998 111.232 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.92 -38.21 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 4.5 111.219 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 34.8 t70 -46.68 -47.83 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.204 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -49.35 76.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 4.5700000000000003 111.19 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.88 -30.09 70.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 4.5999999999999996 111.147 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.2 mt -79.46 -36.1 39.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 4.6299999999999999 111.245 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.84 -20.06 64.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 4.6699999999999999 111.163 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.89 68.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 4.7000000000000002 111.24 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -107.0 8.47 30.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 4.7300000000000004 111.219 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.58 60.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.178 -0.769 . . . . 4.7699999999999996 111.178 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 72.9 mmtt -109.94 -174.15 2.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 4.7999999999999998 111.191 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.4 t -151.89 163.62 38.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 4.8300000000000001 111.178 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 136' ' ' ASP . . . -66.42 -57.77 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 4.8700000000000001 111.177 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.53 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.0 pp -164.95 164.93 20.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 4.9000000000000004 111.191 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.2 mmt -110.37 100.02 8.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 4.9299999999999997 111.147 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.88 130.01 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 4.9699999999999998 111.215 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 208' ' ' THR . 39.5 t-20 -70.27 111.93 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 5.0 111.2 169.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.76 7.55 44.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 5.0300000000000002 111.217 -170.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -109.83 -48.11 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 5.0700000000000003 111.263 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.7 121.22 81.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 5.0999999999999996 111.208 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.0 -31.26 8.18 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.717 1.611 . . . . 5.1299999999999999 111.224 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -73.82 -33.59 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 5.1699999999999999 111.167 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -53.03 -37.1 61.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 5.2000000000000002 111.168 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.7 p -99.06 15.31 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 5.2300000000000004 111.199 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 91.0 t90 -66.78 -46.63 55.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 5.2699999999999996 111.254 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 41.7 Cg_endo -87.94 -4.05 7.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.676 1.584 . . . . 5.2999999999999998 111.203 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.46 -51.46 68.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 5.3300000000000001 111.215 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.33 -31.42 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 5.3700000000000001 111.2 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.4 -35.15 79.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 5.4000000000000004 111.164 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.23 80.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 5.4299999999999997 111.197 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.48 -43.46 90.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.204 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.82 26.2 4.83 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.197 -0.761 . . . . 5.5 111.197 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.95 -31.69 4.67 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.257 -0.737 . . . . 5.5300000000000002 111.257 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.75 110.01 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 5.5700000000000003 111.241 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.29 35.82 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 5.5999999999999996 111.159 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -120.14 141.43 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 5.6299999999999999 111.133 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -70.06 128.17 35.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 5.6699999999999999 111.219 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -100.0 89.26 3.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 5.7000000000000002 111.216 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 88.7 tt0 -152.14 95.07 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 5.7300000000000004 111.199 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 96.8 m-20 73.26 -67.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 5.7699999999999996 111.179 174.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.92 25.0 0.07 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.246 -0.742 . . . . 5.7999999999999998 111.246 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -107.92 120.01 41.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.331 . . . . 5.8300000000000001 111.153 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -122.24 88.08 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 5.8700000000000001 111.175 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -86.49 128.66 34.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 5.9000000000000004 111.159 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 pt -72.33 -17.0 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 5.9299999999999997 111.192 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.23 -20.02 52.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 5.9699999999999998 111.196 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.75 174.42 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 6.0 111.165 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.33 152.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 6.0300000000000002 111.185 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.87 22.01 36.6 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.177 -0.769 . . . . 6.0700000000000003 111.177 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.9 p -71.04 -20.02 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 6.0999999999999996 111.25 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -113.79 22.56 13.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 6.1299999999999999 111.232 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.17 117.73 29.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 6.1699999999999999 111.196 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.91 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 6.2000000000000002 111.161 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.94 76.81 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.209 -0.756 . . . . 6.2300000000000004 111.209 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.58 80.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 6.2699999999999996 111.172 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.42 -39.05 93.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 6.2999999999999998 111.217 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 6.3300000000000001 111.207 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.84 -44.67 94.35 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.162 -0.775 . . . . 6.3700000000000001 111.162 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 192' ' ' LEU . 0.7 OUTLIER -65.76 -37.33 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 6.4000000000000004 111.234 176.078 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.8 m -61.14 -44.01 98.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 6.4299999999999997 111.173 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -55.66 -46.03 77.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 6.4699999999999998 111.205 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.88 -52.12 66.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 6.5 111.268 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.07 -21.14 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 6.5300000000000002 111.253 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.86 -40.18 79.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 6.5700000000000003 111.242 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.04 -35.61 81.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 6.5999999999999996 111.177 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.28 -52.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.195 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.58 -43.03 99.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 6.6699999999999999 111.231 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -79.94 -10.14 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 6.7000000000000002 111.149 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 59.83 58.46 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 6.7300000000000004 111.182 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -81.17 -22.57 38.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 6.7699999999999996 111.219 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.98 170.75 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.207 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -92.74 161.98 14.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 6.8300000000000001 111.197 -174.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.86 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 6.8700000000000001 111.238 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.01 -30.06 67.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 6.9000000000000004 111.18 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 150' ' ' ASN . 49.8 m -51.77 130.78 29.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.206 175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -157.49 176.72 12.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 6.9699999999999998 111.197 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -64.04 -21.2 66.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 7.0 111.175 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.0 p -69.7 -25.6 63.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 7.0300000000000002 111.226 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.52 -32.27 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 7.0700000000000003 111.19 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 225' ' ' THR . . . -61.04 -44.69 97.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 7.0999999999999996 111.202 177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.97 -39.55 93.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 7.1299999999999999 111.207 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.12 -47.19 86.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.219 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.94 63.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 7.2000000000000002 111.211 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.64 -38.89 92.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 7.2300000000000004 111.183 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 234' ' ' ASN . 97.7 m-20 -93.33 -39.69 10.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 7.2699999999999996 111.175 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.52 -23.06 59.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 7.2999999999999998 111.218 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.35 51.23 6.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.229 -0.748 . . . . 7.3300000000000001 111.229 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.92 3.25 25.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 7.3700000000000001 111.227 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 154.04 36.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 7.4000000000000004 111.241 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.57 -29.87 18.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 7.4299999999999997 111.212 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 21.6 ptt? -152.3 170.0 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 7.4699999999999998 111.185 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.413 HG21 ' HB1' ' A' ' 213' ' ' ALA . 12.3 t -170.18 152.82 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 7.5 111.161 170.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 94.0 mt -91.89 120.07 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 7.5300000000000002 111.236 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -160.8 -172.12 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 7.5700000000000003 111.167 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -120.36 -165.09 12.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.165 -0.774 . . . . 7.5999999999999996 111.165 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.13 64.65 8.39 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.708 1.606 . . . . 7.6299999999999999 111.245 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -125.41 -30.07 3.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 7.6699999999999999 111.224 171.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.19 -5.22 30.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 7.7000000000000002 111.246 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -76.91 -19.15 57.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 7.7300000000000004 111.175 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 95.5 p -72.85 -10.06 59.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 7.7699999999999996 111.196 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 218' ' ' ASN . 65.8 m-80 -95.01 5.41 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 7.7999999999999998 111.187 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.9 -51.29 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 7.8300000000000001 111.198 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -77.39 -25.32 50.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 7.8700000000000001 111.199 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 87.5 m -64.99 -45.95 83.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 7.9000000000000004 111.227 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 85.2 p -82.58 -14.72 54.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 7.9299999999999997 111.259 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 59.57 45.4 13.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 7.9699999999999998 111.18 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 73.6 t -128.03 142.82 42.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 8.0 111.207 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 119' ' ' LYS . 97.4 m-20 -74.75 112.57 11.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 8.0299999999999994 111.222 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -112.84 143.04 44.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 8.0700000000000003 111.177 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -118.58 167.47 13.04 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.147 -0.781 . . . . 8.0999999999999996 111.147 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.65 160.75 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 8.1300000000000008 111.17 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -135.76 -176.65 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 8.1699999999999999 111.201 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.01 120.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 8.1999999999999993 111.206 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.535 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 91.5 mt -87.8 -42.2 0.5 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.134 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 78.2 Cg_exo -53.22 112.42 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.695 1.597 . . . . 8.2699999999999996 111.156 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 88.0 m -124.48 112.11 16.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 8.3000000000000007 111.168 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -110.01 128.75 55.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 8.3300000000000001 111.126 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 85.1 tttt 45.17 46.04 9.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 8.3699999999999992 111.176 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.9 14.49 78.48 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.205 -0.758 . . . . 8.4000000000000004 111.205 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -129.98 109.99 16.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.181 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.8 130.63 38.24 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.746 1.631 . . . . 8.4700000000000006 111.187 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.6 t -105.1 -99.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 8.5 111.126 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -136.87 151.94 73.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 8.5299999999999994 111.223 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -60.4 144.57 99.52 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.737 1.624 . . . . 8.5700000000000003 111.181 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -92.96 148.31 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 8.5999999999999996 111.162 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.35 126.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 8.6300000000000008 111.213 -175.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -85.83 162.83 36.1 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -129.28 136.41 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 8.6999999999999993 111.141 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 67.1 mt -109.82 148.74 30.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 8.7300000000000004 111.165 172.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -161.63 169.98 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 8.7699999999999996 111.234 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.15 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 8.8000000000000007 111.162 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.46 179.66 16.41 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.226 -0.749 . . . . 8.8300000000000001 111.226 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.3 mt -100.98 136.01 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 8.8699999999999992 111.194 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.91 124.72 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 8.9000000000000004 111.167 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.13 -22.42 66.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 8.9299999999999997 111.231 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -5.51 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 8.9700000000000006 111.237 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -79.48 129.88 70.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 9.0 111.2 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.52 -3.33 13.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.708 1.605 . . . . 9.0299999999999994 111.233 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -120.01 60.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 9.0700000000000003 111.263 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -75.85 -30.38 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 9.0999999999999996 111.183 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -68.06 -46.46 71.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 9.1300000000000008 111.223 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 64.3 tp -62.76 -44.13 97.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 9.1699999999999999 111.18 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.29 98.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 9.1999999999999993 111.128 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -63.25 -40.22 96.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 9.2300000000000004 111.183 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.68 -54.78 42.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 9.2699999999999996 111.222 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -52.28 -50.0 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 9.3000000000000007 111.275 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.63 -43.6 93.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 9.3300000000000001 111.219 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -83.41 -61.76 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 9.3699999999999992 111.232 -168.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -92.98 -8.56 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 9.4000000000000004 111.262 -162.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.0 -50.09 2.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 9.4299999999999997 111.231 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.0 tp -78.42 -60.0 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 9.4700000000000006 111.163 -174.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.8 mm? -75.2 69.93 2.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 9.5 111.177 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 29.5 p -136.86 178.02 7.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 9.5299999999999994 111.14 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.18 -25.75 68.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 9.5700000000000003 111.202 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -98.49 -34.59 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.5999999999999996 111.221 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.91 -48.71 59.27 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.35 -45.37 84.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 9.6699999999999999 111.186 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.32 -46.12 91.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 9.6999999999999993 111.217 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.64 74.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 9.7300000000000004 111.136 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.79 -40.65 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 9.7699999999999996 111.204 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.516 ' HB3' HD23 ' A' ' 299' ' ' LEU . 91.9 m-20 -78.22 0.67 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 9.8000000000000007 111.281 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.89 -35.93 82.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 9.8300000000000001 111.152 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.2 -28.33 9.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 9.8699999999999992 111.177 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.45 164.06 19.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 9.9000000000000004 111.19 -176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.97 139.95 79.5 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.702 1.601 . . . . 9.9299999999999997 111.206 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 294' ' ' ASN . 98.7 mt -70.12 -18.6 63.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.166 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.01 -26.53 71.44 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.197 -0.761 . . . . 10.0 111.197 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -60.13 127.09 30.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 10.029999999999999 111.189 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.9 134.25 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 10.07 111.193 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 108' ' ' ILE . . . -114.42 -27.18 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 10.1 111.168 164.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.19 144.99 27.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 10.130000000000001 111.162 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -65.55 -47.35 76.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 10.17 111.224 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.8 m -62.67 -40.05 95.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 10.199999999999999 111.204 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -65.17 -40.37 94.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 10.23 111.226 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -60.75 -33.39 72.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 10.27 111.238 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.12 -33.11 71.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 10.300000000000001 111.174 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -70.31 -29.9 66.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 10.33 111.188 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.15 -29.84 61.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 10.369999999999999 111.169 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.01 73.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 10.4 111.189 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.33 -34.36 68.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 10.43 111.166 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.02 118.35 48.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 10.470000000000001 111.159 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.7 -35.51 93.34 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.744 1.629 . . . . 10.5 111.153 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -79.98 -52.58 7.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 10.529999999999999 111.156 -172.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.428 HG22 ' HG2' ' A' ' 321' ' ' MET . 50.4 mm -79.17 -27.34 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 10.57 111.163 -170.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.31 -36.72 33.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 10.6 111.172 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.15 95.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.188 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.8 m -69.95 -39.85 75.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 10.67 111.107 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.428 ' HG2' HG22 ' A' ' 317' ' ' ILE . 38.8 mmt -68.37 -35.42 77.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 10.699999999999999 111.233 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.53 -42.4 87.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 10.73 111.233 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -64.91 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 10.77 111.238 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 10.800000000000001 111.232 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.49 -42.77 99.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.83 111.271 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.04 -9.83 38.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 10.869999999999999 111.262 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.97 -165.16 35.45 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.23 164.31 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 10.93 111.17 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.4 pt -111.32 162.87 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 10.970000000000001 111.214 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -84.95 164.72 40.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 11.0 111.18 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.06 138.53 82.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.72 1.614 . . . . 11.029999999999999 111.182 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -107.51 28.27 8.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 11.07 111.221 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 335' ' ' GLN . 89.3 mt -90.62 125.26 60.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 11.1 111.202 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.49 -24.36 31.01 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.736 1.624 . . . . 11.130000000000001 111.183 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.438 ' H ' HG22 ' A' ' 333' ' ' ILE . 61.7 mt-30 -80.57 -1.46 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 11.17 111.129 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.1 mmm -95.16 6.9 47.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 11.199999999999999 111.164 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.4 p -64.55 -33.78 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 11.23 111.133 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.29 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 11.27 111.163 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -60.98 -47.59 85.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 11.300000000000001 111.172 175.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.38 -49.06 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 11.33 111.219 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.36 -47.01 65.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.172 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.37 86.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.244 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.97 -46.38 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 11.43 111.192 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.75 -44.85 70.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 11.470000000000001 111.233 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.8 m -65.21 -40.56 94.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.203 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.76 -34.08 77.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 11.529999999999999 111.174 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.82 -48.9 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 11.57 111.167 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 8.9 tp -74.88 -25.18 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 11.6 111.201 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.76 -48.29 55.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 11.630000000000001 111.219 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.64 76.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 11.67 111.208 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.07 87.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.175 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 11.73 111.161 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.34 27.02 8.92 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.216 -0.754 . . . . 11.77 111.216 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -82.75 -35.08 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 11.800000000000001 111.23 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -151.38 174.77 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 11.83 111.135 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -85.0 171.97 11.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 11.869999999999999 111.177 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -72.19 -24.16 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 11.9 111.237 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.01 -47.89 60.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 11.93 111.161 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -68.5 -28.45 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 11.970000000000001 111.162 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.13 -51.33 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 12.0 111.208 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.29 -20.35 48.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 12.029999999999999 111.205 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.86 -52.42 56.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 12.07 111.151 171.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.84 -37.4 86.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.429 . . . . 12.1 111.246 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.45 81.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 12.130000000000001 111.212 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -55.31 -44.5 75.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 12.17 111.208 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.8 m -59.31 -44.54 92.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 12.199999999999999 111.237 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.85 -30.13 67.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 12.23 111.151 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 86.8 mt -69.06 -41.09 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 12.27 111.22 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.9 p -86.8 -15.08 40.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 12.300000000000001 111.258 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.508 0 CA-C-N 116.148 -0.478 . . . . 12.33 111.209 177.728 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.762 0.315 . . . . 0.029999999999999999 111.191 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt -116.27 125.57 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.070000000000000007 111.175 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.0 144.93 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.10000000000000001 111.199 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.04 129.94 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.13 111.211 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.02 19.56 21.24 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.153 -0.779 . . . . 0.17000000000000001 111.153 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -140.16 146.61 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.20000000000000001 111.196 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 275' ' ' LEU . 88.2 mt -112.29 140.75 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.23000000000000001 111.264 172.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.84 118.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.27000000000000002 111.218 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 59' ' ' ILE . 89.5 mt -107.88 123.9 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.29999999999999999 111.213 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -110.09 130.66 55.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.33000000000000002 111.201 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.42 120.09 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.37 111.231 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.58 125.35 26.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.40000000000000002 111.156 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.15 -170.83 40.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.151 -0.78 . . . . 0.42999999999999999 111.151 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.04 -51.9 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.46999999999999997 111.157 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.73 158.8 42.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.5 111.254 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.99 -8.87 4.82 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.229 -0.748 . . . . 0.53000000000000003 111.229 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -64.93 -24.56 67.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 111.257 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.54 -42.73 70.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.59999999999999998 111.219 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.58 -40.41 97.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.155 -0.778 . . . . 0.63 111.155 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.17 -23.61 51.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.328 . . . . 0.67000000000000004 111.183 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -33.4 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.147 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.77 -42.85 97.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.164 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.93 -25.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.77000000000000002 111.184 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -33.52 87.45 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.13 -0.788 . . . . 0.80000000000000004 111.13 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.61 -43.91 92.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.82999999999999996 111.151 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.97 -35.98 76.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.87 111.222 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.08 -42.73 93.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.90000000000000002 111.172 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.59 -35.76 81.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.93000000000000005 111.234 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -64.35 -30.05 71.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.96999999999999997 111.182 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -99.89 -34.7 10.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.252 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -107.05 -29.03 9.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 1.03 111.239 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.95 6.55 75.56 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.186 -0.766 . . . . 1.0700000000000001 111.186 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.7 mm -89.22 127.86 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 1.1000000000000001 111.176 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.6 134.33 33.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.1299999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -115.49 124.44 71.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 1.1699999999999999 111.265 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -115.69 125.97 53.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 1.2 111.249 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.19 131.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.23 111.198 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -128.84 156.12 44.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 1.27 111.208 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -111.49 85.64 6.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 1.3 111.178 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 147.51 45.91 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.713 1.608 . . . . 1.3300000000000001 111.19 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -137.03 5.23 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 1.3700000000000001 111.182 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -124.96 35.05 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 1.3999999999999999 111.16 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.98 -35.15 74.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 1.4299999999999999 111.199 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.3 -40.04 64.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.47 111.199 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -84.66 -26.94 27.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 1.5 111.144 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.02 -19.81 43.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.217 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.481 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.2 m-30 -55.04 -57.43 19.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 1.5700000000000001 111.231 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 72.8 Cg_endo -72.96 -23.33 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.732 1.621 . . . . 1.6000000000000001 111.16 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -67.7 -36.4 80.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.302 -0.408 . . . . 1.6299999999999999 111.162 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.8 m -100.02 -28.08 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 1.6699999999999999 111.183 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 1.7 111.229 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -15.89 60.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 1.73 111.2 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 p -109.88 -18.39 13.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 1.77 111.145 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.96 42.52 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.214 -0.754 . . . . 1.8 111.214 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -111.22 -175.0 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.8300000000000001 111.154 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.07 -172.15 25.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.172 -0.771 . . . . 1.8700000000000001 111.172 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.0 -176.49 2.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.666 1.578 . . . . 1.8999999999999999 111.212 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -99.27 -48.03 4.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 1.9299999999999999 111.211 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.441 ' HB ' HG12 ' A' ' 9' ' ' ILE . 83.4 mt -117.93 134.96 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 1.97 111.195 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -121.72 137.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 2.0 111.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -105.39 137.95 42.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 2.0299999999999998 111.206 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.99 163.38 18.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 2.0699999999999998 111.173 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.22 165.93 12.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 2.1000000000000001 111.173 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -53.96 -33.52 57.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.1299999999999999 111.197 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 340' ' ' TRP . 76.1 m-20 -102.51 16.27 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 2.1699999999999999 111.206 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -110.01 -0.02 18.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 2.2000000000000002 111.165 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -69.97 -27.55 64.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 2.23 111.225 -170.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.7 -39.74 61.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 2.27 111.218 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -30.82 78.77 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.178 -0.769 . . . . 2.2999999999999998 111.178 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.64 -37.07 11.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.24 -174.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.08 64.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 2.3700000000000001 111.174 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -84.51 -28.23 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 2.3999999999999999 111.195 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 -15.62 56.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.4300000000000002 111.249 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 31.55 30.28 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.229 -0.748 . . . . 2.4700000000000002 111.229 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -118.65 33.73 5.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 2.5 111.211 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.0 tp -152.37 125.16 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 2.5299999999999998 111.158 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.68 157.67 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 2.5699999999999998 111.22 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.87 80.01 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 2.6000000000000001 111.21 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.57 114.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 2.6299999999999999 111.258 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.469 HG23 ' HB2' ' A' ' 103' ' ' LEU . 53.0 m -100.9 121.58 51.9 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 2.6699999999999999 111.219 -168.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HB3' ' CD2' ' A' ' 106' ' ' TYR . 58.1 Cg_endo -67.43 125.27 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.18 173.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -85.03 -168.28 2.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 2.73 111.176 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.89 -32.86 71.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 2.77 111.181 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.61 -35.05 76.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 2.7999999999999998 111.168 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.93 -24.82 21.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 2.8300000000000001 111.201 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.69 -35.03 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.8700000000000001 111.158 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -89.25 -34.96 16.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 2.8999999999999999 111.202 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -81.03 -30.08 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 2.9300000000000002 111.175 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -104.56 166.11 10.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 2.9700000000000002 111.249 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.448 ' CE2' ' HA ' ' A' ' 303' ' ' ALA . 19.7 m-85 -60.14 138.14 91.33 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 3.0 111.228 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.31 -13.56 28.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.687 1.591 . . . . 3.0299999999999998 111.214 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.71 -21.98 24.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 3.0699999999999998 111.164 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -107.37 -19.74 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 3.1000000000000001 111.185 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -60.14 -42.63 95.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 3.1299999999999999 111.188 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.98 -15.55 29.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 3.1699999999999999 111.137 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.28 13.31 8.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 3.2000000000000002 111.2 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.2 m -120.19 71.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 3.23 111.24 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -141.33 139.15 33.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 3.27 111.163 -158.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -162.44 139.85 8.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 3.2999999999999998 111.175 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 65.8 30.55 10.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 3.3300000000000001 111.186 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.72 86.78 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.149 -0.78 . . . . 3.3700000000000001 111.149 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.15 155.68 48.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.821 0.343 . . . . 3.3999999999999999 111.216 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.469 ' HB2' HG23 ' A' ' 80' ' ' THR . 90.1 mt -79.06 142.43 36.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 3.4300000000000002 111.151 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 pt -124.93 -5.01 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 3.4700000000000002 111.226 -162.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.14 160.41 39.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 3.5 111.244 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 86.9 m-85 -99.09 125.07 42.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 3.5299999999999998 111.139 166.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.66 131.16 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.702 1.601 . . . . 3.5699999999999998 111.135 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.24 -55.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 3.6000000000000001 111.18 -169.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.77 156.36 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 3.6299999999999999 111.206 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.04 161.01 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 3.6699999999999999 111.161 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -149.31 110.57 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 3.7000000000000002 111.132 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.44 135.85 44.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 3.73 111.227 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.13 145.07 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 3.77 111.164 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 99.0 p -150.15 169.4 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 3.7999999999999998 111.199 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -115.13 130.21 56.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 3.8300000000000001 111.221 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.75 147.79 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 3.8700000000000001 111.23 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -138.19 159.03 43.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 3.8999999999999999 111.132 167.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 122' ' ' LEU . 34.4 t-20 -107.85 104.75 14.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 3.9300000000000002 111.257 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.0 mttt -57.67 -34.8 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 3.9700000000000002 111.203 -174.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.34 -47.72 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 4.0 111.227 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.21 -58.46 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 4.0300000000000002 111.288 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 118' ' ' ASN . 68.2 mt -125.04 76.26 67.23 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 4.0700000000000003 111.285 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.43 -17.61 39.0 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.691 1.594 . . . . 4.0999999999999996 111.224 -174.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -97.81 104.84 23.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 4.1299999999999999 111.198 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.18 155.47 64.48 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.635 1.557 . . . . 4.1699999999999999 111.241 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.38 144.22 60.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 4.2000000000000002 111.238 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.18 -19.88 31.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 4.2300000000000004 111.215 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -150.07 -177.33 5.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 4.2699999999999996 111.238 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -64.58 -41.73 96.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 4.2999999999999998 111.212 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.27 -23.1 66.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 4.3300000000000001 111.185 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -87.71 -15.34 37.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 4.3700000000000001 111.174 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 82.7 mt -68.94 -50.48 22.12 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 4.4000000000000004 111.179 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 92.1 Cg_endo -75.93 -18.98 16.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.661 1.574 . . . . 4.4299999999999997 111.199 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.0 85.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 4.4699999999999998 111.201 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.75 -28.65 60.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 4.5 111.214 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.62 -42.51 98.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 4.5300000000000002 111.179 173.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.78 -48.1 72.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 4.5700000000000003 111.201 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -61.84 -40.98 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 4.5999999999999996 111.191 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 223' ' ' ALA . 26.0 tp -72.25 -31.78 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 4.6299999999999999 111.215 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.73 -39.52 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 4.6699999999999999 111.158 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.76 71.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 4.7000000000000002 111.228 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.89 -14.86 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.488 . . . . 4.7300000000000004 111.222 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.13 16.49 18.64 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.277 -0.729 . . . . 4.7699999999999996 111.277 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -134.26 154.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 4.7999999999999998 111.212 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.5 t -100.96 146.92 26.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 4.8300000000000001 111.225 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -112.73 -20.61 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 4.8700000000000001 111.205 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.7 tp -125.58 114.57 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 4.9000000000000004 111.17 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.402 ' SD ' ' OG1' ' A' ' 222' ' ' THR . 97.9 mtp -145.0 110.08 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 4.9299999999999997 111.22 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -101.21 -179.97 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 4.9699999999999998 111.186 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.649 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . 61.0 t-20 -96.06 105.26 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 5.0 111.216 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 151' ' ' LEU . 3.2 mm? -89.21 9.38 25.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 5.0300000000000002 111.209 -173.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -110.64 -9.98 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 5.0700000000000003 111.234 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -144.6 113.28 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 5.0999999999999996 111.193 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.12 -33.56 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.719 1.613 . . . . 5.1299999999999999 111.221 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -55.24 -33.03 62.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 5.1699999999999999 111.197 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.649 ' HB2' ' HB3' ' A' ' 150' ' ' ASN . 77.9 m-85 -104.99 25.57 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 5.2000000000000002 111.22 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.8 p -121.97 -14.38 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 5.2300000000000004 111.141 166.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.593 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 88.7 t90 -66.12 -40.1 34.04 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 5.2699999999999996 111.192 176.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 74.4 Cg_exo -55.45 -19.54 23.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.758 1.639 . . . . 5.2999999999999998 111.201 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.4 tp -42.77 -51.54 5.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 5.3300000000000001 111.223 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 47.7 pt -86.19 -9.99 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 5.3700000000000001 111.169 -173.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.94 -25.78 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 5.4000000000000004 111.173 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.95 98.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 5.4299999999999997 111.225 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -95.69 9.83 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.216 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.21 29.6 73.34 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.177 -0.769 . . . . 5.5 111.177 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.89 -37.89 28.41 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -71.79 131.64 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 5.5700000000000003 111.179 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 55.02 55.29 7.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 5.5999999999999996 111.202 168.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -127.38 162.45 26.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.428 . . . . 5.6299999999999999 111.223 165.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -125.33 147.55 49.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 5.6699999999999999 111.237 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -164.82 136.66 4.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 5.7000000000000002 111.191 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -149.88 90.05 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 5.7300000000000004 111.165 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 53.87 40.37 31.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 5.7699999999999996 111.15 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.61 -26.04 22.54 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.153 -0.779 . . . . 5.7999999999999998 111.153 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.03 -180.0 7.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 5.8300000000000001 111.208 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.54 103.35 8.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 5.8700000000000001 111.237 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -99.83 114.09 27.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 5.9000000000000004 111.169 -175.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.39 -18.62 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 5.9299999999999997 111.2 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 5.9699999999999998 111.217 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.3 141.76 58.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 6.0 111.161 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.85 173.45 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 6.0300000000000002 111.177 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -83.8 9.0 63.87 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.242 -0.743 . . . . 6.0700000000000003 111.242 -168.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.28 -2.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 6.0999999999999996 111.187 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -131.33 10.03 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 6.1299999999999999 111.199 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.08 139.46 36.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 6.1699999999999999 111.164 174.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.66 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 6.2000000000000002 111.179 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.64 93.54 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.761 . . . . 6.2300000000000004 111.199 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.23 92.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 6.2699999999999996 111.247 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.1 -47.3 62.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 6.2999999999999998 111.22 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.27 92.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 6.3300000000000001 111.239 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -46.73 88.46 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.245 -0.742 . . . . 6.3700000000000001 111.245 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.17 -43.46 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 6.4000000000000004 111.197 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -50.95 -29.29 11.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 6.4299999999999997 111.172 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -53.29 -60.62 3.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 6.4699999999999998 111.17 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.9 mt -78.48 -25.36 45.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 6.5 111.234 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.59 -47.37 85.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 6.5300000000000002 111.243 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -75.01 -35.44 61.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 6.5700000000000003 111.222 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.483 ' HB3' ' HG2' ' A' ' 204' ' ' MET . 5.1 mp -75.76 -18.97 59.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 6.5999999999999996 111.197 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 93.8 mt -91.71 -40.6 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 6.6299999999999999 111.213 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.78 -38.09 77.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 6.6699999999999999 111.22 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.96 13.57 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 6.7000000000000002 111.146 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 56.94 46.19 19.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 6.7300000000000004 111.193 172.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -94.98 -49.91 5.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 6.7699999999999996 111.26 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.483 ' HG2' ' HB3' ' A' ' 198' ' ' LEU . 97.5 mmm -74.31 144.99 44.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 6.7999999999999998 111.224 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -86.56 114.57 23.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 6.8300000000000001 111.164 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.58 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.8700000000000001 111.22 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.28 -30.3 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 6.9000000000000004 111.175 -176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 m -64.97 128.96 37.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.262 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.06 -166.76 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 6.9699999999999998 111.189 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -69.92 -48.81 57.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 7.0 111.122 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -67.49 -29.84 69.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 7.0300000000000002 111.21 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.7 mt -66.96 -44.94 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 7.0700000000000003 111.194 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.36 93.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.141 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.92 -40.04 40.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 7.1299999999999999 111.138 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.0 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.208 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.04 -9.12 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 7.2000000000000002 111.214 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.53 -25.02 56.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 7.2300000000000004 111.205 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -89.39 -24.04 22.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 7.2699999999999996 111.171 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.01 -25.42 32.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 7.2999999999999998 111.148 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.26 29.13 28.62 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.277 -0.729 . . . . 7.3300000000000001 111.277 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.55 -19.13 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 7.3700000000000001 111.233 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.402 ' OG1' ' SD ' ' A' ' 148' ' ' MET . 96.9 m -119.59 127.59 53.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 7.4000000000000004 111.142 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 139' ' ' LEU . . . -93.51 -31.22 14.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 7.4299999999999997 111.135 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 17.2 ptp -157.46 159.68 37.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 7.4699999999999998 111.183 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.0 t -160.39 -173.17 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 7.5 111.181 170.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.62 122.27 58.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 7.5300000000000002 111.207 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 9.5 t-20 -166.79 -178.99 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 7.5700000000000003 111.279 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.52 -165.23 41.07 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.44 79.61 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.669 1.579 . . . . 7.6299999999999999 111.153 -174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -175.02 -22.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.428 . . . . 7.6699999999999999 111.231 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -68.75 -47.52 66.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 7.7000000000000002 111.177 -172.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -86.33 2.17 48.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 7.7300000000000004 111.156 -170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.3 p -84.51 -9.44 58.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 7.7699999999999996 111.188 171.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -94.85 -7.16 41.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 7.7999999999999998 111.213 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.89 -24.31 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 7.8300000000000001 111.191 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -30.9 29.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 7.8700000000000001 111.189 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.4 m -62.29 -40.12 95.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 7.9000000000000004 111.205 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 49.5 m -71.35 -24.73 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 7.9299999999999997 111.226 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 63.12 54.47 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 7.9699999999999998 111.188 174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.66 167.47 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 8.0 111.196 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -81.09 126.41 31.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 8.0299999999999994 111.266 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.434 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 53.4 p90 -145.85 164.44 31.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 8.0700000000000003 111.193 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.41 -179.38 30.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.148 -0.781 . . . . 8.0999999999999996 111.148 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.61 140.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 8.1300000000000008 111.158 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -138.18 -174.84 3.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 8.1699999999999999 111.258 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.26 159.16 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 8.1999999999999993 111.13 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 247' ' ' LEU . 2.4 pt? -139.93 50.01 2.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 8.2300000000000004 111.197 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 74.0 Cg_endo -73.13 149.97 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.714 1.609 . . . . 8.2699999999999996 111.184 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.9 m -148.66 117.76 6.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 8.3000000000000007 111.254 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -105.46 85.24 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 8.3300000000000001 111.152 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 86.5 mttt 57.02 35.35 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 8.3699999999999992 111.206 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.34 -14.05 28.07 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.261 -0.736 . . . . 8.4000000000000004 111.261 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -117.92 109.98 40.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 8.4299999999999997 111.217 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.17 139.01 41.13 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.66 1.573 . . . . 8.4700000000000006 111.253 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.9 t -139.99 -75.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 8.5 111.29 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.474 ' HB3' ' HA2' ' A' ' 327' ' ' GLY . 70.1 mmtt -144.41 146.21 31.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 8.5299999999999994 111.201 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 165.97 30.6 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.742 1.628 . . . . 8.5700000000000003 111.223 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.16 139.21 44.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 8.5999999999999996 111.229 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.94 115.28 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 8.6300000000000008 111.213 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.68 151.38 32.28 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.2 -0.76 . . . . 8.6699999999999999 111.2 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.65 133.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 8.6999999999999993 111.148 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 50.0 tp -102.53 134.3 46.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 8.7300000000000004 111.141 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 98.6 p -132.99 173.78 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 8.7699999999999996 111.219 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.31 40.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 8.8000000000000007 111.211 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -157.74 -173.05 25.66 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.224 -0.751 . . . . 8.8300000000000001 111.224 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -102.41 127.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 8.8699999999999992 111.187 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.15 135.66 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 8.9000000000000004 111.211 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.27 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 8.9299999999999997 111.206 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -99.42 19.54 15.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 8.9700000000000006 111.267 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 16.5 t -69.78 121.55 82.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 9.0 111.207 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 -26.47 19.09 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.648 1.565 . . . . 9.0299999999999994 111.162 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -119.62 62.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.0700000000000003 111.219 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -65.08 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 9.0999999999999996 111.177 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.51 -49.2 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 9.1300000000000008 111.219 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.44 ' HB2' HD21 ' A' ' 7' ' ' LEU . 99.5 mt -68.52 -34.75 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 9.1699999999999999 111.228 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.54 99.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 9.1999999999999993 111.237 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -47.94 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 9.2300000000000004 111.183 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.95 -40.1 95.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.259 -0.428 . . . . 9.2699999999999996 111.163 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -59.8 -52.04 67.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 9.3000000000000007 111.138 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.08 -44.58 94.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 9.3300000000000001 111.191 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.57 -35.12 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 9.3699999999999992 111.18 -167.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -93.9 -23.2 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 9.4000000000000004 111.172 -170.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -122.66 -66.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 9.4299999999999997 111.224 -171.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 67.3 tp -50.41 -56.03 13.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 9.4700000000000006 111.192 -167.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.9 mt -104.0 38.35 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 9.5 111.192 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.5 p -119.14 -165.73 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 9.5299999999999994 111.259 167.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.84 -10.87 60.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 9.5700000000000003 111.174 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -88.11 -54.41 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 9.5999999999999996 111.209 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.33 6.38 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.171 -0.772 . . . . 9.6300000000000008 111.171 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.13 -34.67 76.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 9.6699999999999999 111.189 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.55 -41.27 80.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 9.6999999999999993 111.216 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.32 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 9.7300000000000004 111.263 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.5 t -86.28 -40.3 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 9.7699999999999996 111.152 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.99 -23.62 63.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 9.8000000000000007 111.246 -172.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.71 -14.83 62.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 9.8300000000000001 111.175 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -111.16 -34.61 6.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 9.8699999999999992 111.164 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.98 162.67 20.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 9.9000000000000004 111.225 -174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.17 159.53 15.14 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.711 1.607 . . . . 9.9299999999999997 111.16 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.441 ' HB3' ' HG ' ' A' ' 311' ' ' LEU . 94.7 mt -99.75 39.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 9.9700000000000006 111.241 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.06 -61.26 7.57 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.198 -0.761 . . . . 10.0 111.198 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.18 153.98 2.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 10.029999999999999 111.19 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.06 159.55 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 10.07 111.153 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 90' ' ' TYR . . . -83.84 -30.2 26.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 10.1 111.174 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -67.03 121.61 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 10.130000000000001 111.16 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -68.31 -17.49 64.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.194 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 t -58.33 -40.36 81.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 10.199999999999999 111.223 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -108.65 7.29 26.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 10.23 111.209 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -57.7 -50.0 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 10.27 111.199 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.58 -29.97 61.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 10.300000000000001 111.18 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.61 -37.06 84.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 10.33 111.219 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' A' ' 299' ' ' LEU . 9.8 mp -82.73 -37.51 24.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 10.369999999999999 111.196 175.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -77.99 -4.65 48.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 10.4 111.196 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.13 -41.58 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 10.43 111.151 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.27 120.71 70.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 10.470000000000001 111.168 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.13 -29.72 47.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.703 1.602 . . . . 10.5 111.255 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.22 -23.14 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 10.529999999999999 111.175 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.3 mt -98.65 -39.42 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 10.57 111.202 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.49 -34.23 70.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 10.6 111.19 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.68 62.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.630000000000001 111.202 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 94.4 m -95.23 -42.33 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.243 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.7 mtp -65.01 -41.94 94.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 10.699999999999999 111.18 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 10.73 111.183 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -76.97 -16.94 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 10.77 111.237 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.54 49.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 10.800000000000001 111.228 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -80.34 -19.93 45.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 10.83 111.235 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.43 -4.14 32.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 10.869999999999999 111.086 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 256' ' ' LYS . . . -87.83 -170.06 45.85 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -86.41 99.95 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 10.93 111.205 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.15 136.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 10.970000000000001 111.203 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 53.0 ttm -46.59 124.93 7.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 11.0 111.258 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 54.3 Cg_exo -60.28 155.58 45.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.705 1.603 . . . . 11.029999999999999 111.2 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -94.89 15.99 17.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 11.07 111.274 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 82.4 mt -80.49 125.04 81.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 11.1 111.253 -169.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.51 -40.36 79.09 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.747 1.631 . . . . 11.130000000000001 111.154 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.26 -38.97 93.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 11.17 111.24 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.0 mmm -75.13 -23.74 57.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 11.199999999999999 111.165 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 41.6 t -62.64 -40.9 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 11.23 111.175 169.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.84 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 11.27 111.269 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -66.66 -27.38 67.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 11.300000000000001 111.235 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 65' ' ' ASP . 87.4 t90 -54.36 -46.51 73.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 11.33 111.198 -173.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -99.24 -23.0 15.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 11.369999999999999 111.213 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.57 91.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 11.4 111.214 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.58 -36.54 66.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 11.43 111.193 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.6 ttp180 -54.72 -45.1 74.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 11.470000000000001 111.208 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 95.6 m -61.66 -40.03 93.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 11.5 111.21 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.22 88.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.192 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.5 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 11.57 111.191 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.7 -48.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 11.6 111.135 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -69.03 -28.92 67.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 11.630000000000001 111.167 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.6 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 11.67 111.218 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.85 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 11.699999999999999 111.2 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -74.65 -17.41 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 11.73 111.182 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.76 26.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.231 -0.748 . . . . 11.77 111.231 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -99.99 -38.71 8.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 11.800000000000001 111.223 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -129.85 168.75 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 11.83 111.116 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 33.9 p -92.62 175.04 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 11.869999999999999 111.18 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.1 m -67.2 -14.36 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 11.9 111.19 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.69 -49.3 5.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 11.93 111.188 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.14 -39.34 75.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 11.970000000000001 111.169 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.81 96.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 12.0 111.228 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.84 -24.78 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 12.029999999999999 111.158 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.32 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 12.07 111.148 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -64.71 -39.63 93.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 12.1 111.169 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.4 80.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 12.130000000000001 111.18 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -71.95 -42.92 66.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 12.17 111.144 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.4 m -60.04 -36.91 78.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 12.199999999999999 111.159 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -80.13 -11.44 59.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 12.23 111.172 -173.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.3 mt -115.01 -66.81 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 12.27 111.211 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.9 p -96.1 -20.42 18.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 12.300000000000001 111.213 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--O 1.2 -1.545 0 CA-C-N 116.194 -0.457 . . . . 12.33 111.225 175.444 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.821 0.343 . . . . 0.029999999999999999 111.156 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm -88.26 110.18 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.070000000000000007 111.22 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.97 129.92 39.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.10000000000000001 111.178 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.2 139.96 58.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.13 111.23 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.58 2.29 57.57 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.17000000000000001 111.206 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.07 155.03 45.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.816 0.341 . . . . 0.20000000000000001 111.18 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.6 tp -104.18 115.05 29.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.23000000000000001 111.167 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -117.68 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.27000000000000002 111.196 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.21 114.97 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.29999999999999999 111.195 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -102.75 113.05 26.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.33000000000000002 111.249 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.6 tt -125.11 139.94 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.37 111.24 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -88.48 109.9 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.40000000000000002 111.178 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.4 47.82 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.213 -0.755 . . . . 0.42999999999999999 111.213 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -77.81 -69.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.46999999999999997 111.205 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -129.98 31.4 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.5 111.217 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.92 -19.68 69.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.239 -0.744 . . . . 0.53000000000000003 111.239 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -60.56 -24.37 65.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 0.56999999999999995 111.211 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -63.12 -49.95 72.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.59999999999999998 111.193 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.95 96.47 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.203 -0.759 . . . . 0.63 111.203 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.72 -31.48 66.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.818 0.342 . . . . 0.67000000000000004 111.22 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.12 91.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.69999999999999996 111.225 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.16 -35.02 74.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.72999999999999998 111.196 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 -41.25 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.77000000000000002 111.236 174.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -27.93 69.31 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.14 -0.784 . . . . 0.80000000000000004 111.14 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.45 -33.99 74.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.826 0.346 . . . . 0.82999999999999996 111.206 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.25 -39.05 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.87 111.199 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -61.02 -42.38 98.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 111.166 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.27 -41.59 99.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.93000000000000005 111.21 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.01 -35.96 69.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.96999999999999997 111.216 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.07 -40.12 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.178 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.5 p -103.27 -27.21 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.226 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.85 4.8 78.54 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.219 -0.753 . . . . 1.0700000000000001 111.219 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.5 mm -87.34 115.0 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 1.1000000000000001 111.212 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.03 124.9 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 1.1299999999999999 111.204 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.15 136.01 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.1699999999999999 111.248 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.4 t -142.56 147.84 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 1.2 111.171 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.32 132.68 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 1.23 111.217 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -140.02 176.37 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 1.27 111.262 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -119.02 75.25 14.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.3 111.149 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.15 158.32 49.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.695 1.596 . . . . 1.3300000000000001 111.217 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -123.15 -179.99 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 1.3700000000000001 111.182 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 55.09 34.63 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 1.3999999999999999 111.195 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.9 mt -74.92 -22.97 58.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 1.4299999999999999 111.284 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -70.03 -12.06 61.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.47 111.235 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.28 -36.05 5.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 1.5 111.199 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -71.33 -38.66 71.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 1.53 111.147 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.489 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.4 m-30 -61.39 -56.28 35.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 1.5700000000000001 111.206 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -66.95 -23.63 46.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.81 1.674 . . . . 1.6000000000000001 111.204 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -70.07 -45.22 67.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 111.196 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.51 -19.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 1.6699999999999999 111.192 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.0 -25.76 68.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.7 111.207 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.11 60.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 1.73 111.216 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p -109.7 -15.21 14.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 1.77 111.175 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.44 23.6 28.49 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.13 -0.788 . . . . 1.8 111.13 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.13 170.08 8.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 1.8300000000000001 111.208 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.92 179.03 21.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.233 -0.747 . . . . 1.8700000000000001 111.233 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 -174.74 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.642 1.561 . . . . 1.8999999999999999 111.267 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.25 -51.39 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 1.9299999999999999 111.244 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.94 134.22 57.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 1.97 111.245 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -129.77 127.07 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 2.0 111.236 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -98.75 127.64 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 2.0299999999999998 111.204 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -130.0 142.36 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 2.0699999999999998 111.118 169.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.06 145.0 56.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.218 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -46.61 -36.15 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 2.1299999999999999 111.258 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -81.66 -5.26 57.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 2.1699999999999999 111.211 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.64 -0.05 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 2.2000000000000002 111.206 174.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -65.02 -56.56 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 2.23 111.194 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.0 -33.52 74.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.185 -0.766 . . . . 2.27 111.185 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.34 -44.81 94.94 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.226 -0.749 . . . . 2.2999999999999998 111.226 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.01 -40.43 75.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.182 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.8 68.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 2.3700000000000001 111.183 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -60.39 -29.9 69.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 2.3999999999999999 111.205 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -68.12 -25.4 65.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 2.4300000000000002 111.193 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.37 32.38 22.72 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.19 -0.764 . . . . 2.4700000000000002 111.19 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -104.4 4.82 33.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 2.5 111.191 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.77 140.04 44.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 2.5299999999999998 111.191 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.71 154.51 20.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 2.5699999999999998 111.211 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.402 ' HA ' HG22 ' A' ' 104' ' ' ILE . 88.6 tt0 -74.82 134.74 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 2.6000000000000001 111.205 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.05 130.02 63.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 2.6299999999999999 111.184 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.2 m -116.83 113.34 40.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 2.6699999999999999 111.253 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.52 156.7 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.637 1.558 . . . . 2.7000000000000002 111.186 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.21 155.65 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 2.73 111.214 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.15 -53.83 52.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 2.77 111.205 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.41 84.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.7999999999999998 111.163 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -54.87 -51.94 64.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 2.8300000000000001 111.214 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -55.9 -42.72 76.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 2.8700000000000001 111.167 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.6 -29.68 70.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 2.8999999999999999 111.199 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.26 -17.93 58.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 2.9300000000000002 111.205 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 97.5 mt -83.41 153.5 24.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.9700000000000002 111.191 172.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.35 148.73 97.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 3.0 111.199 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.96 -15.0 18.93 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.699 1.599 . . . . 3.0299999999999998 111.252 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -96.55 -21.01 17.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 3.0699999999999998 111.154 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -78.43 -14.83 59.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 3.1000000000000001 111.191 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.419 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 49.8 m0 -63.05 -45.49 92.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.476 . . . . 3.1299999999999999 111.254 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.4 -11.82 60.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 3.1699999999999999 111.15 -170.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.54 -1.98 57.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 3.2000000000000002 111.237 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.55 10.3 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 3.23 111.228 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 94' ' ' TRP . 71.6 mtp180 -87.63 144.75 26.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 3.27 111.196 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 94.4 t80 -142.25 123.61 14.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 3.2999999999999998 111.161 171.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 97.5 m-20 65.0 20.75 12.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 3.3300000000000001 111.222 -169.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.56 -2.71 74.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.245 -0.742 . . . . 3.3700000000000001 111.245 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -115.44 144.24 44.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 3.3999999999999999 111.229 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.95 126.14 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 3.4300000000000002 111.214 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 78' ' ' GLU . 28.7 pt -130.12 14.96 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 3.4700000000000002 111.281 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.8 169.43 5.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 3.5 111.187 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -119.47 145.96 40.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 3.5299999999999998 111.183 170.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.94 -178.17 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.69 1.593 . . . . 3.5699999999999998 111.203 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.86 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 3.6000000000000001 111.153 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 3.6299999999999999 111.184 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -105.61 157.91 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.6699999999999999 111.168 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -87.48 179.98 6.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 3.7000000000000002 111.198 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.81 143.33 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 3.73 111.174 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.754 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.9 pp -160.03 144.37 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 3.77 111.219 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.2 t -169.96 -171.88 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 3.7999999999999998 111.171 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.1 tp -71.55 112.49 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 3.8300000000000001 111.229 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.75 125.92 71.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 3.8700000000000001 111.135 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -125.11 146.75 49.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 3.8999999999999999 111.217 -168.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -79.96 123.72 28.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 3.9300000000000002 111.237 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.53 -14.21 62.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 3.9700000000000002 111.171 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -89.98 -29.84 18.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 4.0 111.233 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.1 mt -98.55 -51.22 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 4.0300000000000002 111.164 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 46.6 tp -141.35 79.65 17.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 4.0700000000000003 111.191 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.25 -14.98 28.59 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.235 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -105.04 99.97 22.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 4.1299999999999999 111.21 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.43 156.98 45.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.255 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.19 167.18 28.0 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.686 1.59 . . . . 4.2000000000000002 111.239 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.42 -21.37 38.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 4.2300000000000004 111.206 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.2 t -161.54 172.02 17.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 4.2699999999999996 111.186 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -77.02 -12.02 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 4.2999999999999998 111.19 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.06 -8.75 57.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 4.3300000000000001 111.242 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.48 -4.28 31.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.3700000000000001 111.26 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.542 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 82.8 mt -69.69 -43.81 22.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 4.4000000000000004 111.158 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 55.4 Cg_exo -53.77 -40.15 81.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.71 1.607 . . . . 4.4299999999999997 111.171 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.8 90.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.4699999999999998 111.184 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.0 mt -64.99 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 4.5 111.255 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 4.5300000000000002 111.194 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.65 -31.57 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 4.5700000000000003 111.178 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.32 -32.83 55.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 4.5999999999999996 111.191 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.35 -5.09 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 4.6299999999999999 111.209 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.03 -39.99 75.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 4.6699999999999999 111.224 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.76 -29.31 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 4.7000000000000002 111.206 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.02 -18.74 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 4.7300000000000004 111.199 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 23.71 38.98 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.151 -0.779 . . . . 4.7699999999999996 111.151 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -100.08 149.32 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 4.7999999999999998 111.197 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -96.35 146.53 24.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 4.8300000000000001 111.191 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -100.24 5.54 44.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 4.8700000000000001 111.178 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 tp -160.34 130.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 4.9000000000000004 111.2 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 91.4 mmm -135.02 154.93 51.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 4.9299999999999997 111.237 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.84 165.05 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 4.9699999999999998 111.211 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 58.1 t-20 -73.9 89.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 5.0 111.159 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.16 -38.92 82.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.272 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.36 -53.81 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 5.0700000000000003 111.222 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 155' ' ' TYR . 43.0 tp10 -79.05 122.46 84.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 5.0999999999999996 111.194 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.86 -20.18 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.653 1.569 . . . . 5.1299999999999999 111.195 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.473 ' H ' ' HG3' ' A' ' 153' ' ' GLU . 82.6 t80 -59.44 -22.63 61.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 5.1699999999999999 111.203 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -113.95 29.66 7.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 5.2000000000000002 111.247 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 -22.93 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 5.2300000000000004 111.167 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.74 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 56.5 p-90 -84.57 -23.11 0.32 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 5.2699999999999996 111.213 -173.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.74 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 59.1 Cg_exo -49.1 -40.72 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.679 1.586 . . . . 5.2999999999999998 111.169 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.02 -34.98 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.151 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.36 -32.2 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 5.3700000000000001 111.215 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.11 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 5.4000000000000004 111.17 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.66 -28.33 69.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 5.4299999999999997 111.205 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -89.11 -28.75 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 5.4699999999999998 111.22 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.74 41.88 2.41 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.202 -0.759 . . . . 5.5 111.202 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -107.84 -14.58 16.96 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.189 -0.764 . . . . 5.5300000000000002 111.189 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -105.26 99.04 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 5.5700000000000003 111.179 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.81 47.57 10.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 5.5999999999999996 111.115 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -126.06 139.99 52.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 5.6299999999999999 111.188 171.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.17 134.36 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.155 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -87.34 79.92 8.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 5.7000000000000002 111.173 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 82.8 tt0 -137.98 66.02 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 5.7300000000000004 111.217 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 77.0 m-20 73.38 -72.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 5.7699999999999996 111.154 173.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -147.34 13.82 1.43 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.167 -0.773 . . . . 5.7999999999999998 111.167 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.08 114.31 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 5.8300000000000001 111.225 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -118.39 77.06 1.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 5.8700000000000001 111.241 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -65.03 127.32 31.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 5.9000000000000004 111.163 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.46 -12.93 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 5.9299999999999997 111.155 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -74.6 -22.07 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 5.9699999999999998 111.165 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -95.62 103.27 15.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 6.0 111.182 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.14 133.84 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 6.0300000000000002 111.194 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.73 39.27 3.1 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.279 -0.728 . . . . 6.0700000000000003 111.279 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.56 -20.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 6.0999999999999996 111.164 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -111.33 14.26 21.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 6.1299999999999999 111.173 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -76.85 150.64 36.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 6.1699999999999999 111.254 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.94 83.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 6.2000000000000002 111.217 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.47 -28.94 72.02 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.9 76.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 6.2699999999999996 111.174 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -79.3 -36.48 39.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 6.2999999999999998 111.206 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.87 74.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.184 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.22 -38.69 94.04 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.175 -0.77 . . . . 6.3700000000000001 111.175 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.5 tp -69.21 -35.3 76.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 6.4000000000000004 111.163 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.0 m -58.97 -39.36 81.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 6.4299999999999997 111.247 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.25 -43.46 97.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.229 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.43 -46.24 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 6.5 111.185 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.61 -26.98 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 6.5300000000000002 111.16 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -73.3 -36.8 66.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 6.5700000000000003 111.194 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.93 -34.67 78.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 6.5999999999999996 111.202 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.99 -44.87 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.169 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.74 -37.71 82.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 6.6699999999999999 111.213 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -86.72 4.97 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 6.7000000000000002 111.188 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 59.83 40.73 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 6.7300000000000004 111.135 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -98.86 -30.63 12.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 6.7699999999999996 111.238 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 96.6 mmm -120.07 141.53 49.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 6.7999999999999998 111.211 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.04 147.2 28.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 6.8300000000000001 111.138 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.55 -30.25 68.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 6.8700000000000001 111.176 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -85.11 -9.63 57.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 6.9000000000000004 111.244 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -57.04 128.73 38.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 6.9299999999999997 111.209 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 43.6 p30 -140.03 -165.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 6.9699999999999998 111.195 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -61.22 -47.35 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 7.0 111.212 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.7 p -70.09 -27.66 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 7.0300000000000002 111.176 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.16 -45.89 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 7.0700000000000003 111.233 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.7 98.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 7.0999999999999996 111.163 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -67.92 -37.09 81.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 7.1299999999999999 111.161 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.81 82.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 7.1699999999999999 111.219 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 7.2000000000000002 111.276 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -69.79 -25.95 64.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 7.2300000000000004 111.253 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -73.07 -14.68 61.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 7.2699999999999996 111.191 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.51 -17.66 13.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 7.2999999999999998 111.18 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.95 27.75 33.37 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.206 -0.758 . . . . 7.3300000000000001 111.206 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 7.3700000000000001 111.2 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 85.8 m -128.34 124.29 36.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 7.4000000000000004 111.203 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.12 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 7.4299999999999997 111.164 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -156.54 165.01 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 7.4699999999999998 111.207 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.0 t -146.56 178.96 7.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 7.5 111.221 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.6 tt -122.26 112.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 7.5300000000000002 111.147 174.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -169.98 -178.62 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 7.5700000000000003 111.224 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -108.16 -165.7 21.28 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.222 -0.751 . . . . 7.5999999999999996 111.222 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -61.9 -18.9 63.67 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.745 1.63 . . . . 7.6299999999999999 111.214 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 7.6699999999999999 111.171 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.77 -25.7 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.203 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.415 ' HA ' HD12 ' A' ' 235' ' ' ILE . 51.9 t90 -80.02 -10.02 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 7.7300000000000004 111.202 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -64.99 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 7.7699999999999996 111.204 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -84.79 -29.97 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 7.7999999999999998 111.218 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 232' ' ' TRP . 88.8 mt -66.59 -38.59 81.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 7.8300000000000001 111.193 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.3 -40.97 86.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 7.8700000000000001 111.148 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 93.8 m -65.05 -40.89 95.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 7.9000000000000004 111.255 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.8 p -77.92 -13.41 59.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 7.9299999999999997 111.231 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 60.02 50.15 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 7.9699999999999998 111.171 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.82 140.27 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 8.0 111.234 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -77.88 92.0 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 8.0299999999999994 111.244 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -101.08 140.84 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 8.0700000000000003 111.225 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.01 -179.64 20.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.159 -0.776 . . . . 8.0999999999999996 111.159 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 141.83 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.87 0.367 . . . . 8.1300000000000008 111.172 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.2 t -123.06 -171.54 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 8.1699999999999999 111.207 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -122.09 109.92 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 8.1999999999999993 111.247 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.555 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 88.2 mt -83.05 -40.54 0.82 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 8.2300000000000004 111.19 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 85.7 Cg_exo -52.76 110.28 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.723 1.616 . . . . 8.2699999999999996 111.197 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -139.89 130.0 25.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 8.3000000000000007 111.167 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -117.23 108.83 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 8.3300000000000001 111.263 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 58.08 35.59 25.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 8.3699999999999992 111.185 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.11 -8.56 69.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.158 -0.777 . . . . 8.4000000000000004 111.158 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -104.28 109.98 63.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.197 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.86 148.46 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.746 1.63 . . . . 8.4700000000000006 111.128 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.7 p -135.03 -105.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 8.5 111.184 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 48.8 tptt -159.52 133.58 5.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 8.5299999999999994 111.182 -170.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 77.2 Cg_exo -55.02 144.0 70.65 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.693 1.595 . . . . 8.5700000000000003 111.155 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -69.54 131.04 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 8.5999999999999996 111.249 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.05 -178.93 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 8.6300000000000008 111.152 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.23 -160.52 10.41 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.56 169.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 8.6999999999999993 111.209 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.86 119.92 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 8.7300000000000004 111.191 165.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.5 m -103.2 113.61 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 8.7699999999999996 111.2 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.28 115.44 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 8.8000000000000007 111.176 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -115.24 178.19 17.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.21 -0.756 . . . . 8.8300000000000001 111.21 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 99.1 mt -111.92 130.65 65.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 8.8699999999999992 111.267 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.29 126.06 26.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 8.9000000000000004 111.203 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.51 64.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 8.9299999999999997 111.126 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -94.35 -5.03 47.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 8.9700000000000006 111.132 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.32 132.63 95.27 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 9.0 111.185 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.6 -10.21 17.2 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.734 1.623 . . . . 9.0299999999999994 111.204 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -121.4 60.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 9.0700000000000003 111.2 -175.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.55 -29.03 52.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 9.0999999999999996 111.156 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.84 -40.03 76.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 9.1300000000000008 111.167 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.76 -35.6 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 9.1699999999999999 111.127 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.05 90.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 9.1999999999999993 111.146 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.49 -43.58 84.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 9.2300000000000004 111.246 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -56.48 -53.88 52.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 9.2699999999999996 111.214 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -54.73 -57.24 12.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 9.3000000000000007 111.163 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.1 -52.62 64.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 9.3300000000000001 111.232 -174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -79.41 -45.12 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 9.3699999999999992 111.174 -165.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -98.94 -11.8 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 9.4000000000000004 111.217 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -125.0 -65.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 9.4299999999999997 111.21 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 69.8 tp -59.62 -49.12 78.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 9.4700000000000006 111.229 -169.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 72.6 mt -97.78 40.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 9.5 111.195 -171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.0 p -105.07 176.58 5.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 9.5299999999999994 111.234 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.76 -30.33 70.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 9.5700000000000003 111.192 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -87.05 -40.08 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 9.5999999999999996 111.171 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -61.85 -46.98 93.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.245 -0.742 . . . . 9.6300000000000008 111.245 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.71 -21.97 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 9.6699999999999999 111.225 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -69.91 -39.36 76.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 9.6999999999999993 111.256 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.43 -29.55 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 9.7300000000000004 111.219 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 73.7 t -73.27 -42.85 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 9.7699999999999996 111.174 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -85.32 5.18 31.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 9.8000000000000007 111.255 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -54.25 -40.01 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 9.8300000000000001 111.208 167.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -106.88 -32.76 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 9.8699999999999992 111.163 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.93 160.04 41.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 9.9000000000000004 111.198 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.62 140.17 75.99 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.646 1.564 . . . . 9.9299999999999997 111.174 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.69 -17.74 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 9.9700000000000006 111.18 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.84 68.47 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.27 101.79 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 10.029999999999999 111.253 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.58 129.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 10.07 111.258 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -114.47 -10.62 12.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 10.1 111.258 165.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.61 117.18 27.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 10.130000000000001 111.204 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.04 -42.11 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.166 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.3 p -64.89 -30.01 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 10.199999999999999 111.179 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -72.16 -42.23 66.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 10.23 111.201 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.72 -30.02 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.205 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.15 -28.66 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 10.300000000000001 111.245 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.85 -32.06 40.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 10.33 111.172 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.25 -29.2 69.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 10.369999999999999 111.219 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.63 -18.61 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 10.4 111.173 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.97 -31.64 69.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 10.43 111.242 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 317' ' ' ILE . 10.1 t70 -70.0 121.53 83.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 10.470000000000001 111.231 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.96 -34.9 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.688 1.592 . . . . 10.5 111.181 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.53 -53.5 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 10.529999999999999 111.23 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 314' ' ' ASP . 94.9 mt -64.45 -30.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 10.57 111.292 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.02 62.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 10.6 111.105 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.35 90.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.421 . . . . 10.630000000000001 111.235 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.0 m -70.27 -40.06 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 10.67 111.161 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.9 mmt -70.55 -31.36 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.149 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.58 -45.93 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 10.73 111.195 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -75.93 -31.99 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 10.77 111.213 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.96 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 10.800000000000001 111.225 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.09 -25.43 67.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 10.83 111.173 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.06 -24.71 40.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 10.869999999999999 111.162 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -74.88 158.06 50.91 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.205 -0.758 . . . . 10.9 111.205 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -127.11 163.66 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.764 0.316 . . . . 10.93 111.259 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 48.7 mm -110.4 133.29 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 10.970000000000001 111.178 -169.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.89 122.38 79.01 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 11.0 111.244 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.15 150.52 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.754 1.636 . . . . 11.029999999999999 111.166 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -113.57 -25.22 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 11.07 111.23 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 97.6 mt -40.07 130.01 1.61 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 11.1 111.138 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.98 -37.72 68.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.708 1.605 . . . . 11.130000000000001 111.186 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.05 -39.51 92.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 11.17 111.21 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 99.7 mmm -75.09 -34.23 61.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 11.199999999999999 111.135 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.2 m -69.67 -33.35 72.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 11.23 111.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 11.27 111.179 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -65.57 -35.92 82.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 11.300000000000001 111.16 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.488 ' HE3' ' HA ' ' A' ' 340' ' ' TRP . 4.2 m95 -70.01 -38.41 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 11.33 111.233 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -60.7 -40.29 91.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.176 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.41 73.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 11.4 111.175 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.84 -29.7 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 11.43 111.174 -174.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -69.94 -38.76 76.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 11.470000000000001 111.247 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.2 m -69.33 -37.3 77.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 11.5 111.208 173.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.32 94.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 11.529999999999999 111.172 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.57 -24.73 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 11.57 111.223 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.04 -45.97 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 11.6 111.177 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.23 -36.55 83.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 11.630000000000001 111.164 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.06 -43.75 61.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.452 . . . . 11.67 111.186 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.226 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.3 p -71.37 -15.02 62.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 11.73 111.231 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 92.19 25.69 20.96 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 111.24 -0.744 . . . . 11.77 111.24 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.03 -39.9 7.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 11.800000000000001 111.186 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -113.86 172.5 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 11.83 111.249 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -99.94 165.68 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 11.869999999999999 111.199 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.85 -16.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 11.9 111.227 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.85 -51.11 4.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 11.93 111.236 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -70.3 -31.42 68.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 11.970000000000001 111.129 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.79 -40.35 95.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 12.0 111.192 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.61 -30.83 61.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 12.029999999999999 111.125 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.42 -45.54 83.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 12.07 111.218 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.08 -41.92 99.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 12.1 111.197 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.79 -45.22 75.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 12.130000000000001 111.198 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -56.68 -36.58 69.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 12.17 111.224 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.3 m -47.86 -35.09 9.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 12.199999999999999 111.172 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -104.29 -34.99 8.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 12.23 111.161 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.13 -48.72 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 12.27 111.166 -174.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.4 p -112.92 -29.78 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 12.300000000000001 111.268 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.2 -1.501 0 CA-C-N 116.163 -0.471 . . . . 12.33 111.259 178.846 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.817 0.342 . . . . 0.070000000000000007 111.189 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -53.52 136.23 38.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.10000000000000001 111.235 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.25 144.97 32.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.13 111.173 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.32 16.77 63.82 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.211 -0.756 . . . . 0.17000000000000001 111.211 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.06 149.67 52.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.20000000000000001 111.22 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -122.86 101.22 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.23000000000000001 111.171 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.1 t -98.18 125.06 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.27000000000000002 111.212 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.6 mt -121.07 112.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.29999999999999999 111.202 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -92.09 92.75 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.33000000000000002 111.221 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -71.02 150.12 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.37 111.176 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -132.13 111.98 11.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.162 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.04 174.11 26.32 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.171 -0.771 . . . . 0.42999999999999999 111.171 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 -50.18 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.46999999999999997 111.195 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -125.01 -135.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.5 111.192 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.49 -7.65 78.17 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.53000000000000003 111.224 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -64.77 -54.67 27.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.56999999999999995 111.201 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.32 -40.69 97.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.59999999999999998 111.228 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.84 -53.35 44.79 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.225 -0.75 . . . . 0.63 111.225 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.0 tp -70.68 -32.4 69.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.67000000000000004 111.239 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.76 97.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.202 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.33 -38.27 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.219 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.91 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.77000000000000002 111.193 173.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.46 -38.42 96.32 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 0.80000000000000004 111.22 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.7 -44.42 96.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.82999999999999996 111.176 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.98 -41.49 92.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.87 111.209 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -59.28 -48.35 81.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.90000000000000002 111.241 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -64.35 -34.11 77.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.93000000000000005 111.185 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -69.18 -31.64 70.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.96999999999999997 111.22 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.05 -31.36 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.221 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.5 p -101.85 -29.87 11.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 1.03 111.201 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.04 5.68 83.0 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.223 -0.751 . . . . 1.0700000000000001 111.223 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.58 121.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 1.1000000000000001 111.219 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -61.67 119.51 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 1.1299999999999999 111.176 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.02 131.08 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 1.1699999999999999 111.247 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -123.43 110.26 14.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.2 111.164 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.7 t -101.84 131.77 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 1.23 111.186 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -152.92 169.98 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 1.27 111.215 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -140.3 76.87 25.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.3 111.194 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.83 80.0 2.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.724 1.616 . . . . 1.3300000000000001 111.213 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 29.7 t0 -52.29 162.97 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 1.3700000000000001 111.215 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 93.0 mttt 68.12 43.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.3999999999999999 111.173 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.29 -21.56 64.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 1.4299999999999999 111.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.89 -27.27 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 1.47 111.204 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -114.18 -25.48 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 1.5 111.209 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -94.37 -36.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 1.53 111.13 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 85.7 t80 -63.51 -43.06 77.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 1.5700000000000001 111.199 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 88.6 Cg_exo -53.05 -31.35 53.45 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.716 1.611 . . . . 1.6000000000000001 111.213 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -64.19 -32.94 74.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 1.6299999999999999 111.206 -173.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.7 m -100.06 -26.22 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 1.6699999999999999 111.167 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.7 111.206 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.33 -4.91 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.73 111.243 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -115.0 5.0 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 1.77 111.203 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.57 58.65 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.176 -0.77 . . . . 1.8 111.176 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -120.02 -165.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 1.8300000000000001 111.193 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.23 -162.96 12.67 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.159 -0.776 . . . . 1.8700000000000001 111.159 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.88 178.17 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.711 1.607 . . . . 1.8999999999999999 111.206 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.46 -40.85 10.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.9299999999999999 111.189 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.38 138.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 1.97 111.18 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.8 tt -143.92 138.78 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 2.0 111.199 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 29.8 m-85 -105.12 142.78 34.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 2.0299999999999998 111.233 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -134.49 155.6 50.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 2.0699999999999998 111.194 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . . . -68.13 159.22 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 2.1000000000000001 111.153 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -53.98 -33.58 57.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 2.1299999999999999 111.2 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -82.11 -49.94 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 2.1699999999999999 111.205 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -65.32 -31.13 72.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 2.2000000000000002 111.19 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -56.8 -36.11 69.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.23 111.18 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.08 -39.18 49.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.15 -0.78 . . . . 2.27 111.15 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.23 64.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.772 . . . . 2.2999999999999998 111.171 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.24 -49.3 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 2.3300000000000001 111.222 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.88 78.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 2.3700000000000001 111.212 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -58.2 -41.8 84.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.214 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.0 p -66.83 -17.9 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 2.4300000000000002 111.213 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.6 25.79 37.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.228 -0.749 . . . . 2.4700000000000002 111.228 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.61 2.54 44.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 2.5 111.205 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.17 117.27 28.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 2.5299999999999998 111.225 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.82 153.36 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.235 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.62 129.19 39.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 2.6000000000000001 111.206 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.36 129.59 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 2.6299999999999999 111.227 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 p -129.36 87.08 54.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 2.6699999999999999 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -58.48 150.17 70.22 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 2.7000000000000002 111.209 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -43.78 139.68 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 2.73 111.201 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.84 -39.59 39.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 2.77 111.174 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.79 85.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 2.7999999999999998 111.197 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -66.93 -40.07 87.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 2.8300000000000001 111.215 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.39 -30.87 71.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 2.8700000000000001 111.172 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.64 -35.02 67.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 2.8999999999999999 111.212 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.99 -16.22 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 2.9300000000000002 111.224 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -75.52 121.76 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 2.9700000000000002 111.191 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -69.14 144.79 95.69 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 3.0 111.217 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.36 -34.89 72.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.666 1.577 . . . . 3.0299999999999998 111.235 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 7.6 m-30 -64.62 -32.65 74.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 3.0699999999999998 111.184 -175.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -108.1 -21.61 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 3.1000000000000001 111.175 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -70.25 -41.32 73.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 3.1299999999999999 111.188 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.86 -27.82 63.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 3.1699999999999999 111.216 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.12 -21.03 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.2000000000000002 111.213 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.0 m -111.68 25.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 3.23 111.165 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -102.71 167.88 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 3.27 111.201 171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 37.1 t80 -163.29 130.02 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 3.2999999999999998 111.152 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 95.7 m-20 65.0 21.48 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 3.3300000000000001 111.224 -173.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.96 11.16 77.21 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.193 -0.763 . . . . 3.3700000000000001 111.193 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -122.84 143.03 50.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 3.3999999999999999 111.195 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.5 tp -75.09 118.74 18.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 3.4300000000000002 111.189 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 pt -117.53 -20.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 3.4700000000000002 111.203 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.13 177.09 9.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 3.5 111.227 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -140.84 142.62 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 3.5299999999999998 111.209 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.3 155.98 41.6 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.728 1.618 . . . . 3.5699999999999998 111.217 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 tp -134.74 -30.0 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 3.6000000000000001 111.186 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.49 149.64 29.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 3.6299999999999999 111.22 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -124.99 120.58 58.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 3.6699999999999999 111.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -124.68 157.22 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.7000000000000002 111.191 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.05 155.01 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 3.73 111.236 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.34 175.8 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 3.77 111.173 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.3 p -171.78 170.19 5.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 3.7999999999999998 111.175 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.492 HD23 ' C ' ' A' ' 115' ' ' LEU . 5.9 tt -97.1 99.94 11.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 3.8300000000000001 111.212 175.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.16 127.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 3.8700000000000001 111.194 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -140.26 160.81 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 3.8999999999999999 111.177 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -75.77 109.02 9.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 3.9300000000000002 111.183 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -81.33 -37.8 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 3.9700000000000002 111.173 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -54.97 -45.14 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 4.0 111.205 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.81 -61.25 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 4.0300000000000002 111.17 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.9 mt -127.58 92.64 42.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 4.0700000000000003 111.21 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.01 -19.0 46.21 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.665 1.577 . . . . 4.0999999999999996 111.205 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -98.47 105.83 32.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 4.1299999999999999 111.2 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.51 164.91 23.4 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.697 1.598 . . . . 4.1699999999999999 111.227 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.05 125.43 17.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.68 1.587 . . . . 4.2000000000000002 111.196 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.48 -23.64 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 4.2300000000000004 111.185 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 130' ' ' GLU . 14.3 t -157.48 -177.25 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 4.2699999999999996 111.186 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -71.49 -25.3 62.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 4.2999999999999998 111.163 -170.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.453 ' H ' HG23 ' A' ' 128' ' ' THR . 98.7 mt-10 -71.25 -17.26 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 4.3300000000000001 111.215 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -100.41 4.38 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 4.3700000000000001 111.226 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.515 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 24.8 mm -75.23 -51.03 3.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.4000000000000004 111.176 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.515 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 94.6 Cg_endo -74.58 -13.39 22.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.692 1.595 . . . . 4.4299999999999997 111.181 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.7 78.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 4.4699999999999998 111.178 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.03 -30.05 22.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 4.5 111.194 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.82 -33.43 75.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 4.5300000000000002 111.181 168.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.77 -45.08 72.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 4.5700000000000003 111.161 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.35 -30.48 71.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 4.5999999999999996 111.254 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.74 -14.66 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.178 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.65 -44.56 73.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 4.6699999999999999 111.226 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.93 -16.86 60.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 4.7000000000000002 111.213 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -95.11 3.01 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 4.7300000000000004 111.225 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.96 25.19 69.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.243 -0.743 . . . . 4.7699999999999996 111.243 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -136.97 -179.93 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 4.7999999999999998 111.227 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.2 t -149.9 140.29 22.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 4.8300000000000001 111.196 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.33 -45.6 19.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 4.8700000000000001 111.227 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.453 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 31.8 tp -77.79 124.84 28.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 4.9000000000000004 111.176 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 99.3 mmm -124.99 50.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 4.9299999999999997 111.214 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -76.36 147.4 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 4.9699999999999998 111.214 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -71.66 102.05 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 5.0 111.219 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.31 -19.14 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.201 -172.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -39.96 96.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 5.0700000000000003 111.157 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -98.56 160.03 29.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.21 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.36 3.51 6.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.668 1.578 . . . . 5.1299999999999999 111.225 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -49.41 -55.01 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 5.1699999999999999 111.248 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.67 36.54 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 5.2000000000000002 111.192 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.2 p -126.34 -22.95 3.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 5.2300000000000004 111.152 168.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.487 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 88.8 t90 -67.56 -48.26 44.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 5.2699999999999996 111.2 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 91.5 Cg_endo -76.99 -14.97 16.73 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.713 1.608 . . . . 5.2999999999999998 111.192 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.85 -44.28 93.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 5.3300000000000001 111.229 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 87.2 mt -65.45 -45.03 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 5.3700000000000001 111.189 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.19 65.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 5.4000000000000004 111.162 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.13 72.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.175 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -64.97 -27.01 68.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.231 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.41 -3.64 50.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.226 -0.75 . . . . 5.5 111.226 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.8 -12.97 70.65 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.171 -0.771 . . . . 5.5300000000000002 111.171 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.93 130.33 31.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 5.5700000000000003 111.176 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.18 21.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 5.5999999999999996 111.195 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -140.0 90.11 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 5.6299999999999999 111.194 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.199 -178.214 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 57.1 t0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.814 0.34 . . . . 5.9000000000000004 111.193 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.3 pt -112.27 16.37 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 5.9299999999999997 111.197 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.29 -28.97 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 5.9699999999999998 111.194 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -74.99 169.72 17.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 6.0 111.216 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.43 124.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 6.0300000000000002 111.206 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.99 -18.94 25.56 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.0 m -68.66 -14.58 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.75 0.309 . . . . 6.0999999999999996 111.161 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -88.26 5.0 43.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 6.1299999999999999 111.208 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -95.28 150.02 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 6.1699999999999999 111.207 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.18 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 6.2000000000000002 111.22 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.92 99.91 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.206 -0.758 . . . . 6.2300000000000004 111.206 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.24 90.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 6.2699999999999996 111.223 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.4 -35.07 79.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.2999999999999998 111.213 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.07 92.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 6.3300000000000001 111.22 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.7 -45.25 96.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.166 -0.774 . . . . 6.3700000000000001 111.166 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.7 tp -71.9 -32.57 67.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 6.4000000000000004 111.213 178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.5 m -62.29 -40.1 95.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 6.4299999999999997 111.181 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -59.75 -45.92 90.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 6.4699999999999998 111.187 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.8 tp -53.16 -59.47 4.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 6.5 111.197 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 6.5300000000000002 111.194 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.27 -41.41 94.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 6.5700000000000003 111.233 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.419 ' HB2' ' SD ' ' A' ' 204' ' ' MET . 79.8 mt -76.4 -23.01 54.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 6.5999999999999996 111.17 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.66 -43.2 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.217 168.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.91 -24.23 62.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 6.6699999999999999 111.207 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -89.73 5.46 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 6.7000000000000002 111.214 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 63.61 37.5 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 6.7300000000000004 111.193 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -110.76 -34.98 6.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 6.7699999999999996 111.253 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 198' ' ' LEU . 76.4 mtp -108.79 154.41 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 6.7999999999999998 111.161 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -127.02 111.56 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 6.8300000000000001 111.215 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.71 -17.9 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 6.8700000000000001 111.182 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -84.51 -26.09 28.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 6.9000000000000004 111.25 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -61.23 132.25 53.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 6.9299999999999997 111.181 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -139.39 -165.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 6.9699999999999998 111.189 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -58.77 -50.06 75.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 7.0 111.144 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.0 p -69.56 -32.61 71.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.192 -171.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.75 -46.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 7.0700000000000003 111.188 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.17 93.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 7.0999999999999996 111.219 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.49 -46.04 87.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 7.1299999999999999 111.199 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.26 96.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 7.1699999999999999 111.191 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.0 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 7.2000000000000002 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -70.59 -45.03 66.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 7.2300000000000004 111.212 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.76 -32.72 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 7.2699999999999996 111.226 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -83.49 -26.11 30.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 7.2999999999999998 111.159 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.28 19.92 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.168 -0.773 . . . . 7.3300000000000001 111.168 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -70.99 -30.07 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 7.3700000000000001 111.227 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.2 p -117.08 164.18 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 7.4000000000000004 111.217 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.78 -22.28 31.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 7.4299999999999997 111.205 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.64 170.28 21.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 7.4699999999999998 111.177 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.7 t -148.0 140.0 24.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 7.5 111.195 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 147' ' ' LEU . 88.2 mt -112.82 117.01 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 7.5300000000000002 111.183 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' A' ' 235' ' ' ILE . 7.4 t-20 -158.83 177.68 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 7.5700000000000003 111.169 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -79.6 170.46 54.19 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.227 -0.749 . . . . 7.5999999999999996 111.227 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.35 -17.08 21.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 7.6299999999999999 111.207 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -70.3 -30.08 66.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 7.6699999999999999 111.168 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.63 -4.84 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 7.7000000000000002 111.154 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 4.2 t90 -62.26 -29.52 70.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 7.7300000000000004 111.215 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 92.0 p -64.85 -21.43 66.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 7.7699999999999996 111.224 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.2 -30.1 12.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 7.7999999999999998 111.218 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 227' ' ' ASN . 83.3 mt -65.28 -34.68 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.227 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -80.16 7.83 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 7.8700000000000001 111.219 -169.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.5 m -58.31 -32.5 68.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 7.9000000000000004 111.207 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 66.5 m -69.98 -19.0 63.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 7.9299999999999997 111.21 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 60.43 38.91 19.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 7.9699999999999998 111.217 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.45 169.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 8.0 111.204 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -73.36 107.78 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 8.0299999999999994 111.206 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -102.44 133.42 47.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 8.0700000000000003 111.176 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -104.01 179.34 25.03 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.206 -0.758 . . . . 8.0999999999999996 111.206 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.9 137.89 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.757 0.313 . . . . 8.1300000000000008 111.193 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -145.88 -175.21 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 8.1699999999999999 111.214 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.2 t -78.87 125.24 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 8.1999999999999993 111.253 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.582 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 56.7 tp -79.7 -51.37 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 8.2300000000000004 111.202 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 89.2 Cg_endo -80.38 154.94 21.65 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.696 1.597 . . . . 8.2699999999999996 111.209 -173.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 85.1 m -124.98 109.88 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 8.3000000000000007 111.164 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.78 104.78 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 8.3300000000000001 111.22 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 55.25 35.05 24.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 8.3699999999999992 111.23 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.86 76.15 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.192 -0.763 . . . . 8.4000000000000004 111.192 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -129.99 109.97 16.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 8.4299999999999997 111.209 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.77 150.3 61.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.693 1.595 . . . . 8.4700000000000006 111.168 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 83.7 p -139.34 -72.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 8.5 111.232 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 47.3 tptt -159.42 129.89 3.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 8.5299999999999994 111.193 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.413 ' HA ' ' HG3' ' A' ' 248' ' ' PRO . 51.3 Cg_exo -55.03 157.04 14.19 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.739 1.626 . . . . 8.5700000000000003 111.22 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -67.28 146.0 54.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 8.5999999999999996 111.208 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.402 ' HB ' HD13 ' A' ' 329' ' ' ILE . 85.7 t -109.72 113.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 8.6300000000000008 111.175 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.07 115.04 5.01 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.163 -0.775 . . . . 8.6699999999999999 111.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.4 t -101.89 116.42 45.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 8.6999999999999993 111.2 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 63' ' ' ALA . 10.4 mp -73.16 144.82 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 8.7300000000000004 111.225 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 99.4 p -142.43 159.63 41.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 8.7699999999999996 111.203 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -130.52 156.23 45.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 8.8000000000000007 111.198 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.15 175.55 20.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.264 -0.735 . . . . 8.8300000000000001 111.264 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.8 129.97 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 8.8699999999999992 111.183 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.54 120.96 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.181 -173.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.76 -23.46 66.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 8.9299999999999997 111.186 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.0 58.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 8.9700000000000006 111.236 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.1 t -83.28 121.46 76.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 9.0 111.183 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.12 3.32 7.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.705 1.603 . . . . 9.0299999999999994 111.201 169.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.26 36.92 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 9.0700000000000003 111.241 -172.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -62.34 -24.11 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 9.0999999999999996 111.232 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.69 -30.48 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 9.1300000000000008 111.252 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -72.09 -43.37 64.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 9.1699999999999999 111.206 174.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.68 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 9.1999999999999993 111.218 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.79 -56.35 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.2300000000000004 111.2 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -65.46 -43.03 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 9.2699999999999996 111.183 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.39 -50.21 73.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 9.3000000000000007 111.19 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.76 -53.13 61.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 9.3300000000000001 111.203 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.79 -30.67 56.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 9.3699999999999992 111.181 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -97.62 -27.4 14.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 9.4000000000000004 111.238 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.71 -64.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 9.4299999999999997 111.223 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 45.5 tp -60.85 -41.84 96.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 9.4700000000000006 111.242 -166.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 37.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.205 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 97.4 m -114.78 141.38 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 9.5299999999999994 111.249 170.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -49.05 -40.49 31.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 9.5700000000000003 111.221 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.06 -46.37 85.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 9.5999999999999996 111.14 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.66 -40.55 90.27 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.241 -0.744 . . . . 9.6300000000000008 111.241 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.29 -35.5 81.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 9.6699999999999999 111.185 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.75 -40.85 84.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 9.6999999999999993 111.224 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 9.7300000000000004 111.22 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.79 -37.66 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 9.7699999999999996 111.182 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.573 ' HB3' HD23 ' A' ' 299' ' ' LEU . 98.1 m-20 -81.88 5.06 20.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.428 . . . . 9.8000000000000007 111.207 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.15 -33.22 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 9.8300000000000001 111.209 165.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -107.42 -38.73 5.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8699999999999992 111.179 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -87.78 161.44 44.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.9000000000000004 111.191 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -55.03 144.65 67.65 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.671 1.581 . . . . 9.9299999999999997 111.186 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.573 HD23 ' HB3' ' A' ' 294' ' ' ASN . 93.7 mt -68.37 -20.6 64.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 9.9700000000000006 111.232 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.94 -26.81 67.71 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.185 -0.766 . . . . 10.0 111.185 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.18 133.99 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 10.029999999999999 111.191 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.6 138.66 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 10.07 111.191 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.49 -48.02 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 10.1 111.186 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 85.0 mt -116.82 152.54 34.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 10.130000000000001 111.242 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -54.44 -37.24 64.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 10.17 111.182 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.0 p -56.18 -29.46 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 10.199999999999999 111.195 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -88.59 -35.83 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 10.23 111.2 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -60.06 -27.44 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 10.27 111.205 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.33 -30.4 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.151 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.77 -31.65 35.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 10.33 111.193 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.45 -21.72 62.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 10.369999999999999 111.219 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.95 66.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 10.4 111.203 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.82 -30.08 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 10.43 111.145 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 119.03 75.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.178 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.49 -35.47 96.69 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.73 1.62 . . . . 10.5 111.217 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -85.08 -51.11 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 10.529999999999999 111.218 -172.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.19 -39.81 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 10.57 111.172 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.04 85.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 10.6 111.187 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.21 86.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 10.630000000000001 111.181 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -64.51 -44.87 89.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 10.67 111.187 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.8 mmm -67.07 -34.65 78.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 10.699999999999999 111.183 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.5 -45.85 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 10.73 111.194 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 256' ' ' LYS . 99.3 m-20 -73.18 -22.42 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 10.77 111.159 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.05 -31.82 65.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 10.800000000000001 111.248 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.97 -18.29 64.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 10.83 111.177 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.25 -8.89 59.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 10.869999999999999 111.202 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -104.83 -141.89 11.13 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 10.9 111.226 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -145.0 136.34 25.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 10.93 111.174 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.402 HD13 ' HB ' ' A' ' 259' ' ' VAL . 49.2 mm -77.58 128.94 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 10.970000000000001 111.194 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 37.5 mmt -79.55 116.01 57.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 11.0 111.231 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.94 155.12 57.98 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.724 1.616 . . . . 11.029999999999999 111.195 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -97.61 20.09 12.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 11.07 111.202 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.91 128.27 91.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 11.1 111.153 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.24 -43.59 52.38 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.714 1.61 . . . . 11.130000000000001 111.223 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -64.99 -40.77 95.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 11.17 111.186 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.4 mmm -64.73 -39.37 93.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 11.199999999999999 111.214 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.1 t -60.52 -45.82 92.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.179 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.3 88.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 11.27 111.211 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -64.87 -33.45 76.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 11.300000000000001 111.18 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -69.97 -39.78 75.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 11.33 111.222 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.97 -30.08 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 11.369999999999999 111.211 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.61 71.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.18 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 93.5 t -85.5 -29.46 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 11.43 111.202 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.2 -25.3 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 11.470000000000001 111.219 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 76.0 p -85.99 -29.72 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 11.5 111.213 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.72 92.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.529999999999999 111.189 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.47 -23.43 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 11.57 111.21 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.9 mm -88.33 -38.04 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 11.6 111.206 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.531 ' HB3' ' HG2' ' A' ' 355' ' ' GLN . 96.0 m-20 -65.0 -32.42 74.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 11.630000000000001 111.214 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.3 -39.8 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 11.67 111.19 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.23 86.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 11.699999999999999 111.199 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.7 p -80.73 -19.43 45.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 11.73 111.209 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 90.58 18.03 50.07 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.222 -0.751 . . . . 11.77 111.222 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -70.2 -37.98 75.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 11.800000000000001 111.228 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.531 ' HG2' ' HB3' ' A' ' 349' ' ' ASN . 2.6 pt20 -147.0 168.74 20.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 11.83 111.176 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 45.0 p -81.18 175.14 10.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 11.869999999999999 111.141 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.88 -44.74 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 11.9 111.161 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.17 -48.15 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 11.93 111.18 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.59 -36.23 80.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 11.970000000000001 111.193 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.02 70.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 12.0 111.216 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.55 -15.92 55.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 12.029999999999999 111.219 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.18 -49.12 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 12.07 111.202 168.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.76 -39.04 92.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 12.1 111.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.45 -46.65 89.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 12.130000000000001 111.221 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.71 -47.63 76.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 12.17 111.178 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 12.199999999999999 111.197 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.6 mt . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.779 0.323 . . . . 0.070000000000000007 111.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.15 129.93 42.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.10000000000000001 111.215 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -57.68 128.97 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.13 111.206 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.91 48.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -126.33 98.02 5.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.771 0.319 . . . . 0.20000000000000001 111.195 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.05 119.72 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.23000000000000001 111.204 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.29 118.83 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.27000000000000002 111.238 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.9 mt -121.21 112.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.29999999999999999 111.189 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -103.38 117.12 33.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.33000000000000002 111.222 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.1 tt -115.61 137.05 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.37 111.208 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.64 114.94 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.40000000000000002 111.228 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.01 -172.46 39.86 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.209 -0.756 . . . . 0.42999999999999999 111.209 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -108.47 -39.18 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.329 . . . . 0.46999999999999997 111.219 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.14 149.83 43.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.5 111.191 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.26 0.83 4.52 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.215 -0.754 . . . . 0.53000000000000003 111.215 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 37' ' ' VAL . 43.8 p90 -62.71 -20.09 64.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.56999999999999995 111.204 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.67 -30.5 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 0.59999999999999998 111.205 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.69 -47.24 91.61 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.24 -0.744 . . . . 0.63 111.24 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HB2' HG11 ' A' ' 37' ' ' VAL . 82.2 mt -72.58 -30.79 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.67000000000000004 111.173 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.29 83.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.69999999999999996 111.21 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.4 -39.69 91.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.173 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 82.5 t -71.23 -34.85 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.77000000000000002 111.144 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.16 -27.12 73.83 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.182 -0.767 . . . . 0.80000000000000004 111.182 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 -48.4 81.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.82999999999999996 111.197 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.0 -41.79 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.87 111.205 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.37 -51.34 69.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.90000000000000002 111.274 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.93 -38.16 90.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.93000000000000005 111.262 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.36 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.96999999999999997 111.159 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.32 -35.01 12.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.186 -173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -103.4 -29.96 10.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.03 111.234 -174.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.55 4.56 79.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.166 -0.774 . . . . 1.0700000000000001 111.166 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.2 124.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 1.1000000000000001 111.24 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.94 150.06 47.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 1.1299999999999999 111.153 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -125.02 125.12 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 1.1699999999999999 111.234 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -121.33 109.84 15.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 1.2 111.221 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' A' ' 20' ' ' LEU . 35.1 t -105.07 130.12 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.187 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -151.07 166.49 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 1.27 111.198 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -100.03 123.26 47.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 1.3 111.216 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -79.6 165.03 23.11 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.617 1.545 . . . . 1.3300000000000001 111.201 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -121.0 141.03 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 1.3700000000000001 111.187 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 55.04 46.71 23.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 1.3999999999999999 111.238 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.02 -50.72 68.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 1.4299999999999999 111.211 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -52.57 -43.64 65.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 1.47 111.169 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.5 111.185 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -97.08 -7.0 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.192 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.474 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 5.2 m-30 -55.19 -54.8 46.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 1.5700000000000001 111.155 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -70.66 -12.21 30.84 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.68 1.587 . . . . 1.6000000000000001 111.21 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.98 -8.61 51.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.154 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.97 -57.68 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 1.6699999999999999 111.209 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.29 -23.11 43.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 1.7 111.199 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.58 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.73 111.172 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -104.2 -19.88 13.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.77 111.182 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.09 58.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.161 -0.775 . . . . 1.8 111.161 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -129.59 -165.43 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.8300000000000001 111.182 -170.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.42 -165.76 14.37 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.195 -0.762 . . . . 1.8700000000000001 111.195 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.49 167.16 27.78 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.665 1.577 . . . . 1.8999999999999999 111.201 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -80.04 -62.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 1.9299999999999999 111.186 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -99.78 139.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 1.97 111.208 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 tt -141.53 134.91 30.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 2.0 111.225 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.43 144.93 32.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 2.0299999999999998 111.315 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -156.39 148.45 23.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 2.0699999999999998 111.248 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.41 158.0 24.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 2.1000000000000001 111.175 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -60.6 -17.02 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 2.1299999999999999 111.244 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -42.91 -48.34 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 2.1699999999999999 111.159 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -134.98 27.45 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 2.2000000000000002 111.162 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.53 -42.61 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 2.23 111.176 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.77 -46.42 93.49 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.92 89.28 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.181 -0.767 . . . . 2.2999999999999998 111.181 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.05 -43.59 73.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 2.3300000000000001 111.157 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.84 -37.58 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 2.3700000000000001 111.143 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -67.07 -30.81 70.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.151 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -73.79 -13.89 61.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 2.4300000000000002 111.16 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.81 19.14 52.72 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.169 -0.772 . . . . 2.4700000000000002 111.169 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.89 -38.61 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.806 0.336 . . . . 2.5 111.234 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 tp -102.63 132.32 48.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 2.5299999999999998 111.239 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.54 137.09 32.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 2.5699999999999998 111.207 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -77.52 156.12 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 2.6000000000000001 111.203 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.2 mt -113.79 122.67 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 2.6299999999999999 111.204 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.2 m -120.58 96.74 48.88 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 2.6699999999999999 111.15 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.03 148.2 49.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.732 1.621 . . . . 2.7000000000000002 111.226 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -81.76 -179.37 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 2.73 111.188 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.73 -45.81 74.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 2.77 111.19 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.88 86.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 2.7999999999999998 111.232 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.41 -36.46 84.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 2.8300000000000001 111.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.71 -34.59 78.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 2.8700000000000001 111.235 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -71.35 -34.97 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 2.8999999999999999 111.155 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.1 -20.55 59.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 2.9300000000000002 111.186 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.6 mt -75.02 135.26 41.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 2.9700000000000002 111.193 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -63.29 138.89 97.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 3.0 111.162 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -50.15 -47.74 22.69 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.647 1.565 . . . . 3.0299999999999998 111.186 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.14 -47.66 81.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.0699999999999998 111.169 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -70.77 -21.69 62.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 3.1000000000000001 111.212 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -69.97 -41.53 74.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 3.1299999999999999 111.233 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -78.05 -24.01 47.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 3.1699999999999999 111.252 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.62 90.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 3.2000000000000002 111.197 -174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.71 79.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.23 111.207 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HB3' HD23 ' A' ' 103' ' ' LEU . 54.4 ptt85 -156.68 161.05 39.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 3.27 111.163 175.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 44.3 t80 -159.98 136.37 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 3.2999999999999998 111.246 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 95.0 m-20 64.98 29.89 12.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 3.3300000000000001 111.216 -175.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.77 53.89 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.187 -0.765 . . . . 3.3700000000000001 111.187 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -165.07 147.44 8.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 3.3999999999999999 111.159 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 98' ' ' ARG . 94.2 mt -64.9 136.39 56.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 3.4300000000000002 111.232 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 pt -115.2 -14.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 3.4700000000000002 111.224 -176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.0 172.92 5.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 3.5 111.226 -174.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -119.73 123.43 28.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 3.5299999999999998 111.18 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.8 139.54 33.72 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.667 1.578 . . . . 3.5699999999999998 111.2 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.32 -4.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 3.6000000000000001 111.223 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.75 144.75 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 3.6299999999999999 111.193 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.67 128.22 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 3.6699999999999999 111.242 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.68 151.21 46.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 3.7000000000000002 111.218 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.64 164.98 11.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 3.73 111.215 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 tp -143.85 124.1 13.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 3.77 111.214 172.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.9 p -163.05 -174.29 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 3.7999999999999998 111.17 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.9 tp -103.48 120.08 40.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 3.8300000000000001 111.177 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 116' ' ' ILE . 3.8 mp -102.93 141.36 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 3.8700000000000001 111.24 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -136.8 150.61 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 3.8999999999999999 111.159 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -91.28 117.33 29.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.9300000000000002 111.251 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.09 -34.88 79.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 3.9700000000000002 111.196 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.94 -47.6 84.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 4.0 111.205 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.2 tp -80.35 -52.36 7.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 4.0300000000000002 111.186 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.53 99.53 52.56 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 4.0700000000000003 111.174 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 -17.84 19.12 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.739 1.626 . . . . 4.0999999999999996 111.159 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -85.01 116.81 67.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 4.1299999999999999 111.144 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.42 117.9 5.19 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.716 1.61 . . . . 4.1699999999999999 111.232 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.97 129.62 31.17 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.718 1.612 . . . . 4.2000000000000002 111.181 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.01 -45.09 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 4.2300000000000004 111.186 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.6 t -136.3 -177.59 4.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 4.2699999999999996 111.173 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.65 -34.16 21.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 4.2999999999999998 111.207 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.77 -15.61 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 4.3300000000000001 111.215 -163.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -91.45 -9.44 44.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 4.3700000000000001 111.186 -176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.594 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 93.1 mt -74.02 -45.0 6.59 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 4.4000000000000004 111.195 -171.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.7 Cg_exo -57.0 -40.38 84.52 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.67 1.58 . . . . 4.4299999999999997 111.191 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.37 99.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 4.4699999999999998 111.183 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.7 tp -63.95 -42.98 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.427 . . . . 4.5 111.268 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.95 -35.05 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.239 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.04 -37.02 75.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 4.5700000000000003 111.218 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.04 -31.91 69.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 4.5999999999999996 111.176 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.0 mt -82.18 -15.9 51.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 4.6299999999999999 111.155 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.93 -44.53 63.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 4.6699999999999999 111.156 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.37 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 4.7000000000000002 111.24 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.03 -7.29 33.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 4.7300000000000004 111.196 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.16 62.43 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.163 -0.775 . . . . 4.7699999999999996 111.163 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 74.4 mmtt -114.96 179.28 3.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.8 0.333 . . . . 4.7999999999999998 111.212 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -137.82 143.94 41.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 4.8300000000000001 111.196 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -59.78 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 4.8700000000000001 111.249 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 132' ' ' ILE . 64.6 tp -128.13 115.64 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 4.9000000000000004 111.166 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.8 mmm -111.68 136.03 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 4.9299999999999997 111.198 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -171.68 164.99 6.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 4.9699999999999998 111.27 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -79.69 112.71 17.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 5.0 111.211 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.2 tp -63.18 -32.36 73.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 5.0300000000000002 111.182 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -96.66 7.54 46.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 5.0700000000000003 111.229 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -110.04 114.23 56.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 5.0999999999999996 111.172 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.32 -39.22 81.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.697 1.598 . . . . 5.1299999999999999 111.214 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -50.49 -40.02 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 5.1699999999999999 111.154 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -79.96 -37.52 34.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 5.2000000000000002 111.273 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.3 p -105.17 17.73 23.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 5.2300000000000004 111.156 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.557 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 88.3 t90 -66.73 -49.67 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 5.2699999999999996 111.286 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 83.6 Cg_endo -80.01 -14.92 12.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 5.2999999999999998 111.193 -174.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.9 tp -60.95 -33.99 74.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 5.3300000000000001 111.175 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.35 -30.02 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 5.3700000000000001 111.244 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.09 -43.75 10.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 5.4000000000000004 111.208 -172.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.4 -11.48 59.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 5.4299999999999997 111.213 -169.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -78.59 -4.42 48.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 5.4699999999999998 111.241 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.84 12.25 2.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.199 -0.76 . . . . 5.5 111.199 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.04 -19.66 25.74 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.241 -0.743 . . . . 5.5300000000000002 111.241 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.61 109.98 11.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 5.5700000000000003 111.172 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 68.39 35.3 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 5.5999999999999996 111.138 173.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.78 54.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 5.6299999999999999 111.235 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 177' ' ' ASP . 73.0 mmtt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 5.6699999999999999 111.157 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 170' ' ' LYS . 53.7 t0 . . . . . 0 CA--C 1.523 -0.074 0 CA-C-O 120.804 0.335 . . . . 5.9000000000000004 111.201 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.3 pt -98.36 -2.25 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 5.9299999999999997 111.166 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.01 -33.91 38.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 5.9699999999999998 111.165 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -64.76 139.99 58.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 6.0 111.173 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 184' ' ' ASP . 85.0 t -72.93 123.88 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 6.0300000000000002 111.18 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.14 93.24 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -76.0 -24.94 16.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.769 0.319 . . . . 6.0999999999999996 111.171 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . 51.2 t0 -89.6 64.51 6.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 6.1299999999999999 111.13 -177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -138.76 160.0 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 6.1699999999999999 111.222 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.41 80.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 6.2000000000000002 111.164 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.04 -47.36 83.05 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.4 90.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 6.2699999999999996 111.183 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.55 -44.14 91.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 6.2999999999999998 111.18 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.03 79.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.18 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.53 -45.03 97.18 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.225 -0.75 . . . . 6.3700000000000001 111.225 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.94 -38.55 86.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 6.4000000000000004 111.223 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -59.96 -50.91 71.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.233 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.28 -38.18 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 6.4699999999999998 111.213 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.8 tp -49.99 -53.22 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 6.5 111.203 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.6 -33.26 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 6.5300000000000002 111.162 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 94.4 m-20 -54.72 -42.86 72.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 6.5700000000000003 111.249 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.42 -33.34 74.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 6.5999999999999996 111.132 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.91 -48.7 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 6.6299999999999999 111.125 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.92 -25.95 31.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 6.6699999999999999 111.163 -171.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 96.1 m-20 -94.95 15.5 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 6.7000000000000002 111.202 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.01 52.3 5.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 6.7300000000000004 111.214 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -115.12 -34.47 5.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 6.7699999999999996 111.209 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 98.9 mmm -139.81 169.34 17.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.147 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -153.06 175.03 13.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 6.8300000000000001 111.215 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -86.9 2.65 48.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 6.8700000000000001 111.141 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.39 1.8 55.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 6.9000000000000004 111.186 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.6 p -80.9 164.99 22.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 6.9299999999999997 111.259 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -158.12 170.0 23.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.149 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -59.66 -48.58 81.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 7.0 111.252 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 88.7 p -70.86 -30.01 66.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 7.0300000000000002 111.201 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.25 -46.97 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 7.0700000000000003 111.227 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.8 88.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 7.0999999999999996 111.2 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.81 -42.12 88.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 7.1299999999999999 111.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.05 94.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.177 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.42 -34.27 77.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 7.2000000000000002 111.164 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -64.59 -43.17 94.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 7.2300000000000004 111.231 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.77 -35.87 81.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2699999999999996 111.223 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -77.62 -26.61 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2999999999999998 111.205 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.01 31.64 22.78 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.228 -0.749 . . . . 7.3300000000000001 111.228 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -90.08 -6.01 55.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 7.3700000000000001 111.186 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 95.8 m -106.58 132.11 52.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 7.4000000000000004 111.253 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -86.81 -44.22 11.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 7.4299999999999997 111.253 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 61.9 mtm -135.39 152.65 51.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 7.4699999999999998 111.157 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -161.69 147.06 13.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 7.5 111.22 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.42 115.7 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 7.5300000000000002 111.244 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -154.9 166.82 32.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 7.5700000000000003 111.264 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.65 -176.46 18.38 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.219 -0.752 . . . . 7.5999999999999996 111.219 166.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -56.15 -26.73 61.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.671 1.581 . . . . 7.6299999999999999 111.218 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -60.18 -22.05 62.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 7.6699999999999999 111.21 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.03 24.98 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 7.7000000000000002 111.178 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -101.81 10.03 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 7.7300000000000004 111.241 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.8 p -70.49 -32.68 70.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 7.7699999999999996 111.213 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -89.04 -34.02 16.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 7.7999999999999998 111.212 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.46 -38.85 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 7.8300000000000001 111.207 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -72.74 -32.26 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 7.8700000000000001 111.188 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -99.31 8.72 44.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 7.9000000000000004 111.175 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 85.1 p -70.71 -18.43 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 7.9299999999999997 111.171 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 63.92 24.02 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 7.9699999999999998 111.211 -170.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.76 131.25 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 8.0 111.18 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.13 133.78 51.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 8.0299999999999994 111.144 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -145.34 158.68 43.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 8.0700000000000003 111.197 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.01 179.69 18.01 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.178 -0.769 . . . . 8.0999999999999996 111.178 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 73.5 t -133.52 131.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 8.1300000000000008 111.188 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 46.4 p -119.74 167.82 11.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 8.1699999999999999 111.163 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.77 119.94 51.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 8.1999999999999993 111.216 -166.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.493 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 85.9 mt -82.97 -42.97 0.87 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 8.2300000000000004 111.221 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 76.5 Cg_exo -45.48 113.28 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.71 1.606 . . . . 8.2699999999999996 111.183 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 92.3 m -124.57 134.36 52.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 8.3000000000000007 111.216 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -127.17 117.74 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 8.3300000000000001 111.233 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 57.24 34.97 25.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 8.3699999999999992 111.17 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.51 13.21 82.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.168 -0.773 . . . . 8.4000000000000004 111.168 176.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -130.0 110.01 16.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.337 . . . . 8.4299999999999997 111.192 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.48 142.04 48.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.671 1.581 . . . . 8.4700000000000006 111.222 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.6 p -125.01 -84.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 8.5 111.245 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.26 155.2 76.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 8.5299999999999994 111.266 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 155.0 72.37 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.725 1.617 . . . . 8.5700000000000003 111.247 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -76.9 132.04 38.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 8.5999999999999996 111.127 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -106.72 126.77 62.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 8.6300000000000008 111.247 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.01 149.42 16.79 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.165 -0.774 . . . . 8.6699999999999999 111.165 170.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 77.2 t -125.54 130.4 72.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 8.6999999999999993 111.216 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 56.1 tp -97.66 121.05 39.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 8.7300000000000004 111.222 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 72.4 m -123.64 146.94 47.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 8.7699999999999996 111.194 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -78.14 162.93 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 8.8000000000000007 111.192 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.29 171.51 36.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.215 -0.754 . . . . 8.8300000000000001 111.215 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.71 132.31 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 8.8699999999999992 111.196 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -59.99 120.89 10.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 8.9000000000000004 111.211 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.84 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 8.9299999999999997 111.194 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -98.9 -0.3 42.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 8.9700000000000006 111.216 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -64.95 131.09 95.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 9.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.95 -15.09 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.715 1.61 . . . . 9.0299999999999994 111.214 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -123.52 61.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 9.0700000000000003 111.175 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -72.27 -22.53 61.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 9.0999999999999996 111.25 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -33.15 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 9.1300000000000008 111.159 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.2 -41.56 90.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 9.1699999999999999 111.198 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.16 94.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 9.1999999999999993 111.215 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -55.36 -49.94 70.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 9.2300000000000004 111.2 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -62.16 -56.92 13.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 9.2699999999999996 111.258 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.55 -55.05 33.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 9.3000000000000007 111.183 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.46 -50.01 74.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 9.3300000000000001 111.24 -172.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.03 -49.73 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 9.3699999999999992 111.223 -172.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -98.39 -13.45 20.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 9.4000000000000004 111.164 -158.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.53 -49.89 1.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 9.4299999999999997 111.203 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.03 -53.45 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 9.4700000000000006 111.191 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.5 mp -76.75 59.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.23 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.3 p -139.76 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 9.5299999999999994 111.209 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -56.78 -47.5 80.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 9.5700000000000003 111.231 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.36 -33.24 69.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 9.5999999999999996 111.261 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.84 -47.89 88.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.26 -0.736 . . . . 9.6300000000000008 111.26 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.18 -50.09 62.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.767 0.318 . . . . 9.6699999999999999 111.156 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.73 -35.05 73.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 9.6999999999999993 111.187 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.16 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.7300000000000004 111.191 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.71 -44.06 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 9.7699999999999996 111.173 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.51 -0.11 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 9.8000000000000007 111.21 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -77.58 -16.36 58.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 9.8300000000000001 111.164 168.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -110.47 -33.18 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 9.8699999999999992 111.244 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -96.2 160.23 30.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 9.9000000000000004 111.189 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.97 154.06 23.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.736 1.624 . . . . 9.9299999999999997 111.216 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.16 -6.9 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 9.9700000000000006 111.142 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.54 -44.01 85.69 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.17 -0.772 . . . . 10.0 111.17 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.43 125.46 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.731 0.3 . . . . 10.029999999999999 111.205 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.3 p -152.06 141.14 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 10.07 111.189 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -139.02 35.86 2.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 10.1 111.218 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.14 148.0 46.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 10.130000000000001 111.152 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.06 -49.98 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 10.17 111.204 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.4 p -68.79 -25.36 64.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 10.199999999999999 111.209 -173.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -79.99 -50.49 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 10.23 111.23 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.98 -38.34 72.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.171 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.11 -39.85 93.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 10.300000000000001 111.167 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -75.48 -32.82 60.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 10.33 111.173 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.16 -24.3 57.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 10.369999999999999 111.168 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.78 -14.56 62.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 10.4 111.201 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.24 -30.06 70.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 10.43 111.209 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -78.52 117.65 67.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 10.470000000000001 111.148 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.71 -34.99 86.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.685 1.59 . . . . 10.5 111.146 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.74 -29.71 67.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.529999999999999 111.219 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.78 -29.96 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 10.57 111.224 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.38 94.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 10.6 111.205 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.2 99.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.206 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.3 m -68.03 -44.63 76.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.196 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 56.7 mtt -73.74 -37.11 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.22 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.77 -44.01 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 10.73 111.23 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -64.8 -36.8 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 10.77 111.179 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.49 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 10.800000000000001 111.156 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -72.03 -37.45 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 10.83 111.117 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.03 -0.02 54.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.149 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.34 -136.77 9.49 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.245 -0.742 . . . . 10.9 111.245 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -149.07 147.29 28.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 10.93 111.188 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.3 pt -117.11 162.61 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 10.970000000000001 111.205 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -59.37 117.43 22.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 11.0 111.188 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 149.36 88.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.672 1.581 . . . . 11.029999999999999 111.183 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -105.05 39.91 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 11.07 111.202 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 74.9 mt -88.74 118.76 69.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 11.1 111.255 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.83 -17.97 13.58 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.674 1.582 . . . . 11.130000000000001 111.225 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.14 -5.01 58.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 11.17 111.226 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.6 mmm -110.77 19.1 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 11.199999999999999 111.255 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.1 m -65.65 -50.94 63.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 11.23 111.181 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.15 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 11.27 111.217 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -71.13 -47.27 58.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 11.300000000000001 111.216 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -70.13 -35.77 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 11.33 111.261 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -58.15 -51.96 67.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 11.369999999999999 111.196 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -31.49 72.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 11.4 111.143 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.21 -43.07 88.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 11.43 111.181 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.31 -40.05 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 11.470000000000001 111.167 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.3 m -57.3 -41.11 79.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 11.5 111.212 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.01 71.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 11.529999999999999 111.194 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.04 -25.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.186 -172.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.79 -46.03 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 11.6 111.195 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.53 -27.39 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 11.630000000000001 111.221 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.77 -39.13 36.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 11.67 111.184 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.48 86.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 11.699999999999999 111.216 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -74.4 -14.97 60.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 11.73 111.203 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.39 31.89 40.18 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.14 -0.784 . . . . 11.77 111.14 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -100.01 -38.28 8.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.78 0.324 . . . . 11.800000000000001 111.177 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -124.96 159.18 31.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 11.83 111.207 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.3 p -81.66 176.92 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 11.869999999999999 111.204 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 10.7 m -70.59 -21.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 11.9 111.199 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -89.84 -36.71 14.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 11.93 111.187 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -69.09 -36.72 77.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.151 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.92 87.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 12.0 111.171 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.84 -32.48 73.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 12.029999999999999 111.191 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.94 -59.96 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 12.07 111.248 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.38 -41.1 89.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 12.1 111.235 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.26 85.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 12.130000000000001 111.19 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.7 -46.45 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 12.17 111.202 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.2 m . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 12.199999999999999 111.208 -177.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.862 0.363 . . . . 0.070000000000000007 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.18 150.1 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.10000000000000001 111.214 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.03 125.13 22.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.13 111.217 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.74 14.29 58.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.143 -0.783 . . . . 0.17000000000000001 111.143 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -132.06 155.01 48.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 0.20000000000000001 111.23 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -116.27 109.98 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.23000000000000001 111.186 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.94 123.76 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.27000000000000002 111.179 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.29999999999999999 111.264 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.404 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.3 m0 -109.98 128.74 55.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.33000000000000002 111.175 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 86.5 mt -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.37 111.165 -173.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' HB2' ' CE3' ' A' ' 62' ' ' TRP . 57.0 t-20 -62.34 122.17 15.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.40000000000000002 111.224 172.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.9 -174.31 15.14 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.14 -0.784 . . . . 0.42999999999999999 111.14 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -99.95 -19.93 16.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.46999999999999997 111.264 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.45 144.16 28.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.5 111.175 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.73 -18.81 8.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.174 -0.771 . . . . 0.53000000000000003 111.174 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -47.59 -55.12 9.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.767 0.318 . . . . 0.56999999999999995 111.197 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -94.23 -27.04 16.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.59999999999999998 111.268 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.13 -57.23 19.33 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.255 -0.738 . . . . 0.63 111.255 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.7 tp -74.57 -29.14 61.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.67000000000000004 111.229 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -32.6 63.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.69999999999999996 111.164 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -59.21 -33.54 71.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.72999999999999998 111.172 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.26 -40.16 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.77000000000000002 111.228 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.25 -28.94 71.68 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.285 -0.726 . . . . 0.80000000000000004 111.285 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.66 -42.52 99.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.82999999999999996 111.135 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.3 -48.45 70.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.87 111.165 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -56.17 -44.16 79.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.90000000000000002 111.197 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.29 -42.07 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.93000000000000005 111.178 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.89 -35.0 69.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.96999999999999997 111.257 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -78.71 -35.9 44.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.256 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -106.26 -28.31 10.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 1.03 111.212 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.75 5.06 74.94 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.24 -0.744 . . . . 1.0700000000000001 111.24 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mm -86.5 114.78 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 1.1000000000000001 111.219 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.92 124.06 19.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 111.181 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.36 126.14 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 1.1699999999999999 111.177 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -126.46 116.77 21.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 1.2 111.234 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.5 125.01 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 1.23 111.186 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.6 mt-10 -132.71 161.35 34.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 1.27 111.194 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -117.15 102.78 52.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 1.3 111.188 172.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.56 167.95 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.709 1.606 . . . . 1.3300000000000001 111.186 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.6 t0 -100.19 102.86 14.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 1.3700000000000001 111.142 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.18 70.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 1.3999999999999999 111.2 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 68.5 mt -59.98 -20.69 59.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 1.4299999999999999 111.214 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -49.23 -35.03 16.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 1.47 111.185 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -109.86 -25.58 10.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 1.5 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 43' ' ' LEU . 87.1 tttt -79.98 -24.4 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 1.53 111.141 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.467 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -50.67 -57.39 13.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 1.5700000000000001 111.2 -177.098 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -68.61 -24.65 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.663 1.575 . . . . 1.6000000000000001 111.209 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.11 -37.31 72.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.173 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -88.59 -24.16 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 1.6699999999999999 111.197 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.26 -30.82 71.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 1.7 111.158 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.0 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 1.73 111.273 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -101.53 -15.39 17.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 1.77 111.131 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.5 32.55 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.208 -0.757 . . . . 1.8 111.208 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -110.02 169.97 8.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 1.8300000000000001 111.179 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.44 179.99 31.86 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.21 -0.756 . . . . 1.8700000000000001 111.21 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.37 -178.08 3.55 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.669 1.579 . . . . 1.8999999999999999 111.154 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -84.55 -56.53 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.9299999999999999 111.241 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -114.16 138.93 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 1.97 111.283 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.68 121.07 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 2.0 111.193 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 22.0 m-85 -98.2 107.89 20.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 2.0299999999999998 111.162 167.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.513 ' CE3' ' HB2' ' A' ' 12' ' ' ASN . 24.3 t-105 -148.33 157.26 43.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 2.0699999999999998 111.172 -172.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.7 140.95 53.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.1000000000000001 111.226 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -58.62 -26.19 63.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 2.1299999999999999 111.149 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -76.7 -6.7 53.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 2.1699999999999999 111.232 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -129.13 -24.94 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 111.19 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.04 -29.98 67.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 2.23 111.187 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -28.82 73.57 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.21 -0.756 . . . . 2.27 111.21 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.78 -31.89 59.77 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.159 -0.776 . . . . 2.2999999999999998 111.159 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -64.54 -36.15 83.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.203 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.77 69.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 2.3700000000000001 111.153 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -55.33 -42.59 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 2.3999999999999999 111.2 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 99.9 p -70.64 -15.05 62.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 2.4300000000000002 111.222 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.22 22.04 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.195 -0.762 . . . . 2.4700000000000002 111.195 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -107.24 -8.67 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 2.5 111.25 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -105.08 135.08 47.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 2.5299999999999998 111.214 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.96 134.97 53.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 2.5699999999999998 111.166 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -74.5 91.03 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 2.6000000000000001 111.243 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.95 98.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 2.6299999999999999 111.154 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.6 m -91.46 115.39 64.38 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 2.6699999999999999 111.224 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -56.39 144.99 81.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.702 1.601 . . . . 2.7000000000000002 111.169 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.96 163.05 28.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 2.73 111.134 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.31 -36.39 53.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 2.77 111.187 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.64 74.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 2.7999999999999998 111.263 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -70.25 -31.23 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 2.8300000000000001 111.226 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -57.56 -33.86 68.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 2.8700000000000001 111.216 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -81.72 -16.1 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 2.8999999999999999 111.245 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 305' ' ' LYS . 70.1 mmtt -85.02 -35.03 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 2.9300000000000002 111.199 -170.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.63 161.14 20.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 2.9700000000000002 111.141 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -60.02 144.67 86.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 3.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.96 -25.12 66.96 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.684 1.589 . . . . 3.0299999999999998 111.224 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -65.68 -49.05 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 3.0699999999999998 111.18 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.5 p -89.12 -24.13 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.262 -0.426 . . . . 3.1000000000000001 111.204 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -69.96 -46.79 64.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 3.1299999999999999 111.192 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.89 -15.43 61.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 3.1699999999999999 111.188 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.24 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 3.2000000000000002 111.179 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.15 78.92 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 3.23 111.227 -169.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HB3' HD23 ' A' ' 103' ' ' LEU . 33.7 ptt-85 -149.82 165.1 33.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 3.27 111.193 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -131.97 114.43 14.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 3.2999999999999998 111.221 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 61.94 37.2 15.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 3.3300000000000001 111.163 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.8 7.68 83.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.213 -0.755 . . . . 3.3700000000000001 111.213 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.96 107.25 15.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 3.3999999999999999 111.171 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.409 HD23 ' HB3' ' A' ' 98' ' ' ARG . 58.0 mt -59.33 128.99 39.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 3.4300000000000002 111.12 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -112.36 -20.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 3.4700000000000002 111.228 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.35 176.0 6.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 3.5 111.268 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -113.25 127.32 26.96 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 3.5299999999999998 111.231 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.45 138.95 47.72 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.718 1.612 . . . . 3.5699999999999998 111.273 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.4 mm -116.14 -47.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 3.6000000000000001 111.243 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.73 154.98 50.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 3.6299999999999999 111.179 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 134.96 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 3.6699999999999999 111.252 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -124.9 123.41 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 3.7000000000000002 111.186 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.26 151.18 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 3.73 111.218 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.2 tp -138.18 125.81 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 3.77 111.166 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 t -159.98 -168.54 2.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 3.7999999999999998 111.179 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.95 125.54 36.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 3.8300000000000001 111.173 -168.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.86 139.99 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 3.8700000000000001 111.267 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -136.55 144.92 44.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 3.8999999999999999 111.205 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -75.52 123.5 25.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 3.9300000000000002 111.216 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -70.97 -30.1 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 3.9700000000000002 111.185 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -77.85 -43.26 30.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 4.0 111.209 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.14 -44.64 59.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 4.0300000000000002 111.163 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -128.54 77.3 77.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 4.0700000000000003 111.238 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.69 -25.01 74.97 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.659 1.573 . . . . 4.0999999999999996 111.198 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -105.19 100.07 23.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 4.1299999999999999 111.26 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.0 155.4 52.8 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.706 1.604 . . . . 4.1699999999999999 111.196 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 154.55 59.31 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.691 1.594 . . . . 4.2000000000000002 111.253 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -85.32 -15.64 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 4.2300000000000004 111.192 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.2 t -160.0 162.66 34.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 4.2699999999999996 111.192 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -59.4 -23.25 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 4.2999999999999998 111.215 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.43 -22.83 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.3300000000000001 111.185 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -96.76 2.97 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 4.3700000000000001 111.226 -176.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.528 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 70.4 mt -66.93 -54.33 21.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 4.4000000000000004 111.191 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 67.5 Cg_endo -71.78 -18.52 28.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.735 1.623 . . . . 4.4299999999999997 111.233 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.98 -24.69 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 4.4699999999999998 111.197 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.2 -6.88 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 4.5 111.162 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.37 -35.01 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 4.5300000000000002 111.174 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.03 -39.88 83.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 4.5700000000000003 111.213 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.61 -27.85 68.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 4.5999999999999996 111.158 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.01 -0.36 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 4.6299999999999999 111.207 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.15 -26.27 68.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 4.6699999999999999 111.228 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.97 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 4.7000000000000002 111.232 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -99.92 -20.01 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 4.7300000000000004 111.183 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.61 24.8 44.88 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.145 -0.782 . . . . 4.7699999999999996 111.145 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -119.04 164.94 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 4.7999999999999998 111.19 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t -111.34 158.46 19.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 4.8300000000000001 111.213 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.1 -72.86 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.178 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.3 tp -156.94 129.0 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 4.9000000000000004 111.166 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mmm -84.73 140.55 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 4.9299999999999997 111.242 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.02 138.42 53.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 4.9699999999999998 111.165 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -82.91 119.78 24.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 5.0 111.209 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.407 HD21 HD11 ' A' ' 195' ' ' LEU . 99.0 mt -114.81 -25.52 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 5.0300000000000002 111.181 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.07 -39.82 90.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 5.0700000000000003 111.184 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.97 118.4 56.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 5.0999999999999996 111.208 -172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.96 -34.91 88.34 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.654 1.569 . . . . 5.1299999999999999 111.16 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -53.5 -37.69 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 5.1699999999999999 111.215 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.28 25.63 8.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 5.2000000000000002 111.245 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.3 p -103.34 -15.23 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 5.2300000000000004 111.154 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 75.0 t90 -68.67 -48.2 32.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 5.2699999999999996 111.217 175.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 67.6 Cg_endo -74.79 -4.36 15.29 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.674 1.582 . . . . 5.2999999999999998 111.193 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.8 mt -65.3 -21.04 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 5.3300000000000001 111.176 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.7 mt -109.68 -41.46 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 5.3700000000000001 111.173 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.02 -44.47 89.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 5.4000000000000004 111.232 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.01 -34.33 78.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 5.4299999999999997 111.233 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -64.2 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 5.4699999999999998 111.219 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.57 23.74 6.74 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.248 -0.741 . . . . 5.5 111.248 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.53 -22.05 17.61 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.169 -0.772 . . . . 5.5300000000000002 111.169 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 68.1 t80 -111.59 145.15 39.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 5.5700000000000003 111.122 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 67.55 22.79 9.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 5.5999999999999996 111.175 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.36 173.22 11.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 5.6299999999999999 111.171 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 5.6699999999999999 111.166 175.42 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.5 t0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.781 0.324 . . . . 5.9000000000000004 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.86 -34.11 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 5.9299999999999997 111.198 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -30.04 71.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 5.9699999999999998 111.156 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -65.59 143.03 57.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 6.0 111.169 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 183' ' ' VAL . 70.9 t -47.83 124.08 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 6.0300000000000002 111.142 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -98.48 14.31 62.18 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.229 -0.749 . . . . 6.0700000000000003 111.229 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.483 ' H ' HG12 ' A' ' 181' ' ' VAL . 25.0 m -123.63 31.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 6.0999999999999996 111.189 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -127.67 9.95 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 6.1299999999999999 111.25 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.38 161.38 14.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 6.1699999999999999 111.148 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.17 72.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 6.2000000000000002 111.148 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.32 -37.09 90.43 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.177 -0.769 . . . . 6.2300000000000004 111.177 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.2 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 6.2699999999999996 111.185 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.74 -40.76 75.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 6.2999999999999998 111.254 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.55 -28.91 68.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.146 -0.479 . . . . 6.3300000000000001 111.207 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -20.13 66.74 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.154 -0.778 . . . . 6.3700000000000001 111.154 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 347' ' ' VAL . 86.7 mt -104.99 -34.9 7.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 6.4000000000000004 111.203 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.9 m -64.56 -52.53 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 6.4299999999999997 111.233 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.62 -38.62 87.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 6.4699999999999998 111.193 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 151' ' ' LEU . 54.1 tp -58.17 -53.33 59.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 6.5 111.203 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.77 -42.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 6.5300000000000002 111.212 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.92 -39.67 86.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 6.5700000000000003 111.204 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 84.7 mt -70.4 -35.4 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 6.5999999999999996 111.23 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.24 -40.79 89.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.188 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.79 -24.62 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 6.6699999999999999 111.205 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.71 5.18 52.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 6.7000000000000002 111.22 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 60.65 35.26 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 6.7300000000000004 111.224 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -74.88 -34.06 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.215 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -145.21 149.93 35.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 6.7999999999999998 111.17 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -94.65 151.52 19.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 6.8300000000000001 111.243 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.94 -24.53 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 6.8700000000000001 111.229 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.77 -16.75 56.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 6.9000000000000004 111.146 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -56.4 118.03 4.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 6.9299999999999997 111.232 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -119.97 -164.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 6.9699999999999998 111.22 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.09 -47.83 81.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 7.0 111.167 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 82.5 p -75.09 -25.51 58.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 7.0300000000000002 111.183 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.5 mm -67.65 -52.26 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 7.0700000000000003 111.182 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.99 90.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 7.0999999999999996 111.201 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.39 -42.46 91.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 7.1299999999999999 111.218 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.08 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.173 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -26.67 68.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 7.2000000000000002 111.224 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -81.65 -45.28 15.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 7.2300000000000004 111.197 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.66 -30.12 64.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 7.2699999999999996 111.188 -174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -9.75 56.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 7.2999999999999998 111.222 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.16 32.87 51.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.194 -0.762 . . . . 7.3300000000000001 111.194 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -81.43 -29.33 33.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.764 0.316 . . . . 7.3700000000000001 111.191 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.1 p -100.24 160.04 14.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 7.4000000000000004 111.204 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.06 -24.76 16.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 7.4299999999999997 111.189 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 90.2 mmm -109.88 149.94 29.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 7.4699999999999998 111.168 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -159.64 179.61 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 7.5 111.174 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.2 mt -121.1 124.17 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 7.5300000000000002 111.178 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -165.01 179.94 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 7.5700000000000003 111.279 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -74.84 139.33 25.1 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.245 -0.742 . . . . 7.5999999999999996 111.245 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.32 129.84 35.51 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.67 1.58 . . . . 7.6299999999999999 111.188 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 57.39 49.93 12.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 7.6699999999999999 111.217 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.86 75.37 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 7.7000000000000002 111.226 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.427 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 48.4 m0 -68.28 -17.13 64.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 7.7300000000000004 111.146 -170.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 97.0 p -66.18 -19.97 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 7.7699999999999996 111.208 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -118.98 -19.41 8.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 7.7999999999999998 111.105 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.8 mt -90.77 -61.33 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.195 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.97 -39.55 75.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 7.8700000000000001 111.205 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 83.9 m -52.45 -44.93 65.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 7.9000000000000004 111.159 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 84.9 p -81.27 -10.47 59.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 7.9299999999999997 111.195 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 59.99 40.23 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 7.9699999999999998 111.247 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.63 135.06 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 8.0 111.161 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -73.85 111.24 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 8.0299999999999994 111.227 -175.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.31 145.02 44.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 8.0700000000000003 111.159 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.08 178.65 17.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.189 -0.764 . . . . 8.0999999999999996 111.189 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.89 139.96 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 8.1300000000000008 111.166 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.1 t -142.5 176.55 8.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 8.1699999999999999 111.209 171.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.57 112.85 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 8.1999999999999993 111.139 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.57 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 40.6 tp -63.46 -53.76 49.47 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 8.2300000000000004 111.212 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 70.8 Cg_endo -74.81 147.34 34.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.688 1.592 . . . . 8.2699999999999996 111.191 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.4 m -116.27 125.34 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 8.3000000000000007 111.177 174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -99.98 90.08 4.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 8.3300000000000001 111.188 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 52.14 55.47 9.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 8.3699999999999992 111.19 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 99.27 -23.59 35.68 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.221 -0.752 . . . . 8.4000000000000004 111.221 171.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -129.95 109.97 16.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 8.4299999999999997 111.232 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -54.98 130.71 42.2 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.719 1.613 . . . . 8.4700000000000006 111.194 173.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.7 t -114.97 -94.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 8.5 111.188 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.94 145.53 30.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 8.5299999999999994 111.185 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.73 -176.42 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.731 1.62 . . . . 8.5700000000000003 111.175 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -86.58 156.4 20.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 8.5999999999999996 111.201 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.14 117.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 8.6300000000000008 111.179 -173.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.57 150.05 19.03 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.222 -0.751 . . . . 8.6699999999999999 111.222 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.98 121.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.894 0.378 . . . . 8.6999999999999993 111.183 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.4 tp -95.44 110.93 22.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 8.7300000000000004 111.214 172.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 89.5 p -112.51 151.7 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 8.7699999999999996 111.156 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -111.48 126.93 55.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 8.8000000000000007 111.176 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.98 177.68 19.12 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.236 -0.746 . . . . 8.8300000000000001 111.236 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 80.2 mt -111.67 122.87 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 8.8699999999999992 111.184 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -60.75 128.9 38.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 8.9000000000000004 111.137 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.85 63.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 8.9299999999999997 111.232 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -87.17 -5.01 59.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 8.9700000000000006 111.108 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.9 t -80.43 132.39 58.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 9.0 111.179 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.68 -5.4 14.73 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.749 1.633 . . . . 9.0299999999999994 111.191 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -118.0 59.92 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 9.0700000000000003 111.218 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -77.76 -28.89 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 9.0999999999999996 111.243 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.45 -38.6 65.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 9.1300000000000008 111.265 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.41 -37.73 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 9.1699999999999999 111.199 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.83 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 9.1999999999999993 111.216 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.1 -48.85 70.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 9.2300000000000004 111.192 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.69 -47.6 77.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 9.2699999999999996 111.127 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.05 -41.06 74.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 9.3000000000000007 111.21 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.14 -3.76 58.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.3300000000000001 111.223 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.41 -50.01 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 9.3699999999999992 111.244 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -121.21 4.96 10.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 9.4000000000000004 111.163 -164.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -125.0 -62.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 9.4299999999999997 111.143 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.56 -53.29 58.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 9.4700000000000006 111.155 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 64.1 mt -85.03 60.8 6.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 9.5 111.199 -174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.6 p -134.94 167.53 20.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 9.5299999999999994 111.248 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.47 -34.62 78.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 9.5700000000000003 111.177 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.07 -35.18 22.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 9.5999999999999996 111.166 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.81 -48.76 63.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.69 -28.25 65.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 9.6699999999999999 111.232 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -69.41 -36.12 76.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 9.6999999999999993 111.148 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.01 78.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 9.7300000000000004 111.187 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -70.41 -39.95 77.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 9.7699999999999996 111.217 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.14 5.02 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8000000000000007 111.139 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -54.65 -50.21 68.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 9.8300000000000001 111.182 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -106.8 -18.16 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 9.8699999999999992 111.147 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -103.08 162.76 19.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 9.9000000000000004 111.277 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.45 144.93 48.67 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 121.729 1.619 . . . . 9.9299999999999997 111.198 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.23 -6.89 59.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 9.9700000000000006 111.18 -170.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -56.96 -35.9 70.95 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.139 -0.784 . . . . 10.0 111.139 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.19 127.98 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 10.029999999999999 111.12 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 304' ' ' LEU . 7.6 p -152.77 129.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 10.07 111.236 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -125.13 26.48 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 10.1 111.168 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.405 ' H ' HG22 ' A' ' 302' ' ' VAL . 36.2 tp -157.65 130.99 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 10.130000000000001 111.221 -172.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 86.7 tttt -61.78 -46.52 89.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 10.17 111.188 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 68.0 m -55.07 -38.25 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 10.199999999999999 111.16 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -71.39 -41.81 69.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 10.23 111.226 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.58 -34.27 66.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 10.27 111.237 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.48 -29.98 68.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 10.300000000000001 111.244 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -96.52 -30.02 13.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 10.33 111.142 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.45 -30.95 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 10.369999999999999 111.182 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.14 -9.12 54.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 10.4 111.196 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.93 -28.42 67.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 10.43 111.156 173.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -80.62 115.59 56.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.470000000000001 111.177 173.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.52 -38.81 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.726 1.618 . . . . 10.5 111.205 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.64 -39.87 70.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.166 -172.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.67 -40.04 76.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 10.57 111.194 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.59 -43.37 89.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 10.6 111.234 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.93 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 10.630000000000001 111.158 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 90.0 m -63.37 -43.06 98.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.199 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.98 -38.32 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 10.699999999999999 111.19 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -63.27 -46.16 88.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.197 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.96 -33.79 76.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 10.77 111.212 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.05 -45.68 84.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 10.800000000000001 111.167 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.23 -39.84 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 10.83 111.174 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -95.95 6.15 49.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 10.869999999999999 111.224 -174.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.65 -156.03 26.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.234 -0.746 . . . . 10.9 111.234 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -130.6 116.18 17.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 10.93 111.249 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 97.7 mt -105.08 137.0 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 10.970000000000001 111.209 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 83.0 mtp -63.35 130.57 94.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 11.0 111.235 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 50.7 Cg_exo -55.01 144.39 68.67 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 11.029999999999999 111.204 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -120.17 55.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 11.07 111.151 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 335' ' ' GLN . 82.0 mt -126.63 130.42 23.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 11.1 111.215 -178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.13 -29.22 74.23 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.697 1.598 . . . . 11.130000000000001 111.229 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 333' ' ' ILE . 90.6 mt-30 -64.02 -41.71 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 11.17 111.19 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 95.3 mmm -65.34 -37.25 86.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 11.199999999999999 111.249 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 39.4 t -59.92 -41.41 91.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 11.23 111.242 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.41 -36.65 83.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 11.27 111.252 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -64.98 -36.69 85.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 11.300000000000001 111.183 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -68.22 -29.76 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 11.33 111.177 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -62.76 -41.4 99.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 11.369999999999999 111.187 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.37 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 11.4 111.267 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.7 -42.59 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 11.43 111.153 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.5 -45.12 95.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 11.470000000000001 111.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.4 m -64.99 -39.94 94.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 11.5 111.241 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.29 -45.42 91.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 11.529999999999999 111.162 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 192' ' ' LEU . 70.1 t -64.72 -40.52 89.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 11.57 111.243 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.1 mt -65.13 -43.82 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 11.6 111.222 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.78 -37.37 87.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 11.630000000000001 111.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.0 -44.37 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 11.67 111.203 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.03 79.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 11.699999999999999 111.218 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.4 p -82.93 -14.95 53.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 11.73 111.22 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.25 12.26 65.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.22 -0.752 . . . . 11.77 111.22 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -70.04 -40.81 74.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 11.800000000000001 111.145 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -129.89 166.92 19.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 11.83 111.248 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -83.46 174.47 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 11.869999999999999 111.181 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -44.1 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 11.9 111.187 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.92 -42.75 80.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 11.93 111.201 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -64.74 -40.35 95.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 11.970000000000001 111.211 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.91 -48.49 73.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 12.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.26 -23.18 60.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 12.029999999999999 111.198 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.12 -48.48 73.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 12.07 111.186 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.63 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 12.1 111.241 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.54 93.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 12.130000000000001 111.173 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.35 -40.62 97.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 12.17 111.16 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 95.9 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 12.199999999999999 111.248 178.782 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.763 0.316 . . . . 0.070000000000000007 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -95.58 139.96 31.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.243 -0.435 . . . . 0.10000000000000001 111.231 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.68 125.04 21.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.13 111.199 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.64 5.21 60.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.2 -0.76 . . . . 0.17000000000000001 111.2 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HG2' ' HB2' ' A' ' 34' ' ' LYS . 96.0 mttt -133.47 148.56 51.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.20000000000000001 111.116 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.2 mt -113.74 140.76 48.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.23000000000000001 111.152 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.93 110.89 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.27000000000000002 111.178 172.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.445 HG12 ' HB ' ' A' ' 59' ' ' ILE . 69.8 mt -113.79 116.21 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.29999999999999999 111.235 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.417 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 38.7 m0 -105.46 119.76 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.33000000000000002 111.164 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.43 139.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.37 111.208 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -67.63 119.31 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.142 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.81 -177.99 26.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.144 -0.782 . . . . 0.42999999999999999 111.144 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -102.71 -35.03 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.46999999999999997 111.138 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.83 163.26 28.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.5 111.201 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.41 -7.9 9.01 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.149 -0.781 . . . . 0.53000000000000003 111.149 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -60.75 -23.23 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.317 . . . . 0.56999999999999995 111.188 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -67.23 -36.43 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.59999999999999998 111.167 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.59 -44.86 94.46 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.28 -0.728 . . . . 0.63 111.28 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 37' ' ' VAL . 80.4 mt -70.15 -32.74 70.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.753 0.311 . . . . 0.67000000000000004 111.162 175.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.03 92.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.69999999999999996 111.181 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -61.41 -34.76 75.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.72999999999999998 111.207 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.95 -39.78 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.77000000000000002 111.256 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.09 79.78 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.27 -0.732 . . . . 0.80000000000000004 111.27 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.07 -37.39 84.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.337 . . . . 0.82999999999999996 111.227 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.89 -37.43 87.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.87 111.169 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -30.0 67.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.90000000000000002 111.183 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.39 -36.48 66.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.93000000000000005 111.145 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -82.79 -39.15 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.96999999999999997 111.238 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.71 -50.22 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.199 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -102.46 -49.34 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.03 111.202 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.44 21.57 3.01 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.213 -0.755 . . . . 1.0700000000000001 111.213 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.56 122.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 1.1000000000000001 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HB2' ' HG2' ' A' ' 6' ' ' LYS . 99.1 mttt -87.97 127.75 35.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 1.1299999999999999 111.182 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.22 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 1.1699999999999999 111.218 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -115.42 125.05 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 1.2 111.158 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 20' ' ' LEU . 40.2 t -114.95 126.38 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.195 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -129.96 162.6 28.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.27 111.201 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -112.32 106.84 55.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.228 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 78.7 Cg_endo -75.51 175.82 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.66 1.573 . . . . 1.3300000000000001 111.194 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -131.49 109.84 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 1.3700000000000001 111.219 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 58.07 69.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 1.3999999999999999 111.183 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.02 -18.59 61.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 1.4299999999999999 111.199 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -64.54 -15.08 60.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.202 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -99.24 -34.84 10.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 1.5 111.195 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -89.89 -48.66 7.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.53 111.208 -166.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 2.6 m-30 -56.47 -47.49 98.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.19 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 80.3 Cg_exo -50.46 -35.07 44.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.731 1.62 . . . . 1.6000000000000001 111.229 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -79.86 -47.47 15.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 1.6299999999999999 111.247 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -78.42 -16.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 1.6699999999999999 111.256 -174.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 1.7 111.204 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.66 -15.49 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 1.73 111.208 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -108.5 -14.97 14.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 1.77 111.194 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.55 30.25 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.249 -0.74 . . . . 1.8 111.249 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -110.16 169.99 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.327 . . . . 1.8300000000000001 111.221 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.48 -173.83 25.72 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.201 -0.76 . . . . 1.8700000000000001 111.201 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.63 173.22 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.68 1.587 . . . . 1.8999999999999999 111.258 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -88.77 -50.93 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 1.9299999999999999 111.221 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HB ' HG12 ' A' ' 9' ' ' ILE . 84.9 mt -116.27 132.97 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.97 111.162 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.1 mt -114.2 117.56 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 2.0 111.139 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -114.07 106.5 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 111.234 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -150.46 159.97 44.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 2.0699999999999998 111.155 -166.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.12 158.52 27.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.213 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.408 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 46.3 m170 -71.58 -2.8 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 2.1299999999999999 111.197 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.41 -30.94 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 2.1699999999999999 111.188 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mmt-85 -129.95 -27.92 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 2.2000000000000002 111.159 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -55.04 -43.34 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 2.23 111.211 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.31 -28.32 72.1 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.244 -0.742 . . . . 2.27 111.244 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.71 -11.32 81.88 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.145 -0.782 . . . . 2.2999999999999998 111.145 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -69.6 -29.94 67.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.717 0.294 . . . . 2.3300000000000001 111.188 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.71 -35.18 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 2.3700000000000001 111.242 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -70.02 -38.71 75.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 2.3999999999999999 111.202 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.3 p -69.82 -19.99 63.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 2.4300000000000002 111.221 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.31 23.98 25.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.168 -0.773 . . . . 2.4700000000000002 111.168 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.6 30.91 6.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 2.5 111.234 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.9 tp -151.1 115.32 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 2.5299999999999998 111.224 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.77 162.44 24.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 2.5699999999999998 111.184 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -85.65 86.86 7.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 2.6000000000000001 111.211 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 mm -98.47 101.93 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 2.6299999999999999 111.15 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -92.94 120.76 66.89 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 2.6699999999999999 111.203 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.14 141.27 80.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.713 1.609 . . . . 2.7000000000000002 111.194 176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -89.65 -174.28 4.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.24 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.67 -38.63 67.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 2.77 111.209 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.22 79.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 2.7999999999999998 111.187 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.82 -22.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 2.8300000000000001 111.155 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -62.52 -29.62 70.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 2.8700000000000001 111.168 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -97.61 -30.17 13.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 2.8999999999999999 111.205 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -79.98 -35.17 37.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 2.9300000000000002 111.255 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -94.57 149.49 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.9700000000000002 111.192 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -73.35 135.02 79.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 3.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.07 -46.94 29.25 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.643 1.562 . . . . 3.0299999999999998 111.208 -170.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.52 -46.82 85.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 3.0699999999999998 111.241 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.3 p -82.41 -15.92 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 3.1000000000000001 111.228 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 85.8 t90 -65.98 -52.34 50.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 3.1299999999999999 111.259 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -85.78 9.98 14.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 3.1699999999999999 111.271 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.89 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 3.2000000000000002 111.239 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -104.07 24.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 3.23 111.175 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.2 ttt180 -76.57 129.98 37.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 3.27 111.206 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -157.95 132.81 8.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 3.2999999999999998 111.241 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 68.49 35.05 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 3.3300000000000001 111.149 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.59 -35.13 4.93 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.226 -0.75 . . . . 3.3700000000000001 111.226 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -130.62 171.95 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 3.3999999999999999 111.182 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.8 mp -77.94 145.17 36.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 3.4300000000000002 111.231 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.8 14.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 3.4700000000000002 111.136 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -168.92 178.89 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 3.5 111.15 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -110.07 117.54 51.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 3.5299999999999998 111.177 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.04 136.73 76.42 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.71 1.607 . . . . 3.5699999999999998 111.204 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.1 mm -112.96 -60.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 3.6000000000000001 111.3 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -154.93 162.61 41.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 3.6299999999999999 111.145 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.01 159.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 3.6699999999999999 111.193 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.25 126.76 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 3.7000000000000002 111.137 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.02 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 3.73 111.219 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.4 tp -124.26 111.58 16.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 3.77 111.19 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 t -166.91 -171.65 1.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 3.7999999999999998 111.18 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.2 tp -53.06 108.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 3.8300000000000001 111.198 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 244' ' ' VAL . 81.0 mt -92.55 114.13 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 3.8700000000000001 111.153 165.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -124.28 153.63 41.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 3.8999999999999999 111.165 -169.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -85.05 113.46 21.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 3.9300000000000002 111.147 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.34 -30.85 69.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 3.9700000000000002 111.182 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -72.1 -30.21 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 4.0 111.135 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.2 -13.8 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 4.0300000000000002 111.24 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 38.1 tp -142.97 79.79 14.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 4.0700000000000003 111.214 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.17 -19.48 29.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.757 1.638 . . . . 4.0999999999999996 111.205 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -120.16 89.97 43.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 4.1299999999999999 111.183 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.55 157.48 48.77 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.27 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.38 154.74 45.9 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.77 1.646 . . . . 4.2000000000000002 111.172 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.56 -5.24 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 4.2300000000000004 111.217 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -164.3 156.14 16.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 4.2699999999999996 111.19 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -59.79 -18.84 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 4.2999999999999998 111.221 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.67 -14.46 60.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 4.3300000000000001 111.164 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.67 6.03 47.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 4.3700000000000001 111.202 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.5 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 30.3 mm -74.19 -44.17 6.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.2 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 89.7 Cg_exo -49.24 -41.91 41.14 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.662 1.575 . . . . 4.4299999999999997 111.217 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.26 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 4.4699999999999998 111.167 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.16 -52.75 11.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 4.5 111.261 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.96 -37.79 61.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 4.5300000000000002 111.206 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.42 -57.72 10.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 4.5700000000000003 111.191 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.94 -30.61 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 4.5999999999999996 111.233 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.4 ' HB3' ' HG3' ' A' ' 144' ' ' LYS . 95.0 mt -77.08 -30.44 55.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 4.6299999999999999 111.248 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.98 -37.5 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 4.6699999999999999 111.216 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.62 -28.45 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 4.7000000000000002 111.213 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.45 -1.66 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 4.7300000000000004 111.149 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.25 25.26 40.63 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' A' ' 139' ' ' LEU . 29.9 pttt -129.95 160.09 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 4.7999999999999998 111.19 175.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.9 t -138.82 144.86 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 4.8300000000000001 111.219 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.03 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 4.8700000000000001 111.17 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 mt -110.38 121.58 45.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 4.9000000000000004 111.118 169.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.8 tpp -150.16 115.26 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 4.9299999999999997 111.211 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.7 176.0 7.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 4.9699999999999998 111.226 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -79.91 120.26 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 5.0 111.153 160.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 151' ' ' LEU . 4.0 mm? -90.23 -37.96 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 5.0300000000000002 111.223 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -65.16 -42.34 93.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 5.0700000000000003 111.146 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.9 126.45 75.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 5.0999999999999996 111.205 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.29 -21.26 31.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.681 1.587 . . . . 5.1299999999999999 111.202 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.39 -38.2 73.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 5.1699999999999999 111.192 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -99.33 14.93 27.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 5.2000000000000002 111.2 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.2 p -103.1 -10.92 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 5.2300000000000004 111.169 173.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.545 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 51.5 t-105 -72.43 -42.74 8.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 5.2699999999999996 111.19 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 70.8 Cg_exo -55.04 -33.27 82.76 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.73 1.62 . . . . 5.2999999999999998 111.171 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.455 HD13 ' HG ' ' A' ' 195' ' ' LEU . 63.1 mt -69.26 -24.63 64.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 5.3300000000000001 111.188 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 49.0 mm -81.3 -40.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 5.3700000000000001 111.218 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.15 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 5.4000000000000004 111.162 174.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.52 76.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 5.4299999999999997 111.153 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.04 -62.03 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 5.4699999999999998 111.206 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.99 -8.34 70.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.236 -0.746 . . . . 5.5 111.236 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.44 55.1 3.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.167 -0.773 . . . . 5.5300000000000002 111.167 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.78 151.67 33.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 5.5700000000000003 111.256 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 48.19 42.26 17.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 5.5999999999999996 111.24 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -139.93 78.82 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 5.6299999999999999 111.163 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 5.6699999999999999 111.216 -174.507 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.79 0.329 . . . . 5.9000000000000004 111.178 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 pt -95.28 5.45 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 5.9299999999999997 111.25 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.56 28.18 8.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 5.9699999999999998 111.191 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -82.25 169.97 15.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 6.0 111.157 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 95.6 t -112.87 124.84 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 6.0300000000000002 111.169 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -66.2 -39.36 94.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.212 -0.755 . . . . 6.0700000000000003 111.212 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.51 0.08 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 6.0999999999999996 111.156 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -106.16 -4.84 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 6.1299999999999999 111.226 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -83.31 160.04 21.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 6.1699999999999999 111.22 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.69 70.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 6.2000000000000002 111.193 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.82 -33.67 63.77 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.237 -0.745 . . . . 6.2300000000000004 111.237 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.76 -28.63 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 6.2699999999999996 111.154 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.04 -64.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 6.2999999999999998 111.157 -174.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.39 -34.78 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 6.3300000000000001 111.151 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -33.44 87.23 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.273 -0.731 . . . . 6.3700000000000001 111.273 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.0 tp -75.0 -39.58 61.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 6.4000000000000004 111.236 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.9 m -54.57 -46.47 73.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.179 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -63.19 -47.6 81.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 6.4699999999999998 111.177 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.5 tt -50.0 -54.03 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 6.5 111.209 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.43 -36.47 76.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.144 -0.48 . . . . 6.5300000000000002 111.19 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.07 -35.02 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.5700000000000003 111.203 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.44 -27.14 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 6.5999999999999996 111.194 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.91 -36.91 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 6.6299999999999999 111.241 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.79 -21.66 59.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 6.6699999999999999 111.265 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -90.04 3.68 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 6.7000000000000002 111.216 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 62.26 35.09 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 6.7300000000000004 111.235 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -106.9 -30.01 9.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 6.7699999999999996 111.19 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 95.7 mtp -125.92 160.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 6.7999999999999998 111.169 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -125.2 118.92 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 6.8300000000000001 111.265 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.84 -24.07 67.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 6.8700000000000001 111.223 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -81.83 -10.09 59.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 6.9000000000000004 111.173 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.8 m -54.59 108.54 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.174 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -89.98 179.82 5.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 6.9699999999999998 111.202 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -63.28 -49.09 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 7.0 111.248 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.1 p -65.06 -24.03 67.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 7.0300000000000002 111.167 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.31 -47.95 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 7.0700000000000003 111.272 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.27 90.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.208 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.43 -51.97 63.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 7.1299999999999999 111.247 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.76 94.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 7.1699999999999999 111.201 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.45 94.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 7.2000000000000002 111.213 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.93 -45.48 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 7.2300000000000004 111.181 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -69.94 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 7.2699999999999996 111.201 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.85 -11.78 56.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.2999999999999998 111.206 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.33 26.12 48.81 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.163 -0.775 . . . . 7.3300000000000001 111.163 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -78.53 -34.44 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 7.3700000000000001 111.199 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 84.9 m -123.87 112.42 17.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 7.4000000000000004 111.172 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.29 93.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 7.4299999999999997 111.18 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 62.3 ttp -127.31 119.99 27.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 7.4699999999999998 111.226 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 41.1 p -127.58 179.97 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 7.5 111.19 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.16 118.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 7.5300000000000002 111.24 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -108.23 120.83 43.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.438 . . . . 7.5700000000000003 111.199 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 232' ' ' TRP . . . -77.87 -172.9 39.87 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.254 -0.739 . . . . 7.5999999999999996 111.254 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.13 -34.45 87.66 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.618 1.545 . . . . 7.6299999999999999 111.163 -175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -71.59 -31.54 67.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 7.6699999999999999 111.234 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.77 6.67 13.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 7.7000000000000002 111.239 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.461 ' N ' ' O ' ' A' ' 228' ' ' GLY . 92.3 t90 -54.15 -36.39 63.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 7.7300000000000004 111.227 -170.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.1 p -62.39 -17.37 58.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 7.7699999999999996 111.228 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -57.63 -49.93 74.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 7.7999999999999998 111.234 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.0 tp -74.45 -28.47 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 7.8300000000000001 111.158 -173.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.75 -35.29 57.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 7.8700000000000001 111.233 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 76.1 m -67.15 -31.66 72.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 7.9000000000000004 111.163 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 60.6 p -69.62 -15.03 63.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 7.9299999999999997 111.171 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 58.44 50.24 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 7.9699999999999998 111.187 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.07 175.83 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 8.0 111.183 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -85.32 119.48 25.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 8.0299999999999994 111.15 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.44 160.07 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 8.0700000000000003 111.24 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -164.21 -168.17 25.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.245 -0.742 . . . . 8.0999999999999996 111.245 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 116' ' ' ILE . 77.6 t -131.25 140.08 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 8.1300000000000008 111.205 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -122.69 -173.76 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 8.1699999999999999 111.248 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.12 113.44 43.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 8.1999999999999993 111.188 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.544 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 74.2 mt -83.88 -45.41 0.78 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 8.2300000000000004 111.145 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 79.3 Cg_endo -80.64 156.01 21.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.694 1.596 . . . . 8.2699999999999996 111.168 -167.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.9 p -119.8 161.31 20.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 8.3000000000000007 111.279 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -123.36 100.94 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 8.3300000000000001 111.187 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 59.4 32.82 22.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 8.3699999999999992 111.221 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.82 62.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -122.11 110.03 33.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 8.4299999999999997 111.165 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.37 143.74 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.669 1.579 . . . . 8.4700000000000006 111.248 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -139.54 -74.93 0.36 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 8.5 111.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -131.26 158.55 74.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 8.5299999999999994 111.231 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.56 161.76 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.662 1.575 . . . . 8.5700000000000003 111.257 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -73.97 125.76 28.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 8.5999999999999996 111.198 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.2 t -111.08 124.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 8.6300000000000008 111.196 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -81.77 143.74 23.59 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.175 -0.77 . . . . 8.6699999999999999 111.175 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 65.7 t -121.11 130.03 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 8.6999999999999993 111.167 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.38 131.95 52.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 8.7300000000000004 111.176 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.5 p -145.07 154.74 42.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 8.7699999999999996 111.2 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -119.14 132.59 56.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 8.8000000000000007 111.117 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.22 -179.32 16.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.184 -0.766 . . . . 8.8300000000000001 111.184 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -108.78 130.65 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.788 0.328 . . . . 8.8699999999999992 111.237 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -60.7 134.06 56.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 8.9000000000000004 111.144 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.98 -18.43 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 8.9299999999999997 111.201 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.98 58.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 8.9700000000000006 111.248 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.0 t -65.0 127.93 93.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 9.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.01 -14.97 20.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.743 1.629 . . . . 9.0299999999999994 111.234 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -130.02 74.95 1.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 9.0700000000000003 111.202 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -80.08 -22.91 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 9.0999999999999996 111.22 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -74.12 -35.56 64.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 9.1300000000000008 111.215 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.7 -42.48 77.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 9.1699999999999999 111.259 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -38.98 92.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 9.1999999999999993 111.189 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -56.19 -51.45 67.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 9.2300000000000004 111.204 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.33 -42.12 99.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 9.2699999999999996 111.115 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.92 -42.45 80.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 9.3000000000000007 111.225 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.1 -3.55 58.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 9.3300000000000001 111.167 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -103.21 -50.83 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 9.3699999999999992 111.169 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -124.73 4.88 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 9.4000000000000004 111.266 -164.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -125.07 -70.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 9.4299999999999997 111.143 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 66.3 tp -65.43 -57.58 7.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 9.4700000000000006 111.246 -172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.96 61.78 7.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 9.5 111.218 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 31.4 p -129.94 -171.13 2.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 9.5299999999999994 111.223 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -75.5 -9.91 58.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 9.5700000000000003 111.196 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -116.13 -33.81 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 9.5999999999999996 111.214 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.78 -51.04 31.94 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.158 -0.777 . . . . 9.6300000000000008 111.158 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.02 -20.69 59.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.74 0.305 . . . . 9.6699999999999999 111.135 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.1 -47.17 84.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 9.6999999999999993 111.186 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.13 80.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 9.7300000000000004 111.218 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.54 -39.72 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 9.7699999999999996 111.177 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.92 7.27 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 9.8000000000000007 111.252 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.89 -43.04 80.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 9.8300000000000001 111.237 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -98.45 -20.41 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.8699999999999992 111.248 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.96 155.24 47.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 9.9000000000000004 111.202 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.21 144.98 79.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.714 1.609 . . . . 9.9299999999999997 111.251 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 24.51 12.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.168 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -66.95 -27.2 73.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.205 -0.758 . . . . 10.0 111.205 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.98 27.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 10.029999999999999 111.203 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.6 p -159.0 141.02 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 10.07 111.19 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.68 60.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 10.1 111.168 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 38.5 tp -60.25 125.06 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 10.130000000000001 111.157 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.64 -34.85 72.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 10.17 111.261 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 47.0 t -53.78 -52.2 60.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 10.199999999999999 111.184 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -66.46 -44.14 83.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 10.23 111.199 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -52.78 -42.45 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 10.27 111.261 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.81 -40.59 79.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.228 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -29.96 63.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 10.33 111.26 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.32 -17.86 33.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 10.369999999999999 111.226 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.81 -17.45 63.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 10.4 111.216 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.7 -30.67 71.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 10.43 111.177 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -77.93 118.25 70.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 10.470000000000001 111.221 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -57.6 -39.89 84.64 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.704 1.603 . . . . 10.5 111.181 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.66 -40.04 69.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 10.529999999999999 111.255 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.3 mt -69.97 -40.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 10.57 111.163 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.96 78.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 10.6 111.223 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.78 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 10.630000000000001 111.162 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -68.57 -42.84 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 10.67 111.216 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.0 mtt -66.51 -34.39 77.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 10.699999999999999 111.244 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.65 -47.08 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.152 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -76.05 -31.66 58.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 10.77 111.218 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.5 93.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 10.800000000000001 111.277 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 10.83 111.221 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.43 13.69 17.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.216 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.6 -175.02 40.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.162 -0.775 . . . . 10.9 111.162 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.443 ' HA ' ' OE1' ' A' ' 328' ' ' GLU . 5.2 tp10 -99.96 139.65 35.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 10.93 111.226 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 94.3 mt -94.75 130.43 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 10.970000000000001 111.165 -171.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.408 ' SD ' ' HB2' ' A' ' 64' ' ' HIS . 47.2 ttm -60.0 116.64 18.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 11.0 111.17 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.61 160.16 18.17 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.764 1.643 . . . . 11.029999999999999 111.246 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -109.85 20.21 18.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 11.07 111.113 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 333' ' ' ILE . 3.8 mp -86.12 122.93 72.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 11.1 111.171 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.99 -47.02 29.82 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.669 1.579 . . . . 11.130000000000001 111.269 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.81 -46.31 90.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 11.17 111.293 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.406 ' H ' HG22 ' A' ' 333' ' ' ILE . 67.1 mtt -60.06 -43.05 95.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 11.199999999999999 111.129 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.3 m -57.23 -41.14 78.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 11.23 111.117 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.63 94.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 11.27 111.213 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -71.7 -29.63 64.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.300000000000001 111.226 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -59.94 -51.98 67.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 11.33 111.163 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.73 -38.44 86.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 11.369999999999999 111.132 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -54.8 -37.72 66.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 11.4 111.211 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.4 t -71.7 -40.69 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 11.43 111.182 174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -51.06 -37.68 47.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 11.470000000000001 111.148 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.5 p -94.24 -26.98 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 11.5 111.184 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.08 -38.03 89.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 11.529999999999999 111.152 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.61 -21.6 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 11.57 111.203 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.95 -45.54 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 11.6 111.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 11.630000000000001 111.268 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.06 -39.59 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 11.67 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.28 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 11.699999999999999 111.161 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.9 p -78.31 -13.66 59.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 11.73 111.163 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.94 25.87 33.29 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.213 -0.755 . . . . 11.77 111.213 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -90.07 -48.55 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 11.800000000000001 111.178 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -124.99 165.22 18.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 11.83 111.242 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -84.77 175.06 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 11.869999999999999 111.131 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.7 t -59.31 -44.86 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 11.9 111.185 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 11.93 111.254 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.13 -44.67 87.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 11.970000000000001 111.221 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.67 94.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 12.0 111.226 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.75 -24.99 48.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 12.029999999999999 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.43 -48.31 78.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 12.07 111.178 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -69.46 -33.91 73.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 12.1 111.118 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.5 75.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 12.130000000000001 111.184 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -70.02 -56.66 6.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 12.17 111.151 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 12.199999999999999 111.171 -173.003 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.837 0.351 . . . . 0.070000000000000007 111.229 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -98.15 155.09 17.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.10000000000000001 111.139 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -93.67 155.05 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.13 111.212 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.24 16.82 54.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.235 -0.746 . . . . 0.17000000000000001 111.235 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.81 160.0 21.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.746 0.308 . . . . 0.20000000000000001 111.237 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.6 pp -145.89 153.95 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.254 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.35 135.26 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.27000000000000002 111.187 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 37' ' ' VAL . 83.5 mt -115.6 124.97 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.29999999999999999 111.222 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -103.61 105.15 15.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.33000000000000002 111.233 172.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.8 tt -115.48 137.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.37 111.187 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -81.03 108.94 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 111.195 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.0 -173.15 46.07 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.217 -0.753 . . . . 0.42999999999999999 111.217 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -104.98 -53.04 2.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.819 0.343 . . . . 0.46999999999999997 111.186 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.12 18.71 5.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.5 111.156 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.96 -23.65 69.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.183 -0.767 . . . . 0.53000000000000003 111.183 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -53.81 -32.71 53.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.56999999999999995 111.184 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.45 -41.56 96.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.59999999999999998 111.214 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -34.88 83.39 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.218 -0.753 . . . . 0.63 111.218 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 284' ' ' LEU . 83.1 mt -81.95 -25.87 34.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 0.67000000000000004 111.197 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.63 47.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.69999999999999996 111.207 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.72999999999999998 111.246 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.56 -17.85 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.77000000000000002 111.182 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.77 -31.94 81.37 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.207 -0.757 . . . . 0.80000000000000004 111.207 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.67 -46.15 80.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.82999999999999996 111.178 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.68 -50.03 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.87 111.235 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.90000000000000002 111.199 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.79 -39.09 80.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.93000000000000005 111.223 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.23 -32.22 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.96999999999999997 111.24 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -71.31 -40.53 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.248 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.4 p -113.91 -29.97 6.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 1.03 111.181 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.62 -0.3 63.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 1.0700000000000001 111.22 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.3 mm -76.57 110.99 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.1000000000000001 111.211 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.0 124.99 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 1.1299999999999999 111.225 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.54 121.49 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 1.1699999999999999 111.171 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.16 121.31 37.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 1.2 111.241 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 9' ' ' ILE . 40.7 t -118.18 125.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 1.23 111.136 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.27 165.73 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 1.27 111.172 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -121.45 70.07 23.45 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.215 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.42 161.99 33.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.687 1.591 . . . . 1.3300000000000001 111.231 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -124.82 -178.32 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.3700000000000001 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 54.99 39.73 31.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 1.3999999999999999 111.217 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.95 -9.17 59.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 1.4299999999999999 111.186 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.24 -27.98 69.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 1.47 111.209 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.07 -34.59 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.5 111.212 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.25 -46.43 80.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 1.53 111.183 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.535 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 81.1 t80 -62.56 -53.41 57.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 1.5700000000000001 111.132 -173.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 46.8 Cg_endo -67.76 -25.73 39.45 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.686 1.591 . . . . 1.6000000000000001 111.172 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -65.21 -35.27 80.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 1.6299999999999999 111.271 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -97.29 -26.17 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.6699999999999999 111.213 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.96 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 1.7 111.242 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.72 67.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.73 111.152 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 p -96.69 3.54 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.77 111.162 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.72 20.24 56.48 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.21 -0.756 . . . . 1.8 111.21 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -119.99 -166.02 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 1.8300000000000001 111.222 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.53 -164.87 12.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.205 -0.758 . . . . 1.8700000000000001 111.205 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.17 -176.32 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.714 1.609 . . . . 1.8999999999999999 111.221 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 276' ' ' ALA . 43.4 m-20 -103.33 -40.26 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.9299999999999999 111.252 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.37 138.36 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 1.97 111.226 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 42.0 mm -113.96 122.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.0 111.267 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 27.1 m-85 -100.02 110.96 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 2.0299999999999998 111.242 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.485 ' C ' ' CD1' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -145.03 -175.0 4.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 2.0699999999999998 111.228 -173.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.12 176.75 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 2.1000000000000001 111.16 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -87.43 14.58 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 2.1299999999999999 111.18 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -96.75 -29.97 13.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 111.193 172.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -118.28 12.35 13.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 2.2000000000000002 111.164 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -70.01 -21.15 63.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 2.23 111.242 -172.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.97 -12.74 83.14 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.51 -54.34 37.94 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.26 -0.736 . . . . 2.2999999999999998 111.26 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 5.2 m-30 -88.89 -20.43 24.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.3300000000000001 111.196 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.48 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 2.3700000000000001 111.236 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -68.67 -31.03 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 2.3999999999999999 111.166 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -75.18 -28.96 60.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 2.4300000000000002 111.192 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.28 31.56 33.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.253 -0.739 . . . . 2.4700000000000002 111.253 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -99.58 1.16 43.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.75 0.31 . . . . 2.5 111.199 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.76 131.53 34.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 2.5299999999999998 111.26 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 149.23 34.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 2.5699999999999998 111.194 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.07 124.37 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 2.6000000000000001 111.224 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.6 mt -115.05 129.4 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 2.6299999999999999 111.212 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -125.03 104.63 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 2.6699999999999999 111.152 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.98 148.52 45.36 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.714 1.609 . . . . 2.7000000000000002 111.207 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -84.91 179.99 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.215 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.4 -49.89 74.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 2.77 111.212 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.2 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 2.7999999999999998 111.194 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.02 -45.06 83.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 2.8300000000000001 111.216 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.31 -27.93 69.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.199 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -94.64 -19.71 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 2.8999999999999999 111.204 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -79.92 -29.99 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 2.9300000000000002 111.247 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.12 150.52 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 2.9700000000000002 111.169 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.19 135.66 96.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 3.0 111.154 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.1 -47.64 24.81 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.73 1.62 . . . . 3.0299999999999998 111.161 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.8 -54.96 23.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 3.0699999999999998 111.239 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.7 m -60.06 -36.87 78.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 3.1000000000000001 111.161 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -65.65 -42.73 91.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 3.1299999999999999 111.182 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.19 -19.92 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 3.1699999999999999 111.242 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -30.0 67.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 3.2000000000000002 111.219 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 332' ' ' ASN . 27.4 m -106.07 18.78 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 3.23 111.182 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -100.01 130.06 46.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 3.27 111.206 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -141.6 119.8 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 3.2999999999999998 111.148 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 65.55 43.85 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 3.3300000000000001 111.233 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.51 -42.27 2.35 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.178 -0.769 . . . . 3.3700000000000001 111.178 171.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -109.97 -178.78 3.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.807 0.336 . . . . 3.3999999999999999 111.216 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.47 154.47 18.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 3.4300000000000002 111.213 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.7 pt -113.99 -4.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 3.4700000000000002 111.157 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 167.22 21.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 3.5 111.181 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.3 m-30 -110.61 137.88 20.86 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 3.5299999999999998 111.17 170.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 46.9 Cg_exo -61.59 143.7 97.08 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.652 1.568 . . . . 3.5699999999999998 111.213 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 262' ' ' LEU . 95.1 mt -109.2 -58.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 3.6000000000000001 111.195 178.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.62 160.9 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 3.6299999999999999 111.217 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -107.77 145.87 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 3.6699999999999999 111.191 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -120.04 -179.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 3.7000000000000002 111.196 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.421 ' H ' ' HD3' ' A' ' 229' ' ' PRO . . . -128.55 167.89 16.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 3.73 111.198 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.522 HD21 ' HD3' ' A' ' 159' ' ' PRO . 65.1 tp -161.55 118.47 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 3.77 111.175 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -162.15 -178.02 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 3.7999999999999998 111.206 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 247' ' ' LEU . 52.2 tp -95.09 126.72 40.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 3.8300000000000001 111.15 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.2 mt -109.27 132.66 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 3.8700000000000001 111.173 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -148.7 159.16 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 3.8999999999999999 111.17 -172.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.33 117.55 30.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 3.9300000000000002 111.177 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 94.8 mttt -68.72 -47.49 66.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 3.9700000000000002 111.23 -175.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.69 -39.13 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 4.0 111.269 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.7 tp -65.48 -42.54 92.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.154 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.1 mt -125.02 73.46 65.59 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 4.0700000000000003 111.111 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 75.4 Cg_endo -79.58 142.3 16.19 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.195 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' PRO . 99.1 m-20 -70.64 149.76 95.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 4.1299999999999999 111.222 -12.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 89.4 Cg_exo -52.21 132.48 43.96 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.676 1.584 . . . . 4.1699999999999999 111.222 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 76.2 Cg_exo -53.08 133.55 52.56 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.723 1.615 . . . . 4.2000000000000002 111.223 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -112.68 -17.11 12.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 4.2300000000000004 111.198 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -157.33 176.92 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 4.2699999999999996 111.186 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -75.13 -19.96 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 4.2999999999999998 111.221 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.1 -13.19 61.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 4.3300000000000001 111.205 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -107.29 13.69 26.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 4.3700000000000001 111.2 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.572 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 94.3 mt -76.63 -41.26 2.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.197 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 85.8 Cg_exo -53.37 -28.39 43.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.739 1.626 . . . . 4.4299999999999997 111.167 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.96 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 4.4699999999999998 111.166 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.8 tp -79.15 -43.92 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 4.5 111.241 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -31.81 71.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 4.5300000000000002 111.21 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.67 -28.73 58.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 4.5700000000000003 111.206 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -80.12 -32.07 39.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 4.5999999999999996 111.261 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 91.7 mt -86.13 -7.67 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 4.6299999999999999 111.182 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.95 -44.94 78.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 4.6699999999999999 111.133 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.74 68.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 4.7000000000000002 111.144 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.61 -8.8 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 4.7300000000000004 111.211 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 27.53 60.25 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.206 -0.758 . . . . 4.7699999999999996 111.206 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 75.1 mmtt -115.55 159.13 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.873 0.368 . . . . 4.7999999999999998 111.177 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.9 t -98.86 153.92 18.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 4.8300000000000001 111.229 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.74 -26.75 64.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 4.8700000000000001 111.167 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.16 154.92 34.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 4.9000000000000004 111.16 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.8 mtm -108.11 115.7 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 4.9299999999999997 111.256 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.525 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 93.8 m-85 -95.5 130.81 42.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 4.9699999999999998 111.244 -154.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -117.69 77.29 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 5.0 111.152 164.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 149' ' ' PHE . 96.6 mt -97.86 -0.83 44.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 5.0300000000000002 111.139 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -71.54 -22.04 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 5.0700000000000003 111.224 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.44 150.96 53.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.269 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.17 -15.03 18.47 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.679 1.586 . . . . 5.1299999999999999 111.205 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.18 -29.21 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 5.1699999999999999 111.146 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -74.11 -41.03 62.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 5.2000000000000002 111.199 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -96.34 -8.56 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 5.2300000000000004 111.187 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.49 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 77.2 t90 -58.04 -46.0 99.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 5.2699999999999996 111.186 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD3' HD21 ' A' ' 113' ' ' LEU . 98.4 Cg_endo -84.05 -20.08 4.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.65 1.567 . . . . 5.2999999999999998 111.197 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.35 -45.86 75.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.164 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.96 -33.61 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 5.3700000000000001 111.198 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.46 -4.16 59.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 5.4000000000000004 111.217 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.02 72.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.4299999999999997 111.245 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -91.08 -10.06 43.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.179 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.25 25.12 49.37 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.153 -0.779 . . . . 5.5 111.153 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.82 -1.99 36.74 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.214 -0.755 . . . . 5.5300000000000002 111.214 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.13 106.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 5.5700000000000003 111.237 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 64.55 22.25 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 5.5999999999999996 111.211 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.37 147.29 28.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 5.6299999999999999 111.166 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 177' ' ' ASP . 24.1 ttmm . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 5.6699999999999999 111.194 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 170' ' ' LYS . 68.6 t0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.797 0.332 . . . . 5.9000000000000004 111.22 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.9 tt -69.97 -17.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 5.9299999999999997 111.203 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -80.04 -17.45 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 5.9699999999999998 111.17 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.82 169.92 16.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 6.0 111.2 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.57 91.23 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 6.0300000000000002 111.167 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.07 32.1 7.86 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.162 -0.775 . . . . 6.0700000000000003 111.162 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.45 -22.58 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.759 0.314 . . . . 6.0999999999999996 111.143 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -99.6 12.51 36.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.197 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.44 141.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 6.1699999999999999 111.177 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.43 -37.01 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 6.2000000000000002 111.179 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.63 -32.73 45.21 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.15 -0.78 . . . . 6.2300000000000004 111.15 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.82 -48.51 58.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.339 . . . . 6.2699999999999996 111.196 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -69.8 -24.17 63.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 6.2999999999999998 111.172 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 6.3300000000000001 111.187 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.07 -39.73 96.52 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.232 -0.747 . . . . 6.3700000000000001 111.232 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.5 tp -72.33 -30.62 64.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 6.4000000000000004 111.227 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.1 m -64.41 -42.69 95.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 6.4299999999999997 111.22 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -58.72 -47.18 85.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 6.4699999999999998 111.207 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.3 tp -46.56 -45.04 18.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 6.5 111.18 174.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -74.02 -36.85 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 6.5300000000000002 111.175 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.97 -36.84 68.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 6.5700000000000003 111.171 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.13 -32.86 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 6.5999999999999996 111.195 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.43 -40.03 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 6.6299999999999999 111.104 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.85 -29.63 70.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 6.6699999999999999 111.151 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -76.19 -8.96 58.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 6.7000000000000002 111.225 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 64.85 35.09 8.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 6.7300000000000004 111.174 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -129.15 53.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 6.7699999999999996 111.173 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 47.5 ttm -159.15 147.63 18.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 6.7999999999999998 111.224 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -146.5 114.63 6.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.429 . . . . 6.8300000000000001 111.159 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.42 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 6.8700000000000001 111.183 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.38 -25.89 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 6.9000000000000004 111.211 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.8 p -75.24 149.89 38.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 6.9299999999999997 111.213 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.78 -165.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 6.9699999999999998 111.211 -170.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.86 -51.87 67.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.0 111.165 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.1 p -70.83 -29.71 65.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 7.0300000000000002 111.244 -171.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.99 -45.03 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 7.0700000000000003 111.223 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 7.0999999999999996 111.171 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.24 -41.45 94.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 7.1299999999999999 111.22 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.0 -36.29 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 7.1699999999999999 111.158 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.06 93.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 7.2000000000000002 111.167 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.38 -33.44 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 7.2300000000000004 111.212 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -60.06 -39.35 85.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 7.2699999999999996 111.236 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 -30.22 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 7.2999999999999998 111.2 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.1 34.99 13.08 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.259 -0.737 . . . . 7.3300000000000001 111.259 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.14 -35.0 68.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 7.3700000000000001 111.204 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.9 m -129.99 139.18 51.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 7.4000000000000004 111.189 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.35 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 7.4299999999999997 111.143 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -85.09 153.68 22.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 7.4699999999999998 111.241 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.1 t -169.3 179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 7.5 111.287 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.34 118.63 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 7.5300000000000002 111.17 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -160.69 177.89 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 7.5700000000000003 111.189 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.79 -134.38 7.83 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.168 -0.773 . . . . 7.5999999999999996 111.168 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.421 ' HD3' ' H ' ' A' ' 112' ' ' ALA . 83.7 Cg_endo -81.77 -177.11 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.169 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 69.87 17.95 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 7.6699999999999999 111.161 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.66 -24.09 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 7.7000000000000002 111.188 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.455 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 97.9 m95 -69.52 -14.95 63.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 7.7300000000000004 111.123 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.6 p -64.96 -20.95 66.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 7.7699999999999996 111.216 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.05 -28.56 8.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 7.7999999999999998 111.225 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.2 mt -64.85 -45.11 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 7.8300000000000001 111.254 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -74.55 -33.8 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 7.8700000000000001 111.198 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.7 m -64.14 -44.6 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 7.9000000000000004 111.234 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.9 p -78.18 -15.04 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 7.9299999999999997 111.235 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.63 45.97 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 7.9699999999999998 111.217 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.84 141.21 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 8.0 111.157 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -74.87 78.69 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 8.0299999999999994 111.209 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -89.96 127.65 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 8.0700000000000003 111.183 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.407 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -100.4 166.39 19.72 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.223 -0.751 . . . . 8.0999999999999996 111.223 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 88.5 t -139.6 134.98 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.773 0.32 . . . . 8.1300000000000008 111.253 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.2 t -135.06 150.17 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 8.1699999999999999 111.21 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.4 t -70.29 110.81 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 8.1999999999999993 111.16 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 53.0 tp -75.38 -47.82 4.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 8.2300000000000004 111.282 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 85.7 Cg_endo -78.41 143.2 19.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.764 1.642 . . . . 8.2699999999999996 111.228 -173.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 78.8 m -107.74 133.59 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 8.3000000000000007 111.182 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -108.46 99.71 9.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 8.3300000000000001 111.221 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 57.69 35.14 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 8.3699999999999992 111.12 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 98.6 -15.57 60.84 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.175 -0.77 . . . . 8.4000000000000004 111.175 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -130.06 110.0 16.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 8.4299999999999997 111.161 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.8 151.69 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.7 1.6 . . . . 8.4700000000000006 111.268 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 98.9 p -137.6 -75.01 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 8.5 111.201 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 326' ' ' LYS . 74.5 mmtt -134.07 163.35 51.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 8.5299999999999994 111.163 -174.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.97 144.47 56.5 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.721 1.614 . . . . 8.5700000000000003 111.173 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.41 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 86.3 t80 -73.81 140.59 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 8.5999999999999996 111.185 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 261' ' ' VAL . 61.6 t -107.1 106.76 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 8.6300000000000008 111.221 -170.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -84.93 85.08 1.58 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.169 -0.773 . . . . 8.6699999999999999 111.169 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 259' ' ' VAL . 36.9 t -68.18 142.35 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 8.6999999999999993 111.188 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 74.1 mt -91.87 154.9 18.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 8.7300000000000004 111.257 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 91.2 p -143.71 155.13 44.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 8.7699999999999996 111.199 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 60' ' ' ILE . . . -121.76 124.3 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 8.8000000000000007 111.245 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -103.97 177.29 24.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.177 -0.769 . . . . 8.8300000000000001 111.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 87.5 mt -124.14 132.0 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 8.8699999999999992 111.2 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -69.32 114.28 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.148 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.54 -24.72 66.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 8.9299999999999997 111.163 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 8.9700000000000006 111.217 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -66.06 136.74 95.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 9.0 111.235 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.79 -12.1 26.24 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.727 1.618 . . . . 9.0299999999999994 111.206 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.59 21.51 8.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 9.0700000000000003 111.201 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -62.78 -21.88 66.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 9.0999999999999996 111.174 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.36 -34.5 77.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 9.1300000000000008 111.194 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 9.1699999999999999 111.155 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . . . -65.03 -41.86 94.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 9.1999999999999993 111.168 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.75 -44.55 81.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 9.2300000000000004 111.234 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -80.11 -52.75 7.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 9.2699999999999996 111.227 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -63.8 -37.05 85.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 9.3000000000000007 111.224 -171.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 284' ' ' LEU . 40.1 tp -68.12 -48.16 66.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 9.3300000000000001 111.187 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -72.08 -28.98 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 9.3699999999999992 111.182 -173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -99.56 -40.2 7.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 9.4000000000000004 111.181 -166.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.17 -54.84 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 9.4299999999999997 111.15 -169.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 20' ' ' LEU . 95.1 mt -64.1 -49.59 71.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 9.4700000000000006 111.148 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.85 51.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 9.5 111.165 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 76.7 p -124.97 -175.94 3.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 9.5299999999999994 111.153 170.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -53.29 -40.56 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 9.5700000000000003 111.197 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.35 -37.95 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 9.5999999999999996 111.134 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.37 -43.24 93.09 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.99 -36.23 83.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 9.6699999999999999 111.231 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -69.04 -41.86 77.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 9.6999999999999993 111.204 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.26 87.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 9.7300000000000004 111.154 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 68.0 t -74.91 -40.83 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 9.7699999999999996 111.17 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.563 ' HB3' HD23 ' A' ' 299' ' ' LEU . 96.7 m-20 -75.93 -2.93 32.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 9.8000000000000007 111.203 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.05 -38.14 67.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 9.8300000000000001 111.195 165.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -108.5 -34.03 6.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 9.8699999999999992 111.158 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.03 160.63 40.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 9.9000000000000004 111.205 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.65 139.38 67.29 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.667 1.578 . . . . 9.9299999999999997 111.167 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 294' ' ' ASN . 95.0 mt -66.38 -24.19 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 9.9700000000000006 111.153 -175.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.77 -28.84 70.71 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.153 -0.779 . . . . 10.0 111.153 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.91 122.83 13.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.779 0.323 . . . . 10.029999999999999 111.228 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.85 136.6 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.16 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -103.36 -34.79 8.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 10.1 111.188 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.16 138.72 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 10.130000000000001 111.176 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -61.36 -39.04 89.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 10.17 111.222 168.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 44.6 t -56.05 -48.62 75.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 10.199999999999999 111.175 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.55 -37.71 83.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 10.23 111.224 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.67 -36.74 77.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 10.27 111.173 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.73 -30.03 70.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 10.300000000000001 111.248 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.4 -32.16 62.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 10.33 111.198 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.22 -26.18 62.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 10.369999999999999 111.226 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.88 -19.22 65.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 10.4 111.324 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.48 -24.93 67.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 10.43 111.221 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -101.92 109.99 61.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 10.470000000000001 111.205 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.97 -32.92 80.78 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.659 1.573 . . . . 10.5 111.188 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.55 -28.09 67.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 10.529999999999999 111.264 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -91.01 -38.5 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 10.57 111.218 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.02 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 10.6 111.254 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.48 -35.5 74.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 10.630000000000001 111.231 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.1 p -91.33 -19.95 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 10.67 111.211 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.0 mmt -74.21 -35.92 63.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 10.699999999999999 111.205 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.5 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 10.73 111.285 171.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.32 -42.75 99.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 10.77 111.2 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.42 93.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 10.800000000000001 111.21 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.05 -42.5 99.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 10.83 111.179 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.407 ' HB2' ' HG3' ' A' ' 256' ' ' LYS . 99.7 mttt -94.95 7.53 45.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 10.869999999999999 111.198 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.88 -162.66 35.9 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.268 -0.733 . . . . 10.9 111.268 172.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -119.8 132.38 55.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 10.93 111.213 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.17 136.22 25.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 10.970000000000001 111.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 50.0 tpp -59.93 114.41 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 11.0 111.247 173.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.31 133.74 51.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.678 1.585 . . . . 11.029999999999999 111.221 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 97' ' ' VAL . 42.5 t-20 -94.18 72.81 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 11.07 111.207 173.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 80.4 mt -123.15 116.11 28.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 11.1 111.185 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.06 -33.45 73.6 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.632 1.555 . . . . 11.130000000000001 111.26 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -71.46 -27.86 63.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 11.17 111.23 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -86.88 -20.62 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 11.199999999999999 111.157 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 98.2 p -64.15 -29.98 71.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.178 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.97 -49.51 70.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 11.27 111.247 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -56.76 -48.74 77.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 11.300000000000001 111.173 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -68.75 -43.58 75.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 11.33 111.176 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 -73.89 -30.55 62.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 11.369999999999999 111.259 -176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.65 75.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 11.4 111.188 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.28 -21.82 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 11.43 111.279 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -56.56 -48.93 76.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 11.470000000000001 111.186 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 71.0 p -65.2 -29.7 70.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 11.5 111.175 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.03 -44.22 89.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 11.529999999999999 111.173 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.77 -38.52 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.173 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.92 -42.69 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 11.6 111.208 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -65.0 -39.17 93.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 11.630000000000001 111.21 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.45 -21.96 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 11.67 111.206 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.52 -30.39 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 11.699999999999999 111.22 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.5 p -86.16 -22.16 27.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 11.73 111.181 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.85 30.35 26.56 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.233 -0.747 . . . . 11.77 111.233 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -109.94 2.61 19.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 11.800000000000001 111.238 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -159.58 137.01 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 11.83 111.212 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 62.1 p -70.0 164.97 22.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 11.869999999999999 111.255 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.5 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 11.9 111.233 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.19 -46.99 88.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 11.93 111.207 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.87 -37.53 79.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 11.970000000000001 111.191 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.69 92.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 12.0 111.214 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 94.5 mt -74.98 -24.89 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 12.029999999999999 111.18 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.71 -49.3 73.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 12.07 111.167 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.84 -34.21 77.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.208 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.01 -59.56 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 12.130000000000001 111.2 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -54.94 -43.25 73.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 12.17 111.209 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 83.7 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 12.199999999999999 111.26 178.871 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.1 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.777 0.323 . . . . 0.070000000000000007 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -55.01 130.04 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.10000000000000001 111.226 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.27 129.44 40.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.13 111.194 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.62 27.94 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.258 -0.737 . . . . 0.17000000000000001 111.258 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.98 132.53 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.20000000000000001 111.252 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.71 120.02 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.23000000000000001 111.211 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.34 115.04 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.27000000000000002 111.212 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 37' ' ' VAL . 73.6 mt -115.05 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.29999999999999999 111.197 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -110.09 129.06 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.33000000000000002 111.194 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.0 mt -101.42 115.08 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.37 111.158 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -97.7 89.24 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.40000000000000002 111.225 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.5 -145.65 7.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.264 -0.735 . . . . 0.42999999999999999 111.264 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.47 22.77 8.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.46999999999999997 111.195 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -102.29 156.87 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.5 111.248 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.95 -164.98 38.01 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.185 -0.766 . . . . 0.53000000000000003 111.185 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -158.98 25.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.56999999999999995 111.215 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -59.68 -40.29 87.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.59999999999999998 111.187 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.07 -27.51 28.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.212 -0.755 . . . . 0.63 111.212 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.91 -40.51 95.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.67000000000000004 111.262 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.05 78.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.69999999999999996 111.178 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -65.0 -29.07 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.72999999999999998 111.227 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.5 t -72.66 -40.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.77000000000000002 111.188 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.87 82.18 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.234 -0.746 . . . . 0.80000000000000004 111.234 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.79 -36.88 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 111.175 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.53 -24.07 45.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.87 111.239 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.02 -32.68 70.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.90000000000000002 111.157 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -74.8 -36.95 62.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.93000000000000005 111.202 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.31 -46.06 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.96999999999999997 111.188 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.54 -58.79 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.163 -170.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -89.45 -49.27 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 1.03 111.2 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.49 21.4 3.03 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.205 -0.758 . . . . 1.0700000000000001 111.205 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.29 114.99 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 1.1000000000000001 111.191 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.25 110.08 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 1.1299999999999999 111.169 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.2 t -97.91 121.49 48.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 1.1699999999999999 111.119 -174.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.0 m -117.97 121.03 39.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.2 111.266 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 9' ' ' ILE . 46.9 t -107.36 125.38 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 1.23 111.207 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.99 172.04 12.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 1.27 111.237 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.445 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 37.2 t60 -139.97 52.73 3.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 1.3 111.168 -174.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 72.8 Cg_endo -72.01 152.67 57.42 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.649 1.566 . . . . 1.3300000000000001 111.26 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -101.92 -177.04 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.433 . . . . 1.3700000000000001 111.217 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 53.12 46.1 27.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 1.3999999999999999 111.233 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 90.3 mt -93.84 -37.75 11.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 1.4299999999999999 111.176 -174.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 pm0 -69.66 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 1.47 111.218 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -89.48 -19.58 24.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 1.5 111.19 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -110.19 -25.14 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 1.53 111.232 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.2 m-30 -58.51 -45.14 99.69 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 1.5700000000000001 111.22 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 64.8 Cg_exo -55.48 -30.96 76.16 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.656 1.57 . . . . 1.6000000000000001 111.247 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.02 -43.74 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.191 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -75.63 -23.32 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.6699999999999999 111.147 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -24.47 66.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 1.7 111.205 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.75 -8.05 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 1.73 111.167 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.0 p -114.01 -11.93 12.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 1.77 111.23 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.3 25.51 30.84 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.231 -0.748 . . . . 1.8 111.231 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -114.81 170.71 8.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 1.8300000000000001 111.244 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.48 -174.4 16.6 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.202 -0.759 . . . . 1.8700000000000001 111.202 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -74.87 -176.39 2.82 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.757 1.638 . . . . 1.8999999999999999 111.155 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -104.18 -48.12 3.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 1.9299999999999999 111.181 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -112.4 133.16 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 1.97 111.174 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.8 mt -131.2 129.78 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 2.0 111.152 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -85.93 142.89 28.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 2.0299999999999998 111.195 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 98.4 m95 -141.21 163.95 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 2.0699999999999998 111.231 174.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.46 166.22 11.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 2.1000000000000001 111.167 164.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -61.29 -30.28 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 2.1299999999999999 111.178 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -82.07 -0.86 46.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 2.1699999999999999 111.244 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.4 -25.06 7.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 2.2000000000000002 111.179 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 62' ' ' TRP . 8.8 m-85 -58.63 -43.18 89.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 2.23 111.186 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.97 -48.24 87.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 2.27 111.204 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.88 -38.03 42.71 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.192 -0.763 . . . . 2.2999999999999998 111.192 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -69.92 -37.4 75.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 2.3300000000000001 111.192 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.85 -36.17 64.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 2.3700000000000001 111.201 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.14 -42.44 85.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 2.3999999999999999 111.195 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.7 p -71.13 -14.98 62.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 2.4300000000000002 111.12 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.17 32.21 23.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.254 -0.738 . . . . 2.4700000000000002 111.254 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.14 -6.65 25.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.842 0.353 . . . . 2.5 111.188 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 tp -114.9 133.82 55.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 2.5299999999999998 111.229 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.92 146.84 37.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 2.5699999999999998 111.218 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.57 129.27 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 2.6000000000000001 111.257 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -121.02 133.45 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 2.6299999999999999 111.179 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -120.83 101.5 45.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 2.6699999999999999 111.235 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.36 147.44 32.62 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 121.692 1.595 . . . . 2.7000000000000002 111.176 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.99 148.97 38.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 2.73 111.194 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -53.45 -47.64 69.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 2.77 111.187 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 2.7999999999999998 111.191 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.15 -51.32 64.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 2.8300000000000001 111.175 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.9 -19.94 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 2.8700000000000001 111.185 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.46 -34.96 68.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 2.8999999999999999 111.149 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.56 -22.47 56.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 2.9300000000000002 111.222 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.72 154.93 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 2.9700000000000002 111.164 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.03 136.11 87.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 3.0 111.184 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.03 -14.96 23.54 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.676 1.584 . . . . 3.0299999999999998 111.227 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -80.37 -31.78 37.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 3.0699999999999998 111.191 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.4 p -96.03 -23.17 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 3.1000000000000001 111.201 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -62.51 -40.06 95.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 3.1299999999999999 111.199 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.6 -8.22 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 3.1699999999999999 111.235 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.36 -3.71 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 3.2000000000000002 111.232 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.5 66.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 3.23 111.226 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -129.76 154.98 46.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 3.27 111.179 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -153.1 129.9 10.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.205 -0.452 . . . . 3.2999999999999998 111.214 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 t30 62.62 29.85 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 3.3300000000000001 111.202 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.23 88.34 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.166 -0.774 . . . . 3.3700000000000001 111.166 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.55 145.55 47.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.766 0.317 . . . . 3.3999999999999999 111.18 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -71.37 137.52 48.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 3.4300000000000002 111.198 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.2 pt -123.94 -2.58 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 3.4700000000000002 111.224 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.6 168.87 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 3.5 111.211 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -109.52 129.15 24.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 3.5299999999999998 111.243 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.32 133.06 20.29 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.683 1.589 . . . . 3.5699999999999998 111.185 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.6 mt -113.23 -63.43 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 3.6000000000000001 111.192 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.39 149.87 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 3.6299999999999999 111.25 -172.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.13 157.04 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 3.6699999999999999 111.222 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -115.49 151.09 35.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 3.7000000000000002 111.217 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.21 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 3.73 111.195 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -127.49 172.48 10.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 3.77 111.204 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.9 p -138.71 150.32 46.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 3.7999999999999998 111.11 -172.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tt -94.25 106.42 18.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 3.8300000000000001 111.191 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 81.7 mt -92.18 125.14 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 3.8700000000000001 111.178 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.38 158.54 43.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 3.8999999999999999 111.202 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -84.93 99.94 11.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 3.9300000000000002 111.187 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -56.01 -47.83 77.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 3.9700000000000002 111.128 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.72 -52.19 65.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 4.0 111.217 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.93 -60.11 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 4.0300000000000002 111.214 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.45 87.64 51.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 4.0700000000000003 111.237 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.27 -14.71 25.55 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.681 1.587 . . . . 4.0999999999999996 111.173 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -90.53 110.05 38.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 4.1299999999999999 111.184 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.53 157.65 25.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.661 1.574 . . . . 4.1699999999999999 111.183 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.01 141.06 79.9 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.692 1.595 . . . . 4.2000000000000002 111.153 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.91 -18.7 36.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 4.2300000000000004 111.216 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 130' ' ' GLU . 14.6 t -157.67 -178.28 7.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 4.2699999999999996 111.182 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -65.65 -35.67 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 4.2999999999999998 111.215 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.411 ' H ' HG23 ' A' ' 128' ' ' THR . 98.3 mt-10 -74.24 -6.58 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 4.3300000000000001 111.2 -174.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -104.63 9.94 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 4.3700000000000001 111.174 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.558 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 88.7 mt -71.47 -41.62 10.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 4.4000000000000004 111.15 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 84.2 Cg_exo -52.53 -30.52 45.02 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.715 1.61 . . . . 4.4299999999999997 111.153 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.75 -37.05 67.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 4.4699999999999998 111.205 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -67.23 -47.88 69.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 4.5 111.194 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.13 -29.33 70.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 4.5300000000000002 111.223 -171.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.9 -44.95 64.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 4.5700000000000003 111.158 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -94.01 -30.93 14.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 4.5999999999999996 111.139 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.96 -27.8 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.202 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.42 -41.62 63.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 4.6699999999999999 111.214 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.18 -5.74 59.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 4.7000000000000002 111.225 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.74 12.34 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 4.7300000000000004 111.175 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.08 24.9 70.3 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -140.2 179.78 6.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 4.7999999999999998 111.134 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -151.38 138.05 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 4.8300000000000001 111.175 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.43 -60.61 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.141 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.7 tp -135.96 119.54 17.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 4.9000000000000004 111.221 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mtm -115.48 101.51 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 4.9299999999999997 111.174 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -110.06 135.84 50.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 4.9699999999999998 111.203 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -59.99 113.97 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 5.0 111.194 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.78 -24.84 63.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 5.0300000000000002 111.245 -169.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -100.84 -39.61 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 5.0700000000000003 111.22 -171.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 155' ' ' TYR . 87.8 tt0 -78.71 128.32 77.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 5.0999999999999996 111.217 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -73.21 -20.2 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.738 1.626 . . . . 5.1299999999999999 111.149 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.406 ' H ' ' HG2' ' A' ' 153' ' ' GLU . 74.0 t80 -54.48 -43.24 71.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 5.1699999999999999 111.131 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -79.9 -19.99 46.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 5.2000000000000002 111.234 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 64.8 p -99.35 -5.54 29.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 5.2300000000000004 111.221 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.61 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 83.1 t90 -62.24 -45.42 90.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 5.2699999999999996 111.255 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 40.7 Cg_exo -61.29 -38.54 64.59 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.731 1.621 . . . . 5.2999999999999998 111.167 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.74 -60.02 4.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 5.3300000000000001 111.201 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 167' ' ' TYR . 20.8 tt -70.18 -22.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 5.3700000000000001 111.181 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -88.78 -4.07 58.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 5.4000000000000004 111.205 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -113.1 -10.47 13.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.214 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -95.57 -31.46 13.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 5.4699999999999998 111.188 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.6 33.35 2.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 5.5 111.223 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.64 11.35 23.4 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.443 ' HB2' HG23 ' A' ' 161' ' ' ILE . 84.1 t80 -131.84 109.77 10.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 5.5700000000000003 111.187 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 63.62 33.18 13.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 5.5999999999999996 111.234 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -124.96 95.3 4.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 5.6299999999999999 111.205 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.6699999999999999 111.141 171.778 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.3 t0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.732 0.301 . . . . 5.9000000000000004 111.264 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.4 pt -114.97 29.64 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 5.9299999999999997 111.191 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.57 -59.96 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 5.9699999999999998 111.203 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -90.32 169.96 10.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 6.0 111.184 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 183' ' ' VAL . 97.0 t -88.82 139.85 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 6.0300000000000002 111.217 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.33 24.07 15.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.17 -0.772 . . . . 6.0700000000000003 111.17 -169.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 181' ' ' VAL . 7.8 p -65.55 -20.81 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 6.0999999999999996 111.23 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -105.36 23.1 14.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 6.1299999999999999 111.235 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -95.58 136.79 35.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 6.1699999999999999 111.179 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.74 -27.83 63.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 6.2000000000000002 111.209 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.77 -31.6 81.43 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.129 -0.788 . . . . 6.2300000000000004 111.129 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -45.09 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 6.2699999999999996 111.18 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -66.18 -40.97 90.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 6.2999999999999998 111.177 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.99 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.285 -0.416 . . . . 6.3300000000000001 111.165 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.24 -41.22 92.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 6.3700000000000001 111.218 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 30.2 tp -69.69 -36.18 75.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 6.4000000000000004 111.138 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.8 m -62.86 -41.68 99.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 6.4299999999999997 111.233 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.23 -44.52 95.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.193 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.7 tp -56.85 -41.32 77.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 6.5 111.136 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 199' ' ' ILE . 54.1 t -70.34 -34.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 6.5300000000000002 111.205 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.9 -34.3 77.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 6.5700000000000003 111.192 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.66 -23.35 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.5999999999999996 111.198 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 196' ' ' VAL . 92.9 mt -78.85 -49.78 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 6.6299999999999999 111.151 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.67 -25.35 53.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 6.6699999999999999 111.129 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -94.65 10.77 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 6.7000000000000002 111.25 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 59.98 52.47 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 6.7300000000000004 111.194 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -107.17 -29.84 9.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.236 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 19.0 ptp -155.13 164.95 38.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 6.7999999999999998 111.198 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -145.0 -169.96 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 6.8300000000000001 111.171 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.1 82.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 6.8700000000000001 111.184 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.22 -37.86 86.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 6.9000000000000004 111.239 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.2 m -53.88 109.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.217 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -147.19 -164.34 1.98 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.257 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -50.64 -42.6 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 7.0 111.199 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.3 p -66.84 -18.27 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 7.0300000000000002 111.21 -169.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -103.35 -54.91 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 7.0700000000000003 111.194 176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.0 -61.7 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 7.0999999999999996 111.213 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -92.75 -53.63 4.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 7.1299999999999999 111.266 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.04 -52.4 49.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 7.1699999999999999 111.217 -167.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.66 95.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 7.2000000000000002 111.171 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.06 -51.08 70.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 7.2300000000000004 111.216 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.02 -32.08 73.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 7.2699999999999996 111.176 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -63.55 -43.78 96.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 7.2999999999999998 111.226 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 122.31 19.38 3.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.193 -0.763 . . . . 7.3300000000000001 111.193 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 7.3700000000000001 111.234 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.7 m -113.38 124.99 53.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 7.4000000000000004 111.198 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.63 76.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 7.4299999999999997 111.181 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -167.83 144.98 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 7.4699999999999998 111.253 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.3 t -155.96 163.79 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 7.5 111.226 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.55 130.3 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 7.5300000000000002 111.135 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -156.96 173.78 16.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 7.5700000000000003 111.229 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.0 -61.21 7.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.179 -0.769 . . . . 7.5999999999999996 111.179 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.94 144.96 98.79 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.219 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -79.61 156.53 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 7.6699999999999999 111.191 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.2 13.65 30.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 7.7000000000000002 111.183 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -62.81 -32.07 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 7.7300000000000004 111.237 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.7 p -87.61 -9.84 53.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 7.7699999999999996 111.172 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -95.42 0.99 53.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 7.7999999999999998 111.185 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 242' ' ' TYR . 83.7 mt -69.19 -55.22 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 7.8300000000000001 111.201 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.78 -24.13 62.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 7.8700000000000001 111.178 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.0 m -65.03 -46.94 79.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 7.9000000000000004 111.216 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 69.0 m -100.01 -2.65 33.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 7.9299999999999997 111.191 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.04 34.91 13.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 7.9699999999999998 111.211 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.97 135.96 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 8.0 111.206 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.13 122.55 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 8.0299999999999994 111.2 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.41 ' H ' HG12 ' A' ' 235' ' ' ILE . 76.0 m-85 -118.35 146.34 44.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 8.0700000000000003 111.176 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -110.91 157.31 15.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.212 -0.755 . . . . 8.0999999999999996 111.212 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.72 130.03 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 8.1300000000000008 111.174 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -141.98 -169.96 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 8.1699999999999999 111.145 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 98.6 t -93.02 118.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 8.1999999999999993 111.169 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.574 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 49.9 tp -90.25 -45.0 0.4 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 8.2300000000000004 111.133 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 74.2 Cg_exo -55.28 128.1 29.06 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.706 1.604 . . . . 8.2699999999999996 111.179 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.2 m -138.88 126.6 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 8.3000000000000007 111.184 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.85 127.37 44.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 8.3300000000000001 111.197 -175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 86.3 tttt 44.62 45.14 7.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 8.3699999999999992 111.184 -170.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.04 78.78 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -130.0 109.93 16.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 8.4299999999999997 111.233 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.11 137.09 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.728 1.619 . . . . 8.4700000000000006 111.184 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 62.8 p -154.94 -75.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 8.5 111.241 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 323' ' ' ASN . 48.7 tttp -159.95 138.51 7.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 8.5299999999999994 111.171 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' A' ' 248' ' ' PRO . 63.3 Cg_endo -74.25 168.6 24.42 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.227 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 330' ' ' MET . 16.5 t80 -54.94 116.87 2.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 8.5999999999999996 111.177 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.54 104.32 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 8.6300000000000008 111.192 -163.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.39 140.03 21.59 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.196 -0.762 . . . . 8.6699999999999999 111.196 164.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.35 108.31 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.311 . . . . 8.6999999999999993 111.193 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 51.1 tp -57.31 120.36 8.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 8.7300000000000004 111.167 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.8 m -138.29 153.54 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 8.7699999999999996 111.172 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.59 137.9 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 8.8000000000000007 111.207 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.97 -174.48 14.98 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.227 -0.749 . . . . 8.8300000000000001 111.227 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.0 mt -111.88 128.64 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 8.8699999999999992 111.191 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -57.81 123.09 14.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.251 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 8.9299999999999997 111.196 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.13 54.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 8.9700000000000006 111.272 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.99 127.98 93.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 9.0 111.206 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.7 -4.1 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.717 1.612 . . . . 9.0299999999999994 111.225 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -110.06 30.79 6.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 9.0700000000000003 111.145 -171.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -51.95 -36.71 50.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 9.0999999999999996 111.183 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.26 -49.64 75.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 9.1300000000000008 111.188 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.16 -43.3 95.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 9.1699999999999999 111.195 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 9.1999999999999993 111.131 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -68.3 -42.27 79.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 9.2300000000000004 111.154 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -56.89 -49.53 75.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 9.2699999999999996 111.209 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -57.54 -59.94 4.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 9.3000000000000007 111.179 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.81 -38.8 82.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 9.3300000000000001 111.194 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.94 -43.84 10.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 9.3699999999999992 111.218 -168.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -103.51 -6.18 22.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 9.4000000000000004 111.224 -166.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.94 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 9.4299999999999997 111.194 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.67 -60.55 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 9.4700000000000006 111.169 -166.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.17 64.9 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 9.5 111.164 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 24.5 p -130.05 -179.99 5.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 9.5299999999999994 111.275 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.96 -27.01 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 9.5700000000000003 111.158 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -92.93 -39.89 10.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 9.5999999999999996 111.173 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -64.78 -46.77 88.71 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.196 -0.762 . . . . 9.6300000000000008 111.196 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.02 -15.5 60.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 9.6699999999999999 111.202 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -65.49 -38.4 89.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 9.6999999999999993 111.201 169.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.31 37.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 9.7300000000000004 111.217 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.19 -45.45 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 9.7699999999999996 111.166 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -87.56 10.5 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 9.8000000000000007 111.235 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.59 -42.98 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 9.8300000000000001 111.193 165.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -95.61 -32.44 12.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 9.8699999999999992 111.168 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.17 158.69 43.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 9.9000000000000004 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.08 130.02 36.09 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.747 1.631 . . . . 9.9299999999999997 111.18 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 78.1 mt -58.24 -41.89 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 9.9700000000000006 111.25 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.46 -20.25 67.53 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.214 -0.754 . . . . 10.0 111.214 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.85 75.26 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 10.029999999999999 111.236 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.07 150.67 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.177 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.66 -8.96 21.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 10.1 111.237 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.403 HD23 ' HB2' ' A' ' 307' ' ' TYR . 31.6 tp -81.77 119.99 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 10.130000000000001 111.145 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -68.83 -39.47 79.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 10.17 111.227 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.0 t -51.35 -49.53 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 10.199999999999999 111.236 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.403 ' HB2' HD23 ' A' ' 304' ' ' LEU . 60.2 t80 -70.49 -40.29 73.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 10.23 111.172 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -52.41 -39.55 61.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 10.27 111.225 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.88 -30.11 71.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 10.300000000000001 111.246 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -71.59 -34.77 70.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.33 111.192 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.79 -18.31 61.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 10.369999999999999 111.202 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.62 -18.59 62.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 10.4 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -27.2 66.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 10.43 111.176 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -100.19 110.05 58.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.243 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -55.38 -31.16 76.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.645 1.563 . . . . 10.5 111.244 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 10.529999999999999 111.211 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.33 -44.81 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 10.57 111.198 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.48 -31.76 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 10.6 111.242 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.28 73.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 10.630000000000001 111.174 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.0 p -93.09 -20.19 20.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 10.67 111.232 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.3 mmt -71.64 -31.04 66.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 10.699999999999999 111.245 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.71 -44.94 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 10.73 111.176 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . 90.5 m-20 -73.06 -26.19 61.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.77 111.146 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.3 90.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 10.800000000000001 111.2 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.06 -34.91 64.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 10.83 111.092 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -94.97 0.13 54.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 10.869999999999999 111.187 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.61 -164.78 40.39 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.192 -0.763 . . . . 10.9 111.192 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -124.03 138.04 54.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 10.93 111.217 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.0 mm -102.83 135.26 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 10.970000000000001 111.178 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 258' ' ' PHE . 28.6 ttt -70.13 116.24 42.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 11.0 111.141 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.13 159.23 37.4 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 11.029999999999999 111.185 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -105.83 50.01 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.489 . . . . 11.07 111.209 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 86.4 mt -85.9 124.95 70.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 11.1 111.239 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.06 -29.32 22.6 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.709 1.606 . . . . 11.130000000000001 111.248 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -69.09 -37.24 78.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 11.17 111.166 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 89.9 mtp -79.75 -27.82 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 11.199999999999999 111.223 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -57.82 -49.74 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 11.23 111.166 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.6 82.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 11.27 111.18 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -68.26 -36.77 79.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 11.300000000000001 111.196 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -68.96 -32.48 72.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 11.33 111.195 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -61.92 -41.25 97.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 11.369999999999999 111.254 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.37 90.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 11.4 111.188 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.16 -40.09 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 11.43 111.154 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -64.31 -32.49 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 11.470000000000001 111.244 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.9 m -75.32 -39.86 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.193 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.98 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.223 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.84 -16.34 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.243 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.12 -28.74 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 11.6 111.138 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.45 -29.81 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 11.630000000000001 111.191 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -88.36 -32.29 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 11.67 111.194 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.07 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 11.699999999999999 111.151 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.9 p -75.75 -16.25 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 11.73 111.15 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.95 10.06 79.48 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.202 -0.759 . . . . 11.77 111.202 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -81.6 -49.66 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 11.800000000000001 111.268 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -110.75 169.61 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 11.83 111.198 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.0 p -85.74 175.18 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 11.869999999999999 111.224 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.1 m -69.35 -14.56 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 11.9 111.215 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -95.03 -42.62 8.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 11.93 111.205 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -75.32 -35.2 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 11.970000000000001 111.16 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.95 94.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 12.0 111.193 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.03 -39.22 69.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 12.029999999999999 111.242 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -51.83 -38.89 57.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 12.07 111.185 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -49.97 -43.0 49.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.176 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.54 -35.46 27.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 12.130000000000001 111.247 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.05 -31.02 69.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 12.17 111.154 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 12.199999999999999 111.188 -177.733 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.818 0.342 . . . . 0.070000000000000007 111.22 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -67.63 142.26 56.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.10000000000000001 111.184 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.72 138.58 31.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.13 111.127 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.25 28.01 9.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.182 -0.767 . . . . 0.17000000000000001 111.182 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -146.57 145.42 30.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 0.20000000000000001 111.216 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.8 mt -111.98 98.34 7.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.23000000000000001 111.255 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.91 112.04 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.27000000000000002 111.141 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -105.89 122.35 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.29999999999999999 111.209 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -109.9 129.98 55.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.33000000000000002 111.23 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 11' ' ' ILE . 18.6 tt -149.53 123.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.37 111.222 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.02 150.01 22.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.40000000000000002 111.198 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.42 172.02 38.12 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.221 -0.752 . . . . 0.42999999999999999 111.221 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -79.87 76.88 6.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.831 0.348 . . . . 0.46999999999999997 111.224 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -103.76 179.96 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.5 111.129 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.07 63.93 4.4 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.222 -0.751 . . . . 0.53000000000000003 111.222 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -68.4 -24.11 64.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.56999999999999995 111.182 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -70.07 -49.94 46.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.59999999999999998 111.224 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.56 96.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.63 111.224 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.5 tp -69.7 -31.73 69.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.67000000000000004 111.16 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.73 72.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.183 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -63.19 -42.55 99.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.72999999999999998 111.16 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.63 -21.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.77000000000000002 111.232 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.81 68.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.19 -0.764 . . . . 0.80000000000000004 111.19 171.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -67.37 -42.61 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.745 0.307 . . . . 0.82999999999999996 111.165 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.39 -48.56 79.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.87 111.169 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.63 -44.25 85.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.90000000000000002 111.147 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.2 -37.44 87.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.93000000000000005 111.227 -176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -75.09 -34.99 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.96999999999999997 111.233 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -70.75 -39.51 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 1.0 111.218 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.6 p -110.51 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 1.03 111.202 -170.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 5.45 75.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.229 -0.749 . . . . 1.0700000000000001 111.229 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.89 119.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 1.1000000000000001 111.199 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -64.95 123.93 20.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 1.1299999999999999 111.243 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.72 125.03 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 1.1699999999999999 111.181 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.5 m -130.38 136.33 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 1.2 111.17 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.4 t -113.79 124.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 1.23 111.171 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.86 158.62 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 1.27 111.197 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -114.3 86.49 12.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 1.3 111.154 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.25 178.11 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.697 1.598 . . . . 1.3300000000000001 111.23 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -146.96 174.78 11.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 1.3700000000000001 111.228 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 53.19 37.84 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 1.3999999999999999 111.185 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.09 -24.94 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.442 . . . . 1.4299999999999999 111.182 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.26 -12.55 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 1.47 111.182 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -110.04 -23.06 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 1.5 111.213 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -92.92 -38.81 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.53 111.168 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.6 m-30 -59.97 -46.41 98.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 1.5700000000000001 111.202 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 79.5 Cg_exo -51.75 -36.06 60.67 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.685 1.59 . . . . 1.6000000000000001 111.228 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -75.7 -48.43 21.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 47' ' ' PHE . 25.9 m -74.56 -18.38 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 1.6699999999999999 111.208 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.06 -30.59 71.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 1.7 111.175 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.67 -12.16 57.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.187 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.9 p -114.04 -14.94 12.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.77 111.167 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.92 39.7 16.2 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 1.8 111.215 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -113.23 -168.42 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 1.8300000000000001 111.196 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.48 -169.23 13.12 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.214 -0.754 . . . . 1.8700000000000001 111.214 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.86 -170.15 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.701 1.601 . . . . 1.8999999999999999 111.222 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -103.13 -38.59 7.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 1.9299999999999999 111.158 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -122.2 132.9 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 1.97 111.177 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -125.1 120.78 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 2.0 111.192 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -85.07 146.12 27.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 2.0299999999999998 111.177 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -159.92 158.4 30.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 2.0699999999999998 111.171 173.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.94 174.27 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 2.1000000000000001 111.218 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -58.06 -32.93 68.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.232 -0.44 . . . . 2.1299999999999999 111.199 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -91.56 6.67 44.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 2.1699999999999999 111.219 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -114.64 -20.02 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 2.2000000000000002 111.161 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.34 -50.82 71.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 2.23 111.192 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -46.77 75.89 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.765 . . . . 2.27 111.186 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.89 95.05 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.171 -0.771 . . . . 2.2999999999999998 111.171 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -78.89 -24.88 43.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 2.3300000000000001 111.199 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.62 -23.16 31.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 2.3700000000000001 111.242 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -62.59 -33.71 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 2.3999999999999999 111.19 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -69.22 -28.75 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 2.4300000000000002 111.15 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.99 51.32 7.76 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.22 -0.752 . . . . 2.4700000000000002 111.22 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 75' ' ' LEU . 3.8 pp -132.03 20.05 4.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 2.5 111.221 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.88 134.29 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 2.5299999999999998 111.195 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.51 158.9 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 2.5699999999999998 111.24 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -89.62 159.25 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 2.6000000000000001 111.255 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.1 mt -130.07 137.85 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 2.6299999999999999 111.15 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.5 m -95.11 114.99 64.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.6699999999999999 111.235 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.6 155.14 27.6 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.151 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -90.03 169.98 10.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 2.73 111.197 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.11 -59.91 2.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 2.77 111.255 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.96 78.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 2.7999999999999998 111.165 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -54.87 -50.34 68.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.442 . . . . 2.8300000000000001 111.207 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -57.54 -43.86 84.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 2.8700000000000001 111.147 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.03 -34.98 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 2.8999999999999999 111.162 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -79.55 -21.87 44.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 2.9300000000000002 111.153 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.416 HD23 HD23 ' A' ' 304' ' ' LEU . 90.9 mt -88.09 151.42 22.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.9700000000000002 111.188 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -67.56 156.66 88.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 3.0 111.196 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.19 3.0 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.7 1.6 . . . . 3.0299999999999998 111.167 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -122.6 10.63 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.175 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.4 p -119.52 -35.43 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 3.1000000000000001 111.247 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -70.12 -40.0 75.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 3.1299999999999999 111.139 173.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -77.85 -30.98 51.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 3.1699999999999999 111.183 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.37 65.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 3.2000000000000002 111.168 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.21 20.98 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 3.23 111.142 -172.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 44.1 mtm105 -95.21 170.38 9.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 3.27 111.18 172.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -160.42 119.61 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 3.2999999999999998 111.215 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.1 t30 60.64 34.24 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 3.3300000000000001 111.217 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.98 7.7 83.4 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.262 -0.735 . . . . 3.3700000000000001 111.262 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -131.22 130.01 42.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 3.3999999999999999 111.269 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.1 tt -70.02 129.99 40.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 3.4300000000000002 111.212 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -113.93 -25.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 3.4700000000000002 111.223 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.85 165.85 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 3.5 111.199 -171.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -111.0 140.81 23.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 3.5299999999999998 111.193 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.14 -179.77 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.678 1.585 . . . . 3.5699999999999998 111.19 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.0 tp -165.06 -21.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 3.6000000000000001 111.15 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.33 145.55 23.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 3.6299999999999999 111.188 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.52 125.73 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 111.208 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -114.93 154.98 27.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 3.7000000000000002 111.218 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.02 175.91 9.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 3.73 111.188 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 113' ' ' LEU . 1.7 pp -143.21 146.54 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 3.77 111.173 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -168.36 179.97 4.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 3.7999999999999998 111.251 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.525 ' HB2' HD22 ' A' ' 247' ' ' LEU . 55.0 tp -95.41 112.2 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 3.8300000000000001 111.206 -174.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 tt -114.21 137.28 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 3.8700000000000001 111.236 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.59 150.52 46.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 3.8999999999999999 111.174 -172.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -85.83 120.27 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 3.9300000000000002 111.264 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.85 -35.09 67.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 3.9700000000000002 111.176 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.65 -33.94 77.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 4.0 111.188 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.02 -48.63 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.111 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.7 tp -154.98 111.12 2.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 4.0700000000000003 111.219 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.99 -17.67 19.39 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.697 1.598 . . . . 4.0999999999999996 111.197 -172.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -56.46 114.07 7.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 4.1299999999999999 111.217 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.7 134.81 15.41 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.71 1.606 . . . . 4.1699999999999999 111.218 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.511 ' HG3' ' SD ' ' A' ' 224' ' ' MET . 79.5 Cg_endo -77.61 140.59 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.753 1.636 . . . . 4.2000000000000002 111.171 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -100.14 -45.01 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 4.2300000000000004 111.239 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 t -158.41 -178.64 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.161 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -62.38 -38.33 89.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 4.2999999999999998 111.165 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.01 -15.45 62.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 4.3300000000000001 111.216 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -89.06 -14.31 36.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 4.3700000000000001 111.212 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.59 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.3 mt -67.54 -44.93 46.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 4.4000000000000004 111.205 -172.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 54.3 Cg_exo -55.07 -37.74 93.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.674 1.583 . . . . 4.4299999999999997 111.171 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.95 -36.88 72.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 4.4699999999999998 111.222 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.93 -32.92 74.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 4.5 111.193 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -56.38 -36.27 68.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 4.5300000000000002 111.249 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.88 -30.52 71.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 4.5700000000000003 111.153 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.2 -24.58 32.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 4.5999999999999996 111.146 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 -3.28 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 4.6299999999999999 111.198 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.22 -29.06 70.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 4.6699999999999999 111.221 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.94 79.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 4.7000000000000002 111.183 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -107.85 -9.94 15.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 4.7300000000000004 111.218 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.4 40.47 33.04 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.216 -0.754 . . . . 4.7699999999999996 111.216 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -111.62 155.3 23.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.313 . . . . 4.7999999999999998 111.225 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 t -99.71 141.44 32.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 4.8300000000000001 111.235 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.476 ' HB1' ' HE2' ' A' ' 224' ' ' MET . . . -85.93 -6.78 59.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 4.8700000000000001 111.204 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 198' ' ' LEU . 31.0 tp -165.37 133.41 3.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 4.9000000000000004 111.226 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 26.0 ttt -156.73 134.53 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 4.9299999999999997 111.189 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -129.03 -176.93 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 4.9699999999999998 111.183 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -84.75 120.32 26.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 5.0 111.276 168.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 tp -52.56 -38.9 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 5.0300000000000002 111.191 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -122.44 39.3 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 5.0700000000000003 111.225 -165.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -146.71 118.31 4.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 5.0999999999999996 111.175 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.09 -26.6 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.677 1.585 . . . . 5.1299999999999999 111.226 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -56.7 -41.07 76.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 5.1699999999999999 111.155 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 5.2000000000000002 111.225 -174.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.1 p -98.87 -6.31 29.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 5.2300000000000004 111.174 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.565 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.6 t90 -68.49 -43.76 32.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 5.2699999999999996 111.179 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 63.9 Cg_exo -55.76 -31.67 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.702 1.601 . . . . 5.2999999999999998 111.157 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 65.6 tp -61.73 -59.94 4.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 5.3300000000000001 111.238 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.51 -25.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.3700000000000001 111.202 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.24 67.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 5.4000000000000004 111.211 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.03 77.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 5.4299999999999997 111.211 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -78.01 -29.96 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 5.4699999999999998 111.186 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 92.41 50.0 2.67 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.167 -0.773 . . . . 5.5 111.167 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -55.87 -59.47 10.54 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 5.5300000000000002 111.204 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 50.4 p90 -112.58 169.84 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 5.5700000000000003 111.233 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 65.15 20.27 11.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 5.5999999999999996 111.222 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.97 150.04 43.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 5.6299999999999999 111.195 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.1 tttp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 5.6699999999999999 111.236 174.468 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.788 0.328 . . . . 5.9000000000000004 111.195 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.2 pt -75.2 -16.94 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 5.9299999999999997 111.215 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.73 -26.67 54.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 5.9699999999999998 111.211 -172.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.29 170.21 11.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 6.0 111.195 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -72.64 125.41 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 6.0300000000000002 111.181 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.59 60.4 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.175 -0.77 . . . . 6.0700000000000003 111.175 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.64 -37.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 6.0999999999999996 111.204 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -85.12 -3.57 58.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.238 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -71.35 155.59 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 6.1699999999999999 111.248 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.34 -33.66 67.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 6.2000000000000002 111.221 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.63 -27.26 73.12 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.213 -0.755 . . . . 6.2300000000000004 111.213 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.1 78.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.718 0.294 . . . . 6.2699999999999996 111.197 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.33 -43.05 95.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 6.2999999999999998 111.24 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.24 93.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 6.3300000000000001 111.145 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.92 97.44 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.212 -0.755 . . . . 6.3700000000000001 111.212 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.56 -29.64 61.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 6.4000000000000004 111.214 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 69.9 m -61.96 -44.33 96.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 6.4299999999999997 111.158 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -64.99 -37.45 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 6.4699999999999998 111.195 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.17 -46.86 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 6.5 111.193 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.25 -39.81 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 6.5300000000000002 111.248 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.37 -31.47 72.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 6.5700000000000003 111.198 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.402 HD13 HD23 ' A' ' 147' ' ' LEU . 46.5 tp -66.94 -41.29 87.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 6.5999999999999996 111.215 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 43.1 pt -83.0 -19.47 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 6.6299999999999999 111.232 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.15 -39.84 75.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 6.6699999999999999 111.133 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.23 -9.62 59.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 6.7000000000000002 111.204 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.38 54.29 2.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 6.7300000000000004 111.178 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -79.94 -20.37 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 6.7699999999999996 111.219 172.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -141.49 150.27 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.7999999999999998 111.174 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -127.01 170.02 12.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 6.8300000000000001 111.185 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.15 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 6.8700000000000001 111.225 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.16 -30.47 71.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 6.9000000000000004 111.196 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.8 m -59.42 125.01 21.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 6.9299999999999997 111.171 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -129.97 -166.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 6.9699999999999998 111.215 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -55.74 -50.04 71.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 7.0 111.146 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.7 p -73.15 -25.23 60.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.21 -171.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.0 mm -75.04 -51.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 7.0700000000000003 111.164 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.07 -32.87 74.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 7.0999999999999996 111.237 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -70.15 -52.17 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 7.1299999999999999 111.257 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.66 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 7.1699999999999999 111.181 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 221' ' ' GLU . . . -55.07 -36.3 65.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 7.2000000000000002 111.165 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -94.21 -41.01 9.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 7.2300000000000004 111.237 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.2 -41.91 80.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 7.2699999999999996 111.184 -173.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.17 -9.04 49.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 7.2999999999999998 111.187 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.61 27.38 59.2 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.771 . . . . 7.3300000000000001 111.171 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 216' ' ' ALA . 75.6 mm-40 -68.44 -29.88 68.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 7.3700000000000001 111.183 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.4 p -109.7 167.89 9.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 7.4000000000000004 111.132 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.63 -38.57 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4299999999999997 111.226 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.511 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 64.4 ttp -144.95 145.03 31.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 7.4699999999999998 111.159 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -163.56 174.22 12.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 7.5 111.175 170.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -100.94 128.82 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 7.5300000000000002 111.234 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -163.84 177.79 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 7.5700000000000003 111.194 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -112.09 163.5 12.19 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.62 117.2 3.91 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.632 1.555 . . . . 7.6299999999999999 111.208 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 175.04 -35.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 7.6699999999999999 111.225 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -109.95 4.31 21.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.241 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.02 -19.98 59.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 7.7300000000000004 111.206 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 90.5 p -65.71 -20.06 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 7.7699999999999996 111.227 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -72.79 -24.57 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 7.7999999999999998 111.19 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.05 -38.01 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 7.8300000000000001 111.178 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.63 -34.96 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 7.8700000000000001 111.201 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.6 m -66.52 -41.16 89.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 7.9000000000000004 111.219 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 88.8 p -73.18 -14.68 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 7.9299999999999997 111.194 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 59.98 51.52 5.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 7.9699999999999998 111.222 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.1 m -118.16 164.43 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 8.0 111.17 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -84.61 139.27 32.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 8.0299999999999994 111.193 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -153.8 165.0 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 8.0700000000000003 111.183 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.88 163.84 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.137 -0.785 . . . . 8.0999999999999996 111.137 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.88 129.55 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 8.1300000000000008 111.225 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 34.9 p -133.15 171.6 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 8.1699999999999999 111.181 171.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.35 150.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 8.1999999999999993 111.189 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.655 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 2.7 pt? -140.96 51.58 2.53 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.199 -175.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 46.0 Cg_endo -62.57 146.94 95.44 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.737 1.624 . . . . 8.2699999999999996 111.228 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 42.6 m -139.66 117.04 11.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 8.3000000000000007 111.25 -174.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.73 73.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 8.3300000000000001 111.212 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 60.56 56.1 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 8.3699999999999992 111.235 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.33 10.47 85.95 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.212 -0.755 . . . . 8.4000000000000004 111.212 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -130.02 110.01 16.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 8.4299999999999997 111.205 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 136.7 14.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.694 1.596 . . . . 8.4700000000000006 111.265 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.2 m -125.19 -87.37 0.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 8.5 111.168 167.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -143.17 142.72 22.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 8.5299999999999994 111.194 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.37 166.33 27.71 Favored 'Trans proline' 0 C--N 1.328 -0.54 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.124 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -73.41 138.05 45.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 8.5999999999999996 111.209 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.43 168.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 8.6300000000000008 111.191 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -144.64 163.19 27.96 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.13 -0.788 . . . . 8.6699999999999999 111.13 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.3 t -125.14 134.84 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 8.6999999999999993 111.19 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 49.1 tp -89.95 133.4 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 8.7300000000000004 111.227 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 90.1 p -143.94 169.97 16.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 8.7699999999999996 111.203 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 8.8000000000000007 111.256 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.15 -169.04 12.87 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.209 -0.756 . . . . 8.8300000000000001 111.209 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 89.4 mt -116.08 135.19 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 8.8699999999999992 111.221 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -60.94 131.11 49.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.172 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.95 -21.19 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 8.9299999999999997 111.197 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -91.53 -4.94 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 8.9700000000000006 111.194 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t -64.5 122.73 80.09 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 9.0 111.165 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.15 -17.9 18.86 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.706 1.604 . . . . 9.0299999999999994 111.215 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -110.55 60.04 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 9.0700000000000003 111.251 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -72.09 -36.66 69.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 9.0999999999999996 111.201 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.56 -37.64 80.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 9.1300000000000008 111.172 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.2 mt -72.33 -40.77 67.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 9.1699999999999999 111.169 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.1 95.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 9.1999999999999993 111.221 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.82 -44.11 90.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 9.2300000000000004 111.256 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -60.04 -43.49 95.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 9.2699999999999996 111.204 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -61.59 -52.08 65.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 9.3000000000000007 111.25 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.02 -20.1 65.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 9.3300000000000001 111.193 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -87.22 -60.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 9.3699999999999992 111.198 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -102.14 -6.46 23.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 9.4000000000000004 111.212 -162.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -124.01 -27.22 3.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 9.4299999999999997 111.21 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.84 -45.83 16.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 9.4700000000000006 111.209 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.92 71.11 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 9.5 111.216 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 42.0 p -138.58 176.03 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 9.5299999999999994 111.199 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -51.78 -36.97 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 9.5700000000000003 111.235 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -92.51 -38.72 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 9.5999999999999996 111.201 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.6 -60.2 8.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.0 tp -56.86 -45.58 82.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 9.6699999999999999 111.156 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.77 -54.18 47.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 9.6999999999999993 111.198 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.53 84.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 9.7300000000000004 111.17 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.2 -43.38 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 9.7699999999999996 111.165 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -98.39 7.53 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 9.8000000000000007 111.258 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.07 -39.3 74.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 9.8300000000000001 111.174 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -97.98 10.48 40.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 9.8699999999999992 111.198 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -130.0 160.39 65.43 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 9.9000000000000004 111.184 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.96 144.96 65.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.724 1.616 . . . . 9.9299999999999997 111.171 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.8 39.18 2.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.248 -0.433 . . . . 9.9700000000000006 111.18 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -54.88 -42.06 78.41 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.21 -0.756 . . . . 10.0 111.21 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -167.07 144.3 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 10.029999999999999 111.179 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.07 173.68 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 10.07 111.13 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.14 -36.63 19.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 10.1 111.157 -172.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.416 HD23 HD23 ' A' ' 89' ' ' LEU . 96.2 mt -81.56 143.26 32.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 10.130000000000001 111.191 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.29 -45.01 23.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 10.17 111.192 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 97.2 p -65.07 -31.9 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 10.199999999999999 111.158 -173.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -75.98 -46.12 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 10.23 111.17 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.25 -31.7 71.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 10.27 111.213 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -53.88 -41.49 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 10.300000000000001 111.2 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -71.34 -37.47 71.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 10.33 111.214 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.1 mp -67.56 -20.29 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 10.369999999999999 111.244 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.03 -18.51 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 10.4 111.256 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.55 -27.88 69.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 10.43 111.177 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.65 115.15 63.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 10.470000000000001 111.213 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.53 -34.37 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.706 1.604 . . . . 10.5 111.177 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.86 -31.99 73.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.19 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 95.8 mt -78.32 -39.99 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 10.57 111.19 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 321' ' ' MET . . . -56.24 -33.61 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 10.6 111.191 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.34 -35.04 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 10.630000000000001 111.177 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 66.4 p -105.18 -20.15 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.228 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.453 ' HB3' ' HA ' ' A' ' 318' ' ' ALA . 60.9 ttp -65.08 -58.7 5.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 10.699999999999999 111.208 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -54.12 -41.6 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.73 111.185 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.35 -29.95 60.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 10.77 111.177 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.07 -35.32 76.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 10.800000000000001 111.232 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.05 -35.04 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 10.83 111.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.17 -4.95 34.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 10.869999999999999 111.164 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.62 -178.84 52.46 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.127 -0.789 . . . . 10.9 111.127 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -119.59 157.12 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 10.93 111.207 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.6 pt -119.76 166.68 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 10.970000000000001 111.189 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.8 tpp -60.04 130.0 88.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 11.0 111.198 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.19 141.45 58.83 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.753 1.636 . . . . 11.029999999999999 111.204 174.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.13 20.59 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 11.07 111.179 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 335' ' ' GLN . 83.8 mt -95.68 130.04 32.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 11.1 111.201 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.75 -41.76 53.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.667 1.578 . . . . 11.130000000000001 111.157 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.4 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.4 mt-30 -63.52 -44.61 93.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 11.17 111.135 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.96 -31.84 73.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 11.199999999999999 111.209 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.1 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 11.23 111.182 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.97 76.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 11.27 111.211 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -67.2 -27.48 67.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 11.300000000000001 111.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -60.03 -38.22 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 11.33 111.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -72.13 -30.1 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 11.369999999999999 111.172 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.4 74.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 11.4 111.201 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.44 -24.99 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 11.43 111.23 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -57.66 -50.2 73.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 11.470000000000001 111.205 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.7 m -60.68 -38.23 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 11.5 111.235 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -55.81 -40.09 72.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 11.529999999999999 111.157 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -47.95 82.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.265 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 348' ' ' ILE . 8.2 tp -74.6 -23.19 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 11.6 111.158 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.64 -27.59 45.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 11.630000000000001 111.187 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.0 -27.71 32.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 11.67 111.186 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.49 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 11.699999999999999 111.183 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.6 p -72.65 -16.22 61.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 11.73 111.272 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.05 35.24 27.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.249 -0.74 . . . . 11.77 111.249 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -99.98 -35.09 9.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 11.800000000000001 111.214 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -127.97 157.07 41.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 11.83 111.137 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -77.45 177.48 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 11.869999999999999 111.224 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.99 -21.26 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 11.9 111.237 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -92.33 -37.69 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 11.93 111.196 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -66.99 -38.18 85.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.172 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.06 -41.77 94.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 12.0 111.185 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.0 -15.29 51.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 12.029999999999999 111.173 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.99 -56.63 8.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 12.07 111.225 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.96 -32.81 74.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 12.1 111.204 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.09 -56.68 19.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 12.130000000000001 111.236 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.76 -34.27 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 12.17 111.222 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.8 m . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 12.199999999999999 111.237 173.797 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.798 0.332 . . . . 0.070000000000000007 111.22 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.62 153.77 38.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.10000000000000001 111.2 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.05 125.02 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.13 111.199 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 18.07 60.62 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -134.12 150.03 51.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.20000000000000001 111.187 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -119.57 119.94 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.23000000000000001 111.23 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.85 116.24 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.27000000000000002 111.196 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.415 ' HB ' HG22 ' A' ' 37' ' ' VAL . 74.2 mt -121.79 116.62 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.29999999999999999 111.185 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.87 107.12 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.33000000000000002 111.234 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.8 tt -115.79 139.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.37 111.186 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -76.66 109.65 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.40000000000000002 111.2 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.76 -171.75 43.04 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.212 -0.755 . . . . 0.42999999999999999 111.212 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -109.95 -43.6 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.46999999999999997 111.229 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 88.2 tttt -151.41 40.01 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.5 111.241 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -14.77 68.67 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.19 -0.764 . . . . 0.53000000000000003 111.19 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -56.71 -30.96 64.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.56999999999999995 111.225 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.96 -37.95 89.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.59999999999999998 111.194 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.48 -31.72 11.22 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.16 -0.776 . . . . 0.63 111.16 -177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.2 tp -73.48 -46.58 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.67000000000000004 111.24 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.43 68.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.69999999999999996 111.173 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.71 -38.93 64.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.72999999999999998 111.17 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -75.71 -23.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.77000000000000002 111.258 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.64 -5.54 81.55 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.206 -0.758 . . . . 0.80000000000000004 111.206 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.49 -24.13 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.327 . . . . 0.82999999999999996 111.201 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.32 -25.48 66.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.87 111.197 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.90000000000000002 111.298 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.95 -28.37 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.93000000000000005 111.205 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.26 -35.65 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.96999999999999997 111.184 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.87 -47.93 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.255 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -124.21 -20.98 5.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 1.03 111.191 -172.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.11 27.15 24.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.186 -0.765 . . . . 1.0700000000000001 111.186 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.3 mt -105.43 128.18 59.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 1.1000000000000001 111.169 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.38 124.98 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 1.1299999999999999 111.24 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -99.4 119.46 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 1.1699999999999999 111.201 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.5 m -114.76 123.81 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.2 111.199 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' ' 9' ' ' ILE . 72.5 t -114.59 131.57 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.23 111.217 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.71 170.34 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 1.27 111.227 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.96 68.74 80.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 1.3 111.206 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.94 161.64 38.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.749 1.633 . . . . 1.3300000000000001 111.227 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -120.27 171.48 8.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 1.3700000000000001 111.232 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 54.96 37.22 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 1.3999999999999999 111.215 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.0 mt -66.85 -37.0 83.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 1.4299999999999999 111.176 -174.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -70.8 -11.99 61.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 1.47 111.208 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -102.91 -6.12 22.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.5 111.197 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.88 -39.91 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.53 111.197 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.579 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 m-85 -62.46 -39.3 54.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.5700000000000001 111.232 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 76.9 Cg_exo -52.39 -24.4 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.697 1.598 . . . . 1.6000000000000001 111.172 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -109.12 -17.39 13.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 1.6299999999999999 111.186 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.9 t -105.64 -58.77 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 1.6699999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.24 -33.1 75.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 1.7 111.25 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.21 -25.64 68.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.73 111.192 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 p -96.57 5.79 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 1.77 111.192 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.82 18.1 58.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.196 -0.762 . . . . 1.8 111.196 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -110.95 172.31 6.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 1.8300000000000001 111.178 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.01 -163.4 16.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.15 -0.78 . . . . 1.8700000000000001 111.15 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.59 -172.86 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.611 1.541 . . . . 1.8999999999999999 111.206 -175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -96.83 -44.35 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 1.9299999999999999 111.176 173.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.77 135.7 58.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 1.97 111.229 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.7 mt -130.55 130.0 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 2.0 111.225 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.55 138.82 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 2.0299999999999998 111.186 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -141.76 167.94 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 2.0699999999999998 111.216 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.47 158.14 24.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 2.1000000000000001 111.192 164.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -43.83 -41.35 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 2.1299999999999999 111.17 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -83.19 -18.29 39.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 2.1699999999999999 111.21 -174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.11 -19.55 24.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 2.2000000000000002 111.199 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.05 -30.02 67.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.23 111.194 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.18 98.49 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 2.27 111.219 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.74 -44.55 80.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.172 -0.771 . . . . 2.2999999999999998 111.172 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -68.15 -33.28 74.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.234 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.34 -39.81 64.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.19 -0.459 . . . . 2.3700000000000001 111.181 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -65.11 -30.06 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 2.3999999999999999 111.141 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -74.15 -12.91 60.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 2.4300000000000002 111.2 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 27.73 50.47 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.206 -0.758 . . . . 2.4700000000000002 111.206 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -110.39 -6.05 15.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.836 0.35 . . . . 2.5 111.241 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.6 tp -98.39 130.32 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 2.5299999999999998 111.186 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 146.19 24.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.185 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -82.46 159.8 22.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.6000000000000001 111.223 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.8 102.95 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 2.6299999999999999 111.184 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -52.27 111.6 2.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 2.6699999999999999 111.26 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.31 145.64 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.665 1.577 . . . . 2.7000000000000002 111.223 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.38 169.98 9.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 2.73 111.247 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -84.36 -29.11 26.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 2.77 111.17 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.16 91.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 2.7999999999999998 111.241 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.444 ' HA ' ' HB3' ' A' ' 88' ' ' LYS . 59.1 m-85 -80.04 -22.5 42.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 2.8300000000000001 111.186 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.93 -39.95 75.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 2.8700000000000001 111.249 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -94.71 -33.19 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 2.8999999999999999 111.181 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 85' ' ' PHE . 58.1 tptt -64.8 -43.57 92.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 2.9300000000000002 111.148 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -85.23 142.3 29.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 2.9700000000000002 111.147 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -66.85 127.98 93.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 3.0 111.204 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.11 -35.05 80.72 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.656 1.571 . . . . 3.0299999999999998 111.155 -168.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -52.86 -44.6 66.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.197 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -90.91 -23.24 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.1000000000000001 111.141 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -60.0 -43.96 94.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 3.1299999999999999 111.138 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -86.06 -9.51 56.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 3.1699999999999999 111.175 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.27 48.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 3.2000000000000002 111.181 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.452 HG21 ' HD3' ' A' ' 107' ' ' PRO . 29.4 m -114.99 26.24 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 3.23 111.19 -170.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -139.74 154.72 47.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 3.27 111.192 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 66.3 t80 -148.4 127.51 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 3.2999999999999998 111.203 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 97.8 m-20 65.04 26.19 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 3.3300000000000001 111.188 -174.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.4 -42.0 2.04 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.151 -0.78 . . . . 3.3700000000000001 111.151 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.61 135.53 33.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 3.3999999999999999 111.151 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.99 143.24 43.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 3.4300000000000002 111.167 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -115.83 -13.45 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 3.4700000000000002 111.179 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.59 160.54 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 3.5 111.168 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -109.95 133.98 20.82 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 3.5299999999999998 111.256 169.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.604 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 72.6 Cg_endo -81.02 -178.46 4.4 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.692 1.595 . . . . 3.5699999999999998 111.25 -172.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 107' ' ' PRO . 16.3 tt 163.94 14.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 3.6000000000000001 111.23 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -171.22 144.78 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.6299999999999999 111.228 174.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.98 157.0 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 3.6699999999999999 111.183 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -140.02 109.94 6.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 3.7000000000000002 111.214 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.91 156.25 36.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 3.73 111.233 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.2 tp -134.24 116.73 15.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 3.77 111.184 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.0 p -161.56 169.84 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 3.7999999999999998 111.251 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.75 117.52 24.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 3.8300000000000001 111.207 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -108.09 148.48 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 3.8700000000000001 111.259 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -146.27 154.88 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 3.8999999999999999 111.212 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -83.28 122.52 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 3.9300000000000002 111.137 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 241' ' ' ASN . 97.9 mttt -64.6 -19.2 65.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 3.9700000000000002 111.232 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -89.95 -26.91 20.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 4.0 111.153 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -54.71 3.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 4.0300000000000002 111.163 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.52 82.4 18.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 4.0700000000000003 111.187 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.04 -15.01 29.27 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.769 1.646 . . . . 4.0999999999999996 111.204 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -106.95 97.49 17.96 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 4.1299999999999999 111.184 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.1 163.75 34.51 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.731 1.621 . . . . 4.1699999999999999 111.158 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.82 152.09 68.88 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.662 1.575 . . . . 4.2000000000000002 111.175 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.7 -10.92 30.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 4.2300000000000004 111.168 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -156.97 -176.54 6.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.168 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -79.7 -26.55 40.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 4.2999999999999998 111.212 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.04 -22.08 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 4.3300000000000001 111.138 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.11 -15.91 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.3700000000000001 111.259 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.519 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.7 mt -66.95 -51.35 38.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 4.4000000000000004 111.142 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 96.1 Cg_endo -75.73 -22.5 13.52 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.72 1.613 . . . . 4.4299999999999997 111.193 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.56 89.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 4.4699999999999998 111.232 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.92 -38.21 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 4.5 111.219 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 34.8 t70 -46.68 -47.83 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.204 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -49.35 76.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 4.5700000000000003 111.19 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.88 -30.09 70.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 4.5999999999999996 111.147 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.2 mt -79.46 -36.1 39.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 4.6299999999999999 111.245 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.84 -20.06 64.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 4.6699999999999999 111.163 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.89 68.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 4.7000000000000002 111.24 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -107.0 8.47 30.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 4.7300000000000004 111.219 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.58 60.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.178 -0.769 . . . . 4.7699999999999996 111.178 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 72.9 mmtt -109.94 -174.15 2.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 4.7999999999999998 111.191 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.4 t -151.89 163.62 38.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 4.8300000000000001 111.178 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 136' ' ' ASP . . . -66.42 -57.77 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 4.8700000000000001 111.177 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.53 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.0 pp -164.95 164.93 20.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 4.9000000000000004 111.191 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.2 mmt -110.37 100.02 8.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 4.9299999999999997 111.147 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.88 130.01 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 4.9699999999999998 111.215 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 208' ' ' THR . 39.5 t-20 -70.27 111.93 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 5.0 111.2 169.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.76 7.55 44.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 5.0300000000000002 111.217 -170.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -109.83 -48.11 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 5.0700000000000003 111.263 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.7 121.22 81.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 5.0999999999999996 111.208 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.0 -31.26 8.18 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.717 1.611 . . . . 5.1299999999999999 111.224 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -73.82 -33.59 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 5.1699999999999999 111.167 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -53.03 -37.1 61.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 5.2000000000000002 111.168 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.7 p -99.06 15.31 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 5.2300000000000004 111.199 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 91.0 t90 -66.78 -46.63 55.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 5.2699999999999996 111.254 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 41.7 Cg_endo -87.94 -4.05 7.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.676 1.584 . . . . 5.2999999999999998 111.203 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.46 -51.46 68.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 5.3300000000000001 111.215 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.33 -31.42 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 5.3700000000000001 111.2 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.4 -35.15 79.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 5.4000000000000004 111.164 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.23 80.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 5.4299999999999997 111.197 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.48 -43.46 90.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.204 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.82 26.2 4.83 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.197 -0.761 . . . . 5.5 111.197 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.95 -31.69 4.67 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.257 -0.737 . . . . 5.5300000000000002 111.257 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.75 110.01 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 5.5700000000000003 111.241 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.29 35.82 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 5.5999999999999996 111.159 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -120.14 141.43 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 5.6299999999999999 111.133 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 5.6699999999999999 111.219 178.625 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.7 t0 . . . . . 0 CA--C 1.523 -0.075 0 CA-C-O 120.868 0.366 . . . . 5.9000000000000004 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 pt -72.33 -17.0 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 5.9299999999999997 111.192 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.23 -20.02 52.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 5.9699999999999998 111.196 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.75 174.42 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 6.0 111.165 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.33 152.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 6.0300000000000002 111.185 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.87 22.01 36.6 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.177 -0.769 . . . . 6.0700000000000003 111.177 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.9 p -71.04 -20.02 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 6.0999999999999996 111.25 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -113.79 22.56 13.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 6.1299999999999999 111.232 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.17 117.73 29.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 6.1699999999999999 111.196 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.91 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 6.2000000000000002 111.161 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.94 76.81 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.209 -0.756 . . . . 6.2300000000000004 111.209 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.58 80.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 6.2699999999999996 111.172 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.42 -39.05 93.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 6.2999999999999998 111.217 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 6.3300000000000001 111.207 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.84 -44.67 94.35 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.162 -0.775 . . . . 6.3700000000000001 111.162 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 192' ' ' LEU . 0.7 OUTLIER -65.76 -37.33 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 6.4000000000000004 111.234 176.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.8 m -61.14 -44.01 98.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 6.4299999999999997 111.173 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -55.66 -46.03 77.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 6.4699999999999998 111.205 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.88 -52.12 66.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 6.5 111.268 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.07 -21.14 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 6.5300000000000002 111.253 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.86 -40.18 79.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 6.5700000000000003 111.242 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.04 -35.61 81.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 6.5999999999999996 111.177 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.28 -52.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.195 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.58 -43.03 99.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 6.6699999999999999 111.231 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -79.94 -10.14 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 6.7000000000000002 111.149 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 59.83 58.46 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 6.7300000000000004 111.182 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -81.17 -22.57 38.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 6.7699999999999996 111.219 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.98 170.75 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.207 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -92.74 161.98 14.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 6.8300000000000001 111.197 -174.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.86 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 6.8700000000000001 111.238 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.01 -30.06 67.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 6.9000000000000004 111.18 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 150' ' ' ASN . 49.8 m -51.77 130.78 29.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.206 175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -157.49 176.72 12.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 6.9699999999999998 111.197 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -64.04 -21.2 66.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 7.0 111.175 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.0 p -69.7 -25.6 63.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 7.0300000000000002 111.226 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.52 -32.27 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 7.0700000000000003 111.19 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 225' ' ' THR . . . -61.04 -44.69 97.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 7.0999999999999996 111.202 177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.97 -39.55 93.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 7.1299999999999999 111.207 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.12 -47.19 86.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.219 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.94 63.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 7.2000000000000002 111.211 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.64 -38.89 92.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 7.2300000000000004 111.183 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 234' ' ' ASN . 97.7 m-20 -93.33 -39.69 10.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 7.2699999999999996 111.175 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.52 -23.06 59.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 7.2999999999999998 111.218 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.35 51.23 6.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.229 -0.748 . . . . 7.3300000000000001 111.229 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.92 3.25 25.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 7.3700000000000001 111.227 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 154.04 36.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 7.4000000000000004 111.241 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.57 -29.87 18.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 7.4299999999999997 111.212 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 21.6 ptt? -152.3 170.0 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 7.4699999999999998 111.185 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.413 HG21 ' HB1' ' A' ' 213' ' ' ALA . 12.3 t -170.18 152.82 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 7.5 111.161 170.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 94.0 mt -91.89 120.07 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 7.5300000000000002 111.236 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -160.8 -172.12 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 7.5700000000000003 111.167 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -120.36 -165.09 12.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.165 -0.774 . . . . 7.5999999999999996 111.165 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.13 64.65 8.39 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.708 1.606 . . . . 7.6299999999999999 111.245 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -125.41 -30.07 3.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 7.6699999999999999 111.224 171.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.19 -5.22 30.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 7.7000000000000002 111.246 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -76.91 -19.15 57.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 7.7300000000000004 111.175 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 95.5 p -72.85 -10.06 59.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 7.7699999999999996 111.196 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 218' ' ' ASN . 65.8 m-80 -95.01 5.41 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 7.7999999999999998 111.187 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.9 -51.29 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 7.8300000000000001 111.198 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -77.39 -25.32 50.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 7.8700000000000001 111.199 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 87.5 m -64.99 -45.95 83.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 7.9000000000000004 111.227 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 85.2 p -82.58 -14.72 54.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 7.9299999999999997 111.259 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 59.57 45.4 13.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 7.9699999999999998 111.18 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 73.6 t -128.03 142.82 42.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 8.0 111.207 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 119' ' ' LYS . 97.4 m-20 -74.75 112.57 11.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 8.0299999999999994 111.222 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -112.84 143.04 44.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 8.0700000000000003 111.177 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -118.58 167.47 13.04 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.147 -0.781 . . . . 8.0999999999999996 111.147 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.65 160.75 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 8.1300000000000008 111.17 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -135.76 -176.65 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 8.1699999999999999 111.201 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.01 120.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 8.1999999999999993 111.206 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.535 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 91.5 mt -87.8 -42.2 0.5 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.134 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 78.2 Cg_exo -53.22 112.42 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.695 1.597 . . . . 8.2699999999999996 111.156 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 88.0 m -124.48 112.11 16.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 8.3000000000000007 111.168 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -110.01 128.75 55.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 8.3300000000000001 111.126 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 85.1 tttt 45.17 46.04 9.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 8.3699999999999992 111.176 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.9 14.49 78.48 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.205 -0.758 . . . . 8.4000000000000004 111.205 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -129.98 109.99 16.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.181 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.8 130.63 38.24 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.746 1.631 . . . . 8.4700000000000006 111.187 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.6 t -105.1 -99.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 8.5 111.126 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -136.87 151.94 73.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 8.5299999999999994 111.223 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -60.4 144.57 99.52 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.737 1.624 . . . . 8.5700000000000003 111.181 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -92.96 148.31 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 8.5999999999999996 111.162 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.35 126.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 8.6300000000000008 111.213 -175.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -85.83 162.83 36.1 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -129.28 136.41 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 8.6999999999999993 111.141 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 67.1 mt -109.82 148.74 30.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 8.7300000000000004 111.165 172.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -161.63 169.98 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 8.7699999999999996 111.234 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.15 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 8.8000000000000007 111.162 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.46 179.66 16.41 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.226 -0.749 . . . . 8.8300000000000001 111.226 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.3 mt -100.98 136.01 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 8.8699999999999992 111.194 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.91 124.72 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 8.9000000000000004 111.167 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.13 -22.42 66.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 8.9299999999999997 111.231 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -5.51 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 8.9700000000000006 111.237 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -79.48 129.88 70.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 9.0 111.2 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.52 -3.33 13.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.708 1.605 . . . . 9.0299999999999994 111.233 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -120.01 60.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 9.0700000000000003 111.263 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -75.85 -30.38 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 9.0999999999999996 111.183 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -68.06 -46.46 71.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 9.1300000000000008 111.223 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 64.3 tp -62.76 -44.13 97.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 9.1699999999999999 111.18 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.29 98.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 9.1999999999999993 111.128 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -63.25 -40.22 96.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 9.2300000000000004 111.183 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.68 -54.78 42.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 9.2699999999999996 111.222 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -52.28 -50.0 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 9.3000000000000007 111.275 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.63 -43.6 93.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 9.3300000000000001 111.219 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -83.41 -61.76 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 9.3699999999999992 111.232 -168.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -92.98 -8.56 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 9.4000000000000004 111.262 -162.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.0 -50.09 2.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 9.4299999999999997 111.231 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.0 tp -78.42 -60.0 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 9.4700000000000006 111.163 -174.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.8 mm? -75.2 69.93 2.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 9.5 111.177 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 29.5 p -136.86 178.02 7.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 9.5299999999999994 111.14 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.18 -25.75 68.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 9.5700000000000003 111.202 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -98.49 -34.59 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.5999999999999996 111.221 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.91 -48.71 59.27 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.35 -45.37 84.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 9.6699999999999999 111.186 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.32 -46.12 91.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 9.6999999999999993 111.217 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.64 74.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 9.7300000000000004 111.136 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.79 -40.65 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 9.7699999999999996 111.204 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.516 ' HB3' HD23 ' A' ' 299' ' ' LEU . 91.9 m-20 -78.22 0.67 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 9.8000000000000007 111.281 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.89 -35.93 82.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 9.8300000000000001 111.152 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.2 -28.33 9.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 9.8699999999999992 111.177 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.45 164.06 19.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 9.9000000000000004 111.19 -176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.97 139.95 79.5 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.702 1.601 . . . . 9.9299999999999997 111.206 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 294' ' ' ASN . 98.7 mt -70.12 -18.6 63.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.166 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.01 -26.53 71.44 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.197 -0.761 . . . . 10.0 111.197 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -60.13 127.09 30.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 10.029999999999999 111.189 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.9 134.25 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 10.07 111.193 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 108' ' ' ILE . . . -114.42 -27.18 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 10.1 111.168 164.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.19 144.99 27.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 10.130000000000001 111.162 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -65.55 -47.35 76.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 10.17 111.224 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.8 m -62.67 -40.05 95.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 10.199999999999999 111.204 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -65.17 -40.37 94.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 10.23 111.226 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -60.75 -33.39 72.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 10.27 111.238 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.12 -33.11 71.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 10.300000000000001 111.174 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -70.31 -29.9 66.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 10.33 111.188 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.15 -29.84 61.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 10.369999999999999 111.169 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.01 73.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 10.4 111.189 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.33 -34.36 68.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 10.43 111.166 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.02 118.35 48.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 10.470000000000001 111.159 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.7 -35.51 93.34 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.744 1.629 . . . . 10.5 111.153 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -79.98 -52.58 7.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 10.529999999999999 111.156 -172.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.428 HG22 ' HG2' ' A' ' 321' ' ' MET . 50.4 mm -79.17 -27.34 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 10.57 111.163 -170.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.31 -36.72 33.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 10.6 111.172 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.15 95.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.188 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.8 m -69.95 -39.85 75.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 10.67 111.107 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.428 ' HG2' HG22 ' A' ' 317' ' ' ILE . 38.8 mmt -68.37 -35.42 77.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 10.699999999999999 111.233 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.53 -42.4 87.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 10.73 111.233 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -64.91 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 10.77 111.238 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 10.800000000000001 111.232 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.49 -42.77 99.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.83 111.271 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.04 -9.83 38.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 10.869999999999999 111.262 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.97 -165.16 35.45 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.23 164.31 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 10.93 111.17 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.4 pt -111.32 162.87 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 10.970000000000001 111.214 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -84.95 164.72 40.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 11.0 111.18 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.06 138.53 82.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.72 1.614 . . . . 11.029999999999999 111.182 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -107.51 28.27 8.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 11.07 111.221 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 335' ' ' GLN . 89.3 mt -90.62 125.26 60.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 11.1 111.202 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.49 -24.36 31.01 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.736 1.624 . . . . 11.130000000000001 111.183 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.438 ' H ' HG22 ' A' ' 333' ' ' ILE . 61.7 mt-30 -80.57 -1.46 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 11.17 111.129 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.1 mmm -95.16 6.9 47.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 11.199999999999999 111.164 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.4 p -64.55 -33.78 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 11.23 111.133 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.29 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 11.27 111.163 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -60.98 -47.59 85.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 11.300000000000001 111.172 175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.38 -49.06 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 11.33 111.219 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.36 -47.01 65.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.172 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.37 86.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.244 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.97 -46.38 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 11.43 111.192 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.75 -44.85 70.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 11.470000000000001 111.233 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.8 m -65.21 -40.56 94.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.203 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.76 -34.08 77.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 11.529999999999999 111.174 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.82 -48.9 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 11.57 111.167 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 8.9 tp -74.88 -25.18 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 11.6 111.201 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.76 -48.29 55.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 11.630000000000001 111.219 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.64 76.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 11.67 111.208 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.07 87.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.175 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 11.73 111.161 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.34 27.02 8.92 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.216 -0.754 . . . . 11.77 111.216 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -82.75 -35.08 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 11.800000000000001 111.23 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -151.38 174.77 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 11.83 111.135 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -85.0 171.97 11.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 11.869999999999999 111.177 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -72.19 -24.16 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 11.9 111.237 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.01 -47.89 60.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 11.93 111.161 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -68.5 -28.45 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 11.970000000000001 111.162 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.13 -51.33 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 12.0 111.208 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.29 -20.35 48.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 12.029999999999999 111.205 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.86 -52.42 56.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 12.07 111.151 171.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.84 -37.4 86.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.429 . . . . 12.1 111.246 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.45 81.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 12.130000000000001 111.212 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -55.31 -44.5 75.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 12.17 111.208 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.8 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 12.199999999999999 111.237 177.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.8 0.333 . . . . 0.070000000000000007 111.175 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.0 144.93 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.10000000000000001 111.199 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.04 129.94 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.13 111.211 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.02 19.56 21.24 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.153 -0.779 . . . . 0.17000000000000001 111.153 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -140.16 146.61 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.20000000000000001 111.196 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 275' ' ' LEU . 88.2 mt -112.29 140.75 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.23000000000000001 111.264 172.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.84 118.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.27000000000000002 111.218 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 59' ' ' ILE . 89.5 mt -107.88 123.9 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.29999999999999999 111.213 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -110.09 130.66 55.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.33000000000000002 111.201 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.42 120.09 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.37 111.231 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.58 125.35 26.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.40000000000000002 111.156 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.15 -170.83 40.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.151 -0.78 . . . . 0.42999999999999999 111.151 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.04 -51.9 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.46999999999999997 111.157 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.73 158.8 42.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.5 111.254 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.99 -8.87 4.82 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.229 -0.748 . . . . 0.53000000000000003 111.229 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -64.93 -24.56 67.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 111.257 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.54 -42.73 70.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.59999999999999998 111.219 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.58 -40.41 97.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.155 -0.778 . . . . 0.63 111.155 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.17 -23.61 51.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.328 . . . . 0.67000000000000004 111.183 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -33.4 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.147 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.77 -42.85 97.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.164 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.93 -25.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.77000000000000002 111.184 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -33.52 87.45 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.13 -0.788 . . . . 0.80000000000000004 111.13 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.61 -43.91 92.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.82999999999999996 111.151 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.97 -35.98 76.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.87 111.222 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.08 -42.73 93.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.90000000000000002 111.172 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.59 -35.76 81.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.93000000000000005 111.234 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -64.35 -30.05 71.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.96999999999999997 111.182 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -99.89 -34.7 10.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.252 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -107.05 -29.03 9.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 1.03 111.239 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.95 6.55 75.56 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.186 -0.766 . . . . 1.0700000000000001 111.186 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.7 mm -89.22 127.86 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 1.1000000000000001 111.176 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.6 134.33 33.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.1299999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -115.49 124.44 71.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 1.1699999999999999 111.265 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -115.69 125.97 53.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 1.2 111.249 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.19 131.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.23 111.198 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -128.84 156.12 44.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 1.27 111.208 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -111.49 85.64 6.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 1.3 111.178 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 147.51 45.91 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.713 1.608 . . . . 1.3300000000000001 111.19 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -137.03 5.23 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 1.3700000000000001 111.182 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -124.96 35.05 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 1.3999999999999999 111.16 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.98 -35.15 74.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 1.4299999999999999 111.199 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.3 -40.04 64.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.47 111.199 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -84.66 -26.94 27.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 1.5 111.144 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.02 -19.81 43.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.217 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.481 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.2 m-30 -55.04 -57.43 19.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 1.5700000000000001 111.231 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 72.8 Cg_endo -72.96 -23.33 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.732 1.621 . . . . 1.6000000000000001 111.16 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -67.7 -36.4 80.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.302 -0.408 . . . . 1.6299999999999999 111.162 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.8 m -100.02 -28.08 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 1.6699999999999999 111.183 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 1.7 111.229 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -15.89 60.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 1.73 111.2 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 p -109.88 -18.39 13.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 1.77 111.145 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.96 42.52 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.214 -0.754 . . . . 1.8 111.214 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -111.22 -175.0 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.8300000000000001 111.154 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.07 -172.15 25.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.172 -0.771 . . . . 1.8700000000000001 111.172 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.0 -176.49 2.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.666 1.578 . . . . 1.8999999999999999 111.212 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -99.27 -48.03 4.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 1.9299999999999999 111.211 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.441 ' HB ' HG12 ' A' ' 9' ' ' ILE . 83.4 mt -117.93 134.96 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 1.97 111.195 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -121.72 137.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 2.0 111.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -105.39 137.95 42.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 2.0299999999999998 111.206 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.99 163.38 18.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 2.0699999999999998 111.173 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.22 165.93 12.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 2.1000000000000001 111.173 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -53.96 -33.52 57.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.1299999999999999 111.197 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 340' ' ' TRP . 76.1 m-20 -102.51 16.27 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 2.1699999999999999 111.206 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -110.01 -0.02 18.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 2.2000000000000002 111.165 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -69.97 -27.55 64.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 2.23 111.225 -170.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.7 -39.74 61.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 2.27 111.218 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -30.82 78.77 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.178 -0.769 . . . . 2.2999999999999998 111.178 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.64 -37.07 11.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.24 -174.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.08 64.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 2.3700000000000001 111.174 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -84.51 -28.23 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 2.3999999999999999 111.195 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 -15.62 56.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.4300000000000002 111.249 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 31.55 30.28 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.229 -0.748 . . . . 2.4700000000000002 111.229 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -118.65 33.73 5.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 2.5 111.211 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.0 tp -152.37 125.16 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 2.5299999999999998 111.158 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.68 157.67 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 2.5699999999999998 111.22 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.87 80.01 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 2.6000000000000001 111.21 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.57 114.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 2.6299999999999999 111.258 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.469 HG23 ' HB2' ' A' ' 103' ' ' LEU . 53.0 m -100.9 121.58 51.9 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 2.6699999999999999 111.219 -168.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HB3' ' CD2' ' A' ' 106' ' ' TYR . 58.1 Cg_endo -67.43 125.27 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.18 173.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -85.03 -168.28 2.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 2.73 111.176 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.89 -32.86 71.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 2.77 111.181 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.61 -35.05 76.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 2.7999999999999998 111.168 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.93 -24.82 21.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 2.8300000000000001 111.201 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.69 -35.03 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.8700000000000001 111.158 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -89.25 -34.96 16.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 2.8999999999999999 111.202 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -81.03 -30.08 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 2.9300000000000002 111.175 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -104.56 166.11 10.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 2.9700000000000002 111.249 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.448 ' CE2' ' HA ' ' A' ' 303' ' ' ALA . 19.7 m-85 -60.14 138.14 91.33 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 3.0 111.228 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.31 -13.56 28.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.687 1.591 . . . . 3.0299999999999998 111.214 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.71 -21.98 24.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 3.0699999999999998 111.164 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -107.37 -19.74 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 3.1000000000000001 111.185 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -60.14 -42.63 95.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 3.1299999999999999 111.188 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.98 -15.55 29.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 3.1699999999999999 111.137 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.28 13.31 8.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 3.2000000000000002 111.2 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.2 m -120.19 71.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 3.23 111.24 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -141.33 139.15 33.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 3.27 111.163 -158.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -162.44 139.85 8.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 3.2999999999999998 111.175 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 65.8 30.55 10.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 3.3300000000000001 111.186 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.72 86.78 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.149 -0.78 . . . . 3.3700000000000001 111.149 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.15 155.68 48.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.821 0.343 . . . . 3.3999999999999999 111.216 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.469 ' HB2' HG23 ' A' ' 80' ' ' THR . 90.1 mt -79.06 142.43 36.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 3.4300000000000002 111.151 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 pt -124.93 -5.01 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 3.4700000000000002 111.226 -162.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.14 160.41 39.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 3.5 111.244 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 86.9 m-85 -99.09 125.07 42.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 3.5299999999999998 111.139 166.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.66 131.16 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.702 1.601 . . . . 3.5699999999999998 111.135 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.24 -55.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 3.6000000000000001 111.18 -169.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.77 156.36 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 3.6299999999999999 111.206 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.04 161.01 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 3.6699999999999999 111.161 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -149.31 110.57 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 3.7000000000000002 111.132 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.44 135.85 44.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 3.73 111.227 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.13 145.07 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 3.77 111.164 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 99.0 p -150.15 169.4 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 3.7999999999999998 111.199 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -115.13 130.21 56.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 3.8300000000000001 111.221 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.75 147.79 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 3.8700000000000001 111.23 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -138.19 159.03 43.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 3.8999999999999999 111.132 167.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 122' ' ' LEU . 34.4 t-20 -107.85 104.75 14.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 3.9300000000000002 111.257 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.0 mttt -57.67 -34.8 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 3.9700000000000002 111.203 -174.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.34 -47.72 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 4.0 111.227 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.21 -58.46 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 4.0300000000000002 111.288 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 118' ' ' ASN . 68.2 mt -125.04 76.26 67.23 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 4.0700000000000003 111.285 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.43 -17.61 39.0 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.691 1.594 . . . . 4.0999999999999996 111.224 -174.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -97.81 104.84 23.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 4.1299999999999999 111.198 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.18 155.47 64.48 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.635 1.557 . . . . 4.1699999999999999 111.241 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.38 144.22 60.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 4.2000000000000002 111.238 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.18 -19.88 31.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 4.2300000000000004 111.215 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -150.07 -177.33 5.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 4.2699999999999996 111.238 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -64.58 -41.73 96.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 4.2999999999999998 111.212 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.27 -23.1 66.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 4.3300000000000001 111.185 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -87.71 -15.34 37.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 4.3700000000000001 111.174 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 82.7 mt -68.94 -50.48 22.12 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 4.4000000000000004 111.179 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 92.1 Cg_endo -75.93 -18.98 16.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.661 1.574 . . . . 4.4299999999999997 111.199 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.0 85.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 4.4699999999999998 111.201 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.75 -28.65 60.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 4.5 111.214 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.62 -42.51 98.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 4.5300000000000002 111.179 173.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.78 -48.1 72.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 4.5700000000000003 111.201 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -61.84 -40.98 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 4.5999999999999996 111.191 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 223' ' ' ALA . 26.0 tp -72.25 -31.78 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 4.6299999999999999 111.215 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.73 -39.52 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 4.6699999999999999 111.158 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.76 71.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 4.7000000000000002 111.228 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.89 -14.86 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.488 . . . . 4.7300000000000004 111.222 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.13 16.49 18.64 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.277 -0.729 . . . . 4.7699999999999996 111.277 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -134.26 154.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 4.7999999999999998 111.212 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.5 t -100.96 146.92 26.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 4.8300000000000001 111.225 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -112.73 -20.61 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 4.8700000000000001 111.205 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.7 tp -125.58 114.57 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 4.9000000000000004 111.17 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.402 ' SD ' ' OG1' ' A' ' 222' ' ' THR . 97.9 mtp -145.0 110.08 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 4.9299999999999997 111.22 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -101.21 -179.97 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 4.9699999999999998 111.186 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.649 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . 61.0 t-20 -96.06 105.26 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 5.0 111.216 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 151' ' ' LEU . 3.2 mm? -89.21 9.38 25.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 5.0300000000000002 111.209 -173.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -110.64 -9.98 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 5.0700000000000003 111.234 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -144.6 113.28 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 5.0999999999999996 111.193 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.12 -33.56 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.719 1.613 . . . . 5.1299999999999999 111.221 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -55.24 -33.03 62.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 5.1699999999999999 111.197 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.649 ' HB2' ' HB3' ' A' ' 150' ' ' ASN . 77.9 m-85 -104.99 25.57 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 5.2000000000000002 111.22 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.8 p -121.97 -14.38 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 5.2300000000000004 111.141 166.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.593 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 88.7 t90 -66.12 -40.1 34.04 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 5.2699999999999996 111.192 176.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 74.4 Cg_exo -55.45 -19.54 23.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.758 1.639 . . . . 5.2999999999999998 111.201 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.4 tp -42.77 -51.54 5.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 5.3300000000000001 111.223 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 47.7 pt -86.19 -9.99 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 5.3700000000000001 111.169 -173.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.94 -25.78 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 5.4000000000000004 111.173 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.95 98.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 5.4299999999999997 111.225 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -95.69 9.83 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.216 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.21 29.6 73.34 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.177 -0.769 . . . . 5.5 111.177 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.89 -37.89 28.41 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -71.79 131.64 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 5.5700000000000003 111.179 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 55.02 55.29 7.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 5.5999999999999996 111.202 168.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -127.38 162.45 26.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.428 . . . . 5.6299999999999999 111.223 165.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.7 pttt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 5.6699999999999999 111.237 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.2 t0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.831 0.348 . . . . 5.9000000000000004 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.39 -18.62 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 5.9299999999999997 111.2 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 5.9699999999999998 111.217 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.3 141.76 58.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 6.0 111.161 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.85 173.45 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 6.0300000000000002 111.177 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -83.8 9.0 63.87 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.242 -0.743 . . . . 6.0700000000000003 111.242 -168.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.28 -2.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 6.0999999999999996 111.187 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -131.33 10.03 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 6.1299999999999999 111.199 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.08 139.46 36.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 6.1699999999999999 111.164 174.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.66 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 6.2000000000000002 111.179 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.64 93.54 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.761 . . . . 6.2300000000000004 111.199 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.23 92.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 6.2699999999999996 111.247 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.1 -47.3 62.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 6.2999999999999998 111.22 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.27 92.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 6.3300000000000001 111.239 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -46.73 88.46 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.245 -0.742 . . . . 6.3700000000000001 111.245 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.17 -43.46 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 6.4000000000000004 111.197 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -50.95 -29.29 11.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 6.4299999999999997 111.172 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -53.29 -60.62 3.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 6.4699999999999998 111.17 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.9 mt -78.48 -25.36 45.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 6.5 111.234 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.59 -47.37 85.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 6.5300000000000002 111.243 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -75.01 -35.44 61.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 6.5700000000000003 111.222 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.483 ' HB3' ' HG2' ' A' ' 204' ' ' MET . 5.1 mp -75.76 -18.97 59.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 6.5999999999999996 111.197 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 93.8 mt -91.71 -40.6 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 6.6299999999999999 111.213 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.78 -38.09 77.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 6.6699999999999999 111.22 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.96 13.57 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 6.7000000000000002 111.146 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 56.94 46.19 19.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 6.7300000000000004 111.193 172.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -94.98 -49.91 5.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 6.7699999999999996 111.26 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.483 ' HG2' ' HB3' ' A' ' 198' ' ' LEU . 97.5 mmm -74.31 144.99 44.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 6.7999999999999998 111.224 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -86.56 114.57 23.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 6.8300000000000001 111.164 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.58 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.8700000000000001 111.22 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.28 -30.3 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 6.9000000000000004 111.175 -176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 m -64.97 128.96 37.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.262 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.06 -166.76 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 6.9699999999999998 111.189 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -69.92 -48.81 57.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 7.0 111.122 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -67.49 -29.84 69.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 7.0300000000000002 111.21 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.7 mt -66.96 -44.94 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 7.0700000000000003 111.194 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.36 93.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.141 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.92 -40.04 40.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 7.1299999999999999 111.138 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.0 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.208 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.04 -9.12 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 7.2000000000000002 111.214 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.53 -25.02 56.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 7.2300000000000004 111.205 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -89.39 -24.04 22.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 7.2699999999999996 111.171 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.01 -25.42 32.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 7.2999999999999998 111.148 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.26 29.13 28.62 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.277 -0.729 . . . . 7.3300000000000001 111.277 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.55 -19.13 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 7.3700000000000001 111.233 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.402 ' OG1' ' SD ' ' A' ' 148' ' ' MET . 96.9 m -119.59 127.59 53.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 7.4000000000000004 111.142 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 139' ' ' LEU . . . -93.51 -31.22 14.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 7.4299999999999997 111.135 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 17.2 ptp -157.46 159.68 37.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 7.4699999999999998 111.183 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.0 t -160.39 -173.17 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 7.5 111.181 170.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.62 122.27 58.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 7.5300000000000002 111.207 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 9.5 t-20 -166.79 -178.99 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 7.5700000000000003 111.279 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.52 -165.23 41.07 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.44 79.61 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.669 1.579 . . . . 7.6299999999999999 111.153 -174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -175.02 -22.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.428 . . . . 7.6699999999999999 111.231 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -68.75 -47.52 66.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 7.7000000000000002 111.177 -172.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -86.33 2.17 48.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 7.7300000000000004 111.156 -170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.3 p -84.51 -9.44 58.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 7.7699999999999996 111.188 171.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -94.85 -7.16 41.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 7.7999999999999998 111.213 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.89 -24.31 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 7.8300000000000001 111.191 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -30.9 29.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 7.8700000000000001 111.189 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.4 m -62.29 -40.12 95.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 7.9000000000000004 111.205 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 49.5 m -71.35 -24.73 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 7.9299999999999997 111.226 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 63.12 54.47 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 7.9699999999999998 111.188 174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.66 167.47 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 8.0 111.196 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -81.09 126.41 31.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 8.0299999999999994 111.266 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.434 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 53.4 p90 -145.85 164.44 31.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 8.0700000000000003 111.193 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.41 -179.38 30.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.148 -0.781 . . . . 8.0999999999999996 111.148 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.61 140.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 8.1300000000000008 111.158 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -138.18 -174.84 3.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 8.1699999999999999 111.258 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.26 159.16 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 8.1999999999999993 111.13 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 247' ' ' LEU . 2.4 pt? -139.93 50.01 2.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 8.2300000000000004 111.197 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 74.0 Cg_endo -73.13 149.97 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.714 1.609 . . . . 8.2699999999999996 111.184 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.9 m -148.66 117.76 6.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 8.3000000000000007 111.254 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -105.46 85.24 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 8.3300000000000001 111.152 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 86.5 mttt 57.02 35.35 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 8.3699999999999992 111.206 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.34 -14.05 28.07 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.261 -0.736 . . . . 8.4000000000000004 111.261 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -117.92 109.98 40.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 8.4299999999999997 111.217 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.17 139.01 41.13 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.66 1.573 . . . . 8.4700000000000006 111.253 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.9 t -139.99 -75.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 8.5 111.29 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.474 ' HB3' ' HA2' ' A' ' 327' ' ' GLY . 70.1 mmtt -144.41 146.21 31.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 8.5299999999999994 111.201 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 165.97 30.6 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.742 1.628 . . . . 8.5700000000000003 111.223 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.16 139.21 44.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 8.5999999999999996 111.229 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.94 115.28 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 8.6300000000000008 111.213 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.68 151.38 32.28 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.2 -0.76 . . . . 8.6699999999999999 111.2 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.65 133.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 8.6999999999999993 111.148 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 50.0 tp -102.53 134.3 46.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 8.7300000000000004 111.141 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 98.6 p -132.99 173.78 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 8.7699999999999996 111.219 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.31 40.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 8.8000000000000007 111.211 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -157.74 -173.05 25.66 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.224 -0.751 . . . . 8.8300000000000001 111.224 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -102.41 127.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 8.8699999999999992 111.187 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.15 135.66 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 8.9000000000000004 111.211 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.27 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 8.9299999999999997 111.206 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -99.42 19.54 15.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 8.9700000000000006 111.267 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 16.5 t -69.78 121.55 82.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 9.0 111.207 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 -26.47 19.09 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.648 1.565 . . . . 9.0299999999999994 111.162 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -119.62 62.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.0700000000000003 111.219 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -65.08 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 9.0999999999999996 111.177 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.51 -49.2 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 9.1300000000000008 111.219 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.44 ' HB2' HD21 ' A' ' 7' ' ' LEU . 99.5 mt -68.52 -34.75 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 9.1699999999999999 111.228 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.54 99.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 9.1999999999999993 111.237 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -47.94 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 9.2300000000000004 111.183 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.95 -40.1 95.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.259 -0.428 . . . . 9.2699999999999996 111.163 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -59.8 -52.04 67.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 9.3000000000000007 111.138 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.08 -44.58 94.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 9.3300000000000001 111.191 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.57 -35.12 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 9.3699999999999992 111.18 -167.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -93.9 -23.2 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 9.4000000000000004 111.172 -170.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -122.66 -66.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 9.4299999999999997 111.224 -171.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 67.3 tp -50.41 -56.03 13.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 9.4700000000000006 111.192 -167.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.9 mt -104.0 38.35 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 9.5 111.192 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.5 p -119.14 -165.73 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 9.5299999999999994 111.259 167.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.84 -10.87 60.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 9.5700000000000003 111.174 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -88.11 -54.41 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 9.5999999999999996 111.209 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.33 6.38 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.171 -0.772 . . . . 9.6300000000000008 111.171 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.13 -34.67 76.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 9.6699999999999999 111.189 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.55 -41.27 80.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 9.6999999999999993 111.216 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.32 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 9.7300000000000004 111.263 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.5 t -86.28 -40.3 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 9.7699999999999996 111.152 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.99 -23.62 63.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 9.8000000000000007 111.246 -172.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.71 -14.83 62.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 9.8300000000000001 111.175 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -111.16 -34.61 6.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 9.8699999999999992 111.164 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.98 162.67 20.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 9.9000000000000004 111.225 -174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.17 159.53 15.14 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.711 1.607 . . . . 9.9299999999999997 111.16 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.441 ' HB3' ' HG ' ' A' ' 311' ' ' LEU . 94.7 mt -99.75 39.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 9.9700000000000006 111.241 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.06 -61.26 7.57 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.198 -0.761 . . . . 10.0 111.198 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.18 153.98 2.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 10.029999999999999 111.19 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.06 159.55 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 10.07 111.153 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 90' ' ' TYR . . . -83.84 -30.2 26.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 10.1 111.174 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -67.03 121.61 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 10.130000000000001 111.16 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -68.31 -17.49 64.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.194 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 t -58.33 -40.36 81.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 10.199999999999999 111.223 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -108.65 7.29 26.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 10.23 111.209 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -57.7 -50.0 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 10.27 111.199 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.58 -29.97 61.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 10.300000000000001 111.18 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.61 -37.06 84.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 10.33 111.219 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' A' ' 299' ' ' LEU . 9.8 mp -82.73 -37.51 24.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 10.369999999999999 111.196 175.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -77.99 -4.65 48.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 10.4 111.196 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.13 -41.58 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 10.43 111.151 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.27 120.71 70.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 10.470000000000001 111.168 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.13 -29.72 47.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.703 1.602 . . . . 10.5 111.255 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.22 -23.14 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 10.529999999999999 111.175 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.3 mt -98.65 -39.42 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 10.57 111.202 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.49 -34.23 70.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 10.6 111.19 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.68 62.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.630000000000001 111.202 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 94.4 m -95.23 -42.33 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.243 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.7 mtp -65.01 -41.94 94.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 10.699999999999999 111.18 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 10.73 111.183 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -76.97 -16.94 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 10.77 111.237 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.54 49.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 10.800000000000001 111.228 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -80.34 -19.93 45.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 10.83 111.235 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.43 -4.14 32.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 10.869999999999999 111.086 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 256' ' ' LYS . . . -87.83 -170.06 45.85 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -86.41 99.95 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 10.93 111.205 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.15 136.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 10.970000000000001 111.203 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 53.0 ttm -46.59 124.93 7.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 11.0 111.258 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 54.3 Cg_exo -60.28 155.58 45.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.705 1.603 . . . . 11.029999999999999 111.2 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -94.89 15.99 17.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 11.07 111.274 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 82.4 mt -80.49 125.04 81.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 11.1 111.253 -169.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.51 -40.36 79.09 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.747 1.631 . . . . 11.130000000000001 111.154 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.26 -38.97 93.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 11.17 111.24 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.0 mmm -75.13 -23.74 57.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 11.199999999999999 111.165 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 41.6 t -62.64 -40.9 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 11.23 111.175 169.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.84 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 11.27 111.269 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -66.66 -27.38 67.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 11.300000000000001 111.235 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 65' ' ' ASP . 87.4 t90 -54.36 -46.51 73.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 11.33 111.198 -173.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -99.24 -23.0 15.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 11.369999999999999 111.213 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.57 91.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 11.4 111.214 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.58 -36.54 66.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 11.43 111.193 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.6 ttp180 -54.72 -45.1 74.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 11.470000000000001 111.208 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 95.6 m -61.66 -40.03 93.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 11.5 111.21 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.22 88.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.192 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.5 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 11.57 111.191 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.7 -48.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 11.6 111.135 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -69.03 -28.92 67.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 11.630000000000001 111.167 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.6 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 11.67 111.218 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.85 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 11.699999999999999 111.2 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -74.65 -17.41 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 11.73 111.182 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.76 26.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.231 -0.748 . . . . 11.77 111.231 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -99.99 -38.71 8.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 11.800000000000001 111.223 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -129.85 168.75 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 11.83 111.116 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 33.9 p -92.62 175.04 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 11.869999999999999 111.18 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.1 m -67.2 -14.36 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 11.9 111.19 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.69 -49.3 5.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 11.93 111.188 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.14 -39.34 75.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 11.970000000000001 111.169 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.81 96.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 12.0 111.228 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.84 -24.78 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 12.029999999999999 111.158 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.32 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 12.07 111.148 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -64.71 -39.63 93.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 12.1 111.169 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.4 80.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 12.130000000000001 111.18 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -71.95 -42.92 66.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 12.17 111.144 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.4 m . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 12.199999999999999 111.159 -175.493 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 120.811 0.339 . . . . 0.070000000000000007 111.22 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.97 129.92 39.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.10000000000000001 111.178 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.2 139.96 58.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.13 111.23 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.58 2.29 57.57 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.17000000000000001 111.206 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.07 155.03 45.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.816 0.341 . . . . 0.20000000000000001 111.18 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.6 tp -104.18 115.05 29.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.23000000000000001 111.167 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -117.68 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.27000000000000002 111.196 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.21 114.97 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.29999999999999999 111.195 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -102.75 113.05 26.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.33000000000000002 111.249 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.6 tt -125.11 139.94 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.37 111.24 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -88.48 109.9 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.40000000000000002 111.178 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.4 47.82 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.213 -0.755 . . . . 0.42999999999999999 111.213 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -77.81 -69.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.46999999999999997 111.205 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -129.98 31.4 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.5 111.217 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.92 -19.68 69.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.239 -0.744 . . . . 0.53000000000000003 111.239 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -60.56 -24.37 65.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 0.56999999999999995 111.211 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -63.12 -49.95 72.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.59999999999999998 111.193 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.95 96.47 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.203 -0.759 . . . . 0.63 111.203 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.72 -31.48 66.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.818 0.342 . . . . 0.67000000000000004 111.22 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.12 91.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.69999999999999996 111.225 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.16 -35.02 74.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.72999999999999998 111.196 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 -41.25 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.77000000000000002 111.236 174.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -27.93 69.31 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.14 -0.784 . . . . 0.80000000000000004 111.14 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.45 -33.99 74.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.826 0.346 . . . . 0.82999999999999996 111.206 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.25 -39.05 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.87 111.199 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -61.02 -42.38 98.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 111.166 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.27 -41.59 99.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.93000000000000005 111.21 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.01 -35.96 69.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.96999999999999997 111.216 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.07 -40.12 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.178 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.5 p -103.27 -27.21 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.226 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.85 4.8 78.54 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.219 -0.753 . . . . 1.0700000000000001 111.219 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.5 mm -87.34 115.0 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 1.1000000000000001 111.212 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.03 124.9 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 1.1299999999999999 111.204 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.15 136.01 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.1699999999999999 111.248 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.4 t -142.56 147.84 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 1.2 111.171 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.32 132.68 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 1.23 111.217 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -140.02 176.37 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 1.27 111.262 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -119.02 75.25 14.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.3 111.149 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.15 158.32 49.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.695 1.596 . . . . 1.3300000000000001 111.217 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -123.15 -179.99 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 1.3700000000000001 111.182 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 55.09 34.63 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 1.3999999999999999 111.195 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.9 mt -74.92 -22.97 58.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 1.4299999999999999 111.284 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -70.03 -12.06 61.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.47 111.235 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.28 -36.05 5.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 1.5 111.199 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -71.33 -38.66 71.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 1.53 111.147 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.489 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.4 m-30 -61.39 -56.28 35.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 1.5700000000000001 111.206 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -66.95 -23.63 46.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.81 1.674 . . . . 1.6000000000000001 111.204 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -70.07 -45.22 67.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 111.196 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.51 -19.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 1.6699999999999999 111.192 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.0 -25.76 68.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.7 111.207 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.11 60.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 1.73 111.216 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p -109.7 -15.21 14.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 1.77 111.175 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.44 23.6 28.49 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.13 -0.788 . . . . 1.8 111.13 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.13 170.08 8.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 1.8300000000000001 111.208 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.92 179.03 21.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.233 -0.747 . . . . 1.8700000000000001 111.233 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 -174.74 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.642 1.561 . . . . 1.8999999999999999 111.267 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.25 -51.39 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 1.9299999999999999 111.244 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.94 134.22 57.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 1.97 111.245 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -129.77 127.07 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 2.0 111.236 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -98.75 127.64 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 2.0299999999999998 111.204 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -130.0 142.36 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 2.0699999999999998 111.118 169.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.06 145.0 56.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.218 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -46.61 -36.15 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 2.1299999999999999 111.258 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -81.66 -5.26 57.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 2.1699999999999999 111.211 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.64 -0.05 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 2.2000000000000002 111.206 174.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -65.02 -56.56 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 2.23 111.194 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.0 -33.52 74.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.185 -0.766 . . . . 2.27 111.185 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.34 -44.81 94.94 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.226 -0.749 . . . . 2.2999999999999998 111.226 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.01 -40.43 75.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.182 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.8 68.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 2.3700000000000001 111.183 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -60.39 -29.9 69.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 2.3999999999999999 111.205 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -68.12 -25.4 65.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 2.4300000000000002 111.193 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.37 32.38 22.72 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.19 -0.764 . . . . 2.4700000000000002 111.19 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -104.4 4.82 33.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 2.5 111.191 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.77 140.04 44.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 2.5299999999999998 111.191 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.71 154.51 20.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 2.5699999999999998 111.211 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.402 ' HA ' HG22 ' A' ' 104' ' ' ILE . 88.6 tt0 -74.82 134.74 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 2.6000000000000001 111.205 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.05 130.02 63.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 2.6299999999999999 111.184 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.2 m -116.83 113.34 40.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 2.6699999999999999 111.253 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.52 156.7 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.637 1.558 . . . . 2.7000000000000002 111.186 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.21 155.65 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 2.73 111.214 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.15 -53.83 52.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 2.77 111.205 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.41 84.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.7999999999999998 111.163 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -54.87 -51.94 64.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 2.8300000000000001 111.214 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -55.9 -42.72 76.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 2.8700000000000001 111.167 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.6 -29.68 70.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 2.8999999999999999 111.199 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.26 -17.93 58.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 2.9300000000000002 111.205 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 97.5 mt -83.41 153.5 24.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.9700000000000002 111.191 172.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.35 148.73 97.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 3.0 111.199 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.96 -15.0 18.93 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.699 1.599 . . . . 3.0299999999999998 111.252 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -96.55 -21.01 17.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 3.0699999999999998 111.154 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -78.43 -14.83 59.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 3.1000000000000001 111.191 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.419 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 49.8 m0 -63.05 -45.49 92.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.476 . . . . 3.1299999999999999 111.254 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.4 -11.82 60.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 3.1699999999999999 111.15 -170.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.54 -1.98 57.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 3.2000000000000002 111.237 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.55 10.3 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 3.23 111.228 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 94' ' ' TRP . 71.6 mtp180 -87.63 144.75 26.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 3.27 111.196 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 94.4 t80 -142.25 123.61 14.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 3.2999999999999998 111.161 171.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 97.5 m-20 65.0 20.75 12.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 3.3300000000000001 111.222 -169.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.56 -2.71 74.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.245 -0.742 . . . . 3.3700000000000001 111.245 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -115.44 144.24 44.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 3.3999999999999999 111.229 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.95 126.14 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 3.4300000000000002 111.214 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 78' ' ' GLU . 28.7 pt -130.12 14.96 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 3.4700000000000002 111.281 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.8 169.43 5.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 3.5 111.187 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -119.47 145.96 40.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 3.5299999999999998 111.183 170.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.94 -178.17 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.69 1.593 . . . . 3.5699999999999998 111.203 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.86 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 3.6000000000000001 111.153 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 3.6299999999999999 111.184 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -105.61 157.91 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.6699999999999999 111.168 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -87.48 179.98 6.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 3.7000000000000002 111.198 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.81 143.33 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 3.73 111.174 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.754 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.9 pp -160.03 144.37 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 3.77 111.219 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.2 t -169.96 -171.88 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 3.7999999999999998 111.171 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.1 tp -71.55 112.49 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 3.8300000000000001 111.229 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.75 125.92 71.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 3.8700000000000001 111.135 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -125.11 146.75 49.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 3.8999999999999999 111.217 -168.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -79.96 123.72 28.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 3.9300000000000002 111.237 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.53 -14.21 62.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 3.9700000000000002 111.171 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -89.98 -29.84 18.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 4.0 111.233 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.1 mt -98.55 -51.22 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 4.0300000000000002 111.164 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 46.6 tp -141.35 79.65 17.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 4.0700000000000003 111.191 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.25 -14.98 28.59 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.235 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -105.04 99.97 22.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 4.1299999999999999 111.21 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.43 156.98 45.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.255 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.19 167.18 28.0 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.686 1.59 . . . . 4.2000000000000002 111.239 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.42 -21.37 38.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 4.2300000000000004 111.206 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.2 t -161.54 172.02 17.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 4.2699999999999996 111.186 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -77.02 -12.02 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 4.2999999999999998 111.19 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.06 -8.75 57.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 4.3300000000000001 111.242 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.48 -4.28 31.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.3700000000000001 111.26 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.542 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 82.8 mt -69.69 -43.81 22.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 4.4000000000000004 111.158 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 55.4 Cg_exo -53.77 -40.15 81.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.71 1.607 . . . . 4.4299999999999997 111.171 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.8 90.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.4699999999999998 111.184 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.0 mt -64.99 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 4.5 111.255 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 4.5300000000000002 111.194 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.65 -31.57 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 4.5700000000000003 111.178 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.32 -32.83 55.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 4.5999999999999996 111.191 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.35 -5.09 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 4.6299999999999999 111.209 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.03 -39.99 75.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 4.6699999999999999 111.224 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.76 -29.31 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 4.7000000000000002 111.206 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.02 -18.74 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 4.7300000000000004 111.199 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 23.71 38.98 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.151 -0.779 . . . . 4.7699999999999996 111.151 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -100.08 149.32 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 4.7999999999999998 111.197 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -96.35 146.53 24.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 4.8300000000000001 111.191 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -100.24 5.54 44.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 4.8700000000000001 111.178 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 tp -160.34 130.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 4.9000000000000004 111.2 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 91.4 mmm -135.02 154.93 51.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 4.9299999999999997 111.237 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.84 165.05 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 4.9699999999999998 111.211 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 58.1 t-20 -73.9 89.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 5.0 111.159 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.16 -38.92 82.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.272 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.36 -53.81 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 5.0700000000000003 111.222 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 155' ' ' TYR . 43.0 tp10 -79.05 122.46 84.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 5.0999999999999996 111.194 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.86 -20.18 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.653 1.569 . . . . 5.1299999999999999 111.195 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.473 ' H ' ' HG3' ' A' ' 153' ' ' GLU . 82.6 t80 -59.44 -22.63 61.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 5.1699999999999999 111.203 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -113.95 29.66 7.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 5.2000000000000002 111.247 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 -22.93 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 5.2300000000000004 111.167 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.74 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 56.5 p-90 -84.57 -23.11 0.32 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 5.2699999999999996 111.213 -173.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.74 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 59.1 Cg_exo -49.1 -40.72 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.679 1.586 . . . . 5.2999999999999998 111.169 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.02 -34.98 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.151 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.36 -32.2 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 5.3700000000000001 111.215 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.11 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 5.4000000000000004 111.17 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.66 -28.33 69.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 5.4299999999999997 111.205 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -89.11 -28.75 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 5.4699999999999998 111.22 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.74 41.88 2.41 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.202 -0.759 . . . . 5.5 111.202 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -107.84 -14.58 16.96 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.189 -0.764 . . . . 5.5300000000000002 111.189 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -105.26 99.04 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 5.5700000000000003 111.179 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.81 47.57 10.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 5.5999999999999996 111.115 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -126.06 139.99 52.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 5.6299999999999999 111.188 171.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 80.8 tttt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.155 172.738 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.3 t0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.804 0.335 . . . . 5.9000000000000004 111.163 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.46 -12.93 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 5.9299999999999997 111.155 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -74.6 -22.07 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 5.9699999999999998 111.165 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -95.62 103.27 15.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 6.0 111.182 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.14 133.84 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 6.0300000000000002 111.194 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.73 39.27 3.1 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.279 -0.728 . . . . 6.0700000000000003 111.279 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.56 -20.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 6.0999999999999996 111.164 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -111.33 14.26 21.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 6.1299999999999999 111.173 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -76.85 150.64 36.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 6.1699999999999999 111.254 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.94 83.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 6.2000000000000002 111.217 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.47 -28.94 72.02 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.9 76.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 6.2699999999999996 111.174 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -79.3 -36.48 39.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 6.2999999999999998 111.206 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.87 74.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.184 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.22 -38.69 94.04 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.175 -0.77 . . . . 6.3700000000000001 111.175 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.5 tp -69.21 -35.3 76.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 6.4000000000000004 111.163 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.0 m -58.97 -39.36 81.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 6.4299999999999997 111.247 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.25 -43.46 97.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.229 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.43 -46.24 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 6.5 111.185 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.61 -26.98 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 6.5300000000000002 111.16 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -73.3 -36.8 66.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 6.5700000000000003 111.194 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.93 -34.67 78.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 6.5999999999999996 111.202 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.99 -44.87 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.169 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.74 -37.71 82.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 6.6699999999999999 111.213 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -86.72 4.97 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 6.7000000000000002 111.188 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 59.83 40.73 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 6.7300000000000004 111.135 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -98.86 -30.63 12.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 6.7699999999999996 111.238 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 96.6 mmm -120.07 141.53 49.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 6.7999999999999998 111.211 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.04 147.2 28.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 6.8300000000000001 111.138 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.55 -30.25 68.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 6.8700000000000001 111.176 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -85.11 -9.63 57.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 6.9000000000000004 111.244 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -57.04 128.73 38.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 6.9299999999999997 111.209 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 43.6 p30 -140.03 -165.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 6.9699999999999998 111.195 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -61.22 -47.35 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 7.0 111.212 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.7 p -70.09 -27.66 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 7.0300000000000002 111.176 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.16 -45.89 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 7.0700000000000003 111.233 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.7 98.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 7.0999999999999996 111.163 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -67.92 -37.09 81.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 7.1299999999999999 111.161 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.81 82.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 7.1699999999999999 111.219 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 7.2000000000000002 111.276 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -69.79 -25.95 64.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 7.2300000000000004 111.253 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -73.07 -14.68 61.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 7.2699999999999996 111.191 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.51 -17.66 13.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 7.2999999999999998 111.18 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.95 27.75 33.37 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.206 -0.758 . . . . 7.3300000000000001 111.206 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 7.3700000000000001 111.2 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 85.8 m -128.34 124.29 36.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 7.4000000000000004 111.203 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.12 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 7.4299999999999997 111.164 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -156.54 165.01 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 7.4699999999999998 111.207 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.0 t -146.56 178.96 7.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 7.5 111.221 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.6 tt -122.26 112.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 7.5300000000000002 111.147 174.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -169.98 -178.62 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 7.5700000000000003 111.224 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -108.16 -165.7 21.28 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.222 -0.751 . . . . 7.5999999999999996 111.222 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -61.9 -18.9 63.67 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.745 1.63 . . . . 7.6299999999999999 111.214 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 7.6699999999999999 111.171 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.77 -25.7 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.203 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.415 ' HA ' HD12 ' A' ' 235' ' ' ILE . 51.9 t90 -80.02 -10.02 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 7.7300000000000004 111.202 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -64.99 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 7.7699999999999996 111.204 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -84.79 -29.97 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 7.7999999999999998 111.218 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 232' ' ' TRP . 88.8 mt -66.59 -38.59 81.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 7.8300000000000001 111.193 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.3 -40.97 86.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 7.8700000000000001 111.148 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 93.8 m -65.05 -40.89 95.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 7.9000000000000004 111.255 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.8 p -77.92 -13.41 59.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 7.9299999999999997 111.231 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 60.02 50.15 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 7.9699999999999998 111.171 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.82 140.27 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 8.0 111.234 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -77.88 92.0 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 8.0299999999999994 111.244 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -101.08 140.84 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 8.0700000000000003 111.225 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.01 -179.64 20.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.159 -0.776 . . . . 8.0999999999999996 111.159 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 141.83 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.87 0.367 . . . . 8.1300000000000008 111.172 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.2 t -123.06 -171.54 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 8.1699999999999999 111.207 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -122.09 109.92 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 8.1999999999999993 111.247 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.555 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 88.2 mt -83.05 -40.54 0.82 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 8.2300000000000004 111.19 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 85.7 Cg_exo -52.76 110.28 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.723 1.616 . . . . 8.2699999999999996 111.197 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -139.89 130.0 25.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 8.3000000000000007 111.167 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -117.23 108.83 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 8.3300000000000001 111.263 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 58.08 35.59 25.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 8.3699999999999992 111.185 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.11 -8.56 69.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.158 -0.777 . . . . 8.4000000000000004 111.158 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -104.28 109.98 63.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.197 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.86 148.46 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.746 1.63 . . . . 8.4700000000000006 111.128 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.7 p -135.03 -105.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 8.5 111.184 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 48.8 tptt -159.52 133.58 5.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 8.5299999999999994 111.182 -170.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 77.2 Cg_exo -55.02 144.0 70.65 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.693 1.595 . . . . 8.5700000000000003 111.155 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -69.54 131.04 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 8.5999999999999996 111.249 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.05 -178.93 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 8.6300000000000008 111.152 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.23 -160.52 10.41 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.56 169.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 8.6999999999999993 111.209 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.86 119.92 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 8.7300000000000004 111.191 165.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.5 m -103.2 113.61 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 8.7699999999999996 111.2 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.28 115.44 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 8.8000000000000007 111.176 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -115.24 178.19 17.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.21 -0.756 . . . . 8.8300000000000001 111.21 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 99.1 mt -111.92 130.65 65.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 8.8699999999999992 111.267 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.29 126.06 26.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 8.9000000000000004 111.203 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.51 64.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 8.9299999999999997 111.126 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -94.35 -5.03 47.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 8.9700000000000006 111.132 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.32 132.63 95.27 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 9.0 111.185 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.6 -10.21 17.2 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.734 1.623 . . . . 9.0299999999999994 111.204 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -121.4 60.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 9.0700000000000003 111.2 -175.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.55 -29.03 52.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 9.0999999999999996 111.156 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.84 -40.03 76.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 9.1300000000000008 111.167 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.76 -35.6 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 9.1699999999999999 111.127 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.05 90.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 9.1999999999999993 111.146 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.49 -43.58 84.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 9.2300000000000004 111.246 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -56.48 -53.88 52.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 9.2699999999999996 111.214 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -54.73 -57.24 12.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 9.3000000000000007 111.163 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.1 -52.62 64.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 9.3300000000000001 111.232 -174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -79.41 -45.12 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 9.3699999999999992 111.174 -165.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -98.94 -11.8 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 9.4000000000000004 111.217 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -125.0 -65.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 9.4299999999999997 111.21 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 69.8 tp -59.62 -49.12 78.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 9.4700000000000006 111.229 -169.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 72.6 mt -97.78 40.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 9.5 111.195 -171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.0 p -105.07 176.58 5.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 9.5299999999999994 111.234 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.76 -30.33 70.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 9.5700000000000003 111.192 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -87.05 -40.08 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 9.5999999999999996 111.171 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -61.85 -46.98 93.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.245 -0.742 . . . . 9.6300000000000008 111.245 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.71 -21.97 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 9.6699999999999999 111.225 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -69.91 -39.36 76.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 9.6999999999999993 111.256 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.43 -29.55 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 9.7300000000000004 111.219 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 73.7 t -73.27 -42.85 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 9.7699999999999996 111.174 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -85.32 5.18 31.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 9.8000000000000007 111.255 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -54.25 -40.01 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 9.8300000000000001 111.208 167.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -106.88 -32.76 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 9.8699999999999992 111.163 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.93 160.04 41.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 9.9000000000000004 111.198 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.62 140.17 75.99 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.646 1.564 . . . . 9.9299999999999997 111.174 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.69 -17.74 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 9.9700000000000006 111.18 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.84 68.47 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.27 101.79 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 10.029999999999999 111.253 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.58 129.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 10.07 111.258 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -114.47 -10.62 12.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 10.1 111.258 165.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.61 117.18 27.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 10.130000000000001 111.204 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.04 -42.11 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.166 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.3 p -64.89 -30.01 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 10.199999999999999 111.179 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -72.16 -42.23 66.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 10.23 111.201 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.72 -30.02 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.205 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.15 -28.66 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 10.300000000000001 111.245 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.85 -32.06 40.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 10.33 111.172 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.25 -29.2 69.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 10.369999999999999 111.219 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.63 -18.61 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 10.4 111.173 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.97 -31.64 69.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 10.43 111.242 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 317' ' ' ILE . 10.1 t70 -70.0 121.53 83.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 10.470000000000001 111.231 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.96 -34.9 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.688 1.592 . . . . 10.5 111.181 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.53 -53.5 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 10.529999999999999 111.23 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 314' ' ' ASP . 94.9 mt -64.45 -30.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 10.57 111.292 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.02 62.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 10.6 111.105 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.35 90.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.421 . . . . 10.630000000000001 111.235 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.0 m -70.27 -40.06 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 10.67 111.161 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.9 mmt -70.55 -31.36 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.149 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.58 -45.93 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 10.73 111.195 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -75.93 -31.99 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 10.77 111.213 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.96 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 10.800000000000001 111.225 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.09 -25.43 67.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 10.83 111.173 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.06 -24.71 40.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 10.869999999999999 111.162 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -74.88 158.06 50.91 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.205 -0.758 . . . . 10.9 111.205 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -127.11 163.66 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.764 0.316 . . . . 10.93 111.259 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 48.7 mm -110.4 133.29 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 10.970000000000001 111.178 -169.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.89 122.38 79.01 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 11.0 111.244 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.15 150.52 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.754 1.636 . . . . 11.029999999999999 111.166 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -113.57 -25.22 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 11.07 111.23 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 97.6 mt -40.07 130.01 1.61 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 11.1 111.138 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.98 -37.72 68.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.708 1.605 . . . . 11.130000000000001 111.186 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.05 -39.51 92.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 11.17 111.21 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 99.7 mmm -75.09 -34.23 61.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 11.199999999999999 111.135 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.2 m -69.67 -33.35 72.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 11.23 111.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 11.27 111.179 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -65.57 -35.92 82.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 11.300000000000001 111.16 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.488 ' HE3' ' HA ' ' A' ' 340' ' ' TRP . 4.2 m95 -70.01 -38.41 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 11.33 111.233 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -60.7 -40.29 91.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.176 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.41 73.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 11.4 111.175 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.84 -29.7 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 11.43 111.174 -174.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -69.94 -38.76 76.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 11.470000000000001 111.247 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.2 m -69.33 -37.3 77.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 11.5 111.208 173.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.32 94.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 11.529999999999999 111.172 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.57 -24.73 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 11.57 111.223 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.04 -45.97 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 11.6 111.177 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.23 -36.55 83.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 11.630000000000001 111.164 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.06 -43.75 61.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.452 . . . . 11.67 111.186 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.226 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.3 p -71.37 -15.02 62.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 11.73 111.231 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 92.19 25.69 20.96 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 111.24 -0.744 . . . . 11.77 111.24 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.03 -39.9 7.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 11.800000000000001 111.186 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -113.86 172.5 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 11.83 111.249 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -99.94 165.68 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 11.869999999999999 111.199 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.85 -16.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 11.9 111.227 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.85 -51.11 4.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 11.93 111.236 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -70.3 -31.42 68.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 11.970000000000001 111.129 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.79 -40.35 95.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 12.0 111.192 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.61 -30.83 61.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 12.029999999999999 111.125 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.42 -45.54 83.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 12.07 111.218 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.08 -41.92 99.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 12.1 111.197 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.79 -45.22 75.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 12.130000000000001 111.198 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -56.68 -36.58 69.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 12.17 111.224 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.3 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 12.199999999999999 111.172 -176.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.827 0.346 . . . . 0.029999999999999999 111.216 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.02 145.89 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.070000000000000007 111.189 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -53.52 136.23 38.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 0.10000000000000001 111.235 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.25 144.97 32.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.13 111.173 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.32 16.77 63.82 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.211 -0.756 . . . . 0.17000000000000001 111.211 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.06 149.67 52.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.20000000000000001 111.22 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.5 tp -122.86 101.22 7.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.23000000000000001 111.171 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.1 t -98.18 125.06 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.27000000000000002 111.212 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.6 mt -121.07 112.43 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.29999999999999999 111.202 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -92.09 92.75 8.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.33000000000000002 111.221 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -71.02 150.12 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.37 111.176 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -132.13 111.98 11.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.162 -173.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.04 174.11 26.32 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.171 -0.771 . . . . 0.42999999999999999 111.171 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.66 -50.18 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.34 . . . . 0.46999999999999997 111.195 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -125.01 -135.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 0.5 111.192 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.49 -7.65 78.17 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.224 -0.75 . . . . 0.53000000000000003 111.224 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -64.77 -54.67 27.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.775 0.321 . . . . 0.56999999999999995 111.201 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.32 -40.69 97.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.59999999999999998 111.228 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.84 -53.35 44.79 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.225 -0.75 . . . . 0.63 111.225 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.0 tp -70.68 -32.4 69.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.67000000000000004 111.239 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.76 97.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.202 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.33 -38.27 87.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.219 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.91 -39.23 84.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.77000000000000002 111.193 173.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.46 -38.42 96.32 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 0.80000000000000004 111.22 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.7 -44.42 96.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 0.82999999999999996 111.176 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.98 -41.49 92.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.87 111.209 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -59.28 -48.35 81.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.90000000000000002 111.241 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -64.35 -34.11 77.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.93000000000000005 111.185 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -69.18 -31.64 70.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.96999999999999997 111.22 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.05 -31.36 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.221 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.5 p -101.85 -29.87 11.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 1.03 111.201 -175.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.04 5.68 83.0 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.223 -0.751 . . . . 1.0700000000000001 111.223 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.3 mm -83.58 121.14 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 1.1000000000000001 111.219 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.3 tttt -61.67 119.51 8.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 1.1299999999999999 111.176 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.02 131.08 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 1.1699999999999999 111.247 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -123.43 110.26 14.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.2 111.164 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.7 t -101.84 131.77 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 1.23 111.186 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -152.92 169.98 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 1.27 111.215 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -140.3 76.87 25.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.3 111.194 -175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.83 80.0 2.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.724 1.616 . . . . 1.3300000000000001 111.213 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 29.7 t0 -52.29 162.97 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 1.3700000000000001 111.215 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 93.0 mttt 68.12 43.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 1.3999999999999999 111.173 -175.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.29 -21.56 64.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 1.4299999999999999 111.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -59.89 -27.27 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 1.47 111.204 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -114.18 -25.48 8.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 1.5 111.209 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -94.37 -36.28 12.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 1.53 111.13 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 85.7 t80 -63.51 -43.06 77.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 1.5700000000000001 111.199 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 88.6 Cg_exo -53.05 -31.35 53.45 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.716 1.611 . . . . 1.6000000000000001 111.213 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -64.19 -32.94 74.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 1.6299999999999999 111.206 -173.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.7 m -100.06 -26.22 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 1.6699999999999999 111.167 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 1.7 111.206 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.33 -4.91 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.73 111.243 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.8 p -115.0 5.0 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 1.77 111.203 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.35 33.57 58.65 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.176 -0.77 . . . . 1.8 111.176 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -120.02 -165.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.816 0.341 . . . . 1.8300000000000001 111.193 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.23 -162.96 12.67 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.159 -0.776 . . . . 1.8700000000000001 111.159 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.88 178.17 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.711 1.607 . . . . 1.8999999999999999 111.206 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.46 -40.85 10.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.9299999999999999 111.189 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.38 138.15 52.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 1.97 111.18 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.8 tt -143.92 138.78 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 2.0 111.199 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 29.8 m-85 -105.12 142.78 34.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 2.0299999999999998 111.233 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -134.49 155.6 50.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 2.0699999999999998 111.194 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HA ' ' HG ' ' A' ' 262' ' ' LEU . . . -68.13 159.22 31.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 2.1000000000000001 111.153 166.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -53.98 -33.58 57.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 2.1299999999999999 111.2 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -82.11 -49.94 9.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 2.1699999999999999 111.205 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -65.32 -31.13 72.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 2.2000000000000002 111.19 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -56.8 -36.11 69.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.23 111.18 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.08 -39.18 49.19 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.15 -0.78 . . . . 2.27 111.15 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.23 64.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.772 . . . . 2.2999999999999998 111.171 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -64.24 -49.3 72.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 2.3300000000000001 111.222 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.99 -37.88 78.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 2.3700000000000001 111.212 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.9 tt0 -58.2 -41.8 84.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.214 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.0 p -66.83 -17.9 65.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 2.4300000000000002 111.213 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.6 25.79 37.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.228 -0.749 . . . . 2.4700000000000002 111.228 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.61 2.54 44.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 2.5 111.205 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.0 tp -89.17 117.27 28.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 2.5299999999999998 111.225 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.82 153.36 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.235 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.62 129.19 39.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 2.6000000000000001 111.206 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.36 129.59 75.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 2.6299999999999999 111.227 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.9 p -129.36 87.08 54.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 2.6699999999999999 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -58.48 150.17 70.22 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 2.7000000000000002 111.209 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -43.78 139.68 2.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 2.73 111.201 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.84 -39.59 39.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 2.77 111.174 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.79 85.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 2.7999999999999998 111.197 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -66.93 -40.07 87.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 2.8300000000000001 111.215 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.39 -30.87 71.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 2.8700000000000001 111.172 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.64 -35.02 67.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 2.8999999999999999 111.212 173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.99 -16.22 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 2.9300000000000002 111.224 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.6 mt -75.52 121.76 22.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 2.9700000000000002 111.191 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -69.14 144.79 95.69 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 3.0 111.217 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.36 -34.89 72.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.666 1.577 . . . . 3.0299999999999998 111.235 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 7.6 m-30 -64.62 -32.65 74.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 3.0699999999999998 111.184 -175.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -108.1 -21.61 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 3.1000000000000001 111.175 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -70.25 -41.32 73.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 3.1299999999999999 111.188 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.86 -27.82 63.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 3.1699999999999999 111.216 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.12 -21.03 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.2000000000000002 111.213 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.0 m -111.68 25.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 3.23 111.165 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -102.71 167.88 9.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 3.27 111.201 171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.425 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 37.1 t80 -163.29 130.02 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 3.2999999999999998 111.152 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 95.7 m-20 65.0 21.48 12.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 3.3300000000000001 111.224 -173.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.96 11.16 77.21 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.193 -0.763 . . . . 3.3700000000000001 111.193 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -122.84 143.03 50.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 3.3999999999999999 111.195 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 32.5 tp -75.09 118.74 18.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 3.4300000000000002 111.189 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 pt -117.53 -20.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 3.4700000000000002 111.203 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.13 177.09 9.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 3.5 111.227 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -140.84 142.62 28.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 3.5299999999999998 111.209 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.3 155.98 41.6 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.728 1.618 . . . . 3.5699999999999998 111.217 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.7 tp -134.74 -30.0 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 3.6000000000000001 111.186 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.49 149.64 29.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 3.6299999999999999 111.22 -174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.2 t -124.99 120.58 58.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 3.6699999999999999 111.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -124.68 157.22 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 3.7000000000000002 111.191 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.05 155.01 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 3.73 111.236 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.34 175.8 9.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 3.77 111.173 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.3 p -171.78 170.19 5.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 3.7999999999999998 111.175 176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.492 HD23 ' C ' ' A' ' 115' ' ' LEU . 5.9 tt -97.1 99.94 11.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 3.8300000000000001 111.212 175.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.16 127.1 44.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 3.8700000000000001 111.194 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -140.26 160.81 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 3.8999999999999999 111.177 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -75.77 109.02 9.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 3.9300000000000002 111.183 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -81.33 -37.8 27.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 3.9700000000000002 111.173 -173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -54.97 -45.14 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 4.0 111.205 176.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.5 tp -74.81 -61.25 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 4.0300000000000002 111.17 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.9 mt -127.58 92.64 42.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 4.0700000000000003 111.21 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.01 -19.0 46.21 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.665 1.577 . . . . 4.0999999999999996 111.205 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -98.47 105.83 32.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 4.1299999999999999 111.2 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.51 164.91 23.4 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.697 1.598 . . . . 4.1699999999999999 111.227 -175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.05 125.43 17.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.68 1.587 . . . . 4.2000000000000002 111.196 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.48 -23.64 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 4.2300000000000004 111.185 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 130' ' ' GLU . 14.3 t -157.48 -177.25 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 4.2699999999999996 111.186 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -71.49 -25.3 62.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 4.2999999999999998 111.163 -170.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.453 ' H ' HG23 ' A' ' 128' ' ' THR . 98.7 mt-10 -71.25 -17.26 62.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 4.3300000000000001 111.215 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -100.41 4.38 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 4.3700000000000001 111.226 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.515 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 24.8 mm -75.23 -51.03 3.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 4.4000000000000004 111.176 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.515 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 94.6 Cg_endo -74.58 -13.39 22.43 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.692 1.595 . . . . 4.4299999999999997 111.181 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.7 78.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 4.4699999999999998 111.178 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.03 -30.05 22.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 4.5 111.194 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -63.82 -33.43 75.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 4.5300000000000002 111.181 168.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.77 -45.08 72.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 4.5700000000000003 111.161 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -65.35 -30.48 71.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 4.5999999999999996 111.254 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.74 -14.66 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.178 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -54.65 -44.56 73.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 4.6699999999999999 111.226 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.93 -16.86 60.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 4.7000000000000002 111.213 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -95.11 3.01 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 4.7300000000000004 111.225 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.96 25.19 69.83 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.243 -0.743 . . . . 4.7699999999999996 111.243 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -136.97 -179.93 6.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.775 0.321 . . . . 4.7999999999999998 111.227 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.2 t -149.9 140.29 22.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 4.8300000000000001 111.196 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.33 -45.6 19.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 4.8700000000000001 111.227 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.453 ' HA ' ' HB ' ' A' ' 226' ' ' ILE . 31.8 tp -77.79 124.84 28.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 4.9000000000000004 111.176 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 99.3 mmm -124.99 50.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 4.9299999999999997 111.214 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -76.36 147.4 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 4.9699999999999998 111.214 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -71.66 102.05 2.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 5.0 111.219 166.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.31 -19.14 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.201 -172.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -39.96 96.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 5.0700000000000003 111.157 169.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -98.56 160.03 29.03 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.21 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.36 3.51 6.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.668 1.578 . . . . 5.1299999999999999 111.225 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -49.41 -55.01 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 5.1699999999999999 111.248 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -111.67 36.54 3.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 5.2000000000000002 111.192 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.2 p -126.34 -22.95 3.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 5.2300000000000004 111.152 168.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.487 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 88.8 t90 -67.56 -48.26 44.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 5.2699999999999996 111.2 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 91.5 Cg_endo -76.99 -14.97 16.73 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.713 1.608 . . . . 5.2999999999999998 111.192 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.85 -44.28 93.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 5.3300000000000001 111.229 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 87.2 mt -65.45 -45.03 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 5.3700000000000001 111.189 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.19 65.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 5.4000000000000004 111.162 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.46 -34.13 72.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.175 -173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -64.97 -27.01 68.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.231 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 102.41 -3.64 50.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.226 -0.75 . . . . 5.5 111.226 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.8 -12.97 70.65 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.171 -0.771 . . . . 5.5300000000000002 111.171 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.93 130.33 31.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 5.5700000000000003 111.176 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.43 32.18 21.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 5.5999999999999996 111.195 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -140.0 90.11 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 5.6299999999999999 111.194 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -125.02 166.42 16.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.199 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -166.87 140.04 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 5.7000000000000002 111.191 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -150.19 96.18 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 5.7300000000000004 111.194 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 45.62 53.87 8.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 5.7699999999999996 111.193 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.1 16.07 65.73 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.186 -0.765 . . . . 5.7999999999999998 111.186 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -129.91 169.23 15.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 5.8300000000000001 111.216 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -129.63 139.38 51.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 5.8700000000000001 111.207 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -94.51 106.73 18.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 5.9000000000000004 111.193 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.3 pt -112.27 16.37 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 5.9299999999999997 111.197 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.29 -28.97 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 5.9699999999999998 111.194 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -74.99 169.72 17.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 6.0 111.216 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.43 124.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 6.0300000000000002 111.206 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.99 -18.94 25.56 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -165.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.0 m -68.66 -14.58 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.75 0.309 . . . . 6.0999999999999996 111.161 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -88.26 5.0 43.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 6.1299999999999999 111.208 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -95.28 150.02 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 6.1699999999999999 111.207 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.99 -30.18 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 6.2000000000000002 111.22 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.92 99.91 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.206 -0.758 . . . . 6.2300000000000004 111.206 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.24 90.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 6.2699999999999996 111.223 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -65.4 -35.07 79.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 6.2999999999999998 111.213 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.07 92.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 6.3300000000000001 111.22 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.7 -45.25 96.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.166 -0.774 . . . . 6.3700000000000001 111.166 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.7 tp -71.9 -32.57 67.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 6.4000000000000004 111.213 178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.5 m -62.29 -40.1 95.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 6.4299999999999997 111.181 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -59.75 -45.92 90.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 6.4699999999999998 111.187 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.8 tp -53.16 -59.47 4.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 6.5 111.197 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.25 -45.16 94.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 6.5300000000000002 111.194 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -65.27 -41.41 94.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 6.5700000000000003 111.233 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.419 ' HB2' ' SD ' ' A' ' 204' ' ' MET . 79.8 mt -76.4 -23.01 54.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 6.5999999999999996 111.17 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.66 -43.2 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.217 168.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.91 -24.23 62.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 6.6699999999999999 111.207 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -89.73 5.46 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 6.7000000000000002 111.214 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 63.61 37.5 10.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 6.7300000000000004 111.193 175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -110.76 -34.98 6.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 6.7699999999999996 111.253 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' A' ' 198' ' ' LEU . 76.4 mtp -108.79 154.41 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 6.7999999999999998 111.161 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -127.02 111.56 14.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 6.8300000000000001 111.215 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.71 -17.9 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 6.8700000000000001 111.182 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -84.51 -26.09 28.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 6.9000000000000004 111.25 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -61.23 132.25 53.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 6.9299999999999997 111.181 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -139.39 -165.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 6.9699999999999998 111.189 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -58.77 -50.06 75.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 7.0 111.144 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.0 p -69.56 -32.61 71.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.192 -171.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 94.5 mt -69.75 -46.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 7.0700000000000003 111.188 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.17 93.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 7.0999999999999996 111.219 177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -58.49 -46.04 87.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 7.1299999999999999 111.199 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.26 96.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 7.1699999999999999 111.191 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.0 78.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 7.2000000000000002 111.215 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -70.59 -45.03 66.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 7.2300000000000004 111.212 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.76 -32.72 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 7.2699999999999996 111.226 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -83.49 -26.11 30.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 7.2999999999999998 111.159 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.28 19.92 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.168 -0.773 . . . . 7.3300000000000001 111.168 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -70.99 -30.07 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 7.3700000000000001 111.227 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.2 p -117.08 164.18 15.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 7.4000000000000004 111.217 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.78 -22.28 31.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 7.4299999999999997 111.205 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.64 170.28 21.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 7.4699999999999998 111.177 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.7 t -148.0 140.0 24.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 7.5 111.195 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.453 ' HB ' ' HA ' ' A' ' 147' ' ' LEU . 88.2 mt -112.82 117.01 54.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 7.5300000000000002 111.183 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.415 ' HB3' HD11 ' A' ' 235' ' ' ILE . 7.4 t-20 -158.83 177.68 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 7.5700000000000003 111.169 -176.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -79.6 170.46 54.19 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.227 -0.749 . . . . 7.5999999999999996 111.227 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.35 -17.08 21.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.691 1.594 . . . . 7.6299999999999999 111.207 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -70.3 -30.08 66.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 7.6699999999999999 111.168 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.63 -4.84 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 7.7000000000000002 111.154 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 4.2 t90 -62.26 -29.52 70.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 7.7300000000000004 111.215 -176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 92.0 p -64.85 -21.43 66.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 7.7699999999999996 111.224 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.2 -30.1 12.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 7.7999999999999998 111.218 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 227' ' ' ASN . 83.3 mt -65.28 -34.68 72.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.227 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -80.16 7.83 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 7.8700000000000001 111.219 -169.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.5 m -58.31 -32.5 68.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 7.9000000000000004 111.207 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 66.5 m -69.98 -19.0 63.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 7.9299999999999997 111.21 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 60.43 38.91 19.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 7.9699999999999998 111.217 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.45 169.91 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 8.0 111.204 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -73.36 107.78 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 8.0299999999999994 111.206 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -102.44 133.42 47.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 8.0700000000000003 111.176 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -104.01 179.34 25.03 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.206 -0.758 . . . . 8.0999999999999996 111.206 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.9 137.89 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.757 0.313 . . . . 8.1300000000000008 111.193 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -145.88 -175.21 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 8.1699999999999999 111.214 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.2 t -78.87 125.24 38.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 8.1999999999999993 111.253 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.582 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 56.7 tp -79.7 -51.37 1.18 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 8.2300000000000004 111.202 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 89.2 Cg_endo -80.38 154.94 21.65 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.696 1.597 . . . . 8.2699999999999996 111.209 -173.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 85.1 m -124.98 109.88 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 8.3000000000000007 111.164 171.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.78 104.78 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 8.3300000000000001 111.22 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 55.25 35.05 24.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 8.3699999999999992 111.23 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.07 -2.86 76.15 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.192 -0.763 . . . . 8.4000000000000004 111.192 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -129.99 109.97 16.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 8.4299999999999997 111.209 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.77 150.3 61.86 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.693 1.595 . . . . 8.4700000000000006 111.168 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 83.7 p -139.34 -72.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 8.5 111.232 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.428 ' HD3' ' HB3' ' A' ' 323' ' ' ASN . 47.3 tptt -159.42 129.89 3.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 8.5299999999999994 111.193 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.413 ' HA ' ' HG3' ' A' ' 248' ' ' PRO . 51.3 Cg_exo -55.03 157.04 14.19 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.739 1.626 . . . . 8.5700000000000003 111.22 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -67.28 146.0 54.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 8.5999999999999996 111.208 -174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.402 ' HB ' HD13 ' A' ' 329' ' ' ILE . 85.7 t -109.72 113.93 45.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 8.6300000000000008 111.175 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.07 115.04 5.01 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.163 -0.775 . . . . 8.6699999999999999 111.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.4 t -101.89 116.42 45.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 8.6999999999999993 111.2 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 63' ' ' ALA . 10.4 mp -73.16 144.82 46.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 8.7300000000000004 111.225 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 99.4 p -142.43 159.63 41.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 8.7699999999999996 111.203 -174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -130.52 156.23 45.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 8.8000000000000007 111.198 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.15 175.55 20.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.264 -0.735 . . . . 8.8300000000000001 111.264 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.8 129.97 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 8.8699999999999992 111.183 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.54 120.96 12.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.181 -173.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.76 -23.46 66.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 8.9299999999999997 111.186 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.0 58.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 8.9700000000000006 111.236 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.1 t -83.28 121.46 76.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 9.0 111.183 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.12 3.32 7.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.705 1.603 . . . . 9.0299999999999994 111.201 169.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -103.26 36.92 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 9.0700000000000003 111.241 -172.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -62.34 -24.11 67.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 9.0999999999999996 111.232 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.69 -30.48 51.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 9.1300000000000008 111.252 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -72.09 -43.37 64.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 9.1699999999999999 111.206 174.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.24 -34.68 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 9.1999999999999993 111.218 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -59.79 -56.35 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.2300000000000004 111.2 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -65.46 -43.03 91.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 9.2699999999999996 111.183 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.39 -50.21 73.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 9.3000000000000007 111.19 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.76 -53.13 61.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 9.3300000000000001 111.203 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -76.79 -30.67 56.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 9.3699999999999992 111.181 -167.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -97.62 -27.4 14.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 9.4000000000000004 111.238 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -123.71 -64.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 9.4299999999999997 111.223 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 45.5 tp -60.85 -41.84 96.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 9.4700000000000006 111.242 -166.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 37.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.205 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 97.4 m -114.78 141.38 47.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 9.5299999999999994 111.249 170.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -49.05 -40.49 31.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 9.5700000000000003 111.221 -172.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -58.06 -46.37 85.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 9.5999999999999996 111.14 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.66 -40.55 90.27 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.241 -0.744 . . . . 9.6300000000000008 111.241 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.29 -35.5 81.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.823 0.344 . . . . 9.6699999999999999 111.185 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -67.75 -40.85 84.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 9.6999999999999993 111.224 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 9.7300000000000004 111.22 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.79 -37.66 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 9.7699999999999996 111.182 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.573 ' HB3' HD23 ' A' ' 299' ' ' LEU . 98.1 m-20 -81.88 5.06 20.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.428 . . . . 9.8000000000000007 111.207 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.15 -33.22 75.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 9.8300000000000001 111.209 165.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -107.42 -38.73 5.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8699999999999992 111.179 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -87.78 161.44 44.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.9000000000000004 111.191 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -55.03 144.65 67.65 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.671 1.581 . . . . 9.9299999999999997 111.186 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.573 HD23 ' HB3' ' A' ' 294' ' ' ASN . 93.7 mt -68.37 -20.6 64.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 9.9700000000000006 111.232 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.94 -26.81 67.71 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.185 -0.766 . . . . 10.0 111.185 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.18 133.99 55.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 10.029999999999999 111.191 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.6 138.66 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 10.07 111.191 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.49 -48.02 4.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 10.1 111.186 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 85.0 mt -116.82 152.54 34.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 10.130000000000001 111.242 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -54.44 -37.24 64.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 10.17 111.182 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.0 p -56.18 -29.46 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 10.199999999999999 111.195 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -88.59 -35.83 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 10.23 111.2 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -60.06 -27.44 66.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 10.27 111.205 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.33 -30.4 70.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.151 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -80.77 -31.65 35.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 10.33 111.193 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.45 -21.72 62.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 10.369999999999999 111.219 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.95 66.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 10.4 111.203 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -68.82 -30.08 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 10.43 111.145 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.87 119.03 75.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.178 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.49 -35.47 96.69 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.73 1.62 . . . . 10.5 111.217 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -85.08 -51.11 6.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 10.529999999999999 111.218 -172.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.19 -39.81 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 10.57 111.172 -177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.47 -45.04 85.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 10.6 111.187 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -37.21 86.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 10.630000000000001 111.181 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -64.51 -44.87 89.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 10.67 111.187 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.8 mmm -67.07 -34.65 78.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 10.699999999999999 111.183 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.5 -45.85 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 10.73 111.194 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.428 ' HB3' ' HD3' ' A' ' 256' ' ' LYS . 99.3 m-20 -73.18 -22.42 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 10.77 111.159 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.05 -31.82 65.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 10.800000000000001 111.248 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -68.97 -18.29 64.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 10.83 111.177 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.25 -8.89 59.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 10.869999999999999 111.202 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -104.83 -141.89 11.13 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.226 -0.749 . . . . 10.9 111.226 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -145.0 136.34 25.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 10.93 111.174 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.402 HD13 ' HB ' ' A' ' 259' ' ' VAL . 49.2 mm -77.58 128.94 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 10.970000000000001 111.194 177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 37.5 mmt -79.55 116.01 57.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 11.0 111.231 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.94 155.12 57.98 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.724 1.616 . . . . 11.029999999999999 111.195 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -97.61 20.09 12.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 11.07 111.202 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.91 128.27 91.89 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 11.1 111.153 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.24 -43.59 52.38 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.714 1.61 . . . . 11.130000000000001 111.223 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -64.99 -40.77 95.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 11.17 111.186 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.4 mmm -64.73 -39.37 93.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 11.199999999999999 111.214 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.1 t -60.52 -45.82 92.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.179 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.3 88.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 11.27 111.211 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -64.87 -33.45 76.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 11.300000000000001 111.18 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -69.97 -39.78 75.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 11.33 111.222 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.97 -30.08 71.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 11.369999999999999 111.211 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.61 71.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.18 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 93.5 t -85.5 -29.46 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 11.43 111.202 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.2 -25.3 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 11.470000000000001 111.219 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 76.0 p -85.99 -29.72 23.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 11.5 111.213 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.69 -40.72 92.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.529999999999999 111.189 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 19.0 m -69.47 -23.43 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 11.57 111.21 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.9 mm -88.33 -38.04 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 11.6 111.206 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.531 ' HB3' ' HG2' ' A' ' 355' ' ' GLN . 96.0 m-20 -65.0 -32.42 74.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 11.630000000000001 111.214 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.3 -39.8 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 11.67 111.19 176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.23 86.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 11.699999999999999 111.199 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.7 p -80.73 -19.43 45.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 11.73 111.209 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 90.58 18.03 50.07 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.222 -0.751 . . . . 11.77 111.222 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -70.2 -37.98 75.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 11.800000000000001 111.228 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.531 ' HG2' ' HB3' ' A' ' 349' ' ' ASN . 2.6 pt20 -147.0 168.74 20.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 11.83 111.176 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 45.0 p -81.18 175.14 10.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 11.869999999999999 111.141 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.88 -44.74 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 11.9 111.161 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.17 -48.15 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 11.93 111.18 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -67.59 -36.23 80.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 11.970000000000001 111.193 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.02 70.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 12.0 111.216 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.55 -15.92 55.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 12.029999999999999 111.219 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.18 -49.12 68.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 12.07 111.202 168.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -64.76 -39.04 92.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 12.1 111.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.45 -46.65 89.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 12.130000000000001 111.221 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -55.71 -47.63 76.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 12.17 111.178 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.6 m -59.01 -44.82 91.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 12.199999999999999 111.197 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.97 -36.93 85.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 12.23 111.239 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 92.1 mt -70.83 -39.98 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 12.27 111.231 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 75.7 p -84.54 -15.04 47.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 12.300000000000001 111.236 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.199 -1.559 0 CA-C-N 116.182 -0.463 . . . . 12.33 111.201 177.644 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.76 0.314 . . . . 0.029999999999999999 111.212 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.9 115.1 47.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.192 -0.458 . . . . 0.070000000000000007 111.252 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.15 129.93 42.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.263 -0.426 . . . . 0.10000000000000001 111.215 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -57.68 128.97 39.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.13 111.206 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.91 48.28 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -126.33 98.02 5.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.771 0.319 . . . . 0.20000000000000001 111.195 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 tp -79.05 119.72 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.23000000000000001 111.204 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -100.29 118.83 47.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.27000000000000002 111.238 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.9 mt -121.21 112.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.29999999999999999 111.189 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -103.38 117.12 33.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.33000000000000002 111.222 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.1 tt -115.61 137.05 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.37 111.208 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.64 114.94 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.40000000000000002 111.228 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.01 -172.46 39.86 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.209 -0.756 . . . . 0.42999999999999999 111.209 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -108.47 -39.18 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.329 . . . . 0.46999999999999997 111.219 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -140.14 149.83 43.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.5 111.191 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.26 0.83 4.52 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.215 -0.754 . . . . 0.53000000000000003 111.215 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 37' ' ' VAL . 43.8 p90 -62.71 -20.09 64.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.56999999999999995 111.204 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.67 -30.5 71.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 0.59999999999999998 111.205 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.69 -47.24 91.61 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.24 -0.744 . . . . 0.63 111.24 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HB2' HG11 ' A' ' 37' ' ' VAL . 82.2 mt -72.58 -30.79 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.67000000000000004 111.173 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.29 83.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.69999999999999996 111.21 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.4 -39.69 91.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.173 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 82.5 t -71.23 -34.85 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.77000000000000002 111.144 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.16 -27.12 73.83 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.182 -0.767 . . . . 0.80000000000000004 111.182 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.34 -48.4 81.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.82999999999999996 111.197 174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.0 -41.79 97.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.87 111.205 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.37 -51.34 69.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.90000000000000002 111.274 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.93 -38.16 90.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.93000000000000005 111.262 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -67.36 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.96999999999999997 111.159 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.32 -35.01 12.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.186 -173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.8 p -103.4 -29.96 10.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.03 111.234 -174.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.55 4.56 79.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.166 -0.774 . . . . 1.0700000000000001 111.166 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.2 124.98 47.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 1.1000000000000001 111.24 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.94 150.06 47.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 1.1299999999999999 111.153 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -125.02 125.12 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 1.1699999999999999 111.234 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.8 m -121.33 109.84 15.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 1.2 111.221 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' A' ' 20' ' ' LEU . 35.1 t -105.07 130.12 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.187 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -151.07 166.49 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 1.27 111.198 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -100.03 123.26 47.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 1.3 111.216 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -79.6 165.03 23.11 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.617 1.545 . . . . 1.3300000000000001 111.201 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -121.0 141.03 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 1.3700000000000001 111.187 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 55.04 46.71 23.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 1.3999999999999999 111.238 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.02 -50.72 68.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 1.4299999999999999 111.211 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -52.57 -43.64 65.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.448 . . . . 1.47 111.169 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.83 -24.14 61.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 1.5 111.185 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -97.08 -7.0 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.192 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.474 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 5.2 m-30 -55.19 -54.8 46.46 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 1.5700000000000001 111.155 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -70.66 -12.21 30.84 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.68 1.587 . . . . 1.6000000000000001 111.21 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -89.98 -8.61 51.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.154 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.97 -57.68 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 1.6699999999999999 111.209 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.29 -23.11 43.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 1.7 111.199 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.39 -35.58 77.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 1.73 111.172 177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.6 p -104.2 -19.88 13.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 1.77 111.182 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.02 31.09 58.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.161 -0.775 . . . . 1.8 111.161 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -129.59 -165.43 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.8300000000000001 111.182 -170.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.42 -165.76 14.37 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.195 -0.762 . . . . 1.8700000000000001 111.195 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.49 167.16 27.78 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.665 1.577 . . . . 1.8999999999999999 111.201 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -80.04 -62.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 1.9299999999999999 111.186 167.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -99.78 139.89 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 1.97 111.208 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 tt -141.53 134.91 30.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 2.0 111.225 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.43 144.93 32.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 2.0299999999999998 111.315 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -156.39 148.45 23.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 2.0699999999999998 111.248 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.41 158.0 24.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 2.1000000000000001 111.175 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -60.6 -17.02 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 2.1299999999999999 111.244 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -42.91 -48.34 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 2.1699999999999999 111.159 -175.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -134.98 27.45 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 2.2000000000000002 111.162 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -71.53 -42.61 67.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 2.23 111.176 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.77 -46.42 93.49 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.96 -38.92 89.28 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.181 -0.767 . . . . 2.2999999999999998 111.181 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.05 -43.59 73.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 2.3300000000000001 111.157 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.84 -37.58 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 2.3700000000000001 111.143 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -67.07 -30.81 70.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 2.3999999999999999 111.151 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.8 p -73.79 -13.89 61.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 2.4300000000000002 111.16 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.81 19.14 52.72 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.169 -0.772 . . . . 2.4700000000000002 111.169 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.89 -38.61 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.806 0.336 . . . . 2.5 111.234 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 tp -102.63 132.32 48.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 2.5299999999999998 111.239 175.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.54 137.09 32.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 2.5699999999999998 111.207 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -77.52 156.12 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 2.6000000000000001 111.203 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.2 mt -113.79 122.67 68.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 2.6299999999999999 111.204 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.2 m -120.58 96.74 48.88 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 2.6699999999999999 111.15 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.03 148.2 49.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.732 1.621 . . . . 2.7000000000000002 111.226 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -81.76 -179.37 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 2.73 111.188 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.73 -45.81 74.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 2.77 111.19 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.88 86.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 2.7999999999999998 111.232 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.41 -36.46 84.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 2.8300000000000001 111.195 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -64.71 -34.59 78.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 2.8700000000000001 111.235 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -71.35 -34.97 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 2.8999999999999999 111.155 172.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -75.1 -20.55 59.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 2.9300000000000002 111.186 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.6 mt -75.02 135.26 41.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 2.9700000000000002 111.193 176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -63.29 138.89 97.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 3.0 111.162 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -50.15 -47.74 22.69 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.647 1.565 . . . . 3.0299999999999998 111.186 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -63.14 -47.66 81.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 3.0699999999999998 111.169 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.7 p -70.77 -21.69 62.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 3.1000000000000001 111.212 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -69.97 -41.53 74.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 3.1299999999999999 111.233 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -78.05 -24.01 47.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 3.1699999999999999 111.252 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.62 90.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 3.2000000000000002 111.197 -174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.71 79.38 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 3.23 111.207 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HB3' HD23 ' A' ' 103' ' ' LEU . 54.4 ptt85 -156.68 161.05 39.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 3.27 111.163 175.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 44.3 t80 -159.98 136.37 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 3.2999999999999998 111.246 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 95.0 m-20 64.98 29.89 12.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 3.3300000000000001 111.216 -175.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.21 38.77 53.89 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.187 -0.765 . . . . 3.3700000000000001 111.187 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -165.07 147.44 8.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 3.3999999999999999 111.159 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 98' ' ' ARG . 94.2 mt -64.9 136.39 56.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 3.4300000000000002 111.232 177.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 pt -115.2 -14.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 3.4700000000000002 111.224 -176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.0 172.92 5.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 3.5 111.226 -174.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -119.73 123.43 28.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 3.5299999999999998 111.18 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.8 139.54 33.72 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.667 1.578 . . . . 3.5699999999999998 111.2 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.32 -4.99 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 3.6000000000000001 111.223 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.75 144.75 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 3.6299999999999999 111.193 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.67 128.22 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 3.6699999999999999 111.242 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.68 151.21 46.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 3.7000000000000002 111.218 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.64 164.98 11.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 3.73 111.215 176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.5 tp -143.85 124.1 13.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 3.77 111.214 172.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.9 p -163.05 -174.29 3.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 3.7999999999999998 111.17 -171.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.9 tp -103.48 120.08 40.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 3.8300000000000001 111.177 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 116' ' ' ILE . 3.8 mp -102.93 141.36 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 3.8700000000000001 111.24 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -136.8 150.61 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 3.8999999999999999 111.159 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -91.28 117.33 29.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 3.9300000000000002 111.251 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.09 -34.88 79.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 3.9700000000000002 111.196 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.94 -47.6 84.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.429 . . . . 4.0 111.205 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 62.2 tp -80.35 -52.36 7.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 4.0300000000000002 111.186 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -115.53 99.53 52.56 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 4.0700000000000003 111.174 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 -17.84 19.12 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.739 1.626 . . . . 4.0999999999999996 111.159 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -85.01 116.81 67.01 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 4.1299999999999999 111.144 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.42 117.9 5.19 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.716 1.61 . . . . 4.1699999999999999 111.232 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.97 129.62 31.17 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.718 1.612 . . . . 4.2000000000000002 111.181 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -110.01 -45.09 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 4.2300000000000004 111.186 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.6 t -136.3 -177.59 4.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 4.2699999999999996 111.173 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.65 -34.16 21.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 4.2999999999999998 111.207 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.77 -15.61 62.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 4.3300000000000001 111.215 -163.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -91.45 -9.44 44.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 4.3700000000000001 111.186 -176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.594 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 93.1 mt -74.02 -45.0 6.59 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 4.4000000000000004 111.195 -171.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.7 Cg_exo -57.0 -40.38 84.52 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.67 1.58 . . . . 4.4299999999999997 111.191 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.37 99.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 4.4699999999999998 111.183 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.7 tp -63.95 -42.98 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.427 . . . . 4.5 111.268 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.95 -35.05 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.239 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.04 -37.02 75.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 4.5700000000000003 111.218 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.04 -31.91 69.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 4.5999999999999996 111.176 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.0 mt -82.18 -15.9 51.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 4.6299999999999999 111.155 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.93 -44.53 63.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 4.6699999999999999 111.156 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.37 -17.87 59.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 4.7000000000000002 111.24 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.03 -7.29 33.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 4.7300000000000004 111.196 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.61 21.16 62.43 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.163 -0.775 . . . . 4.7699999999999996 111.163 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 74.4 mmtt -114.96 179.28 3.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.8 0.333 . . . . 4.7999999999999998 111.212 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -137.82 143.94 41.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 4.8300000000000001 111.196 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -59.78 2.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 4.8700000000000001 111.249 -173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 132' ' ' ILE . 64.6 tp -128.13 115.64 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 4.9000000000000004 111.166 -172.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.8 mmm -111.68 136.03 51.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 4.9299999999999997 111.198 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -171.68 164.99 6.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 4.9699999999999998 111.27 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -79.69 112.71 17.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 5.0 111.211 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.2 tp -63.18 -32.36 73.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 5.0300000000000002 111.182 -172.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -96.66 7.54 46.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 5.0700000000000003 111.229 -170.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -110.04 114.23 56.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 5.0999999999999996 111.172 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -53.32 -39.22 81.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.697 1.598 . . . . 5.1299999999999999 111.214 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -50.49 -40.02 50.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 5.1699999999999999 111.154 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -79.96 -37.52 34.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 5.2000000000000002 111.273 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 77.3 p -105.17 17.73 23.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 5.2300000000000004 111.156 -171.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.557 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 88.3 t90 -66.73 -49.67 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 5.2699999999999996 111.286 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 83.6 Cg_endo -80.01 -14.92 12.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 5.2999999999999998 111.193 -174.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.9 tp -60.95 -33.99 74.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 5.3300000000000001 111.175 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.35 -30.02 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 5.3700000000000001 111.244 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.09 -43.75 10.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 5.4000000000000004 111.208 -172.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.4 -11.48 59.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 5.4299999999999997 111.213 -169.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -78.59 -4.42 48.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 5.4699999999999998 111.241 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 130.84 12.25 2.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.199 -0.76 . . . . 5.5 111.199 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.04 -19.66 25.74 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.241 -0.743 . . . . 5.5300000000000002 111.241 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.61 109.98 11.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 5.5700000000000003 111.172 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.431 ' HA ' ' CE1' ' A' ' 176' ' ' TYR . . . 68.39 35.3 3.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.217 -0.447 . . . . 5.5999999999999996 111.138 173.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.78 54.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 5.6299999999999999 111.235 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 177' ' ' ASP . 73.0 mmtt -125.19 156.4 38.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 5.6699999999999999 111.157 174.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -149.16 124.86 10.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 5.7000000000000002 111.226 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -149.19 99.55 2.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 5.7300000000000004 111.217 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.44 34.12 23.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 5.7699999999999996 111.2 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.97 11.07 77.39 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.222 -0.751 . . . . 5.7999999999999998 111.222 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.01 155.01 40.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.789 0.328 . . . . 5.8300000000000001 111.225 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CE1' ' HA ' ' A' ' 168' ' ' ALA . 74.0 t80 -81.9 131.25 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 5.8700000000000001 111.171 -178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 170' ' ' LYS . 53.7 t0 -82.82 107.78 15.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 5.9000000000000004 111.201 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.3 pt -98.36 -2.25 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 5.9299999999999997 111.166 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.01 -33.91 38.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 5.9699999999999998 111.165 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -64.76 139.99 58.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 6.0 111.173 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 184' ' ' ASP . 85.0 t -72.93 123.88 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 6.0300000000000002 111.18 177.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.14 93.24 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.24 -0.744 . . . . 6.0700000000000003 111.24 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -76.0 -24.94 16.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.769 0.319 . . . . 6.0999999999999996 111.171 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . 51.2 t0 -89.6 64.51 6.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 6.1299999999999999 111.13 -177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -138.76 160.0 40.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 6.1699999999999999 111.222 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.41 80.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 6.2000000000000002 111.164 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.04 -47.36 83.05 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.4 90.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 6.2699999999999996 111.183 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.55 -44.14 91.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 6.2999999999999998 111.18 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.03 79.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.18 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.53 -45.03 97.18 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.225 -0.75 . . . . 6.3700000000000001 111.225 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.94 -38.55 86.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 6.4000000000000004 111.223 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 87.5 m -59.96 -50.91 71.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.233 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.28 -38.18 84.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 6.4699999999999998 111.213 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.8 tp -49.99 -53.22 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 6.5 111.203 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -71.6 -33.26 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 6.5300000000000002 111.162 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 201' ' ' ASN . 94.4 m-20 -54.72 -42.86 72.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 6.5700000000000003 111.249 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.42 -33.34 74.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 6.5999999999999996 111.132 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.5 mt -74.91 -48.7 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 6.6299999999999999 111.125 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.92 -25.95 31.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 6.6699999999999999 111.163 -171.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 197' ' ' ASP . 96.1 m-20 -94.95 15.5 18.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 6.7000000000000002 111.202 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.01 52.3 5.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 6.7300000000000004 111.214 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -115.12 -34.47 5.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 6.7699999999999996 111.209 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 98.9 mmm -139.81 169.34 17.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.147 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -153.06 175.03 13.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 6.8300000000000001 111.215 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -86.9 2.65 48.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 6.8700000000000001 111.141 -173.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.39 1.8 55.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 6.9000000000000004 111.186 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.6 p -80.9 164.99 22.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 6.9299999999999997 111.259 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -158.12 170.0 23.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.149 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -59.66 -48.58 81.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.473 . . . . 7.0 111.252 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 88.7 p -70.86 -30.01 66.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 7.0300000000000002 111.201 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.6 mt -67.25 -46.97 82.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 7.0700000000000003 111.227 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.8 88.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 7.0999999999999996 111.2 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.81 -42.12 88.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 7.1299999999999999 111.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.05 94.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.177 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.42 -34.27 77.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 7.2000000000000002 111.164 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -64.59 -43.17 94.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 7.2300000000000004 111.231 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.77 -35.87 81.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2699999999999996 111.223 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -77.62 -26.61 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 7.2999999999999998 111.205 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.01 31.64 22.78 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.228 -0.749 . . . . 7.3300000000000001 111.228 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -90.08 -6.01 55.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.737 0.303 . . . . 7.3700000000000001 111.186 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 95.8 m -106.58 132.11 52.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 7.4000000000000004 111.253 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -86.81 -44.22 11.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 7.4299999999999997 111.253 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 61.9 mtm -135.39 152.65 51.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 7.4699999999999998 111.157 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -161.69 147.06 13.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 7.5 111.22 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.42 115.7 39.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 7.5300000000000002 111.244 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -154.9 166.82 32.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 7.5700000000000003 111.264 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -115.65 -176.46 18.38 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.219 -0.752 . . . . 7.5999999999999996 111.219 166.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -56.15 -26.73 61.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.671 1.581 . . . . 7.6299999999999999 111.218 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -60.18 -22.05 62.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 7.6699999999999999 111.21 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -125.03 24.98 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 7.7000000000000002 111.178 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -101.81 10.03 40.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 7.7300000000000004 111.241 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.8 p -70.49 -32.68 70.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 7.7699999999999996 111.213 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -89.04 -34.02 16.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 7.7999999999999998 111.212 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.46 -38.85 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 7.8300000000000001 111.207 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -72.74 -32.26 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 7.8700000000000001 111.188 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -99.31 8.72 44.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 7.9000000000000004 111.175 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 85.1 p -70.71 -18.43 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 7.9299999999999997 111.171 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 63.92 24.02 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 7.9699999999999998 111.211 -170.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.76 131.25 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 8.0 111.18 173.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -66.13 133.78 51.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 8.0299999999999994 111.144 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -145.34 158.68 43.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 8.0700000000000003 111.197 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.01 179.69 18.01 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.178 -0.769 . . . . 8.0999999999999996 111.178 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 73.5 t -133.52 131.64 57.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 8.1300000000000008 111.188 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 46.4 p -119.74 167.82 11.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 8.1699999999999999 111.163 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.8 t -102.77 119.94 51.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 8.1999999999999993 111.216 -166.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.493 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 85.9 mt -82.97 -42.97 0.87 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 8.2300000000000004 111.221 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 76.5 Cg_exo -45.48 113.28 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.71 1.606 . . . . 8.2699999999999996 111.183 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 92.3 m -124.57 134.36 52.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 8.3000000000000007 111.216 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -127.17 117.74 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 8.3300000000000001 111.233 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 57.24 34.97 25.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 8.3699999999999992 111.17 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.51 13.21 82.01 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.168 -0.773 . . . . 8.4000000000000004 111.168 176.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -130.0 110.01 16.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.337 . . . . 8.4299999999999997 111.192 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.48 142.04 48.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.671 1.581 . . . . 8.4700000000000006 111.222 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 47.6 p -125.01 -84.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 8.5 111.245 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -127.26 155.2 76.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 8.5299999999999994 111.266 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 155.0 72.37 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.725 1.617 . . . . 8.5700000000000003 111.247 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -76.9 132.04 38.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 8.5999999999999996 111.127 -175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.1 t -106.72 126.77 62.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 8.6300000000000008 111.247 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.01 149.42 16.79 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.165 -0.774 . . . . 8.6699999999999999 111.165 170.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 77.2 t -125.54 130.4 72.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 8.6999999999999993 111.216 -171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 56.1 tp -97.66 121.05 39.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 8.7300000000000004 111.222 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 72.4 m -123.64 146.94 47.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 8.7699999999999996 111.194 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -78.14 162.93 26.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 8.8000000000000007 111.192 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.29 171.51 36.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.215 -0.754 . . . . 8.8300000000000001 111.215 170.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.71 132.31 68.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 8.8699999999999992 111.196 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -59.99 120.89 10.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 8.9000000000000004 111.211 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.84 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 8.9299999999999997 111.194 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -98.9 -0.3 42.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 8.9700000000000006 111.216 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -64.95 131.09 95.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 9.0 111.189 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -76.95 -15.09 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.715 1.61 . . . . 9.0299999999999994 111.214 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -123.52 61.94 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 9.0700000000000003 111.175 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -72.27 -22.53 61.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 9.0999999999999996 111.25 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -33.15 72.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 9.1300000000000008 111.159 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.2 -41.56 90.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 9.1699999999999999 111.198 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.03 -42.16 94.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 9.1999999999999993 111.215 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -55.36 -49.94 70.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 9.2300000000000004 111.2 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -62.16 -56.92 13.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 9.2699999999999996 111.258 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.55 -55.05 33.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 9.3000000000000007 111.183 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.46 -50.01 74.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 9.3300000000000001 111.24 -172.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.03 -49.73 27.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 9.3699999999999992 111.223 -172.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -98.39 -13.45 20.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 9.4000000000000004 111.164 -158.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.53 -49.89 1.77 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 9.4299999999999997 111.203 -173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.03 -53.45 8.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 9.4700000000000006 111.191 -177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.5 mp -76.75 59.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 9.5 111.23 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.3 p -139.76 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 9.5299999999999994 111.209 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -56.78 -47.5 80.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 9.5700000000000003 111.231 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.36 -33.24 69.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 9.5999999999999996 111.261 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.84 -47.89 88.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.26 -0.736 . . . . 9.6300000000000008 111.26 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 44.8 tp -67.18 -50.09 62.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.767 0.318 . . . . 9.6699999999999999 111.156 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -59.73 -35.05 73.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 9.6999999999999993 111.187 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.16 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.7300000000000004 111.191 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 96.2 t -90.71 -44.06 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 9.7699999999999996 111.173 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.51 -0.11 48.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 9.8000000000000007 111.21 -172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -77.58 -16.36 58.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 9.8300000000000001 111.164 168.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -110.47 -33.18 6.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 9.8699999999999992 111.244 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -96.2 160.23 30.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 9.9000000000000004 111.189 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.97 154.06 23.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.736 1.624 . . . . 9.9299999999999997 111.216 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.16 -6.9 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 9.9700000000000006 111.142 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.54 -44.01 85.69 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.17 -0.772 . . . . 10.0 111.17 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.43 125.46 29.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.731 0.3 . . . . 10.029999999999999 111.205 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.3 p -152.06 141.14 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 10.07 111.189 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -139.02 35.86 2.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 10.1 111.218 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.14 148.0 46.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 10.130000000000001 111.152 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -65.06 -49.98 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 10.17 111.204 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.4 p -68.79 -25.36 64.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 10.199999999999999 111.209 -173.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -79.99 -50.49 10.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 10.23 111.23 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -56.98 -38.34 72.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.171 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.11 -39.85 93.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 10.300000000000001 111.167 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -75.48 -32.82 60.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 10.33 111.173 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.16 -24.3 57.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 10.369999999999999 111.168 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.78 -14.56 62.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 10.4 111.201 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.24 -30.06 70.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 10.43 111.209 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -78.52 117.65 67.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 10.470000000000001 111.148 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.71 -34.99 86.15 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.685 1.59 . . . . 10.5 111.146 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.74 -29.71 67.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.529999999999999 111.219 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.78 -29.96 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 10.57 111.224 175.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.38 94.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 10.6 111.205 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.2 99.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.206 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.3 m -68.03 -44.63 76.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.196 -178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 56.7 mtt -73.74 -37.11 65.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.22 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.77 -44.01 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 10.73 111.23 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -64.8 -36.8 85.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 10.77 111.179 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.49 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 10.800000000000001 111.156 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -72.03 -37.45 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 10.83 111.117 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.03 -0.02 54.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.149 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -100.34 -136.77 9.49 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.245 -0.742 . . . . 10.9 111.245 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -149.07 147.29 28.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 10.93 111.188 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.3 pt -117.11 162.61 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 10.970000000000001 111.205 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -59.37 117.43 22.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 11.0 111.188 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 149.36 88.75 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.672 1.581 . . . . 11.029999999999999 111.183 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -105.05 39.91 1.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 11.07 111.202 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 74.9 mt -88.74 118.76 69.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 11.1 111.255 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.83 -17.97 13.58 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.674 1.582 . . . . 11.130000000000001 111.225 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.14 -5.01 58.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 11.17 111.226 -174.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.6 mmm -110.77 19.1 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 11.199999999999999 111.255 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.1 m -65.65 -50.94 63.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 11.23 111.181 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.15 69.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 11.27 111.217 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -71.13 -47.27 58.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.468 . . . . 11.300000000000001 111.216 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -70.13 -35.77 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 11.33 111.261 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -58.15 -51.96 67.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 11.369999999999999 111.196 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -31.49 72.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 11.4 111.143 -172.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.21 -43.07 88.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 11.43 111.181 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -69.31 -40.05 77.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 11.470000000000001 111.167 177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.3 m -57.3 -41.11 79.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 11.5 111.212 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -49.01 71.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 11.529999999999999 111.194 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.04 -25.41 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.186 -172.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 82.7 mt -75.79 -46.03 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 11.6 111.195 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -69.53 -27.39 65.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 11.630000000000001 111.221 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -78.77 -39.13 36.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 11.67 111.184 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.72 -37.48 86.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 11.699999999999999 111.216 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -74.4 -14.97 60.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 11.73 111.203 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.39 31.89 40.18 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.14 -0.784 . . . . 11.77 111.14 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -100.01 -38.28 8.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.78 0.324 . . . . 11.800000000000001 111.177 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -124.96 159.18 31.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 11.83 111.207 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.3 p -81.66 176.92 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 11.869999999999999 111.204 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 10.7 m -70.59 -21.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 11.9 111.199 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -89.84 -36.71 14.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 11.93 111.187 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -69.09 -36.72 77.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.151 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.92 87.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 12.0 111.171 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.84 -32.48 73.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 12.029999999999999 111.191 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -60.94 -59.96 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 12.07 111.248 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.38 -41.1 89.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 12.1 111.235 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.26 85.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 12.130000000000001 111.19 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.7 -46.45 77.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 12.17 111.202 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.2 m -62.43 -39.96 95.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 12.199999999999999 111.208 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -65.01 -37.21 86.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 12.23 111.175 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.9 mt -73.28 -45.01 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 12.27 111.228 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.0 p -81.99 -15.48 53.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 12.300000000000001 111.201 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.199 -1.553 0 CA-C-N 116.221 -0.445 . . . . 12.33 111.222 177.299 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.736 0.303 . . . . 0.029999999999999999 111.258 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.1 tp -59.59 136.7 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.070000000000000007 111.133 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.18 150.1 48.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.10000000000000001 111.214 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.03 125.13 22.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.13 111.217 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.74 14.29 58.32 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.143 -0.783 . . . . 0.17000000000000001 111.143 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -132.06 155.01 48.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.726 0.298 . . . . 0.20000000000000001 111.23 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -116.27 109.98 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.23000000000000001 111.186 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.94 123.76 63.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.27000000000000002 111.179 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -119.96 123.32 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.29999999999999999 111.264 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.404 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.3 m0 -109.98 128.74 55.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.33000000000000002 111.175 176.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 86.5 mt -121.48 131.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.37 111.165 -173.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' HB2' ' CE3' ' A' ' 62' ' ' TRP . 57.0 t-20 -62.34 122.17 15.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.40000000000000002 111.224 172.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.9 -174.31 15.14 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.14 -0.784 . . . . 0.42999999999999999 111.14 173.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -99.95 -19.93 16.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.358 . . . . 0.46999999999999997 111.264 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.45 144.16 28.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.5 111.175 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.73 -18.81 8.03 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.174 -0.771 . . . . 0.53000000000000003 111.174 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -47.59 -55.12 9.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.767 0.318 . . . . 0.56999999999999995 111.197 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -94.23 -27.04 16.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.59999999999999998 111.268 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.13 -57.23 19.33 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.255 -0.738 . . . . 0.63 111.255 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.7 tp -74.57 -29.14 61.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.333 . . . . 0.67000000000000004 111.229 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.94 -32.6 63.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.69999999999999996 111.164 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -59.21 -33.54 71.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.72999999999999998 111.172 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.1 t -77.26 -40.16 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.77000000000000002 111.228 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.25 -28.94 71.68 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.285 -0.726 . . . . 0.80000000000000004 111.285 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.66 -42.52 99.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.82999999999999996 111.135 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.3 -48.45 70.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 0.87 111.165 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -56.17 -44.16 79.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.90000000000000002 111.197 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.29 -42.07 96.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.93000000000000005 111.178 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.89 -35.0 69.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.96999999999999997 111.257 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -78.71 -35.9 44.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.256 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -106.26 -28.31 10.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 1.03 111.212 -173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.75 5.06 74.94 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.24 -0.744 . . . . 1.0700000000000001 111.24 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mm -86.5 114.78 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 1.1000000000000001 111.219 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.92 124.06 19.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 111.181 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.36 126.14 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 1.1699999999999999 111.177 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -126.46 116.77 21.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 1.2 111.234 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.5 125.01 56.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 1.23 111.186 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.6 mt-10 -132.71 161.35 34.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 1.27 111.194 -174.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -117.15 102.78 52.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 1.3 111.188 172.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.56 167.95 25.44 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.709 1.606 . . . . 1.3300000000000001 111.186 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.6 t0 -100.19 102.86 14.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 1.3700000000000001 111.142 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.18 70.99 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 1.3999999999999999 111.2 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HA ' ' HB3' ' A' ' 46' ' ' LYS . 68.5 mt -59.98 -20.69 59.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 1.4299999999999999 111.214 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -49.23 -35.03 16.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 1.47 111.185 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -109.86 -25.58 10.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 1.5 111.241 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 43' ' ' LEU . 87.1 tttt -79.98 -24.4 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 1.53 111.141 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.467 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -50.67 -57.39 13.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 1.5700000000000001 111.2 -177.098 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -68.61 -24.65 35.33 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.663 1.575 . . . . 1.6000000000000001 111.209 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.11 -37.31 72.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.6299999999999999 111.173 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.5 m -88.59 -24.16 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 1.6699999999999999 111.197 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.26 -30.82 71.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 1.7 111.158 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.88 -28.0 69.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 1.73 111.273 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 69.1 p -101.53 -15.39 17.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 1.77 111.131 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.56 26.5 32.55 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.208 -0.757 . . . . 1.8 111.208 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -110.02 169.97 8.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 1.8300000000000001 111.179 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.44 179.99 31.86 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.21 -0.756 . . . . 1.8700000000000001 111.21 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.37 -178.08 3.55 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.669 1.579 . . . . 1.8999999999999999 111.154 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -84.55 -56.53 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 1.9299999999999999 111.241 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.9 mt -114.16 138.93 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 1.97 111.283 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.0 mt -119.68 121.07 65.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 2.0 111.193 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 22.0 m-85 -98.2 107.89 20.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 2.0299999999999998 111.162 167.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.513 ' CE3' ' HB2' ' A' ' 12' ' ' ASN . 24.3 t-105 -148.33 157.26 43.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 2.0699999999999998 111.172 -172.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.7 140.95 53.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.1000000000000001 111.226 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -58.62 -26.19 63.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 2.1299999999999999 111.149 -174.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -76.7 -6.7 53.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 2.1699999999999999 111.232 -171.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -129.13 -24.94 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 111.19 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.04 -29.98 67.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 2.23 111.187 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.59 -28.82 73.57 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.21 -0.756 . . . . 2.27 111.21 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.78 -31.89 59.77 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.159 -0.776 . . . . 2.2999999999999998 111.159 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -64.54 -36.15 83.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.203 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.31 -41.77 69.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 2.3700000000000001 111.153 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -55.33 -42.59 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 2.3999999999999999 111.2 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 99.9 p -70.64 -15.05 62.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 2.4300000000000002 111.222 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.22 22.04 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.195 -0.762 . . . . 2.4700000000000002 111.195 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -107.24 -8.67 16.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.333 . . . . 2.5 111.25 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -105.08 135.08 47.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 2.5299999999999998 111.214 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.96 134.97 53.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 2.5699999999999998 111.166 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -74.5 91.03 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 2.6000000000000001 111.243 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.95 98.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 2.6299999999999999 111.154 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.6 m -91.46 115.39 64.38 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 2.6699999999999999 111.224 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -56.39 144.99 81.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.702 1.601 . . . . 2.7000000000000002 111.169 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.96 163.05 28.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 2.73 111.134 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.31 -36.39 53.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 2.77 111.187 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.64 74.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 2.7999999999999998 111.263 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -70.25 -31.23 68.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 2.8300000000000001 111.226 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -57.56 -33.86 68.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.471 . . . . 2.8700000000000001 111.216 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -81.72 -16.1 52.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 2.8999999999999999 111.245 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 305' ' ' LYS . 70.1 mmtt -85.02 -35.03 22.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 2.9300000000000002 111.199 -170.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -118.63 161.14 20.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 2.9700000000000002 111.141 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -60.02 144.67 86.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 3.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.96 -25.12 66.96 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.684 1.589 . . . . 3.0299999999999998 111.224 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -65.68 -49.05 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 3.0699999999999998 111.18 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.5 p -89.12 -24.13 22.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.262 -0.426 . . . . 3.1000000000000001 111.204 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -69.96 -46.79 64.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 3.1299999999999999 111.192 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.89 -15.43 61.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 3.1699999999999999 111.188 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.13 -42.24 72.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 3.2000000000000002 111.179 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.15 78.92 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 3.23 111.227 -169.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HB3' HD23 ' A' ' 103' ' ' LEU . 33.7 ptt-85 -149.82 165.1 33.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 3.27 111.193 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -131.97 114.43 14.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 3.2999999999999998 111.221 170.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 61.94 37.2 15.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 3.3300000000000001 111.163 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.8 7.68 83.75 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.213 -0.755 . . . . 3.3700000000000001 111.213 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.96 107.25 15.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 3.3999999999999999 111.171 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.409 HD23 ' HB3' ' A' ' 98' ' ' ARG . 58.0 mt -59.33 128.99 39.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 3.4300000000000002 111.12 -178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -112.36 -20.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 3.4700000000000002 111.228 -170.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.35 176.0 6.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 3.5 111.268 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -113.25 127.32 26.96 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 3.5299999999999998 111.231 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.45 138.95 47.72 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.718 1.612 . . . . 3.5699999999999998 111.273 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.4 mm -116.14 -47.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 3.6000000000000001 111.243 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.73 154.98 50.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 3.6299999999999999 111.179 -176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 134.96 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 3.6699999999999999 111.252 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -124.9 123.41 39.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 3.7000000000000002 111.186 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.26 151.18 36.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 3.73 111.218 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.2 tp -138.18 125.81 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 3.77 111.166 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 t -159.98 -168.54 2.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 3.7999999999999998 111.179 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.95 125.54 36.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 3.8300000000000001 111.173 -168.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.9 mm -107.86 139.99 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 3.8700000000000001 111.267 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -136.55 144.92 44.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 3.8999999999999999 111.205 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -75.52 123.5 25.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 3.9300000000000002 111.216 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -70.97 -30.1 66.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 3.9700000000000002 111.185 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -77.85 -43.26 30.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 4.0 111.209 -176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.14 -44.64 59.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 4.0300000000000002 111.163 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -128.54 77.3 77.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 4.0700000000000003 111.238 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.69 -25.01 74.97 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.659 1.573 . . . . 4.0999999999999996 111.198 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -105.19 100.07 23.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 4.1299999999999999 111.26 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.0 155.4 52.8 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.706 1.604 . . . . 4.1699999999999999 111.196 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 154.55 59.31 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.691 1.594 . . . . 4.2000000000000002 111.253 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -85.32 -15.64 42.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 4.2300000000000004 111.192 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.2 t -160.0 162.66 34.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 4.2699999999999996 111.192 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -59.4 -23.25 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 4.2999999999999998 111.215 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.43 -22.83 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.3300000000000001 111.185 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -96.76 2.97 52.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 4.3700000000000001 111.226 -176.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.528 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 70.4 mt -66.93 -54.33 21.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 4.4000000000000004 111.191 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 67.5 Cg_endo -71.78 -18.52 28.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.735 1.623 . . . . 4.4299999999999997 111.233 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.98 -24.69 67.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 4.4699999999999998 111.197 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.2 -6.88 54.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 4.5 111.162 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.37 -35.01 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 4.5300000000000002 111.174 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.03 -39.88 83.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 4.5700000000000003 111.213 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.61 -27.85 68.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 4.5999999999999996 111.158 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 86.8 mt -85.01 -0.36 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 4.6299999999999999 111.207 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.15 -26.27 68.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 4.6699999999999999 111.228 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.88 -20.97 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 4.7000000000000002 111.232 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -99.92 -20.01 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 4.7300000000000004 111.183 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.61 24.8 44.88 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.145 -0.782 . . . . 4.7699999999999996 111.145 -176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -119.04 164.94 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 4.7999999999999998 111.19 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t -111.34 158.46 19.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 4.8300000000000001 111.213 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.1 -72.86 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.178 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.3 tp -156.94 129.0 7.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 4.9000000000000004 111.166 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mmm -84.73 140.55 31.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 4.9299999999999997 111.242 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.02 138.42 53.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 4.9699999999999998 111.165 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -82.91 119.78 24.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 5.0 111.209 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.407 HD21 HD11 ' A' ' 195' ' ' LEU . 99.0 mt -114.81 -25.52 8.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 5.0300000000000002 111.181 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -66.07 -39.82 90.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 5.0700000000000003 111.184 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.97 118.4 56.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 5.0999999999999996 111.208 -172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.96 -34.91 88.34 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.654 1.569 . . . . 5.1299999999999999 111.16 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -53.5 -37.69 62.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 5.1699999999999999 111.215 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.28 25.63 8.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 5.2000000000000002 111.245 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.3 p -103.34 -15.23 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 5.2300000000000004 111.154 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 75.0 t90 -68.67 -48.2 32.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 5.2699999999999996 111.217 175.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 67.6 Cg_endo -74.79 -4.36 15.29 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.674 1.582 . . . . 5.2999999999999998 111.193 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 58.8 mt -65.3 -21.04 66.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 5.3300000000000001 111.176 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.7 mt -109.68 -41.46 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 5.3700000000000001 111.173 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.02 -44.47 89.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 5.4000000000000004 111.232 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.01 -34.33 78.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 5.4299999999999997 111.233 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -64.2 -32.22 73.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 5.4699999999999998 111.219 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.57 23.74 6.74 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.248 -0.741 . . . . 5.5 111.248 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.53 -22.05 17.61 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.169 -0.772 . . . . 5.5300000000000002 111.169 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 68.1 t80 -111.59 145.15 39.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.859 0.361 . . . . 5.5700000000000003 111.122 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 67.55 22.79 9.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 5.5999999999999996 111.175 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.36 173.22 11.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 5.6299999999999999 111.171 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -139.32 112.88 8.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 5.6699999999999999 111.166 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -79.14 80.11 5.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 5.7000000000000002 111.23 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 25.5 tt0 -145.69 90.01 1.96 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 5.7300000000000004 111.235 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 79.7 m-20 74.12 -69.18 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 5.7699999999999996 111.267 174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.0 25.78 0.07 OUTLIER Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.22 -0.752 . . . . 5.7999999999999998 111.22 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -114.96 103.28 10.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.783 0.325 . . . . 5.8300000000000001 111.201 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -110.46 77.22 1.03 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 5.8700000000000001 111.243 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -81.6 122.88 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 5.9000000000000004 111.16 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.86 -34.11 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.182 -0.463 . . . . 5.9299999999999997 111.198 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.92 -30.04 71.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 5.9699999999999998 111.156 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -65.59 143.03 57.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 6.0 111.169 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 183' ' ' VAL . 70.9 t -47.83 124.08 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 6.0300000000000002 111.142 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -98.48 14.31 62.18 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.229 -0.749 . . . . 6.0700000000000003 111.229 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.483 ' H ' HG12 ' A' ' 181' ' ' VAL . 25.0 m -123.63 31.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.333 . . . . 6.0999999999999996 111.189 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -127.67 9.95 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 6.1299999999999999 111.25 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -93.38 161.38 14.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 6.1699999999999999 111.148 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -60.57 -33.17 72.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 6.2000000000000002 111.148 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.32 -37.09 90.43 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.177 -0.769 . . . . 6.2300000000000004 111.177 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.2 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.845 0.355 . . . . 6.2699999999999996 111.185 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.74 -40.76 75.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 6.2999999999999998 111.254 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.55 -28.91 68.19 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.146 -0.479 . . . . 6.3300000000000001 111.207 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -20.13 66.74 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.154 -0.778 . . . . 6.3700000000000001 111.154 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 347' ' ' VAL . 86.7 mt -104.99 -34.9 7.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 6.4000000000000004 111.203 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.9 m -64.56 -52.53 57.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 6.4299999999999997 111.233 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.62 -38.62 87.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 6.4699999999999998 111.193 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 151' ' ' LEU . 54.1 tp -58.17 -53.33 59.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 6.5 111.203 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.77 -42.45 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 6.5300000000000002 111.212 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.92 -39.67 86.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 6.5700000000000003 111.204 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 84.7 mt -70.4 -35.4 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 6.5999999999999996 111.23 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.24 -40.79 89.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 6.6299999999999999 111.188 174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.79 -24.62 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 6.6699999999999999 111.205 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -92.71 5.18 52.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 6.7000000000000002 111.22 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 60.65 35.26 19.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 6.7300000000000004 111.224 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -74.88 -34.06 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.215 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -145.21 149.93 35.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 6.7999999999999998 111.17 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -94.65 151.52 19.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 6.8300000000000001 111.243 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.94 -24.53 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 6.8700000000000001 111.229 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -78.77 -16.75 56.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 6.9000000000000004 111.146 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -56.4 118.03 4.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 6.9299999999999997 111.232 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -119.97 -164.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 6.9699999999999998 111.22 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -63.09 -47.83 81.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 7.0 111.167 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 82.5 p -75.09 -25.51 58.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 7.0300000000000002 111.183 -173.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.5 mm -67.65 -52.26 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 7.0700000000000003 111.182 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.99 90.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 7.0999999999999996 111.201 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.39 -42.46 91.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 7.1299999999999999 111.218 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.81 -40.08 95.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 7.1699999999999999 111.173 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -26.67 68.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 7.2000000000000002 111.224 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -81.65 -45.28 15.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 7.2300000000000004 111.197 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -72.66 -30.12 64.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 7.2699999999999996 111.188 -174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.77 -9.75 56.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 7.2999999999999998 111.222 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 76.16 32.87 51.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.194 -0.762 . . . . 7.3300000000000001 111.194 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -81.43 -29.33 33.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.764 0.316 . . . . 7.3700000000000001 111.191 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.1 p -100.24 160.04 14.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 7.4000000000000004 111.204 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -95.06 -24.76 16.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 7.4299999999999997 111.189 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 90.2 mmm -109.88 149.94 29.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.294 -0.412 . . . . 7.4699999999999998 111.168 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -159.64 179.61 8.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 7.5 111.174 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.2 mt -121.1 124.17 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.463 . . . . 7.5300000000000002 111.178 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -165.01 179.94 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 7.5700000000000003 111.279 -173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -74.84 139.33 25.1 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.245 -0.742 . . . . 7.5999999999999996 111.245 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -53.32 129.84 35.51 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.67 1.58 . . . . 7.6299999999999999 111.188 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 57.39 49.93 12.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 7.6699999999999999 111.217 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.86 75.37 2.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 7.7000000000000002 111.226 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.427 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 48.4 m0 -68.28 -17.13 64.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 7.7300000000000004 111.146 -170.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 97.0 p -66.18 -19.97 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 7.7699999999999996 111.208 175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -118.98 -19.41 8.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 7.7999999999999998 111.105 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.8 mt -90.77 -61.33 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 7.8300000000000001 111.195 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -69.97 -39.55 75.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 7.8700000000000001 111.205 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 83.9 m -52.45 -44.93 65.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 7.9000000000000004 111.159 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 84.9 p -81.27 -10.47 59.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 7.9299999999999997 111.195 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 59.99 40.23 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 7.9699999999999998 111.247 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 89.4 t -127.63 135.06 64.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 8.0 111.161 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -73.85 111.24 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 8.0299999999999994 111.227 -175.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -117.31 145.02 44.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 8.0700000000000003 111.159 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -116.08 178.65 17.59 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.189 -0.764 . . . . 8.0999999999999996 111.189 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.8 p -141.89 139.96 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 8.1300000000000008 111.166 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.1 t -142.5 176.55 8.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 8.1699999999999999 111.209 171.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 64.6 t -71.57 112.85 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 8.1999999999999993 111.139 -171.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.57 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 40.6 tp -63.46 -53.76 49.47 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 8.2300000000000004 111.212 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 70.8 Cg_endo -74.81 147.34 34.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.688 1.592 . . . . 8.2699999999999996 111.191 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.4 m -116.27 125.34 52.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 8.3000000000000007 111.177 174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -99.98 90.08 4.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 8.3300000000000001 111.188 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 52.14 55.47 9.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 8.3699999999999992 111.19 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 99.27 -23.59 35.68 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.221 -0.752 . . . . 8.4000000000000004 111.221 171.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -129.95 109.97 16.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 8.4299999999999997 111.232 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -54.98 130.71 42.2 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.719 1.613 . . . . 8.4700000000000006 111.194 173.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 45.7 t -114.97 -94.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 8.5 111.188 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -104.94 145.53 30.9 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 8.5299999999999994 111.185 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.73 -176.42 2.8 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.731 1.62 . . . . 8.5700000000000003 111.175 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -86.58 156.4 20.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.462 . . . . 8.5999999999999996 111.201 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -124.14 117.54 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 8.6300000000000008 111.179 -173.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -99.57 150.05 19.03 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.222 -0.751 . . . . 8.6699999999999999 111.222 170.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.98 121.9 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.894 0.378 . . . . 8.6999999999999993 111.183 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 63.4 tp -95.44 110.93 22.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 8.7300000000000004 111.214 172.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 89.5 p -112.51 151.7 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 8.7699999999999996 111.156 -171.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -111.48 126.93 55.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 8.8000000000000007 111.176 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.98 177.68 19.12 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.236 -0.746 . . . . 8.8300000000000001 111.236 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 80.2 mt -111.67 122.87 66.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 8.8699999999999992 111.184 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -60.75 128.9 38.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 8.9000000000000004 111.137 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.85 63.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 8.9299999999999997 111.232 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -87.17 -5.01 59.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 8.9700000000000006 111.108 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.9 t -80.43 132.39 58.99 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 9.0 111.179 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.68 -5.4 14.73 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.749 1.633 . . . . 9.0299999999999994 111.191 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -118.0 59.92 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 9.0700000000000003 111.218 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -77.76 -28.89 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 9.0999999999999996 111.243 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.45 -38.6 65.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 9.1300000000000008 111.265 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.5 mt -67.41 -37.73 83.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 9.1699999999999999 111.199 177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.83 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 9.1999999999999993 111.216 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.1 -48.85 70.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 9.2300000000000004 111.192 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.69 -47.6 77.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 9.2699999999999996 111.127 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.05 -41.06 74.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 9.3000000000000007 111.21 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.14 -3.76 58.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 9.3300000000000001 111.223 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.41 -50.01 3.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 9.3699999999999992 111.244 -171.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -121.21 4.96 10.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 9.4000000000000004 111.163 -164.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -125.0 -62.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 9.4299999999999997 111.143 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 55.4 tp -61.56 -53.29 58.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 9.4700000000000006 111.155 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 64.1 mt -85.03 60.8 6.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 9.5 111.199 -174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.6 p -134.94 167.53 20.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 9.5299999999999994 111.248 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.47 -34.62 78.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 9.5700000000000003 111.177 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.07 -35.18 22.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 9.5999999999999996 111.166 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -65.81 -48.76 63.89 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.69 -28.25 65.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 9.6699999999999999 111.232 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -69.41 -36.12 76.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 9.6999999999999993 111.148 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.01 78.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 9.7300000000000004 111.187 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -70.41 -39.95 77.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 9.7699999999999996 111.217 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.14 5.02 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 9.8000000000000007 111.139 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -54.65 -50.21 68.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 9.8300000000000001 111.182 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -106.8 -18.16 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 9.8699999999999992 111.147 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -103.08 162.76 19.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 9.9000000000000004 111.277 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.45 144.93 48.67 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 121.729 1.619 . . . . 9.9299999999999997 111.198 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.23 -6.89 59.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 9.9700000000000006 111.18 -170.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -56.96 -35.9 70.95 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.139 -0.784 . . . . 10.0 111.139 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -63.19 127.98 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 10.029999999999999 111.12 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 304' ' ' LEU . 7.6 p -152.77 129.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 10.07 111.236 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -125.13 26.48 6.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 10.1 111.168 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.405 ' H ' HG22 ' A' ' 302' ' ' VAL . 36.2 tp -157.65 130.99 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 10.130000000000001 111.221 -172.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 88' ' ' LYS . 86.7 tttt -61.78 -46.52 89.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 10.17 111.188 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 68.0 m -55.07 -38.25 67.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 10.199999999999999 111.16 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -71.39 -41.81 69.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 10.23 111.226 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.58 -34.27 66.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 10.27 111.237 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.48 -29.98 68.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 10.300000000000001 111.244 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -96.52 -30.02 13.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 10.33 111.142 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 26.6 tp -69.45 -30.95 68.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 10.369999999999999 111.182 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.14 -9.12 54.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 10.4 111.196 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.93 -28.42 67.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 10.43 111.156 173.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -80.62 115.59 56.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 10.470000000000001 111.177 173.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.52 -38.81 80.61 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.726 1.618 . . . . 10.5 111.205 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.64 -39.87 70.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.166 -172.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.67 -40.04 76.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 10.57 111.194 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.59 -43.37 89.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 10.6 111.234 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.93 82.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 10.630000000000001 111.158 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 90.0 m -63.37 -43.06 98.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.199 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.98 -38.32 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 10.699999999999999 111.19 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -63.27 -46.16 88.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.197 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.96 -33.79 76.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 10.77 111.212 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.05 -45.68 84.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 10.800000000000001 111.167 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -59.23 -39.84 83.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 10.83 111.174 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -95.95 6.15 49.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 10.869999999999999 111.224 -174.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.65 -156.03 26.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.234 -0.746 . . . . 10.9 111.234 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -130.6 116.18 17.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.331 . . . . 10.93 111.249 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 97.7 mt -105.08 137.0 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 10.970000000000001 111.209 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 83.0 mtp -63.35 130.57 94.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 11.0 111.235 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 50.7 Cg_exo -55.01 144.39 68.67 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.718 1.612 . . . . 11.029999999999999 111.204 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -120.17 55.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 11.07 111.151 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 335' ' ' GLN . 82.0 mt -126.63 130.42 23.86 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 11.1 111.215 -178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.13 -29.22 74.23 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.697 1.598 . . . . 11.130000000000001 111.229 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 333' ' ' ILE . 90.6 mt-30 -64.02 -41.71 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 11.17 111.19 172.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 95.3 mmm -65.34 -37.25 86.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 11.199999999999999 111.249 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 39.4 t -59.92 -41.41 91.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 11.23 111.242 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.41 -36.65 83.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 11.27 111.252 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -64.98 -36.69 85.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 11.300000000000001 111.183 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -68.22 -29.76 68.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 11.33 111.177 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -62.76 -41.4 99.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 11.369999999999999 111.187 175.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.33 -39.37 81.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 11.4 111.267 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.7 -42.59 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 11.43 111.153 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.5 -45.12 95.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 11.470000000000001 111.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.4 m -64.99 -39.94 94.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 11.5 111.241 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.29 -45.42 91.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 11.529999999999999 111.162 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 192' ' ' LEU . 70.1 t -64.72 -40.52 89.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 11.57 111.243 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.1 mt -65.13 -43.82 95.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 11.6 111.222 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.78 -37.37 87.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 11.630000000000001 111.179 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.0 -44.37 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 11.67 111.203 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.03 79.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 11.699999999999999 111.218 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.4 p -82.93 -14.95 53.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 11.73 111.22 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 88.25 12.26 65.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.22 -0.752 . . . . 11.77 111.22 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -70.04 -40.81 74.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 11.800000000000001 111.145 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -129.89 166.92 19.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 11.83 111.248 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -83.46 174.47 10.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 11.869999999999999 111.181 173.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -44.1 98.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 11.9 111.187 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.92 -42.75 80.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 11.93 111.201 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -64.74 -40.35 95.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 11.970000000000001 111.211 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.91 -48.49 73.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 12.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.26 -23.18 60.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 12.029999999999999 111.198 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -65.12 -48.48 73.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 12.07 111.186 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.63 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 12.1 111.241 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.54 93.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 12.130000000000001 111.173 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -63.35 -40.62 97.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 12.17 111.16 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 95.9 m -56.96 -42.74 80.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 12.199999999999999 111.248 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 22.6 tpp85 -66.17 -44.14 84.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 12.23 111.241 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.76 -39.97 87.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 12.27 111.171 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.5 p -88.63 -14.95 36.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 12.300000000000001 111.159 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.201 -1.474 0 CA-C-N 116.188 -0.46 . . . . 12.33 111.216 178.726 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.76 0.314 . . . . 0.029999999999999999 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.7 mt -96.41 115.5 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.070000000000000007 111.223 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -95.58 139.96 31.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.243 -0.435 . . . . 0.10000000000000001 111.231 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.68 125.04 21.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.27 -0.423 . . . . 0.13 111.199 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.64 5.21 60.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.2 -0.76 . . . . 0.17000000000000001 111.2 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HG2' ' HB2' ' A' ' 34' ' ' LYS . 96.0 mttt -133.47 148.56 51.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.20000000000000001 111.116 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.2 mt -113.74 140.76 48.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.23000000000000001 111.152 174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.4 t -115.93 110.89 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.27000000000000002 111.178 172.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.445 HG12 ' HB ' ' A' ' 59' ' ' ILE . 69.8 mt -113.79 116.21 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.29999999999999999 111.235 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.417 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 38.7 m0 -105.46 119.76 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.33000000000000002 111.164 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.43 139.25 45.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.37 111.208 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -67.63 119.31 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.40000000000000002 111.142 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.81 -177.99 26.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.144 -0.782 . . . . 0.42999999999999999 111.144 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -102.71 -35.03 8.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.46999999999999997 111.138 173.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.83 163.26 28.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.5 111.201 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.41 -7.9 9.01 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.149 -0.781 . . . . 0.53000000000000003 111.149 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -60.75 -23.23 64.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.767 0.317 . . . . 0.56999999999999995 111.188 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -67.23 -36.43 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.59999999999999998 111.167 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.59 -44.86 94.46 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.28 -0.728 . . . . 0.63 111.28 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 37' ' ' VAL . 80.4 mt -70.15 -32.74 70.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.753 0.311 . . . . 0.67000000000000004 111.162 175.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.03 92.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.69999999999999996 111.181 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -61.41 -34.76 75.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.72999999999999998 111.207 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.95 -39.78 67.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.77000000000000002 111.256 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.09 79.78 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.27 -0.732 . . . . 0.80000000000000004 111.27 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.07 -37.39 84.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.337 . . . . 0.82999999999999996 111.227 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.89 -37.43 87.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.87 111.169 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -30.0 67.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.472 . . . . 0.90000000000000002 111.183 175.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -73.39 -36.48 66.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.93000000000000005 111.145 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -82.79 -39.15 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.96999999999999997 111.238 -174.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -78.71 -50.22 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 1.0 111.199 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -102.46 -49.34 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 1.03 111.202 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.44 21.57 3.01 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.213 -0.755 . . . . 1.0700000000000001 111.213 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.56 122.29 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 1.1000000000000001 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HB2' ' HG2' ' A' ' 6' ' ' LYS . 99.1 mttt -87.97 127.75 35.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 1.1299999999999999 111.182 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.22 124.25 72.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 1.1699999999999999 111.218 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.3 m -115.42 125.05 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 1.2 111.158 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 20' ' ' LEU . 40.2 t -114.95 126.38 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.195 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -129.96 162.6 28.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 1.27 111.201 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -112.32 106.84 55.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.228 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 78.7 Cg_endo -75.51 175.82 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.66 1.573 . . . . 1.3300000000000001 111.194 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -131.49 109.84 10.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 1.3700000000000001 111.219 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 58.07 69.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 1.3999999999999999 111.183 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.02 -18.59 61.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 1.4299999999999999 111.199 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -64.54 -15.08 60.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.202 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -99.24 -34.84 10.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 1.5 111.195 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -89.89 -48.66 7.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 1.53 111.208 -166.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 2.6 m-30 -56.47 -47.49 98.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 1.5700000000000001 111.19 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 80.3 Cg_exo -50.46 -35.07 44.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.731 1.62 . . . . 1.6000000000000001 111.229 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -79.86 -47.47 15.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 1.6299999999999999 111.247 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 m -78.42 -16.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 1.6699999999999999 111.256 -174.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.74 69.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 1.7 111.204 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.66 -15.49 59.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 1.73 111.208 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -108.5 -14.97 14.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 1.77 111.194 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.55 30.25 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.249 -0.74 . . . . 1.8 111.249 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -110.16 169.99 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.788 0.327 . . . . 1.8300000000000001 111.221 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.48 -173.83 25.72 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.201 -0.76 . . . . 1.8700000000000001 111.201 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.63 173.22 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.68 1.587 . . . . 1.8999999999999999 111.258 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -88.77 -50.93 5.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.216 -0.447 . . . . 1.9299999999999999 111.221 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HB ' HG12 ' A' ' 9' ' ' ILE . 84.9 mt -116.27 132.97 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.97 111.162 177.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.1 mt -114.2 117.56 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 2.0 111.139 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -114.07 106.5 14.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 111.234 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -150.46 159.97 44.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 2.0699999999999998 111.155 -166.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.12 158.52 27.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.213 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.408 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 46.3 m170 -71.58 -2.8 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 2.1299999999999999 111.197 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.41 -30.94 69.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 2.1699999999999999 111.188 173.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mmt-85 -129.95 -27.92 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 2.2000000000000002 111.159 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -55.04 -43.34 73.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 2.23 111.211 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.31 -28.32 72.1 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.244 -0.742 . . . . 2.27 111.244 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.71 -11.32 81.88 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.145 -0.782 . . . . 2.2999999999999998 111.145 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -69.6 -29.94 67.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.717 0.294 . . . . 2.3300000000000001 111.188 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.71 -35.18 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 2.3700000000000001 111.242 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -70.02 -38.71 75.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 2.3999999999999999 111.202 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.3 p -69.82 -19.99 63.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 2.4300000000000002 111.221 177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.31 23.98 25.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.168 -0.773 . . . . 2.4700000000000002 111.168 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.6 30.91 6.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 2.5 111.234 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.9 tp -151.1 115.32 5.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 2.5299999999999998 111.224 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.77 162.44 24.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 2.5699999999999998 111.184 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -85.65 86.86 7.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 2.6000000000000001 111.211 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 mm -98.47 101.93 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 2.6299999999999999 111.15 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -92.94 120.76 66.89 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 2.6699999999999999 111.203 -175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.14 141.27 80.37 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.713 1.609 . . . . 2.7000000000000002 111.194 176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -89.65 -174.28 4.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.24 -175.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.67 -38.63 67.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 2.77 111.209 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.22 79.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 2.7999999999999998 111.187 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -79.82 -22.42 43.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 2.8300000000000001 111.155 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -62.52 -29.62 70.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 2.8700000000000001 111.168 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -97.61 -30.17 13.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 2.8999999999999999 111.205 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -79.98 -35.17 37.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 2.9300000000000002 111.255 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -94.57 149.49 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 2.9700000000000002 111.192 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -73.35 135.02 79.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 3.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.07 -46.94 29.25 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.643 1.562 . . . . 3.0299999999999998 111.208 -170.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -58.52 -46.82 85.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 3.0699999999999998 111.241 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.3 p -82.41 -15.92 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 3.1000000000000001 111.228 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 85.8 t90 -65.98 -52.34 50.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 3.1299999999999999 111.259 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -85.78 9.98 14.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 3.1699999999999999 111.271 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.89 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 3.2000000000000002 111.239 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.9 m -104.07 24.04 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 3.23 111.175 -177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.2 ttt180 -76.57 129.98 37.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 3.27 111.206 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -157.95 132.81 8.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 3.2999999999999998 111.241 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 68.49 35.05 3.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 3.3300000000000001 111.149 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.59 -35.13 4.93 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.226 -0.75 . . . . 3.3700000000000001 111.226 170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -130.62 171.95 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 3.3999999999999999 111.182 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.8 mp -77.94 145.17 36.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 3.4300000000000002 111.231 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -122.8 14.7 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 3.4700000000000002 111.136 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -168.92 178.89 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 3.5 111.15 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -110.07 117.54 51.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 3.5299999999999998 111.177 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.04 136.73 76.42 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.71 1.607 . . . . 3.5699999999999998 111.204 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.1 mm -112.96 -60.86 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 3.6000000000000001 111.3 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -154.93 162.61 41.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 3.6299999999999999 111.145 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.01 159.94 41.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 3.6699999999999999 111.193 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.25 126.76 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 3.7000000000000002 111.137 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.28 145.02 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 3.73 111.219 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.4 tp -124.26 111.58 16.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 3.77 111.19 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 t -166.91 -171.65 1.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 3.7999999999999998 111.18 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.2 tp -53.06 108.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 3.8300000000000001 111.198 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 244' ' ' VAL . 81.0 mt -92.55 114.13 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 3.8700000000000001 111.153 165.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -124.28 153.63 41.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 3.8999999999999999 111.165 -169.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -85.05 113.46 21.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 3.9300000000000002 111.147 175.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.34 -30.85 69.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 3.9700000000000002 111.182 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -72.1 -30.21 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 4.0 111.135 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.2 -13.8 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 4.0300000000000002 111.24 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 38.1 tp -142.97 79.79 14.24 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 4.0700000000000003 111.214 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.17 -19.48 29.55 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.757 1.638 . . . . 4.0999999999999996 111.205 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -120.16 89.97 43.89 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 4.1299999999999999 111.183 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.55 157.48 48.77 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.27 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.38 154.74 45.9 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.77 1.646 . . . . 4.2000000000000002 111.172 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.56 -5.24 43.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 4.2300000000000004 111.217 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.2 t -164.3 156.14 16.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 4.2699999999999996 111.19 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -59.79 -18.84 46.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 4.2999999999999998 111.221 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.67 -14.46 60.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 4.3300000000000001 111.164 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.67 6.03 47.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 4.3700000000000001 111.202 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.5 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 30.3 mm -74.19 -44.17 6.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.2 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 89.7 Cg_exo -49.24 -41.91 41.14 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.662 1.575 . . . . 4.4299999999999997 111.217 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.26 84.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 4.4699999999999998 111.167 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.16 -52.75 11.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 4.5 111.261 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.96 -37.79 61.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 4.5300000000000002 111.206 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.42 -57.72 10.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 4.5700000000000003 111.191 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.94 -30.61 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 4.5999999999999996 111.233 -174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.4 ' HB3' ' HG3' ' A' ' 144' ' ' LYS . 95.0 mt -77.08 -30.44 55.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 4.6299999999999999 111.248 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.98 -37.5 66.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 4.6699999999999999 111.216 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.62 -28.45 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 4.7000000000000002 111.213 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.45 -1.66 43.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 4.7300000000000004 111.149 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.25 25.26 40.63 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' A' ' 139' ' ' LEU . 29.9 pttt -129.95 160.09 34.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 4.7999999999999998 111.19 175.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.9 t -138.82 144.86 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 4.8300000000000001 111.219 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.42 -44.03 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 4.8700000000000001 111.17 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 mt -110.38 121.58 45.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 4.9000000000000004 111.118 169.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.8 tpp -150.16 115.26 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 4.9299999999999997 111.211 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.7 176.0 7.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 4.9699999999999998 111.226 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -79.91 120.26 23.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 5.0 111.153 160.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 151' ' ' LEU . 4.0 mm? -90.23 -37.96 13.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 5.0300000000000002 111.223 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -65.16 -42.34 93.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 5.0700000000000003 111.146 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.9 126.45 75.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 5.0999999999999996 111.205 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.29 -21.26 31.25 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.681 1.587 . . . . 5.1299999999999999 111.202 -173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.39 -38.2 73.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 5.1699999999999999 111.192 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -99.33 14.93 27.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 5.2000000000000002 111.2 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.2 p -103.1 -10.92 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 5.2300000000000004 111.169 173.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.545 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 51.5 t-105 -72.43 -42.74 8.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 5.2699999999999996 111.19 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 70.8 Cg_exo -55.04 -33.27 82.76 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.73 1.62 . . . . 5.2999999999999998 111.171 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.455 HD13 ' HG ' ' A' ' 195' ' ' LEU . 63.1 mt -69.26 -24.63 64.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 5.3300000000000001 111.188 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 49.0 mm -81.3 -40.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 5.3700000000000001 111.218 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.15 65.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 5.4000000000000004 111.162 174.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.08 -33.52 76.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 5.4299999999999997 111.153 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.04 -62.03 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 5.4699999999999998 111.206 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.99 -8.34 70.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.236 -0.746 . . . . 5.5 111.236 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.44 55.1 3.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.167 -0.773 . . . . 5.5300000000000002 111.167 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -149.78 151.67 33.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 5.5700000000000003 111.256 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 48.19 42.26 17.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 5.5999999999999996 111.24 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -139.93 78.82 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 5.6299999999999999 111.163 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -135.42 118.16 16.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 5.6699999999999999 111.216 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -125.52 142.77 51.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 5.7000000000000002 111.169 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 87.3 tt0 -127.85 96.53 4.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 5.7300000000000004 111.263 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 96.3 m-20 65.35 30.33 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 5.7699999999999996 111.236 -172.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.97 6.08 69.95 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.162 -0.775 . . . . 5.7999999999999998 111.162 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -96.04 99.78 11.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 5.8300000000000001 111.217 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -65.06 125.1 23.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 5.8700000000000001 111.143 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -84.3 113.45 21.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 5.9000000000000004 111.178 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.3 pt -95.28 5.45 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 5.9299999999999997 111.25 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.56 28.18 8.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 5.9699999999999998 111.191 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -82.25 169.97 15.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 6.0 111.157 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 95.6 t -112.87 124.84 69.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 6.0300000000000002 111.169 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -66.2 -39.36 94.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.212 -0.755 . . . . 6.0700000000000003 111.212 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.51 0.08 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 6.0999999999999996 111.156 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -106.16 -4.84 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 6.1299999999999999 111.226 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -83.31 160.04 21.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 6.1699999999999999 111.22 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.62 -29.69 70.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 6.2000000000000002 111.193 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.82 -33.67 63.77 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.237 -0.745 . . . . 6.2300000000000004 111.237 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.76 -28.63 22.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 6.2699999999999996 111.154 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -95.04 -64.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 6.2999999999999998 111.157 -174.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.39 -34.78 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 6.3300000000000001 111.151 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -33.44 87.23 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.273 -0.731 . . . . 6.3700000000000001 111.273 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.0 tp -75.0 -39.58 61.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 6.4000000000000004 111.236 177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.9 m -54.57 -46.47 73.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 6.4299999999999997 111.179 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -63.19 -47.6 81.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 6.4699999999999998 111.177 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.5 tt -50.0 -54.03 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 6.5 111.209 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -67.43 -36.47 76.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.144 -0.48 . . . . 6.5300000000000002 111.19 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.07 -35.02 68.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.5700000000000003 111.203 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.44 -27.14 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 6.5999999999999996 111.194 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.91 -36.91 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 6.6299999999999999 111.241 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.79 -21.66 59.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 6.6699999999999999 111.265 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -90.04 3.68 52.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 6.7000000000000002 111.216 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 62.26 35.09 15.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 6.7300000000000004 111.235 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -106.9 -30.01 9.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 6.7699999999999996 111.19 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 95.7 mtp -125.92 160.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 6.7999999999999998 111.169 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -125.2 118.92 27.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 6.8300000000000001 111.265 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.84 -24.07 67.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 6.8700000000000001 111.223 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -81.83 -10.09 59.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 6.9000000000000004 111.173 -174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.8 m -54.59 108.54 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.174 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -89.98 179.82 5.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 6.9699999999999998 111.202 174.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -63.28 -49.09 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 7.0 111.248 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.1 p -65.06 -24.03 67.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 7.0300000000000002 111.167 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.6 mm -75.31 -47.95 33.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 7.0700000000000003 111.272 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.27 90.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.208 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.43 -51.97 63.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 7.1299999999999999 111.247 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.86 -39.76 94.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.445 . . . . 7.1699999999999999 111.201 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.45 94.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 7.2000000000000002 111.213 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.93 -45.48 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 7.2300000000000004 111.181 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -69.94 -35.63 74.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 7.2699999999999996 111.201 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.85 -11.78 56.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.2999999999999998 111.206 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.33 26.12 48.81 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.163 -0.775 . . . . 7.3300000000000001 111.163 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -78.53 -34.44 47.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 7.3700000000000001 111.199 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 84.9 m -123.87 112.42 17.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 7.4000000000000004 111.172 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.29 93.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 7.4299999999999997 111.18 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 62.3 ttp -127.31 119.99 27.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 7.4699999999999998 111.226 -176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 41.1 p -127.58 179.97 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 7.5 111.19 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.16 118.73 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 7.5300000000000002 111.24 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -108.23 120.83 43.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.438 . . . . 7.5700000000000003 111.199 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 232' ' ' TRP . . . -77.87 -172.9 39.87 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.254 -0.739 . . . . 7.5999999999999996 111.254 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.13 -34.45 87.66 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.618 1.545 . . . . 7.6299999999999999 111.163 -175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -71.59 -31.54 67.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 7.6699999999999999 111.234 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.77 6.67 13.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 7.7000000000000002 111.239 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.461 ' N ' ' O ' ' A' ' 228' ' ' GLY . 92.3 t90 -54.15 -36.39 63.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 7.7300000000000004 111.227 -170.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.1 p -62.39 -17.37 58.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 7.7699999999999996 111.228 -172.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -57.63 -49.93 74.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 7.7999999999999998 111.234 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.0 tp -74.45 -28.47 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 7.8300000000000001 111.158 -173.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -76.75 -35.29 57.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 7.8700000000000001 111.233 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 76.1 m -67.15 -31.66 72.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 7.9000000000000004 111.163 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 60.6 p -69.62 -15.03 63.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 7.9299999999999997 111.171 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 58.44 50.24 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 7.9699999999999998 111.187 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.07 175.83 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 8.0 111.183 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -85.32 119.48 25.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 8.0299999999999994 111.15 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.44 160.07 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 8.0700000000000003 111.24 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -164.21 -168.17 25.86 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.245 -0.742 . . . . 8.0999999999999996 111.245 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 116' ' ' ILE . 77.6 t -131.25 140.08 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 8.1300000000000008 111.205 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -122.69 -173.76 2.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 8.1699999999999999 111.248 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 68.0 t -107.12 113.44 43.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 8.1999999999999993 111.188 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.544 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 74.2 mt -83.88 -45.41 0.78 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 8.2300000000000004 111.145 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 79.3 Cg_endo -80.64 156.01 21.23 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.694 1.596 . . . . 8.2699999999999996 111.168 -167.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.9 p -119.8 161.31 20.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 8.3000000000000007 111.279 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -123.36 100.94 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 8.3300000000000001 111.187 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 59.4 32.82 22.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 8.3699999999999992 111.221 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.82 62.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -122.11 110.03 33.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.311 . . . . 8.4299999999999997 111.165 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.37 143.74 48.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.669 1.579 . . . . 8.4700000000000006 111.248 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -139.54 -74.93 0.36 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 8.5 111.208 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -131.26 158.55 74.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 8.5299999999999994 111.231 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.56 161.76 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.662 1.575 . . . . 8.5700000000000003 111.257 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -73.97 125.76 28.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 8.5999999999999996 111.198 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.2 t -111.08 124.97 68.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 8.6300000000000008 111.196 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -81.77 143.74 23.59 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.175 -0.77 . . . . 8.6699999999999999 111.175 174.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 65.7 t -121.11 130.03 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 8.6999999999999993 111.167 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.38 131.95 52.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 8.7300000000000004 111.176 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.5 p -145.07 154.74 42.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 8.7699999999999996 111.2 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -119.14 132.59 56.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 8.8000000000000007 111.117 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.22 -179.32 16.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.184 -0.766 . . . . 8.8300000000000001 111.184 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -108.78 130.65 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.788 0.328 . . . . 8.8699999999999992 111.237 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -60.7 134.06 56.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 8.9000000000000004 111.144 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.98 -18.43 61.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 8.9299999999999997 111.201 -176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.55 -3.98 58.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 8.9700000000000006 111.248 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.0 t -65.0 127.93 93.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 9.0 111.183 -175.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.01 -14.97 20.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.743 1.629 . . . . 9.0299999999999994 111.234 175.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -130.02 74.95 1.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 9.0700000000000003 111.202 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -80.08 -22.91 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 9.0999999999999996 111.22 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -74.12 -35.56 64.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 9.1300000000000008 111.215 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.7 -42.48 77.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 9.1699999999999999 111.259 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -38.98 92.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 9.1999999999999993 111.189 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -56.19 -51.45 67.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 9.2300000000000004 111.204 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.33 -42.12 99.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 9.2699999999999996 111.115 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.92 -42.45 80.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 9.3000000000000007 111.225 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.1 -3.55 58.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 9.3300000000000001 111.167 -176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -103.21 -50.83 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 9.3699999999999992 111.169 -171.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -124.73 4.88 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 9.4000000000000004 111.266 -164.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -125.07 -70.66 0.74 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 9.4299999999999997 111.143 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 66.3 tp -65.43 -57.58 7.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 9.4700000000000006 111.246 -172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.96 61.78 7.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 9.5 111.218 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 31.4 p -129.94 -171.13 2.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 9.5299999999999994 111.223 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -75.5 -9.91 58.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 9.5700000000000003 111.196 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -116.13 -33.81 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 9.5999999999999996 111.214 -176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.78 -51.04 31.94 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.158 -0.777 . . . . 9.6300000000000008 111.158 -173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.02 -20.69 59.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.74 0.305 . . . . 9.6699999999999999 111.135 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -58.1 -47.17 84.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 9.6999999999999993 111.186 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.13 80.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 9.7300000000000004 111.218 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.54 -39.72 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 9.7699999999999996 111.177 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -93.92 7.27 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 9.8000000000000007 111.252 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.89 -43.04 80.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 9.8300000000000001 111.237 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -98.45 -20.41 17.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.8699999999999992 111.248 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.96 155.24 47.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 9.9000000000000004 111.202 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.21 144.98 79.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.714 1.609 . . . . 9.9299999999999997 111.251 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.69 24.51 12.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.168 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -66.95 -27.2 73.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.205 -0.758 . . . . 10.0 111.205 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.98 27.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.825 0.345 . . . . 10.029999999999999 111.203 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.6 p -159.0 141.02 4.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 10.07 111.19 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.68 60.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 10.1 111.168 -177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 38.5 tp -60.25 125.06 22.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 10.130000000000001 111.157 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.64 -34.85 72.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.49 . . . . 10.17 111.261 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 47.0 t -53.78 -52.2 60.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 10.199999999999999 111.184 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -66.46 -44.14 83.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 10.23 111.199 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -52.78 -42.45 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 10.27 111.261 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.81 -40.59 79.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 10.300000000000001 111.228 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -72.58 -29.96 63.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 10.33 111.26 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.32 -17.86 33.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 10.369999999999999 111.226 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.81 -17.45 63.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 10.4 111.216 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.7 -30.67 71.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 10.43 111.177 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -77.93 118.25 70.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 10.470000000000001 111.221 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -57.6 -39.89 84.64 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.704 1.603 . . . . 10.5 111.181 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.66 -40.04 69.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 10.529999999999999 111.255 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.3 mt -69.97 -40.05 78.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 10.57 111.163 174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.96 78.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 10.6 111.223 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.78 97.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 10.630000000000001 111.162 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -68.57 -42.84 77.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 10.67 111.216 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.0 mtt -66.51 -34.39 77.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 10.699999999999999 111.244 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -52.65 -47.08 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 10.73 111.152 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -76.05 -31.66 58.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 10.77 111.218 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.5 93.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 10.800000000000001 111.277 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 10.83 111.221 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -114.43 13.69 17.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 10.869999999999999 111.216 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -76.6 -175.02 40.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.162 -0.775 . . . . 10.9 111.162 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.443 ' HA ' ' OE1' ' A' ' 328' ' ' GLU . 5.2 tp10 -99.96 139.65 35.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 10.93 111.226 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 94.3 mt -94.75 130.43 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 10.970000000000001 111.165 -171.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.408 ' SD ' ' HB2' ' A' ' 64' ' ' HIS . 47.2 ttm -60.0 116.64 18.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 11.0 111.17 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.61 160.16 18.17 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.764 1.643 . . . . 11.029999999999999 111.246 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -109.85 20.21 18.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 11.07 111.113 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 333' ' ' ILE . 3.8 mp -86.12 122.93 72.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 11.1 111.171 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.99 -47.02 29.82 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.669 1.579 . . . . 11.130000000000001 111.269 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.81 -46.31 90.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 11.17 111.293 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.406 ' H ' HG22 ' A' ' 333' ' ' ILE . 67.1 mtt -60.06 -43.05 95.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 11.199999999999999 111.129 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.3 m -57.23 -41.14 78.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 11.23 111.117 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.63 94.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 11.27 111.213 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -71.7 -29.63 64.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 11.300000000000001 111.226 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -59.94 -51.98 67.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 11.33 111.163 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -66.73 -38.44 86.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 11.369999999999999 111.132 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -54.8 -37.72 66.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 11.4 111.211 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.4 t -71.7 -40.69 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 11.43 111.182 174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -51.06 -37.68 47.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 11.470000000000001 111.148 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.5 p -94.24 -26.98 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 11.5 111.184 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.08 -38.03 89.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 11.529999999999999 111.152 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.61 -21.6 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 11.57 111.203 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.95 -45.54 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 11.6 111.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 11.630000000000001 111.268 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -65.06 -39.59 93.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 11.67 111.156 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.28 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.274 -0.421 . . . . 11.699999999999999 111.161 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.9 p -78.31 -13.66 59.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 11.73 111.163 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 86.94 25.87 33.29 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.213 -0.755 . . . . 11.77 111.213 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -90.07 -48.55 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 11.800000000000001 111.178 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -124.99 165.22 18.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 11.83 111.242 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -84.77 175.06 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 11.869999999999999 111.131 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.7 t -59.31 -44.86 93.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 11.9 111.185 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.27 -42.54 75.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 11.93 111.254 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -65.13 -44.67 87.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 11.970000000000001 111.221 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.67 94.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 12.0 111.226 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.75 -24.99 48.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 12.029999999999999 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.43 -48.31 78.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 12.07 111.178 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -69.46 -33.91 73.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 12.1 111.118 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.99 -45.5 75.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 12.130000000000001 111.184 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -70.02 -56.66 6.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 12.17 111.151 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.2 m -51.55 -43.45 62.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 12.199999999999999 111.171 -173.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.65 -29.91 70.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 12.23 111.193 -171.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 48.0 pt -105.01 -4.37 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 12.27 111.253 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.4 p -115.0 1.71 14.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 12.300000000000001 111.168 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.534 0 CA-C-N 116.245 -0.434 . . . . 12.33 111.152 178.381 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.808 0.337 . . . . 0.029999999999999999 111.167 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.2 mm -99.1 124.77 52.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.070000000000000007 111.229 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -98.15 155.09 17.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.10000000000000001 111.139 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -93.67 155.05 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.13 111.212 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.24 16.82 54.99 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.235 -0.746 . . . . 0.17000000000000001 111.235 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.81 160.0 21.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.746 0.308 . . . . 0.20000000000000001 111.237 -175.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.6 pp -145.89 153.95 41.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.254 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -125.35 135.26 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.431 . . . . 0.27000000000000002 111.187 -173.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 37' ' ' VAL . 83.5 mt -115.6 124.97 72.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.29999999999999999 111.222 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -103.61 105.15 15.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.33000000000000002 111.233 172.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 1.8 tt -115.48 137.44 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.37 111.187 -175.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -81.03 108.94 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 111.195 175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.0 -173.15 46.07 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.217 -0.753 . . . . 0.42999999999999999 111.217 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -104.98 -53.04 2.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.819 0.343 . . . . 0.46999999999999997 111.186 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.12 18.71 5.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.5 111.156 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.96 -23.65 69.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.183 -0.767 . . . . 0.53000000000000003 111.183 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -53.81 -32.71 53.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.56999999999999995 111.184 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -64.45 -41.56 96.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.59999999999999998 111.214 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.92 -34.88 83.39 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.218 -0.753 . . . . 0.63 111.218 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 284' ' ' LEU . 83.1 mt -81.95 -25.87 34.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 0.67000000000000004 111.197 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.17 -26.63 47.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.69999999999999996 111.207 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -63.72 -36.63 84.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.72999999999999998 111.246 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.56 -17.85 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.208 -0.451 . . . . 0.77000000000000002 111.182 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.77 -31.94 81.37 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.207 -0.757 . . . . 0.80000000000000004 111.207 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.67 -46.15 80.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.82999999999999996 111.178 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.68 -50.03 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.87 111.235 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.90000000000000002 111.199 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.79 -39.09 80.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.93000000000000005 111.223 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -74.23 -32.22 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.96999999999999997 111.24 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -71.31 -40.53 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.248 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.4 p -113.91 -29.97 6.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 1.03 111.181 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.62 -0.3 63.07 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.22 -0.752 . . . . 1.0700000000000001 111.22 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.3 mm -76.57 110.99 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 1.1000000000000001 111.211 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.0 124.99 23.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 1.1299999999999999 111.225 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.54 121.49 57.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 1.1699999999999999 111.171 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.16 121.31 37.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 1.2 111.241 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 9' ' ' ILE . 40.7 t -118.18 125.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 1.23 111.136 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.27 165.73 21.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 1.27 111.172 -171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -121.45 70.07 23.45 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 1.3 111.215 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.42 161.99 33.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.687 1.591 . . . . 1.3300000000000001 111.231 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -124.82 -178.32 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 1.3700000000000001 111.241 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 54.99 39.73 31.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 1.3999999999999999 111.217 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.95 -9.17 59.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 1.4299999999999999 111.186 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.24 -27.98 69.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 1.47 111.209 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.07 -34.59 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.5 111.212 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.25 -46.43 80.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 1.53 111.183 -174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.535 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 81.1 t80 -62.56 -53.41 57.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 1.5700000000000001 111.132 -173.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 46.8 Cg_endo -67.76 -25.73 39.45 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.686 1.591 . . . . 1.6000000000000001 111.172 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -65.21 -35.27 80.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 1.6299999999999999 111.271 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -97.29 -26.17 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.6699999999999999 111.213 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.19 -30.96 69.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 1.7 111.242 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.72 67.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 1.73 111.152 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 p -96.69 3.54 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.77 111.162 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.72 20.24 56.48 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.21 -0.756 . . . . 1.8 111.21 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -119.99 -166.02 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 1.8300000000000001 111.222 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.53 -164.87 12.01 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.205 -0.758 . . . . 1.8700000000000001 111.205 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.17 -176.32 2.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.714 1.609 . . . . 1.8999999999999999 111.221 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 276' ' ' ALA . 43.4 m-20 -103.33 -40.26 6.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 1.9299999999999999 111.252 171.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.37 138.36 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 1.97 111.226 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 264' ' ' ALA . 42.0 mm -113.96 122.03 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.0 111.267 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 27.1 m-85 -100.02 110.96 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 2.0299999999999998 111.242 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.485 ' C ' ' CD1' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -145.03 -175.0 4.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 2.0699999999999998 111.228 -173.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.12 176.75 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 2.1000000000000001 111.16 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -87.43 14.58 7.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 2.1299999999999999 111.18 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -96.75 -29.97 13.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 111.193 172.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -118.28 12.35 13.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 2.2000000000000002 111.164 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -70.01 -21.15 63.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 2.23 111.242 -172.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.97 -12.74 83.14 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.22 -0.752 . . . . 2.27 111.22 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.51 -54.34 37.94 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.26 -0.736 . . . . 2.2999999999999998 111.26 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 5.2 m-30 -88.89 -20.43 24.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 2.3300000000000001 111.196 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.48 81.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 2.3700000000000001 111.236 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -68.67 -31.03 69.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 2.3999999999999999 111.166 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -75.18 -28.96 60.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 2.4300000000000002 111.192 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.28 31.56 33.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.253 -0.739 . . . . 2.4700000000000002 111.253 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -99.58 1.16 43.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.75 0.31 . . . . 2.5 111.199 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.76 131.53 34.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 2.5299999999999998 111.26 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 149.23 34.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 2.5699999999999998 111.194 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.07 124.37 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 2.6000000000000001 111.224 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.6 mt -115.05 129.4 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 2.6299999999999999 111.212 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.0 m -125.03 104.63 29.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 2.6699999999999999 111.152 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.98 148.52 45.36 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.714 1.609 . . . . 2.7000000000000002 111.207 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.0 p30 -84.91 179.99 7.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 2.73 111.215 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.4 -49.89 74.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 2.77 111.212 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.2 73.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 2.7999999999999998 111.194 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.02 -45.06 83.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 2.8300000000000001 111.216 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.31 -27.93 69.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 2.8700000000000001 111.199 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -94.64 -19.71 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 2.8999999999999999 111.204 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -79.92 -29.99 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 2.9300000000000002 111.247 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.12 150.52 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 2.9700000000000002 111.169 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.19 135.66 96.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 3.0 111.154 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.1 -47.64 24.81 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.73 1.62 . . . . 3.0299999999999998 111.161 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.8 -54.96 23.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 3.0699999999999998 111.239 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.7 m -60.06 -36.87 78.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 3.1000000000000001 111.161 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -65.65 -42.73 91.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 3.1299999999999999 111.182 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -75.19 -19.92 59.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 3.1699999999999999 111.242 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -30.0 67.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 3.2000000000000002 111.219 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 332' ' ' ASN . 27.4 m -106.07 18.78 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 3.23 111.182 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -100.01 130.06 46.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 3.27 111.206 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -141.6 119.8 12.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 3.2999999999999998 111.148 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 65.55 43.85 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 3.3300000000000001 111.233 172.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.51 -42.27 2.35 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.178 -0.769 . . . . 3.3700000000000001 111.178 171.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -109.97 -178.78 3.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.807 0.336 . . . . 3.3999999999999999 111.216 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.47 154.47 18.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 3.4300000000000002 111.213 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.7 pt -113.99 -4.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 3.4700000000000002 111.157 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.53 167.22 21.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 3.5 111.181 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.3 m-30 -110.61 137.88 20.86 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 3.5299999999999998 111.17 170.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 46.9 Cg_exo -61.59 143.7 97.08 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.652 1.568 . . . . 3.5699999999999998 111.213 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 262' ' ' LEU . 95.1 mt -109.2 -58.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 3.6000000000000001 111.195 178.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.62 160.9 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 3.6299999999999999 111.217 -170.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.0 m -107.77 145.87 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 3.6699999999999999 111.191 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -120.04 -179.97 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 3.7000000000000002 111.196 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.421 ' H ' ' HD3' ' A' ' 229' ' ' PRO . . . -128.55 167.89 16.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 3.73 111.198 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.522 HD21 ' HD3' ' A' ' 159' ' ' PRO . 65.1 tp -161.55 118.47 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 3.77 111.175 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.0 p -162.15 -178.02 6.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 3.7999999999999998 111.206 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 247' ' ' LEU . 52.2 tp -95.09 126.72 40.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.194 -0.457 . . . . 3.8300000000000001 111.15 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.2 mt -109.27 132.66 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 3.8700000000000001 111.173 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -148.7 159.16 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 3.8999999999999999 111.17 -172.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.33 117.55 30.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 3.9300000000000002 111.177 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 94.8 mttt -68.72 -47.49 66.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 3.9700000000000002 111.23 -175.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -71.69 -39.13 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 4.0 111.269 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.7 tp -65.48 -42.54 92.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.154 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 42.1 mt -125.02 73.46 65.59 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 4.0700000000000003 111.111 -165.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 75.4 Cg_endo -79.58 142.3 16.19 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.195 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' PRO . 99.1 m-20 -70.64 149.76 95.39 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 4.1299999999999999 111.222 -12.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 89.4 Cg_exo -52.21 132.48 43.96 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.676 1.584 . . . . 4.1699999999999999 111.222 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 76.2 Cg_exo -53.08 133.55 52.56 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.723 1.615 . . . . 4.2000000000000002 111.223 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -112.68 -17.11 12.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 4.2300000000000004 111.198 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -157.33 176.92 12.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 4.2699999999999996 111.186 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -75.13 -19.96 59.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 4.2999999999999998 111.221 -171.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.1 -13.19 61.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 4.3300000000000001 111.205 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -107.29 13.69 26.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 4.3700000000000001 111.2 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.572 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 94.3 mt -76.63 -41.26 2.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 4.4000000000000004 111.197 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 85.8 Cg_exo -53.37 -28.39 43.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.739 1.626 . . . . 4.4299999999999997 111.167 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.96 55.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 4.4699999999999998 111.166 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.8 tp -79.15 -43.92 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 4.5 111.241 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -60.89 -31.81 71.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 4.5300000000000002 111.21 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.67 -28.73 58.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 4.5700000000000003 111.206 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -80.12 -32.07 39.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 4.5999999999999996 111.261 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 91.7 mt -86.13 -7.67 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 4.6299999999999999 111.182 179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.95 -44.94 78.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 4.6699999999999999 111.133 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.13 -27.74 68.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 4.7000000000000002 111.144 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.61 -8.8 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 4.7300000000000004 111.211 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.96 27.53 60.25 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.206 -0.758 . . . . 4.7699999999999996 111.206 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 75.1 mmtt -115.55 159.13 21.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.873 0.368 . . . . 4.7999999999999998 111.177 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.9 t -98.86 153.92 18.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 4.8300000000000001 111.229 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.74 -26.75 64.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 4.8700000000000001 111.167 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.16 154.92 34.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 4.9000000000000004 111.16 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.8 mtm -108.11 115.7 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 4.9299999999999997 111.256 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.525 ' HB3' ' HG ' ' A' ' 151' ' ' LEU . 93.8 m-85 -95.5 130.81 42.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 4.9699999999999998 111.244 -154.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -117.69 77.29 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 5.0 111.152 164.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 149' ' ' PHE . 96.6 mt -97.86 -0.83 44.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 5.0300000000000002 111.139 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -71.54 -22.04 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 5.0700000000000003 111.224 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -120.44 150.96 53.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 5.0999999999999996 111.269 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.17 -15.03 18.47 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.679 1.586 . . . . 5.1299999999999999 111.205 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.18 -29.21 70.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 5.1699999999999999 111.146 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -74.11 -41.03 62.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 5.2000000000000002 111.199 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -96.34 -8.56 32.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 5.2300000000000004 111.187 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.49 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 77.2 t90 -58.04 -46.0 99.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 5.2699999999999996 111.186 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD3' HD21 ' A' ' 113' ' ' LEU . 98.4 Cg_endo -84.05 -20.08 4.49 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.65 1.567 . . . . 5.2999999999999998 111.197 -173.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.7 tp -67.35 -45.86 75.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.164 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.96 -33.61 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 5.3700000000000001 111.198 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -85.46 -4.16 59.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 5.4000000000000004 111.217 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.02 72.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 5.4299999999999997 111.245 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -91.08 -10.06 43.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.179 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.25 25.12 49.37 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.153 -0.779 . . . . 5.5 111.153 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.82 -1.99 36.74 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.214 -0.755 . . . . 5.5300000000000002 111.214 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.13 106.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 5.5700000000000003 111.237 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 64.55 22.25 12.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 5.5999999999999996 111.211 172.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -105.37 147.29 28.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 5.6299999999999999 111.166 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 177' ' ' ASP . 24.1 ttmm -57.28 120.13 7.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 5.6699999999999999 111.194 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -76.38 73.81 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 5.7000000000000002 111.163 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -150.03 99.27 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 5.7300000000000004 111.182 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 58.85 -119.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 5.7699999999999996 111.222 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.01 23.31 19.39 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.144 -0.782 . . . . 5.7999999999999998 111.144 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.69 140.13 38.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 5.8300000000000001 111.227 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -128.15 75.02 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 5.8700000000000001 111.196 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 170' ' ' LYS . 68.6 t0 -96.1 103.86 15.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 5.9000000000000004 111.22 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.9 tt -69.97 -17.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 5.9299999999999997 111.203 -174.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -80.04 -17.45 52.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 5.9699999999999998 111.17 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.82 169.92 16.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.248 -0.433 . . . . 6.0 111.2 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.1 t -89.57 91.23 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 6.0300000000000002 111.167 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.07 32.1 7.86 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.162 -0.775 . . . . 6.0700000000000003 111.162 -172.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.45 -22.58 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.759 0.314 . . . . 6.0999999999999996 111.143 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -99.6 12.51 36.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.197 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.44 141.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 6.1699999999999999 111.177 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.43 -37.01 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 6.2000000000000002 111.179 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.63 -32.73 45.21 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.15 -0.78 . . . . 6.2300000000000004 111.15 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.82 -48.51 58.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.339 . . . . 6.2699999999999996 111.196 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -69.8 -24.17 63.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 6.2999999999999998 111.172 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 6.3300000000000001 111.187 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.07 -39.73 96.52 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.232 -0.747 . . . . 6.3700000000000001 111.232 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 17.5 tp -72.33 -30.62 64.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.769 0.319 . . . . 6.4000000000000004 111.227 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.1 m -64.41 -42.69 95.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 6.4299999999999997 111.22 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -58.72 -47.18 85.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 6.4699999999999998 111.207 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.3 tp -46.56 -45.04 18.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 6.5 111.18 174.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -74.02 -36.85 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 6.5300000000000002 111.175 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.97 -36.84 68.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 6.5700000000000003 111.171 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.13 -32.86 74.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 6.5999999999999996 111.195 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.43 -40.03 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 6.6299999999999999 111.104 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.85 -29.63 70.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 6.6699999999999999 111.151 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -76.19 -8.96 58.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 6.7000000000000002 111.225 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 64.85 35.09 8.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 6.7300000000000004 111.174 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -129.15 53.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 6.7699999999999996 111.173 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 47.5 ttm -159.15 147.63 18.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 6.7999999999999998 111.224 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -146.5 114.63 6.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.429 . . . . 6.8300000000000001 111.159 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.42 67.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 6.8700000000000001 111.183 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -66.38 -25.89 67.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 6.9000000000000004 111.211 -174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.8 p -75.24 149.89 38.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 6.9299999999999997 111.213 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.78 -165.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 6.9699999999999998 111.211 -170.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.86 -51.87 67.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 7.0 111.165 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.1 p -70.83 -29.71 65.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 7.0300000000000002 111.244 -171.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.99 -45.03 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 7.0700000000000003 111.223 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.18 -37.76 88.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 7.0999999999999996 111.171 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.24 -41.45 94.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 7.1299999999999999 111.22 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.0 -36.29 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 7.1699999999999999 111.158 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.06 93.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 7.2000000000000002 111.167 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -70.38 -33.44 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 7.2300000000000004 111.212 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -60.06 -39.35 85.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 7.2699999999999996 111.236 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.63 -30.22 41.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 7.2999999999999998 111.2 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.1 34.99 13.08 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.259 -0.737 . . . . 7.3300000000000001 111.259 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.14 -35.0 68.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 7.3700000000000001 111.204 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.9 m -129.99 139.18 51.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 7.4000000000000004 111.189 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.35 3.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 7.4299999999999997 111.143 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -85.09 153.68 22.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 7.4699999999999998 111.241 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.1 t -169.3 179.41 3.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 7.5 111.287 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.34 118.63 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 7.5300000000000002 111.17 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -160.69 177.89 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 7.5700000000000003 111.189 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -105.79 -134.38 7.83 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.168 -0.773 . . . . 7.5999999999999996 111.168 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.421 ' HD3' ' H ' ' A' ' 112' ' ' ALA . 83.7 Cg_endo -81.77 -177.11 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.169 -176.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 69.87 17.95 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 7.6699999999999999 111.161 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.66 -24.09 21.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 7.7000000000000002 111.188 174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.455 ' HA ' ' HB ' ' A' ' 235' ' ' ILE . 97.9 m95 -69.52 -14.95 63.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 7.7300000000000004 111.123 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 94.6 p -64.96 -20.95 66.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 7.7699999999999996 111.216 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.05 -28.56 8.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 7.7999999999999998 111.225 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 232' ' ' TRP . 97.2 mt -64.85 -45.11 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 7.8300000000000001 111.254 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -74.55 -33.8 62.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 7.8700000000000001 111.198 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 59.7 m -64.14 -44.6 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 7.9000000000000004 111.234 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.9 p -78.18 -15.04 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 7.9299999999999997 111.235 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 58.63 45.97 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 7.9699999999999998 111.217 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.84 141.21 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 8.0 111.157 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -74.87 78.69 2.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 8.0299999999999994 111.209 -175.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -89.96 127.65 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 8.0700000000000003 111.183 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.407 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -100.4 166.39 19.72 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.223 -0.751 . . . . 8.0999999999999996 111.223 177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 88.5 t -139.6 134.98 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.773 0.32 . . . . 8.1300000000000008 111.253 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.2 t -135.06 150.17 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 8.1699999999999999 111.21 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.4 t -70.29 110.81 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 8.1999999999999993 111.16 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.508 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 53.0 tp -75.38 -47.82 4.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 8.2300000000000004 111.282 -173.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 85.7 Cg_endo -78.41 143.2 19.29 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.764 1.642 . . . . 8.2699999999999996 111.228 -173.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 78.8 m -107.74 133.59 51.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 8.3000000000000007 111.182 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -108.46 99.71 9.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 8.3300000000000001 111.221 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 57.69 35.14 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 8.3699999999999992 111.12 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 98.6 -15.57 60.84 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.175 -0.77 . . . . 8.4000000000000004 111.175 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -130.06 110.0 16.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 8.4299999999999997 111.161 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.8 151.69 46.24 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.7 1.6 . . . . 8.4700000000000006 111.268 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 98.9 p -137.6 -75.01 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 8.5 111.201 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 326' ' ' LYS . 74.5 mmtt -134.07 163.35 51.76 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 8.5299999999999994 111.163 -174.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.97 144.47 56.5 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.721 1.614 . . . . 8.5700000000000003 111.173 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.41 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 86.3 t80 -73.81 140.59 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 8.5999999999999996 111.185 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 261' ' ' VAL . 61.6 t -107.1 106.76 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 8.6300000000000008 111.221 -170.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -84.93 85.08 1.58 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.169 -0.773 . . . . 8.6699999999999999 111.169 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 259' ' ' VAL . 36.9 t -68.18 142.35 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 8.6999999999999993 111.188 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 108' ' ' ILE . 74.1 mt -91.87 154.9 18.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 8.7300000000000004 111.257 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 91.2 p -143.71 155.13 44.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 8.7699999999999996 111.199 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 60' ' ' ILE . . . -121.76 124.3 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 8.8000000000000007 111.245 174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -103.97 177.29 24.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.177 -0.769 . . . . 8.8300000000000001 111.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 87.5 mt -124.14 132.0 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 8.8699999999999992 111.2 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -69.32 114.28 7.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 8.9000000000000004 111.148 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.54 -24.72 66.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 8.9299999999999997 111.163 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 8.9700000000000006 111.217 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -66.06 136.74 95.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 9.0 111.235 -174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.79 -12.1 26.24 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.727 1.618 . . . . 9.0299999999999994 111.206 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.59 21.51 8.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 9.0700000000000003 111.201 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -62.78 -21.88 66.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 9.0999999999999996 111.174 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.36 -34.5 77.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 9.1300000000000008 111.194 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -67.51 -35.22 78.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 9.1699999999999999 111.155 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . . . -65.03 -41.86 94.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 9.1999999999999993 111.168 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -56.75 -44.55 81.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 9.2300000000000004 111.234 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -80.11 -52.75 7.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 9.2699999999999996 111.227 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -63.8 -37.05 85.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 9.3000000000000007 111.224 -171.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 284' ' ' LEU . 40.1 tp -68.12 -48.16 66.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 9.3300000000000001 111.187 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -72.08 -28.98 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 9.3699999999999992 111.182 -173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -99.56 -40.2 7.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 9.4000000000000004 111.181 -166.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.17 -54.84 2.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 9.4299999999999997 111.15 -169.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 20' ' ' LEU . 95.1 mt -64.1 -49.59 71.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 9.4700000000000006 111.148 -169.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.85 51.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 9.5 111.165 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 76.7 p -124.97 -175.94 3.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 9.5299999999999994 111.153 170.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -53.29 -40.56 64.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 9.5700000000000003 111.197 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -73.35 -37.95 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 9.5999999999999996 111.134 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.37 -43.24 93.09 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.99 -36.23 83.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.777 0.322 . . . . 9.6699999999999999 111.231 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -69.04 -41.86 77.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 9.6999999999999993 111.204 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.26 87.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 9.7300000000000004 111.154 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 68.0 t -74.91 -40.83 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 9.7699999999999996 111.17 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.563 ' HB3' HD23 ' A' ' 299' ' ' LEU . 96.7 m-20 -75.93 -2.93 32.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 9.8000000000000007 111.203 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.05 -38.14 67.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 9.8300000000000001 111.195 165.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -108.5 -34.03 6.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 9.8699999999999992 111.158 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.03 160.63 40.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 9.9000000000000004 111.205 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.65 139.38 67.29 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.667 1.578 . . . . 9.9299999999999997 111.167 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 294' ' ' ASN . 95.0 mt -66.38 -24.19 66.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 9.9700000000000006 111.153 -175.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -61.77 -28.84 70.71 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.153 -0.779 . . . . 10.0 111.153 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.91 122.83 13.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.779 0.323 . . . . 10.029999999999999 111.228 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.85 136.6 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.16 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -103.36 -34.79 8.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 10.1 111.188 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 11.2 mp -95.16 138.72 32.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 10.130000000000001 111.176 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -61.36 -39.04 89.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.236 -0.438 . . . . 10.17 111.222 168.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 44.6 t -56.05 -48.62 75.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 10.199999999999999 111.175 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.55 -37.71 83.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 10.23 111.224 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.67 -36.74 77.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 10.27 111.173 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.73 -30.03 70.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 10.300000000000001 111.248 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.4 -32.16 62.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 10.33 111.198 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.22 -26.18 62.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 10.369999999999999 111.226 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.88 -19.22 65.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 10.4 111.324 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.48 -24.93 67.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 10.43 111.221 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -101.92 109.99 61.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 10.470000000000001 111.205 172.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.97 -32.92 80.78 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.659 1.573 . . . . 10.5 111.188 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.55 -28.09 67.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 10.529999999999999 111.264 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -91.01 -38.5 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 10.57 111.218 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.02 65.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 10.6 111.254 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.48 -35.5 74.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 10.630000000000001 111.231 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.1 p -91.33 -19.95 22.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 10.67 111.211 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.0 mmt -74.21 -35.92 63.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 10.699999999999999 111.205 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.9 -40.5 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 10.73 111.285 171.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.32 -42.75 99.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 10.77 111.2 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.42 93.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 10.800000000000001 111.21 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -63.05 -42.5 99.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 10.83 111.179 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.407 ' HB2' ' HG3' ' A' ' 256' ' ' LYS . 99.7 mttt -94.95 7.53 45.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 10.869999999999999 111.198 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.88 -162.66 35.9 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.268 -0.733 . . . . 10.9 111.268 172.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -119.8 132.38 55.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 10.93 111.213 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 96.4 mt -93.17 136.22 25.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 10.970000000000001 111.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 50.0 tpp -59.93 114.41 9.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 11.0 111.247 173.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.31 133.74 51.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.678 1.585 . . . . 11.029999999999999 111.221 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 97' ' ' VAL . 42.5 t-20 -94.18 72.81 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 11.07 111.207 173.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 80.4 mt -123.15 116.11 28.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 11.1 111.185 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.06 -33.45 73.6 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.632 1.555 . . . . 11.130000000000001 111.26 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -71.46 -27.86 63.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 11.17 111.23 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -86.88 -20.62 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 11.199999999999999 111.157 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 98.2 p -64.15 -29.98 71.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 11.23 111.178 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.97 -49.51 70.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 11.27 111.247 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -56.76 -48.74 77.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 11.300000000000001 111.173 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -68.75 -43.58 75.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 11.33 111.176 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 -73.89 -30.55 62.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 11.369999999999999 111.259 -176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.65 75.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 11.4 111.188 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.28 -21.82 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 11.43 111.279 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -56.56 -48.93 76.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 11.470000000000001 111.186 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 71.0 p -65.2 -29.7 70.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 11.5 111.175 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.03 -44.22 89.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 11.529999999999999 111.173 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.77 -38.52 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.173 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.92 -42.69 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 11.6 111.208 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -65.0 -39.17 93.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 11.630000000000001 111.21 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.45 -21.96 59.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 11.67 111.206 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.52 -30.39 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 11.699999999999999 111.22 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.5 p -86.16 -22.16 27.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 11.73 111.181 177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.85 30.35 26.56 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.233 -0.747 . . . . 11.77 111.233 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -109.94 2.61 19.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 11.800000000000001 111.238 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -159.58 137.01 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 11.83 111.212 176.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 62.1 p -70.0 164.97 22.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 11.869999999999999 111.255 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.5 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 11.9 111.233 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.19 -46.99 88.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 11.93 111.207 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -68.87 -37.53 79.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 11.970000000000001 111.191 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.69 92.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 12.0 111.214 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 94.5 mt -74.98 -24.89 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 12.029999999999999 111.18 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.71 -49.3 73.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 12.07 111.167 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.84 -34.21 77.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.208 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.01 -59.56 4.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 12.130000000000001 111.2 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -54.94 -43.25 73.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 12.17 111.209 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 83.7 m -58.15 -49.05 78.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 12.199999999999999 111.26 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.03 -30.0 67.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 12.23 111.232 -177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.6 mt -67.37 -40.74 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 12.27 111.136 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.8 p -89.22 -15.69 33.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 12.300000000000001 111.234 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.511 0 CA-C-N 116.171 -0.468 . . . . 12.33 111.217 178.149 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.823 0.344 . . . . 0.029999999999999999 111.196 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.15 134.98 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.070000000000000007 111.204 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -55.01 130.04 40.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.10000000000000001 111.226 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -56.27 129.44 40.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.13 111.194 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.19 26.62 27.94 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.258 -0.737 . . . . 0.17000000000000001 111.258 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -134.98 132.53 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.785 0.326 . . . . 0.20000000000000001 111.252 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -112.71 120.02 40.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.23000000000000001 111.211 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.34 115.04 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.27000000000000002 111.212 -178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 37' ' ' VAL . 73.6 mt -115.05 113.2 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.29999999999999999 111.197 -177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -110.09 129.06 55.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.33000000000000002 111.194 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.0 mt -101.42 115.08 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.37 111.158 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -97.7 89.24 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.40000000000000002 111.225 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.5 -145.65 7.56 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.264 -0.735 . . . . 0.42999999999999999 111.264 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -124.47 22.77 8.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.46999999999999997 111.195 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -102.29 156.87 17.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.5 111.248 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.95 -164.98 38.01 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.185 -0.766 . . . . 0.53000000000000003 111.185 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -158.98 25.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.56999999999999995 111.215 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -59.68 -40.29 87.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.59999999999999998 111.187 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.07 -27.51 28.2 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.212 -0.755 . . . . 0.63 111.212 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.91 -40.51 95.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.67000000000000004 111.262 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.05 78.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.69999999999999996 111.178 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -65.0 -29.07 69.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.72999999999999998 111.227 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.5 t -72.66 -40.13 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.77000000000000002 111.188 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -31.87 82.18 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.234 -0.746 . . . . 0.80000000000000004 111.234 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.79 -36.88 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 111.175 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.53 -24.07 45.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.87 111.239 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.02 -32.68 70.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.90000000000000002 111.157 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -74.8 -36.95 62.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.93000000000000005 111.202 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.31 -46.06 61.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.96999999999999997 111.188 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.54 -58.79 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.163 -170.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.8 m -89.45 -49.27 6.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 1.03 111.2 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.49 21.4 3.03 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.205 -0.758 . . . . 1.0700000000000001 111.205 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.0 mm -97.29 114.99 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 1.1000000000000001 111.191 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.25 110.08 8.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 1.1299999999999999 111.169 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.2 t -97.91 121.49 48.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 1.1699999999999999 111.119 -174.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.0 m -117.97 121.03 39.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 1.2 111.266 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 9' ' ' ILE . 46.9 t -107.36 125.38 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 1.23 111.207 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -129.99 172.04 12.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 1.27 111.237 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.445 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 37.2 t60 -139.97 52.73 3.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 1.3 111.168 -174.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 39' ' ' HIS . 72.8 Cg_endo -72.01 152.67 57.42 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.649 1.566 . . . . 1.3300000000000001 111.26 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -101.92 -177.04 3.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.433 . . . . 1.3700000000000001 111.217 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 53.12 46.1 27.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 1.3999999999999999 111.233 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 90.3 mt -93.84 -37.75 11.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 1.4299999999999999 111.176 -174.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 pm0 -69.66 -11.91 61.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 1.47 111.218 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -89.48 -19.58 24.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 1.5 111.19 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 76.1 mmtt -110.19 -25.14 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 1.53 111.232 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.2 m-30 -58.51 -45.14 99.69 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 1.5700000000000001 111.22 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 64.8 Cg_exo -55.48 -30.96 76.16 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.656 1.57 . . . . 1.6000000000000001 111.247 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.02 -43.74 12.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.191 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -75.63 -23.32 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.6699999999999999 111.147 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -24.47 66.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 1.7 111.205 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.75 -8.05 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 1.73 111.167 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.0 p -114.01 -11.93 12.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 1.77 111.23 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.3 25.51 30.84 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.231 -0.748 . . . . 1.8 111.231 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -114.81 170.71 8.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.753 0.311 . . . . 1.8300000000000001 111.244 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.48 -174.4 16.6 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.202 -0.759 . . . . 1.8700000000000001 111.202 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -74.87 -176.39 2.82 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.757 1.638 . . . . 1.8999999999999999 111.155 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -104.18 -48.12 3.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 1.9299999999999999 111.181 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -112.4 133.16 59.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 1.97 111.174 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.8 mt -131.2 129.78 63.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 2.0 111.152 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -85.93 142.89 28.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 2.0299999999999998 111.195 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 98.4 m95 -141.21 163.95 31.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 2.0699999999999998 111.231 174.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.46 166.22 11.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.202 -0.454 . . . . 2.1000000000000001 111.167 164.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -61.29 -30.28 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 2.1299999999999999 111.178 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.9 p30 -82.07 -0.86 46.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 2.1699999999999999 111.244 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -117.4 -25.06 7.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 2.2000000000000002 111.179 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 62' ' ' TRP . 8.8 m-85 -58.63 -43.18 89.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 2.23 111.186 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.97 -48.24 87.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 2.27 111.204 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.88 -38.03 42.71 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.192 -0.763 . . . . 2.2999999999999998 111.192 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -69.92 -37.4 75.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 2.3300000000000001 111.192 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.85 -36.17 64.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 2.3700000000000001 111.201 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -58.14 -42.44 85.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 2.3999999999999999 111.195 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.7 p -71.13 -14.98 62.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 2.4300000000000002 111.12 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.17 32.21 23.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.254 -0.738 . . . . 2.4700000000000002 111.254 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.14 -6.65 25.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.842 0.353 . . . . 2.5 111.188 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.1 tp -114.9 133.82 55.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 2.5299999999999998 111.229 -177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.92 146.84 37.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 2.5699999999999998 111.218 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.57 129.27 37.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 2.6000000000000001 111.257 170.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.0 mt -121.02 133.45 67.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 2.6299999999999999 111.179 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -120.83 101.5 45.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 2.6699999999999999 111.235 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.36 147.44 32.62 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 121.692 1.595 . . . . 2.7000000000000002 111.176 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.99 148.97 38.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 2.73 111.194 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -53.45 -47.64 69.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 2.77 111.187 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.53 93.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 2.7999999999999998 111.191 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.15 -51.32 64.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 2.8300000000000001 111.175 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -69.9 -19.94 63.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.444 . . . . 2.8700000000000001 111.185 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.46 -34.96 68.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 2.8999999999999999 111.149 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.56 -22.47 56.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 2.9300000000000002 111.222 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.72 154.93 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 2.9700000000000002 111.164 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -70.03 136.11 87.24 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 3.0 111.184 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.03 -14.96 23.54 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.676 1.584 . . . . 3.0299999999999998 111.227 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -80.37 -31.78 37.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 3.0699999999999998 111.191 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.4 p -96.03 -23.17 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 3.1000000000000001 111.201 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -62.51 -40.06 95.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 3.1299999999999999 111.199 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.6 -8.22 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 3.1699999999999999 111.235 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.36 -3.71 55.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 3.2000000000000002 111.232 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.5 66.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 3.23 111.226 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -129.76 154.98 46.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 3.27 111.179 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -153.1 129.9 10.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.205 -0.452 . . . . 3.2999999999999998 111.214 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.9 t30 62.62 29.85 16.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 3.3300000000000001 111.202 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.23 88.34 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.166 -0.774 . . . . 3.3700000000000001 111.166 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.55 145.55 47.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.766 0.317 . . . . 3.3999999999999999 111.18 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -71.37 137.52 48.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 3.4300000000000002 111.198 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.2 pt -123.94 -2.58 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 3.4700000000000002 111.224 -172.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -166.6 168.87 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 3.5 111.211 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -109.52 129.15 24.24 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 3.5299999999999998 111.243 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.32 133.06 20.29 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.683 1.589 . . . . 3.5699999999999998 111.185 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 85.6 mt -113.23 -63.43 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 3.6000000000000001 111.192 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.39 149.87 49.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 3.6299999999999999 111.25 -172.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.13 157.04 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 3.6699999999999999 111.222 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -115.49 151.09 35.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 3.7000000000000002 111.217 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.18 175.21 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 3.73 111.195 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -127.49 172.48 10.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 3.77 111.204 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.9 p -138.71 150.32 46.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 3.7999999999999998 111.11 -172.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tt -94.25 106.42 18.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 3.8300000000000001 111.191 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 81.7 mt -92.18 125.14 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 3.8700000000000001 111.178 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -141.38 158.54 43.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 3.8999999999999999 111.202 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -84.93 99.94 11.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 3.9300000000000002 111.187 -173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -56.01 -47.83 77.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 3.9700000000000002 111.128 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -56.72 -52.19 65.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 4.0 111.217 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.93 -60.11 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 4.0300000000000002 111.214 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.45 87.64 51.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 4.0700000000000003 111.237 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.27 -14.71 25.55 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.681 1.587 . . . . 4.0999999999999996 111.173 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -90.53 110.05 38.38 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 4.1299999999999999 111.184 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.53 157.65 25.28 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.661 1.574 . . . . 4.1699999999999999 111.183 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.01 141.06 79.9 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.692 1.595 . . . . 4.2000000000000002 111.153 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.91 -18.7 36.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 4.2300000000000004 111.216 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 130' ' ' GLU . 14.6 t -157.67 -178.28 7.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 4.2699999999999996 111.182 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 60.2 m95 -65.65 -35.67 81.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 4.2999999999999998 111.215 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.411 ' H ' HG23 ' A' ' 128' ' ' THR . 98.3 mt-10 -74.24 -6.58 48.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 4.3300000000000001 111.2 -174.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -104.63 9.94 35.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 4.3700000000000001 111.174 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.558 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 88.7 mt -71.47 -41.62 10.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 4.4000000000000004 111.15 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 84.2 Cg_exo -52.53 -30.52 45.02 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.715 1.61 . . . . 4.4299999999999997 111.153 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.75 -37.05 67.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 4.4699999999999998 111.205 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -67.23 -47.88 69.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 4.5 111.194 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.13 -29.33 70.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 4.5300000000000002 111.223 -171.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.9 -44.95 64.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 4.5700000000000003 111.158 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -94.01 -30.93 14.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 4.5999999999999996 111.139 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.96 -27.8 69.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 4.6299999999999999 111.202 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.42 -41.62 63.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 4.6699999999999999 111.214 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.18 -5.74 59.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 4.7000000000000002 111.225 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -105.74 12.34 31.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 4.7300000000000004 111.175 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.08 24.9 70.3 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.215 -0.754 . . . . 4.7699999999999996 111.215 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -140.2 179.78 6.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 4.7999999999999998 111.134 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -151.38 138.05 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 4.8300000000000001 111.175 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.43 -60.61 3.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 4.8700000000000001 111.141 -173.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.7 tp -135.96 119.54 17.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 4.9000000000000004 111.221 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mtm -115.48 101.51 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 4.9299999999999997 111.174 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -110.06 135.84 50.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 4.9699999999999998 111.203 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -59.99 113.97 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 5.0 111.194 169.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.78 -24.84 63.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 5.0300000000000002 111.245 -169.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -100.84 -39.61 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 5.0700000000000003 111.22 -171.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 155' ' ' TYR . 87.8 tt0 -78.71 128.32 77.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 5.0999999999999996 111.217 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -73.21 -20.2 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.738 1.626 . . . . 5.1299999999999999 111.149 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.406 ' H ' ' HG2' ' A' ' 153' ' ' GLU . 74.0 t80 -54.48 -43.24 71.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 5.1699999999999999 111.131 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -79.9 -19.99 46.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 5.2000000000000002 111.234 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 64.8 p -99.35 -5.54 29.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 5.2300000000000004 111.221 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.61 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 83.1 t90 -62.24 -45.42 90.44 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 5.2699999999999996 111.255 178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 40.7 Cg_exo -61.29 -38.54 64.59 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.731 1.621 . . . . 5.2999999999999998 111.167 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.74 -60.02 4.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 5.3300000000000001 111.201 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 167' ' ' TYR . 20.8 tt -70.18 -22.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 5.3700000000000001 111.181 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -88.78 -4.07 58.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 5.4000000000000004 111.205 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -113.1 -10.47 13.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 5.4299999999999997 111.214 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -95.57 -31.46 13.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 5.4699999999999998 111.188 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.6 33.35 2.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 5.5 111.223 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -113.64 11.35 23.4 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.443 ' HB2' HG23 ' A' ' 161' ' ' ILE . 84.1 t80 -131.84 109.77 10.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 5.5700000000000003 111.187 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 63.62 33.18 13.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 5.5999999999999996 111.234 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -124.96 95.3 4.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 5.6299999999999999 111.205 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -51.7 125.03 13.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.6699999999999999 111.141 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -93.68 126.85 39.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 5.7000000000000002 111.242 -172.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 78.5 tt0 -140.01 73.01 1.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 5.7300000000000004 111.21 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 77.7 m-20 80.3 -65.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 5.7699999999999996 111.165 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.02 15.0 1.93 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.18 -0.768 . . . . 5.7999999999999998 111.18 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -92.19 144.66 25.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.82 0.343 . . . . 5.8300000000000001 111.198 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.85 73.83 1.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 5.8700000000000001 111.187 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -90.07 161.55 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 5.9000000000000004 111.264 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.4 pt -114.97 29.64 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 5.9299999999999997 111.191 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.57 -59.96 2.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 5.9699999999999998 111.203 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -90.32 169.96 10.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 6.0 111.184 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 183' ' ' VAL . 97.0 t -88.82 139.85 16.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 6.0300000000000002 111.217 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.33 24.07 15.68 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.17 -0.772 . . . . 6.0700000000000003 111.17 -169.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 181' ' ' VAL . 7.8 p -65.55 -20.81 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.776 0.322 . . . . 6.0999999999999996 111.23 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -105.36 23.1 14.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 6.1299999999999999 111.235 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -95.58 136.79 35.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 6.1699999999999999 111.179 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.74 -27.83 63.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 6.2000000000000002 111.209 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.77 -31.6 81.43 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.129 -0.788 . . . . 6.2300000000000004 111.129 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.01 -45.09 86.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 6.2699999999999996 111.18 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -66.18 -40.97 90.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 6.2999999999999998 111.177 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.48 -44.99 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.285 -0.416 . . . . 6.3300000000000001 111.165 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.24 -41.22 92.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 6.3700000000000001 111.218 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 30.2 tp -69.69 -36.18 75.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 6.4000000000000004 111.138 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 80.8 m -62.86 -41.68 99.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 6.4299999999999997 111.233 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.23 -44.52 95.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.193 174.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.7 tp -56.85 -41.32 77.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 6.5 111.136 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 199' ' ' ILE . 54.1 t -70.34 -34.79 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 6.5300000000000002 111.205 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.9 -34.3 77.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 6.5700000000000003 111.192 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.66 -23.35 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.5999999999999996 111.198 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 196' ' ' VAL . 92.9 mt -78.85 -49.78 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 6.6299999999999999 111.151 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.67 -25.35 53.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 6.6699999999999999 111.129 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -94.65 10.77 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 6.7000000000000002 111.25 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 59.98 52.47 5.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 6.7300000000000004 111.194 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -107.17 -29.84 9.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 6.7699999999999996 111.236 170.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 19.0 ptp -155.13 164.95 38.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 6.7999999999999998 111.198 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -145.0 -169.96 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 6.8300000000000001 111.171 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.1 82.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 6.8700000000000001 111.184 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.22 -37.86 86.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 6.9000000000000004 111.239 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.2 m -53.88 109.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.217 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -147.19 -164.34 1.98 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.242 -0.435 . . . . 6.9699999999999998 111.257 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -50.64 -42.6 56.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 7.0 111.199 -176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.3 p -66.84 -18.27 65.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 7.0300000000000002 111.21 -169.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -103.35 -54.91 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 7.0700000000000003 111.194 176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.0 -61.7 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 7.0999999999999996 111.213 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -92.75 -53.63 4.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 7.1299999999999999 111.266 -173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.04 -52.4 49.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 7.1699999999999999 111.217 -167.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -41.66 95.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 7.2000000000000002 111.171 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.06 -51.08 70.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 7.2300000000000004 111.216 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.02 -32.08 73.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 7.2699999999999996 111.176 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -63.55 -43.78 96.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 7.2999999999999998 111.226 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 122.31 19.38 3.2 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.193 -0.763 . . . . 7.3300000000000001 111.193 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.13 -23.03 28.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 7.3700000000000001 111.234 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.7 m -113.38 124.99 53.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 7.4000000000000004 111.198 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.13 -33.63 76.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 7.4299999999999997 111.181 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -167.83 144.98 4.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 7.4699999999999998 111.253 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.3 t -155.96 163.79 39.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 7.5 111.226 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.55 130.3 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 7.5300000000000002 111.135 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -156.96 173.78 16.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 7.5700000000000003 111.229 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -57.0 -61.21 7.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.179 -0.769 . . . . 7.5999999999999996 111.179 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.94 144.96 98.79 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.708 1.605 . . . . 7.6299999999999999 111.219 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -79.61 156.53 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 7.6699999999999999 111.191 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.2 13.65 30.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 7.7000000000000002 111.183 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -62.81 -32.07 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 7.7300000000000004 111.237 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.7 p -87.61 -9.84 53.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 7.7699999999999996 111.172 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -95.42 0.99 53.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 7.7999999999999998 111.185 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 242' ' ' TYR . 83.7 mt -69.19 -55.22 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 7.8300000000000001 111.201 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.78 -24.13 62.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 7.8700000000000001 111.178 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 97.0 m -65.03 -46.94 79.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 7.9000000000000004 111.216 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 69.0 m -100.01 -2.65 33.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 7.9299999999999997 111.191 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.04 34.91 13.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 7.9699999999999998 111.211 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.97 135.96 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 8.0 111.206 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.13 122.55 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 8.0299999999999994 111.2 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.41 ' H ' HG12 ' A' ' 235' ' ' ILE . 76.0 m-85 -118.35 146.34 44.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 8.0700000000000003 111.176 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -110.91 157.31 15.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.212 -0.755 . . . . 8.0999999999999996 111.212 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.72 130.03 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.323 . . . . 8.1300000000000008 111.174 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -141.98 -169.96 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 8.1699999999999999 111.145 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 98.6 t -93.02 118.08 37.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 8.1999999999999993 111.169 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.574 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . 49.9 tp -90.25 -45.0 0.4 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 8.2300000000000004 111.133 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 247' ' ' LEU . 74.2 Cg_exo -55.28 128.1 29.06 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.706 1.604 . . . . 8.2699999999999996 111.179 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.2 m -138.88 126.6 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 8.3000000000000007 111.184 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.85 127.37 44.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 8.3300000000000001 111.197 -175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 86.3 tttt 44.62 45.14 7.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 8.3699999999999992 111.184 -170.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.04 78.78 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.255 -0.738 . . . . 8.4000000000000004 111.255 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -130.0 109.93 16.89 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 8.4299999999999997 111.233 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.11 137.09 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.728 1.619 . . . . 8.4700000000000006 111.184 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 62.8 p -154.94 -75.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 8.5 111.241 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 323' ' ' ASN . 48.7 tttp -159.95 138.51 7.68 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 8.5299999999999994 111.171 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.446 ' HD3' ' HG2' ' A' ' 248' ' ' PRO . 63.3 Cg_endo -74.25 168.6 24.42 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.227 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 330' ' ' MET . 16.5 t80 -54.94 116.87 2.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 8.5999999999999996 111.177 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.54 104.32 14.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 8.6300000000000008 111.192 -163.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.39 140.03 21.59 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.196 -0.762 . . . . 8.6699999999999999 111.196 164.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.35 108.31 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.311 . . . . 8.6999999999999993 111.193 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 51.1 tp -57.31 120.36 8.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 8.7300000000000004 111.167 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.8 m -138.29 153.54 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 8.7699999999999996 111.172 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.59 137.9 50.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 8.8000000000000007 111.207 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.97 -174.48 14.98 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.227 -0.749 . . . . 8.8300000000000001 111.227 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.0 mt -111.88 128.64 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 8.8699999999999992 111.191 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -57.81 123.09 14.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.251 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 8.9299999999999997 111.196 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.13 -14.13 54.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 8.9700000000000006 111.272 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.99 127.98 93.52 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 9.0 111.206 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.7 -4.1 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.717 1.612 . . . . 9.0299999999999994 111.225 172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -110.06 30.79 6.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 9.0700000000000003 111.145 -171.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -51.95 -36.71 50.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 9.0999999999999996 111.183 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -57.26 -49.64 75.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 9.1300000000000008 111.188 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.16 -43.3 95.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 9.1699999999999999 111.195 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.06 -43.06 93.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 9.1999999999999993 111.131 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -68.3 -42.27 79.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 9.2300000000000004 111.154 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -56.89 -49.53 75.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 9.2699999999999996 111.209 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -57.54 -59.94 4.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 9.3000000000000007 111.179 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.81 -38.8 82.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 9.3300000000000001 111.194 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.94 -43.84 10.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 9.3699999999999992 111.218 -168.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -103.51 -6.18 22.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 9.4000000000000004 111.224 -166.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -124.94 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 9.4299999999999997 111.194 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.67 -60.55 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 9.4700000000000006 111.169 -166.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.17 64.9 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 9.5 111.164 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 24.5 p -130.05 -179.99 5.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 9.5299999999999994 111.275 171.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.96 -27.01 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 9.5700000000000003 111.158 175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -92.93 -39.89 10.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 9.5999999999999996 111.173 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -64.78 -46.77 88.71 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.196 -0.762 . . . . 9.6300000000000008 111.196 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.02 -15.5 60.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 9.6699999999999999 111.202 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -65.49 -38.4 89.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 9.6999999999999993 111.201 169.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -78.92 -38.31 37.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 9.7300000000000004 111.217 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.19 -45.45 71.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 9.7699999999999996 111.166 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -87.56 10.5 17.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 9.8000000000000007 111.235 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.59 -42.98 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 9.8300000000000001 111.193 165.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -95.61 -32.44 12.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 9.8699999999999992 111.168 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -90.17 158.69 43.59 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 9.9000000000000004 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.08 130.02 36.09 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.747 1.631 . . . . 9.9299999999999997 111.18 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 78.1 mt -58.24 -41.89 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 9.9700000000000006 111.25 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.46 -20.25 67.53 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.214 -0.754 . . . . 10.0 111.214 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.85 75.26 4.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 10.029999999999999 111.236 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -140.07 150.67 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 10.07 111.177 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -101.66 -8.96 21.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 10.1 111.237 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.403 HD23 ' HB2' ' A' ' 307' ' ' TYR . 31.6 tp -81.77 119.99 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 10.130000000000001 111.145 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -68.83 -39.47 79.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 10.17 111.227 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.0 t -51.35 -49.53 61.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 10.199999999999999 111.236 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.403 ' HB2' HD23 ' A' ' 304' ' ' LEU . 60.2 t80 -70.49 -40.29 73.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 10.23 111.172 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -52.41 -39.55 61.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 10.27 111.225 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.88 -30.11 71.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 10.300000000000001 111.246 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -71.59 -34.77 70.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.33 111.192 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.79 -18.31 61.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 10.369999999999999 111.202 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.62 -18.59 62.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 10.4 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.97 -27.2 66.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 10.43 111.176 175.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -100.19 110.05 58.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 10.470000000000001 111.243 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -55.38 -31.16 76.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.645 1.563 . . . . 10.5 111.244 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.47 -29.29 68.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 10.529999999999999 111.211 -174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.8 mt -85.33 -44.81 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 10.57 111.198 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.48 -31.76 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 10.6 111.242 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.5 -35.28 73.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 10.630000000000001 111.174 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.0 p -93.09 -20.19 20.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 10.67 111.232 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.3 mmt -71.64 -31.04 66.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 10.699999999999999 111.245 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -57.71 -44.94 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 10.73 111.176 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . 90.5 m-20 -73.06 -26.19 61.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 10.77 111.146 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.3 90.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 10.800000000000001 111.2 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.06 -34.91 64.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 10.83 111.092 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -94.97 0.13 54.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 10.869999999999999 111.187 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.61 -164.78 40.39 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.192 -0.763 . . . . 10.9 111.192 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -124.03 138.04 54.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 10.93 111.217 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.0 mm -102.83 135.26 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 10.970000000000001 111.178 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 258' ' ' PHE . 28.6 ttt -70.13 116.24 42.38 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 11.0 111.141 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.13 159.23 37.4 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 11.029999999999999 111.185 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -105.83 50.01 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.489 . . . . 11.07 111.209 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 86.4 mt -85.9 124.95 70.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 11.1 111.239 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.06 -29.32 22.6 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.709 1.606 . . . . 11.130000000000001 111.248 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -69.09 -37.24 78.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 11.17 111.166 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 89.9 mtp -79.75 -27.82 40.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 11.199999999999999 111.223 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -57.82 -49.74 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 11.23 111.166 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.6 82.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 11.27 111.18 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -68.26 -36.77 79.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 11.300000000000001 111.196 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -68.96 -32.48 72.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 11.33 111.195 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -61.92 -41.25 97.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 11.369999999999999 111.254 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.37 90.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 11.4 111.188 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.2 t -65.16 -40.09 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 11.43 111.154 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -64.31 -32.49 74.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 11.470000000000001 111.244 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.9 m -75.32 -39.86 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.193 172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.98 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.223 -175.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 35.5 m -66.84 -16.34 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 11.57 111.243 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 46.7 mm -90.12 -28.74 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 11.6 111.138 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -63.45 -29.81 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 11.630000000000001 111.191 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -88.36 -32.29 18.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 11.67 111.194 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.72 -30.07 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 11.699999999999999 111.151 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.9 p -75.75 -16.25 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 11.73 111.15 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.95 10.06 79.48 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.202 -0.759 . . . . 11.77 111.202 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -81.6 -49.66 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.861 0.362 . . . . 11.800000000000001 111.268 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -110.75 169.61 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 11.83 111.198 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.0 p -85.74 175.18 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 11.869999999999999 111.224 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.1 m -69.35 -14.56 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 11.9 111.215 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -95.03 -42.62 8.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 11.93 111.205 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -75.32 -35.2 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 11.970000000000001 111.16 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.95 94.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 12.0 111.193 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 88.6 mt -72.03 -39.22 69.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 12.029999999999999 111.242 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -51.83 -38.89 57.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 12.07 111.185 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -49.97 -43.0 49.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 12.1 111.176 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.54 -35.46 27.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 12.130000000000001 111.247 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.05 -31.02 69.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 12.17 111.154 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.4 m -52.08 -38.8 58.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 12.199999999999999 111.188 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -102.6 -35.53 8.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 12.23 111.142 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 96.3 mt -68.05 -47.16 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 12.27 111.172 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.4 p -109.63 -31.94 7.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 12.300000000000001 111.207 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.2 -1.516 0 CA-C-N 116.172 -0.467 . . . . 12.33 111.172 177.146 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.774 0.321 . . . . 0.029999999999999999 111.214 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.3 mt -78.58 126.99 39.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.070000000000000007 111.22 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -67.63 142.26 56.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.10000000000000001 111.184 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.72 138.58 31.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.13 111.127 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.25 28.01 9.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.182 -0.767 . . . . 0.17000000000000001 111.182 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -146.57 145.42 30.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 0.20000000000000001 111.216 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.8 mt -111.98 98.34 7.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.23000000000000001 111.255 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.91 112.04 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.27000000000000002 111.141 172.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -105.89 122.35 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.29999999999999999 111.209 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.4 m0 -109.9 129.98 55.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.33000000000000002 111.23 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 11' ' ' ILE . 18.6 tt -149.53 123.7 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 0.37 111.222 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.02 150.01 22.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.40000000000000002 111.198 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.42 172.02 38.12 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.221 -0.752 . . . . 0.42999999999999999 111.221 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -79.87 76.88 6.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.831 0.348 . . . . 0.46999999999999997 111.224 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -103.76 179.96 4.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.5 111.129 -173.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.07 63.93 4.4 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.222 -0.751 . . . . 0.53000000000000003 111.222 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -68.4 -24.11 64.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.56999999999999995 111.182 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -70.07 -49.94 46.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.59999999999999998 111.224 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.56 96.13 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.63 111.224 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.5 tp -69.7 -31.73 69.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.368 . . . . 0.67000000000000004 111.16 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.86 -33.73 72.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.183 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -63.19 -42.55 99.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.72999999999999998 111.16 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.63 -21.8 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.77000000000000002 111.232 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.81 68.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.19 -0.764 . . . . 0.80000000000000004 111.19 171.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -67.37 -42.61 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.745 0.307 . . . . 0.82999999999999996 111.165 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.39 -48.56 79.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.87 111.169 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -57.63 -44.25 85.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.90000000000000002 111.147 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -65.2 -37.44 87.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.93000000000000005 111.227 -176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -75.09 -34.99 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.96999999999999997 111.233 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -70.75 -39.51 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 1.0 111.218 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.6 p -110.51 -28.17 8.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 1.03 111.202 -170.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 5.45 75.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.229 -0.749 . . . . 1.0700000000000001 111.229 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.89 119.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 1.1000000000000001 111.199 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -64.95 123.93 20.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.472 . . . . 1.1299999999999999 111.243 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.72 125.03 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 1.1699999999999999 111.181 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.5 m -130.38 136.33 48.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 1.2 111.17 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.4 t -113.79 124.94 70.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 1.23 111.171 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.86 158.62 33.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 1.27 111.197 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -114.3 86.49 12.08 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 1.3 111.154 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.25 178.11 7.83 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.697 1.598 . . . . 1.3300000000000001 111.23 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -146.96 174.78 11.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 1.3700000000000001 111.228 172.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 53.19 37.84 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 1.3999999999999999 111.185 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.09 -24.94 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.442 . . . . 1.4299999999999999 111.182 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.26 -12.55 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 1.47 111.182 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -110.04 -23.06 11.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 1.5 111.213 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -92.92 -38.81 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.53 111.168 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 4.6 m-30 -59.97 -46.41 98.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 1.5700000000000001 111.202 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 79.5 Cg_exo -51.75 -36.06 60.67 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.685 1.59 . . . . 1.6000000000000001 111.228 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -75.7 -48.43 21.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.6299999999999999 111.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 47' ' ' PHE . 25.9 m -74.56 -18.38 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 1.6699999999999999 111.208 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.06 -30.59 71.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 1.7 111.175 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.67 -12.16 57.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.187 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.9 p -114.04 -14.94 12.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 1.77 111.167 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.92 39.7 16.2 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.215 -0.754 . . . . 1.8 111.215 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -113.23 -168.42 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.749 0.309 . . . . 1.8300000000000001 111.196 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.48 -169.23 13.12 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.214 -0.754 . . . . 1.8700000000000001 111.214 172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.86 -170.15 0.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.701 1.601 . . . . 1.8999999999999999 111.222 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -103.13 -38.59 7.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 1.9299999999999999 111.158 171.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.6 mt -122.2 132.9 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 1.97 111.177 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -125.1 120.78 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 2.0 111.192 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -85.07 146.12 27.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 2.0299999999999998 111.177 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -159.92 158.4 30.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 2.0699999999999998 111.171 173.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.94 174.27 6.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 2.1000000000000001 111.218 170.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -58.06 -32.93 68.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.232 -0.44 . . . . 2.1299999999999999 111.199 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -91.56 6.67 44.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 2.1699999999999999 111.219 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -114.64 -20.02 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 2.2000000000000002 111.161 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.34 -50.82 71.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 2.23 111.192 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -46.77 75.89 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.765 . . . . 2.27 111.186 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.89 95.05 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.171 -0.771 . . . . 2.2999999999999998 111.171 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -78.89 -24.88 43.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.321 . . . . 2.3300000000000001 111.199 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.62 -23.16 31.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 2.3700000000000001 111.242 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -62.59 -33.71 75.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 2.3999999999999999 111.19 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.2 p -69.22 -28.75 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 2.4300000000000002 111.15 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.99 51.32 7.76 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.22 -0.752 . . . . 2.4700000000000002 111.22 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 75' ' ' LEU . 3.8 pp -132.03 20.05 4.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 2.5 111.221 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.88 134.29 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 2.5299999999999998 111.195 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.51 158.9 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 2.5699999999999998 111.24 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -89.62 159.25 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 2.6000000000000001 111.255 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.1 mt -130.07 137.85 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 2.6299999999999999 111.15 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.5 m -95.11 114.99 64.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 2.6699999999999999 111.235 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.6 155.14 27.6 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.151 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -90.03 169.98 10.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 2.73 111.197 173.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -69.11 -59.91 2.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 2.77 111.255 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.96 78.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 2.7999999999999998 111.165 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -54.87 -50.34 68.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.442 . . . . 2.8300000000000001 111.207 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -57.54 -43.86 84.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 2.8700000000000001 111.147 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.03 -34.98 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 2.8999999999999999 111.162 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -79.55 -21.87 44.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 2.9300000000000002 111.153 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.416 HD23 HD23 ' A' ' 304' ' ' LEU . 90.9 mt -88.09 151.42 22.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.9700000000000002 111.188 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -67.56 156.66 88.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 3.0 111.196 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.19 3.0 7.83 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.7 1.6 . . . . 3.0299999999999998 111.167 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -122.6 10.63 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.175 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.4 p -119.52 -35.43 3.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 3.1000000000000001 111.247 171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -70.12 -40.0 75.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 3.1299999999999999 111.139 173.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -77.85 -30.98 51.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 3.1699999999999999 111.183 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.37 65.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 3.2000000000000002 111.168 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.21 20.98 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 3.23 111.142 -172.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 44.1 mtm105 -95.21 170.38 9.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 3.27 111.18 172.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -160.42 119.61 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 3.2999999999999998 111.215 172.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.1 t30 60.64 34.24 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 3.3300000000000001 111.217 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.98 7.7 83.4 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.262 -0.735 . . . . 3.3700000000000001 111.262 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -131.22 130.01 42.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 3.3999999999999999 111.269 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 98' ' ' ARG . 8.1 tt -70.02 129.99 40.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 3.4300000000000002 111.212 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 pt -113.93 -25.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 3.4700000000000002 111.223 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.85 165.85 28.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 3.5 111.199 -171.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -111.0 140.81 23.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 3.5299999999999998 111.193 169.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.14 -179.77 5.35 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.678 1.585 . . . . 3.5699999999999998 111.19 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.0 tp -165.06 -21.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 3.6000000000000001 111.15 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.33 145.55 23.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 3.6299999999999999 111.188 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.52 125.73 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 111.208 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -114.93 154.98 27.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 3.7000000000000002 111.218 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.02 175.91 9.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 3.73 111.188 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 113' ' ' LEU . 1.7 pp -143.21 146.54 33.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 3.77 111.173 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -168.36 179.97 4.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 3.7999999999999998 111.251 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.525 ' HB2' HD22 ' A' ' 247' ' ' LEU . 55.0 tp -95.41 112.2 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 3.8300000000000001 111.206 -174.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 tt -114.21 137.28 48.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 3.8700000000000001 111.236 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -138.59 150.52 46.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 3.8999999999999999 111.174 -172.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -85.83 120.27 27.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 3.9300000000000002 111.264 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -72.85 -35.09 67.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 3.9700000000000002 111.176 -176.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.65 -33.94 77.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 4.0 111.188 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.02 -48.63 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 4.0300000000000002 111.111 171.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.7 tp -154.98 111.12 2.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 4.0700000000000003 111.219 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.99 -17.67 19.39 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.697 1.598 . . . . 4.0999999999999996 111.197 -172.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -56.46 114.07 7.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 4.1299999999999999 111.217 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.7 134.81 15.41 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.71 1.606 . . . . 4.1699999999999999 111.218 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.511 ' HG3' ' SD ' ' A' ' 224' ' ' MET . 79.5 Cg_endo -77.61 140.59 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.753 1.636 . . . . 4.2000000000000002 111.171 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -100.14 -45.01 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 4.2300000000000004 111.239 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 t -158.41 -178.64 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.161 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.0 t90 -62.38 -38.33 89.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 4.2999999999999998 111.165 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.01 -15.45 62.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 4.3300000000000001 111.216 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -89.06 -14.31 36.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 4.3700000000000001 111.212 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.59 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.3 mt -67.54 -44.93 46.4 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 4.4000000000000004 111.205 -172.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 54.3 Cg_exo -55.07 -37.74 93.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.674 1.583 . . . . 4.4299999999999997 111.171 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.95 -36.88 72.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 4.4699999999999998 111.222 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.93 -32.92 74.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 4.5 111.193 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -56.38 -36.27 68.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 4.5300000000000002 111.249 175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.88 -30.52 71.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 4.5700000000000003 111.153 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.2 -24.58 32.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 4.5999999999999996 111.146 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 -3.28 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 4.6299999999999999 111.198 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.22 -29.06 70.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 4.6699999999999999 111.221 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.94 79.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 4.7000000000000002 111.183 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -107.85 -9.94 15.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 4.7300000000000004 111.218 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.4 40.47 33.04 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.216 -0.754 . . . . 4.7699999999999996 111.216 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -111.62 155.3 23.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.756 0.313 . . . . 4.7999999999999998 111.225 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 t -99.71 141.44 32.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 4.8300000000000001 111.235 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.476 ' HB1' ' HE2' ' A' ' 224' ' ' MET . . . -85.93 -6.78 59.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 4.8700000000000001 111.204 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 198' ' ' LEU . 31.0 tp -165.37 133.41 3.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 4.9000000000000004 111.226 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 26.0 ttt -156.73 134.53 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 4.9299999999999997 111.189 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -129.03 -176.93 4.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 4.9699999999999998 111.183 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -84.75 120.32 26.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 5.0 111.276 168.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 tp -52.56 -38.9 60.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 5.0300000000000002 111.191 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -122.44 39.3 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 5.0700000000000003 111.225 -165.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -146.71 118.31 4.78 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 5.0999999999999996 111.175 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.09 -26.6 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.677 1.585 . . . . 5.1299999999999999 111.226 -175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -56.7 -41.07 76.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 5.1699999999999999 111.155 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -85.7 -25.05 26.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 5.2000000000000002 111.225 -174.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.1 p -98.87 -6.31 29.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 5.2300000000000004 111.174 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.565 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.6 t90 -68.49 -43.76 32.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 5.2699999999999996 111.179 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 63.9 Cg_exo -55.76 -31.67 81.25 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.702 1.601 . . . . 5.2999999999999998 111.157 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 65.6 tp -61.73 -59.94 4.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 5.3300000000000001 111.238 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 tt -69.51 -25.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 5.3700000000000001 111.202 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.24 67.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 5.4000000000000004 111.211 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.03 77.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 5.4299999999999997 111.211 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -78.01 -29.96 49.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 5.4699999999999998 111.186 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 92.41 50.0 2.67 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.167 -0.773 . . . . 5.5 111.167 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -55.87 -59.47 10.54 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.204 -0.758 . . . . 5.5300000000000002 111.204 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 50.4 p90 -112.58 169.84 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.752 0.311 . . . . 5.5700000000000003 111.233 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 65.15 20.27 11.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 5.5999999999999996 111.222 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.97 150.04 43.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 5.6299999999999999 111.195 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -135.92 83.38 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 5.6699999999999999 111.236 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -54.93 107.95 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 5.7000000000000002 111.184 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -149.94 92.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 5.7300000000000004 111.222 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 58.05 35.0 24.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 5.7699999999999996 111.249 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.36 -2.26 77.83 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.197 -0.761 . . . . 5.7999999999999998 111.197 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -99.97 154.42 18.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 5.8300000000000001 111.162 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -142.05 156.98 45.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 5.8700000000000001 111.171 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -152.49 120.58 6.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 5.9000000000000004 111.195 -175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 42.2 pt -75.2 -16.94 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 5.9299999999999997 111.215 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.73 -26.67 54.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 5.9699999999999998 111.211 -172.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.29 170.21 11.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 6.0 111.195 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -72.64 125.41 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 6.0300000000000002 111.181 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.59 60.4 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.175 -0.77 . . . . 6.0700000000000003 111.175 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.64 -37.43 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 6.0999999999999996 111.204 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -85.12 -3.57 58.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 6.1299999999999999 111.238 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -71.35 155.59 40.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 6.1699999999999999 111.248 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.34 -33.66 67.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 6.2000000000000002 111.221 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.63 -27.26 73.12 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.213 -0.755 . . . . 6.2300000000000004 111.213 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.1 78.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.718 0.294 . . . . 6.2699999999999996 111.197 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.33 -43.05 95.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 6.2999999999999998 111.24 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.24 93.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 6.3300000000000001 111.145 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.01 -40.92 97.44 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.212 -0.755 . . . . 6.3700000000000001 111.212 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.56 -29.64 61.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 6.4000000000000004 111.214 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 69.9 m -61.96 -44.33 96.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 6.4299999999999997 111.158 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -64.99 -37.45 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 6.4699999999999998 111.195 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 54.4 tp -65.17 -46.86 79.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 6.5 111.193 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.25 -39.81 85.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 6.5300000000000002 111.248 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.37 -31.47 72.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 6.5700000000000003 111.198 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.402 HD13 HD23 ' A' ' 147' ' ' LEU . 46.5 tp -66.94 -41.29 87.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 6.5999999999999996 111.215 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 43.1 pt -83.0 -19.47 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 6.6299999999999999 111.232 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -70.15 -39.84 75.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 6.6699999999999999 111.133 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -78.23 -9.62 59.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 6.7000000000000002 111.204 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.38 54.29 2.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 6.7300000000000004 111.178 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -79.94 -20.37 45.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 6.7699999999999996 111.219 172.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -141.49 150.27 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 6.7999999999999998 111.174 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -127.01 170.02 12.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 6.8300000000000001 111.185 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.17 -27.15 68.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 6.8700000000000001 111.225 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.16 -30.47 71.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 6.9000000000000004 111.196 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.8 m -59.42 125.01 21.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 6.9299999999999997 111.171 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -129.97 -166.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 6.9699999999999998 111.215 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -55.74 -50.04 71.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 7.0 111.146 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 86.7 p -73.15 -25.23 60.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 7.0300000000000002 111.21 -171.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.0 mm -75.04 -51.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 7.0700000000000003 111.164 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.07 -32.87 74.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 7.0999999999999996 111.237 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -70.15 -52.17 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 7.1299999999999999 111.257 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.66 67.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 7.1699999999999999 111.181 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 221' ' ' GLU . . . -55.07 -36.3 65.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 7.2000000000000002 111.165 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -94.21 -41.01 9.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 7.2300000000000004 111.237 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.2 -41.91 80.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 7.2699999999999996 111.184 -173.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.17 -9.04 49.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 7.2999999999999998 111.187 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.61 27.38 59.2 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.171 -0.771 . . . . 7.3300000000000001 111.171 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 216' ' ' ALA . 75.6 mm-40 -68.44 -29.88 68.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 7.3700000000000001 111.183 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.4 p -109.7 167.89 9.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 7.4000000000000004 111.132 168.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.63 -38.57 9.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 7.4299999999999997 111.226 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.511 ' SD ' ' HG3' ' A' ' 126' ' ' PRO . 64.4 ttp -144.95 145.03 31.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 7.4699999999999998 111.159 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -163.56 174.22 12.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 7.5 111.175 170.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 93.8 mt -100.94 128.82 52.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 7.5300000000000002 111.234 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -163.84 177.79 8.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 7.5700000000000003 111.194 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -112.09 163.5 12.19 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.62 117.2 3.91 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.632 1.555 . . . . 7.6299999999999999 111.208 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . 175.04 -35.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 7.6699999999999999 111.225 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -109.95 4.31 21.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.241 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.02 -19.98 59.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 7.7300000000000004 111.206 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 90.5 p -65.71 -20.06 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 7.7699999999999996 111.227 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -72.79 -24.57 60.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 7.7999999999999998 111.19 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.05 -38.01 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 7.8300000000000001 111.178 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.63 -34.96 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 7.8700000000000001 111.201 170.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.6 m -66.52 -41.16 89.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 7.9000000000000004 111.219 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 88.8 p -73.18 -14.68 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 7.9299999999999997 111.194 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 59.98 51.52 5.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 7.9699999999999998 111.222 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.1 m -118.16 164.43 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 8.0 111.17 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -84.61 139.27 32.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 8.0299999999999994 111.193 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -153.8 165.0 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 8.0700000000000003 111.183 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.88 163.84 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.137 -0.785 . . . . 8.0999999999999996 111.137 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 69.0 t -137.88 129.55 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 8.1300000000000008 111.225 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 34.9 p -133.15 171.6 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 8.1699999999999999 111.181 171.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -114.35 150.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 8.1999999999999993 111.189 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.655 ' O ' ' HG ' ' A' ' 247' ' ' LEU . 2.7 pt? -140.96 51.58 2.53 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.199 -175.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 46.0 Cg_endo -62.57 146.94 95.44 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.737 1.624 . . . . 8.2699999999999996 111.228 174.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 42.6 m -139.66 117.04 11.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 8.3000000000000007 111.25 -174.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -133.73 73.72 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 8.3300000000000001 111.212 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 60.56 56.1 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 8.3699999999999992 111.235 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.33 10.47 85.95 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.212 -0.755 . . . . 8.4000000000000004 111.212 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -130.02 110.01 16.87 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 8.4299999999999997 111.205 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.2 136.7 14.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.694 1.596 . . . . 8.4700000000000006 111.265 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.2 m -125.19 -87.37 0.61 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 8.5 111.168 167.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -143.17 142.72 22.29 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 8.5299999999999994 111.194 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.37 166.33 27.71 Favored 'Trans proline' 0 C--N 1.328 -0.54 0 C-N-CA 121.702 1.601 . . . . 8.5700000000000003 111.124 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -73.41 138.05 45.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 8.5999999999999996 111.209 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.43 168.78 17.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 8.6300000000000008 111.191 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -144.64 163.19 27.96 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.13 -0.788 . . . . 8.6699999999999999 111.13 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 67.3 t -125.14 134.84 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 8.6999999999999993 111.19 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 49.1 tp -89.95 133.4 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 8.7300000000000004 111.227 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 90.1 p -143.94 169.97 16.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 8.7699999999999996 111.203 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -141.79 144.34 33.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 8.8000000000000007 111.256 175.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -125.15 -169.04 12.87 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.209 -0.756 . . . . 8.8300000000000001 111.209 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 89.4 mt -116.08 135.19 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 8.8699999999999992 111.221 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -60.94 131.11 49.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 8.9000000000000004 111.172 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.95 -21.19 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 8.9299999999999997 111.197 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -91.53 -4.94 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 8.9700000000000006 111.194 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.1 t -64.5 122.73 80.09 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 9.0 111.165 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.15 -17.9 18.86 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.706 1.604 . . . . 9.0299999999999994 111.215 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -110.55 60.04 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 9.0700000000000003 111.251 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -72.09 -36.66 69.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 9.0999999999999996 111.201 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.56 -37.64 80.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 9.1300000000000008 111.172 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.2 mt -72.33 -40.77 67.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 9.1699999999999999 111.169 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.1 95.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 9.1999999999999993 111.221 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -64.82 -44.11 90.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 9.2300000000000004 111.256 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -60.04 -43.49 95.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 9.2699999999999996 111.204 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -61.59 -52.08 65.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 9.3000000000000007 111.25 175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.02 -20.1 65.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 9.3300000000000001 111.193 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -87.22 -60.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 9.3699999999999992 111.198 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -102.14 -6.46 23.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 9.4000000000000004 111.212 -162.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -124.01 -27.22 3.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 9.4299999999999997 111.21 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 34.4 tp -80.84 -45.83 16.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 9.4700000000000006 111.209 170.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.92 71.11 1.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 9.5 111.216 -170.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 42.0 p -138.58 176.03 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 9.5299999999999994 111.199 166.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -51.78 -36.97 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 9.5700000000000003 111.235 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -92.51 -38.72 11.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 9.5999999999999996 111.201 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -60.6 -60.2 8.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.215 -0.754 . . . . 9.6300000000000008 111.215 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.0 tp -56.86 -45.58 82.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 9.6699999999999999 111.156 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -55.77 -54.18 47.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 9.6999999999999993 111.198 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.53 84.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 9.7300000000000004 111.17 -172.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 53.5 t -67.2 -43.38 88.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 9.7699999999999996 111.165 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -98.39 7.53 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 9.8000000000000007 111.258 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.07 -39.3 74.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 9.8300000000000001 111.174 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -97.98 10.48 40.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 9.8699999999999992 111.198 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -130.0 160.39 65.43 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 9.9000000000000004 111.184 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.96 144.96 65.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.724 1.616 . . . . 9.9299999999999997 111.171 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.3 mt -109.8 39.18 2.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.248 -0.433 . . . . 9.9700000000000006 111.18 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -54.88 -42.06 78.41 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.21 -0.756 . . . . 10.0 111.21 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -167.07 144.3 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.349 . . . . 10.029999999999999 111.179 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.07 173.68 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 10.07 111.13 -172.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.14 -36.63 19.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 10.1 111.157 -172.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.416 HD23 HD23 ' A' ' 89' ' ' LEU . 96.2 mt -81.56 143.26 32.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 10.130000000000001 111.191 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -78.29 -45.01 23.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 10.17 111.192 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 97.2 p -65.07 -31.9 73.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 10.199999999999999 111.158 -173.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -75.98 -46.12 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 10.23 111.17 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.25 -31.7 71.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 10.27 111.213 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -53.88 -41.49 67.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 10.300000000000001 111.2 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -71.34 -37.47 71.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 10.33 111.214 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.1 mp -67.56 -20.29 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 10.369999999999999 111.244 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.03 -18.51 64.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 10.4 111.256 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.55 -27.88 69.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 10.43 111.177 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.65 115.15 63.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 10.470000000000001 111.213 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.53 -34.37 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.706 1.604 . . . . 10.5 111.177 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.86 -31.99 73.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 10.529999999999999 111.19 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 95.8 mt -78.32 -39.99 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 10.57 111.19 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 321' ' ' MET . . . -56.24 -33.61 65.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 10.6 111.191 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.34 -35.04 69.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 10.630000000000001 111.177 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 66.4 p -105.18 -20.15 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 10.67 111.228 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.453 ' HB3' ' HA ' ' A' ' 318' ' ' ALA . 60.9 ttp -65.08 -58.7 5.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 10.699999999999999 111.208 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -54.12 -41.6 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 10.73 111.185 -177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -75.35 -29.95 60.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 10.77 111.177 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.07 -35.32 76.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 10.800000000000001 111.232 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.05 -35.04 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 10.83 111.153 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.17 -4.95 34.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 10.869999999999999 111.164 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.62 -178.84 52.46 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.127 -0.789 . . . . 10.9 111.127 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -119.59 157.12 29.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 10.93 111.207 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.6 pt -119.76 166.68 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 10.970000000000001 111.189 -168.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.8 tpp -60.04 130.0 88.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 11.0 111.198 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.19 141.45 58.83 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.753 1.636 . . . . 11.029999999999999 111.204 174.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -106.13 20.59 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 11.07 111.179 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 335' ' ' GLN . 83.8 mt -95.68 130.04 32.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 11.1 111.201 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -50.75 -41.76 53.26 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.667 1.578 . . . . 11.130000000000001 111.157 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.4 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.4 mt-30 -63.52 -44.61 93.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 11.17 111.135 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.2 mmm -64.96 -31.84 73.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 11.199999999999999 111.209 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.1 m -62.81 -41.58 99.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 11.23 111.182 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.97 76.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 11.27 111.211 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -67.2 -27.48 67.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 11.300000000000001 111.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -60.03 -38.22 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 11.33 111.227 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -72.13 -30.1 64.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 11.369999999999999 111.172 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.4 74.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.165 -0.471 . . . . 11.4 111.201 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.44 -24.99 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 11.43 111.23 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -57.66 -50.2 73.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 11.470000000000001 111.205 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.7 m -60.68 -38.23 84.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 11.5 111.235 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -55.81 -40.09 72.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 11.529999999999999 111.157 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.45 -47.95 82.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 11.57 111.265 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 348' ' ' ILE . 8.2 tp -74.6 -23.19 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 11.6 111.158 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.64 -27.59 45.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 11.630000000000001 111.187 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -82.0 -27.71 32.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 11.67 111.186 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.49 66.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 11.699999999999999 111.183 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.6 p -72.65 -16.22 61.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 11.73 111.272 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.05 35.24 27.93 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.249 -0.74 . . . . 11.77 111.249 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -99.98 -35.09 9.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 11.800000000000001 111.214 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -127.97 157.07 41.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 11.83 111.137 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -77.45 177.48 7.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 11.869999999999999 111.224 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.99 -21.26 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 11.9 111.237 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -92.33 -37.69 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 11.93 111.196 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -66.99 -38.18 85.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 11.970000000000001 111.172 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -65.06 -41.77 94.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 12.0 111.185 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.0 -15.29 51.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 12.029999999999999 111.173 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.99 -56.63 8.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 12.07 111.225 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -64.96 -32.81 74.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 12.1 111.204 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 368' ' ' ILE . . . -59.09 -56.68 19.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 12.130000000000001 111.236 171.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -54.76 -34.27 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 12.17 111.222 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.8 m -59.57 -35.91 75.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 12.199999999999999 111.237 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.45 -24.13 56.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 12.23 111.131 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 364' ' ' ALA . 39.1 mm -77.39 -61.01 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 12.27 111.201 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.7 p -122.27 -25.41 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 12.300000000000001 111.146 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--O 1.201 -1.495 0 CA-C-N 116.157 -0.474 . . . . 12.33 111.155 -178.656 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.783 0.325 . . . . 0.029999999999999999 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.12 124.95 37.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.070000000000000007 111.22 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.62 153.77 38.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.10000000000000001 111.2 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.05 125.02 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.13 111.199 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.72 18.07 60.62 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.24 -0.744 . . . . 0.17000000000000001 111.24 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -134.12 150.03 51.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.777 0.322 . . . . 0.20000000000000001 111.187 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 tp -119.57 119.94 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.23000000000000001 111.23 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.85 116.24 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.27000000000000002 111.196 -173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.415 ' HB ' HG22 ' A' ' 37' ' ' VAL . 74.2 mt -121.79 116.62 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.29999999999999999 111.185 -175.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.87 107.12 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.33000000000000002 111.234 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.8 tt -115.79 139.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.37 111.186 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -76.66 109.65 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.40000000000000002 111.2 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.76 -171.75 43.04 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.212 -0.755 . . . . 0.42999999999999999 111.212 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -109.95 -43.6 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.46999999999999997 111.229 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 88.2 tttt -151.41 40.01 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.5 111.241 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -14.77 68.67 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.19 -0.764 . . . . 0.53000000000000003 111.19 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -56.71 -30.96 64.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.802 0.334 . . . . 0.56999999999999995 111.225 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -64.96 -37.95 89.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.59999999999999998 111.194 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.48 -31.72 11.22 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.16 -0.776 . . . . 0.63 111.16 -177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.2 tp -73.48 -46.58 47.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.67000000000000004 111.24 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.43 68.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.69999999999999996 111.173 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -53.71 -38.93 64.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.72999999999999998 111.17 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -75.71 -23.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.77000000000000002 111.258 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.64 -5.54 81.55 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.206 -0.758 . . . . 0.80000000000000004 111.206 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.49 -24.13 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.327 . . . . 0.82999999999999996 111.201 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -67.32 -25.48 66.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.87 111.197 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.90000000000000002 111.298 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.95 -28.37 69.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.93000000000000005 111.205 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.26 -35.65 8.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.462 . . . . 0.96999999999999997 111.184 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -69.87 -47.93 60.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.255 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.8 p -124.21 -20.98 5.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 1.03 111.191 -172.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.11 27.15 24.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.186 -0.765 . . . . 1.0700000000000001 111.186 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.3 mt -105.43 128.18 59.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 1.1000000000000001 111.169 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.38 124.98 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 1.1299999999999999 111.24 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -99.4 119.46 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 1.1699999999999999 111.201 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.5 m -114.76 123.81 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.2 111.199 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' ' 9' ' ' ILE . 72.5 t -114.59 131.57 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.23 111.217 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -128.71 170.34 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 1.27 111.227 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.96 68.74 80.09 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 1.3 111.206 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.94 161.64 38.59 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.749 1.633 . . . . 1.3300000000000001 111.227 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -120.27 171.48 8.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.435 . . . . 1.3700000000000001 111.232 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 54.96 37.22 28.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 1.3999999999999999 111.215 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.0 mt -66.85 -37.0 83.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 1.4299999999999999 111.176 -174.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -70.8 -11.99 61.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 1.47 111.208 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -102.91 -6.12 22.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.5 111.197 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.88 -39.91 4.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.53 111.197 -175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.579 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 m-85 -62.46 -39.3 54.48 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.5700000000000001 111.232 -171.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 47' ' ' PHE . 76.9 Cg_exo -52.39 -24.4 21.45 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.697 1.598 . . . . 1.6000000000000001 111.172 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -109.12 -17.39 13.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 1.6299999999999999 111.186 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 80.9 t -105.64 -58.77 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 1.6699999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.24 -33.1 75.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 1.7 111.25 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.21 -25.64 68.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 1.73 111.192 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.1 p -96.57 5.79 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 1.77 111.192 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.82 18.1 58.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.196 -0.762 . . . . 1.8 111.196 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -110.95 172.31 6.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 1.8300000000000001 111.178 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.01 -163.4 16.41 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.15 -0.78 . . . . 1.8700000000000001 111.15 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.59 -172.86 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.611 1.541 . . . . 1.8999999999999999 111.206 -175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -96.83 -44.35 7.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 1.9299999999999999 111.176 173.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.77 135.7 58.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 1.97 111.229 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.7 mt -130.55 130.0 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 2.0 111.225 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.55 138.82 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 2.0299999999999998 111.186 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -141.76 167.94 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 2.0699999999999998 111.216 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.47 158.14 24.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 2.1000000000000001 111.192 164.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -43.83 -41.35 5.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 2.1299999999999999 111.17 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -83.19 -18.29 39.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 2.1699999999999999 111.21 -174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.11 -19.55 24.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 2.2000000000000002 111.199 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.05 -30.02 67.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.23 111.194 174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.52 -43.18 98.49 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.219 -0.752 . . . . 2.27 111.219 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.74 -44.55 80.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.172 -0.771 . . . . 2.2999999999999998 111.172 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -68.15 -33.28 74.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.234 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.34 -39.81 64.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.19 -0.459 . . . . 2.3700000000000001 111.181 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -65.11 -30.06 70.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 2.3999999999999999 111.141 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -74.15 -12.91 60.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 2.4300000000000002 111.2 174.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 27.73 50.47 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.206 -0.758 . . . . 2.4700000000000002 111.206 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -110.39 -6.05 15.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.836 0.35 . . . . 2.5 111.241 -174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.6 tp -98.39 130.32 45.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 2.5299999999999998 111.186 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 146.19 24.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 2.5699999999999998 111.185 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -82.46 159.8 22.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 2.6000000000000001 111.223 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.0 mt -124.8 102.95 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 2.6299999999999999 111.184 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 91.5 m -52.27 111.6 2.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 2.6699999999999999 111.26 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.31 145.64 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.665 1.577 . . . . 2.7000000000000002 111.223 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.38 169.98 9.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 2.73 111.247 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -84.36 -29.11 26.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 2.77 111.17 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.16 91.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 2.7999999999999998 111.241 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.444 ' HA ' ' HB3' ' A' ' 88' ' ' LYS . 59.1 m-85 -80.04 -22.5 42.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 2.8300000000000001 111.186 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.93 -39.95 75.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 2.8700000000000001 111.249 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -94.71 -33.19 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 2.8999999999999999 111.181 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 85' ' ' PHE . 58.1 tptt -64.8 -43.57 92.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 2.9300000000000002 111.148 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.6 mt -85.23 142.3 29.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 2.9700000000000002 111.147 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -66.85 127.98 93.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 3.0 111.204 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -54.11 -35.05 80.72 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.656 1.571 . . . . 3.0299999999999998 111.155 -168.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -52.86 -44.6 66.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 3.0699999999999998 111.197 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 p -90.91 -23.24 20.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.1000000000000001 111.141 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -60.0 -43.96 94.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 3.1299999999999999 111.138 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -86.06 -9.51 56.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 3.1699999999999999 111.175 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.8 -17.27 48.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 3.2000000000000002 111.181 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.452 HG21 ' HD3' ' A' ' 107' ' ' PRO . 29.4 m -114.99 26.24 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 3.23 111.19 -170.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -139.74 154.72 47.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 3.27 111.192 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 66.3 t80 -148.4 127.51 12.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 3.2999999999999998 111.203 178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 97.8 m-20 65.04 26.19 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 3.3300000000000001 111.188 -174.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.4 -42.0 2.04 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.151 -0.78 . . . . 3.3700000000000001 111.151 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -85.61 135.53 33.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 3.3999999999999999 111.151 -174.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.7 mp -74.99 143.24 43.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 3.4300000000000002 111.167 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 pt -115.83 -13.45 11.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 3.4700000000000002 111.179 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.59 160.54 43.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 3.5 111.168 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -109.95 133.98 20.82 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 3.5299999999999998 111.256 169.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.604 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 72.6 Cg_endo -81.02 -178.46 4.4 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.692 1.595 . . . . 3.5699999999999998 111.25 -172.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 107' ' ' PRO . 16.3 tt 163.94 14.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 3.6000000000000001 111.23 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -171.22 144.78 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 3.6299999999999999 111.228 174.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.98 157.0 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 3.6699999999999999 111.183 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -140.02 109.94 6.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 3.7000000000000002 111.214 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.91 156.25 36.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 3.73 111.233 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 69.2 tp -134.24 116.73 15.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 3.77 111.184 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.0 p -161.56 169.84 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 3.7999999999999998 111.251 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.75 117.52 24.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 3.8300000000000001 111.207 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -108.09 148.48 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 3.8700000000000001 111.259 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -146.27 154.88 42.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 3.8999999999999999 111.212 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -83.28 122.52 28.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 3.9300000000000002 111.137 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 241' ' ' ASN . 97.9 mttt -64.6 -19.2 65.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 3.9700000000000002 111.232 -173.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -89.95 -26.91 20.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 4.0 111.153 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -93.67 -54.71 3.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 4.0300000000000002 111.163 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.52 82.4 18.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 4.0700000000000003 111.187 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.04 -15.01 29.27 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.769 1.646 . . . . 4.0999999999999996 111.204 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -106.95 97.49 17.96 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 4.1299999999999999 111.184 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.1 163.75 34.51 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.731 1.621 . . . . 4.1699999999999999 111.158 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.82 152.09 68.88 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 121.662 1.575 . . . . 4.2000000000000002 111.175 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.7 -10.92 30.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 4.2300000000000004 111.168 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -156.97 -176.54 6.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 4.2699999999999996 111.168 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -79.7 -26.55 40.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 4.2999999999999998 111.212 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.04 -22.08 60.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 4.3300000000000001 111.138 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -86.11 -15.91 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 4.3700000000000001 111.259 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.519 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 85.7 mt -66.95 -51.35 38.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 4.4000000000000004 111.142 -175.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 96.1 Cg_endo -75.73 -22.5 13.52 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.72 1.613 . . . . 4.4299999999999997 111.193 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.56 89.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 4.4699999999999998 111.232 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.7 mt -69.92 -38.21 76.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 4.5 111.219 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 146' ' ' ALA . 34.8 t70 -46.68 -47.83 20.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 4.5300000000000002 111.204 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -49.35 76.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 4.5700000000000003 111.19 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.88 -30.09 70.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 4.5999999999999996 111.147 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 82.2 mt -79.46 -36.1 39.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 4.6299999999999999 111.245 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -68.84 -20.06 64.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 4.6699999999999999 111.163 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.89 68.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 4.7000000000000002 111.24 172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -107.0 8.47 30.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 4.7300000000000004 111.219 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.58 60.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.178 -0.769 . . . . 4.7699999999999996 111.178 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 72.9 mmtt -109.94 -174.15 2.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 4.7999999999999998 111.191 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.4 t -151.89 163.62 38.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 4.8300000000000001 111.178 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 136' ' ' ASP . . . -66.42 -57.77 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 4.8700000000000001 111.177 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.53 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.0 pp -164.95 164.93 20.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 4.9000000000000004 111.191 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.2 mmt -110.37 100.02 8.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 4.9299999999999997 111.147 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.88 130.01 55.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 4.9699999999999998 111.215 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 208' ' ' THR . 39.5 t-20 -70.27 111.93 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 5.0 111.2 169.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 89.3 mt -93.76 7.55 44.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 5.0300000000000002 111.217 -170.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -109.83 -48.11 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 5.0700000000000003 111.263 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.7 121.22 81.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 5.0999999999999996 111.208 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.0 -31.26 8.18 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.717 1.611 . . . . 5.1299999999999999 111.224 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -73.82 -33.59 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 5.1699999999999999 111.167 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -53.03 -37.1 61.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 5.2000000000000002 111.168 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.7 p -99.06 15.31 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 5.2300000000000004 111.199 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 91.0 t90 -66.78 -46.63 55.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 5.2699999999999996 111.254 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 41.7 Cg_endo -87.94 -4.05 7.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.676 1.584 . . . . 5.2999999999999998 111.203 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 39.7 tp -61.46 -51.46 68.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 5.3300000000000001 111.215 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.33 -31.42 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 5.3700000000000001 111.2 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.4 -35.15 79.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 5.4000000000000004 111.164 173.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.23 80.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 5.4299999999999997 111.197 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.48 -43.46 90.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 5.4699999999999998 111.204 167.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.82 26.2 4.83 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.197 -0.761 . . . . 5.5 111.197 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.95 -31.69 4.67 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.257 -0.737 . . . . 5.5300000000000002 111.257 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -65.75 110.01 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 5.5700000000000003 111.241 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 61.29 35.82 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 5.5999999999999996 111.159 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -120.14 141.43 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 5.6299999999999999 111.133 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -70.06 128.17 35.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 5.6699999999999999 111.219 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -100.0 89.26 3.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 5.7000000000000002 111.216 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 88.7 tt0 -152.14 95.07 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 5.7300000000000004 111.199 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 96.8 m-20 73.26 -67.4 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 5.7699999999999996 111.179 174.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.92 25.0 0.07 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.246 -0.742 . . . . 5.7999999999999998 111.246 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -107.92 120.01 41.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.331 . . . . 5.8300000000000001 111.153 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -122.24 88.08 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 5.8700000000000001 111.175 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -86.49 128.66 34.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 5.9000000000000004 111.159 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.8 pt -72.33 -17.0 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 5.9299999999999997 111.192 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.23 -20.02 52.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 5.9699999999999998 111.196 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.75 174.42 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 6.0 111.165 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.33 152.84 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 6.0300000000000002 111.185 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.87 22.01 36.6 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.177 -0.769 . . . . 6.0700000000000003 111.177 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.9 p -71.04 -20.02 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 6.0999999999999996 111.25 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -113.79 22.56 13.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 6.1299999999999999 111.232 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.17 117.73 29.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 6.1699999999999999 111.196 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.91 71.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 6.2000000000000002 111.161 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.63 -36.94 76.81 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.209 -0.756 . . . . 6.2300000000000004 111.209 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.58 80.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 6.2699999999999996 111.172 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.42 -39.05 93.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 6.2999999999999998 111.217 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 6.3300000000000001 111.207 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.84 -44.67 94.35 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.162 -0.775 . . . . 6.3700000000000001 111.162 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 192' ' ' LEU . 0.7 OUTLIER -65.76 -37.33 86.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 6.4000000000000004 111.234 176.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.8 m -61.14 -44.01 98.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 6.4299999999999997 111.173 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -55.66 -46.03 77.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 6.4699999999999998 111.205 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.3 tp -59.88 -52.12 66.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 6.5 111.268 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.07 -21.14 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 6.5300000000000002 111.253 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.86 -40.18 79.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 6.5700000000000003 111.242 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.9 mt -65.04 -35.61 81.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 6.5999999999999996 111.177 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.28 -52.96 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.195 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.58 -43.03 99.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 6.6699999999999999 111.231 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -79.94 -10.14 59.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 6.7000000000000002 111.149 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 59.83 58.46 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 6.7300000000000004 111.182 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -81.17 -22.57 38.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 6.7699999999999996 111.219 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.98 170.75 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 6.7999999999999998 111.207 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -92.74 161.98 14.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 6.8300000000000001 111.197 -174.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.86 -31.05 72.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 6.8700000000000001 111.238 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.01 -30.06 67.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 6.9000000000000004 111.18 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 150' ' ' ASN . 49.8 m -51.77 130.78 29.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 6.9299999999999997 111.206 175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -157.49 176.72 12.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 6.9699999999999998 111.197 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -64.04 -21.2 66.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 7.0 111.175 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 89.0 p -69.7 -25.6 63.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 7.0300000000000002 111.226 171.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.52 -32.27 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 7.0700000000000003 111.19 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 225' ' ' THR . . . -61.04 -44.69 97.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 7.0999999999999996 111.202 177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.97 -39.55 93.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 7.1299999999999999 111.207 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.12 -47.19 86.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.219 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.94 63.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 7.2000000000000002 111.211 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.64 -38.89 92.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 7.2300000000000004 111.183 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 234' ' ' ASN . 97.7 m-20 -93.33 -39.69 10.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 7.2699999999999996 111.175 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.52 -23.06 59.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 7.2999999999999998 111.218 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 77.35 51.23 6.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.229 -0.748 . . . . 7.3300000000000001 111.229 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -106.92 3.25 25.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 7.3700000000000001 111.227 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 154.04 36.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 7.4000000000000004 111.241 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.57 -29.87 18.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 7.4299999999999997 111.212 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 146' ' ' ALA . 21.6 ptt? -152.3 170.0 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 7.4699999999999998 111.185 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.413 HG21 ' HB1' ' A' ' 213' ' ' ALA . 12.3 t -170.18 152.82 4.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 7.5 111.161 170.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 94.0 mt -91.89 120.07 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 7.5300000000000002 111.236 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -160.8 -172.12 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 7.5700000000000003 111.167 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -120.36 -165.09 12.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.165 -0.774 . . . . 7.5999999999999996 111.165 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.13 64.65 8.39 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.708 1.606 . . . . 7.6299999999999999 111.245 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -125.41 -30.07 3.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 7.6699999999999999 111.224 171.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.19 -5.22 30.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 7.7000000000000002 111.246 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -76.91 -19.15 57.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 7.7300000000000004 111.175 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 95.5 p -72.85 -10.06 59.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 7.7699999999999996 111.196 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 218' ' ' ASN . 65.8 m-80 -95.01 5.41 52.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 7.7999999999999998 111.187 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.9 -51.29 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 7.8300000000000001 111.198 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -77.39 -25.32 50.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 7.8700000000000001 111.199 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 87.5 m -64.99 -45.95 83.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 7.9000000000000004 111.227 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 85.2 p -82.58 -14.72 54.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 7.9299999999999997 111.259 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 59.57 45.4 13.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 7.9699999999999998 111.18 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 73.6 t -128.03 142.82 42.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 8.0 111.207 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 119' ' ' LYS . 97.4 m-20 -74.75 112.57 11.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 8.0299999999999994 111.222 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -112.84 143.04 44.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 8.0700000000000003 111.177 173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -118.58 167.47 13.04 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.147 -0.781 . . . . 8.0999999999999996 111.147 176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.65 160.75 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.334 . . . . 8.1300000000000008 111.17 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.5 t -135.76 -176.65 4.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 8.1699999999999999 111.201 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.01 120.02 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 8.1999999999999993 111.206 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.535 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 91.5 mt -87.8 -42.2 0.5 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 8.2300000000000004 111.134 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 78.2 Cg_exo -53.22 112.42 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.695 1.597 . . . . 8.2699999999999996 111.156 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 88.0 m -124.48 112.11 16.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 8.3000000000000007 111.168 -174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -110.01 128.75 55.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 8.3300000000000001 111.126 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 85.1 tttt 45.17 46.04 9.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 8.3699999999999992 111.176 -174.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.9 14.49 78.48 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.205 -0.758 . . . . 8.4000000000000004 111.205 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -129.98 109.99 16.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.181 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.8 130.63 38.24 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.746 1.631 . . . . 8.4700000000000006 111.187 173.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 29.6 t -105.1 -99.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 8.5 111.126 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -136.87 151.94 73.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 8.5299999999999994 111.223 176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -60.4 144.57 99.52 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.737 1.624 . . . . 8.5700000000000003 111.181 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -92.96 148.31 22.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 8.5999999999999996 111.162 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.35 126.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 8.6300000000000008 111.213 -175.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -85.83 162.83 36.1 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -129.28 136.41 59.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 8.6999999999999993 111.141 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 67.1 mt -109.82 148.74 30.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 8.7300000000000004 111.165 172.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -161.63 169.98 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 8.7699999999999996 111.234 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -120.82 136.15 54.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 8.8000000000000007 111.162 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.46 179.66 16.41 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.226 -0.749 . . . . 8.8300000000000001 111.226 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 91.3 mt -100.98 136.01 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 8.8699999999999992 111.194 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -70.91 124.72 25.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 8.9000000000000004 111.167 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.13 -22.42 66.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 8.9299999999999997 111.231 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -5.51 59.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 8.9700000000000006 111.237 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -79.48 129.88 70.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 9.0 111.2 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.52 -3.33 13.51 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.708 1.605 . . . . 9.0299999999999994 111.233 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -120.01 60.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 9.0700000000000003 111.263 -174.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -75.85 -30.38 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 9.0999999999999996 111.183 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -68.06 -46.46 71.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 9.1300000000000008 111.223 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 64.3 tp -62.76 -44.13 97.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 9.1699999999999999 111.18 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.29 98.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 9.1999999999999993 111.128 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -63.25 -40.22 96.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 9.2300000000000004 111.183 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -59.68 -54.78 42.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 9.2699999999999996 111.222 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -52.28 -50.0 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 9.3000000000000007 111.275 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.63 -43.6 93.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 9.3300000000000001 111.219 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -83.41 -61.76 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 9.3699999999999992 111.232 -168.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -92.98 -8.56 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 9.4000000000000004 111.262 -162.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -120.0 -50.09 2.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 9.4299999999999997 111.231 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 56.0 tp -78.42 -60.0 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 9.4700000000000006 111.163 -174.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.8 mm? -75.2 69.93 2.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 9.5 111.177 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 29.5 p -136.86 178.02 7.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 9.5299999999999994 111.14 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.18 -25.75 68.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 9.5700000000000003 111.202 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -98.49 -34.59 10.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 9.5999999999999996 111.221 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.91 -48.71 59.27 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.243 -0.743 . . . . 9.6300000000000008 111.243 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.35 -45.37 84.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 9.6699999999999999 111.186 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.32 -46.12 91.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 9.6999999999999993 111.217 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.64 74.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 9.7300000000000004 111.136 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.79 -40.65 69.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 9.7699999999999996 111.204 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.516 ' HB3' HD23 ' A' ' 299' ' ' LEU . 91.9 m-20 -78.22 0.67 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 9.8000000000000007 111.281 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.89 -35.93 82.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 9.8300000000000001 111.152 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -108.2 -28.33 9.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 9.8699999999999992 111.177 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -96.45 164.06 19.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 9.9000000000000004 111.19 -176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.97 139.95 79.5 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.702 1.601 . . . . 9.9299999999999997 111.206 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 294' ' ' ASN . 98.7 mt -70.12 -18.6 63.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 9.9700000000000006 111.166 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -65.01 -26.53 71.44 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.197 -0.761 . . . . 10.0 111.197 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -60.13 127.09 30.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 10.029999999999999 111.189 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.9 134.25 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 10.07 111.193 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 108' ' ' ILE . . . -114.42 -27.18 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 10.1 111.168 164.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 78.5 mt -85.19 144.99 27.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 10.130000000000001 111.162 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -65.55 -47.35 76.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 10.17 111.224 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.8 m -62.67 -40.05 95.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 10.199999999999999 111.204 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -65.17 -40.37 94.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 10.23 111.226 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -60.75 -33.39 72.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 10.27 111.238 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.12 -33.11 71.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 10.300000000000001 111.174 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -70.31 -29.9 66.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 10.33 111.188 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.15 -29.84 61.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 10.369999999999999 111.169 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.01 73.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 10.4 111.189 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.33 -34.36 68.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 10.43 111.166 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.02 118.35 48.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 10.470000000000001 111.159 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.7 -35.51 93.34 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.744 1.629 . . . . 10.5 111.153 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -79.98 -52.58 7.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 10.529999999999999 111.156 -172.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.428 HG22 ' HG2' ' A' ' 321' ' ' MET . 50.4 mm -79.17 -27.34 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 10.57 111.163 -170.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.31 -36.72 33.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 10.6 111.172 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.15 95.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 10.630000000000001 111.188 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.8 m -69.95 -39.85 75.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 10.67 111.107 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.428 ' HG2' HG22 ' A' ' 317' ' ' ILE . 38.8 mmt -68.37 -35.42 77.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 10.699999999999999 111.233 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.53 -42.4 87.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 10.73 111.233 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -64.91 -38.07 89.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 10.77 111.238 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 10.800000000000001 111.232 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.49 -42.77 99.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 10.83 111.271 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.04 -9.83 38.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 10.869999999999999 111.262 -175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.97 -165.16 35.45 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -131.23 164.31 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 10.93 111.17 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.4 pt -111.32 162.87 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 10.970000000000001 111.214 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -84.95 164.72 40.6 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 11.0 111.18 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.06 138.53 82.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.72 1.614 . . . . 11.029999999999999 111.182 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -107.51 28.27 8.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 11.07 111.221 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 335' ' ' GLN . 89.3 mt -90.62 125.26 60.08 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 11.1 111.202 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.49 -24.36 31.01 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.736 1.624 . . . . 11.130000000000001 111.183 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.438 ' H ' HG22 ' A' ' 333' ' ' ILE . 61.7 mt-30 -80.57 -1.46 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 11.17 111.129 178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.1 mmm -95.16 6.9 47.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 11.199999999999999 111.164 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.4 p -64.55 -33.78 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 11.23 111.133 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.29 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 11.27 111.163 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -60.98 -47.59 85.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 11.300000000000001 111.172 175.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.38 -49.06 78.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 11.33 111.219 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -69.36 -47.01 65.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.172 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.37 86.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 11.4 111.244 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.97 -46.38 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 11.43 111.192 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.75 -44.85 70.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 11.470000000000001 111.233 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.8 m -65.21 -40.56 94.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 11.5 111.203 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.76 -34.08 77.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 11.529999999999999 111.174 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.82 -48.9 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 11.57 111.167 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 8.9 tp -74.88 -25.18 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 11.6 111.201 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.76 -48.29 55.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 11.630000000000001 111.219 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.64 76.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 11.67 111.208 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.07 87.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.175 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -74.33 -15.31 60.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 11.73 111.161 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 98.34 27.02 8.92 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.216 -0.754 . . . . 11.77 111.216 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -82.75 -35.08 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 11.800000000000001 111.23 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -151.38 174.77 12.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 11.83 111.135 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -85.0 171.97 11.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 11.869999999999999 111.177 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -72.19 -24.16 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 11.9 111.237 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.01 -47.89 60.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 11.93 111.161 170.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -68.5 -28.45 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 11.970000000000001 111.162 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.13 -51.33 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 12.0 111.208 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.29 -20.35 48.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 12.029999999999999 111.205 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.86 -52.42 56.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 12.07 111.151 171.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.84 -37.4 86.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.255 -0.429 . . . . 12.1 111.246 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.45 81.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 12.130000000000001 111.212 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -55.31 -44.5 75.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 12.17 111.208 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 91.8 m -59.31 -44.54 92.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 12.199999999999999 111.237 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.85 -30.13 67.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 12.23 111.151 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 86.8 mt -69.06 -41.09 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 12.27 111.22 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.9 p -86.8 -15.08 40.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 12.300000000000001 111.258 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.508 0 CA-C-N 116.148 -0.478 . . . . 12.33 111.209 177.728 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.762 0.315 . . . . 0.029999999999999999 111.191 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt -116.27 125.57 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.070000000000000007 111.175 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.0 144.93 42.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.10000000000000001 111.199 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.04 129.94 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.13 111.211 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.02 19.56 21.24 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.153 -0.779 . . . . 0.17000000000000001 111.153 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -140.16 146.61 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 0.20000000000000001 111.196 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 275' ' ' LEU . 88.2 mt -112.29 140.75 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.23000000000000001 111.264 172.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.84 118.25 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.449 . . . . 0.27000000000000002 111.218 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.441 HG12 ' HB ' ' A' ' 59' ' ' ILE . 89.5 mt -107.88 123.9 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.29999999999999999 111.213 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -110.09 130.66 55.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.33000000000000002 111.201 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.42 120.09 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.37 111.231 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.58 125.35 26.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.40000000000000002 111.156 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.15 -170.83 40.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.151 -0.78 . . . . 0.42999999999999999 111.151 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.04 -51.9 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 0.46999999999999997 111.157 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.73 158.8 42.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 0.5 111.254 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.99 -8.87 4.82 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.229 -0.748 . . . . 0.53000000000000003 111.229 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -64.93 -24.56 67.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 111.257 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.54 -42.73 70.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 0.59999999999999998 111.219 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.58 -40.41 97.56 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.155 -0.778 . . . . 0.63 111.155 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.17 -23.61 51.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.328 . . . . 0.67000000000000004 111.183 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -33.4 63.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.147 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.77 -42.85 97.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.72999999999999998 111.164 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.93 -25.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.77000000000000002 111.184 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.89 -33.52 87.45 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.13 -0.788 . . . . 0.80000000000000004 111.13 172.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.61 -43.91 92.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.82999999999999996 111.151 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -59.97 -35.98 76.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.87 111.222 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -65.08 -42.73 93.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.90000000000000002 111.172 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.59 -35.76 81.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.93000000000000005 111.234 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -64.35 -30.05 71.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.96999999999999997 111.182 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -99.89 -34.7 10.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.252 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -107.05 -29.03 9.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 1.03 111.239 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.95 6.55 75.56 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.186 -0.766 . . . . 1.0700000000000001 111.186 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.7 mm -89.22 127.86 41.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 1.1000000000000001 111.176 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -88.6 134.33 33.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.1299999999999999 111.181 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -115.49 124.44 71.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 1.1699999999999999 111.265 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -115.69 125.97 53.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 1.2 111.249 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.19 131.11 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 1.23 111.198 -176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -128.84 156.12 44.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 1.27 111.208 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -111.49 85.64 6.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 1.3 111.178 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 147.51 45.91 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.713 1.608 . . . . 1.3300000000000001 111.19 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -137.03 5.23 2.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 1.3700000000000001 111.182 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -124.96 35.05 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 1.3999999999999999 111.16 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.98 -35.15 74.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 1.4299999999999999 111.199 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.3 -40.04 64.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 1.47 111.199 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -84.66 -26.94 27.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 1.5 111.144 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -81.02 -19.81 43.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.217 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.481 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.2 m-30 -55.04 -57.43 19.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 1.5700000000000001 111.231 -174.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 72.8 Cg_endo -72.96 -23.33 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.732 1.621 . . . . 1.6000000000000001 111.16 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -67.7 -36.4 80.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.302 -0.408 . . . . 1.6299999999999999 111.162 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.8 m -100.02 -28.08 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 1.6699999999999999 111.183 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.45 -30.89 69.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 1.7 111.229 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.42 -15.89 60.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 1.73 111.2 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 p -109.88 -18.39 13.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 1.77 111.145 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.96 42.52 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.214 -0.754 . . . . 1.8 111.214 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -111.22 -175.0 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.8300000000000001 111.154 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.07 -172.15 25.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.172 -0.771 . . . . 1.8700000000000001 111.172 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.0 -176.49 2.66 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.666 1.578 . . . . 1.8999999999999999 111.212 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -99.27 -48.03 4.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 1.9299999999999999 111.211 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.441 ' HB ' HG12 ' A' ' 9' ' ' ILE . 83.4 mt -117.93 134.96 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 1.97 111.195 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.0 mt -121.72 137.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 2.0 111.24 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -105.39 137.95 42.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 2.0299999999999998 111.206 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.99 163.38 18.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 2.0699999999999998 111.173 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.22 165.93 12.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.468 . . . . 2.1000000000000001 111.173 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -53.96 -33.52 57.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.1299999999999999 111.197 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 340' ' ' TRP . 76.1 m-20 -102.51 16.27 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 2.1699999999999999 111.206 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -110.01 -0.02 18.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 2.2000000000000002 111.165 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -69.97 -27.55 64.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 2.23 111.225 -170.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.7 -39.74 61.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.218 -0.753 . . . . 2.27 111.218 -175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.6 -30.82 78.77 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.178 -0.769 . . . . 2.2999999999999998 111.178 -174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.64 -37.07 11.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.801 0.334 . . . . 2.3300000000000001 111.24 -174.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.08 64.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 2.3700000000000001 111.174 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -84.51 -28.23 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 2.3999999999999999 111.195 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.6 p -80.32 -15.62 56.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 2.4300000000000002 111.249 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 31.55 30.28 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.229 -0.748 . . . . 2.4700000000000002 111.229 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -118.65 33.73 5.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 2.5 111.211 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.0 tp -152.37 125.16 8.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 2.5299999999999998 111.158 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.68 157.67 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 2.5699999999999998 111.22 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.87 80.01 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 2.6000000000000001 111.21 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.6 mm -95.57 114.02 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 2.6299999999999999 111.258 -175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.469 HG23 ' HB2' ' A' ' 103' ' ' LEU . 53.0 m -100.9 121.58 51.9 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 2.6699999999999999 111.219 -168.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HB3' ' CD2' ' A' ' 106' ' ' TYR . 58.1 Cg_endo -67.43 125.27 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.721 1.614 . . . . 2.7000000000000002 111.18 173.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -85.03 -168.28 2.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 2.73 111.176 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.89 -32.86 71.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 2.77 111.181 -172.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.61 -35.05 76.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 2.7999999999999998 111.168 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.93 -24.82 21.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 2.8300000000000001 111.201 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.69 -35.03 79.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.8700000000000001 111.158 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -89.25 -34.96 16.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 2.8999999999999999 111.202 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -81.03 -30.08 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 2.9300000000000002 111.175 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.5 mt -104.56 166.11 10.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 2.9700000000000002 111.249 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.448 ' CE2' ' HA ' ' A' ' 303' ' ' ALA . 19.7 m-85 -60.14 138.14 91.33 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 3.0 111.228 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.31 -13.56 28.11 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.687 1.591 . . . . 3.0299999999999998 111.214 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -87.71 -21.98 24.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 3.0699999999999998 111.164 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -107.37 -19.74 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 3.1000000000000001 111.185 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -60.14 -42.63 95.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 3.1299999999999999 111.188 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.98 -15.55 29.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 3.1699999999999999 111.137 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.28 13.31 8.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 3.2000000000000002 111.2 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.2 m -120.19 71.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 3.23 111.24 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -141.33 139.15 33.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 3.27 111.163 -158.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -162.44 139.85 8.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 3.2999999999999998 111.175 174.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 65.8 30.55 10.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 3.3300000000000001 111.186 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.09 -3.72 86.78 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.149 -0.78 . . . . 3.3700000000000001 111.149 171.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.15 155.68 48.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.821 0.343 . . . . 3.3999999999999999 111.216 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.469 ' HB2' HG23 ' A' ' 80' ' ' THR . 90.1 mt -79.06 142.43 36.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 3.4300000000000002 111.151 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 pt -124.93 -5.01 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 3.4700000000000002 111.226 -162.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.14 160.41 39.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 3.5 111.244 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' A' ' 81' ' ' PRO . 86.9 m-85 -99.09 125.07 42.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 3.5299999999999998 111.139 166.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.66 131.16 18.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.702 1.601 . . . . 3.5699999999999998 111.135 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.9 mt -108.24 -55.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 3.6000000000000001 111.18 -169.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.77 156.36 41.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 3.6299999999999999 111.206 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.04 161.01 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 3.6699999999999999 111.161 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -149.31 110.57 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 3.7000000000000002 111.132 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.44 135.85 44.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 3.73 111.227 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.13 145.07 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 3.77 111.164 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 99.0 p -150.15 169.4 21.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 3.7999999999999998 111.199 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -115.13 130.21 56.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 3.8300000000000001 111.221 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.75 147.79 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 3.8700000000000001 111.23 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -138.19 159.03 43.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 3.8999999999999999 111.132 167.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 122' ' ' LEU . 34.4 t-20 -107.85 104.75 14.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 3.9300000000000002 111.257 -172.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.0 mttt -57.67 -34.8 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 3.9700000000000002 111.203 -174.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.34 -47.72 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 4.0 111.227 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.21 -58.46 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 4.0300000000000002 111.288 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 118' ' ' ASN . 68.2 mt -125.04 76.26 67.23 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.157 -0.474 . . . . 4.0700000000000003 111.285 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.43 -17.61 39.0 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.691 1.594 . . . . 4.0999999999999996 111.224 -174.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -97.81 104.84 23.47 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 4.1299999999999999 111.198 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.18 155.47 64.48 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.635 1.557 . . . . 4.1699999999999999 111.241 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.38 144.22 60.95 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.706 1.604 . . . . 4.2000000000000002 111.238 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.18 -19.88 31.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 4.2300000000000004 111.215 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.4 t -150.07 -177.33 5.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 4.2699999999999996 111.238 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -64.58 -41.73 96.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 4.2999999999999998 111.212 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.27 -23.1 66.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 4.3300000000000001 111.185 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -87.71 -15.34 37.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 4.3700000000000001 111.174 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 82.7 mt -68.94 -50.48 22.12 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 4.4000000000000004 111.179 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 92.1 Cg_endo -75.93 -18.98 16.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.661 1.574 . . . . 4.4299999999999997 111.199 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.0 85.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 4.4699999999999998 111.201 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.75 -28.65 60.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 4.5 111.214 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.62 -42.51 98.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 4.5300000000000002 111.179 173.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -65.78 -48.1 72.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 4.5700000000000003 111.201 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -61.84 -40.98 97.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 4.5999999999999996 111.191 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 223' ' ' ALA . 26.0 tp -72.25 -31.78 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 4.6299999999999999 111.215 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.73 -39.52 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 4.6699999999999999 111.158 174.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.76 71.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 4.7000000000000002 111.228 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.89 -14.86 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.488 . . . . 4.7300000000000004 111.222 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.13 16.49 18.64 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.277 -0.729 . . . . 4.7699999999999996 111.277 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -134.26 154.87 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 4.7999999999999998 111.212 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.5 t -100.96 146.92 26.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 4.8300000000000001 111.225 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -112.73 -20.61 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 4.8700000000000001 111.205 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.7 tp -125.58 114.57 18.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 4.9000000000000004 111.17 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.402 ' SD ' ' OG1' ' A' ' 222' ' ' THR . 97.9 mtp -145.0 110.08 5.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 4.9299999999999997 111.22 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -101.21 -179.97 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 4.9699999999999998 111.186 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.649 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . 61.0 t-20 -96.06 105.26 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 5.0 111.216 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 151' ' ' LEU . 3.2 mm? -89.21 9.38 25.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 5.0300000000000002 111.209 -173.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -110.64 -9.98 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 5.0700000000000003 111.234 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -144.6 113.28 5.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 5.0999999999999996 111.193 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.12 -33.56 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.719 1.613 . . . . 5.1299999999999999 111.221 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -55.24 -33.03 62.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 5.1699999999999999 111.197 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.649 ' HB2' ' HB3' ' A' ' 150' ' ' ASN . 77.9 m-85 -104.99 25.57 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 5.2000000000000002 111.22 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.8 p -121.97 -14.38 8.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 5.2300000000000004 111.141 166.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.593 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 88.7 t90 -66.12 -40.1 34.04 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 5.2699999999999996 111.192 176.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 74.4 Cg_exo -55.45 -19.54 23.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.758 1.639 . . . . 5.2999999999999998 111.201 -178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 51.4 tp -42.77 -51.54 5.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 5.3300000000000001 111.223 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 47.7 pt -86.19 -9.99 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 5.3700000000000001 111.169 -173.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.94 -25.78 23.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 5.4000000000000004 111.173 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.95 98.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 5.4299999999999997 111.225 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -95.69 9.83 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 5.4699999999999998 111.216 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.21 29.6 73.34 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.177 -0.769 . . . . 5.5 111.177 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.89 -37.89 28.41 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.208 -0.757 . . . . 5.5300000000000002 111.208 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -71.79 131.64 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 5.5700000000000003 111.179 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 55.02 55.29 7.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 5.5999999999999996 111.202 168.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -127.38 162.45 26.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.428 . . . . 5.6299999999999999 111.223 165.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -125.33 147.55 49.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 5.6699999999999999 111.237 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -164.82 136.66 4.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 5.7000000000000002 111.191 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -149.88 90.05 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 5.7300000000000004 111.165 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 53.87 40.37 31.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 5.7699999999999996 111.15 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.61 -26.04 22.54 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.153 -0.779 . . . . 5.7999999999999998 111.153 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.03 -180.0 7.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 5.8300000000000001 111.208 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -123.54 103.35 8.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 5.8700000000000001 111.237 177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -99.83 114.09 27.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 5.9000000000000004 111.169 -175.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.39 -18.62 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 5.9299999999999997 111.2 -173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.66 -21.52 65.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 5.9699999999999998 111.217 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.3 141.76 58.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 6.0 111.161 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.85 173.45 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 6.0300000000000002 111.177 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -83.8 9.0 63.87 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.242 -0.743 . . . . 6.0700000000000003 111.242 -168.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.28 -2.46 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.798 0.332 . . . . 6.0999999999999996 111.187 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -131.33 10.03 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 6.1299999999999999 111.199 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.08 139.46 36.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 6.1699999999999999 111.164 174.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.13 -32.66 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 6.2000000000000002 111.179 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.64 93.54 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.761 . . . . 6.2300000000000004 111.199 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.23 92.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 6.2699999999999996 111.247 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.1 -47.3 62.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 6.2999999999999998 111.22 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.29 -39.27 92.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 6.3300000000000001 111.239 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.93 -46.73 88.46 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.245 -0.742 . . . . 6.3700000000000001 111.245 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.17 -43.46 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 6.4000000000000004 111.197 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -50.95 -29.29 11.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 6.4299999999999997 111.172 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -53.29 -60.62 3.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 6.4699999999999998 111.17 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.9 mt -78.48 -25.36 45.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 6.5 111.234 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.59 -47.37 85.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 6.5300000000000002 111.243 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -75.01 -35.44 61.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 6.5700000000000003 111.222 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.483 ' HB3' ' HG2' ' A' ' 204' ' ' MET . 5.1 mp -75.76 -18.97 59.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 6.5999999999999996 111.197 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 93.8 mt -91.71 -40.6 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 6.6299999999999999 111.213 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.78 -38.09 77.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 6.6699999999999999 111.22 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.96 13.57 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.48 . . . . 6.7000000000000002 111.146 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 56.94 46.19 19.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 6.7300000000000004 111.193 172.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -94.98 -49.91 5.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 6.7699999999999996 111.26 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.483 ' HG2' ' HB3' ' A' ' 198' ' ' LEU . 97.5 mmm -74.31 144.99 44.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 6.7999999999999998 111.224 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -86.56 114.57 23.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 6.8300000000000001 111.164 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.58 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 6.8700000000000001 111.22 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.28 -30.3 64.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 6.9000000000000004 111.175 -176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.5 m -64.97 128.96 37.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 6.9299999999999997 111.262 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -123.06 -166.76 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 6.9699999999999998 111.189 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -69.92 -48.81 57.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 7.0 111.122 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -67.49 -29.84 69.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 7.0300000000000002 111.21 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.7 mt -66.96 -44.94 88.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 7.0700000000000003 111.194 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.36 93.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 7.0999999999999996 111.141 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.92 -40.04 40.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 7.1299999999999999 111.138 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.0 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 7.1699999999999999 111.208 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -74.04 -9.12 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 7.2000000000000002 111.214 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -75.53 -25.02 56.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 7.2300000000000004 111.205 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -89.39 -24.04 22.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 7.2699999999999996 111.171 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.01 -25.42 32.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 7.2999999999999998 111.148 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.26 29.13 28.62 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 111.277 -0.729 . . . . 7.3300000000000001 111.277 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.55 -19.13 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 7.3700000000000001 111.233 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.402 ' OG1' ' SD ' ' A' ' 148' ' ' MET . 96.9 m -119.59 127.59 53.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 7.4000000000000004 111.142 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 139' ' ' LEU . . . -93.51 -31.22 14.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 7.4299999999999997 111.135 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 17.2 ptp -157.46 159.68 37.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 7.4699999999999998 111.183 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.0 t -160.39 -173.17 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 7.5 111.181 170.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -105.62 122.27 58.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 7.5300000000000002 111.207 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 9.5 t-20 -166.79 -178.99 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 7.5700000000000003 111.279 -176.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.52 -165.23 41.07 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.22 -0.752 . . . . 7.5999999999999996 111.22 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.44 79.61 2.73 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.669 1.579 . . . . 7.6299999999999999 111.153 -174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -175.02 -22.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.428 . . . . 7.6699999999999999 111.231 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -68.75 -47.52 66.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 7.7000000000000002 111.177 -172.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -86.33 2.17 48.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 7.7300000000000004 111.156 -170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 53.3 p -84.51 -9.44 58.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 7.7699999999999996 111.188 171.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -94.85 -7.16 41.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 7.7999999999999998 111.213 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.89 -24.31 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 7.8300000000000001 111.191 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -30.9 29.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 7.8700000000000001 111.189 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.4 m -62.29 -40.12 95.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 7.9000000000000004 111.205 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 49.5 m -71.35 -24.73 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 7.9299999999999997 111.226 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 63.12 54.47 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 7.9699999999999998 111.188 174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.66 167.47 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 8.0 111.196 175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -81.09 126.41 31.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 8.0299999999999994 111.266 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.434 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 53.4 p90 -145.85 164.44 31.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 8.0700000000000003 111.193 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.41 -179.38 30.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.148 -0.781 . . . . 8.0999999999999996 111.148 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.61 140.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 8.1300000000000008 111.158 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.7 t -138.18 -174.84 3.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 8.1699999999999999 111.258 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.26 159.16 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 8.1999999999999993 111.13 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 247' ' ' LEU . 2.4 pt? -139.93 50.01 2.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 8.2300000000000004 111.197 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 74.0 Cg_endo -73.13 149.97 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.714 1.609 . . . . 8.2699999999999996 111.184 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.9 m -148.66 117.76 6.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 8.3000000000000007 111.254 168.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -105.46 85.24 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 8.3300000000000001 111.152 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 86.5 mttt 57.02 35.35 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 8.3699999999999992 111.206 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.34 -14.05 28.07 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.261 -0.736 . . . . 8.4000000000000004 111.261 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -117.92 109.98 40.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 8.4299999999999997 111.217 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.17 139.01 41.13 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.66 1.573 . . . . 8.4700000000000006 111.253 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 39.9 t -139.99 -75.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 8.5 111.29 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.474 ' HB3' ' HA2' ' A' ' 327' ' ' GLY . 70.1 mmtt -144.41 146.21 31.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 8.5299999999999994 111.201 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.28 165.97 30.6 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.742 1.628 . . . . 8.5700000000000003 111.223 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.16 139.21 44.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 8.5999999999999996 111.229 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.94 115.28 45.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 8.6300000000000008 111.213 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -80.68 151.38 32.28 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.2 -0.76 . . . . 8.6699999999999999 111.2 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.65 133.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 8.6999999999999993 111.148 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 50.0 tp -102.53 134.3 46.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 8.7300000000000004 111.141 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 98.6 p -132.99 173.78 11.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 8.7699999999999996 111.219 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.31 40.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 8.8000000000000007 111.211 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -157.74 -173.05 25.66 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.224 -0.751 . . . . 8.8300000000000001 111.224 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.8 mt -102.41 127.34 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 8.8699999999999992 111.187 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -60.15 135.66 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 8.9000000000000004 111.211 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.27 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 8.9299999999999997 111.206 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -99.42 19.54 15.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 8.9700000000000006 111.267 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 16.5 t -69.78 121.55 82.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 9.0 111.207 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.8 -26.47 19.09 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.648 1.565 . . . . 9.0299999999999994 111.162 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -119.62 62.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 9.0700000000000003 111.219 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -65.08 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 9.0999999999999996 111.177 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -61.51 -49.2 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 9.1300000000000008 111.219 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.44 ' HB2' HD21 ' A' ' 7' ' ' LEU . 99.5 mt -68.52 -34.75 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 9.1699999999999999 111.228 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.54 99.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 9.1999999999999993 111.237 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -47.94 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 9.2300000000000004 111.183 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.95 -40.1 95.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.259 -0.428 . . . . 9.2699999999999996 111.163 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -59.8 -52.04 67.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 9.3000000000000007 111.138 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.08 -44.58 94.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 9.3300000000000001 111.191 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -87.57 -35.12 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 9.3699999999999992 111.18 -167.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -93.9 -23.2 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 9.4000000000000004 111.172 -170.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -122.66 -66.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 9.4299999999999997 111.224 -171.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 67.3 tp -50.41 -56.03 13.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 9.4700000000000006 111.192 -167.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.9 mt -104.0 38.35 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 9.5 111.192 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.5 p -119.14 -165.73 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 9.5299999999999994 111.259 167.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.84 -10.87 60.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 9.5700000000000003 111.174 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -88.11 -54.41 4.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 9.5999999999999996 111.209 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.33 6.38 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.171 -0.772 . . . . 9.6300000000000008 111.171 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.13 -34.67 76.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 9.6699999999999999 111.189 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.55 -41.27 80.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 9.6999999999999993 111.216 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.89 -25.32 67.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 9.7300000000000004 111.263 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.5 t -86.28 -40.3 14.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 9.7699999999999996 111.152 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.99 -23.62 63.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 9.8000000000000007 111.246 -172.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.71 -14.83 62.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 9.8300000000000001 111.175 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -111.16 -34.61 6.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 9.8699999999999992 111.164 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.98 162.67 20.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 9.9000000000000004 111.225 -174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.17 159.53 15.14 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.711 1.607 . . . . 9.9299999999999997 111.16 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.441 ' HB3' ' HG ' ' A' ' 311' ' ' LEU . 94.7 mt -99.75 39.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 9.9700000000000006 111.241 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -55.06 -61.26 7.57 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 111.198 -0.761 . . . . 10.0 111.198 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.18 153.98 2.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 10.029999999999999 111.19 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.06 159.55 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 10.07 111.153 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.448 ' HA ' ' CE2' ' A' ' 90' ' ' TYR . . . -83.84 -30.2 26.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 10.1 111.174 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -67.03 121.61 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 10.130000000000001 111.16 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -68.31 -17.49 64.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.194 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 t -58.33 -40.36 81.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 10.199999999999999 111.223 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -108.65 7.29 26.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 10.23 111.209 -176.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -57.7 -50.0 74.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 10.27 111.199 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.58 -29.97 61.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 10.300000000000001 111.18 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.61 -37.06 84.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 10.33 111.219 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' A' ' 299' ' ' LEU . 9.8 mp -82.73 -37.51 24.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 10.369999999999999 111.196 175.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -77.99 -4.65 48.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 10.4 111.196 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.13 -41.58 49.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 10.43 111.151 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -88.27 120.71 70.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.17 -0.468 . . . . 10.470000000000001 111.168 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.13 -29.72 47.02 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.703 1.602 . . . . 10.5 111.255 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.22 -23.14 67.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 10.529999999999999 111.175 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.3 mt -98.65 -39.42 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 10.57 111.202 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.49 -34.23 70.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 10.6 111.19 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.68 62.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 10.630000000000001 111.202 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 94.4 m -95.23 -42.33 8.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 10.67 111.243 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 90.7 mtp -65.01 -41.94 94.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 10.699999999999999 111.18 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -61.77 -45.92 91.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 10.73 111.183 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -76.97 -16.94 59.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 10.77 111.237 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.25 -46.54 49.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 10.800000000000001 111.228 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -80.34 -19.93 45.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 10.83 111.235 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.43 -4.14 32.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 10.869999999999999 111.086 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 256' ' ' LYS . . . -87.83 -170.06 45.85 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.212 -0.755 . . . . 10.9 111.212 -177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -86.41 99.95 11.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 10.93 111.205 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.15 136.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 10.970000000000001 111.203 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 331' ' ' PRO . 53.0 ttm -46.59 124.93 7.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 11.0 111.258 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 330' ' ' MET . 54.3 Cg_exo -60.28 155.58 45.39 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.705 1.603 . . . . 11.029999999999999 111.2 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 54.0 p30 -94.89 15.99 17.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 11.07 111.274 173.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 82.4 mt -80.49 125.04 81.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 11.1 111.253 -169.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.51 -40.36 79.09 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.747 1.631 . . . . 11.130000000000001 111.154 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.26 -38.97 93.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 11.17 111.24 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.0 mmm -75.13 -23.74 57.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 11.199999999999999 111.165 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 41.6 t -62.64 -40.9 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 11.23 111.175 169.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.73 -39.84 84.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 11.27 111.269 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -66.66 -27.38 67.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 11.300000000000001 111.235 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 65' ' ' ASP . 87.4 t90 -54.36 -46.51 73.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 11.33 111.198 -173.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -99.24 -23.0 15.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 11.369999999999999 111.213 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.53 -39.57 91.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 11.4 111.214 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.58 -36.54 66.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 11.43 111.193 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.6 ttp180 -54.72 -45.1 74.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 11.470000000000001 111.208 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 95.6 m -61.66 -40.03 93.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 11.5 111.21 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.22 88.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 11.529999999999999 111.192 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.5 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.457 . . . . 11.57 111.191 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.7 -48.87 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 11.6 111.135 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -69.03 -28.92 67.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 11.630000000000001 111.167 -175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.6 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 11.67 111.218 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.85 77.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 11.699999999999999 111.2 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -74.65 -17.41 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 11.73 111.182 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 84.61 30.76 26.14 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.231 -0.748 . . . . 11.77 111.231 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -99.99 -38.71 8.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.846 0.355 . . . . 11.800000000000001 111.223 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -129.85 168.75 16.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 11.83 111.116 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 33.9 p -92.62 175.04 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 11.869999999999999 111.18 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.1 m -67.2 -14.36 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 11.9 111.19 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.69 -49.3 5.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 11.93 111.188 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.14 -39.34 75.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 11.970000000000001 111.169 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.81 96.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 12.0 111.228 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 91.8 mt -77.84 -24.78 48.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 12.029999999999999 111.158 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.32 90.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 12.07 111.148 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -64.71 -39.63 93.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 12.1 111.169 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.4 80.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 12.130000000000001 111.18 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -71.95 -42.92 66.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 12.17 111.144 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.4 m -60.04 -36.91 78.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 12.199999999999999 111.159 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -80.13 -11.44 59.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 12.23 111.172 -173.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.3 mt -115.01 -66.81 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 12.27 111.211 -175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.9 p -96.1 -20.42 18.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 12.300000000000001 111.213 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--O 1.2 -1.545 0 CA-C-N 116.194 -0.457 . . . . 12.33 111.225 175.444 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.821 0.343 . . . . 0.029999999999999999 111.156 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.8 mm -88.26 110.18 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.070000000000000007 111.22 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -72.97 129.92 39.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.10000000000000001 111.178 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.2 139.96 58.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.13 111.23 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.58 2.29 57.57 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.206 -0.758 . . . . 0.17000000000000001 111.206 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -128.07 155.03 45.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.816 0.341 . . . . 0.20000000000000001 111.18 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 60.6 tp -104.18 115.05 29.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.23000000000000001 111.167 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.5 t -117.68 121.9 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.27000000000000002 111.196 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -114.21 114.97 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.29999999999999999 111.195 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -102.75 113.05 26.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.33000000000000002 111.249 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.6 tt -125.11 139.94 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.37 111.24 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -88.48 109.9 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.40000000000000002 111.178 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.21 176.4 47.82 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.213 -0.755 . . . . 0.42999999999999999 111.213 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -77.81 -69.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.46999999999999997 111.205 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -129.98 31.4 4.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.5 111.217 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.92 -19.68 69.93 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.239 -0.744 . . . . 0.53000000000000003 111.239 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -60.56 -24.37 65.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 0.56999999999999995 111.211 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -63.12 -49.95 72.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.59999999999999998 111.193 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.95 96.47 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.203 -0.759 . . . . 0.63 111.203 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.72 -31.48 66.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.818 0.342 . . . . 0.67000000000000004 111.22 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.12 91.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.69999999999999996 111.225 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -60.16 -35.02 74.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.72999999999999998 111.196 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 -41.25 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.77000000000000002 111.236 174.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -27.93 69.31 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.14 -0.784 . . . . 0.80000000000000004 111.14 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.45 -33.99 74.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.826 0.346 . . . . 0.82999999999999996 111.206 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.25 -39.05 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.87 111.199 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -61.02 -42.38 98.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.90000000000000002 111.166 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -63.27 -41.59 99.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.93000000000000005 111.21 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.01 -35.96 69.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.96999999999999997 111.216 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.07 -40.12 60.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.178 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.5 p -103.27 -27.21 12.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.226 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.85 4.8 78.54 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.219 -0.753 . . . . 1.0700000000000001 111.219 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.5 mm -87.34 115.0 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.763 0.316 . . . . 1.1000000000000001 111.212 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.03 124.9 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 1.1299999999999999 111.204 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.15 136.01 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 1.1699999999999999 111.248 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.4 t -142.56 147.84 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 1.2 111.171 172.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 p -146.32 132.68 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 1.23 111.217 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -140.02 176.37 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 1.27 111.262 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -119.02 75.25 14.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 1.3 111.149 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.15 158.32 49.27 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.695 1.596 . . . . 1.3300000000000001 111.217 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.8 p30 -123.15 -179.99 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 1.3700000000000001 111.182 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 55.09 34.63 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 1.3999999999999999 111.195 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.9 mt -74.92 -22.97 58.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 1.4299999999999999 111.284 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -70.03 -12.06 61.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.47 111.235 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.28 -36.05 5.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 1.5 111.199 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -71.33 -38.66 71.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 1.53 111.147 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.489 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.4 m-30 -61.39 -56.28 35.14 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 1.5700000000000001 111.206 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 42.0 Cg_endo -66.95 -23.63 46.76 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.81 1.674 . . . . 1.6000000000000001 111.204 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -70.07 -45.22 67.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 111.196 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.51 -19.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 1.6699999999999999 111.192 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.0 -25.76 68.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.7 111.207 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.11 60.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 1.73 111.216 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p -109.7 -15.21 14.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 1.77 111.175 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.44 23.6 28.49 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.13 -0.788 . . . . 1.8 111.13 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -111.13 170.08 8.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 1.8300000000000001 111.208 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.92 179.03 21.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.233 -0.747 . . . . 1.8700000000000001 111.233 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 -174.74 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.642 1.561 . . . . 1.8999999999999999 111.267 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.25 -51.39 4.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 1.9299999999999999 111.244 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.94 134.22 57.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 1.97 111.245 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.3 mt -129.77 127.07 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 2.0 111.236 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -98.75 127.64 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 2.0299999999999998 111.204 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -130.0 142.36 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 2.0699999999999998 111.118 169.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.06 145.0 56.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 2.1000000000000001 111.218 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -46.61 -36.15 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 2.1299999999999999 111.258 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -81.66 -5.26 57.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 2.1699999999999999 111.211 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.3 mmt-85 -132.64 -0.05 3.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 2.2000000000000002 111.206 174.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -65.02 -56.56 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 2.23 111.194 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.0 -33.52 74.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.185 -0.766 . . . . 2.27 111.185 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.34 -44.81 94.94 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.226 -0.749 . . . . 2.2999999999999998 111.226 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.01 -40.43 75.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 2.3300000000000001 111.182 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -25.8 68.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 2.3700000000000001 111.183 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -60.39 -29.9 69.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 2.3999999999999999 111.205 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -68.12 -25.4 65.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 2.4300000000000002 111.193 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.37 32.38 22.72 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.19 -0.764 . . . . 2.4700000000000002 111.19 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -104.4 4.82 33.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 2.5 111.191 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.77 140.04 44.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 2.5299999999999998 111.191 174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.71 154.51 20.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 2.5699999999999998 111.211 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.402 ' HA ' HG22 ' A' ' 104' ' ' ILE . 88.6 tt0 -74.82 134.74 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 2.6000000000000001 111.205 175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.5 mt -131.05 130.02 63.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 2.6299999999999999 111.184 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 95.2 m -116.83 113.34 40.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 2.6699999999999999 111.253 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.52 156.7 49.62 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.637 1.558 . . . . 2.7000000000000002 111.186 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.21 155.65 34.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 2.73 111.214 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.15 -53.83 52.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 2.77 111.205 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.41 84.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.7999999999999998 111.163 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -54.87 -51.94 64.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 2.8300000000000001 111.214 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -55.9 -42.72 76.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 2.8700000000000001 111.167 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -64.6 -29.68 70.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 2.8999999999999999 111.199 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.26 -17.93 58.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 2.9300000000000002 111.205 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.409 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 97.5 mt -83.41 153.5 24.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 2.9700000000000002 111.191 172.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -65.35 148.73 97.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 3.0 111.199 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.96 -15.0 18.93 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.699 1.599 . . . . 3.0299999999999998 111.252 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -96.55 -21.01 17.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 3.0699999999999998 111.154 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.5 p -78.43 -14.83 59.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 3.1000000000000001 111.191 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.419 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 49.8 m0 -63.05 -45.49 92.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.476 . . . . 3.1299999999999999 111.254 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.4 -11.82 60.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 3.1699999999999999 111.15 -170.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.54 -1.98 57.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 3.2000000000000002 111.237 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.55 10.3 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 3.23 111.228 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 94' ' ' TRP . 71.6 mtp180 -87.63 144.75 26.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 3.27 111.196 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 94.4 t80 -142.25 123.61 14.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 3.2999999999999998 111.161 171.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 99' ' ' TYR . 97.5 m-20 65.0 20.75 12.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 3.3300000000000001 111.222 -169.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.56 -2.71 74.08 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.245 -0.742 . . . . 3.3700000000000001 111.245 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -115.44 144.24 44.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.763 0.316 . . . . 3.3999999999999999 111.229 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.8 mt -70.95 126.14 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 3.4300000000000002 111.214 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 78' ' ' GLU . 28.7 pt -130.12 14.96 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 3.4700000000000002 111.281 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.8 169.43 5.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 3.5 111.187 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -119.47 145.96 40.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 3.5299999999999998 111.183 170.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.94 -178.17 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.69 1.593 . . . . 3.5699999999999998 111.203 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.86 -21.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 3.6000000000000001 111.153 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.51 155.12 8.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 3.6299999999999999 111.184 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -105.61 157.91 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.6699999999999999 111.168 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -87.48 179.98 6.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 3.7000000000000002 111.198 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.81 143.33 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 3.73 111.174 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.754 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.9 pp -160.03 144.37 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 3.77 111.219 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.2 t -169.96 -171.88 1.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 3.7999999999999998 111.171 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.1 tp -71.55 112.49 7.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 3.8300000000000001 111.229 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.75 125.92 71.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 3.8700000000000001 111.135 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -125.11 146.75 49.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 3.8999999999999999 111.217 -168.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -79.96 123.72 28.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 3.9300000000000002 111.237 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.53 -14.21 62.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 3.9700000000000002 111.171 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -89.98 -29.84 18.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 4.0 111.233 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 98.1 mt -98.55 -51.22 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 4.0300000000000002 111.164 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 46.6 tp -141.35 79.65 17.33 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 4.0700000000000003 111.191 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.25 -14.98 28.59 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.694 1.596 . . . . 4.0999999999999996 111.235 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -105.04 99.97 22.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 4.1299999999999999 111.21 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.43 156.98 45.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.657 1.571 . . . . 4.1699999999999999 111.255 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.19 167.18 28.0 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.686 1.59 . . . . 4.2000000000000002 111.239 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.42 -21.37 38.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 4.2300000000000004 111.206 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.2 t -161.54 172.02 17.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 4.2699999999999996 111.186 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -77.02 -12.02 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 4.2999999999999998 111.19 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.06 -8.75 57.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 4.3300000000000001 111.242 175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.48 -4.28 31.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 4.3700000000000001 111.26 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.542 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 82.8 mt -69.69 -43.81 22.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 4.4000000000000004 111.158 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 55.4 Cg_exo -53.77 -40.15 81.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.71 1.607 . . . . 4.4299999999999997 111.171 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.8 90.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.4699999999999998 111.184 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.0 mt -64.99 -32.68 74.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 4.5 111.255 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -64.8 -39.76 94.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 4.5300000000000002 111.194 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.65 -31.57 70.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 4.5700000000000003 111.178 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.32 -32.83 55.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 4.5999999999999996 111.191 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.35 -5.09 57.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 4.6299999999999999 111.209 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -57.03 -39.99 75.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 4.6699999999999999 111.224 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.76 -29.31 70.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 4.7000000000000002 111.206 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.02 -18.74 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 4.7300000000000004 111.199 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 23.71 38.98 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.151 -0.779 . . . . 4.7699999999999996 111.151 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -100.08 149.32 23.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 4.7999999999999998 111.197 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -96.35 146.53 24.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 4.8300000000000001 111.191 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -100.24 5.54 44.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.435 . . . . 4.8700000000000001 111.178 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.0 tp -160.34 130.03 5.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 4.9000000000000004 111.2 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 91.4 mmm -135.02 154.93 51.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 4.9299999999999997 111.237 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.84 165.05 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 4.9699999999999998 111.211 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 58.1 t-20 -73.9 89.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 5.0 111.159 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.16 -38.92 82.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 5.0300000000000002 111.272 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -53.36 -53.81 45.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 5.0700000000000003 111.222 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 155' ' ' TYR . 43.0 tp10 -79.05 122.46 84.47 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 5.0999999999999996 111.194 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.86 -20.18 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.653 1.569 . . . . 5.1299999999999999 111.195 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.473 ' H ' ' HG3' ' A' ' 153' ' ' GLU . 82.6 t80 -59.44 -22.63 61.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 5.1699999999999999 111.203 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -113.95 29.66 7.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 5.2000000000000002 111.247 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 61.8 p -120.36 -22.93 6.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 5.2300000000000004 111.167 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.74 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 56.5 p-90 -84.57 -23.11 0.32 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 5.2699999999999996 111.213 -173.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.74 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 59.1 Cg_exo -49.1 -40.72 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.679 1.586 . . . . 5.2999999999999998 111.169 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.02 -34.98 79.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 5.3300000000000001 111.151 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.36 -32.2 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 5.3700000000000001 111.215 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.11 73.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 5.4000000000000004 111.17 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.66 -28.33 69.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 5.4299999999999997 111.205 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -89.11 -28.75 19.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 5.4699999999999998 111.22 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 101.74 41.88 2.41 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.202 -0.759 . . . . 5.5 111.202 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -107.84 -14.58 16.96 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.189 -0.764 . . . . 5.5300000000000002 111.189 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -105.26 99.04 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.735 0.302 . . . . 5.5700000000000003 111.179 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 59.81 47.57 10.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 5.5999999999999996 111.115 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -126.06 139.99 52.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 5.6299999999999999 111.188 171.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -106.17 134.36 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 5.6699999999999999 111.155 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -87.34 79.92 8.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 5.7000000000000002 111.173 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 173' ' ' ASN . 82.8 tt0 -137.98 66.02 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 5.7300000000000004 111.217 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 172' ' ' GLU . 77.0 m-20 73.38 -72.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 5.7699999999999996 111.154 173.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -147.34 13.82 1.43 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.167 -0.773 . . . . 5.7999999999999998 111.167 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.08 114.31 28.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.888 0.375 . . . . 5.8300000000000001 111.225 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -118.39 77.06 1.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 5.8700000000000001 111.241 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -65.03 127.32 31.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 5.9000000000000004 111.163 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.46 -12.93 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 5.9299999999999997 111.155 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -74.6 -22.07 59.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 5.9699999999999998 111.165 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -95.62 103.27 15.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 6.0 111.182 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.14 133.84 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 6.0300000000000002 111.194 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.73 39.27 3.1 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.279 -0.728 . . . . 6.0700000000000003 111.279 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.56 -20.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 6.0999999999999996 111.164 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -111.33 14.26 21.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 6.1299999999999999 111.173 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -76.85 150.64 36.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 6.1699999999999999 111.254 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.94 83.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 6.2000000000000002 111.217 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.47 -28.94 72.02 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.174 -0.77 . . . . 6.2300000000000004 111.174 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.9 76.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 6.2699999999999996 111.174 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -79.3 -36.48 39.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 6.2999999999999998 111.206 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.87 74.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 6.3300000000000001 111.184 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.22 -38.69 94.04 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.175 -0.77 . . . . 6.3700000000000001 111.175 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.5 tp -69.21 -35.3 76.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 6.4000000000000004 111.163 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 71.0 m -58.97 -39.36 81.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 6.4299999999999997 111.247 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.25 -43.46 97.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 6.4699999999999998 111.229 176.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.43 -46.24 90.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 6.5 111.185 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.61 -26.98 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 6.5300000000000002 111.16 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -73.3 -36.8 66.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.261 -0.427 . . . . 6.5700000000000003 111.194 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.93 -34.67 78.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 6.5999999999999996 111.202 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.99 -44.87 20.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 6.6299999999999999 111.169 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.74 -37.71 82.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 6.6699999999999999 111.213 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -86.72 4.97 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 6.7000000000000002 111.188 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 59.83 40.73 19.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 6.7300000000000004 111.135 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -98.86 -30.63 12.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 6.7699999999999996 111.238 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 96.6 mmm -120.07 141.53 49.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 6.7999999999999998 111.211 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.04 147.2 28.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 6.8300000000000001 111.138 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.55 -30.25 68.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 6.8700000000000001 111.176 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -85.11 -9.63 57.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 6.9000000000000004 111.244 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.7 m -57.04 128.73 38.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 6.9299999999999997 111.209 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 43.6 p30 -140.03 -165.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 6.9699999999999998 111.195 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -61.22 -47.35 86.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 7.0 111.212 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 83.7 p -70.09 -27.66 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 7.0300000000000002 111.176 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 37.7 mm -65.16 -45.89 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 7.0700000000000003 111.233 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.7 98.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 7.0999999999999996 111.163 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -67.92 -37.09 81.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 7.1299999999999999 111.161 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.81 82.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 7.1699999999999999 111.219 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.16 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 7.2000000000000002 111.276 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -69.79 -25.95 64.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 7.2300000000000004 111.253 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -73.07 -14.68 61.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 7.2699999999999996 111.191 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -111.51 -17.66 13.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 7.2999999999999998 111.18 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.95 27.75 33.37 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.206 -0.758 . . . . 7.3300000000000001 111.206 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -93.61 2.53 56.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 7.3700000000000001 111.2 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 85.8 m -128.34 124.29 36.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 7.4000000000000004 111.203 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.61 -37.12 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 7.4299999999999997 111.164 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -156.54 165.01 37.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 7.4699999999999998 111.207 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.0 t -146.56 178.96 7.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 7.5 111.221 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.6 tt -122.26 112.95 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 7.5300000000000002 111.147 174.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -169.98 -178.62 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 7.5700000000000003 111.224 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -108.16 -165.7 21.28 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.222 -0.751 . . . . 7.5999999999999996 111.222 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -61.9 -18.9 63.67 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.745 1.63 . . . . 7.6299999999999999 111.214 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 7.6699999999999999 111.171 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.77 -25.7 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 7.7000000000000002 111.203 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.415 ' HA ' HD12 ' A' ' 235' ' ' ILE . 51.9 t90 -80.02 -10.02 59.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 7.7300000000000004 111.202 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -64.99 -31.12 72.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 7.7699999999999996 111.204 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -84.79 -29.97 24.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 7.7999999999999998 111.218 175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 232' ' ' TRP . 88.8 mt -66.59 -38.59 81.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 7.8300000000000001 111.193 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.3 -40.97 86.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 7.8700000000000001 111.148 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 93.8 m -65.05 -40.89 95.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 7.9000000000000004 111.255 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.8 p -77.92 -13.41 59.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 7.9299999999999997 111.231 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 60.02 50.15 6.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 7.9699999999999998 111.171 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.82 140.27 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 8.0 111.234 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -77.88 92.0 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 8.0299999999999994 111.244 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -101.08 140.84 34.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 8.0700000000000003 111.225 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -111.01 -179.64 20.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.159 -0.776 . . . . 8.0999999999999996 111.159 171.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 141.83 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.87 0.367 . . . . 8.1300000000000008 111.172 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.2 t -123.06 -171.54 2.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 8.1699999999999999 111.207 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -122.09 109.92 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 8.1999999999999993 111.247 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.555 ' N ' ' CD ' ' A' ' 248' ' ' PRO . 88.2 mt -83.05 -40.54 0.82 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 8.2300000000000004 111.19 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 247' ' ' LEU . 85.7 Cg_exo -52.76 110.28 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.723 1.616 . . . . 8.2699999999999996 111.197 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 89.2 m -139.89 130.0 25.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 8.3000000000000007 111.167 -175.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -117.23 108.83 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 8.3300000000000001 111.263 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 58.08 35.59 25.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 8.3699999999999992 111.185 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.11 -8.56 69.97 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.158 -0.777 . . . . 8.4000000000000004 111.158 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -104.28 109.98 63.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.766 0.317 . . . . 8.4299999999999997 111.197 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.86 148.46 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.746 1.63 . . . . 8.4700000000000006 111.128 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.7 p -135.03 -105.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 8.5 111.184 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 48.8 tptt -159.52 133.58 5.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 8.5299999999999994 111.182 -170.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 77.2 Cg_exo -55.02 144.0 70.65 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.693 1.595 . . . . 8.5700000000000003 111.155 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -69.54 131.04 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 8.5999999999999996 111.249 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.05 -178.93 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 8.6300000000000008 111.152 -171.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -128.23 -160.52 10.41 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.174 -0.77 . . . . 8.6699999999999999 111.174 170.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.56 169.63 21.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 8.6999999999999993 111.209 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 67.9 tp -96.86 119.92 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 8.7300000000000004 111.191 165.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.5 m -103.2 113.61 27.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 8.7699999999999996 111.2 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -100.28 115.44 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 8.8000000000000007 111.176 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -115.24 178.19 17.66 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.21 -0.756 . . . . 8.8300000000000001 111.21 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 99.1 mt -111.92 130.65 65.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.798 0.332 . . . . 8.8699999999999992 111.267 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.29 126.06 26.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 8.9000000000000004 111.203 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.82 -18.51 64.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 8.9299999999999997 111.126 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -94.35 -5.03 47.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 8.9700000000000006 111.132 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.6 t -65.32 132.63 95.27 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 9.0 111.185 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.6 -10.21 17.2 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.734 1.623 . . . . 9.0299999999999994 111.204 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -121.4 60.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 9.0700000000000003 111.2 -175.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.55 -29.03 52.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 9.0999999999999996 111.156 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.84 -40.03 76.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 9.1300000000000008 111.167 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.76 -35.6 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 9.1699999999999999 111.127 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.05 90.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 9.1999999999999993 111.146 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.49 -43.58 84.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 9.2300000000000004 111.246 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -56.48 -53.88 52.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 9.2699999999999996 111.214 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -54.73 -57.24 12.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 9.3000000000000007 111.163 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.1 -52.62 64.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 9.3300000000000001 111.232 -174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -79.41 -45.12 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 9.3699999999999992 111.174 -165.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -98.94 -11.8 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 9.4000000000000004 111.217 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -125.0 -65.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 9.4299999999999997 111.21 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 69.8 tp -59.62 -49.12 78.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 9.4700000000000006 111.229 -169.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 72.6 mt -97.78 40.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 9.5 111.195 -171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 38.0 p -105.07 176.58 5.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.24 -0.436 . . . . 9.5299999999999994 111.234 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.76 -30.33 70.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 9.5700000000000003 111.192 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -87.05 -40.08 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 9.5999999999999996 111.171 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -61.85 -46.98 93.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.245 -0.742 . . . . 9.6300000000000008 111.245 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.71 -21.97 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 9.6699999999999999 111.225 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -69.91 -39.36 76.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 9.6999999999999993 111.256 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.43 -29.55 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 9.7300000000000004 111.219 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 73.7 t -73.27 -42.85 57.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 9.7699999999999996 111.174 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -85.32 5.18 31.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 9.8000000000000007 111.255 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -54.25 -40.01 67.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 9.8300000000000001 111.208 167.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -106.88 -32.76 7.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 9.8699999999999992 111.163 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -89.93 160.04 41.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 9.9000000000000004 111.198 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.62 140.17 75.99 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 121.646 1.564 . . . . 9.9299999999999997 111.174 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.69 -17.74 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 9.9700000000000006 111.18 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.84 68.47 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.27 101.79 4.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 10.029999999999999 111.253 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.58 129.91 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 10.07 111.258 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -114.47 -10.62 12.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 10.1 111.258 165.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 42.4 tp -88.61 117.18 27.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 10.130000000000001 111.204 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.04 -42.11 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 10.17 111.166 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 96.3 p -64.89 -30.01 70.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 10.199999999999999 111.179 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -72.16 -42.23 66.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 10.23 111.201 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -63.72 -30.02 71.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 10.27 111.205 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.15 -28.66 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 10.300000000000001 111.245 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -79.85 -32.06 40.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 10.33 111.172 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.25 -29.2 69.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 10.369999999999999 111.219 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.63 -18.61 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 10.4 111.173 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.97 -31.64 69.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 10.43 111.242 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 317' ' ' ILE . 10.1 t70 -70.0 121.53 83.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 10.470000000000001 111.231 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.96 -34.9 88.23 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 121.688 1.592 . . . . 10.5 111.181 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.53 -53.5 4.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 10.529999999999999 111.23 -174.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 314' ' ' ASP . 94.9 mt -64.45 -30.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 10.57 111.292 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.02 62.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 10.6 111.105 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.97 -38.35 90.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.421 . . . . 10.630000000000001 111.235 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.0 m -70.27 -40.06 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 10.67 111.161 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.9 mmt -70.55 -31.36 68.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 10.699999999999999 111.149 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -55.58 -45.93 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 10.73 111.195 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -75.93 -31.99 59.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 10.77 111.213 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.96 71.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 10.800000000000001 111.225 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.09 -25.43 67.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 10.83 111.173 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.06 -24.71 40.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 10.869999999999999 111.162 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -74.88 158.06 50.91 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.205 -0.758 . . . . 10.9 111.205 -177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -127.11 163.66 23.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.764 0.316 . . . . 10.93 111.259 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 48.7 mm -110.4 133.29 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 10.970000000000001 111.178 -169.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 55.6 ttm -64.89 122.38 79.01 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 11.0 111.244 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.15 150.52 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.754 1.636 . . . . 11.029999999999999 111.166 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -113.57 -25.22 8.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 11.07 111.23 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 97.6 mt -40.07 130.01 1.61 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 11.1 111.138 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.98 -37.72 68.09 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.708 1.605 . . . . 11.130000000000001 111.186 -172.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -62.05 -39.51 92.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 11.17 111.21 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 99.7 mmm -75.09 -34.23 61.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 11.199999999999999 111.135 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 49.2 m -69.67 -33.35 72.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 11.23 111.194 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.95 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 11.27 111.179 172.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -65.57 -35.92 82.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 11.300000000000001 111.16 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.488 ' HE3' ' HA ' ' A' ' 340' ' ' TRP . 4.2 m95 -70.01 -38.41 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 11.33 111.233 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -60.7 -40.29 91.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 11.369999999999999 111.176 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.41 73.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 11.4 111.175 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.84 -29.7 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 11.43 111.174 -174.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -69.94 -38.76 76.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 11.470000000000001 111.247 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.2 m -69.33 -37.3 77.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 11.5 111.208 173.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.32 94.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 11.529999999999999 111.172 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.57 -24.73 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 11.57 111.223 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.04 -45.97 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 11.6 111.177 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -66.23 -36.55 83.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 11.630000000000001 111.164 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.06 -43.75 61.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.452 . . . . 11.67 111.186 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -64.98 -34.82 79.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 11.699999999999999 111.226 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 87.3 p -71.37 -15.02 62.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 11.73 111.231 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 92.19 25.69 20.96 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 111.24 -0.744 . . . . 11.77 111.24 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.03 -39.9 7.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 11.800000000000001 111.186 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -113.86 172.5 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 11.83 111.249 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.6 p -99.94 165.68 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 11.869999999999999 111.199 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.85 -16.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 11.9 111.227 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.85 -51.11 4.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 11.93 111.236 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -70.3 -31.42 68.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 11.970000000000001 111.129 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.79 -40.35 95.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 12.0 111.192 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.61 -30.83 61.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 12.029999999999999 111.125 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.42 -45.54 83.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 12.07 111.218 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.08 -41.92 99.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 12.1 111.197 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.79 -45.22 75.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 12.130000000000001 111.198 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -56.68 -36.58 69.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 12.17 111.224 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 82.3 m -47.86 -35.09 9.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 12.199999999999999 111.172 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -104.29 -34.99 8.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 12.23 111.161 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.13 -48.72 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 12.27 111.166 -174.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.4 p -112.92 -29.78 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 12.300000000000001 111.268 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.2 -1.501 0 CA-C-N 116.163 -0.471 . . . . 12.33 111.259 178.846 . . . . . . . . 0 0 . 1 stop_ save_